lkkj&laxzg - national pharmaceutical pricing authority · 2020. 4. 15. · iii,e&(m) 1...

314

Upload: others

Post on 23-Jan-2021

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;
Page 2: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;
Page 3: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

Lkkj&laxzg¼dEisufM;e½

vkS"k/k ¼ewY; fu;a=k.k½ vkns’k] 1995 ds v/khuvuqlwfpr iziqat vkS"k/kksa ¼cYd MªXl½

vkSjvuqlwfpr fofufeZfr ¼QkWjeqys’ku½ iSdks dh dhersa

¼15 Qjojh] 2008 rd ;Fkk la’kksf/kr½

jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.kjlk;u ,oa iSVªksjlk;u foHkkxjlk;u vkSj moZjd ea=kky;

Hkkjr ljdkj

Page 4: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k¼,u-ih-ih-,-½}kjk izdkf’kr

Qjojh] 2008

Page 5: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

izkDdFku

jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼,uihih,½] nok ¼ewY; fu;a=k.k½ vknss’k]1995 ds v/khu vuqlwfpr cYd&nokvksa vkSj mudh QkWewZys’kuksa ds ewY; fu/kkZfjrvkSj la’kksf/kr djrk gSA o"kZ 2006 esa igyh ckj ,uihih, us jkti=k&vf/klwpukvksa,oa ewY;ksa ds fu/kkZj.k rFkk la’kks/ku ls lEcfU/kr ewY; vkns’kksa ds vk/kkj ij vuqlwfprcYd nokvksa vkSj QkWewZys’kuksa ds ewY;ksa dk lkj&laxzg ¼dEisufM;e½ ladfyr djusdk iz;kl fd;k FkkA gesa izlUurk gS fd mi;ksxdrkZvksa us bls Lohdkj fd;k gSA

lkj&laxzg ds bl prqFkZ laLdj.k dks izLrqr djrs gq, gesa [kq’kh gSA bllaLdj.k esa 15 Qjojh] 2008 rd fu/kkZfjr vkSj la’kksf/kr ewY; lfEefyr fd, x,gSaA bl dEisufM;e esa ;Fkk&vuqikr ¼izks&jkVk½ vk/kkj ij vksjy fyfDoM~l ds ewY;,oa Mhihlhvks] 1995 ds iSjk 10¼ch½ ds rgr fu/kkZfjr ewY; Hkh ’kkfey fd, x, gSaAvkxkeh laLdj.kksa esa lq/kkj ds fy, vkidh izfriqf"V ¼QhM cSd½ ,oa vkids lq>koksadks ikdj ge d‘rK gksaxsA dEisufM;e gekjh osclkbV ij Hkh ,uihih, }kjkle;≤ ij fd, tkus okys ewY;&fu/kkZj.k vkSj la’kks/kuksa ds ckn v|ru ewY;ksads lkFk] miyC/k gSA vr% osclkbV ij dEisufM;e dh lkW¶V&dkWih esa uohureewY; ’kkfey gSaA

gekjs iz;klksa ds ckotwn dqN =kqfV;k¡ gks ldrh gSa( vr,o] ewy jkti=k&vf/klwpukvksa] ewY; vkns’kksa ds izkekf.kd ikB ;k osclkbV www.nppaindia.nic.indk lUnHkZ djuk mi;ksxh gksxkA

gesa vkids lq>koksa ,oa izfriqf"V ¼QhM cSd½ dh izrh{kk gSA

¼v’kksd dqekj½ubZ fnYyh] 15 Qjojh] 2008

Page 6: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

i

Øe fooj.k i‘"B la[;kla[;k

1. izR;k[;ku ¼fMlDysej½ 1

2. izLrkouk 2

Hkkx&1

vaxzsth o.kZekyk Øe esa Mhihlhvks] 1995 ds rgrvf/klwfpr iziqat vkS"k/kksa ds fu/kkZfjr ewY; 3 - 9

Hkkx&2vaxzsth o.kZekyk Øe esa iziqat vkS"kf/k okbt+vf/klwfpr fofufeZfr ds fu/kkZjfr ewY; 10 - 251

,&(A)

1 ,fMªuksØkse eksukslsfedkjckt+ksu vU; vkS"k/k ds lkFk 10

2 ,feuksQkbfyu xksfy;ka 10

3-4 ,eksfM;kDohu xksfy;ka 10

5-9 ,ukyftu xksfy;ka bUtsD’ku vU; vkS"k/k ds lkFk 10

10-45 ,lfizu vkSj vU; vkS"k/k ds lkFk xksfy;ka@dSilwy 11-14

ch&(B)

1-4 fcdsEihflfyu xksfy;ka 15

5-131 fcVkfeFkkt+ksu vkSj vU; vkS"k/k ds lkFk xksfy;ka@bUtsD’ku@Mªksi@ 15-30

vkW;UVesUV@Øhe

lh&(C)

1-5 dSIVksfizy xksfy;ka 31

6-21 dkckZest+kikbu xksfy;ka@flji 31-32

22-73 lsQkMªksDlhy xksfy;ka@dSilwy@flji vkSj vU; vkS"k/k ds lkFk 32-37

74-91 flQkVksDlkbe bUtsD’ku vkSj vU; vkS"k/k ds lkFk bUtsD’ku 37-39

92-99 lsQkt+ksfyu lksfM;e bUtsD’ku 39-40

100 flVªhekbM vU; vkS"k/k ds lkFk 40

101-123 DyksjksDohu xksfy;ka@bUtsD’ku@flji 40-41

124-137 Dyksjizksekt+kbu xksfy;ka@bUtsD’ku@flji vkSj vU; vkS"k/k ds lkFk 41-43

138-184 flizks¶ykWDlkflu xksfy;ka@vk¡[kks dk Mªksi@vkW;UVesUV@ 43-47

bu¶;wt+u vkSj vU; vkS"k/k ds lkFk185-260 DyksDlkflyhu vkSj vU; vkS"k/k ds lkFk xksfy;ka@dSilwy@ 47-56

bUtsD’ku@flji@

vuqØef.kdk

Page 7: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

ii

Øe fooj.k i‘"B la[;kla[;k

Mh&(D)

1-42 MsDlkfeFkklksu xksfy;ka@dSilwy @Mªksi vkSj vU; vkS"k/k ds lkFk 57-61

43-55 MsDlVªksizksiksDlhQsu xksfy;ka@dSilwy vU; vkS"k?k ds lkFk 61-62

56-73 Mk;kslfeu xksfy;ka vU; vkS"k/k ds lkFk 62-64

74-120 MkWDlhlkbdfyu xksfy;ka@dSilwy@flji @vU; vkS"k/k ds lkFk 64-68

121-124 Mh&iSfUFkuksy@dSfY’k;e iSUVksfFkusV xksfy;ka@bUtSaD’ku@yks’ku 68

125 MkbZ&vkbMks gkbMªksDlhDohu xksfy;ka 68

bZ&(E)

1-37 ,fjFkzksekbflu lksY;w’ku@yks’ku@tWy@Øhe@vkW;UVesUV@xksfy;ka vU; vkS"k/k ds lkFk 69-71

71-122 ,sQsMjhu@fl;wMks,sQsMjhu xksfy;ka@flji vU; vkS"k/k ds lkFk 71-82

123-143 bVksQkbfyu xksfy;ka@,Ei;wy@flji vU; vkS"k/k ds lkFk 83-85

,Q&(F)

1-7 QseksfVfMu xksfy;ka@bUtsD’ku vkSj vU; vkS"k/k ds lkFk 86

8-17 zQsfelsfVu vkW;UVesUV vU; vkS"k/k ds lkFk 86-87

18-31 zQwlkekbM xksfy;ka@bUtsD’ku vkSj vU; vkS"k/k ds lkFk 87-88

32-80 ¶;wjkt+ksfyMksu xksfy;ka vkSj vU; vkS"k/k ds lkFk xksfy;ka@flji 89-93

th&(G)

1-63 tSUVkekbflu bUtsD’ku@Mªksi@vkW;UVesUV@Øhe@Mªksi vU; vkS"k/k ds lkFk 94-102

64-74 fxfyfit+kbM xksfy;ka vkSj vU; vkS"k/k ds lkFk 102-103

75-81 xzslks¶;wyfou xksfy;ka vkSj vU; vkS"k/k ds lkFk 103

vkbZ&(I)

1-38 bC;wizksQsu xksfy;ka@lLisUlu@tWy vkSj vU; vkS"k/k ds lkFk xksfy;ka@flji@lLisUlu 104-107

39-48 vkbZlh,pD;w xksfy;ka@Øhe vkSj vU; vkS"k/k ds lkFk 107-108

49-50 bUlwfyu ok;y 108

,y&(L)

1-13 ysoksMksik xksfy;ka vU; vkS"k/k ds lkFk 109-110

14-26 fyudksekbflu dSilwy@flji@bUtsD’ku@tWy 110-111

vU; vkS"k/k ds lkFk

Page 8: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

iii

,e&(M)

1 escgkbMªksfyu xksfy;ka 112

2-4 feFkk;yMksik xksfy;ka 112

5-133 eSVªksfuMkt+ksy vkSj vU; vkS"k/k ds lkFk xksfy;ka@dSilwy@ 112-126

bUtsD’ku@lLisUlu

,u&(N)

1-28 usfyfMfDld ,sflM xksfy;ka@lLisUlu@flji vkSj vU; vkS"k/k ds lkFk 127-129

29-81 uksj¶yksDlhu vkSj vU; vkS"k/k ds lkFk xksfy;ka@Mªksi@flji@bUtsD’ku 129-134

82-113 usizksDlsu xksfy;ka@dSilwy@tWy 134-136

vks&(O)

1-5 vkWDldkckZest+kikbu xksfy;ka 137

6-20 vkWDlhVsVªklkbdfyu dSilwy@xksfy;ka@bUtsD’ku 137-138

ih&(P)

1 ihlh,e,Dl ¼isjkDyksjksesVkfDlhysuksy½ Øhe 139

2-27 iSuhflfyu xksfy;ka vkSj bUtsD’ku vkSj vU; vkS"k/k ds lkFk 139-140

28-31 iSUVktksflu @bUtsD’ku xksfy;ka vkSj vU; vkS"k/k ds lkFk 141

32-35 iSUVksDlhQkbfyu xksfy;ka@bUtsD’ku vkSj vU; vkS"k/k ds lkFk 141

36-45 Qsfujkekbu esfy,V xksfy;ka@bUtsD’ku@,DlisDVksjsUV 142

46-50 fQuk;y cwVkt+ksu xksfy;ka@bUtsD’ku 142-143

51-91 izsMuhlksyksu xksfy;ka@flji@lLisUlu vkSj feFkk;yiszsMuhlksyksu ,sflVsV bUtsD’ku 143-146

92-98 ik;jsUVy iseks,sV xksfy;ka@flji vkSj vU; vkS"k/k ds lkFk 146

vkj&(R)

1-27 jsuhfVMhu xksfy;ka@bUtsD’ku vkSj vU; vkS"k/k ds lkFk 147-150

28-94 fjQsEihflu vkSj vU; vkS"k/k ds lkFk xksfy;ka@dSilwy@flji@fdV 150-157

Øe fooj.k i‘"B la[;kla[;k

Page 9: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

iv

,l&(S)

1-128 lsyC;wVkeksy vkSj vU; vkS"k/k ds lkFk xksfy;ka@dSilwy@flji@ 158-171

bUgSyj@jslikbjsVjh lksY;w’ku vkSj ysoklsyC;wVkeksyjksVkdSi@@lksY;w’ku

129-136 fLizuksySDVksu vkSj vU; vkS"k/k ds lkFk xksfy;ka 171-172

137-143 LVªsIVksekbflu vkSj vU; vkS"k/k ds lkFk bUtsD’ku 172-173

144-170 lYQkfM;kft+u$VªkbZfeFkksfize xksfy;ka vkSj 173-175

flYoj lYQkfM;kft+u Øhe171-177 lYQkMksdlhu$ik;fjfeFkkekbu xksfy;ka@flji 175-176

178-189 lYQkfeFkkDlkt+ksy$VªkbZfeFkksfize xksfy;ka@flji 176-177

Vh&(T)

1-17 VsVªklkbdfyu dSilwy@xksfy;ka 178-179

18-93 fFk;ksQkbfyu xksfy;ka@flji vkSj vU; vkS"k/k ds lkFk 179-186

94 Fkk;feu izksfiy MkbZ lYQsV xksfy;ka 186

95-109 VksYukQVsV yks’ku@lksY;w’ku@Øhe vkSj vU; vkS"k/k ds lkFk 186-188

110-125 VªkbZfeFkksfize xksfy;ka@lLisUlu@butsD’ku@Mªksi vU; vkS"k/k ds lkFk 188-189

oh&(V)

1-10 osjkikfey xksfy;ka@bUtsD’ku 190

11-23 foVkfeu , dSilwy@xksfy;ka@bUtsD’ku vU; vkS"k/k ds lkFk 190-191

24-25 foVkfeu ch1$ch2 ¼fjcw¶ysfou½ xksfy;ka 191

26-50 foVkfeu lh vkSj vU; vkS"k/k ds lkFk xksfy;ka@dSilwy@bUtsD’ku@Mªksi 192-194

51-78 foVkfeu bZ xksfy;ka@dSilwy@bUtsD’ku@Øhe vU; vkS"k/k ds lkFk 194-197

79-317 eYVhfoVkfeu vU; vkS"k/k ds lkFk xksfy;ka@dSilwy@flji@bUtsD’ku 197-243

vkbZoh f¶y;wMl (I.V. Fluids)

Mhihlhvks] 1995 ds iSjk 10 ch ds v/khu ¼xSj vuqlwfpr enksa½ ds fu/kkZfjr ewY;

1-10 MsDlVªkst@lkekU; lsykbu@MsDlVªkst 244

lkekU; lsykbu bUtsD’ku@lksY;w’ku ds lkFk

1-24 Mhihlhvks] 1995 ds iSjk 10 ch ds v/khu fu/kkZfjr ewY; vf/kdre [kqnjk ewY;¼mRikn ’kqYd vkSj LFkkuh; djksa lfgr½ 245-247

layXud&1 dk-vk- la[;k 435¼v½ fnukad 29.03.2006 dk lanHkZ 248-249

layXud&2 dk-vk- la[;k 1064¼v½ fnukad 11.07.2006 dk lanHkZ 250-251

Øe fooj.k i‘"B la[;kla[;k

Page 10: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

v

Øe fooj.k i‘"B la[;kla[;k

Hkkx&2

vaxzsth o.kZekyk Øe esa dEiuh okbt+vf/klwfpr fofufeZfr ds fu/kkZjfr ukWu flafyx ewY; 252-294

1. ,cksV ysc bafM;k fyfeVsMvkfjusd ,,p xksfy;ka 252

2. ,dksLV jsesfMt+ izkbosV fyfeVsM 252

3. ,Øku QkekZ 252

4. ,xyksesM fyfeVsM 252

5. vxzke jsesfMt+ 252

6. ,xzksu jsesfMt+ 252

7. vxzoky QkekZfl;wfVdy 252

8. vtUrk QkekZ 252

9. ,ycVZ MsfoM fyfeVsM 252

10. ,yD;wj QkekZfl;wfVdy yscksjsfVªt+ ¼bafM;k½ 252

11. ,YMs esfM bEiSDl fyfeVsM 252

12. ,yfEcd dsfedyl odZl 252-253

13. ,ydse ysc- fyfeVsM 253

14. ,fYid jsesfMt+ 253

15. ,yikbu 253

16. ,Yil QkekZfl;wfVdy izkbosV fyfeVsM 253

17. vyfV;l ¼;wfuekdZ QkekZ½ 253

18. vejhdu jsesfMt+ 253

19. ,aXyks zQsap Mªx ,aM baMLVªht fyfeVsM 253-254

20. ,aVht+u ,p- ds;j 254

21. ,idks QkekZ 254

22. visDl jsesfMt+ 254

23. vkjczks QkekZfl;wfVdy 254

24. vkjs&,Dl yscksjsfVªt izkbosV fyfeVsM 254

25. vkjxksu jesfMt+ 254

26. ,fjLVks QkekZ izkbosV fyfeVsM 254

27. vjlk QkekZfl;wfVDyl izkbosV fyfeVsM 254

28. v’kksd QkekZfl;wfVdy 254

29. ,LVªk&vkbZMh,y fyfeVsM 254

30. ,ofUVl QkekZ fyfeVsM 254-255

31. csuj QkekZdSi ¼bafM;k½ izkbosV fyfeVsM 255-256

32. cSDlVj ¼bafM;k½ ih- fyfeVsM ¼chvkbZih,y½ 256

Page 11: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

vi

Øe fooj.k i‘"B la[;kla[;k

33. cSUxy bE;wfufV fyfeVsMch-vkbZ-ch dkWEiysDl xksfy;ka 256

34. csusV QkekZfl;wfVDyl 256

35. csLVksdse 256

36. Hkfo";k QkekZ izk- fy- 256

37. ck;ksdse QkekZ baMLVhªt 256

38. ck;ksflu tsusfVd ,aM QkekZ 256

39. ck;ksdksu fyfeVsM 256

40. ck;ksxkMZ vkWjxsfuDl 256

41. ck;ksyksft+dy&bZ fyfeVsM 256

42. ck;ks&LVkj QkekZ 257

43. ck;ks&Lohl QkekZ 257

44. ck;ksVsd esfMdy izkbosV fyfeVsM 257

45. chvkbZih,y ¼jsfMdks jsesfMt+½ 257

46. CY;w ØkWl 257

47. cksgfjatj bUxsyfge bafM;k izk- fyfeVsM 257

48. cwVl QkekZfl;wfVDyl fyfeVsM 257

49. czkWu yscksjsVhªt fyfeVsM 257

50. czksfl;k QkekZ ¼vkbZ½ izkbosV fyfeVsM 257

51. czkWu ,aM cdZ izkbosV fyfeVsM 257

52. ch,l, QkekZ 257

53. dspsV 257

54. dsfMyk gsYFk ds;j ih- fyfeVsM 257-258

55. dsfMyk QkekZ ¼izkbosV½ fyfeVsM 258

56. dsiysV bafM;k izkbosV fyfeVsM 258

57. lsUV;wj yscksjsVªht izkbosV fyfeVsM 258-259

58. lsVkMsy 259

59. lh,Q,y QkekZ ¼ih½ fyfeVsM 259

60. pSMjQ 259

61. psfeMk ysc 259

62. psfeuksok jsesfMt+ izkbosV fyfeVsM 259

63. fliyk fyfeVsM 259

64. dkWecsV MªXl fyfeVsM 259

65. dksesM dsfedyl izkbosV fyfeVsM 259

66. dUlsIV QkekZfl;wfVDy fyfeVsM 259

67. dksleksl 259

68. ØkWl ysUMl 260

Page 12: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

vii

Øe fooj.k i‘"B la[;kla[;k

69. lk;ukfeM bafM;k fyfeVsM 260

70. MsQksfgYl QkekZ izkbosV fyfeVsM 260

71. MsYVk ,jksesfVd izkbosV fyfeVsM 260

72. Ms~l esfMdy LVksjl ¼esU;wQsDpfjax½ fyfeVsM 260

73. Mksdks jsesfMt+ 260

74. MkW- jsM~Mh yscksjsVªht fyfeVsM 260

75. MªkDV baVjus’kuy 260

76. MªkDV QkekZfl;wfVDy izk- fyfeVsM 260

77. M~d fcy MªXl 260

78. MhMCY;wMh QkekZfl;wfVDyl 260

79. Mk;ukfed 260

80. bZ-edZ ¼vkbZ½ fyfeVsM 260-261

81. bZLV vQjhdu ¼vkbZ½ jsesfMt+ ¼ih½ fyfeVsM 261

82. bZLV vejhdu 261

83. bZLV bafM;k QkekZ odZl 261

84. ,YMj gsYFkds;j izkbosV fyfeVsM 262

85. ,fytsUV dsfedy baVjizkbtsl izkbosV fyfeVsM 262

86. byh&fyyh ,aM daiuh izkbosV fyfeVsM 262-267

87. ,eD;wj QkekZ fyfeVsM 268

88. ,fey QkekZfl;wfVdy bafM;k fyfeVsM 268

89. ,UMksdkMZ bafM;k izkbosV fyfeVsM 268

90. bjkst+ QkekZ fyfeVsM 268

91. ,ldst+ QkekZ 268

92. ,fFkdks QkekZ 268

93. ,fFkysDl gsYFkds;j izkbosV fyfeVsM 268

94. b;wQksfjd QkekZ izkbosV fyfeVsM 268

95. ,QMhlh fyfeVsM 268

96. Qkbu ds;j QkekZ 268

97. QkbuD;wj 268

98. QksjV~l bafM;k 268

99. zQsadks bafM;k QkekZ ih- fyfeVsM 268-269

100. zQsadfyu yscksjsVªht ¼bafM;k½ izkbosV fyfeVsM 269

101. QwyQksMZ ¼vkbZ½ fyfeVsM 269

102. th ukbu ekdsZfVax 269

103. th-lh-,e- yscksjsVªht 269

104. tsusdk ,p- ds;j 269

Page 13: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

viii

Øe fooj.k i‘"B la[;kla[;k

105. ftuks QkekZfl;wfVdy fyfeVsM 269

106. teZu jsesfMt+ fyfeVsM 269-270

107. XySDlks bafM;k fyfeVsM 270

108. XySDlks fLeFkdyk;u QkekZ fyfeVsM 270

109. XysuekdZ QkekZ izkbosV fyfeVsM 270

110. XysuekdZ ¼ekbfy;l½ 270

111. xqM yd QkekZfl;wfVdy izkbosV fyfeVsM 270

112. xzsfUMDl QkekZfl;fVdy fyfeVsM 271

113. xzqi 271

114. xqtjkr VªWl ysc fyfeVsM 271

115. gennZ ¼okDQ½ yscksjsVªht 271

116. gsesDl QkekZ 271

117. gsYFk ds;j QkWeZ;wys’ku izkbosV fyfeVsM 271

118. fg;jys LVªhV QkekZ 271

119. gsyDl gsYFk ds;j 271

120. gsfy;l QkekZfl;wfVdy 271

121. fgUnqLrku ,aVhck;ksfVDl fyfeVsM 271-272

122. gkbZVsd dSilwy izkbosV fyfeVsM 272

123. gksLV esfj;u jly fyfeVsM 272

124. gkbft;k QkekZfl;wfVdy 272

125. vkbZMhih,y 272

126. baM&Loh¶V fyfeVsM 272

127. baMdseh 272

128. bafMdks jsesfMt+ fyfeVsM 272

129. bafM QkekZ 272

130. baMksdks jsesfMt+ fyfeVsM 272

131. baMks zQsap ysc fyfeVsM 272

132. bUQkj ¼bafM;k½ fyfeVsM 272-273

133. bUVªk ysc 273

134. bidk ysc fyfeVsM 273

135. vkbZvkj,e QkekZ 273

136. ts-ds- MªXl ,aM QkekZ 273

137. txluiky QkekZfl;wfVdy 273

138. tkjlu QkekZfl;wfVdy 273

139. tsu cjDV 273

140. tqxr QkekZ 273

Page 14: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

ix

Øe fooj.k i‘"B la[;kla[;k

141. dukZVdk ,aVhck;ksfVd QkekZfl;wfVDyl fy- 273

142. dseosy izkbosV fyfeVsM 273

143. dsuVªsd ysc 273

144. [kaMsyoky ysc fyfeVsM 274

145. fde ysc izk- fy- 274

146. dykj lsgu izkbosV fyfeVsM 274

147. uksy QkekZfl;wfVdy fyfeVsM 274

148. dksijsu fyfeVsM 274

149. ØsLi 274

150. fDod gsYFk ds;j 274

151. ykW ck;ksfØLV QkekZfl;wfVdy fyfeVsM 274

152. ysUlj gsYFk ds;j izkbosV fyfeVsM 274

153. ysUlj QkekZ izk- fy- 274

154. ykdZ yscksjsVªht ¼vkbZ½ izkbosV fyfeVsM 275

155. fyUdksu QkekZfl;wfVdy fyfeVsM 275

156. fyVkdk QkekZfl;wfVdy fyfeVsM 275

157. yksxksl QkekZ 275

158. Y;wfiu yscksjsVªht fyfeVsM 275

159. yk;dk ysc fyfeVsM 275

160. ,e- ts- QkekZ izkbosV fyfeVsM 275-276

161. eku QkekZ 276

162. esd ysc izkbosV fyfeVsM 276

163. esdfy;ksMl fyfeVsM 276

164. esxul ck;ksVsd 276

165. eykMh M�ªXl ,aM QkekZ fyfeVsM 276

166. eerk QkekZ 276

167. euh"k ,p- ds;j 276

168. esudkbaM QkekZfl;wfVdy izkbosV fyfeVsM 276

169. ekijk yscksjsVªht izkbosV fyfeVsM 276

170. ekjlkbZ QkekZ izkbosV fyfeVsM 277

171. eSDl bafM;k fyfeVsM 277

172. ,eMhlh 277

173. esfMdks ysc 277

174. esfM;ksjYl ysc izkbosV fyfeVsM 277

175. esfMiksy QkekZfl;wfVDyl 277

176. esfMLisu 277

Page 15: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

x

177. esfMLisu fyfeVsM 277

178. esxnwr dsfedy fyfeVsM 277

179. edZ ¼vkbZ½ fyfeVsM 277

180. ejdjh yscksjsVªht fyfeVsM 277

181. esfjfM;u esfMds;j fyfeVsM 277

182. esfjUM fyfeVsM 277

183. es;j vkWjxsfud izkbosV fyfeVsM 277

184. ekbØks ysc fyfeVsM 277

185. ekbØksuksok QkekZfl;wfVDyl izk- fyfeVsM 277

186. ,e-vkbZ-th gsYFkds;j 278

187. eksnh eqaMh QkekZfl;wfVdy fyfeVsM 278

188. eksjsl QkekZfl;wfVDyl izk- fyfeVsM 278

189. eksjisu ysc fyfeVsM 278

190. ekmUV esVVj 278

191. eqdwj QkekZ 278

192. ,u-vkj- tsV baVjizkbts+l 278

193. usllsUV esfMds;j izkbosV fyfeVsM 278

194. usVdks QkekZ fyfeVsM 278

195. usfoy yscksjsVªht 278

196. fu;ks QkekZ izkbosV fyfeVsM 278

197. usLVj 278

198. fudksyl fijkey ¼vkbZ½ fyfeVsM 278

199. fu¶y ck;kslkbal 279

200. ukscy esfMds;j izkbosV fyfeVsM 279

201. uksbj 279

202. uksjfMd QkE;wZys’ku 279

203. uksjfMd QkekZ 279

204. uksfjl esfMflu 279

205. uksokjfVt+ 279

206. uksok uksjfMLd fyfeVsM 279-280

207. U;wVy QkekZ 280

208. vksscltZ ck;ksVsd 280

209. vksdkok ysc fyfeVsM 280

210. vksjfcV baVjus’kuy 280

211. vksojfll gsYFkds;j fyfeVsM 280

212. ih ,aM ch yscksjsVªht izkbosV fyfeVsM 280

Øe fooj.k i‘"B la[;kla[;k

Page 16: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

xi

213. isutkWu QkekZ 281

214. isjsUVªy MªXl ¼vkbZ½ fyfeVsM 281

215. isjsDl QkekZ 281

216. ikdZ Msfol ¼bafM;k½ fyfeVsM 281

217. ihlhvkbZ QkekZfl;wfVdy izkbosV fyfeVsM 281

218. ipZ 281

219. QkbesDl baVjus’kuy fyfeVsM 281

220. fQLdj fyfeVsM 281

221. Qkbt+j fyfeVsM 281

222. Qkbt+j izksMDV bafM;k izk- fyfeVsM 282

223. QkekZ MªXl ,aM dsfedy 283

224. QkesZf’k;k 283

225. QkesZf’k;k ,aM vit+kWu bafM;k fyfeVsM 283

226. QkesZf’k;k gsYFkds;j 283

227. QkekZflUFk QkWE;wZys’kUl fyfeVsM 283

228. QkekZVsd gsYFk ds;j 283

229. ihvkbZ,y 283

230. ik;ks’k QkekZfl;wfVdy fyfeVsM 284

231. fijkey gsYFk ds;j fyfeVsM 284

232. iysfFkdks QkekZ fyfeVsM 284

233. izse QkekZfl;wfVdy 284

234. fiz;ky QkekZ 284

235. izksdse 284

236. izksfQd vkWjxsfud fyfeVsM 284

237. izksVsd ¼fliyk dk ,d fMfot+u½ 284

238. I;ksj gsYFk 284

239. jsfMDl ck;ksVsd 284

240. jsfyl bafM;k fyfeVsM 284

241. jsekst+ yscksjsVªht izkbosV fyfeVsM 284

242. jsucsDlh ysc- fyfeVsM 284

243. jsiVkdksl czsV ,aM dEiuh fyfeVsM 284-285

244. jsDl gsYFk ds;j izk- fyfeVsM 285

245. jsfo;u gsYFk ds;j 285

246. jseUM QkekZfl;wfVdy izkbosV fyfeVsM 285

247. jsfdV~ csudkbt+j ¼bafM;k½ fyfeVsM 285-286

248. jsfMdks jsesfMt+ ¼chvkbZih,y½ 286

Øe fooj.k i‘"B la[;kla[;k

Page 17: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

xii

249. jsdfouk ysc fyfeVsM 286

250. jsesM ,p- ds;j 286

251. jsesfMDl QkekZ izkbosV fyfeVsM 286

252. jsdLVj 286

253. jksgEcl QkekZfl;wfVdy izkbosV fyfeVsM 286

254. jksgu iksysUd ¼vkbZ½ fyfeVsM 286

255. fjdfouk QkekZ 286

256. jly bafM;k fyfeVsM 286-287

257. vkj-ih-th ykbQ lkbal 287

258. lsQ Qjfe;ksu fyfeVsM 287

259. ,l-th- QkekZfl;wfVdy 287

260. lehj jsesfMt+ 287

261. lselu ysc izkbosV fyfeVsM 287

262. lsucjh gsYFk ds;j 287

263. lsUMkst+ QkekZ fyfeVsM 287

264. lsUVs~ fot+u 287

265. lkjkHkkbZ dsfedy 287-288

266. lhxy ysc ¼bafM;k½ izkbosV fyfeVsM 288

267. lsfeV QkekZ ,aM dsfedy izkbosV fyfeVsM 288

268. lselu QkekZ izkbZosV fyfeVsM 288

269. lkYd QkekZ izkbosV fyfeVsM 288

270. lUFkk ck;ksVsdfud izkbosV fyfeVsM 288

271. f’kUVks vkWjxsfud izkbosV fyfeVsM 288

272. Js;k ykbQ lkbal izkbosV fyfeVsM 288-289

273. fljk QkekZfl;wfVdy fyfeVsM 289

274. flLVk QkekZfl;wfVdy 289

275. flxek ysc fyfeVsM 289

276. flfydkWu QkekZ 289

277. fl;kseksUM QkekZfl;wfVdy 289

278. flofyax VsDuksyksfTl 289

279. LdkbZesDl yscksjsVªht+ izkbosV fyfeVsM 289

280. fLeFk LVsuLVªhV QkekZ fyfeVsM 289

281. lksy QkekZfl;wfVdy fyfeVsM 289

282. lksyl 289

283. lksesfVdks ysc 290

284. ,lihih,y ,fFkdy fMfot+u 290

Øe fooj.k i‘"B la[;kla[;k

Page 18: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

xiii

Øe fooj.k i‘"B la[;kla[;k

285. LVsMesM izkbosV fyfeVsM 290

286. LVªkbMl ,jdksysc fyfeVsM 290

287. lu QkekZ 290

288. lquht+ QkekZ izkbosV fyfeVsM 290

289. lujkbt+ baVjus’kuy ysc fyfeVsM 290

290. ljekmUV ysc 290

291. lk;uksdse QkekZ izkbosV fyfeVsM 290

292. lk;uksdse QkekZfl;wfVDyl fyfeVsM 290

293. flfUFkdks QkWE;wZys’kUl fyfeVsM 290

294. fllesM 290

295. VsCysVl bafM;k fyfeVsM 291

296. VkVk QkekZ fyfeVsM 291

297. Vksjl QkekZ 291

298. Vksjl ysc 291

299. fn ,axyks zQsap MªXl ,aM baMLVªht+ fyfeVsM 291

300. Fksfel dsfedy fyfeVsM 291

301. VksjsUV QkekZ 291

302. VkWLd baVjus’kuy 291

303. VªkbZMksl ysc fyfeVsM 291

304. VhVhds gsYFkds;j fyfeVsM 291

305. V~foykbV esjdsUVkbYl 292

306. ;wlhch ¼vkbZ½ fyfeVsM 292

307. vYVªk&fØ;ksu QkekZ 292

308. ;wfudse ysc bafM;k fyfeVsM 292

309. ;wfudse@flMesd ysc fyfeVsM 292

310. ;wfuekdZ 292

311. ;wfud QkekZ ysc fyfeVsM 292

312. ;wfu&lsuD;ks fyfeVsM 292

313. ;wuhlpZ 292

314. ;wfuolZy esfMds;j fyfeVsM 292

315. ;w,loh fyfeVsM 292

316. oslQkWj ¼bafM;k½ 292

317. osadkVs’kojk ck;kslsUVªh ¼vkbZ½ fyfeVsM 292

318. osysl QkekZfl;wfVdy fyfeVsM 293

319. osUMj 293

320. fou esfMds;j 293

Page 19: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

xiv

321. oksdkMZ 293-294

322. ok;Fk ysMjys fyfeVsM 294

323. ;’k QkekZ izkbosV fyfeVsM 294

324. fteV QkekZ 294

325. tsuu gsYFk ds;j fyfeVsM 294

326. tk;Ml dsfMyk 294

Øe fooj.k i‘"B la[;kla[;k

Page 20: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 1 -

izR;k[;ku ¼fMlDysej½

blesa ’kkfey vk¡dM+ks ls ;g vFkZ ugha gS fd ;g lkj&laxzg

¼dEisufM;e½] jkti=k&vf/klwpuk@ewY; vkns’k dk izkekf.kd ikB

gSA izkekf.kd ikB ds fy, d‘i;k bl lEcU/k esa tkjh lEc)

jkti=k&vf/klwpuk @ ewY; vkns’k dk lUnHkZ djsaA

Page 21: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 2 -

izLrkoukvkS"k/k ¼ewY;&fu;a=k.k½ vkns’k] 1995 ds iSjk 3] iSjk 8] iSjk 9 vkSj iSjk 11 ds

v/khu iznÙk ’kfDr;ksa dk iz;ksx djrs gq, jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k¼,uihih,½] bl vkns’k dh igyh vuqlwph esa fo’ks"k #i ls mfYyf[kr 74 iziqatcYd&nokvksa] muds O;qRiknkas ¼Msjk;osfVOt½ vkSj QkewZys’kuksa ds ewY;ksa dks fu/kkZfjrvkSj la’kksf/kr djrk gSA 8 vuqlwfpr cYd nokvksa esa] vkS"k/k ,oa lkSUn;Z izlk/kuvf/kfu;e] 1940 ¼1940 dk 23½ dh nwljh vuqlwph esa fo’ks"k #i ls mfYyf[krvkS"k/k&dks’k ¼QkekZdksiksb;ky½ ;k vU; ekudksa ds vuqdwy djrs gq, muds lkYV]bLVj] LVsfj;ks&vkblksej vkSj O;qRikn Hkh ’kkfey gS vkSj tks fdlh Hkh QkewZys’ku esa,d vo;o ds #i esa mi;ksx fd, tkrs gSaA

vuqlwfpr cYd nokvksa ds lEcU/k esa iSjk 3 vkSj iSjk 11 ds v/khu vf/klwfprewY;] vf/kdre foØ; ewY; ¼mRikn&’kqYd vkSj LFkkuh; djksa dks NksM+dj½ gksrs gSavkSj os 15 Qjojh] 2008 dh fLFkfr ds vuqlkj bl lkj&laxzg ¼dEisufM;e½ dsHkkx&1 esa fn;s x, gSaA QkWewZys’ku&iSdksa ds ekeysa esa ,uihih, lerqY; vf/kdre[kqnjk ewY; ¼,evkjih½ Hkh vf/klwfpr djrk gSA

lkj&laxzg ds Hkkx&2, esa iSjk 9 vkSj iSjk 11 ds v/khu vf/klwfpr mPpreewY;] cktkj esa lkekU;r;k miyC/k vuqlwfpr QkWewZys’ku&iSdksa ds lEcU/k esa vaxzstho.kZekyk Øe esa cYd nokvksa ds vuqlkj ladfyr fd, x, gSaA bu ewY;ksa esamRikn&’kqYd vkSj LFkkuh; dj] ;fn dksbZ gS rks ’kkfey ugha gSaA cM+h dEifu;ksa dslkekU;r% miyC/k czkaM&uke vks-vkj-th-&vkbZ-,e-,l- vk¡dM+ks ds vuqlkj izR;sdQkWewZy’ku&iSd ds lkeus n’kkZ fn;s x, gSaA vkxs] mlh dks iwjk djus ds fy,] tgk¡dgha miyC/k gksa] izdkf’kr if=kdkvksa tSls Mªx VwMs vkSj bafM;u Mªx fjO;w esa Nisvk¡dM+ks ds vuqlkj czkaM&ukeksa dk lanHkZ fd;k x;k gSA dEisufM;e esa Mhihlhvks]1995 ds iSjk 10¼ch½ ds v/khu fu/kkZfjr ewY; Hkh ’kkfey gSaA

QkWewZys’ku&iSdksa ds ukWu&lhfyax ewY;] mDr vksn’k ds iSjk 8 vkSj 11 dsv/khu fu/kkZfjr fd, tkrs gSaA dEisufM;e esa] mRikn&’kqYd vkSj LFkkuh; djksa dksNksM+dj ewY; ’kkfey gSa ,oa dEiuh@czkaM fo’ks"khd‘r gSaA 15 Qjojh] 2008 dsvuqlkj ,uihih, }kjk vfUre fu/kkZfjr ukWu&lhfyax ewY;] dEisufM;e ds Hkkx 2chesa fn, x, gSaA

Page 22: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 3 -

Ø-la- vuqlwfpr iziqat vkS"k/k dk uke ;wfuV vf/kdre fcØh ewY; jkti=k vkns’k jkti=k¼#i;s½ dh dk-vk- vkns’k dh

la[;k frfFk

1. ,eksfMDohu¼v½ ,eksfMDohu ,plh,y fdxzk- 675.00 865¼v½ 01.06.2007

2. ,lfizu fdxzk- 148.00 132¼v½ 23.01.2008

3. fcVkfeFkkt+ksu¼v½ fcVkfeFkkt+ksu MkbZ&lksfM;e QksLQsV xzke 149.00 863¼v½ 01.06.2007

¼c½ fcVkfeFkkt+ksu osyjsV xzke 176.00 863¼v½ 01.06.2007

¼l½ fcVkfeFkkt+ksu ,YdksgkWy xzke 185.00 863¼v½ 01.06.2007

4. dkckZest+kikbu fdxzk- 2179.00 412¼v½ 21.03.2007

5. DyksjksDohu¼v½ DyksjksDohu lYQsV fdxzk- 1692.00 568¼v½ 21.02.1997

¼c½ DyksjksDohu QksLQsV fdxzk- 745.00 412¼v½ 21.03.2007

6. DyksjksDlhysuksYl¼v½ MkbZDyksjksesVsDlhysuksy fdxzk- 241.00 565¼v½ 06.08.1997

¼c½ isjkDyksjksesVsDlhysuksy fdxzk- 270.00 741¼v½ 19.05.2006

7. DyksDlkflyhu¼v½ DyksDlkflyhu lksfM;e fdxzk- 1359.00 1593¼v½ 25.09.2007

¼vksjy xzsM½

¼c½ DyksDlkflyhu lksfM;e fdxzk- 1904.00 1593¼v½ 25.09.2007

¼LVsjkby½

8. dsiVksfizy fdxzk- 11971.00 443¼v½ 13.06.1997

9. lsQkMªksDlhy¼v½ lsQksMªksDlhy eksuksgkbMªsV fdxzk- 2466.00 412¼v½ 21.03.2007

vkS"k/k ¼ewY; fu;a=k.k½ vkns’k] 1995 ds v/khu vf/klwfpr vuqlwfpr iziqat vkS"k/kksa ¼cYd MªXl½ ds ewY;

Page 23: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 4 -

Ø-la- vuqlwfpr iziqat vkS"k/k dk uke ;wfuV vf/kdre fcØh ewY; jkti=k vkns’k jkti=k¼#i;s½ dh dk-vk- vkns’k dh

la[;k frfFk

10. flQkVksDlkbe¼v½ flQkVksDlkbe lksfM;e ¼LVsjkby½fdxzk- 7166.00 412¼v½ 21.03.2007

11. lsQkt+ksfyu¼v½ lsQkt+ksfyu lksfM;e ¼LVsjkby½ fdxzk- 5977.00 1592¼v½ 25.09.2007

12. DyksjizksikekbM fdxzk- 328.00 1279¼v½ 27.07.2007

13. flizks¶yksDlklhu fdxzk- 4190.00 227¼v½ 20.03.1997

14. MsDlkfeFkkt+ksu xzke 114.00 755¼v½ 06.08.2001

¼v½ MsDlkfeFkkt+ksu lksfM;e QksLQsV xzke 125.00 755¼v½ 06.08.2001

¼c½ MsDlkfeFkkt+ksu VªkbZfeFkkby xzke 158.67 481¼v½ 02.07.1993

,sflVsV

15. MsDlVªksizksiksDlhQsu¼v½ MsDlVªksizksiksDlhQsu ,plh,y fdxzk- 3812.00 412¼v½ 21.03.2007

¼c½ MsDlVªksizksiksDlhQsu usilkbysV fdxzk- 5137.00 412¼v½ 21.03.2007

16. MkWDlhlkbdfyu¼v½ MkWDlhlkbdfyu ,plh,y@ fdxzk- 1749.00 2008¼v½ 29.11.2007

MkWDlhlkbdfyu gkbdysV

17. ,sQsMjhu¼v½ ,sQsMjhu ,plh,y fdxzk- 1158.00 412¼v½ 21.03.2007

¼c½ fl;wMks,sQsMjhu fdxzk- 1819.00 412¼v½ 21.03.2007

¼l½ ,sQsMjhu jslhusV fdxzk- 954.00 922¼v½ 21.12.1994

¼n½ ,sQsMjhu lYQsV fdxzk- 1971.00 321¼v½ 09.05.1991

Page 24: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 5 -

Ø-la- vuqlwfpr iziqat vkS"k/k dk uke ;wfuV vf/kdre fcØh ewY; jkti=k vkns’k jkti=k¼#i;s½ dh dk-vk- vkns’k dh

la[;k frfFk

18. ,sfjFkzksekbflu¼v½ ,sfjFkzksekbflu csl fdxzk- 2082.00 412¼v½ 21.03.2007

¼c½ ,sfjFkzksekbflu bFkk;y lDlhusV fdxzk- 2845.00 412¼v½ 21.03.2007

¼l½ ,sfjFkzksekbflu ,LVksysV fdxzk- 2054.00 412¼v½ 21.03.2007

¼n½ ,sfjFkzksekbflu LVh;jsV fdxzk- 1423.00 412¼v½ 21.03.2007

¼o½ ,sfjFkzksekbflu izksfi;ksusV fdxzk- 2253.00 412¼v½ 21.03.2007

19. zQsesflVhu¼v½ zQsesflVhu lYQsV fdxzk- 13732.00 565¼v½ 06.08.1997

20. zQwlkekbM fdxzk- 1442.00 410¼v½ 21.03.2007

21. ¶;wjktksfyMksu fdxzk- 325.00 864¼v½ 01.06.2007

22. QseksfVMhu fdxzk- 1042.00 2009¼v½ 29.11.2007

23. tsUVkekbflu¼v½ tsUVkekbflu lYQsV xzke 12.74 650¼v½ 03.07.1995

24. fxfyfit+kbM fdxzk- 29244.00 1043¼v½ 11.07.2006

25. xzslks¶;wyohu fdxzk- 4270.00 419¼v½ 11.05.2001

26. gsykstsusVsM gkbMªksDlhD;wuksfyu¼v½ vkbMksDyksjkgkbMªksDlh D;wuksfyu fdxzk- 823.00 412¼v½ 21.03.2007

¼c½ MkbZ&vkbMksDyksjkgkbMªksDlhD;wuksfyu fdxzk- 547.00 728¼v½ 21.08.1995

27. bC;wizksQsu fdxzk- 404.00 412¼v½ 21.03.2007

Page 25: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 6 -

28. bUlwfyu¼v½ bUlwfyu ¼cksokbu½ ,e;w 24017.00 564¼v½ 06.08.1997

¼c½ áweu bUlwfyu fdxzk- 3215351.00 412¼v½ 21.03.2007

29. ykbusLVªkuksy fdxzk- 73995.00 414¼v½ 24.03.2005

¼v½ bFkk;ysLVªkuksy fdxzk- 80465.00 564¼v½ 06.08.1997

30. escgkbMªksfyu¼v½ escgkbMªksfyu usisfMlkbysV fdxzk- 1268.00 120¼v½ 10.02.1998

31. esVkfet+ksy ¼,uyft+u½ fdxzk- 459.00 1638¼v½ 29.09.2006

32. feFkk;y Mksik fdxzk- 4205.00 564¼v½ 06.08.1997

33. eSVªksfuMkt+ksy fdxzk- 471.00 164¼v½ 07.02.2006

¼v½ eSVªksfuMkt+ksy csUtq,sV fdxzk- 401.00 164¼v½ 07.02.2006

34. usfyfMfDld ,sflM fdxzk- 1616.00 412¼v½ 21.03.2007

35. usijksDlsu fdxzk- 1313.00 1591¼v½ 25.09.2007

¼v½ usijksDlsu lksfM;e fdxzk- 1452.00 1591¼v½ 25.09.2007

36. uksj¶yksDlhu fdxzk- 841.00 134¼v½ 23.01.2008

37. vkWDlhVsVªklkbdfyu¼v½ vkWDlhVsVªklkbdfyu fdxzk- 1552.00 412¼v½ 21.03.2007

,EQksVsfjd csl

¼c½ vkWDlhVsVªklkbfDyu ,plh,y fdxzk- 1097.00 414¼v½ 24.03.2005

Ø-la- vuqlwfpr iziqat vkS"k/k dk uke ;wfuV vf/kdre fcØh ewY; jkti=k vkns’k jkti=k¼#i;s½ dh dk-vk- vkns’k dh

la[;k frfFk

Page 26: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 7 -

Ø-la- vuqlwfpr iziqat vkS"k/k dk uke ;wfuV vf/kdre fcØh ewY; jkti=k vkns’k jkti=k¼#i;s½ dh dk-vk- vkns’k dh

la[;k frfFk

38. isfuflyhu¼v½ iksVkf’k;e isfuflyhu th fc;w 727.00 201¼v½ 07.03.2001

¼igyk fØLVy½

¼c½ izksdsu isfuflyhu fc;w 958.00 418¼v½ 27.03.2006

¼l½ lksfM;e isfuflyhu th fc;w 824.00 1837¼v½ 29.12.2005

¼n½ cSUtkFkhu isfuflyhu th fdxzk- 2670.00 866¼v½ 01.06.2007

¼o½ iksVkf’k;e isfuflyhu th fc;w 1106.00 805¼v½ 20.08.2001

¼j½ iksVkf’k;e isfuflyhu oh fc;w 1001.00 806¼v½ 20.08.2001

39. iSUVktksflu fdxzk- 22395.00 867¼v½ 01.06.2007

40. Qsfujkekbu esy,sV fdxzk- 1168.00 2013¼v½ 29.11.2007

41. izsMuhlksyksu fdxzk- 56289.00 412¼v½ 21.03.2007

¼v½ izsMuhlksyksu ,sflVsV fdxzk- 31219.00 412¼v½ 21.03.2007

42. ik;jsUVy

¼v½ ik;jsUVy iseks,sV fdxzk- 1182.00 135¼v½ 23.01.2008

43. isUVksDlhQkbfyu fdxzk- 1675.00 2012¼v½ 29.11.2007

44. fQuk;ycwVkt+ksu fdxzk- 352.00 1133¼v½ 15.10.2004

45. jsuhfVMhu¼v½ jsuhfVMhu ,plh,y fdxzk- 636.00 412¼v½ 21.03.2007

46. fjQsEihflu fdxzk- 3493.00 412¼v½ 21.03.2007

Page 27: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 8 -

47. lsyC;wVkeksy¼v½ lsyC;wVkeksy lYQsV fdxzk- 4804.00 412¼v½ 21.03.2007

48. fLizuksySDVksu fdxzk- 25667.00 414¼v½ 24.03.2005

49. LVªsIVksekbflu¼v½ LVªsIVksekbflu lYQsV ¼csl esa½ fdxzk- 2381.00 873¼v½ 15.09.2000

50. lYQkMkbft+u fdxzk- 565.00 564¼v½ 06.08.1997

51. lYQkfMehfMu fdxzk- 460.00 590¼v½ 12.08.1994

52. lYQkfeFkkWDlkt+ksy fdxzk- 361.00 133¼v½ 23.01.2008

53. lYQkeksDlksy fdxzk- 588.00 418¼v½ 27.03.2006

54. VsVªklkbdfyu¼v½ VsVªklkbdfyu ,plh,y fdxzk- 782.00 1065¼v½ 29.10.2001

¼c½ Dyksj VsVªklkbdfyu ,plh,y fdxzk- 1877.00 479¼v½ 03.07.1997

¼l½ MkbZfeFkk;y Dyksj VsVªklkbdfyu fdxzk- 4559.00 206¼v½ 13.03.1999

55. fFk;ksQkbfyu fdxzk- 438.00 2011¼v½ 29.11.2007

¼v½ ,feuksQkbfyu fdxzk- 419.00 2010¼v½ 29.11.2007

¼c½ gkbMªksDlh bFkk;y fFk;ksQkbfyu fdxzk- 504.00 2011¼v½ 29.11.2007

56. VksYukQVsV fdxzk- 4121.00 412¼v½ 21.03.2007

57. VªkbZesFkksfize fdxzk- 828.00 418¼v½ 27.03.2006

58. osjkikfey¼v½ osjkikfey ,plh,y fdxzk- 4109.00 564¼v½ 06.08.1997

Ø-la- vuqlwfpr iziqat vkS"k/k dk uke ;wfuV vf/kdre fcØh ewY; jkti=k vkns’k jkti=k¼#i;s½ dh dk-vk- vkns’k dh

la[;k frfFk

Page 28: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 9 -

Ø-la- vuqlwfpr iziqat vkS"k/k dk uke ;wfuV vf/kdre fcØh ewY; jkti=k vkns’k jkti=k¼#i;s½ dh dk-vk- vkns’k dh

la[;k frfFk

59. foVkfeu ,¼v½ foVkfeu , ,sflVsV 1000 2956.00 411¼v½ 21.03.2007

¼MªkbZ ikmMj½ ,e;w @fc;w-¼0.5 ,evkbZ;w @xzke½

¼c½ foVkfeu , ,sflVsV 1000 2295.00 411¼v½ 21.03.2007

¼vkW;yh fyfDoM½ ,e;w @fc;w-¼1.0 ,evkbZ;w @xzke½

¼l½ foVkfeu , ikfeVsV 1000 2685.00 411¼v½ 21.03.2007

¼vkW;yh fyfDoM½ ,e;w @fc;w-¼1.0 / 1.7 ,evkbZ;w @xzke½

60. foVkfeu lh lknh fdxzk- 366.00 1280¼v½ 27.07.2007

¼v½ foVkfeu lh fyfir fdxzk- 353.00 1280¼v½ 27.07.2007

¼c½ lksfM;e ,LdksjcsV fdxzk- 381.00 1280¼v½ 27.07.2007

61. foVkfeu ch-1 ¼Fkk;feu½¼v½ foVkfeu ch-1 ,plh,y fdxzk- 1418.00 1102¼v½ 23.12.1998

¼c½ foVkfeu ch-1 eksuksukbVªsV fdxzk- 1160.00 1102¼v½ 23.12.1998

62. foVkfeu ch-2 ¼fjcw¶ysfou½ fdxzk- 950.00 418¼v½ 27.03.2006

¼v½ foVkfeu ch-2 - 5 QksLQsV fdxzk- 2217.00 1300¼v½ 14.09.2005

63. foVkfeu bZ

¼v½ foVkfeu bZ ,sflVsV fdxzk- 791.00 412¼v½ 21.03.2007

uksV % (1) v] c] l ---------- Mhihlhvks] 1995 dh igyh vuqlwph esa fo’ks"khd‘r iziqat vkS"k/kksa ds lkYV@bLVj@vkblksej@O;qRink gSaA

(2) 74 vuqlwfpr iziqat vkS"k/k esa ls cph gqbZ 11 iziqat vkS"k/k dk dksbZ Hkh vf/klwfpr ewY; ugha gSaA

Page 29: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 10 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

, (A)

1. ,MjsuksØkse eksukslsfedkcZtks;$ 10 dk 10.06 758(v) 19.05.2006esukMkyksu lksfM;e ckbZlYQkbV iRrk@fCyLVj,Ldksjfcd$#fVu$MkbZcsflddSfY’k;e QksLQsV xksfy;ka,MjsuksØkse eksukslsfedkcZtks;&330 ,elhthesukMkyksu lksfM;e ckbZlYQkbV,Ldksjfcd&100 fexzk-#fVu&50 fexzk-MkbZcsfld dSfY’k;e QksLQsV&125 fexzk-

2. ,feuksQkbfyu xksfy;ka 1000 ,pMhihbZ 93.18 390(v) 03.06.1996 eS- th-,l-ds- ,feuksQkbfyu100 fexzk-@ xksfy;ka cksry xksfy;ka

eS- fu;ksu feuksQkby xksfy;ka

3. ,eksfM;kDohu xksfy;ka 10 dk 4.86 1327(v) 01.08.2007 eS- fliyk ,lfizu xksfy;kacsl 200 fexzk- @ xksfy;ka ,,y_iRrk

4. ,eksfM;kDohu xksfy;ka 10 dk 4.62 1327(v) 01.08.2007 eS- fliyk ,lfizu xksfy;kacsl 200 fexzk- @ xksfy;ka ,,y_fCyLVj

5. ,uyftu xksfy;ka 10 dk 5.12 199(v) 14.02.2007 eS- lsuksQh ,oufVl uksoyft+u xksfy;ka500 fexzk-@xksfy;ka iRrk@fCyLVj eS- lsuksQh ,oufVl csjkyxu xksfy;ka

eS- ,ydse ,uyftu xksfy;ka

6. ,uyftu xksfy;ka 100 dh 36.62 1319(v) 01.08.2007

500 fexzk-@xksfy;ka t+kj@cksry

7. ,uyftu bUtsD’ku 2 fefy dk 3.72 199(v) 14.02.2007 eS- lsuksQh ,oufVl uksoyft+u bUts-500 fexzk-@ fefy ,Ei;wy

8. ,uyftu bUtsD’ku 30 fefy dk 18.66 1051(v) 11.07.2006 eS- lsuksQh ,oufVl uksoyft+u bUts-500 fexzk-@ fefy ok;y

9. ,uyftu$fQuk;y cwVktksu$ 30 fefy dk 16.80 2030(v) 30.11.2007 eS- lsuksQh ,oufVl uksoyft+u bUts-fyXuksdsu ,plh,y$ ok;ycsUtk;y ,YdksgWy bUtsD’kuizR;sd fefy esa,uyftu 150 fexzk-fQuk;y cwVktksu 150 fexzk-fyXuksdsu ,plh,y 10 fexzk-csUtk;y ,YdksgWy 2% MCY;w@MCY;w

Page 30: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 11 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

10. ,lfizu xksfy;ka 10 dk 1.10 1097(v) 08.12.2000 eS- esuks QkekZ esukslfizu xksfy;ka50 fexzk-@ xksfy;ka iRrk@fCyLVj eSa- V~foykbV ekdsZUfVy ,lsyk;V xksfy;ka

eS- fu;ksu ,,l, xksfy;ka

11. ,lfizu xksfy;ka 10 dk 1.22 1097(v) 08.12.2000 eS- ;w,loh bdkslfizu xksfy;k75 fexzk-@ xksfy;ka iRrk@fCyLVj eSa- esuks QkekZ esukslfizu xksfy;k

eSa- ,LVªktsusdk yksMkslfizu xksfy;keSa- bUVkl LizkbuVkleSa- ekbØks ,ldsM

12. ,lfizu xksfy;ka 10 dk 1.36 1097(v) 08.12.2000 eS- eksjQsu fVuhlfizu xksfy;k80 fexzk-@ xksfy;ka iRrk@fCyLVj eSa- dUlsiV QkekZ ,lfidksV

13. ,lfizu xksfy;ka 10 dk 1.28 1097(v) 08.12.2000 eS- jsfdV csudkbtj dksylfizu xksfy;k100 fexzk-@ xksfy;ka iRrk@fCyLVj eSa- fliyk ,lfizu xksfy;k

eSa- fliyk ,lfizu ,fUVªdfyfir xksfy;k

eS- esuks QkekZ eksukslfizu xksfy;keS- ,eD;wj U;wlfizu xksfy;keS- ,eD;wj U;wlfizu ,fUVªd

fyfir xksfy;k

14. ,lfizu xksfy;ka 10 dk 1.72 1097(v) 08.12.2000 eS- esuks QkekZ esukslfizu xksfy;k150 fexzk-@ xksfy;ka iRrk@fCyLVj eSa- iysfFkdks ,lfilksy

eS- ,eD;wj U;wlfizueS- V~foykbV ekdsZfUVy ,l;ykbVeS- ekbØks ,ldsM

15. ,lfizu xksfy;ka 15 dk 2.39 1076(v) 19.05.2006

125 fexzk-@ xksfy;ka iRrk@fCyLVj

16. ,lfizu xksfy;ka 14 dk 2.20 747(v) 19.05.2006 eS- ;wfulpZ yksfizu&Mh,l162.5 fexzk-@ xksfy;ka iRrk@fCyLVj

17. ,lfizu xksfy;ka 30 dk 8.53 747(v) 19.05.2006 eS- usVdks dksVklfizu500 fexzk-@ xksfy;ka iRrk@fCyLVj

18. ,lfizu fMys;M fjfyt xksfy;ka 14 dk 2.40 606(v) 29.06.2001 eS- V~foykbV ekdsZUfVy ,lyk;V Mhvkj50 fexzk-@ xksfy;ka iRrk@fCyLVj xksfy;k

eS- teZu jsesfMt+ ,lfizu fMys;M

19. ,lfizu fMys;M fjfyt xksfy;ka 14 dk 2.44 606(v) 29.06.2001 eS- jsucsDlh LisUV60 fexzk-@ xksfy;ka iRrk@fCyLVj

20. ,lfizu fMys;M fjfyt xksfy;ka 14 dk 3.48 386(v) 02.04.2003 eS- flj;k vksiVkt&7575 fexzk-@ xksfy;ka iRrk@fCyLVj eS- dksesM ,fldkse&75

Page 31: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 12 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

eS- ,LVªk TosUl ,lfizu

21. ,lfizu fMys;M fjfyt xksfy;ka 14 dk 5.48 386(v) 02.04.2003 eS- lh,Q,y yksfizu150 fexzk-@ xksfy;ka iRrk@fCyLVj eS- ,ydse estksjy

eS- ;w,loh bdkslfizu

22. ,lfizu fMys;M fjfyt xksfy;ka 14 dk 8.66 386(v) 02.04.2003 eS- dkfMZds;j ,ldsM325 fexzk-@ xksfy;ka iRrk@fCyLVj

23. ,lfizu xksfy;ka 10 dk 2.34 788(v) 09.07.2003 eS- jsfdV csudkbtj fMlfizu,lfizu&350 fexzk- iRrk@fCyLVjdSfY’k;e dkcksZusV & 105 fexzk-,UgkbMªl flfVªd,flM & 35 fexzk- @xksfy;ka

24. ,lfizu vkSj fVdyksfifMu xksfy;ka 10 dk 19.28 1076(v) 11.07.2006,lfizu&75 fexzk- iRrk@fCyLVjfVdyksfifMu&250 fexzk-@xksfy;ka

25. ,lfizu vkSj DyksfiMksxzsy xksfy;ka 10 dk 24.74 432(v) 28.03.2005 eS- VksjsUV QkekZ fMiykV&,,lfizu&75 fexzk- iRrk@fCyLVj eS- bUVkl dysfoDl&,l xksfy;kaDyksfiMksxzsy ck;lYQsV eS- bUVkl izsok&,l xksfy;kDyksfiMksxzsy&75 fexzk- ds cjkcj eS- ;wfudse DyksMjsy QksVZ

eS- fliyk Dyksfiokl&,iheS- LVsuds;j lsjksfou&, xksfy;k

26. ,lfizu vkSj DyksfiMksxzsy xksfy;ka 10 dk 24.96 432(v) 28.03.2005 eS- Js;k ykbQ lkbal ,lfixzsy,lfizu&150 fexzk- iRrk@fCyLVj eS- ;w,loh Dyksfixzsy ,DyksfiMksxzsy ck;lYQsV eS- ck;ksdse DyksiksM ,DyksfiMksxzsy&150 fexzk- ds cjkcj eS- VksjsUV fMiysV ,

eS- bUVkl izsok ,,l

27. ,lfizu vkSj DyksfiMksxzsy xksfy;ka 10 dk 25.00 432(v) 28.03.2005 eS- ;wuhlpZ DyksMjsy QksVZ,lfizu&162.5 fexzk- iRrk@fCyLVjDyksfiMksxzsy ck;lYQsVDyksfiMksxzsy&75 fexzk- ds cjkcj

28. ,lfizu vkSj DyksfiMksxzsy xksfy;ka 10 dk 24.94 432(v) 28.03.2005 eS- ;wuhlpZ DyksMjsy Iyl,lfizu ¼fyfir QkeZ esa½&75 fexzk- iRrk@fCyLVj eS- buMksdks jsesfMt DyksfijsM&,DyksfiMksxzsy ck;lYQsV eS- ,yMj dksylfizuDyksfiMksxzsy&75 fexzk- ds cjkcj eS- VksjsUV fMiysV ,

eS- csLVksdse DyksmMl

29. ,lfizu vkSj DyksfiMksxzsy xksfy;ka 10 dk 25.18 432(v) 28.03.2005 eS- ;w,loh Dyksihxzsy&,,lfizu ¼fyfir QkeZ esa½&150 fexzk- iRrk@fCyLVj eS- buMksdks jsesfMt DyksfijsM&,DyksfiMksxzsy ck;lYQsV eS- bUVjk ysc xzsysV&,DyksfiMksxzsy&75 fexzk- ds cjkcj eS- ,yMj Dykslihj

eS- VksjsUV fMiysV ,

Page 32: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 13 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

31. ,lfizu vkSj DyksfiMksxzsy xksfy;ka 10 dk 25.22 432(v) 28.03.2005 eS- ;wuhlpZ DyksMjsy QksVZ,lfizu ¼fyfir QkeZ esa½&162.5 fexzk- iRrk@fCyLVjDyksfiMksxzsy ck;lYQsVDyksfiMksxzsy&75 fexzk- ds cjkcj

32. ,lfizu vkSj DyksfiMksxzsy dSilwy 10 dk 26.80 432(v) 28.03.2005 eS- Y;wfiu DyksfiVsc&, dSilwy,lfizu ¼fyfir QkeZ esa½&75 fexzk- iRrk@fCyLVj eS- lu QkekZ dksEchiysV dSilwyDyksfiMksxzsy ck;lYQsV eS- ekbØks ysc Iysxsfju&, dSilwyDyksfiMksxzsy&75 fexzk- ds cjkcj@dSi- eS- fudksYl fijkey LVªksfeDl&, dSilwy

eS- ;w,loh Dyksfixzsy&, dSilwy

33. ,lfizu vkSj DyksfiMksxzsy dSilwy 10 dk 27.22 747(v) 19.05.2006 eS-Js;k ykbQ lkabl ,lfixzsy,lfizu ¼fyfir QkeZ esa½&150 fexzk- iRrk@fCyLVj eS-esdfyvksMl QkekZ ek;ksxzsy ,ih dSilwyDyksfiMksxzsy ck;lYQsV eS- Cy;w ØkWl ,ufVcsu ,,lihDyksfiMksxzsy&75 fexzk- ds cjkcj@dSi- eS- ck;ksdse dyslfizu dSilwy

eS- esMys QkekZ IysVf zQu

34. ,lfizu vkSj MkbisjkMkeksy xksfy;ka 10 dk 5.04 433(v) 28.03.2005 eS- VksjsUV dkfMZosy Iyl,lfizu &40 fexzk- iRrk@fCyLVjMkbisjkMkeksy &75 fexzk-@xksfy;ka

35. ,lfizu vkSj MkbisjkMkeksy xksfy;ka 10 dk 5.10 433(v) 28.03.2005 eS- ;w,loh Mk;uklfizu,lfizu &60 fexzk- iRrk@fCyLVjMkbisjkMkeksy &75 fexzk-@xksfy;ka

36. ,lfizu vkSj vkblkslksjckbM 10 dk 12.40 1663(v) 03.10.2006 eS- ;w,loh bdkslfeueksuksukbVªsV xksfy;ka iRrk@fCyLVj eS- lu QkekZ eksukslfizu Mh,l,lfizu ¼fyfir QkWeZ esa½&150 fexzk- eS- VksjsUV oslksfizu ,lMhMkbZY;wVsM vkblkslksjckbM eksuksukbVªsVvkblkslksjckbM eksuksukbVªsV ¼,lvkj@Vhvkj@lhvkj@Mhvkj QkeZ esa½&30 fexzk-@xksfy;ka

37. ,lfizu vkSj vkblkslksjckbM 10 dk 13.54 1663(v) 03.10.2006 eS- lu QkekZ eksukslfizu Mh,leksuksukbVªsV xksfy;ka iRrk@fCyLVj eS- VksjsUV oslksfizu,lfizu ¼fyfir QkWeZ esa½&150 fexzk-MkbZY;wVsM vkblkslksjckbM eksuksukbVªsVvkblkslksjckbM eksuksukbVªsV ¼,lvkj@Vhvkj@lhvkj@Mhvkj QkeZ esa½&60 fexzk-@xksfy;ka

38. ,lfizu vkSj vkblkslksjckbM 10 dk 9.12 1663(v) 03.10.2006 eS- ;w,loh bdkslfizueksuksukbVªsV xksfy;ka iRrk@fCyLVj eS- fudksYl fijkey bleksfju,lfizu ¼fyfir QkWeZ esa½&75 fexzk- eS- dsfMyk lksykslfizuMkbZY;wVsM vkblkslksjckbM eksuksukbVªsVvkblkslksjckbM eksuksukbVªsV ¼,lvkj@Vhvkj@lhvkj@Mhvkj QkeZ esa½&30 fexzk-@xksfy;ka

Page 33: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 14 -

39. ,lfizu vkSj vkblkslksjckbM 10 dk 12.34 1059(v) 11.07.2006 eS- vksVfljk tsusfVdk ,likbVªsVeksuksukbVªsV dSilwy iRrk@fCyLVj,lfizu ¼fyfir QkWeZ esa½&150 fexzk-MkbZY;wVsM vkblkslksjckbM eksuksukbVªsVvkblkslksjckbM eksuksukbVªsV ¼,lvkj@Vhvkj@lhvkj@Mhvkj QkeZ esa½&30 fexzk-@xksfy;ka

40. ,lfizu vkSj vkblkslksjckbM 10 dk 9.44 1059(v) 11.07.2006 eS- ;wuhdse vkblksyksfizueksuksukbVªsV dSilwy iRrk@fCyLVj eS- lu QkekZ eksukslfizu,lfizu ¼fyfir QkWeZ esa½&75 fexzk- eS- oksdkMZ ukbVªsuMkbZY;wVsM vkblkslksjckbM eksuksukbVªsVvkblkslksjckbM eksuksukbVªsV ¼,lvkj@Vhvkj@lhvkj@Mhvkj QkeZ esa½&30 fexzk-@xksfy;ka

41. ,lfizu vkSj vkblkslksjckbM 10 dk 13.22 1059(v) 11.07.2006 eS- ;wuhdse vkblksyksfizueksuksukbVªsV dSilwy iRrk@fCyLVj eS- lu QkekZ eksukslfizu,lfizu ¼fyfir QkWeZ esa½&75 fexzk- eS- ekbØks ysc ukbVªksfQDl&,,lMkbZY;wVsM vkblkslksjckbM eksuksukbVªsVvkblkslksjckbM eksuksukbVªsV ¼,lvkj@Vhvkj@lhvkj@Mhvkj QkeZ esa½&60 fexzk-@xksfy;ka

42. ,lfizu vkSj vkblkslksjckbM 10 dk 6.48 434(v) 28.03.2005 eS- vksVfljk tsusfVdk ,likbVªsVeksuksukbVªsV dSilwy iRrk@fCyLVj,lfizu ¼fyfir QkWeZ esa½&150 fexzk-MkbZY;wVsM vkblkslksjckbM eksuksukbVªsVvkblkslksjckbM eksuksukbVªsV ¼,lvkj@Vhvkj@lhvkj@Mhvkj QkeZ esa½&60 fexzk-@xksfy;ka

43. ,lfizu vkSj ,VªksokfLVu dSilwy 10 dk 17.42 440(v) 23.03.2007

izR;sd dSilwy esa iRrk@fCyLVj,lfizu & 75 fexzk-,VªksokfLVu & 10 fexzk-

44. ,flVk;y lsfyflfyd ,sflM$ 10 dk 3.02 2026(v) 30.11.2007

dSfY’k;e dkcksZusV$ ,,y_iRrkflfVªd ,sflM xksfy;ka 0.04 fefeizR;sd ,sQosZlUV fVfd;k esa,flVk;y lsfyflfyd ,sflM & 350 fexzk-dSfY’k;e dkcksZusV & 105 fexzk-,UgkbMªl flfVªd ,sflM & 35 fexzk-

45. ,lfizu $dSfQu xksfy;ka 10 dk 2.88 169(v) 28.01.2007

izR;sd fVfd;k esa iRrk@fCyLVj,lfizu & 350 fexzk-dSfQu ¼,UgkbMªl½ & 20 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 34: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 15 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

ch (B)

1. fcdsEihflfyu xksfy;ka 2 dk 5.82 701(v) 02.08.1995 eS- ,LVªk tsudk isuxyksc200 fexzk- @ xksfy;ka ¼fyfir½ ,,y_iRrk

2. fcdsEihflfyu xksfy;ka 4 dk 11.16 701(v) 02.08.1995 eS- ,LVªk tsudk isuxyksc200 fexzk- @ xksfy;ka ¼fyfir½ ,,y_iRrk

3. fcdsEihflfyu xksfy;ka 2 dk 10.62 701(v) 02.08.1995 eS- ,LVªk tsudk isuxyksc400 fexzk- @ xksfy;ka ¼fyfir½ ,,y_iRrk

4. fcdsEihflfyu xksfy;ka 4 dk 20.76 701(v) 02.08.1995 eS- ,LVªk tsudk isuxyksc400 fexzk- @ xksfy;ka ¼fyfir½ ,,y_iRrk

5. fcVkfeFkkt+ksu xksfy;ka 10 dk 3.44 226(v) 14.02.2007 eS- XysDlks csVuklksy xksfy;ka0.5 fexzk-@xksfy;ka lksfM;e QksLQsV esa ,,y_iRrk eS- baM&LohQ~V LVsehu xksfy;ka

eS- ekbØks ysc dksfVZy xksfy;ka

6. fcVkfeFkkt+ksu xksfy;ka 10 dk 3.26 226(v) 14.02.2007 eS- QwyQksMZ lsysLVksu xksfy;ka0.5 fexzk-@xksfy;ka lksfM;e QksLQsV esa ,,y_fCyLVj eS- osysl osykdksMZ xksfy;ka

eS- csLVksdse csVkfou xksfy;ka

7. fcVkfeFkkt+ksu QksVZ xksfy;ka 10 dk 5.86 226(v) 14.02.20070.5 fexzk-@xksfy;ka lksfM;e QksLQsV esa ,,y_iRrk

8. fcVkfeFkkt+ksu QksVZ xksfy;ka 10 dk 5.62 226(v) 14.02.20071.0 fexzk-@xksfy;ka lksfM;e QksLQsV esa ,,y_fCyLVj

9. fcVkfeFkkt+ksu xksfy;ka 10 dk iRrk 3.96 226(v) 14.02.2007 eS- XysDlks csVuklksy xksfy;ka1.0 fexzk-@xksfy;ka eS- baM&LohQ~V LVsfeu xksfy;ka

eS- dksesM csykj xksfy;ka

10. fcVkfeFkkt+ksu xksfy;ka 10 dk 3.32 468(v) 16.05.20000.5 fexzk- fcVkfeFkktksu ,YdksgWy esa ,,y_iRrk

11. fcVkfeFkkt+ksu xksfy;ka 10 dk 3.16 226(v) 14.02.20070.5 fexzk- fcVkfeFkktksu ,YdksgWy esa ,,y_fCyLVj

12. fcVkfeFkkt+ksu lksfM;e QksLQsV bUtsD’ku&4 1 fefy dk 4.10 226(v) 14.02.2007 eS- XysDlks csVuklksy bUtsD’ku4 fexzk- csl @fefy ,Ei;wy eS- baM&LohQ~V LVsfeu bUtsD’ku

eS- ihch ysc osuhdksVZ bUtsD’ku

13. fcVkfeFkkt+ksu bUtsD’ku 2 fefy dk 6.76 226(v) 14.02.2007fcVkfeFkkt+ksu ¼lksfM;e QksLQsV ok;y@,Ei;wyds leku½ 4 fexzk-@fefy

14. fcVkfeFkkt+ksu Mªksi 10 fefy dh 7.00 226(v) 14.02.20070.5 fexzk-@fefy cksry

Page 35: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 16 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

15. fcVkfeFkkt+ksu vksjy Mªksi 15 fefy dh 9.32 468(v) 16.05.2000 eS- XysDlks csVuklksy Mªksi0.5 fexzk-@fefy ¼lksfM;e QksLQsV esa½ cksry eS- baM&LohQ~V LVsfeu Mªksi

Mªksij lfgr eS- esu dkbaM U;wdksMZ Mªksi

16. fcVkfeFkkt+ksu vksjy Mªksi 10 fefy dh 8.86 76(v) 15.01.2004 eS- QwyQksMZ lsyLVksu xksfy;kafcVkfeFkkt+ksu ¼lksfM;e cksry MªksijQksLQsV esa½-0.5 fexzk-@fefy vkSj dkVZu lfgr

17. fcVkfeFkkt+ksu vk¡[kksa dk Mªksi 5 fefy dh 8.70 226(v) 14.02.2007izR;sd fefy esa ok;y Mªksij vkSjfcVkfeFkkt+ksu & 0.1% dkVZu lfgr

18. fcVkfeFkkt+ksu$fu;ksekbflu 5 fefy dh 8.74 226(v) 14.02.2007vk¡[kksa dk Mªksi ok;y Mªksij vkSjizR;sd fefy esa dkVZu lfgrfcVkfeFkkt+ksu & 0.1%fu;ksekbflu & 0.35%

19. fcVkfeFkkt+ksu vkSj 5 fefy dh 8.00 76(v) 15.01.2004 eS- XysDlks csVkuklksy Mªksifu;ksekbflu bZ@bZ Mªksi cksry MªksijfcVkfeFkkt+ksu ¼lksfM;e vkSj dkVZu lfgrQksLQsV esa½-0.1% MCY;w@ohfu;ksekbflu lYQsV-0.5% MCY;w@oh

20. fcVkfeFkkt+ksu vkSj 5 fefy dh 3.84 76(v) 15.01.2004 eS- XysDlks csVkuklksy MªksitSUVkekbflu bZ@bZ Mªksi cksry MªksijfcVkfeFkkt+ksu ¼lksfM;e vkSj dkVZu lfgrQksLQsV esa½-0.1% MCY;w@ohtSUVkekbflu lYQsV-0.03% MCY;w@oh

21. fcVkfeFkkt+ksu MkbZizksfi;ksusV 5 xzke dh 4.90 226(v) 14.02.2007vkW;UVesUV@Øhe V~;wcizR;sd xzke esafcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%0.05% fcVkfeFkkt+ksu ds cjkcj

22. fcVkfeFkkt+ksu MkbZizksfi;ksusV 10 xzke dh 6.74 226(v) 14.02.2007 eS- ØkWl ysaM fMizksosV ØhevkW;UVesUV@Øhe V~;wc eS- edZ csVkfey ØheizR;sd xzke esa eS- Y;wfiu Y;wfiMeZ ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064% eS- QwyQksMZ fMiysu Øhe0.05% fcVkfeFkkt+ksu ds cjkcj

23. fcVkfeFkkt+ksu MkbZizksfi;ksusV 15 xzke dh 8.40 226(v) 14.02.2007 eS- ekbØks ysc csVktWy ØhevkW;UVesUV@Øhe V~;wc eS- lh,Q,y jksosV ØheizR;sd xzke esa eS- ,isDl csVt+h ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064% eS- cky QkekZ dksfVZMeZ Øhe0.05% fcVkfeFkkt+ksu ds cjkcj

Page 36: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 17 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

24. fcVkfeFkkt+ksu vkW;UVesUV@Øhe 20 xzke dh 10.26 226(v) 14.02.2007 eS- ØkWl yssaM fMizksosV ØheizR;sd xzke esa V~;wc eS- ekbØks ysc csVktWyfcVkfeFkkt+ksu-0.05% eS- vksdkok ysc ,Dt+hosV

25. fcVkfeFkkt+ksu MkbZizksfi;ksusV 20 xzke dh 10.22 226(v) 14.02.2007 eS- ØkWl yssaM fMizksosV ØhevkW;UVesUV@Øhe V~;wc eS- ,MhvkbZih,l ,t+ksusV ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%

26. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 5 xzke dh 4.94 226(v) 14.02.2007lsfyflfyd ,sflM vkW;UVesUV@Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%0.05% fcVkfeFkkt+ksu ds cjkcjlsfyflfyd ,sflM 3.00%

27. fcVkfeFkkt+ksu MkbZizksfi;ksusV vkSj 10 xzke dh 6.80 226(v) 14.02.2007 eS- eSfUVl QkekZ tkscsVk&,llsfyfklfyd ,sflM vkW;UVesUV@Øhe V~;wc eS- foy bEiSDl fMcsDl&,lfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064% eS- ,fenhi fMcsV&,l0.05% fcVkfeFkkt+ksu ds cjkcjlsfyfklfyd ,sflM-3.00%

28. fcVkfeFkkt+ksu MkbZizksfi;ksusV vkSj 15 xzke dh 8.50 226(v) 14.02.2007 eS- ekbØks csVktWy&,llsfyfklfyd ,sflM vkW;UVesUV@Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%0.05% fcVkfeFkkt+ksu ds cjkcjlsfyfklfyd ,sflM-3.00%

29. fcVkfeFkkt+ksu MkbZizksfi;ksusV vkSj 5 xzke dh 4.94 226(v) 14.02.2007tSUVkekbflu vkW;UVesUV@Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%0.05% fcVkfeFkkt+ksu ds cjkcjtSUVkekbflu -0.1%

30. fcVkfeFkkt+ksu MkbZizksfi;ksusV vkSj 10 xzke dh 6.84 226(v) 14.02.2007 eS- osUMj fMcsMªe&thtSUVkekbflu vkW;UVesUV@Øhe V~;wc eS- esuVhl QkekZ tkscsVk&thfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%0.05% fcVkfeFkkt+ksu ds cjkcjtSUVkekbflu -0.1%

31. fcVkfeFkkt+ksu MkbZizksfi;ksusV vkSj 15 xzke dh 8.54 226(v) 14.02.2007 eS- ekbØks ysc csVktWy&thtSUVkekbflu vkW;UVesUV@Øhe V~;wc eS- cky QkekZ dksfVZMeZ&thfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%0.05% fcVkfeFkkt+ksu ds cjkcjtSUVkekbflu -0.1%

32. fcVkfeFkkt+ksu MkbZizksfi;ksusV vkSj 5 xzke dh 4.98 226(v) 14.02.2007 eS- ØkWl ysaM tsUVkysu&lh ØhetSUVkekbflu vkSj DyksfVªekt+ksy V~;wc eS- QwyQksMZ DokfMZMªe ,,QvkW;UVesUV@ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%0.05% fcVkfeFkkt+ksu ds cjkcjtSUVkekbflu -0.1% vkSj DyksfVªekt+ksy-1.00%

Page 37: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 18 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

33. fcVkfeFkkt+ksu MkbZizksfi;ksusV vkSj 10 xzke dh 6.92 226(v) 14.02.2007 eS- ØkWl ysaM tsUVkysu&lh ØhetSUVkekbflu vkSj DyksfVªekt+ksy V~;wc eS- QwyQksMZ DokfMZMªe ,,QvkW;UVesUV@Øhe eS- ,MhvkbZih,l ,tksusV thlhfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064% eS- ,elu esMhdse csVk&lhth0.05% fcVkfeFkkt+ksu ds cjkcjtSUVkekbflu -0.1% vkSj DyksfVªekt+ksy-1.00%

34. fcVkfeFkkt+ksu MkbZizksfi;ksusV vkSj 15 xzke dh 8.64 22(v) 14.02.2007 eS- flj;k ,ihdksVZ &thlhtSUVkekbflu vkSj DyksfVªekt+ksy V~;wc eS- Mkykl QkekZ Qaxks &thchvkW;UVesUV@ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%0.05% fcVkfeFkkt+ksu ds cjkcjtSUVkekbflu -0.1% vkSj DyksfVªekt+ksy-1.00%

35. fcVkfeFkkt+ksu osyjsV$VksYukQVsV$ 5 xzke dh 5.52 828(v) 15.06.2005 eS- QwyQksMZ DokfMZMªe &,u,QtSUVkekbflu $ vkbZlh,pD;w Øhe V~;wc eS- fliyk QksjMªefcVkfeFkkt+ksu osyjsV-0.61 fexzk- eS- tsxluiky Dohl ØheVksYukQVsV-10 fexzk- eS- chih,y bldhu ØhetSUVkekbflu lYQsV-1 fexzk- eS- bUV~kl Dokfyl ØhevkbZlh,pD;w-10 fexzk- eS- baM&LohQ~V DokMªh feDl

36. fcVkfeFkkt+ksu osyjsV$VksYukQVsV$ 10 xzke dh 8.22 828(v) 15.06.2005 eS- QwyQksMZ DokfMZMeZ &,u,QtSUVkekbflu $ vkbZlh,pD;w Øhe V~;wc eS- fliyk QksjMeZfcVkfeFkkt+ksu osyjsV-0.61 fexzk- eS- chih,y bldhu ØheVksYukQVsV-10 fexzk-tSUVkekbflu lYQsV-1 fexzk-vkbZlh,pD;w-10 fexzk-

37. fcVkfeFkkt+ksu osyjsV$VksYukQVsV$ 5 xzke dh 5.24 828(v) 15.06.2005 eS- QwyQksMZ DokfMZMeZ &,u,QtSUVkekbflu $ vkbZlh,pD;w Øhe V~;wc eS- fliyk QksjMeZfcVkfeFkkt+ksu osyjsV-0.5 fexzk-VksYukQVsV-10 fexzk-tSUVkekbflu lYQsV-1 fexzk-vkbZlh,pD;w-10 fexzk-

38. fcVkfeFkkt+ksu osyjsV$VksYukQVsV$ 15 xzke dh 10.12 828(v) 15.06.2005 eS- baM&LohQ~V DokMªh feDl ØhetSUVkekbflu $ vkbZlh,pD;w Øhe V~;wcfcVkfeFkkt+ksu osyjsV-0.5 fexzk-VksYukQVsV-10 fexzk-tSUVkekbflu lYQsV-1 fexzk-vkbZlh,pD;w-10 fexzk-

39. fcVkfeFkkt+ksu$fu;ksekbflu$ 10 xzke dh 10.86 226(v) 14.02.2007 eS- Y;wfiu osyosV Øhefedksukt+ksy Øhe vuysdM~Z V~;wcfcVkfeFkkt+ksu osyjsV-0.12% MCY;w@MCY;wfu;ksekbflu lYQsV-0.5% MCY;w@MCY;wfedksukt+ksy ukbVªsV-2% MCY;w@MCY;w

Page 38: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 19 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

40. fcVkfeFkkt+ksu$fu;ksekbflu$ 10 xzke dh 10.60 226(v) 14.02.2007 eS- Y;wfiu osyosV Øhefedksukt+ksy Øhe vuysdM~Z V~;wcfcVkfeFkkt+ksu osyjsV-0.12% MCY;w@MCY;wfu;ksekbflu lYQsV-0.5% MCY;w@MCY;wfedksukt+ksy ukbVªsV-2% MCY;w@MCY;w

41. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 10 xzke dh 7.32 226(v) 14.02.2007 eS- edZ csVkfey th,etSUVkekbflu vkSj fedksukt+ksy V~;wc eS- gsfy;l Vh,,Q&th,eukbVªsV vkW;UVesUV@Øhe eS- Y;wfiu Y;wfiMeZ&th,efcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%0.05% fcVkfeFkkt+ksu ds cjkcjtSUVkekbflu-0.10%fedksukt+ksy ukbVªsV-2%

42. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 10 xzke dh 6.88 226(v) 14.02.2007 eS- jsDlVj LVsVe Iylfu;ksekbflu vkW;UVesUV@Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%0.05% fcVkfeFkkt+ksu ds cjkcjfu;ksekbflu lYQsV-0.5%

43. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 10 xzke dh 7.24 226(v) 14.02.2007fedksuktksy ukbVªsV vkW;UVesUV@Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%0.05% fcVkfeFkkt+ksu ds cjkcjfedksuktksy ukbVªsV - 2%

44. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 15 xzke dh 6.64 1347(v) 16.09.2005 eS- ØkWl ysaM LVsVe Iylfu;ksekbflu vkW;UVesUV@Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV0.0125% fcVkfeFkkt+ksu ds cjkcjfcVkfeFkkt+ksu MkbZizksfi;ksusV$lsfyflfyd ,sflM$;wfj;k$ysfDVd ,sflM

45. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ysfDVd 10 xzke dh 6.94 226(v) 14.02.2007 eS- Js;k ,ihdksVZ&,eds,sflM csflyl$;wfj;k$lsfyflfyd V~;wc,sflM$lksfM;e ysDVsV vkW;uVesaV@ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcjlsfyflfyd ,sflM - 3.00%;wfj;k - 10.00%ysfDVd ,sflM csflyl - 3.00%lksfM;e ysDVsV - 2.00%

46. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 10 xzke dh 6.90 226(v) 14.02.2007fu;ksekbflu lYQsV vkW;UVesUV@Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%0.05% fcVkfeFkkt+ksu ds cjkcjfu;ksekbflu lYQsV-0.57%

Page 39: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 20 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

47. fcVkfeFkkt+ksu MkbZizksfi;ksusV$fu;ksekbflu 10 xzke dh 6.98 226(v) 14.02.2007lYQsV$DyksfVªekt+ksy vkW;UVesUV@Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%0.05% fcVkfeFkkt+ksu ds cjkcjfu;ksekbflu lYQsV-0.5%DyksfVªekt+ksy -1.00%

48. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 10 xzke dh 6.84 226(v) 14.02.2007DyksfVªekt+ksy vkW;UVesUV@Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064%0.05% fcVkfeFkkt+ksu ds cjkcjDyksfVªekt+ksy -1.00%

49. fcVkfeFkkt+ksu MkbZizksfi;ksusV$lsfyflfyd 10 xzke dh 6.62 226(v) 14.02.2007,sflM$;wfj;k$ysfDVd ,sflM V~;wccsflyl vkW;uVesaV@ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcjlsfyflfyd ,sflM - 3.00%;wfj;k - 10.00%ysfDVd ,sflM csflyl - 5.00%

50. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 15 xzke dh 8.52 226(v) 14.02.2007 eS- ekbØks csVktWy&,ufu;ksekbflu lYQsV vkW;uVesaV@Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcjfu;ksekbflu lYQsV - 0.25%

51. fcVkfeFkkt+ksu MkbZizksfi;ksusV$fu;ksekbflu$ 5 fefy dh 10.76 1347(v) 16.09.2005iksfyfefDlu ch lYQsV$fyxuksdsu Mªksi ok;y Mªksij lfgrfcVkfeFkkt+ksu MkbZizksfi;ksusV 1 fexzk-fu;ksekbflu - 3400 vkbZ;wiksfyfefDlu ch lYQsV - 10000 vkbZ;wfyxuksdsu ,plh,y 20 fexzk-@fefy

52. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 15 fefy dh 8.62 226(v) 14.02.2007 eS- jsDlVj LVsVe&ch yks’kuDyksfVªekt+ksy yks’ku cksryfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcjDyksfVªekt+ksy - 1.00% @fefy

53. fcVkfeFkkt+ksu MkbZizksfi;ksusV yks’ku 10 fefy dh 6.94 226(v) 14.02.2007 eS- ipZ ysc vYVªkosV yks’kufcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064% cksry0.05% fcVkfeFkkt+ksu ds cjkcj @fefy

54. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 10 fefy dh 7.04 226(v) 14.02.2007 eS- ØkWl ysaM LVsVe IylDyksfVªekt+ksy yks’ku cksryfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcjDyksfVªekt+ksy - 1.00% @fefy

Page 40: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 21 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

55. fcVkfeFkkt+ksu osyjsV$ 15 xzke dh 8.38 450(v) 29.03.2006 eS- fudksYl fijkey ,lft+MeZtSUVkekbflu$ VksYukQVsV$ V~;wcvkbZMksDyksjksgkbMªksDlhD;wuksfyu¼vkbZlh,pD;w½ ØhefcVkfeFkkt+ksu osyjsV 0.61 fexzk-tSUVkekbflu lYQsV 1 fexzk-VksYukQVsV - 10 fexzk-vkbMksDyksjksgkbMªksDlhD;wuksfyu ¼vkbZlh,pD;w½- 10 fexzk- @xzke

56. fcVkfeFkkt+ksu Øhe 30 xzke dh V~;wc 18.50 226(v) 14.02.2007fcVkfeFkkt+ksu 0.1% MCY;w@MCY;w@xzke

57. fcVkfeFkkt+ksu$DyksDohuksy Øhe 30 xzke dh V~;wc 20.16 226(v) 14.02.2007fcVkfeFkkt+ksu 0.1% MCY;w@MCY;wDyksDohuksy 3% @xzke

58. fcVkfeFkkt+ksu$ 30 xzke dh V~;wc 20.74 226(v) 14.02.2007fu;ksekbflu lYQsV ØhefcVkfeFkkt+ksu 0.12% MCY;w@MCY;wfu;ksekbflu lYQsV 0.5% MCY;w@MCY;w@xzke

59. fcVkfeFkkt+ksu$DyksjksDohuksy Øhe 30 xzke dh V~;wc 20.16 226(v) 14.02.2007fcVkfeFkkt+ksu 0.10%DyksjksDohuksy 0.5% MCY;w@MCY;w@xzke

60. fcVkfeFkkt+ksu $tSUVkekbflu 30 xzke dh V~;wc 4.00 755(v) 19.05.2006lYQsV$VksYukQVsV$vkbZlh,pD;w ØhefcVkfeFkkt+ksu 0.6 fexzk-tSUVkekbflu lYQsV 1 fexzk-VksYukQVsV 10 fexzk-vkbZlh,pD;w 10 fexzk-@xzke

61. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 7 xzke dh 6.02 226(v) 14.02.2007tSUVkekbflu lYQsV$ V~;wcDyksfVªekt+ksy ØhefcVkfeFkkt+ksu 0.05%tSUVkekbflu lYQsV - 0.10%DyksfVªekt+ksy - 1% MCY;w@MCY;w@xzke

62. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 16 xzke dh 9.42 226(v) 14.02.2007tSUVkekbflu lYQsV$ V~;wcDyksfVªekt+ksy ØhefcVkfeFkkt+ksu 0.05%tSUVkekbflu lYQsV - 0.10%DyksfVªekt+ksy - 1% MCY;w@MCY;w@xzke

Page 41: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 22 -

63. fcVkfeFkkt+ksu MkbZizksfi;ksusV$lsfyflfyd 20 xzke dh 10.60 226(v) 14.02.2007,sflM$;wfj;k$ ysfDVd ,sflM csflyl$ V~;wclksfM;e ysDVsV ØhefcVkfeFkkt+ksu 0.05%lsfyflfyd ,sflM - 3.00%;wfj;k - 10.00%ysfDVd ,sflM csflyl - 3.00%lksfM;e ysDVsV lksY;w- - 2.00% MCY;w@MCY;w@xzke

64. fcVkfeFkkt+ksu MkbZizksfi;ksusV$fu;ksekbflu 7 xzke dh 6.06 226(v) 14.02.2007 eS- zQsadks bafM;u ljQkt&,l,ulYQsV$DyksfVªekt+ksy vkW;uVesaV@Øhe V~;wc eS- ØkWl ysaM LVsVe IylfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcjfu;ksekbflu lYQsV - 0.5%DyksfVªekt+ksy - 1.00% @xzke

65. fcVkfeFkkt+ksu MkbZizksfi;ksusV$tSUVkekbflu 20 xzke dh 10.62 226(v) 14.02.2007lYQsV$DyksfVªekt+ksy Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064 fexzk-tSUVkekbflu lYQsV - 1fexzk-DyksfVªekt+ksy - 10 fexzk-@xzke

66. fcVkfeFkkt+ksu$E;wfijksflu vkW;UVesUV 5 xzke dh 24.16 755(v) 19.05.2007fcVkfeFkkt+ksu 0.05% V~;wcE;wfijksflu 2% MCY;w@MCY;w@xzke

67. fcVkfeFkkt+ksu $lsfyflfyd ,sflM$ 30 xzke dh 14.32 226(v) 14.02.2007;wfj;k$ ysfDVd ,sflM csflyl$ V~;wcvkW;uV~esUV@ØhefcVkfeFkkt+ksu - 0.05% MCY;w@MCY;wlsfyflfyd ,sflM - 3.00% MCY;w@MCY;w;wfj;k - 10.00% MCY;w@MCY;wysfDVd ,sflM csflyl - 3.00% MCY;w@MCY;w

68 fcVkfeFkkt+ksu $lsfyflfyd 20 xzke dh 10.50 226(v) 14.02.2007,sflM vkW;uV~esUV@Øhe V~;wcfcVkfeFkkt+ksu - 0.05% MCY;w@MCY;wlsfyflfyd ,sflM - 6% MCY;w@MCY;w

69. fcVkfeFkkt+ksu $lsfyflfyd 20 xzke dh 10.34 226(v) 14.02.2007,sflM vkW;uV~esUV@Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV - 0.64 fexzk-lsfyflfyd ,sflM - 30 fexzk-

70 fcVkfeFkkt+ksu $tSUVkekbflu lYQsV$ 5 xzke dh 5.10 755(v) 19.05.2006VksYukQVsV Øhe V~;wcfcVkfeFkkt+ksu osyjsV - 0.05% MCY;w@MCY;wtSUVkekbflu lYQsVtSUVkekbflu - 0.1% MCY;w@MCY;w ds cjkcjVksYukQVsV - 0.1% MCY;w@MCY;w @ xzke

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 42: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 23 -

71. fcVkfeFkkt+ksu $tSUVkekbflu 20 xzke dh 10.40lYQsV vkW;uV~esUV@Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV - 0.64 fexzk-tSUVkekbflu lYQsV - 1 fexzk-

72. fcVkfeFkkt+ksu $lsfyflfyd 20 xzke dh 10.38,sflM vkW;uV~esUV@Øhe V~;wcfcVkfeFkkt+ksuMkbZizksfi;ksusV -0.05% MCY;w@MCY;wlsfyflfyd ,sflM - 3% MCY;w@MCY;w

73. fcVkfeFkkt+ksu yks’ku 30 fefy dh 13.06 226(v) 14.02.2007 eS- ØkWl ysaM MkbZizksosysV yks’kuizR;sd fefy esa cksry eS- lh,Q,y jksosV yks’kufcVkfeFkkt+ksu 0.05% eS- MhbZvkj csVkMsy yks’ku

74. fcVkfeFkkt+ksu yks’ku 20 fefy dh 13.31 755(v) 19.05.2006 eS- Y;wfiu osycsV LdsyiizR;sd fefy esa cksry ,Iyhds’kufcVkfeFkkt+ksu osyjsV 0.12% MCY;w@MCY;w

75. fcVkfeFkkt+ksu$ 30 fefy dh 13.18 226(v) 14.02.2007lsfyflfyd ,sflM yks’ku cksryfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%lsfyflfyd ,sflM 3% / 2 fefy

76. fcVkfeFkkt+ksu$tSUVkekbflu Øhe 7.5 xzke dh 6.08 226(v) 14.02.2007fcVkfeFkkt+ksu MkbZizksfi;ksusV 0.64fexzk- V~;wctSUVkekbflu lYQsV 1 fexzk-@xzke

77. fcVkfeFkkt+ksu$tSUVkekbflu$ 5 xzke dh 5.72 226(v) 14.02.2007DohuksMksDyksj$ V~;wcDyksVªhekt+ksy ØhefcVkfeFkkt+ksu osyjsV-0.061% MCY;w@MCY;wtSUVkekbflu¼lYQsV ds leku½- 0.1% MCY;w@MCY;wDohuksMksDyksj - 3% MCY;w@MCY;wDyksVªhekt+ksy - 1% MCY;w@MCY;w

78. fcVkfeFkkt+ksu osyjsV$ 10 xzke dh 27.56 226(v) 14.02.2007 eS- ft+uks QkekZ ¶;wf’kt+u&ch¶;wflfMd ,sflM Øhe V~;wcfcVkfeFkkt+ksu osyjsVfcVkfeFkktk+su 1 xzke ds cjkcj¶;wflfMd ,sflM 20 fexzk- @xzke

79. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 15 xzke dh V~;wc 9.26 226(v) 14.02.2007tSUVkekbflu $fedkukt+ksyukbVªsV ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV - 0.064%fcVkfeFkkt+ksu - 0.05% MCY;w@MCY;w ds cjkcjtSUVkekbflu - 0.1% MCY;w@MCY;wfedkukt+ksy ukbVªsV - 2% MCY;w@MCY;w

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 43: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 24 -

80. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 10 xzke dh V~;wc 7.04 226(v) 14.02.2007tSUVkekbflu $fedkukt+ksyukbVªsV ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV - 0.064%fcVkfeFkkt+ksu - 0.05%MCY;w@MCY;w ds cjkcjtSUVkekbflu - 0.05% MCY;w@MCY;wfedkukt+ksy ukbVªsV - 1% MCY;w@MCY;w

81. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 16 xzke dh V~;wc 9.34 226(v) 14.02.2007tSUVkekbflu$fu;ksekbflu lYQsV ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV - 0.064%fcVkfeFkkt+ksu - 0.05% MCY;w@MCY;w ds cjkcjtSUVkekbflu - 0.05% MCY;w@MCY;wfu;ksekbflu lYQsV - 0.5% MCY;w@MCY;w

82 fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 16 xzke dh V~;wc 7.04 226(v) 14.02.2007tSUVkekbflu ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV - 0.064%fcVkfeFkkt+ksu - 0.05% MCY;w@MCY;w ds cjkcjtSUVkekbflu - 0.1% MCY;w@MCY;w

83 fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 10 xzke dh V~;wc 5.90 226(v) 14.02.2007vkbMksDyksjksgkbMªksDlhDohuksfyu¼vkbZlh,pD;w½ ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV - 0.064%fcVkfeFkkt+ksu - 0.05% MCY;w@MCY;w ds cjkcjvkbMksDyksjksgkbMªksDlhDohuksfyu - 30 fexzk-

84. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 10 xzke dh 8.18 226(v) 14.02.2007tSUVkekbflu $fedkukt+ksy ukbVªsV Øhe V~;wcfcVkfeFkkt+ksuMkbZizksfi;ksusV - 0.10%MCY;w@MCY;wtSUVkekbflu - 0.1% MCY;w@MCY;wfedkukt+ksy ukbVªsV - 2% MCY;w@MCY;w

85. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 10 xzke dh 6.30 226(v) 14.02.2007tSUVkekbflu $bdksukt+ksy ukbVªsV Øhe V~;wcfcVkfeFkkt+ksuMkbZizksfi;ksusV-0.025%MCY;w@MCY;wtSUVkekbflu - 0.1% MCY;w@MCY;wbdksukt+ksy ukbVªsV - 1% MCY;w@MCY;w

86 fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 15 xzke dh 7.72 226(v) 14.02.2007tSUVkekbflu $bdksukt+ksy ukbVªsV Øhe V~;wcfcVkfeFkkt+ksuMkbZizksfi;ksusV -0.025%MCY;w@MCY;wtSUVkekbflu - 0.1% MCY;w@MCY;wbdksukt+ksy ukbVªsV - 1% MCY;w@MCY;w

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 44: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 25 -

87 fcVkfeFkkt+ksu MkbZizksfi;ksusV$tSUVkekbflu$ 5 xzke dh 5.60 226(v) 14.02.2007vkbMksDyksjksgkbMªksDlhDohuksfyu V~;wc¼vkbZlh,pD;w½ ØhefcVkfeFkkt+ksuMkbZizksfi;ksusV - 0.1% MCY;w@MCY;wtSUVkekbflu csl - 0.2% MCY;w@MCY;wvkbMksDyksjksgkbMªksDlhDohuksfyu - 2% MCY;w@MCY;w

88. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 10 xzke dh V~;wc 6.96 226(v) 14.02.2007lsfyflfyd ,sflM$;wfj;k$ysfDVd ,sflM $lksfM;e ysDVs~VvkW;uV~esUV@ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV - 0.064%fcVkfeFkkt+ksu - 0.05% MCY;w@MCY;w ds cjkcjlsfyflfyd ,sflM - 3.00% MCY;w@MCY;w;wfj;k - 10.00% MCY;w@MCY;wysfDVd ,sflM csflyl - 3.00% MCY;w@MCY;wlksfM;e ysDVs~V - 3.00% MCY;w@MCY;w

89. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 20 xzke dh V~;wc 10.64 226(v) 14.02.2007lsfyflfyd ,sflM$;wfj;k$ysfDVd ,sflM $lksfM;e ysDVs~VvkW;uV~esUV@ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV - 0.064%fcVkfeFkkt+ksu - 0.05% MCY;w@MCY;w ds cjkcjlsfyflfyd ,sflM - 3.00% MCY;w@MCY;w;wfj;k - 10.00% MCY;w@MCY;wysfDVd ,sflM csflyl - 3.00% MCY;w@MCY;wlksfM;e ysDVs~V - 3.00% MCY;w@MCY;w

90. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 10 fefy dh 6.98 226(v) 14.02.2007lsfyflfyd ,sflM yks’ku cksryfcVkfeFkkt+ksu MkbZizksfi;ksusV - 0.064%fcVkfeFkkt+ksu - 0.05% MCY;w@MCY;w ds cjkcjlsfyflfyd ,sflM - 2.00% MCY;w@MCY;w@fefy

91. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 20 fefy dh 10.02 226(v) 14.02.2007lsfyflfyd ,sflM yks’ku cksryfcVkfeFkkt+ksu MkbZizksfi;ksusV - 0.064%fcVkfeFkkt+ksu - 0.05% MCY;w@MCY;w ds cjkcjtSUVkekbflu ¼lYQsV ds leku½ - 0.1% MCY;w@MCY;w@fefy

92. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 5 fefy dk 9.78 1686(v) 03.10.2006fu;ksekbflu lYQsV$ iksfyfefDlu ok;ych lYQsV MªksifcVkfeFkkt+ksu MkbZizksfi;ksusV - 0.064%fcVkfeFkkt+ksu - 0.05% MCY;w@MCY;w ds cjkcjfu;ksekbflu lYQsV - 3400 vkbZ;wiksfyfefDlu ch lYQsV - 10000 vkbZ;w@fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 45: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 26 -

93 fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 20 xzke dh 10.24 1923(v) 08.11.2006lsfyflfyd ,sflM$ysfDVd ,sflM V~;wcØhe@vkW;uVeSaVfcVkfeFkkt+ksuMkbZizksfi;ksusV-0.05% MCY;w@MCY;wlsfyflfyd ,sflM 3% MCY;w@MCY;wysfDVd ,sflM 10% MCY;w@MCY;w

94 fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 10 xzke dh 8.08 1923(v) 08.11.2006tSUVkekbflu$VksYukQVsV V~;wcvkbMksDyksjksgkbMªksDlhD;wuksfyuØhe@vkW;uVeSaVfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.643 fexzk-tSUVkekbflu lYQsV1 fexzk- tSUVkekbflu csl ds cjkcjysfDVd ,sflM 10% MCY;w@MCY;wVksYukQVsV&10 fexzk-vkbMksDyksjksgkbMªksDlhD;wuksfyu&10 fexzk-

95 fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 7 xzke dh V~;wc 6.26 1923(v) 08.11.2006DyksfVªekt+ksy Øhe@vkW;uVeSaVfcVkfeFkkt+ksu MkbZizksfi;ksusV0.05% MCY;w@MCY;w fcVkfeFkkt+ksu ds cjkcjDyksfVªekt+ksy&1% MCY;w@MCY;w

96 fcVkfeFkkt+ksu MkbZizksfi;ksusV 16 xzke dh V~;wc 11.42 1923(v) 08.11.2006Øhe@vkW;uVeSaVfcVkfeFkkt+ksu MkbZizksfi;ksusV0.05% MCY;w@MCY;w fcVkfeFkkt+ksu ds cjkcj

97 fcVkfeFkkt+ksu MkbZizksfi;ksusV 16 xzke dh V~;wc 7.60 1923(v) 08.11.2006Øhe@vkW;uVeSaVfcVkfeFkkt+ksu MkbZizksfi;ksusV0.0125% MCY;w@MCY;w fcVkfeFkkt+ksu ds cjkcj

98 fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 16 xzke dh V~;wc 9.66 1923(v) 08.11.2006tSUVkekbflu$DyksfVªekt+ksyØhe@vkW;uVeSaVfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.05% MCY;w@MCY;wfcVkfeFkkt+ksu ds cjkcjtSUVkekbflu lYQsV&0.1% MCY;w@MCY;wDyksfVªekt+ksy&1.0% MCY;w@MCY;w

99. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 7 xzke dh V~;wc 6.02 1923(v) 08.11.2006tSUVkekbflu$DyksfVªekt+ksyØhe@vkW;uVeSaVfcVkfeFkkt+ksu MkbZizksfi;ksusV0.05% MCY;w@MCY;w fcVkfeFkkt+ksu ds cjkcjtSUVkekbflu lYQsV&0.1% MCY;w@MCY;wDyksfVªekt+ksy&1.0% MCY;w@MCY;w

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 46: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 27 -

100 fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 15 xzke dh V~;wc 7.90 1923(v) 08.11.2006lsfyflfyd ,sflM$;wfj;k$ysfDVd ,sflM$lksfM;eysDVsV Øhe@vkW;uVeSaVfcVkfeFkkt+ksu MkbZizksfi;ksusV0.05% MCY;w@MCY;w fcVkfeFkkt+ksu ds cjkcjlsfyflfyd ,sflM&3.00% MCY;w@MCY;w;wfj;k&10% MCY;w@MCY;wysfDVd ,sflM&3.00% MCY;w@MCY;wlksfM;e ysDVsV2.00% MCY;w@MCY;w ysfDVd ,sflM ds cjkcj

101 fcVkfeFkkt+ksu Øhe 50 xzke dh V~;wc 14.50 215(v) 14.02.2007fcVkfeFkkt+ksuosyjsV&0.05% MCY;w@MCY;w@xzke

102 fcVkfeFkkt+ksu MkbZizksfi;ksusV 28 fefy 12.48 441(v) 23.03.2007yks’ku@lksY;w’ku dh cksryfcVkfeFkkt+ksu MkbZizksfi;ksusV0.05% MCY;w@oh fcVkfeFkkt+ksu ds cjkcj

103 fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 16 fefy 8.98 441(v) 23.03.2007DyksfVªekt+ksy yks’ku@lksY;w’ku dh cksryfcVkfeFkkt+ksu MkbZizksfi;ksusV0.05% MCY;w@oh fcVkfeFkkt+ksu ds cjkcjDyksfVªekt+ksy 1% MCY;w@MCY;w

104 fcVkfeFkkt+ksu$DyksjksØslksy Øhe 17 xzke dh 7.32 1343(v) 01.08.2007fcVkfeFkkt+ksu 0.0125% V~;wcDyksjksØslksy 0.10%

105 fcVkfeFkkt+ksu$DyksjksØslksy Øhe 17 xzke dh 8.80 1343(v) 01.08.2007fcVkfeFkkt+ksu 0.05% V~;wcDyksjksØslksy 0.10%

106 fcVkfeFkkt+ksu$fu;ksekbflu 17 xzke dh 9.06 1343(v) 01.08.2007lYQsV$DyksjksØslksy Øhe V~;wcfcVkfeFkkt+ksu 0.05%fu;ksekbflu lYQsV 0.50%DyksjksØslksy 0.10%

107 fcVkfeFkkt+ksu$DyksfVªekt+ksy$ 17 xzke dh 9.14 1343(v) 01.08.2007tSUVkekbflu lYQsV$DyksjksØslksy Øhe V~;wcfcVkfeFkkt+ksu 0.05%DyksfVªekt+ksy 1.00%tSUVkekbflu lYQsVtSUVkekbflu csl 0.10% ds cjkcjDyksjksØslksy 0.10%

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 47: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 28 -

108. fcVkfeFkkt+ksu Mkbizksfi;ksusV$ 20 xzke dh V~;wc 9.72 1636(v) 27.09.2007fu;ksekbflu vkW;uVesUVfcVkfeFkkt+ksu Mkbizksfi;ksusVfcVkfeFkkt+ksu-0.05%MCY;w@MCY;wfu;ksekbflu lYQsV -0.5%MCY;w@MCY;w

109. fcVkfeFkkt+ksu Mkbizksfi;ksusV$ 20 xzke dh V~;wc 10.50 1636(v) 27.09.2007fedksukt+ksy vkW;uVesUVfcVkfeFkkt+ksu Mkbizksfi;ksusVfcVkfeFkkt+ksu-0.05%MCY;w@MCY;wfedksukt+ksy ukbVªsV -2.0%MCY;w@MCY;w

110. fcVkfeFkkt+ksu Mkbizksfi;ksusV$ 20 xzke dh V~;wc 10.72 1636(v) 27.09.2007tSUVkekbflu$fedksukt+ksy vkW;uVesUVfcVkfeFkkt+ksu Mkbizksfi;ksusVfcVkfeFkkt+ksu-0.05%MCY;w@MCY;wtSUVkekbflu lYQsVtSUVkekbflu-0.1%MCY;w@MCY;w ds cjkcjfedksukt+ksy ukbVªsV -2.0%MCY;w@MCY;w

111. fcVkfeFkkt+ksu$DyksjksØslksy vkW;uVesUV 17 xzke dh V~;wc 7.32 2057(v) 30.11.2007fcVkfeFkkt+ksu-0.0125%DyksjksØslksy-0.10%

112. fcVkfeFkkt+ksu$lsfyflfyd ,sflM$ 16 xzke dh V~;wc 9.42 1636(v) 27.09.2007;wfj;k$ysfDVd ,sflM$lksfM;eysDVsV vkW;uVesUVfcVkfeFkkt+ksu-0.05%lsfyflfyd ,sflM-3.00%;wfj;k-10.00%MCY;w@MCY;wysfDVd ,sflM-3.00%MCY;w@MCY;wlksfM;e ysDVsV -2.0%MCY;w@MCY;w

113. fcVkfeFkkt+ksu $tSUVkekbflu$ 17 xzke dh V~;wc 9.56 1636(v) 27.09.2007DyksjksØslksy vkW;uVesUVfcVkfeFkkt+ksu-0.05%tSUVkekbflu-0.10%DyksjksØslksy -0.10%

114. fcVkfeFkkt+ksu $DyksfVªesDlksy$ 8 xzke dh V~;wc 6.26 1636(v) 27.09.2007DyksjksØslksy vkW;uVesUVfcVkfeFkkt+ksu-0.05%MCY;w@ohDyksfVªesDlksy-1.00%MCY;w@ohDyksjksØslksy -0.10%

115. fcVkfeFkkt+ksu$fu;ksekbflu lYQsV$ 7 xzke dh V~;wc 6.68 1636(v) 27.09.2007VksYukQVsV$DyksfVªesDlksy$DyksjksØslksy vkW;uVesUVfcVkfeFkkt+ksu-0.05%fu;ksekbflu lYQsV -0.5%VksYukQVsV -1.0%DyksfVªesDlksy-1.00%DyksjksØslksy -0.1%

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 48: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 29 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

116. fcVkfeFkkt+ksu Mkbizksfi;ksusV$ 10 xzke dh V~;wc 6.80 1636(v) 27.09.2007fu;ksekbflu lYQsV$fedksukt+ksyukbVªsV$DyksjksØslksy vkW;uVesUVfcVkfeFkkt+ksu Mkbizksfi;ksusV-0.025% 0.05%fu;ksekbflu lYQsV -0.50%fedksukt+ksy ukbVªsV -2.00%DyksjksØslksy -0.1%

117. fcVkfeFkkt+ksu$tSUVkekbflu lYQsV$ 17 xzke dh V~;wc 9.70 1636(v) 27.09.2007DyksfVªekt+ksy vkW;uVesUVfcVkfeFkkt+ksu-0.05%MCY;w@MCY;wtSUVkekbflu lYQsV-0.1%MCY;w@MCY;wDyksfVªekt+ksy-1.0%MCY;w@MCY;w

118. fcVkfeFkkt+ksu$tSUVkekbflu lYQsV$ 8 xzke dh V~;wc 6.32 1636(v) 27.09.2007DyksfVªekt+ksy vkW;uVesUVfcVkfeFkkt+ksu-0.05%MCY;w@MCY;wtSUVkekbflu lYQsV-0.1%MCY;w@MCY;wDyksfVªekt+ksy-1.0%MCY;w@MCY;w

119. fcVkfeFkkt+ksu$DyksfVªekt+ksy yks’ku 16 fefy dk 8.98 2057(v) 30.11.2007fcVkfeFkkt+ksu-0.05%MCY;w@MCY;w dUVsujDyksfVªekt+ksy-1.00%MCY;w@MCY;w@fefy

120. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 30 xzke dh 13.92 2047(v) 30.11.2007ftad lYQsV$DyksjksØslksy Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusVfcVkfeFkkt+ksu -0.05% MCY;w@MCY;wftad lYQsV-0.5% MCY;w@MCY;wDyksjksØslksy-0.1% MCY;w@MCY;w

121. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 20 xzke dh 10.52 2047(v) 30.11.2007lsfyflfyd ,sflM$ V~;wcysfDVd ,sflM$;wfj;k vkW;uVesUVfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.064fexzk-fcVkfeFkkt+ksu-0.05% ds cjkcjlsfyflfyd ,sflM-0.1% MCY;w@MCY;wysfDVd ,sflM-3.00% MCY;w@MCY;w;wfj;k-10.00% MCY;w@MCY;w

122. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 10 xzke dh 23.70 2047(v) 30.11.2007¶;wflfMd ,sflM$DyksjksØslksy Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.05% MCY;w@MCY;w¶;wflfMd ,sflM-2% MCY;w@MCY;wDyksjksØslksy-0.1% MCY;w@MCY;w

Page 49: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 30 -

123. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 30 xzke dh 14.12 2047(v) 30.11.2007tSUVkekbflu Øhe V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusVfcVkfeFkkt+ksu -0.05% MCY;w@MCY;w ds cjkcjtSUVkekbflu lYQsVtSUVkekbflu csl -0.10% MCY;w@MCY;w

124. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 30 xzke dh 14.12 2047(v) 30.11.2007lsfyflfyd ,sflM vkW;uVesUV V~;wcfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.05% MCY;w@MCY;wlsfyflfyd ,sflM-3% MCY;w@MCY;w

125. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 20 fefy dh 10.04 2047(v) 30.11.2007lsfyflfyd ,sflM yks’ku cksryfcVkfeFkkt+ksu MkbZizksfi;ksusVfcVkfeFkkt+ksu-0.05% ds cjkcjlsfyflfyd ,sflM-3.0% MCY;w@oh@fefy

126. fcVkfeFkkt+ksu$ feFkk;y gkbMªksDlh 15 fefy dh 10.46 2047(v) 30.11.2007csUtq,sV$izksfiy gkbMªksDlh cksry Mªksij vkSjcsUtq,sV Mªksi dkVZu lfgrfcVkfeFkkt+ksu -0.5 fexzk-¼lksfM;e QksLQsV ds leku½feFkk;y gkbMªksDlh csUtq,sV-0.06% MCY;w@MCY;wizksfiy gkbMªksDlh csUtq,sV-0.03% MCY;w@MCY;w

127. fcVkfeFkkt+ksu $,clksY;wV ,YdksgWy Øhe 30 xzke dh 22.56 173(v) 29.01.2008fcVkfeFkkt+ksu-0.1% MCY;w@MCY;w V~;wc,clksY;wV ,YdksgWy-76.05% MCY;w@oh

128. fcVkfeFkkt+ksu$DyksfVªekt+ksy$ 7 xzke dh 6.08 173(v) 29.01.2008DyksjksØslksy Øhe V~;wcfcVkfeFkkt+ksu-0.05% MCY;w@ohDyksfVªekt+ksy-1.00% MCY;w@ohDyksjksØslksy-0.10% MCY;w@oh

129. fcVkfeFkkt+ksu$DyksfVªekt+ksy$ 7 xzke dh 6.08 173(v) 29.01.2008DyksjksØslksy Øhe V~;wcfcVkfeFkkt+ksu-0.05% MCY;w@ohDyksfVªekt+ksy-1.00% MCY;w@ohDyksjksØslksy-0.10% MCY;w@oh

130. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 8 xzke dh 6.50 173(v) 29.01.2008fu;ksekbflu lYQsV$DyksfVªekt+ksy$ V~;wcDyksjksØslksy ØhefcVkfeFkkt+ksu MkbZizksfi;ksusV-0.05% MCY;w@MCY;wfu;ksekbflu lYQsV-0.50% MCY;w@MCY;wDyksfVªekt+ksy-1% MCY;w@ohDyksjksØslksy-0.10% MCY;w@oh

131. fcVkfeFkkt+ksu flji 50 fefy dh 14.32 173(v) 29.01.2008fcVkfeFkkt+ksu MkbZizksfi;ksusV cksryfcVkfeFkkt+ksu -0.05% MCY;w@oh @fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 50: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 31 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

lh (C)

1. dSIVksfizy xksfy;ka & 25 10 dk 8.48 180(v) 09.03.1998 eS- oksdkMZ ,flVsu xksfy;ka25 fexzk-@xksfy;ka ,,y_iRrk eS- fluesfMd ysc dsisl xksfy;ka

2. dSIVksfizy xksfy;ka & 25 10 dk 8.18 180(v) 09.03.1998 eS- VksjsUV ,aT;ksfizy xksfy;ka25 fexzk-@xksfy;ka ,,y_fCyLVj

3. dSIVksfizy xksfy;ka & 50 10 dk iRrk 15.22 180(v) 09.03.1998 eS- oksdkMZ ,flVsu xksfy;ka50 fexzk-@xksfy;ka

4. dSIVksfizy vkSj 10 dk iRrk 8.54 180(v) 09.03.1998 eS- VksjsUV ,aT;ksfizy Mh;wgkbMªksDyksjfFk;kt+kbM xksfy;ka xksfy;ka25 fexzk- $ 15 fexzk- @xksfy;ka

5. dSIVksfizy xksfy;ka 10 dk 4.40 452(v) 29.03.2006 eS- oksdkMZ ,flVsu xksfy;ka12.5 fexzk-@xksfy;ka iRrk@fCyLVj eS- fluesfMd ysc dsisl xksfy;ka

6. dkckZest+kikbu pckus okyh xksfy;ka 10 dk 6.68 769(v) 19.05.2006 eS- fudksyl fijkey estsVksy xksfy;ka100 fexzk-@xksfy;ka ,,y_iRrk eS- lu QkekZ tsiVksy xksfy;ka

eS- VksjsUV dkckZVksy xksfy;ka

7. dkckZest+kikbu pckus okyh xksfy;ka 10 dk 6.36 769(v) 19.05.2006 eS- bUVkl tsu xksfy;ksa100 fexzk-@xksfy;ka ,,y_fCyLVj

8. dkckZest+kikbu lknh@?kqyu’khy xksfy;ka 10 dk 6.16 769(v) 19.05.2006 eS- fudksyl fijkey estsVksy xksfy;ka100 fexzk-@xksfy;ka ,,y_iRrk eS- ekbØks ysc oflZVksy xksfy;ka

9. dkckZest+kikbu lknh@?kqyu’khy xksfy;ka 10 dk 5.94 769(v) 19.05.2006 eS- fudksyl fijkey estsVksy xksfy;ka100 fexzk-@xksfy;ka ,,y_fCyLVj eS- ekbØks ysc oflZVksy xksfy;ka

10. dkckZest+kikbu xksfy;ka 10 dk 10.96 769(v) 19.05.2006 eS- uksokfVZl VsxfjVksy xksfy;ka200 fexzk-@xksfy;ka ,,y_iRrk eS- fudksyl fijkey estsVksy xksfy;kaa

11. dkckZest+kikbu xksfy;ka 10 dk 10.74 769(v) 19.05.2006 eS- lu QkekZ tsiVksy xksfy;ka200 fexzk-@xksfy;ka ,,y_fCyLVj eS- bUVkl tsu xksfy;ka

eS- VksjsUV dkckZVksy xksfy;kaeS- ekbØks ysc oflZVksy xksfy;ka

12. dkckZest+kikbu xksfy;ka 10 dk 22.50 1154(v) 20.10.2004 eS- uksokfVZl VsxfjVksy xksfy;ka400 fexzk-@xksfy;ka ,,y_iRrk eS- fudksyl fijkey estsVksy xksfy;kaa

13. dkckZest+kikbu xksfy;ka 10 dk 22.18 769(v) 19.05.2006 eS- lu QkekZ tsiVksy xksfy;ka400 fexzk-@xksfy;ka ,,y_fCyLVj eS- bUVkl tsu xksfy;ka

eS- ekbØks ysc oflZVksy xksfy;ka

14. dkckZest+kikbu ,lvkj@lhvkj@ 10 dk 13.06 769(v) 19.05.2006 eS- uksokfVZl VsxfjVksy xksfy;kaMhvkj@fjVkMZ xksfy;ka ,,y_iRrk eS- fudksyl fijkey estsVksy xksfy;kaa200 fexzk-@,lvkj@lhvkj@Mhvkj eS- VksjsUV dkckZVksy xksfy;ka@fjVkMZ xksfy;ka

Page 51: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 32 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

15. dkckZest+kikbu ,lvkj@lhvkj@ 10 dk 12.74 769(v) 19.05.2006 eS- ekbØks ysc oflZVksy xksfy;kaMhvkj@fjVkMZ xksfy;ka ,,y_fCyLVj200 fexzk-@,lvkj@lhvkj@Mhvkj@fjVkMZ xksfy;ka

16. dkckZest+kikbu ,lvkj@lhvkj@ 10 dk 17.86 769(v) 19.05.2006 eS- fudksyl fijkey estsVksy xksfy;kaaMhvkj@fjVkMZ xksfy;ka ,,y_iRrk eS- lu QkekZ tsiVksy xksfy;ka300 fexzk-@,lvkj@lhvkj@Mhvkj eS- bUVkl tsu xksfy;ka@fjVkMZ xksfy;ka

17. dkckZest+kikbu ,lvkj@lhvkj@ 10 dk 17.54 769(v) 19.05.2006 eS- ekbØks ysc oflZVksy xksfy;kaMhvkj@fjVkMZ xksfy;ka ,,y_fCyLVj300 fexzk-@,lvkj@lhvkj@Mhvkj@fjVkMZ xksfy;ka

18. dkckZest+kikbu ,lvkj@lhvkj@ 10 dk 24.78 769(v) 19.05.2006 eS- uksokfVZl VsxfjVksy xksfy;kaMhvkj@fjVkMZ xksfy;ka ,,y_iRrk eS- fudksyl fijkey estsVksy xksfy;kaa400 fexzk-@,lvkj@lhvkj@Mhvkj eS- VksjsUV dkckZVksy xksfy;ka@fjVkMZ xksfy;ka

19. dkckZest+kikbu ,lvkj@lhvkj@ 10 dk 24.46 769(v) 19.05.2006 eS- uksokfVZl VsxfjVksy xksfy;kaMhvkj@fjVkMZ xksfy;ka ,,y_fCyLVj eS- fudksyl fijkey estsVksy xksfy;kaa400 fexzk-@,lvkj@lhvkj@Mhvkj eS- VksjsUV dkckZVksy xksfy;ka@fjVkMZ xksfy;ka

20. dkckZest+kikbu flji 50 fefy dh 11.80 769(v) 19.05.2006 eS- uksokfVZl VsxfjVksy fyfDoM100 fexzk-@ 5 fefy cksry ,e-di lfgr eS- fudksyl fijkey estsVksy fyfDoM

21. dkckZest+kikbu flji 100 fefy dh cksry 19.20 769(v) 19.05.2006 eS- uksokfVZl VsxfjVksy fyfDoM100 fexzk-@ 5 fefy ,e-di vkSj dkVZu lfgr eS- fudksyl fijkey estsVksy fyfDoM

22. lsQkMªksDlhy lknh@?kqyu’khy xksfy;ka-125 4 dk 6.78 784(v) 16.08.2001 eS- baMksdks osisu xksfy;kalsQkMªksDlhy eksuksgkbMªsV ,,y_iRrk eS- CY;w ØkWl cywMªksDl xksfy;ka125 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@xksfy;ka

23. lsQkMªksDlhy lknh@?kqyu’khy xksfy;ka-125 4 dk 6.63 784(v) 16.08.2001 eS- baMksdks osisu xksfy;kalsQkMªksDlhy eksuksgkbMªsV ,,y_fCyLVj eS- CY;w ØkWl cywMªksDl xksfy;ka125 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@xksfy;ka

24. lsQkMªksDlhy lknh@?kqyu’khy xksfy;ka-125 10 dk 9.26 443(v) 30.03.2005 eS- Y;wfiu ysc vksMksDlhy xksfy;ka¼fdM½lsQkMªksDlhy eksuksgkbMªsV ,,y_iRrk eS- ,fjLVks QkekZ lsQkMªksDl xksfy;ka¼fdM½125 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@xksfy;ka eS- fliyk lsQkMksj MhVh xksfy;ka

25. lsQkMªksDlhy lknh@?kqyu’khy xksfy;ka-125 10 dk 8.98 443(v) 30.03.2005 eS- baMksdks osisu xksfy;kalsQkMªksDlhy eksuksgkbMªsV ,,y_fCyLVj eS- VksjsUV MªksDlhy xksfy;ka125 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@xksfy;ka eS- ekbØks ysc ckblsQ xksfy;ka

26. lsQkMªksDlhy lknh@?kqyu’khy xksfy;ka-250 4 dk 13.40 784(v) 16.08.2001 eS- VksjsUV MªksDlhy xksfy;kalsQkMªksDlhy eksuksgkbMªsV ,,y_iRrk eS- Y;wfiu ysc vksMksDlhy xksfy;ka¼fdM½250 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@xksfy;ka eS- baMksdks osisu xksfy;ka

Page 52: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 33 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

27. lsQkMªksDlhy lknh@?kqyu’khy xksfy;ka-250 4 dk 13.22 784(v) 16.08.2001 eS- osysl osykMªksDl xksfy;kalsQkMªksDlhy eksuksgkbMªsV ,,y_fCyLVj250 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@xksfy;ka

28. lsQkMªksDlhy lknh@?kqyu’khy xksfy;ka-250 10 dk 18.56 443(v) 30.03.2005 eS- VksjsUV MªksDlhy xksfy;kalsQkMªksDlhy eksuksgkbMªsV ,,y_iRrk eS- Y;wfiu ysc vksMksDlhy xksfy;ka¼fdM½250 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@xksfy;ka eS- baMksdks osisu xksfy;ka

29. lsQkMªksDlhy lknh@?kqyu’khy xksfy;ka-250 10 dk 18.10 443(v) 30.03.2005 eS- ,fjLVks QkekZ lsQkMªksDl xksfy;ka¼fdM½lsQkMªksDlhy eksuksgkbMªsV ,,y_fCyLVj eS- fliyk lsQkMksj MhVh xksfy;k250 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@xksfy;ka eS- ,QMhlh tkMjks xksfy;k

30. lsQkMªksDlhy lknh@?kqyu’khy xksfy;ka-500 4 dk 13.24 443(v) 30.03.2005 eS- ,fjLVks QkekZ lsQkMªksDllsQkMªksDlhy eksuksgkbMªsV ,,y_iRrk eS- VksjsUV MªksDlhy xksfy;ka500 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@xksfy;ka eS- Y;wfiu ysc vksMksDlhy xksfy;ka¼fdM½

31. lsQkMªksDlhy lknh@?kqyu’khy xksfy;ka-500 4 dk 13.06 443(v) 30.03.2005 eS- baMksdks osisu xksfy;kalsQkMªksDlhy eksuksgkbMªsV ,,y_fCyLVj eS- ,QMhlh tkMjks xksfy;ka500 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@xksfy;ka eS- fliyk lsQkMksj MhVh xksfy;k

32. lsQkMªksDlhy lknh@?kqyu’khy xksfy;ka 4 dk 24.68 443(v) 30.03.2005 eS- Y;wfiu vksMksDlhy xksfy;a¼fdM½lsQkMªksDlhy eksuksgkbMªsV ,,y_iRrk1000 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@xksfy;ka

33. lsQkMªksDlhy lknh@?kqyu’khy xksfy;ka 4 dk 24.44 443(v) 30.03.2005 eS- Y;wfiu vksMksDlhy xksfy;a¼fdM½lsQkMªksDlhy eksuksgkbMªsV ,,y_fCyLVj1000 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@xksfy;ka

34. lsQkMªksDlhy dSilwy 10 dk 17.76 443(v) 30.03.2005 eS- lksyl dsQyksDlhu dSilwylsQkMªksDlhy eksuksgkbMªsV ,,y_iRrk250 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@dSi-

35. lsQkMªksDlhy dSilwy 10 dk 17.36 443(v) 30.03.2005 eS- lksyl dsQyksDlhu dSilwylsQkMªksDlhy eksuksgkbMªsV ,,y_fCyLVj250 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@dSi-

36. lsQkMªksDlhy dSilwy 4 dk 13.10 443(v) 30.03.2005 eS- ,fjLVks QkekZ lsQkMªksDl dSilwylsQkMªksDlhy eksuksgkbMªsV ,,y_iRrk eS- Cy;w ØkWl CywMªksDl dSilwy500 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@dSi-

37. lsQkMªksDlhy dSilwy 4 dk 12.84 443(v) 30.03.2005 eS- ,fjLVks QkekZ lsQkMªksDl dSilwylsQkMªksDlhy eksuksgkbMªsV ,,y_fCyLVj eS- Cy;w ØkWl CywMªksDl dSilwy500 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@dSi-

38. lsQkMªksDlhy dSilwy 4 dk 24.59 443(v) 30.03.2005lsQkMªksDlhy eksuksgkbMªsV ,,y_iRrk1000 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@dSi-

39. lsQkMªksDlhy dSilwy 4 dk 24.34 443(v) 30.03.2005lsQkMªksDlhy eksuksgkbMªsV ,,y_fCyLVj1000 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@dSi-

Page 53: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 34 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

40. lsQkMªksDlhy lLisUlu@flji 30 fefy dh 14.06 169(v) 07.02.2006 eS- fliyk lsQkMksjizR;sd 5 fefy esa cksry ,e- di eS- Y;wfiu vksMksDlhylsQkMªksDlhy eksuksgkbMªsV lfgr eS- ,fjLVks lsQkMªksDl125 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj eS- baMksdks osisu

41. lsQkMªksDlhy lLisUlu@flji 30 fefy dh 12.88 443(v) 30.03.2005 eS- VksjsUV MªksDlhyizR;sd 5 fefy esa cksry eS- ,QMhlh tkMjkslsQkMªksDlhy eksuksgkbMªsV125 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj

42. lsQkMªksDlhy lLisUlu@flji 30 fefy dh 18.52 169(v) 07.02.2006 eS- fliyk lsQkMksjizR;sd 5 fefy esa cksry ,e- di eS- Y;wfiu vksMksDlhylsQkMªksDlhy eksuksgkbMªsV lfgr eS- ,fjLVks lsQkMªksDl250 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj eS- baMksdks osisu

43. lsQkMªksDlhy lLisUlu@flji 30 fefy dh 17.22 443(v) 30.03.2005 eS- VksjsUV MªksDlhyizR;sd 5 fefy esa cksry eS- ,QMhlh tkMjkslsQkMªksDlhy eksuksgkbMªsV250 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj

44. lsQkMªksDlhy MªkbZ flji 30 fefy dh 10.16 443(v) 30.03.2005 eS- ,fjLVks lsQkMªksDlizR;sd 5 fefy esa cksry ,e- di eS- ,fDVo ,p- ds;j ,fDVMªksDllsQkMªksDlhy eksuksgkbMªsV lfgr eS- dksijsu fcM&,ych125 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj eS- izksVsd lsQkMksj

eS- osaMj lsQkds;j

45. lsQkMªksDlhy MªkbZ flji 30 fefy dh 9.70 443(v) 30.03.2005 eS- tsVd lsQkVsdizR;sd 5 fefy esa cksry eS- zQsadfyu ysc lsDlhylsQkMªksDlhy eksuksgkbMªsV125 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj

46. lsQkMªksDlhy MªkbZ flji 60 fefy dh 15.86 443(v) 30.03.2005 eS- dsaVªsd ysc lkbMªksDlhy &,lizR;sd 5 fefy esa cksry ,e-dilsQkMªksDlhy eksuksgkbMªsV lfgr125 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj

47. lsQkMªksDlhy MªkbZ flji 60 fefy dh 15.38 443(v) 30.03.2005 eS- dsaVªsd ysc lkbMªksDlhy&,lizR;sd 5 fefy esa cksrylsQkMªksDlhy eksuksgkbMªsV125 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj

48. lsQkMªksDlhy MªkbZ flji 30 fefy dh 15.78 169(v) 07.02.2006 eS- ekbØks ysc ckblsQizR;sd 5 fefy esa cksry ,e- di eS- izksVsd lsQkMksjlsQkMªksDlhy eksuksgkbMªsV lfgr eS- ck;ksxkMZ vksjxsfudMªksDlhysd250 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj eS- U;wt+su dkbZMªksDl

49. lsQkMªksDlhy MªkbZ flji 30 fefy dh 14.46 443(v) 30.03.2005 eS- ekijk ysc ekijkMªksDlizR;sd 5 fefy esa cksry eS- ikbQj QkekZ ikbZlsQlsQkMªksDlhy eksuksgkbMªsV250 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj

Page 54: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 35 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

50. lsQkMªksDlhy Mªksi 10 fefy dh 12.26 443(v) 30.03.2005 eS- baMksdks osisuizR;sd fefy esa cksry Mªksij eS- ,QMhlh tkMªkslsQkMªksDlhy eksuksgkbMªsV lfgr eS- Cy;w ØkWl cywMªksDl&ih100 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj

51. lsQkMªksDlhy Mªksi 10 fefy dh 11.08 443(v) 30.03.2005 eS- baMksdks osisulsQkMªksDlhy eksuksgkbMªsV cksry eS- ,QMhlh tkMjks100 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj@fefy eS- Cy;w ØkWl cywMªksDl&ih

52. lsQkMªksDlhy $ ,EczksDlksy xksfy;ka 10 dk 8.26 445(v) 30.03.2005 eS- vjksfcanks lsMczksDllsQkMªksDlhy eksuksgkbMªsV iRrk@fCyLVj125 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj,EczksDlksy&15 fexzk- @xksfy;ka

53. lsQkMªksDlhy $ ,EczksDlksy xksfy;ka 10 dk 15.64 445(v) 30.03.2005 eS- lk;kseksaM QkekZ ,EchMªksDllsQkMªksDlhy eksuksgkbMªsV iRrk@fCyLVj eS- vkjksfcanks lsMczksDl250 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj eS- vtUrk dsQMhy&,,Dl,EczksDlksy&30 fexzk- @xksfy;ka eS- baMksdks osisu&,,Dl

54. lsQkMªksDlhy $ ,EczksDlksy xksfy;ka 10 dk 28.60 445(v) 30.03.2005 eS- lk;kseksaM QkekZ ,EchMªksDllsQkMªksDlhy eksuksgkbMªsV iRrk@fCyLVj eS- vkjksfcanks lsMczksDl500 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj eS- vtUrk dsQMhy&,,Dl,EczksDlksy&30 fexzk- @xksfy;ka eS- baMksdks osisu&,,Dl

55. lsQkMªksDlhy $ ,EczksDlksy xksfy;ka 4 dk 11.90 445(v) 30.03.2005 eS- osysl osykMªksDl , ,DllsQkMªksDlhy eksuksgkbMªsV iRrk@fCyLVj500 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcj,EczksDlksy&45 fexzk- @xksfy;ka

56. lsQkMªksDlhy $ izkscsusflM xksfy;ka 6 dk 11.76 446(v) 30.03.2005 eS- MhMCY;wMh MsDl ,y,lsQkMªksDlhy eksuksgkbMªsV iRrk@fCyLVj250 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcjizkscsusflM&250 fexzk- @xksfy;ka

57. lsQkMªksDlhy $ izkscsusflM xksfy;ka 6 dk 22.66 446(v) 30.03.2005 eS- MhMCY;wMh MsDl ,y,lsQkMªksDlhy eksuksgkbMªsV iRrk@fCyLVj500 fexzk- lsQkMªksDlhy ,Ugk- ds cjkcjizkscsusflM&500 fexzk- @xksfy;ka

58. lsQkMªksDlhy eksuksgkbMªsV $ ysfDVd 10 dk 8.36 1346(v) 16.09.2005 eS- Cy;w ØkWl CywMªksDl ,ych xksfy;ka,sflM csflyl xksfy;ka iRrk@fCyLVjlsQkMªksDlhy ¼eksuksgkbMªsV e½sa&125 fexzk-ysfDVd ,sflM csflylLiksZl&30 fefy;u@?kqyu’khy xksfy;ka

59. lsQkMªksDlhy eksuksgkbMªsV $ ysfDVd 10 dk 8.46 1346(v) 16.09.2005 eS- ck;ksxkMZ vksjxsfudMªksDlhysd xksfy;ka,sflM csflyl xksfy;ka iRrk@fCyLVj eS- fllVk QkekZ ysDVkMªksDl xksfy;kalsQkMªksDlhy ¼eksuksgkbMªsV e½sa&125 fexzk-ysfDVd ,sflM csflylLiksZl&60 fefy;u@?kqyu’khy xksfy;ka

Page 55: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 36 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

60. lsQkMªksDlhy eksuksgkbMªsV $ ysfDVd 10 dk 15.74 1346(v) 16.09.2005 eS- Cy;w ØkWl CywMªksDl ,ych xksfy;ka,sflM csflyl xksfy;ka iRrk@fCyLVj eS- flaVks QkekZ zQksfyd ,ych xksfy;kalsQkMªksDlhy ¼eksuksgkbMªsV ds leku½s&250 fexzk- eS- esMkst+ QkekZ esMªksDl xksfy;kaysfDVd ,sflM csflylLiksZl&60 fefy;u@?kqyu’khy xksfy;ka

61. lsQkMªksDlhy eksuksgkbMªsV $ ysfDVd 10 dk 30.04 1346(v) 16.09.2005 eS- flaVks QkekZ zQksfyd ,ych xksfy;ka,sflM csflyl xksfy;ka iRrk@fCyLVj eS- Cy;w ØkWl cywMªksDl ,ych xksfy;kalsQkMªksDlhy ¼eksuksgkbMªsV ds leku½s&500 fexzk- eS- esMkst QkekZ esMªksDl xksfy;kaysfDVd ,sflM csflyl eS- ck;ksxkMZ vksjxsfudMªksDlhysd xksfy;kaLiksZl&60 fefy;u@?kqyu’khy xksfy;ka

62. lsQkMªksDlhy eksuksgkbMªsV $ ysfDVd 30 fefy dh 10.44 1346(v) 16.09.2005 eS- fMldojh esudkabMlsQkLVkj,sflM csflyl MªkbZ flji cksry ,e- dilsQkMªksDlhy ¼eksuksgkbMªsV ds leku½s&125 fexzk- lfgrysfDVd ,sflM csflylLiksZl&60 fefy;u@ 5 fefy

63. lsQkMªksDlhy eksuksgkbMªsV $ ysfDVd 30 fefy dh 14.78 1346(v) 16.09.2005,sflM csflyl MªkbZ flji cksry ,e- dilsQkMªksDlhy ¼eksuksgkbMªsV ds leku½s&250 fexzk- lfgrysfDVd ,sflM csflylLiksZl&60 fefy;u@ 5 fefy

64. lsQkMªksDlhy eksuksgkbMªsV $ ysfDVd 60 fefy dh 24.86 1346(v) 16.09.2005,sflM csflyl MªkbZ flji cksry ,e- dilsQkMªksDlhy ¼eksuksgkbMªsV ds leku½s&250 fexzk- lfgrysfDVd ,sflM csflylLiksZl&60 fefy;u@ 5 fefy

65. lsQkMªksDlhy eksuksgkbMªsV $ 6 dk 30.26 1917(v) 08.11.2006iksVkf’k;e DysO;wysusV xksfy;ka iRrk@fCyLVjizR;sd ?kqyu’khy xksfy;ksa esalsQkMªksDlhy eksuksgkbMªsVlsQkMªksDlhy&250 fexzk- ds cjkcjiksVkf’k;e DysO;wysusVDysO;wysfud ,sflM&125 fexzk- ds cjkcj

66. lsQkMªksDlhy eksuksgkbMªsV $ 6 dk 58.98 1917(v) 08.11.2006iksVkf’k;e DysO;wysusV xksfy;ka iRrk@fCyLVjizR;sd ?kqyu’khy xksfy;ksa esalsQkMªksDlhy eksuksgkbMªsVlsQkMªksDlhy&500 fexzk- ds cjkcjiksVkf’k;e DysO;wysusVDysO;wysfud ,sflM&125 fexzk- ds cjkcj

Page 56: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 37 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

67. lsQkMªksDlhy eksuksgkbMªsV $ 30 fefy ch 35.80 1917(v) 08.11.2006iksVkf’k;e DysO;wysusV lLisUlu cksry ,e-diizR;sd ?kqyu’khy xksfy;ksa esa vkSj dkVZu lfgrlsQkMªksDlhy eksuksgkbMªsVlsQkMªksDlhy&250 fexzk- ds cjkcjiksVkf’k;e DysO;wysusVDysO;wysfud ,sflM&162.5 fexzk- ds cjkcj

68. lsQkMªksDlhy $ ysfDVd 10 dk 18.14 444(v) 30.03.2005,sflM csflyl dSilwy ,,y_iRrklsQkMªksDlhy eksuksgkbMªsVlsQkMªksDlhy&250 fexzk- ds cjkcjysfDVd ,sflM csflylLiksZl&30 fefy;u@ dSilwy

69. lsQkMªksDlhy $ ysfDVd 10 dk 17.74 444(v) 30.03.2005,sflM csflyl dSilwy ,,y_fCyLVjlsQkMªksDlhy eksuksgkbMªsVlsQkMªksDlhy&250 fexzk- ds cjkcjysfDVd ,sflM csflylLiksZl&30 fefy;u@ dSilwy

70. lsQkMªksDlhy $ ysfDVd 6 dk 19.96 444(v) 30.03.2005,sflM csflyl dSilwy ,,y_iRrklsQkMªksDlhy eksuksgkbMªsVlsQkMªksDlhy&500 fexzk- ds cjkcjysfDVd ,sflM csflylLiksZl&60 fefy;u@ dSilwy

71. lsQkMªksDlhy $ ysfDVd 10 dk 19.58 444(v) 30.03.2005,sflM csflyl dSilwy ,,y_fCyLVjlsQkMªksDlhy eksuksgkbMªsVlsQkMªksDlhy&500 fexzk- ds cjkcjysfDVd ,sflM csflylLiksZl&60 fefy;u@ dSilwy

72. lsQkMªksDlhy$ysfDVd ,sflM 10 dk 30.42 2049(v) 30.11.2007csflyl xksfy;ka iRrk@fCyLVjlsQkMªksDlhy ,UgkbMªl-500 fexzk-ysfDVd ,sflM csflyl-90 fefy;u LiksZl

73. lsQkMªksDlhy$ysfDVd ,sflM 10 dk 8.80 2049(v) 30.11.2007csflyl xksfy;ka iRrk@fCyLVjlsQkMªksDlhy ,UgkbMªl -125 fexzk-ysfDVd ,sflM csflyl-120 fefy;u LiksZl

74. flQkVksDlkbe lksfM;e bUtsD’ku&125 fexzk- V~fou iSd 10.36 432(v) 23.03.2007 eS- Y;wfiu ysc lsQkUVªky bUtsD’ku125 fexzk- csl @ ok;y ¼ok;y$,Ei;wy eS- Cy;w ØkWl cywVsDl

bUtsD’ku ds fy, ikuh½ eS- ;wfu lsuD;w fuyLVsV

Page 57: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 38 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

75. flQkVksDlkbe lksfM;e bUtsD’ku&125 fexzk- 1 ok;y 6.76 768(v) 19.05.2006 eS- ,fjLVks ysc vkseuhlsQ125 fexzk- csl @ ok;y

76. flQkVksDlkbe lksfM;e bUtsD’ku&250 fexzk- V~fou iSd 12.60 432(v) 23.03.2007 eS- Y;wfiu ysc lsQkUVªky bUtsD’ku250 fexzk- csl @ ok;y ¼ok;y$,Ei;wy eS- Cy;w ØkWl cywVsDl

bUtsD’ku ds fy, ikuh½ eS- ;wfu lsuD;w fuyLVsV

77. flQkVksDlkbe lksfM;e bUtsD’ku&250 fexzk- 1 ok;y 9.04 768(v) 19.05.2006 eS- ,ofUVl QkekZ DysQjksy250 fexzk- csl @ ok;y eS- oksdkMZ tsVkfDle

eS- jsucsDlh LVsulsQeS- ,fjLVks QkekZ vkseuhlsQ

78. flQkVksDlkbe lksfM;e bUtsD’ku&500 fexzk- V~fou iSd 17.06 432(v) 23.03.2007 eS- Y;wfiu ysc lsQkUVªky bUtsD’ku500 fexzk- csl @ ok;y ¼ok;y$,Ei;wy eS- Cy;w ØkWl cywVsDl

bUtsD’ku ds fy, ikuh½ eS- ;wfu lsuD;w fuyLVsV

79. flQkVksDlkbe lksfM;e bUtsD’ku&500 fexzk- 1 ok;y 13.54 768(v) 19.05.2006 eS- ,ofUVl QkekZ DysQjksy500 fexzk- csl @ ok;y eS- oksdkMZ tsVkfDle

eS- jsucsDlh LVsulsQeS- ,fjLVks QkekZ vkseuhlsQ

80. flQkVksDlkbe lksfM;e bUtsD’ku&750 fexzk- 1 ok;y 17.60 768(v) 19.05.2006750 fexzk- csl @ ok;y

81. flQkVksDlkbe lksfM;e bUtsD’ku&1 xzk- V~fou iSd 26.70 432(v) 23.03.2007 eS- Y;wfiu ysc lsQkUVªky ok;y1 xzke csl @ ok;y ¼ok;y$,Ei;wy eS- ck;ksdse ck;ksVsD; ok;y

bUtsD’ku ds fy, ikuh½ eS- lsuksQh ,ofUVl DysQksju ok;y

82. flQkVksDlkbe lksfM;e bUtsD’ku&1 xzk- 1 ok;y 22.68 768(v) 19.05.2006 eS- Y;wfiu ysc lsQkUVªky ok;y1 xzke csl @ ok;y eS- ck;ksdse ck;ksVsD; ok;y

eS- lsuksQh ,ofUVl DysQksju ok;y

83. flQkVksDlkbe lksfM;e bUtsD’ku&1500 fexzk-1 ok;y 31.48 768(v) 19.05.20061500 fexzk- csl @ ok;y

84. flQkVksDlkbe lksfM;e bUtsD’ku&2 xzk- V~fou iSd 44.34 768(v) 19.05.20062 xzke csl @ ok;y ¼ok;y$,Ei;wy

bUtsD’ku ds fy, ikuh½

85. flQkVksDlkbe lksfM;e bUtsD’ku&1 xzk- 1 ok;y 41.44 768(v) 19.05.20061 xzke csl @ ok;y

86. flQkVksDlkbe lksfM;e $ V~fou iSd 35.36 435(v) 23.03.2007 eS- ,eD;wj vksxVsDl ok;ylYcsDVe lksfM;e bUtsD’ku ¼ok;y$,Ei;wy eS- fu;ksu ,soklsQ ,l ok;yflQkVksDlkbe lksfM;e bUtsD’ku ds fy, ikuh½ eS- oh,pch ykbQlkbal bohesDl ok;y1 xzke flQkVksDlkbe ds cjkcj eS- ,fjLVks fM;ksVsDl ok;ylYcsDVe lksfM;e500 fexzk- lYcsDVe ds cjkcj @ ok;y

Page 58: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 39 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

87. flQkVksDlkbe lksfM;e $ 1 ok;y 32.46 435(v) 23.03.2007 eS- ,eD;wj vksxVsDl ok;ylYcsDVe lksfM;e bUtsD’ku eS- fu;ksu ,soklsQ ,l ok;yflQkVksDlkbe lksfM;e eS- oh,pch ykbQlkbal bohesDl ok;y1 xzke flQkVksDlkbe ds cjkcj eS- ,fjLVks fM;ksVsDl ok;ylYcsDVe lksfM;e500 fexzk- lYcsDVe ds cjkcj @ ok;y

88. flQkVksDlkbe lksfM;e $ V~fou iSd 21.02 435(v) 23.03.2007 eS- ,eD;wj vksxVsDl ok;ylYcsDVe lksfM;e bUtsD’ku ¼ok;y$,Ei;wy eS- ,fjLVks fM;ksVsDl ok;yflQkVksDlkbe lksfM;e bUtsD’ku ds fy, ikuh½ eS- lur lsQvi ok;y500 fexzk- flQkVksDlkbe ds cjkcj eS- VªsUMl QkekZ xksYMlsQ&,l ok;ylYcsDVe lksfM;e250 fexzk- lycsdVe ds cjkcj @ ok;y

89. flQkVksDlkbe lksfM;e $ 1 ok;y 18.02 435(v) 23.03.2007 eS- ,eD;wj vksxVsDl ok;ylYcsDVe lksfM;e bUtsD’ku eS- ,fjLVks fM;ksVsDl ok;yflQkVksDlkbe lksfM;e eS- lur lsQvi ok;y500 fexzk- flQkVksDlkbe ds cjkcj eS- VªsUMl QkekZ xksYMlsQ&,l ok;ylYcsDVe lksfM;e250 fexzk- lYcsDVe ds cjkcj @ ok;y

90. flQkVksDlkbe lksfM;e $ 1 ok;y 11.42 435(v) 23.03.2007lYcsDVe lksfM;e bUtsD’kuflQkVksDlkbe lksfM;e250 fexzk- flQkVksDlkbe ds cjkcjlYcsDVe lksfM;e125 fexzk- lYcsDVe ds cjkcj @ ok;y

91. flQkVksDlkbe lksfM;e $ V~fou iSd 14.96 1326(v) 01.08.2007lYcsDVe lksfM;e bUtsD’ku ¼ 1 ok;y$,Ei;wyflQkVksDlkbe lksfM;e czkseks cwVkby jcM+250 fexzk- flQkVksDlkbe ds cjkcj LVksij vkSj f¶yilYcsDVe lksfM;e vkWQ fly lfgr125 fexzk- lycsdVe ds cjkcj @ ok;y

92. lsQkt+ksfyu lksfM;e bUtsD’ku&125 fexzk- ok;y 6.58 2041(v) 30.11.2007 eS- tk;Ml dsfMyk vksfjt+ksfyu125 fexzk- csl @ok;y

93. lsQkt+ksfyu lksfM;e bUtsD’ku&125 fexzk- V~fou iSd 8.60 605(v) 27.05.2003125 fexzk- csl @ok;y ok;y$,Ei;wy

94. lsQkt+ksfyu lksfM;e bUtsD’ku&250 fexzk- ok;y 8.44 2041(v) 30.11.2007 eS- jsucsDlh jsQfyu250 fexzk- csl @ok;y eS- ,yfEcd ,yflt+ksu

95. lsQkt+ksfyu lksfM;e bUtsD’ku&250 fexzk- V~fou iSd 11.34 2041(v) 30.11.2007 eS- ck;ksdse ,t+ksfyu250 fexzk- csl @ok;y ok;y$,Ei;wy eS- tk;Ml dsfMyk vksfjt+ksfyu

96. lsQkt+ksfyu lksfM;e bUtsD’ku&500 fexzk- ok;y 12.16 2041(v) 30.11.2007 eS- jsucsDlh jsQfyu500 fexzk- csl @ok;y eS- ,yfEcd ,yflt+ksu

Page 59: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 40 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

97. lsQkt+ksfyu lksfM;e bUtsD’ku&500 fexzk- V~fou iSd 15.06 2041(v) 30.11.2007 eS- ck;ksdse ,t+ksfyu500 fexzk- csl @ok;y ok;y$,Ei;wy eS- tk;Ml dsfMyk vksfjt+ksfyu

eS- izse QkekZ izst+ksfyu

98. lsQkt+ksfyu lksfM;e bUtsD’ku&1000 fexzk- ok;y 20.32 2041(v) 30.11.2007 eS- jsucsDlh jsQfyu1000 fexzk- csl @ok;y eS- ,yfEcd ,yflt+ksu

99. lsQkt+ksfyu lksfM;e bUtsD’ku&1000 fexzk- V~fou iSd 23.22 2041(v) 30.11.2007 eS- ck;ksdse ,t+ksfyu1000 fexzk- csl @ok;y ok;y$,Ei;wy eS- tk;Ml dsfMyk vksfjt+ksfyu

eS- izse QkekZ izht+ksfyu

100. flfVªekbM$dSfY’k;e iSUVksfFkusV yks’ku 15 fefy 6.98 1077(v) 11.07.2006flfVªekbM 5% MCY;w@oh dh cksrydSfY’k;e iSUVksfFkusV 2% MCY;w@oh@fefy

101. DyksjksDohu QksLQsV xksfy;ka 10x10 dk 54.18 180(v) 07.02.2006 eS- bidk ysfjxks250 fexzk- @xksfy;ka ¼lknh½ ,,y_iRrk eS- ck;j jslksfpu

102. DyksjksDohu QksLQsV xksfy;ka 10x10 dk 51.56 180(v) 07.02.2006 eS- fudksYl fijkey fuokDohu ih250 fexzk- @xksfy;ka ¼lknh½ ,,y_fCyLVj eS- edZ ,eDohu

eS- baMksdks DyksDohu

103. DyksjksDohu QksLQsV xksfy;ka 5 dk 5.44 430(v) 23.03.2007 eS- bidk ysfjxks Mh,l500 fexzk- @xksfy;ka ¼fQYe fyfir½ iRrk@fCyLVj eS- ck;j jslksfpu

eS- fudksYl fijkey fuokDohu iheS- edZ ,eDohueS- baMksdks DyksDohu

104. DyksjksDohu QksLQsV xksfy;ka 10 dk 5.68 430(v) 23.03.2007 eS- bidk ysfjxks Mh,l250 fexzk- @xksfy;ka ¼fQYe fyfir½ iRrk@fCyLVj eS- ck;j jslksfpu

eS- fudksYl fijkey fuokDohu ih

105. DyksjksDohu QksLQsV bUtsD’ku 30 fefy dk 15.48 430(v) 23.03.2007 eS- bidk ysfjxksDyksjksDohu QksLQsV 64.5 fexzk- ok;y eS- ck;j jslksfpu40 fexzk- DyksjksDohu ds cjkcj@fefy eS- fudksYl fijkey fuokDohu ih

106. DyksjksDohu QksLQsV bUtsD’ku 30 fefy dk 16.48 430(v) 23.03.2007DyksjksDohu QksLQsV 64.5 fexzk- ok;y dkVZu40 fexzk- DyksjksDohu ds cjkcj@fefy lfgr

107. DyksjksDohu QksLQsV bUtsD’ku 5x5 fefy 17.84 388(v) 02.04.2003 eS- bidk ysfjxks64.5 fexzk-@fefy = 40 fexzk- csl@fefy lQsn ,Ei;wy eS- ck;j jslksfpu

eS- fudksYl fijkey fuokDohu ih

108. DyksjksDohu QksLQsV bUtsD’ku 5x5 fefy 18.84 388(v) 02.04.2003 eS- baMksdks DyksDohu64.5 fexzk-@fefy = 40 fexzk- csl@fefy ,Ecj ,Ei;wy

109. DyksjksDohu QksLQsV bUtsD’ku 5 fefy 4.58 171(v) 29.01.2008 eS- Fksfel esfMds;j bZ&okbZosDl64.5 fexzk-@fefy = 40 fexzk- csl@fefy ,Ei;wy eS- LVsMesM ysDohu

Page 60: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 41 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

110. DyksjksDohu QksLQsV bUtsD’ku 5x5 fefy 25.38 430(v) 23.03.2007 eS- Fksfel esfMds;j bZ&okbZosDlDyksjksDohu QksLQsV 64.5 fexzk- ,Ecj ,Ei;wy eS- LVsMesM ysDohu40 fexzk- DyksjksDohu ds cjkcj@fefy

111. DyksjksDohu QksLQsV bUtsD’ku 2 fefy 3.02 2035(v) 30.11.2007 eS- bidk ysfjxks64.5 fexzk-@fefy = 40 fexzk- csl@fefy ,Ecj ,Ei;wy eS- ck;j jslksfpu

112. DyksjksDohu QksLQsV bUtsD’ku 10x2 fefy 33.48 430(v) 23.03.2007 eS- fudksYl fijkey fuokDohu ihDyksjksDohu QksLQsV 64.5 fexzk- ,Ecj ,Ei;wy40 fexzk- DyksjksDohu ds cjkcj@fefy

113. DyksjksDohu QksLQsV flji 60 fefy dh cksry 11.38 180(v) 07.02.2006 eS- bidk ysfjxks160 fexzk- = 100 fexzk- csl@ 10 fefy ,e-di lfgr eS- ck;j jslksfpu

114. DyksjksDohu QksLQsV lLiSUlu 60 fefy dh cksry 12.80 177(v) 09.03.1998 eS- fudksYl fijkey fuokDohu ih160 fexzk- = 100 fexzk- csl@ 10 fefy ,e-di lfgr eS- edZ ,eDohu

115. DyksjksDohu QksLQsV lLiSUlu 60 fefy dh cksry 13.40 430(v) 23.03.2007 eS- baMksdks DyksDohuDyksjksDohu QksLQsV ,e-di lfgr eS- flj;k isjkDohu Mh,l50 fexzk- DyksjksDohu csl ds cjkcj@5 fefy eS- Vksjl ysc Dohuksohu

116. DyksjksDohu QksLQsV lLiSUlu 60 fefy dh cksry 14.74 430(v) 23.03.2007DyksjksDohu QksLQsV ,e-di vkSj50 fexzk- DyksjksDohu csl dkVZu lfgrds cjkcj@5 fefy

117. DyksjksDohu QksLQsV lLiSUlu 60 fefy 10.62 389(v) 02.04.2003 eS- Vksjl ysc DohuksohuDyksjksDohu QksLQsV dk¡p dh cksry eS- flj;k isjkDohu Mh,l50 fexzk- DyksjksDohu csl ds cjkcj@5 fefy

118. DyksjksDohu lYQsV bUtsD’ku&40 10x2 fefy dk 18.30 353(v) 19.04.1995 eS- baM&Loh¶V ekyLoh¶V40 fexzk- @ fefy ,Ei;wy eS- fudksYl fuokDohu ih

119. DyksjksDohu lYQsV bUtsD’ku&40 10x5 fefy dk 26.85 353(v) 19.04.1995 eS- cs;j fjlksfpu40 fexzk- @ fefy ,Ei;wy eS- bidk ysfjxks

120. DyksjksDohu lYQsV xksfy;ka&200 4 dk iRrk 3.08 353(v) 19.04.1995200 fexzk- @ xksfy;ka ¼fyfir½ ,Ei;wy

121. DyksjksDohu lYQsV xksfy;ka&200 10 dk iRrk 8.05 353(v) 19.04.1995200 fexzk- @ xksfy;ka ¼fyfir½ ,Ei;wy

122. DyksjksDohu lLisUlu@fyfDoM 450 fefy dh 42.00 1689(v) 03.10.2006DyksjksDohu 50 fexzk- @ 5 fefy cksry

123. DyksjksDohu$isjkflVkeksy xksfy;ka 10 dk 6.32 181(v) 29.01.2008DyksjksDohu QksLQsV 250 fexzk- iRrk@fCyLVjisjkflVkeksy 250 fexzk-@xksfy;ka

124. Dyksjizksekt+kbu xksfy;ka 10 dk 1.34 606(v) 27.05.2003 eS- fudksyl fijkey ykjxksfDVyDyksjizksekt+kbu ,plh,y&10 fexzk-@ ,,y_iRrkphuh fyfir xksfy;ka

Page 61: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 42 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

125. Dyksjizksekt+kbu xksfy;ka 10 dk 2.28 606(v) 27.05.2003 eS- ,y, QkekZ ,esfVyDyksjizksekt+kbu ,plh,y&25 fexzk-@ ,,y_iRrk eS- fudksyl fijkey ykjxsdfVyphuh fyfir xksfy;ka

126. Dyksjizksekt+kbu xksfy;ka 500 dh 64.30 605(v) 27.08.1997 eS- esMks QkekZ VªsuDyksjDyksjizksekt+kbu ,plh,y&25 fexzk-@ cksry eS- fjyk;al jsfyfVyfyfir xksfy;ka

127. Dyksjizksekt+kbu xksfy;ka 10 dk 3.16 1328(v) 01.08.2007 eS- lu QkekZ lh-ih-tsM- xksfy;kaDyksjizksekt+kbu ,plh,y&50 fexzk-@ iRrk@fCyLVj eS- ,y, QkekZ ,esfVyfyfir xksfy;ka

128. Dyksjizksekt+kbu xksfy;ka 500 dh 110.88 1328(v) 01.08.2007 eS- fudksyl fijkey ykjxsdfVyDyksjizksekt+kbu ,plh,y&50 fexzk-@ cksry@tkj eS- esMks QkekZ VªsuDyksjfyfir xksfy;ka eS- lkbdksVªkfiDl Dykst+hu

129. Dyksjizksekt+kbu xksfy;ka 10 dk 4.84 1328(v) 01.08.2007 eS- lu QkekZ lh-ih-tsM- xksfy;kaDyksjizksekt+kbu ,plh,y&100 fexzk-@ iRrk@fCyLVj eS- ,y, QkekZ ,esfVyfyfir xksfy;ka

130. Dyksjizksekt+kbu xksfy;ka 500 dh 204.16 1328(v) 01.08.2007 eS- fudksyl fijkey ykjxksfDVyDyksjizksekt+kbu ,plh,y&100 fexzk-@ cksry@tkj eS- esMks QkekZ VªsuDyksjfyfir xksfy;ka eS- fjyk;al jsysfVy

eS- lkbdksVªkfiDl Dykst+hu

131. Dyksjizksekt+kbu xksfy;ka 10 dk 8.36 1328(v) 01.08.2007 eS- ,y , QkekZ ,esfVyDyksjizksekt+kbu ,plh,y&200 fexzk-@ iRrk@fCyLVj eS- esMks QkekZ VªsuDyksjfyfir xksfy;ka eS- lkbdksVªkfiDl Dykst+hu

132. Dyksjizksekt+kbu bUtSaD’ku 10x2 fefy dk 25.00 606(v) 27.05.2003 eS- fudksyl Dyksjizksekt+kbuDyksjizksekt+kbu ,plh,y&25 fexzk-@fefy ,Ei;wy

133. Dyksjizksekt+kbu bUtSaD’ku 2 fefy dk 2.50 606(v) 27.05.2003 eS- fudksyl fijkey ykjxsdfVyDyksjizksekt+kbu ,plh,y&25 fexzk-@fefy ,Ei;wy eS- esMks QkekZ VªsuDyksj

eS- bUVkl esxkfVy

134. Dyksjizksekt+kbu flji isfM;fVªd 50 fefy dh cksry 4.94 605(v) 27.08.1997 eS- fudksYl fijkey ykjxsdfVyDyksjizksekt+kbu ,plh,y&5 fexzk-@5 fefy

135. Dyksjizksekt+kbu$ 10 dk 2.86 213(v) 14.02.2007VªkbZ¶Y;wisjkt+kbu$ iRrk@fCyLVjVªkbZgsDlhyQsuhfMy xksfy;kaDyksjizksekt+kbu ,plh,y-25 fexzk-VªkbZ¶Y;wisjkt+kbu ,plh,y-5 fexzk-VªkbZgsDlhyQsuhfMy ,plh,y-2 fexzk-

136. Dyksjizksekt+kbu$ 10 dk 3.62 1328(v) 01.08.2007VªkbZ¶Y;wisjkt+kbu$ iRrk@fCyLVjVªkbZgsDlhyQsuhfMy xksfy;kaDyksjizksekt+kbu ,plh,y-50 fexzk-VªkbZ¶Y;wisjkt+kbu ,plh,y-5 fexzk-VªkbZgsDlhyQsuhfMy ,plh,y-2 fexzk-

Page 62: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 43 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

137. Dyksjizksekt+kbu$ 10 dk 5.20 1328(v) 01.08.2007VªkbZ¶Y;wisjkt+kbu$ iRrk@fCyLVjVªkbZgsDlhyQsuhfMy xksfy;kaDyksjizksekt+kbu ,plh,y-100 fexzk-VªkbZ¶Y;wisjkt+kbu ,plh,y-5 fexzk-VªkbZgsDlhyQsuhfMy ,plh,y-2 fexzk-

138. flizks¶yksDlhu xksfy;ka & 250 4 dk 12.50 438(v) 10.06.1997 eS- jsucsDlh flQjsuflizks¶yksDlhu ,plh,y ,,y_iRrk eS- fliyk fliyksDl250 fexzk- flizks¶yksDlhu ds eS- tk;Ml dsfMyk flizksfcMcjkcj@ ¼fyfir½

139. flizks¶yksDlhu xksfy;ka & 250 4 dk 12.38 438(v) 10.06.1997 eS- ,QMhlh tksDluflizks¶yksDlhu ,plh,y ,,y_fCyLVj eS- ,Ydse ,yflizks250 fexzk- flizks¶yksDlhu ds eS- ekbØks ekbØks¶yksDlcjkcj@ ¼fyfir½

140. flizks¶yksDlhu xksfy;ka & 250 10 dk 30.96 438(v) 10.06.1997 eS- jseaM vkjfliflizks¶yksDlhu ,plh,y ,,y_iRrk eS- flj;k flcsdV250 fexzk- flizks¶yksDlhu ds eS- fudksYl fijkey fcdk;flucjkcj@ ¼fyfir½

141. flizks¶yksDlhu xksfy;ka & 250 10 dk 30.66 438(v) 10.06.1997 eS- jksgEcl QkekZ flijlflizks¶yksDlhu ,plh,y ,,y_fCyLVj eS- Cy;w ØkWl flcjsu250 fexzk- flizks¶yksDlhu dscjkcj@ ¼fyfir½

142. flizks¶yksDlhu xksfy;ka & 500 4 dk 24.02 438(v) 10.06.1997 eS- jsucsDlh flQjsuflizks¶yksDlhu ,plh,y ,,y_iRrk eS- fliyk fliyksDl500 fexzk- flizks¶yksDlhu ds eS- tk;Ml dsfMyk flizksfcMcjkcj@ ¼fyfir½

143. flizks¶yksDlhu xksfy;ka & 500 4 dk 23.92 438(v) 10.06.1997 eS- ,QMhlh tksDluflizks¶yksDlhu ,plh,y ,,y_fCyLVj eS- ,Ydse ,yflizks500 fexzk- flizks¶yksDlhu ds eS- ekbØks ekbØks¶yksDlcjkcj@ ¼fyfir½

144. flizks¶yksDlhu xksfy;ka & 500 10 dk 59.72 438(v) 10.06.1997 eS- jseaM vkjfliflizks¶yksDlhu ,plh,y ,,y_iRrk eS- Js;k flcsDV500 fexzk- flizks¶yksDlhu ds eS- fudksYl fijkey fcdk;flucjkcj@ ¼fyfir½

145. flizks¶yksDlhu xksfy;ka & 500 10 dk 59.42 438(v) 10.06.1997 eS- fudksYl fijkey fcdk;fluflizks¶yksDlhu ,plh,y ,,y_fCyLVj eS- Cy;w ØkWl flcjsu500 fexzk- flizks¶yksDlhu dscjkcj@ ¼fyfir½

146. flizks¶yksDlhu xksfy;ka & 750 2 dk 18.08 438(v) 10.06.1997 eS- jsucsDlh flQjsuflizks¶yksDlhu ,plh,y ,,y_fCyLVj eS- fliyk fliyksDl750 fexzk- flizks¶yksDlhu ds eS- tk;Ml dsfMyk flizksfcMcjkcj@ ¼fyfir½

Page 63: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 44 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

147. flizks¶yksDlhu xksfy;ka & 750 10 dk iRrk 89.08 458(v) 25.06.1997 eS- ,Ydse ,yflizksflizks¶yksDlhu ,plh,y eS- MkW- jsM~Mh flizksysV750 fexzk- flizks¶yksDlhu dscjkcj@ ¼fyfir½

148. flizks¶yksDlhu vkW[kksa dk vkW;UVesaV 5 xzke dh 3.84 438(v) 10.06.1997 eS- fliyk fliyksDl Mhflizks¶yksDlhu ,plh,y V~;wc3 fexzk- flizks¶yksDlhu ds cjkcj@ xzke

149. flizks¶yksDlhu vkW[kksa dk Mªksi 5 fefy dk 5.34 438(v) 10.06.1997 eS- dsfMyk ,p- ds;j flizksfcM vk¡[kksa dk Mªksiflizks¶yksDlhu ysDVsV ok;y Mªksij3 fexzk- flizks¶yksDlhu ds cjkcj@ lfgr¼3 fexzk-@fefy½

150. flizks¶yksDlhu$ 5 fefy dk 7.82 1143(v) 20.11.2001 eS- cksykds;j flizksekdZ & Mh,DlMsDlkfeFkkt+ksu bZ@bZ Mªksi ok;y Mªksij vkSj eS- ekbØks fot+u ekbØks¶yksDl Mh,Dl¼ 0.3 % $ 0.1% ½ @ fefy dkVZu lfgr

151. flizks¶yksDlhu vkW[kksa dk Mªksi 10 fefy dk 5.94 438(v) 10.06.1997 eS- lu QkekZ ¶ykslhflizks¶yksDlhu ysDVsV ok;y Mªksij eS- jsucsDlh flQjsu3 fexzk- flizks¶yksDlhu ds cjkcj@ lfgr¼3 fexzk-@fefy½

152. flizks¶yksDlhu xksfy;ka 10 dk 12.42 1354(v) 25.11.2003 eS- tk;Ml dsfMyk flizksfcMflizks¶yksDlhu & 100 fexzk- ,,y_iRrk eS- ,Ydse ,yflizks

153. flizks¶yksDlhu xksfy;ka 10 dk 12.04 1354(v) 25.11.2003 eS- MkW- jsM~Mh flizksysVflizks¶yksDlhu & 100 fexzk- ,,y_fCyLVj eS- Cy;w ØkWl lscjsu

eS- ,XyksesM fl zQksesM

154. flizks¶yksDlhu vkSj fVfuMkt+ksy xksfy;ka 10 dk 34.64 1354(v) 25.11.2003 eS- fliyk fliyksDl&VhtsMflizks¶yksDlhu gkbMªksDyksjkbM iRrk@fCyLVj eS- jsucsDlh flQjsu lhVh250 fexzk- flizks¶yksDlhu ds cjkcj eS- MkW- jsM~Mh flizksysV ,fVfuMkt+ksy & 300 fexzk- eS- esudkabM flizkstk;y

eS- ,Ydse flizksdse lhVh

155. flizks¶yksDlhu vkSj fVfuMkt+ksy xksfy;ka 10 dk 67.94 1354(v) 25.11.2003 eS- fliyk fliyksDl&VhtsMflizks¶yksDlhu gkbMªksDyksjkbM iRrk@fCyLVj eS- jsucsDlh flQjsu lhVh500 fexzk- flizks¶yksDlhu ds cjkcj eS- MkW- jsM~Mh flizksysV ,fVfuMkt+ksy & 600 fexzk- eS- esudkabM flizkstk;y

eS- ,Ydse flizksdse lhVh

156. flizks¶yksDlhu vkW[kksa dk vkW;uVesaV 3 xzke dh 3.84 1354(v) 25.11.2003 eS- fliyk fliyksDlflizks¶yksDlhu 0.3% MCY;w@MCY;w @xzke V~;wc eS- ,QMhlh tksDlu

eS- vksiFkks jsesMht+ fQuQsDleS- ,aMjs ysc ,fM¶yksDl

157. flizks¶yksDlhu vkW[kksa dk Mªksi 5 fefy dk 6.20 1354(v) 25.11.2003 eS- fliyk fliyksDlflizks¶yksDlhu ok;y Mªksij eS- ,QMhlh tksDlu¼,plh,y esa½ - 0.3% MCY;w@oh@fefy lfgr

Page 64: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 45 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

158. flizks¶yksDlhu vkW[kksa dk Mªksi 10 fefy dk 7.00 1354(v) 25.11.2003 eS- Cy;w ØkWl flcjsuflizks¶yksDlhu ok;y Mªksij eS- tk;Ml dsfMyk flizksfcM¼,plh,y esa½ - 0.3% MCY;w@oh@fefy lfgr eS- ekbØks ekbØks¶yksDl

159. flizks¶yksDlhu vkbZ-oh- bu¶;wt+u 100 fefy dk 17.76 1354(v) 25.11.2003 eS- jsucsDlh flQjsuflizks¶yksDlhu 2 fexzk- izfr fefy ok;y@cksry eS- fliyk fliyksDllksfM;e DyksjkbM - 0.9% MCY;w@oh eS- VksjsUV DphuVksj

eS- tk;Ml dsfMyk flizksfcMeS- csdLVj flizks¶yksDlhu

160. flizks¶yksDlhu vkbZ-oh- bu¶;wt+u 200 fefy dk 31.08 1354(v) 25.11.2003 eS- jsucsDlh flQjsuflizks¶yksDlhu 2 fexzk- izfr fefy ok;y@cksry eS- fliyk fliyksDllksfM;e DyksjkbM - 0.9% MCY;w@oh eS- VksjsUV DphuVksj

eS- tk;Ml dsfMyk flizksfcMeS- csdLVj flizks¶yksDlhu

161. flizks¶yksDlhu vkbZ-oh- bu¶;wt+u 100 fefy dk 17.76 1354(v) 25.11.2003 eS- jsucsDlh flQjsuflizks¶yksDlhu 2 fexzk- izfr fefy ok;y@cksry eS- fliyk fliyksDlMsDlVªkst+ - 5% MCY;w@oh eS- VksjsUV DphuVksj

eS- tk;Ml dsfMyk flizksfcMeS- csdLVj flizks¶yksDlhu

162. flizks¶yksDlhu vkbZ-oh- bu¶;wt+u 200 fefy dk 31.08 1354(v) 25.11.2003 eS- jsucsDlh flQjsuflizks¶yksDlhu 2 fexzk- izfr fefy ok;y@cksry eS- fliyk fliyksDlMsDlVªkst+ - 5% MCY;w@oh eS- VksjsUV fdUVksj

eS- tk;Ml dsfMyk flizksfcMeS- csdLVj flizks¶yksDlhu

163. flizks¶yksDlhu vkSj fVfuMkt+ksy lLiSUlu 30 fefy dh 14.56 1354(v) 25.11.2003 eS- ,xyksesM lsQksesM&VhtsMflizks¶yksDlhu gkbMªksDyksjkbM cksry125 fexzk- flizks¶yksDlhu ds cjkcjfVfuMkt+ksy&150 fexzk-

164. flizks¶yksDlhu vkSj fVfuMkt+ksy lLiSUlu 60 fefy dh 26.14 1354(v) 25.11.2003 eS- ,fjLVks flfVt+ksyflizks¶yksDlhu gkbMªksDyksjkbM cksry125 fexzk- flizks¶yksDlhu ds cjkcjfVfuMkt+ksy&150 fexzk-

165. flizksQyksDlklhu $ 5 xzke dh V~;wc 5.28 759(E) 19.05.2006¶y;wlhuksyksu ,sflVksukbM$DyksfVªekt+ksy$DyksjksØslksy ØheflizksQyksDlklhu&0.5%¶y;wlhuksyksu ,sflVksukbM&0.025%DyksfVªekt+ksy&1.0%DyksjksØslksy&0.1%

Page 65: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 46 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

166. flizksQyksDlklhu $ 15 xzke dh V~;wc 9.50 759(E) 19.05.2006¶y;wlhuksyksu ,sflVksukbM$DyksfVªekt+ksy$DyksjksØslksy ØheflizksQyksDlklhu&0.5%¶y;wlhuksyksu ,sflVksukbM&0.025%DyksfVªekt+ksy&1.0%DyksjksØslksy&0.1%

167. flizksQyksDlklhu $¶y;wlhuksyksu 15 xzke dh V~;wc 7.46 759(E) 19.05.2006,sflVksukbM$DyksfVªekeksDlksy ØheflizksQyksDlklhu&0.5%¶y;wlhuksyksu ,sflVksukbM&0.1%DyksfVªekeksDlksy &1%

168. flizksQyksDlklhu $ 10 dk 52.56 759(E) 19.05.2006vksjfuMkt+ksy xksfy;ka iRrk@fCyLVjflizksQyksDlklhu&500 fexzk-vksjfuMkt+ksy&500fexzk-

169. flizksQyksDlklhu xksfy;ka 5 dk 46.40 1078(E) 11.07.2006flizksQyksDlklhu &1000fexzk-@xksfy;ka iRrk@fCyLVj

170. flizksQyksDlklhu $fVfuMkt+ksy 60 fefy dh 25.74 1691(E) 03.10.2006lLisUlu@flji cksryflizksQyksDlklhu ,plh,yflizksQyksDlklhu 250 fexzk- ds cjkcjfVfuMkt+ksy&300fexzk-@10 fefy

171. flizks¶yksDlhu$MsDlkfeFkkt+ksu 10 fefy dk ok;y 9.34 214(E) 14.02.2007vk¡[k@dku dk Mªksi Mªksij vkSjMsDlkfeFkkt+ksu &0.1% MCY;w@oh dkVZu lfgrflizks¶yksDlhu&0.3% MCY;w@oh@10 fefy

172. flizksQyksDlklhu Øhe 15 xzke 6.30 1340(E) 01.08.2007flizksQyksDlklhu &0.3%MCY;w@oh@xzke dh V~;wc

173. flizks¶yksDlhu lLisUlu 60 fefy dh 14.80 209(v) 29.01.2008flizks¶yksDlhu ,plh,y cksry ,e-diflizks¶yksDlhu-10fexzk- ds cjkcj@10 fefy lfgr

174. flizks¶yksDlhu lLisUlu 10 fefy dh 6.44 209(v) 29.01.2008flizks¶yksDlhu ,plh,y cksry ,e-diflizks¶yksDlhu-10fexzk- ds cjkcj@10 fefy lfgr

175. flizks¶yksDlhu lLisUlu 20 fefy dh 7.94 209(v) 29.01.2008flizks¶yksDlhu ,plh,y cksry ,e-diflizks¶yksDlhu-10fexzk- ds cjkcj@10 fefy lfgr

176. flizks¶yksDlhu lLisUlu 30 fefy dh 9.50 209(v) 29.01.2008flizks¶yksDlhu ,plh,y cksry ,e-diflizks¶yksDlhu-10fexzk- ds cjkcj@10 fefy lfgr

Page 66: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 47 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

177. flizks¶yksDlhu lLisUlu 50 fefy dh 12.44 209(v) 29.01.2008flizks¶yksDlhu ,plh,y cksry ,e-diflizks¶yksDlhu-10fexzk- ds cjkcj@10 fefy lfgr

178. flizks¶yksDlhu lLisUlu 100 fefy dh 20.32 209(v) 29.01.2008flizks¶yksDlhu ,plh,y cksry ,e-diflizks¶yksDlhu-10fexzk- ds cjkcj@10 fefy lfgr

179. flizks¶yksDlhu lLisUlu 150 fefy dh 28.74 209(v) 29.01.2008flizks¶yksDlhu ,plh,y cksry ,e-diflizks¶yksDlhu-10fexzk- ds cjkcj@10 fefy lfgr

180. flizks¶yksDlhu lLisUlu 200 fefy dh 36.06 209(v) 29.01.2008flizks¶yksDlhu ,plh,y cksry ,e-diflizks¶yksDlhu-10fexzk- ds cjkcj@10 fefy lfgr

181. flizks¶yksDlhu lLisUlu 250 fefy dh 43.58 209(v) 29.01.2008flizks¶yksDlhu ,plh,y cksry ,e-diflizks¶yksDlhu-10fexzk- ds cjkcj@10 fefy lfgr

182. flizks¶yksDlhu lLisUlu 500 fefy dh 81.90 209(v) 29.01.2008flizks¶yksDlhu ,plh,y cksry ,e-diflizks¶yksDlhu-10fexzk- ds cjkcj@10 fefy lfgr

183. flizksQyksDlklhu $¶y;ksfluksyksu 20 xzke dh 10.12 211(E) 29.01.2008,sflVksukbM$DyksfVªektksy Øhe V~;wcflizksQyksDlklhu ,plh,yflizksQyksDlklhu 0.5% MCY;w@MCY;w ds cjkcj¶y;ksfluksyksu ,sflVksukbM 0.025% MCY;w@MCY;wDyksfVªektksy&1% MCY;w@MCY;w @xzke

184. flizksQyksDlklhu $fVfuMkt+ksy$ 10 dk 15.98 211(E) 29.01.2008ysfDVd ,sflM csflyl xksfy;ka iRrk@fCyLVjflizksQyksDlklhu 400 fexzk-fVfuMkt+ksy&600fexzk-ysfDVd ,sflM csflyl&60fefy;u LiksZl@fVfd;k

185. ,eksDlhflyhu vkSj DyksDlkflyhu dSilwy 6 dk 22.30 211(v) 19.03.1996 eS- fliyk uksokDyksDl,eksDlhflyhu VªkbZgkbMªsV ,,y_iRrk eS- jsDllsy lqizheksDl250 fexzk- ,eksDlhflyhu esa eS- ekbØks ysc iqYeksDyksDlDyksDlkflyhu lksfM;e eS- ,Ydse ,yeksDl&lh250 fexzk- DyksDlkflyhu esa @ dSilwy

186. ,eksDlhflyhu vkSj DyksDlkflyhu dSilwy 6 dk 21.98 211(v) 19.03.1996 eS- ykdZ ysc ih&eksDl,eksDlhflyhu VªkbZgkbMªsV ,,y_fCyLVj250 fexzk- ,eksDlhflyhu esaDyksDlkflyhu lksfM;e250 fexzk- DyksDlkflyhu esa @ dSilwy

Page 67: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 48 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

187. ,eksDlhflyhu vkSj DyksDlkflyhu dSilwy 10 dk 19.70 181(v) 07.02.2006 eS- ,YMs esMh bEiSDl MseksDlhu Iyl,eksDlhflyhu VªkbZgkbMªsV ,,y_iRrk eS- ,Qh QkekZ ,QhDyksDl250 fexzk- ,eksDlhflyhu esaDyksDlkflyhu lksfM;e250 fexzk- DyksDlkflyhu esa @ dSilwy

188. ,eksDlhflyhu vkSj DyksDlkflyhu dSilwy 10 dk 19.16 181(v) 07.02.2006 eS- ,YMs esMh bEiSDl MseksDlhu Iyl,eksDlhflyhu VªkbZgkbMªsV ,,y_fCyLVj eS- ,Qh QkekZ ,QhDyksDl250 fexzk- ,eksDlhflyhu esaDyksDlkflyhu lksfM;e250 fexzk- DyksDlkflyhu esa @ dSilwy

189. ,eksDlhflyhu vkSj DyksDlkflyhu fdM@ 10 dk 10.38 181(v) 07.02.2006 eS- fliyk uksokDyksDl?kqyu’khy xksfy;ka ,,y_iRrk eS- jsDllsy lqijheksDl,eksDlhflyhu VªkbZgkbMªsV eS- ekbØks ysc iqyeksDyksDl125 fexzk- ,eksDlhflyhu esa eS- ,Ydse ,yeksDl&lhDyksDlkflyhu lksfM;e eS- ykdZ ysc ih&eksDl125 fexzk- DyksDlkflyhu esa @fdM@?kqyu’khy xksfy;ka

190. ,eksDlhflyhu vkSj DyksDlkflyhu fdM@ 10 dk 9.98 181(v) 07.02.2006 eS- Mk;ukfed ysc MheksDl&,Dl?kqyu’khy xksfy;ka ,,y_fCyLVj eS- dksijsu eksDyksDl&dsVh,eksDlhflyhu VªkbZgkbMªsV125 fexzk- ,eksDlhflyhu esaDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu esa @ fdM@?kqyu’khy xksfy;ka

191. ,eksDlhflyhu vkSj DyksDlkflyhu bUtsD’ku V~fou iSd 10.76 886(v) 26.09.2000 eS- fliyk uksokDyksDl bUtSa-,eksDlhflyhu lksfM;e ¼ok;y$,Ei;wy½ eS- dsfMyk QkekZ fleck;ksfVd bUtSa-250 fexzk- ,eksDlhflyhu ds cjkcj eS- tk;Ml dsfMyk fgisuksDl bUtSa-DyksDlkflyhu lksfM;e eS- dksijsu eksDyksDl bUtSa-250 fexzk- DyksDlkflyhu ds cjkcj

192. ,eksDlhflyhu vkSj DyksDlkflyhu bUtsD’ku 1 ok;y 9.26 886(v) 26.09.2000 eS- fliyk uksokDyksDl bUtSa-,eksDlhflyhu lksfM;e eS- dsfMyk QkekZ fleck;ksfVd bUtSa-250 fexzk- ,eksDlhflyhu ds cjkcj eS- tk;Ml dsfMyk fgisuksDl bUtSa-DyksDlkflyhu lksfM;e eS- dksijsu eksDyksDl bUtSa-250 fexzk- DyksDlkflyhu ds cjkcj

193. ,eksDlhflyhu vkSj DyksDlkflyhu bUtsD’ku V~fou iSd 7.98 886(v) 26.09.2000 eS- fliyk uksokDyksDl bUtSa-,eksDlhflyhu lksfM;e ¼ok;y$,Ei;wy½ eS- tk;Ml dsfMyk fgisuksDl bUtSa-125 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu ds cjkcj

194. ,eksDlhflyhu vkSj DyksDlkflyhu bUtsD’ku 1 ok;y 6.48 886(v) 26.09.2000 eS- fliyk uksokDyksDl bUtSa-,eksDlhflyhu lksfM;e eS- tk;Ml dsfMyk fgisuksDl bUtSa-125 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu ds cjkcj

Page 68: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 49 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

195. ,eksDlhflyhu vkSj DyksDlkflyhu bUtsD’ku V~fou iSd 16.66 886(v) 26.09.2000 eS- fliyk uksokDyksDl bUtSa-,eksDlhflyhu lksfM;e ¼ok;y$,Ei;wy½ eS- vEckyky lkjkHkkbZ U;w Mhlh bUtSa-500 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e500 fexzk- DyksDlkflyhu ds cjkcj

196. ,eksDlhflyhu vkSj DyksDlkflyhu bUtsD’ku 1 ok;y 15.16 886(v) 26.09.2000 eS- fliyk uksokDyksDl bUtSa-,eksDlhflyhu lksfM;e eS- vEckyky lkjkHkkbZ U;w Mhlh bUtSa-500 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e500 fexzk- DyksDlkflyhu ds cjkcj

197. ,eksDlhflyhu $DyksDlkflyhu $ysfDVd 10 dk 10.92 181(v) 07.02.2006 eS- ykdZ ysc iksfyeksDl,sflM csflyl fdM@?kqyu’khy xksfy;ka ,,y_iRrk eS- bidk vkbeksDl&Dyks,eksDlhflyhu VªkbZgkbMªsV eS- VhVhds gsYFkds;j useksDyksDl125 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu ds cjkcjysfDVd ,sflM csflyl 60 fey;u LiksZl

198. ,eksDlhflyhu $DyksDlkflyhu $ysfDVd 10 dk 10.52 181(v) 07.02.2006 eS- ykdZ ysc iksfyeksDl,sflM csflyl fdM@?kqyu’khy xksfy;ka ,,y_fCyLVj eS- bidk vkbeksDl&Dyks,eksDlhflyhu VªkbZgkbMªsV eS- VhVhds gsYFkds;j useksDyksDl125 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu ds cjkcjysfDVd ,sflM csflyl 60 fey;u LiksZl

199. ,Eihflyhu vkSj DyksDlkflyhu dSilwy 10 dk 24.38 1637(v) 27.09.2007 eS- ;wuhdse ,EiksDlhu dSilwy,Eihflyhu VªkbZgkbMªsV ,,y_iRrk eS- ck;ksdse ,EihyksDl dSilwy250 fexzk- ,Eihflyhu esa eS- fliyk esxkDyksDl dSilwyDyksDlkflyhu lksfM;e eS- ,Ydse czksfMDyksDl dSilwy250 fexzk- DyksDlkflyhu esa @ dSilwy

200. ,Eihflyhu vkSj DyksDlkflyhu dSilwy 10 dk 19.88 181(v) 07.02.2006 eS- ,QMhlh fM;ksDyksDl dSilwy,Eihflyhu VªkbZgkbMªsV ,,y_fCyLVj eS- ,yfEcd csflDyksDl dSilwy250 fexzk- ,Eihflyhu esaDyksDlkflyhu lksfM;e250 fexzk- DyksDlkflyhu esa @ dSilwy

201. ,Eihflyhu vkSj DyksDlkflyhu dSilwy 10 dk 14.08 1637(v) 27.09.2007 eS- ;wuhdse ,EiksDlhu dSilwy,Eihflyhu VªkbZgkbMªsV ,,y_iRrk eS- ,fjLVks esxkisu dSilwy125 fexzk- ,Eihflyhu esa eS- ,yfEcd csflDyksDl dSilwyDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu esa @ dSilwy

Page 69: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 50 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

202. ,Eihflyhu vkSj DyksDlkflyhu dSilwy 10 dk 11.90 181(v) 07.02.2006 eS- ;wuhdse ,EiksDlhu dSilwy,Eihflyhu VªkbZgkbMªsV ,,y_fCyLVj eS- ,fjLVks esxkisu dSilwy125 fexzk- ,Eihflyhu esa eS- ,yfEcd csflDyksDl dSilwyDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu esa @ dSilwy

203. ,Eihflyhu vkSj 10 dk 10.30 181(v) 07.02.2006 eS- ck;ks&,fFkdy ,EihDyksDl xksfy;kaDyksDlkflyhu fdM xksfy;ka ,,y_iRrk eS- ,yfEcd csflDyksDl xksfy;ka,Eihflyhu VªkbZgkbMªsV eS- dsfMyk QkekZ dSEihyksDl xksfy;ka125 fexzk- ,Eihflyhu esaDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu esa @ xksfy;ka

204. ,Eihflyhu vkSj 10 dk 9.90 181(v) 07.02.2006 eS- ck;ks&,fFkdy ,EihDyksDl xksfy;kaDyksDlkflyhu fdM xksfy;ka ,,y_fCyLVj eS- ,yfEcd csflDyksDl xksfy;ka,Eihflyhu VªkbZgkbMªsV eS- dsfMyk QkekZ dSEihyksDl xksfy;ka125 fexzk- ,Eihflyhu esaDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu esa @ xksfy;ka

205. ,Eihflyhu vkSj DyksDlkflyhu bUtsD’ku 75 xzke 8.10 1637(v) 27.09.2007 eS- baMdseh bafM;ksDl fu;ksusV,Eihflyhu lksfM;e ok;y bUtS-50 fexzk- ,Eihflyhu esa ds fy, ikuh lfgrDyksDlkflyhu lksfM;e25 fexzk- DyksDlkflyhu esa @ ok;y

206. ,Eihflyhu vkSj DyksDlkflyhu bUtsD’ku 1 ok;y 3.94 599(v) 30.08.1996 eS- baMdseh bafM;ksDl fu;ksusV,Eihflyhu lksfM;e50 fexzk- ,Eihflyhu esaDyksDlkflyhu lksfM;e25 fexzk- DyksDlkflyhu esa @ ok;y

207. ,Eihflyhu vkSj DyksDlkflyhu bUtsD’ku 250 fexzk- 9.12 1637(v) 27.09.2007 eS- ;wuhdse ,EiksDlhu bUtsD’ku,Eihflyhu lksfM;e ok;y bUtS-125 fexzk- ,Eihflyhu esa ds fy, ikuh lfgrDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu esa @ ok;y

208. ,Eihflyhu vkSj DyksDlkflyhu bUtsD’ku 1 ok;y 5.36 1098(v) 08.12.2000 eS- ;wuhdse ,EiksDlhu bUtsD’ku,Eihflyhu lksfM;e125 fexzk- ,Eihflyhu esaDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu esa @ ok;y

209. ,Eihflyhu vkSj DyksDlkflyhu bUtSaD’ku 500 fexzk- 10.64 1098(v) 08.12.2000 eS- ;wuhdse ,EiksDlhu bUtsD’ku,Eihflyhu lksfM;e ok;y bUtS- eS- ,fjLVks QkekZ esxkisu bUtsD’ku250 fexzk- ,Eihflyhu esa ds fy, ikuh lfgr eS- ck;ksdse ,EihyksDl bUtsD’kuDyksDlkflyhu lksfM;e eS- ,Ydse czksMhDyksDl bUtsD’ku250 fexzk- DyksDlkflyhu esa @ ok;y eS- ,QMhlh fM;ksDyksDl bUtsD’ku

Page 70: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 51 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

210. ,Eihflyhu vkSj DyksDlkflyhu bUtsD’ku 1 ok;y 7.02 1098(v) 08.12.2000 eS- ;wuhdse ,EiksDlhu bUtsD’ku,Eihflyhu lksfM;e eS- ,fjLVks QkekZ esxkisu bUtsD’ku250 fexzk- ,Eihflyhu esa eS- ck;ksdse ,EihyksDl bUtsD’kuDyksDlkflyhu lksfM;e eS- ,Ydse czksMhDyksDl bUtsD’ku250 fexzk- DyksDlkflyhu esa @ ok;y eS- ,QMhlh fM;ksDyksDl bUtsD’ku

211. ,Eihflyhu vkSj DyksDlkflyhu bUtsD’ku 1 xzke 13.66 1637(v) 27.09.2007 eS- ;wuhdse ,EiksDlhu bUtsD’ku,Eihflyhu lksfM;e ok;y bUtS- eS- ,fjLVks QkekZ esxkisu bUtsD’ku500 fexzk- ,Eihflyhu esa ds fy, ikuh lfgr eS- ck;ksdse ,EihyksDl bUtsD’kuDyksDlkflyhu lksfM;e eS- ,Ydse czksMhDyksDl bUtsD’ku500 fexzk- DyksDlkflyhu esa @ ok;y eS- ,QMhlh fM;ksDyksDl bUtsD’ku

212. ,Eihflyhu vkSj DyksDlkflyhu bUtsD’ku 1 ok;y 10.78 1098(v) 08.12.2000 eS- ;wuhdse ,EiksDlhu bUtsD’ku,Eihflyhu lksfM;e eS- ,fjLVks QkekZ esxkisu bUtsD’ku500 fexzk- ,Eihflyhu esa eS- ck;ksdse ,EihyksDl bUtsD’kuDyksDlkflyhu lksfM;e eS- ,Ydse czksMhDyksDl bUtsD’ku500 fexzk- DyksDlkflyhu esa @ ok;y eS- ,QMhlh fM;ksDyksDl bUtsD’ku

213. ,Eihflyhu vkSj DyksDlkflyhu bUtsD’ku V~fou iSd 5.80 1098(v) 08.12.2000 eS- ck;ksdse ,EihyksDl bUtsD’ku,Eihflyhu lksfM;e ¼ok;y$bUtsD’ku75 fexzk- ,Eihflyhu esa ds fy, ikuh½DyksDlkflyhu lksfM;e25 fexzk- DyksDlkflyhu esa @ ok;y

214. ,Eihflyhu vkSj DyksDlkflyhu bUtsD’ku 1 ok;y 4.30 1098(v) 08.12.2000 eS- ck;ksdse ,EihyksDl bUtsD’ku,Eihflyhu lksfM;e75 fexzk- ,Eihflyhu esaDyksDlkflyhu lksfM;e25 fexzk- DyksDlkflyhu esa @ ok;y

215. ,eksDlhflyhu $DyksDlkflyhu $ 10 dk 20.06 181(v) 07.02.2006 eS- Js;k 2 iSu ,ych dSilwyysfDVd ,sflM csflyl dSilwy ,,y_iRrk eS- dseks ck;ksyksftdy,eksflysd dSilwy,eksDlhflyhu VªkbZgkbMªsV eS- olkZfVy ,eksIyl dSilwy250 fexzk- ,eksDlhflyhu ds cjkcj eS- zQsadfyu ysc ,eksVksDl dSilwyDyksDlkflyhu lksfM;e eS- ,yD;wj QkekZ DykseksDlh dSilwy250 fexzk- DyksDlkflyhu ds cjkcjysfDVd ,sflM csflyl 60 fey;u LiksZl

216. ,eksDlhflyhu $DyksDlkflyhu $ 10 dk 19.52 181(v) 07.02.2006 eS- flj;k 2 iSu ,ych dSilwyysfDVd ,sflM csflyl dSilwy ,,y_fCyLVj eS- dseks ck;ksyksftdy,eksflysd dSilwy,eksDlhflyhu VªkbZgkbMªsV eS- olkZfVy ,eksIyl dSilwy250 fexzk- ,eksDlhflyhu ds cjkcj eS- zQsadfyu ysc ,eksVksDl dSilwyDyksDlkflyhu lksfM;e eS- ,yD;wj QkekZ DykseksDlh dSilwy250 fexzk- DyksDlkflyhu ds cjkcjysfDVd ,sflM csflyl 60 fey;u LiksZl

Page 71: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 52 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

217. ,Eihflyhu $DyksDlkflyhu $ysfDVd 10 dk 14.44 1637(v) 27.09.2007 eS- txluiky ,eIyl,sflM csflyl fdM@?kqyu’khy xksfy;ka ,,y_iRrk,Eihflyhu VªkbZgkbMªsV125 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu ds cjkcjysfDVd ,sflM csflyl 60 fey;u LiksZl

218. ,Eihflyhu $DyksDlkflyhu $ysfDVd 10 dk 10.38 181(v) 07.02.2006 eS- txluiky ,eIyl,sflM csflyl fdM@?kqyu’khy xksfy;ka ,,y_fCyLVj,Eihflyhu VªkbZgkbMªsV125 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu ds cjkcjysfDVd ,sflM csflyl 60 fey;u LiksZl

219. DyksDlkflyhu$,Eihflyhu 10 dk 14.42 2058(v) 30.11.2007 eS- ,fjLVks esxkisufdM@?kqyu’khy xksfy;ka iRrk@fCyLVjDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu ds cjkcj,Eihflyhu ,UgkbMªl125 fexzk- ,eksDlhflyhu ds cjkcj

220. ,Eihflyhu $DyksDlkflyhu 10 dk 10.00 181(v) 07.02.2006 eS- ,fjLVks esxkisufdM@?kqyu’khy xksfy;ka ,,y_fCyLVj,Eihflyhu ,UgkbMªl125 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu ds cjkcj

221. ,Eihflyhu $DyksDlkflyhu $ 10 dk 24.86 1637(v) 27.09.2007 eS- flaVks QkekZ ,EdksIylysfDVd ,sflM csflyl dSilwy ,,y_iRrk eS- ,elu esMhdse ,Eih;kdZ&lh,Eihflyhu VªkbZgkbMªsV eS- xksYMu QkekZ lsMksisu Iyl250 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e250 fexzk- DyksDlkflyhu ds cjkcjysfDVd ,sflM csflyl 60 fey;u LiksZl

222. DyksDlkflyhu $,eksDlhflyhu$ 10 dk 20.36 181(v) 07.02.2006ysfDVd ,sflM csflyl dSilwy ,,y_iRrk,eksDlhflyhu VªkbZgkbMªsV250 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e250 fexzk- DyksDlkflyhu ds cjkcjysfDVd ,sflM csflyl 70 fey;u LiksZl

223. DyksDlkflyhu $,eksDlhflyhu$ 10 dk 19.82 181(v) 07.02.2006ysfDVd ,sflM csflyl dSilwy ,,y_fCyLVj,eksDlhflyhu VªkbZgkbMªsV250 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e250 fexzk- DyksDlkflyhu ds cjkcjysfDVd ,sflM csflyl 70 fey;u LiksZl

Page 72: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 53 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

224. ,Eihflyhu $DyksDlkflyhu $ 10 dk 21.14 181(v) 07.02.2006 eS- flaVks QkekZ ,EdksIylysfDVd ,sflM csflyl dSilwy ,,y_fCyLVj eS- ,elu esMhdse ,Eih;kdZ&lh,Eihflyhu VªkbZgkbMªsV eS- xksYMu QkekZ lsMksisu Iyl250 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e250 fexzk- DyksDlkflyhu ds cjkcjysfDVd ,sflM csflyl 60 fey;u LiksZl

225. ,Eihflyhu $DyksDlkflyhu dSilwy 10 dk 21.42 181(v) 07.02.2006 eS- Mk;ukfed ,Eih&,Dl,Eihflyhu ,UgkbMªl ,,y_iRrk eS- ck;ksdse ,EihyksDl250 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e250 fexzk- DyksDlkflyhu ds cjkcj

226. ,Eihflyhu $DyksDlkflyhu dSilwy 10 dk 20.88 181(v) 07.02.2006 eS- Mk;ukfed ,Eih&,Dl,Eihflyhu ,UgkbMªl ,,y_fCyLVj eS- ck;ksdse ,EihyksDl250 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e250 fexzk- DyksDlkflyhu ds cjkcj

227. ,Eihflyhu $DyksDlkflyhu MªkbZ flji 30 fefy dh 13.50 1637(v) 27.09.2007 eS- ck;ksdse ,EihyksDl,Eihflyhu VªkbZgkbMªsV cksry ,e-di eS- ;wuhdse ,EiksDlhu125 fexzk- ,eksDlhflyhu ds cjkcj lfgrDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu ds cjkcj

228. ,Eihflyhu $DyksDlkflyhu MªkbZ flji 60 fefy dh 20.42 181(v) 07.02.2006 eS- ck;ksdse ,EihyksDl,Eihflyhu VªkbZgkbMªsV cksry ,e-di eS- ,QMhlh fM;ksDyksDl125 fexzk- ,eksDlhflyhu ds cjkcj lfgrDyksDlkflyhu lksfM;e125 fexzk- DyksDlkflyhu ds cjkcj

229. DyksDlkflyhu bUtsD’ku V~fou iSd 6.40 1103(v) 08.12.2000 eS- ck;ksdse ck;ksDyksDlDyksDlkflyhu lksfM;e ¼ok;y$bUtsD’ku eS- yk;dk DyksDl250 fexzk- DyksDlkflyhu ds cjkcj ds fy, ikuh½

230. DyksDlkflyhu bUtsD’ku 1 ok;y 4.90 1103(v) 08.12.2000 eS- ck;ksdse ck;ksDyksDlDyksDlkflyhu lksfM;e eS- yk;dk DyksDl250 fexzk- DyksDlkflyhu ds cjkcj

231. DyksDlkflyhu bUtsD’ku V~fou iSd 7.62 1103(v) 08.12.2000 eS- ck;ksdse ck;ksDyksDlDyksDlkflyhu lksfM;e ¼ok;y$bUtsD’ku eS- yk;dk DyksDl500 fexzk- DyksDlkflyhu ds cjkcj ds fy, ikuh½

232. DyksDlkflyhu bUtsD’ku 1 ok;y 6.12 1103(v) 08.12.2000 eS- ck;ksdse ck;ksDyksDlDyksDlkflyhu lksfM;e eS- yk;dk DyksDl500 fexzk- DyksDlkflyhu ds cjkcj

233. DyksDlkflyhu dSilwy 10 dk 11.52 181(v) 20.07.2000 eS- ck;ksdse ck;ksDyksDlDyksDlkflyhu lksfM;e ,,y_iRrk250 fexzk- DyksDlkflyhu ds cjkcj

Page 73: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 54 -

234. DyksDlkflyhu dSilwy 10 dk 10.84 181(v) 20.07.2000 eS- ck;ksdse ck;ksDyksDlDyksDlkflyhu lksfM;e ,,y_fCyLVj250 fexzk- DyksDlkflyhu ds cjkcj

235. DyksDlkflyhu dSilwy 10 dk 19.86 181(v) 20.07.2000 eS- ck;ksdse ck;ksDyksDlDyksDlkflyhu lksfM;e ,,y_iRrk500 fexzk- DyksDlkflyhu ds cjkcj

236. DyksDlkflyhu dSilwy 10 dk 18.88 181(v) 20.07.2000 eS- ck;ksdse ck;ksDyksDlDyksDlkflyhu lksfM;e ,,y_fCyLVj500 fexzk- DyksDlkflyhu ds cjkcj

237. DyksDlkflyhu MªkbZ flji 40 fefy dh cksry 9.70 679(v) 20.07.2000 eS- yk;dk DyksDlDyksDlkflyhu lksfM;e ,e-di lfgr125 fexzk- DyksDlkflyhu ds cjkcj@5 fefy

238. ,eksDlhflyhu$DyksDlkflyhu xksfy;ka 10 dk 16.26 451(v) 29.03.2006 eS- esdfuy vkSj vkjxleksDlhflyhu,eksDlhflyhu 250 fexzk- ,,y_fCyLVjDyksDlkflyhu 250 fexzk- @xksfy;ka

239. ,Eihflyhu $DyksDlkflyhu $ 10 dk 9.90 451(v) 29.03.2006 eS- olkZfVy odZyksDlysfDVd ,sflM csflyl MhVh xksfy;ka ,,y_fCyLVj,Eihflyhu 125 fexzk-DyksDlkflyhu 125 fexzk-ysfDVd ,sflM csflyl 30 fey;u LiksZl@xksfy;ka

240. ,eksDlhflyhu $DyksDlkflyhu $ 10 dk 10.10 451(v) 29.03.2006 eS- izksfQd vksjxsfud ,EQh fdMysfDVd ,sflM csflyl xksfy;ka ,,y_fCyLVj,eksDlhflyhu 125 fexzk-DyksDlkflyhu 125 fexzk-ysfDVd ,sflM csflyl 30 fey;u LikslZ@xksfy;ka

241. ,eksDlhflyhu $DyksDlkflyhu $ 10 dk 17.26 451(v) 29.03.2006 eS- gsysDl gsyhds;j ysDl&,ychysfDVd ,sflM csflyl xksfy;ka ,,y_fCyLVj,eksDlhflyhu 125 fexzk-DyksDlkflyhu 125 fexzk-ysfDVd ,sflM csflyl 60 fey;u LikslZ@xksfy;ka

242. ,Eihflyhu $DyksDlkflyhu dSilwy 4 dk 14.44 451(v) 29.03.2006 eS- ,yfEcd csflDyksDl,Eihflyhu 500 fexzk- ,,y_fCyLVjDyksDlkflyhu 500 fexzk-

243. ,eksDlhflyhu $DyksDlkflyhu $ 10 dk 18.36 451(v) 29.03.2006 eS- ,aVhtsu ,p- ds;j ,uksDlysfDVd ,sflM csflyl dSilwy ,,y_fCyLVj eS- lsfi;Ul ysc MsUVksDyksDl ,ych,eksDlhflyhu 250 fexzk-DyksDlkflyhu 250 fexzk-ysfDVd ,sflM csflyl 100 fey;u LikslZ@dSilwy

244. ,eksDlhflyhu $DyksDlkflyhu $ 10 dk 18.66 1683(v) 03.10.2006 eS- baM&LohQ~V ,ehDyksDlysfDVd ,sflM csflyl dSilwy ,,y_fCyLVj eS- zQsadQVZ dksdl&,ych,eksDlhflyhu 250 fexzk-DyksDlkflyhu 250 fexzk-ysfDVd ,sflM csflyl 120 fey;u LikslZ@dSilwy

245. ,Eihflyhu $DyksDlkflyhu Mªksi 10 fefy dh 10.02 451(v) 29.03.2006 eS- ck;ksdse ,EihDyksDl,Eihflyhu 100 fexzk- cksryDyksDlkflyhu 50 fexzk- @fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 74: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 55 -

246. ,eksDlhflyhu$DyksDlkflyhu MªkbZ flji 30 fefy dh 10.66 451(v) 29.03.2006 eS- flaVks vksjxsfud dkseksDl MhVh,eksDlhflyhu 125 fexzk- cksryDyksDlkflyhu 125 fexzk- @5 fefy

247. ,eksDlhflyhu$DyksDlkflyhu MªkbZ flji 60 fefy dh 16.60 451(v) 29.03.2006 eS- eklZ fcfly&ih,eksDlhflyhu 125 fexzk- cksryDyksDlkflyhu 125 fexzk- @5 fefy

248. DyksDlkflyhu$,Eihlhfyu flji 30 fefy dh 7.98 451(v) 29.03.2006DyksDlkflyhu 62.5 fexzk- cksry,Eihlhfyu 62.5 fexzk- @5 fefy

249. DyksDlkflyhu$,Eihlhfyu bUtsD’ku 1 ok;y 4.78 451(v) 29.03.2006DyksDlkflyhu 25 fexzk-,Eihlhfyu 25 fexzk- @ok;y

250. DyksDlkflyhu $,eksDlhflyhu$ 6 dk 12.12 753(v) 19.05.2006ysfDVd ,sflM csflyl dSilwy iRrk@fCyLVj,eksDlhflyhu VªkbZgkbMªsV250 fexzk- ,eksDlhflyhu ds cjkcjDyksDlkflyhu lksfM;e250 fexzk- DyksDlkflyhu ds cjkcjysfDVd ,sflM csflyl ¼,afVªd fyfirds leku½ 80 fey;u LiksZl @dSilwy

251. DykWDlklhfyu lksfM;e$ 10 dk 59.30 1050(v) 11.07.2006lsfQfDtkbe$ysfDVd ,sflM iRrk@fCyLVjcsflyl xksfy;kaDykWDlklhfyu lksfM;eDykWDlklhfyu-500 fexzk- ds cjkcj ¼daVªksYM fjfyt+½lsfQfDtkbe VªkbZgkbMªsV ds lekulsfQfDtkbe ,ugkbMªsl-100 fexzk- ds cjkcjysfDVd ,sflM csflyl-45 fefy;e LiksZl@ckbZ&ys;MZ fQYe fyfir fVfd;k

252. DykWDlklhfyu lksfM;e$ 10 dk 110.08 2059(v) 30.11.2007lsfQfDtkbe$ysfDVd ,sflM iRrk@fCyLVjcsflyl xksfy;kaDykWDlklhfyu lksfM;eDykWDlklhfyu-500 fexzk- ds cjkcj ¼daVªksYM fjfyt+½lsfQfDtkbe VªkbZgkbMªsV ds lekulsfQfDtkbe ,ugkbMªsl-200 fexzk- ds cjkcjysfDVd ,sflM csflyl-90 fefy;e LiksZl @ckbZ&ys;MZ fQYe fyfir fVfd;k

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 75: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 56 -

253. DykWDlklhfyu lksfM;e$ 10 dk 29.80 1682(v) 03.10.2006lsfQfDtkbe$$ysfDVd ,sflM iRrk@fCyLVjcsflyl xksfy;kaDykWDlklhfyu lksfM;eDykWDlklhfyu-250 fexzk- ds cjkcj ¼lhvkj@bZvkj½lsfQfDtkbe VªkbZgkbMªsV ds lekulsfQfDtkbe ,ugkbMªsl-50 fexzk- ds cjkcjysfDVd ,sflM csflyl-30 fefy;e LiksZl @ckbZ&ys;MZ fVfd;k

254. DyksDlkflfyu$,Eihlhfyu$ 10 dk iRrk@fCyLVj 17.62 212(E) 14.02.2007ysfDVd ,sflM csflyl dSilwyDyksDlkflfyu lksfM;eDyksDlkflfyu&250 fexzk- ds cjkcj,Eihlhfyu ,UgkbMªsl&250 fexzk-ysfDVd ,sflM csflyl&20 fefy;u LiksZl@dSilwy

255. DyksDlkflfyu$,Eihlhfyu$ 10 dk iRrk@fCyLVj 17.68 212(E) 14.02.2007ysfDVd ,sflM csflyl dSilwyDyksDlkflfyu lksfM;eDyksDlkflfyu&250 fexzk- ds cjkcj,Eihlhfyu ,UgkbMªsl&250 fexzk-ysfDVd ,sflM csflyl&60 fefy;u LiksZl@dSilwy

256. DyksDlkflfyu$,Eihlhfyu$ 10 dk iRrk@fCyLVj 17.32 212(E) 14.02.2007ysfDVd ,sflM csflyl dSilwyDyksDlkflfyu lksfM;eDyksDlkflfyu&250 fexzk- ds cjkcj,Eihlhfyu ¼VªkbZgkbMªsV ds leku½&250 fexzk-ysfDVd ,sflM csflyl&90 fefy;u LiksZl@dSilwy

257. DyksDlkflfyu$,Eihlhfyu xksfy;ka 10 dk iRrk@fCyLVj 28.66 212(E) 14.02.2007DyksDlkflfyu lksfM;eDyksDlkflfyu&500 fexzk- ds cjkcj,Eihlhfyu ¼VªkbZgkbMªsV ds leku½&500 fexzk-@fQYe fyfir fVfd;k

258. DyksDlkflfyu$,eksDlhflfyu bUtsD’ku 1 ok;y 25.90 212(E) 14.02.2007DyksDlkflfyu&1 xzke,eksDlhflfyu&1 xzke@ok;y

259. DyksDlkflfyu$,eksDlhflfyu bUtsD’ku 1 ok;y 6.04 212(E) 14.02.2007DyksDlkflfyu&25 fexzk-,eksDlhflfyu&50 fexzk-

260. DyksDlkflyhu $,eksDlhflyhu$ 10 dk 30.50 175(v) 29.01.2008ysfDVd ,sflM csflyl xksfy;ka iRrk@fCyLVjDyksDlkflyhu lksfM;e250 fexzk- DyksDlkflyhu ds cjkcj,eksDlhflyhu VªkbZgkbMªsV250 fexzk- ,eksDlhflyhu ds cjkcjysfDVd ,sflM csflyl 60 fey;u LiksZl @xksfy;ka

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 76: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 57 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Mh (D)

1. MsDlkfeFkkt+ksu xksfy;ka 10 dk 1.76 217(v) 14.02.2007 eS- tk;Ml dsfMyk Msdt+ksu xksfy;kaMsDlkfeFkkt+ksu lksfM;e QksLQsV iRrk@fCyLVj eS- esfjaM fMdMsu xksfy;ka0.5 fexzk- MsDlkfeFkkt+ksu ds cjkcj@xksfy;ka eS- dsfMyk QkekZ MsDlklksu xksfy;ka

eS- bUVkl MsDlk xksfy;kaeS- jsucsDlh jsuMsDlk xksfy;ka

2. MsDlkfeFkkt+ksu xksfy;ka & 0.5 10x10 dk 15.34 217(v) 14.02.2007 eS- esfjUM fMdMsu xksfy;ka0.5 fexzk-@xksfy;ka iRrk@fCyLVj eS- tk;Ml dsfMyk Msdt+ksu xksfy;ka

eS- fliyk MsDlkfli xksfy;kaeS- bUVkl MsDlk xksfy;kaeS- ok;Fk fyfeVsM ok;eslksu xksfy;ka

3. MsDlkfeFkkt+ksu xksfy;ka & 0.5 2000 dk tkj 181.56 217(v) 14.02.20070.5 fexzk-@xksfy;ka

4. MsDlkfeFkkt+ksu xksfy;ka & 0.5 1000 dk tkj 94.42 217(v) 14.02.2007 eS- tk;Ml dsfMyk MsDlkfeFkkt+ksu xksfy;ka0.5 fexzk-@xksfy;ka eS- dsfMyk QkekZ MsDlkfeFkkt+ksu xksfy;ka

eS- ,yfEcd fMdksjlksu xksfy;ka

5. MsDlkfeFkkt+ksu xksfy;ka & 0.5 500 dk tkj 50.10 217(v) 14.02.20070.5 fexzk-@xksfy;ka

6. MsDlkfeFkkt+ksu xksfy;ka & 1.0 10 dk 1.92 217(v) 14.02.2007 eS- tk;Ml dsfMyk Msdt+ksu xksfy;ka1.0 fexzk-@xksfy;ka iRrk@fCyLVj eS- esfjUM Msdk QkVZ xksfy;ka

7. MsDlkfeFkkt+ksu bUtSaD’ku 2 fefy dk 6.48 217(v) 14.02.2007 eS- Mk;ukfed MsDlkysVMsDlkfeFkkt+ksu lksfM;e ok;yQksLQsV 4.0 fexzk- ¼MkbZ lksfM;e lkYV esa½feFkk;y isjkcsu vkbZih&0.15% MCY;w@ohizksfiy isjkcsu vkbZih&0.015% MCY;w@oh ls0.02% MCY;w@oh @ fefy

8. MsDlkfeFkkt+ksu$tsUVkekbflu 5 fefy dk 8.06 217(v) 14.02.2007 eS- lksfyVs;j vkbZMsDl&thvk¡[k@dku dk Mªksi ok;y Mªksij vkSjMsDlkfeFkkt+ksu vkbZih&0.1% MCY;w@oh dkVZu lfgr¼MsDlkfeFkkt+ksu lksfM;e QksLQsV esa½tsUVkekbflu&0.3% MCY;w@oh¼tsUVkekbflu lYQsV esa½csUtydksfu;e DyksjkbM&0.01% MCY;w@oh,D;wf;l cQMZ fody D;w-,l-

9. MsDlkfeFkkt+ksu$ 5 fefy dk 8.00 1143(v) 20.11.2001DyksjQsfudksy bZ@bZ Mªksi ok;y Mªksij vkSj¼ 0.1% $ 1.0%½ @ fefy dkVZu lfgr

10. MsDlkfeFkkt+ksu$ 5 fefy dk 7.82 1143(v) 20.11.2001 eS- cksyksds;j flizksekdZ&Mh,Dlflizks¶yksDlhu bZ@bZ Mªksi ok;y Mªksij vkSj¼ 0.1% $ 0.3%½ @ fefy dkVZu lfgr

Page 77: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 58 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

11. MsDlkfeFkkt+ksu$DyksjQsfudksy$ 5 fefy dk 9.12 1143(v) 20.11.2001iksfyfefDlu ch lYQsV bZ@bZ Mªksi ok;y Mªksij vkSjizR;sd fefy esa dkVZu lfgrMsDlkfeFkkt+ksu lksfM;e QksLQsV 1 fexzk-DyksjQsfudksy 5 fexzk-iksfyfefDlu ch lYQsV 5000 vkbZ;w

12. MsDlkfeFkkt+ksu$Vkscjkekbflu 5 fefy dh 11.14 1322(v) 01.08.2007csUtkydksfu;e DyksjkbM vk¡[kksa dk Mªksi cksry¼ 1 fexzk- $ 3 fexzk-$0.001fefy½@fefy

13. MsDlkfeFkkt+ksu$ 5 fefy dk 8.20 74(v) 15.01.2004 eS- jsfMDl ck;ksVsd csdVksc&MhVkscjkekbflu bZ@bZ Mªksi ok;y Mªksij vkSj eS- lksfyVs;j vkbVksc MhMsDlkfeFkkt+ksu lksfM;e dkVZu lfgrQksLQsV 0.1% MCY;w@ohVkscjkekbflu lYQsV0.3% MCY;w@oh Vkscjkekbflu ds cjkcj

14. MsDlkfeFkkt+ksu$ 5 fefy dk¡p dh 9.62 217(v) 14.02.2007 eS- jsfMDl ck;ksVsd csdVksc&MhVkscjkekbflu bZ@bZ Mªksi ok;y Mªksij vkSj eS- lksfyVs;j vkbVksc MhMsDlkfeFkkt+ksu lksfM;e dkVZu lfgrQksLQsV 0.1% MCY;w@ohVkscjkekbflu lYQsV0.3% MCY;w@oh Vkscjkekbflu ds cjkcj

15. MsDlkfeFkkt+ksu$ 15 xzke dh V~;wc 17.44 217(v) 14.02.2007 zQseslsfVu$DyksfVªekt+ksyØheMsDlkfeFkkt+ksu,sflVsV&0.1% MCY;w@MCY;w zQseslsfVu lYQsV&1% MCY;w@MCY;wDyksfVªekt+ksy&1% MCY;w@MCY;w

16. MsDlkfeFkkt+ksu lksfM;e QksLQsV$ 5 fefy dk 7.80 1357(v) 16.09.2005DyksjQsfudksy vk¡[kksa dk Mªksi ok;y Mªksij lfgrizR;sd ok;y esaMsDlkfeFkkt+ksu lksfM;e QksLQsV&0.1%DyksjQsfudksy&0.5% @ok;y

17. MsDlkfeFkkt+ksu$tSUVkekbflu Mªksi 10 fefy dh ok;y 10.16 217(v) 14.02.2007MsDlkfeFkkt+ksu&0.1% MCY;w@oh Mªksij lfgrtSUVkekbflu&0.3% MCY;w@oh

18. MsDlkfeFkkt+ksu$fu;ksekbflu 3 xzke dh V~;wc 5.78 217(v) 14.02.2007lYQsV$iksyhfefDlu chlYQsV vkW;uV~esUVMsDlkfeFkkt+ksu&1 fexzk-fu;ksekbflu lYQsV&3.5 fexzk-iksyhfefDlu ch lYQsV&5000 ;wfuV

Page 78: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 59 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

19. MsDlkfeFkkt+ksu$ 5 xzke dh V~;wc 5.16 217(v) 14.02.2007DyksjsekQsuhdksy vkW;uV~esUVMsDlkfeFkkt+ksu lksfM;eQksLQsV&1 fexzk-DyksjsekQsuhdksy&10 fexzk-

20. MsDlkfeFkkt+ksu$DyksjksQsfudksy$ 5 xzke dh V~;wc 6.79 1079(v) 11.07.2006iksfy&ch fefDlu lYQsV vkW;UVesUVMsDlkfeFkkt+ksu lksfM;e QksLQsV&1 fexzk-DyksjksQsfudksy&10 fexzk-iksfy&ch fefDlu lYQsV&5000 vkbZ;w

21. MsDlkfeFkkt+ksu Mªksi 10 fefy dh cksry 6.40 217(v) 14.02.2007MsDlkfeFkkt+ksu lksfM;e Mªksij vkSj dkVZu lfgrQksLQsV&0.01% MCY;w@oh

22. MsDlkfeFkkt+ksu$fu;ksekbflu 10 fefy dh cksry 9.72 217(v) 14.02.2007vk¡[k@dku dk Mªksi dkVZu lfgrMsDlkfeFkkt+ksu lksfM;eQksLQsV&0.1% MCY;w@ohfu;ksekbflu lYQsV&0.5% MCY;w@oh

23. MsDlkfeFkkt+ksu$,Vªksikbu 5 fefy dh cksry 8.20 1079(v) 11.07.2006lYQsV MªksiMsDlkfeFkkt+ksu lksfM;eQksLQsV&0.1%,Vªksikbu lYQsV&1%

24. MsDlkfeFkkt+ksu$fu;wekbflu 20 fefy dh ok;y 6.46 1079(v) 11.07.2006lYQsV MªksiMsDlkfeFkkt+ksu&0.1%fu;wekbflu lYQsV&0.35% MCY;w@oh

25. MsDlkfeFkkt+ksu$,Vªksikbu 5 fefy dh cksry 8.50 1079(v) 11.07.2006lYQsV$DyksjkseQsfudksy MªksiMsDlkfeFkkt+ksu lksfM;eQksLQsV&0.1%,Vªksikbu lYQsV&1%DyksjkseQsfudksy&0.5%

26. MsDlkfeFkkt+ksu$ 5 fefy dh cksry 9.50 1079(v) 11.07.2006DyksjkseQsfudksy$iksfyfeDlhu ch lYQsV MªksiMsDlkfeFkkt+ksu lksfM;eQksLQsV&1 fexzk-DyksjkseQsfudksy&10 fexzk-iksfyfeDlhu ch lYQsV&5000 vkbZ;w

Page 79: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 60 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

27. MsDlkfeFkkt+ksu$fu;wekbflu 2.5 fefy dh ok;y 6.88 1079(v) 11.07.2006bUtSD’kuMsDlkfeFkkt+ksu lksfM;eQksLQsV&0.1%fu;wekbflu lYQsV&0.3%

28. MsDlkfeFkkt+ksu$fu;wekbflu 5 fefy dh ok;y 7.36 1079(v) 11.07.2006bUtSD’kuMsDlkfeFkkt+ksu lksfM;eQksLQsV&0.1%fu;wekbflu lYQsV&0.3%

29. MsDlkfeFkkt+ksu bUtsD’ku 10 fefy dh ok;y 11.24 217(v) 14.02.2007MsDlkfeFkkt+ksu&4 fexzk-@fefy

30. MsDlkfeFkkt+ksu bUtsD’ku 20 fefy dh ok;y 17.32 217(v) 14.02.2007MsDlkfeFkkt+ksu&4 fexzk-@fefy

31. MsDlkfeFkkt+ksu bUtsD’ku 2 fefy dk ,Ei;wy 3.32 214(v) 14.02.2007MsDlkfeFkkt+ksu ¼lksfM;eQksLQsV ds leku½ & 4 fexzk-@2 fefy

32. MsDlkfeFkkt+ksu $vks¶yksDlhu 10 fefy dk 10.14 214(v) 14.02.2007vk¡[k@dku dk Mªksi ok;y Mªksij vkSjMsDlkfeFkkt+ksu &0.1% MCY;w@oh dkVZu lfgrvks¶yksDlhu&0.3% MCY;w@oh @ 10 fefy

33. MsDlkfeFkkt+ksu $fu;ksekbflu$ 5 fefy dk ok;y 7.92 214(v) 14.02.2007cksfjd ,sflM vk¡[k dk Mªksi Mªksij vkSjMsDlkfeFkkt+ksu lksfM;e dkVZu lfgrQksLQsV&0.11% MCY;w@ohfu;ksekbflu lYQsV&0.5% MCY;w@ohcksfjd ,sflM&1.2% MCY;w@oh @ 5 fefy

34. MsDlkfeFkkt+ksu $flizks¶yksDlhu 10 fefy dk ok;y 9.34 214(v) 14.02.2007vk¡[k@dku dk Mªksi Mªksij vkSjMsDlkfeFkkt+ksu &0.1% MCY;w@oh dkVZu lfgrflizks¶yksDlhu&0.3% MCY;w@oh@fefy

35. MsDlkfeFkkt+ksu bUtSD’ku 1 ok;y 6.94 1646(v) 27.09.2007MsDlkfeFkkt+ksu lksfM;e QksLQsVMsDlkfeFkkt+ksu &10 fexzk- ds cjkcj

36. MsDlkfeFkkt+ksu$Vkscjkekbflu$ 10 fefy dk ok;y 12.84 1646(v) 27.09.2007csUtkydksfu;e DyksjkbM vk¡[kks dk Mªksi Mªksij vkSjMsDlkfeFkkt+ksu lksfM;e dkVZu lfgrQksLQsV&0.1% MCY;w@ohVkscjkekbflu &0.3% MCY;w@ohcsUtkydksfu;e DyksjkbM lksY;w’ku &0.02%

Page 80: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 61 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

37. MsDlkfeFkkt+ksu$vks¶yksDlhu $ 10 fefy dk ok;y 8.82 1646(v) 27.09.2007csUtkydksfu;e DyksjkbM Mªksij vkSjvk¡[k@dku dk Mªksi dkVZu lfgrMsDlkfeFkkt+ksu lksfM;e QksLQsV&0.1% MCY;w@ohvks¶yksDlhu &3%csUtkydksfu;e DyksjkbM lksY;w’ku &0.02%

38. Vkscjkekbflu$MsDlkfeFkkt+ksu 3 xzke dh V~;wc 4.84 2043(v) 30.11.2007vk¡[kksa dk vkW;uVesUVVkscjkekbflu lYQsVVkscjkekbflu-0.3%MCY;w@MCY;wMsDlkfeFkkt+ksu lksfM;e QksLQsVMsDlkfeFkkt+ksu-0.1%MCY;w@MCY;w@xzke

39. eksDlh¶yksDlklhu$MsDlkfeFkktksu$ 5 fefy dh cksry 8.50 2043(v) 30.11.2007csUtydksfu;e vk¡[kksa dk MªksieksDlh¶yksDlklhu ,plh,yeksDlh¶yksDlklhu-5 fexzk- ds cjkcjMsDlkfeFkkt+ksu lksfM;e QksLQsVMsDlkfeFkkt+ksu QksLQsV-1 fexzk- ds cjkcjcsUtydksfu;e DyksjkbM-0.01% MCY;w@oh@fefy

40. xsVks¶yksDlklhu$MsDlkfeFkktksu 5 fefy dh cksry 7.48 2043(v) 30.11.2007vk¡[kksa dk MªksixsVks¶yksDlklhu ,plh,yeksDlh¶yksDlklhu-0.3%MCY;w@ohMsDlkfeFkkt+ksu -0.3%MCY;w@oh@fefy

41. MsDlkfeFkktksu$vks¶yksDlklhu$ 10 fefy dh cksry 9.38 2043(v) 30.11.2007csUtydksfu;e vk¡[kksa dk MªksiMsDlkfeFkkt+ksu lksfM;eMsDlkfeFkkt+ksu -0.1%MCY;w@ohvks¶yksDlklhu-0.3%MCY;w@ohcsUtydksfu;e DyksjkbM-0.01% MCY;w@oh

42. MsDlkfeFkktksu$vks¶yksDlklhu$ 5 fefy dh cksry 7.22 2043(v) 30.11.2007csUtydksfu;e vk¡[kksa dk Mªksi Mªksij vkSj dkVZu lfgrMsDlkfeFkkt+ksu lksfM;eMsDlkfeFkkt+ksu -0.1%MCY;w@ohvks¶yksDlklhu-0.3%MCY;w@ohcsUtydksfu;e DyksjkbM-0.01% MCY;w@oh

43. MsDlVªksizksiksDlhQsu ,plh,y vkSj 10 dk 6.26 1344(v) 16.09.2005isjkflVkeksy xksfy;ka ,,y_fCyLVj65 fexzk-$325 fexzk-@xksfy;ka

44. MsDlVªksizksiksDlhQsu ,plh,y$ 10 dk 11.64 1344(v) 16.09.2005 eS- ;wuhesDl ysc ,DlisufMdyksQsud lksfM;e$ iRrk@fCyLVjisjkflVkeksy dSilwy32.5 fexzk-$50 fexzk-$250 fexzk-@dSilwy

Page 81: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 62 -

45. MsDlVªksizksiksDlhQsu ,plh,y$ 8 dk 10.12 1334(v) 16.09.2005 eS- oksdkZM Lisleksa &izksDlhoksuMkbZlkbDyksekbu$,sflVkfeuksQsu dSilwy iRrk@fCyLVj65 fexzk-$10 fexzk-$400 fexzk-@dSilwy

46. MsDlVªksizksiksDlhQsu usilk;ysV$ 8 dk 14.28 1639(v) 27.09.2007 eS- oksdkZM Lisleksa &izksDlhoksuMkbZlkbDyksekbu$,sflVkfeuksQsu dSilwy iRrk@fCyLVj100 fexzk-$10 fexzk-$400 fexzk-@dSilwy

47. MsDlVªksizksiksDlhQsu usilk;ysV$ 8 dk 14.06 1639(v) 27.09.2007,sflVkfeuksQsu dSilwy iRrk@fCyLVj100 fexzk-$400 fexzk-@dSilwy

48. MsDlVªksizksiksDlhQsu ,plh,y$ 10 dk 9.94 1345(v) 16.09.2005 eS- lsuksQh ,ofUVl dksjC;wfVyisjkflVkeksy xksfy;ka iRrk@fCyLVj eS- jsDlVj lqfnuksy65 fexzk-$650 fexzk-@xksfy;ka

49. MsDlVªksizksiksDlhQsu$ 10 dk 9.52 1345(v) 16.09.2005MkbZlkbDyksekbu$ iRrk fCyLVjisjkflVkeksy xksfy;kaMsDlVªksizksiksDlhQsu ,plh,y&65 fexzk-MkbZlkbDyksekbu ,plh,y&10 fexzk-isjkflVkeksy&500 fexzk-

50. MsDlVªksizksiksDlhQsu ,plh,y$fMDyksQsusd 10 dk 5.90 1345(v) 16.09.2005 eS- eksMZu QkekZ t+ksyMsDllksfM;e$isjkflVkeksy xksfy;ka [email protected] fexzk-$50 fexzk-$325 fexzk-@xksfy;ka

51. MsDlVªksizksiksDlhQsu ,plh,y$ 8 dk 9.36 1345(v) 16.09.2005 eS- oksdkZM izksDlhoksu,flVkfeuksQsu dSilwy iRrk@fCyLVj65 fexzk-$400 fexzk-@dSilwy

52. MsDlVªksizksiksDlhQsu ,plh,y$ 6 dk 7.78 1345(v) 16.09.2005 eS- oksdkZM bC;w&izksDlhoksubC;wizksQsu dSilwy iRrk@fCyLVj65 fexzk-$400 fexzk-@dSilwy

53. MsDlVªksizksiksDlhQsu ,plh,y$ 10 dk 7.64 1345(v) 16.09.2005MkbZlkbDyksekbu ,plh,y$ iRrk fCyLVjisjkflVkeksy dSilwy33 fexzk-$ 10 fexzk- $ 300 fexzk-@dSilwy

54. MsDlVªksizksiksDlhQsu ,plh,y$ 10 dk 8.12 1647(v) 27.09.2007isjkflVkeksy xksfy;ka iRrk fCyLVj65 fexzk-$ 400 fexzk-@xksfy;ka

55. MsDlVªksizksiksDlhQsu ,plh,y$ 8 dk 6.62 1647(v) 27.09.2007bC;wizksQsu xksfy;ka iRrk fCyLVj32.5 fexzk-$ 200 fexzk-@xksfy;ka

56. Mk;kslfeu 150 xksfy;ka 10 dk 12.04 137(v) 31.01.2002flaFksfVd Mk;kslfeu&150 fexzk-@xksfy;ka ,,y_iRrk

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 82: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 63 -

57. Mk;kslfeu 150 xksfy;ka 10 dk 11.86 137(v) 31.01.2002flaFksfVd Mk;kslfeu&150 fexzk-@xksfy;ka ,,y_fCyLVj

58. Mk;kslfeu 150 xksfy;ka 10 dk 12.60 137(v) 31.01.2002flaFksfVd ,,y_iRrkMk;kslfeu&150 fexzk-@xksfy;ka ¼fyfir½

59. Mk;kslfeu 150 xksfy;ka 10 dk 12.22 137(v) 31.01.2002flaFksfVd ,,y_fCyLVjMk;kslfeu&150 fexzk-@xksfy;ka ¼fyfir½

60. Mk;kslfeu 300 xksfy;ka 10 dk 22.94 137(v) 31.01.2002 eS- ,yMj osusDlflaFksfVd Mk;kslfeu&300 fexzk-@xksfy;ka ,,y_iRrk

61. Mk;kslfeu 300 xksfy;ka 10 dk 22.76 137(v) 31.01.2002 eS- ,yMj osusDlflaFksfVd Mk;kslfeu&300 fexzk-@xksfy;ka ,,y_fCyLVj

62. Mk;kslfeu 300 xksfy;ka 10 dk 23.90 137(v) 31.01.2002 eS- ,yMj osusDlflaFksfVd Mk;kslfeu&300 fexzk-@ ,,y_iRrkxksfy;ka ¼fyfir½

63. Mk;kslfeu 300 xksfy;ka 10 dk 23.52 137(v) 31.01.2002 eS- ,yMj osusDlflaFksfVd Mk;kslfeu&300 fexzk-@ ,,y_fCyLVjxksfy;ka ¼fyfir½

64. Mk;kslfeu 450 xksfy;ka 10 dk 33.94 137(v) 31.01.2002flaFksfVd Mk;kslfeu&450 fexzk-@xksfy;ka ,,y_iRrk

65. Mk;kslfeu 450 xksfy;ka 10 dk 33.54 137(v) 31.01.2002flaFksfVd Mk;kslfeu&450 fexzk-@xksfy;ka ,,y_fCyLVj

66. Mk;kslfeu 450 xksfy;ka 10 dk 34.94 137(v) 31.01.2002flaFksfVd Mk;kslfeu&450 fexzk-@ ,,y_iRrkxksfy;ka ¼fyfir½

67. Mk;kslfeu 450 xksfy;ka 10 dk 34.50 137(v) 31.01.2002flaFksfVd Mk;kslfeu&450 fexzk-@ ,,y_fCyLVjxksfy;ka ¼fyfir½

68. Mk;kslfeu 500 xksfy;ka 10 dk 37.54 137(v) 31.01.2002 eS- ,yMj osusDlflaFksfVd Mk;kslfeu&500 fexzk-@xksfy;ka ,,y_iRrk

69. Mk;kslfeu 500 xksfy;ka 10 dk 37.14 137(v) 31.01.2002 eS- ,yMj osusDlflaFksfVd Mk;kslfeu&500 fexzk-@xksfy;ka ,,y_fCyLVj

70. Mk;kslfeu 500 xksfy;ka 10 dk 38.62 137(v) 31.01.2002 eS- ,yMj osusDlflaFksfVd Mk;kslfeu&500 fexzk-@ ,,y_iRrkxksfy;ka ¼fyfir½

71. Mk;kslfeu 500 xksfy;ka 10 dk 38.16 137(v) 31.01.2002 eS- ,yMj osusDlflaFksfVd Mk;kslfeu&500 fexzk-@ ,,y_fCyLVjxksfy;ka ¼fyfir½

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 83: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 64 -

72. Mk;kslfeu$feFkk;y gslisjhfMu xksfy;ka 10 dk 35.58 137(v) 31.01.2002450 fexzk-$50 fexzk-@xksfy;ka¼fyfir½ ,,y_iRrk

73. Mk;kslfeu$feFkk;y gslisjhfMu xksfy;ka 10 dk 35.20 137(v) 31.01.2002450 fexzk-$50 fexzk-@xksfy;ka¼fyfir½ ,,y_fCyLVj

74. MkWDlhlkbdfyu ,plh,y dSilwy&100 4 dh 3.98 295(v) 04.03.2004 eS- MkW- jsM~Mh ysc MksDlV dSilwy100 fexzk- csl@dSilwy ok;y@cksry eS- cksEcs VscysV ykW dSilwy

75. MkWDlhlkbdfyu ,plh,y dSilwy&100 6 dh 5.88 295(v) 04.03.2004 eS- ;w,loh MksDlh&1 dSilwy100 fexzk- csl@dSilwy ok;y@cksry eS- U;wykbQ U;wMksDlh dSilwy

76. MkWDlhlkbdfyu ,plh,y @ 10 dk 8.82 2060(v) 30.11.2007 eS- iysfFkdks fefulkbdfyu dSilwygkbZdysV dSilwy iRrk@fCyLVj eS- ekbØks ysc ekbØksMksDl dSilwy100 fexzk- MkWDlhlkbdfyu ds cjkcj@dSilwy

77. MkWDlhlkbdfyu ,plh,y dSilwy&100 10 dk 7.90 298(v) 04.03.2004 eS- tsxluiky MksDlhiky dSilwy100 fexzk- csl@dSilwy ,,y_fCyLVj eS- ck;ksdse ck;ksMksDlh dSilwy

eS- ,fjLVks QkekZ ysUVslfyu dSilwy

78. MkWDlhlkbdfyu eksuksgkbMªsV xksfy;ka 10 dk 6.82 296(v) 04.03.2004 eS- VkbEl MªXl ,aM MksDleks xksfy;ka100 fexzk- csl@xksfy;ka ,,y_iRrk QkekZ izkbosV fyfeVsM

79. MkWDlhlkbdfyu eksuksgkbMªsV xksfy;ka 10 dk 6.44 296(v) 04.03.2004 eS- VkbEl MªXl ,aM MksDleks xksfy;ka100 fexzk- csl@xksfy;ka ,,y_fCyLVj QkekZ izkbosV fyfeVsM

80. MkWDlhlkbdfyu eksuksgkbMªsV xksfy;ka&100 10 dh 7.84 297(v) 04.03.2004 eS- vkse gjs jke jsekMksDl&MhVhMkWDlhlkbdfyu eksuksgkbMªsV ok;y@cksry ,p- ds;j100 fexzk- MkWDlhlkbdfyu ds cjkcj@xksfy;ka

81. MkWDlhlkbdfyu ,plh,y 10 dk 10.56 299(v) 04.03.2004 eS- ekbØks ysc ekbØksMksDl dSilwylhvkj@Mhvkj dSilwy ,,y_iRrk100 fexzk- @lhvkj@Mhvkj dSilwy

82. MkWDlhlkbdfyu ,plh,y 10 dk 10.04 299(v) 04.03.2004 eS- ,YVkst+ QkekZ MksDlh;sVlhvkj@Mhvkj dSilwy ,,y_fCyLVj100 fexzk- @lhvkj@Mhvkj dSilwy

83. MkWDlhlkbdfyu ,plh,y 10 dh 11.82 299(v) 04.03.2004 eS- ,YVkst+ QkekZ MksDlh;sVlhvkj@Mhvkj dSilwy ok;y@cksry100 fexzk- @lhvkj@Mhvkj dSilwy

84. MkWDlhlkbdfyu ,plh,y dSilwy 8 dh 8.28 299(v) 04.03.2004 eS- MkW- jsM~Mh ysc MksDlV dSilwy100 fexzk- @dSilwy ok;y@cksry

85. MkWDlhlkbdfyu ,plh,y dSilwy 30 dh 25.96 299(v) 04.03.2004 eS- U;w ykbQ U;wMksDlh100 fexzk- @dSilwy ok;y@cksry

86. MkWDlhlkbdfyu eksuksgkbMªsV MhVh xksfy;ka 7 dh 7.72@ 1684(v) 03.10.2006 eS- vkjeksj jsesfMt+ osckfluMkWDlhlkbdfyu eksuksgkbMªsV ok;y@cksry100 fexzk- MkWDlhlkbdfyu dscjkcj@MhVh xksfy;ka

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 84: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 65 -

87. MkWDlhlkbdfyu eksuksgkbMªsV MhVh xksfy;ka 10 dk 6.92 299(v) 04.03.2004 eS- vkse gjs jke jsekMksDl MhVhMkWDlhlkbdfyu eksuksgkbMªsV ,,y_iRrk ,p- ds;j100 fexzk- MkWDlhlkbdfyu dscjkcj@MhVh xksfy;ka

88. MkWDlhlkbdfyu eksuksgkbMªsV MhVh xksfy;ka 10 dk 6.54 299(v) 04.03.2004 eS- vkse gjs jke jsekMksDl MhVhMkWDlhlkbdfyu eksuksgkbMªsV ,,y_fCyLVj ,p- ds;j100 fexzk- MkWDlhlkbdfyu dscjkcj@MhVh xksfy;ka

89. MkWDlhlkbdfyu eksuksgkbMªsV MhVh xksfy;ka 7 dh 11.90@ 1684(v) 03.10.2006MkWDlhlkbdfyu eksuksgkbMªsV ok;y@cksry200 fexzk- MkWDlhlkbdfyu dscjkcj@MhVh xksfy;ka

90. MkWDlhlkbdfyu eksuksgkbMªsV xksfy;ka 10 dk 12.10 299(v) 04.03.2004 eS- VkbEl MªXl ,aM MksDleks xksfy;kaMkWDlhlkbdfyu 200 fexzk-@xksfy;ka ,,y_iRrk QkekZ izkbosV fyfeVsM

91. MkWDlhlkbdfyu eksuksgkbMªsV xksfy;ka 10 dk 11.72 299(v) 04.03.2004 eS- VkbEl MªXl ,aM MksDleks xksfy;kaMkWDlhlkbdfyu 200 fexzk-@xksfy;ka ,,y_fCyLVj QkekZ izkbosV fyfeVsM

92. MkWDlhlkbdfyu eksuksgkbMªsV xksfy;ka 10 dh 13.12 299(v) 04.03.2004 eS- VkbEl MªXl ,aM MksDleks xksfy;kaMkWDlhlkbdfyu eksuksgkbMªsV ok;y@cksry QkekZ izkbosV fyfeVsM200 fexzk- MkWDlhlkbdfyu ds cjkcj@xksfy;ka

93. MkWDlhlkbdfyu$fVfuMkt+ksy xksfy;ka 10 dk 11.52 299(v) 04.03.2004 eS- ,okykads QkekZ ,ohMksDl&VhtsMMkWDlhlkbdfyu 100 fexzk- ,,y_iRrk eS- chvkbZih,y lhMksDlh&VhtsMfVfuMkt+ksy 600 fexzk-@xksfy;ka eS- VkbEl MªXl ,aM MksDleks xksfy;ka

QkekZ izkbosV fyfeVsM

94. MkWDlhlkbdfyu$fVfuMkt+ksy xksfy;ka 10 dk 11.08 299(v) 04.03.2004 eS- oksdkZM ,p- ds;j MksDlhfuV&VhtsMMkWDlhlkbdfyu 100 fexzk- ,,y_fCyLVjfVfuMkt+ksy 600 fexzk-@xksfy;ka

95. MkWDlhlkbdfyu MªkbZ flji 30 fefy dh cksry 6.46 299(v) 04.03.2004 eS- iysfFkdks fefulkbdfyu lLis-MkWDlhlkbdfyu 25 fexzk-@ 5 fefy ,e- di lfgr

96. MkWDlhlkbdfyu MªkbZ flji 60 fefy dh cksry 9.06 299(v) 04.03.2004 eS- U;wykbQ ufMt+ fljiMkWDlhlkbdfyu 25 fexzk-@ 5 fefy ,e- di lfgr

97. MkWDlhlkbdfyu Mªksi 10 fefy dh cksry 5.60 299(v) 04.03.2004 eS- Js;k fefulkbdfyuMkWDlhlkbdfyu 50 fexzk-@ 5 fefy Mªksij vkSj dkVZu lfgr

98. MkWDlhlkbdfyu ,plh,y@gkbdysV xksfy;ka 10 dk 5.77 1648(v) 27.09.2007 eS- ysulj QkekZ yk;VsMksDlMkWDlhlkbdfyu ,plh,y@gkbdysV iRrk@fCyLVj eS- fleck;ksfl ysc MksDlh Iyl100 fexzk- MkWDlhlkbdfyu ds cjkcj@xksfy;ka

99. MkWDlhlkbdfyu gkbdysV xksfy;ka 10 dh 7.12 320(v) 09.03.2004 eS- iysfFkdks fefulkbdfyu dSilwyMkWDlhlkbdfyu gkbdysV ok;y@cksry eS- ekbØks ysc ekbØksMksDl dSilwy100 fexzk- MkWDlhlkbdfyu ds cjkcj@xksfy;ka eS- tsxluiky MksDlhiky dSilwy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 85: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 66 -

100. MkWDlhlkbdfyu gkbdysV xksfy;ka 10 dk 10.68 320(v) 09.03.2004MkWDlhlkbdfyu gkbdysV ,,y_iRrk200 fexzk- MkWDlhlkbdfyu ds cjkcj@xksfy;ka

101. MkWDlhlkbdfyu gkbdysV xksfy;ka 10 dk 10.30 320(v) 09.03.2004MkWDlhlkbdfyu gkbdysV ,,y_fCyLVj200 fexzk- MkWDlhlkbdfyu ds cjkcj@xksfy;ka

102. MkWDlhlkbdfyu gkbdysV xksfy;ka 10 dh 11.70 320(v) 09.03.2004MkWDlhlkbdfyu gkbdysV ok;y@cksry200 fexzk- MkWDlhlkbdfyu ds cjkcj@xksfy;ka

103. MkWDlhlkbdfyu gk;dysV$ 8 dk 7.18 178(v) 07.02.2006ysfDVd ,sflM csflyl dSilwy iRrk@fCyLVjMkWDlhlkbdfyu gk;dysV100 fexzk- MkWDlhlkbdfyu ds cjkcjysfDVd ,sflM csflyl&60 fefy;u LiksZl¼,UVk;j fyfir isysVl ds leku½

104. MksDlhlkbdfyu gkbdysV$ 10 dk 4.30 222(v) 14.02.2007ysfDVd ,sflM csflyl dSilwy iRrk@fCyLVjMksDlhlkbdfyu gkbdysVMksDlhlkbdfyu-100 fexzk- ds cjkcjysfDVd ,sflM csflyl-30 fefy;u LiksZl

105. MkWDlhlkbdfyu ,plh,y$ 10 dk 11.92 752(v) 19.05.2006lsjkfV;ksisiVhMst+ dSilwy iRrk@fCyLVjMkWDlhlkbdfyu gkbMªksDyksjkbM100 fexzk- MkWDlhlkbdfyu ds cjkcjlsjkfV;ksisiVhMst+&10 fexzk-

106. MkWDlhlkbdfyu gk;dysV$ 10 dk 8.88 1345(v) 01.08.2007ysfDVd ,sflM csflyl dSilwy iRrk@fCyLVjMkWDlhlkbdfyu gk;dysVMkWDlhlkbdfyu 100 fexzk- ds cjkcjysfDVd ,sflM csflyl&10 fefy;u LiksZl

107. MkWDlhlkbdfyu eksuksgkbMªsV$ysfDVd 10 dk 6.66 1649(v) 27.09.2007,sflM csflyl xksfy;ka iRrk@fCyLVjMkWDlhlkbdfyu eksuksgkbMªsVMkWDlhlkbdfyu - 100 fexzk- ds cjkcjysfDVd ,sflM csflyl - 60 fefy;u LiksZl@?kqyu’khy fVfd;k

108. MkWDlhlkbdfyueksuksgkbMªsV$ysfDVd 10 dk 5.82 1649(v) 27.09.2007,sflM csflyl xksfy;ka iRrk@fCyLVjMkWDlhlkbdfyu ,plh,y@gkbdysVMkWDlhlkbdfyu - 100 fexzk- ds cjkcjysfDVd ,sflM csflyl - 30 fefy;u LiksZl

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 86: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 67 -

109. MkWDlhlkbdfyu eksuksgkbMªsV$ 10 dk 6.50 1649(v) 27.09.2007ysfDVd ,sflM csflyl xksfy;ka iRrk@fCyLVjMkWDlhlkbdfyu eksuksgkbMªsVMkWDlhlkbdfyu - 100 fexzk- ds cjkcjysfDVd ,sflM csflyl - 30 fefy;u LiksZl

110. MkWDlhlkbdfyu xksfy;ka 10 dk 3.36 1649(v) 27.09.2007MkWDlhlkbdfyu ,plh,y@gkbdysV iRrk@fCyLVjMkWDlhlkbdfyu- 50 fexzk- ds cjkcj

111. MkWDlhlkbdfyu xksfy;ka 6 dk 4.18 1649(v) 27.09.2007MkWDlhlkbdfyu ,plh,y@gkbdysV iRrk@fCyLVjMkWDlhlkbdfyu ,UgkbMªsl - 100 fexzk- ds cjkcj

112. MkWDlhlkbdfyu xksfy;ka 10 dk 11.46 1649(v) 27.09.2007MkWDlhlkbdfyu eksuksgkbMªsV iRrk@fCyLVjMkWDlhlkbdfyu ,UgkbMªsl -200 fexzk- ds cjkcj

113. MkWDlhlkbdfyu$ysfDVd ,sflM 10 dk 6.55 1649(v) 27.09.2007csflyl xksfy;ka iRrk@fCyLVjMkWDlhlkbdfyu eksuksgkbMªsVMkWDlhlkbdfyu ,UgkbMªsl -100 fexzk- ds cjkcjysfDVd ,sflM csflyl - 60 fefy;u LiksZl

114. MkWDlhlkbdfyu$vksjfuMkt+ksy xksfy;ka 10 dk 18.34 1649(v) 27.09.2007MkWDlhlkbdfyu eksuksgkbMªsV iRrk@fCyLVjMkWDlhlkbdfyu ,UgkbMªsl -100 fexzk- ds cjkcjvksjfuMkt+ksy - 500 fexzk-

115. MkWDlhlkbdfyu$lsjkfV;ksisIVhMst+ xksfy;ka 10 dk 8.80 1649(v) 27.09.2007MkWDlhlkbdfyu eksuksgkbMªsV iRrk@fCyLVjMkWDlhlkbdfyu ,UgkbMªsl -100 fexzk- ds cjkcjlsjkfV;ksisIVhMst - 10 fexzk-

116. MkWDlhlkbdfyu$,EczksDl+ksy 10 dk 7.60 1649(v) 27.09.2007,plh,y xksfy;ka iRrk@fCyLVjMkWDlhlkbdfyu eksuksgkbMªsVMkWDlhlkbdfyu ,UgkbMªsl -100 fexzk- ds cjkcj,EczksDl+ksy ,plh,y - 30 fexzk-

117. MkWDlhlkbdfyu$fVfuMkt+ksy$ysfDVd 10 dk 12.22 1649(v) 27.09.2007,sflM csflyl xksfy;ka iRrk@fCyLVjMkWDlhlkbdfyu ,plh,y@gkbdysVMkWDlhlkbdfyu -100 fexzk- ds cjkcjfVfuMkt+ksy - 600 fexzk-ysfDVd ,sflM csflyl - 60 fefy;u LiksZl

118. MkWDlhlkbdfyu$fVfuMkt+ksy$ 10 dk 12.94 1649(v) 27.09.2007ysfDVd ,sflM csflyl xksfy;ka iRrk@fCyLVjMkWDlhlkbdfyu eksuksgkbMªsVMkWDlhlkbdfyu -100 fexzk- ds cjkcjfVfuMkt+ksy - 600 fexzk-ysfDVd ,sflM csflyl - 60 fefy;u LiksZl

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 87: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 68 -

119. MkWDlhlkbdfyu$lsjkfV;ksisIVhMst+ xksfy;ka 10 dk 9.98 1649(v) 27.09.2007MkWDlhlkbdfyu eksuksgkbMªsV iRrk@fCyLVjMkWDlhlkbdfyu -100 fexzk- ds cjkcjlsjkfV;ksisIVhMst - 15 fexzk-

120. MkWDlhlkbdfyu$ 10 dk 6.14 179(v) 29.01.2008ysfDVd ,sflM csflyl xksfy;ka iRrk@fCyLVjMkWDlhlkbdfyu gkbMªksDyksjkbMMkWDlhlkbdfyu -100 fexzk- ds cjkcjysfDVd ,sflM csflyl - 60 fefy;u LiksZl@fQYe fyfir fVfd;k

121. dSfY’k;e iSUVksfFkusV xksfy;ka 10 dk 1.48 1931(v) 08.11.2006dSfY’k;e iSUVksfFkusV&50 fexzk-@xksfy;ka iRrk@fCyLVj

122. dSfY’k;e iSUVksfFkusV xksfy;ka 10 dk 1.98 1931(v) 08.11.2006dSfY’k;e iSUVksfFkusV&100 fexzk--@xksfy;ka iRrk@fCyLVj

123. dSfY’k;e iSUVksfFkusV bUtsD’ku 10 fefy dk 7.14 1931(v) 08.11.2006Mh&iSfUFkuksy&50 fexzk- ok;y¼58 fexzk- dSfY’k;e iSUVksfFkusVds cjkcj½ @ fefy

124. flfVªekbM$dSfY’k;e iSUVksfFkusV yks’ku 15 fefy 6.98 1077(v) 11.07.2006flfVªekbM 5% MCY;w@oh dh cksrydSfY’k;e iSUVksfFkusV 2% MCY;w@oh@fefy

125. MkbZ&vkbMks gkbMªksDlhDohu xksfy;ka 10 dk 9.98 1658(v) 27.09.2007MkWDlhlkbdfyu eksuksgkbMªsV iRrk@fCyLVjMkWDlhlkbdfyu -100 fexzk- ds cjkcjlsjkfV;ksisIVhMst - 15 fexzk-

@uksV

¼d½ Åij nh xbZ fofufeZfr;ksa esa vU; la?kVu tSls fd ysfDVd ,sflM csflyl tksM+s tkus dh fLFkfr esa 0.017 :i;sizfr 10 ds xksfy;ka@dSilwy iSd ds fy, izR;sd izR;sd 10 fefy;u LiksZl ;k ysfDVd ,sflM csflyl ds Hkkxgsrq tksM+@?kVk;s tk;saxsA

¼[k½ 10 dh ok;y@cksry rd ds lHkh vU; iSdksa esa vkus okyh leku dEiksft’ku] tc iSd vkdkj esa ifjorZu gksrkgS rks 100 fexzk- ds fy, #i;s 0.59 izfr xksfy;ka vkSj 200 fexzk- ds fy, 1.18 izfr xksfy;ka tksM+s ;k ?kVk;s tkldsaxs tks fd Åij nh xbZ lkj.kh ds LrEHk la[;k 4 esa fn;s izdkf’kr vf/kdre dher ds vk/kkj ij fuEu rjhdsls gks ldrs gSAa

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 88: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 69 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

b (E)

1. ,fjFkzksekbflu lksY;w’ku 25 fefy dh 10.26 1331(v) 16.09.2005 eS- cwVl fijkey ,dusekbflu Iyl,fjFkzksekbflu 4.0% MCY;w@MCY;w cksry dkVZu lfgr,clksY;wV ,Ydksgy 91.5% MCY;w@MCY;w@fefy

2. ,fjFkzksekbflu Iyl lksY;w’ku 25 fefy dh 10.26 1331(v) 16.09.2005 eS- cwVl fijkey ,dusekbflu Iyl,fjFkzksekbflu 4.0% MCY;w@MCY;w cksry dkVZu lfgrfVªfVfu;ksu 0.025% MCY;w@MCY;w,clksY;wV ,Ydksgy 91.5% MCY;w@MCY;w@fefy

3. ,fjFkzksekbflu yks’ku@lksY;w’ku 30 fefy dh 13.42 1332(v) 16.09.2005 eS- fllVksfid ,duslksy lksY;w’ku,fjFkzksekbflu 2% MCY;w@MCY;w@fefy cksry dkVZu lfgr eS- jsdflu jsdflu yks’ku

4. ,fjFkzksekbflu yks’ku@lksY;w’ku 20 fefy dh 8.40 1332(v) 16.09.2005 eS- fl;ksjds;j QkekZ ,ds;j,fjFkzksekbflu 4% MCY;w@MCY;w@fefy cksry dkVZu lfgr

5. ,fjFkzksekbflu yks’ku@lksY;w’ku 20 fefy dh 8.48 1339(v) 16.09.2005 eS- ,cksV ,dusMeZ yks’ku,fjFkzksekbflu 2% MCY;w@MCY;w@fefy cksry dkVZu lfgr

6. ,fjFkzksekbflu yks’ku 25 fefy dh 11.46 1339(v) 16.09.2005 eS- ;w,loh foVkfeu ,fjVksiizR;sd fefy esa cksry dkVZu lfgr,fjFkzksekbflu 3% MCY;w@MCY;w

7. ,fjFkzksekbflu tWy@Øhe@vkW;uVesaV 20 xzke dh V~;wc 10.64 1339(v) 16.09.2005 eS- ;w,loh foVkfeu ,fjVksi,fjFkzksekbflu 3% MCY;w@MCY;w@xzke eS- fliyk vksdkekbflu

8. ,fjFkzksekbflu Øhe@vkW;UVesaV 15 xzke dh V~;wc 8.72 1339(v) 16.09.2005 eS- baM&LohQ~V ,fy;wflu Øhe,fjFkzksekbflu 3% MCY;w@MCY;w@xzke eS- lkjkHkkbZ fijkey fiEiysl vkW;uVesaV

eS- ftuks t+sjh vkW;uVesaV

9. ,fjFkzksekbflu Øhe@vkW;UVesaV 10 xzke dh V~;wc 6.20 1339(v) 16.09.2005 eS- ,cksV ,fjFkzksekbflu Øhe,fjFkzksekbflu 2% MCY;w@MCY;w@xzke

10. ,fjFkzksekbflu tWy@Øhe@vkW;UVesaV 10 xzke dh V~;wc 6.20 1339(v) 16.09.2005 eS- ,cksV ,fjFkzksekbflu Øhe,fjFkzksekbflu 2% MCY;w@MCY;wfVªfVfu;ksu 0.025% MCY;w@MCY;w @xzke

11. ,fjFkzksekbflu tWy@Øhe 60 xzke dh V~;wc 30.08 1339(v) 16.09.2005 eS- lkYdl ,duscsUt+ tWy,fjFkzksekbflu 4% MCY;w@MCY;wcsutk;y isjksDlkbM 5% MCY;w@MCY;w @xzke

12. ,fjFkzksekbflu Øhe@vkW;UVesaV 5 xzke dh V~;wc 4.62 1339(v) 16.09.2005 eS- Vksjl ysc fVisDV,fjFkzksekbflu 2% MCY;w@MCY;w@xzke

13. ,fjFkzksekbflu Øhe@vkW;UVesaV 5 xzke dh V~;wc 4.90 1339(v) 16.09.2005 eS- ftuks t+sjh,fjFkzksekbflu 3% MCY;w@MCY;w@xzke

14. ,fjFkzksekbflu Øhe@vkW;UVesaV 15 xzke dh V~;wc 9.82 1339(v) 16.09.2005 eS- lkYdl QkekZ ,dusYd Øhe,fjFkzksekbflu 4% MCY;w@MCY;w@xzke

Page 89: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 70 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

15. ,fjFkzksekbflu Øhe@vkW;UVesaV 30 xzke dh V~;wc 16.74 1339(v) 16.09.2005 eS- dksesM dsfedyl ,jksesM,fjFkzksekbflu 4% MCY;w@MCY;w@xzke

16. ,fjFkzksekbflu Øhe@vkW;UVesaV 20 xzke dh V~;wc 12.15 1339(v) 16.09.2005 eS- VsysUV QkekZ ,fjysUVizR;sd xzke esa eS- ftuks ,fj,dus tWy,fjFkzksekbflu 4% MCY;w@MCY;w

17. ,fjFkzksekbflu bLVh;jsV xksfy;ka&100 10 dk 6.64 436(v) 23.03.2007 eS- ,yfEcd ,yFkzksflu100 fexzk- csl@xksfy;ka iRrk@fCyLVj eS- Qkjesfl;k ,p ,fjFkzksflu

18. ,fjFkzksekbflu bLVh;jsV xksfy;ka&100 100 dh cksry 63.84 436(v) 23.03.2007 eS- ,yfEcd ,yFkzksflu100 fexzk- csl@xksfy;ka eS- Qkjesfl;k ,p ,fjFkzksflu

19. ,fjFkzksekbflu bLVh;jsV xksfy;ka&250 10 dk 15.48 436(v) 23.03.2007 eS- ,yfEcd ,yFkzksflu250 fexzk- csl@xksfy;ka iRrk@fCyLVj eS- bidk ,YVksflu

20. ,fjFkzksekbflu bLVh;jsV xksfy;ka&250 100 dh cksry 150.68 436(v) 23.03.2007 eS- Qkjesfl;k ,p ,fjFkzksflu250 fexzk- csl@xksfy;ka eS- ,ydse ,fjFkzksekbflu

21. ,fjFkzksekbflu bLVh;jsV xksfy;ka&500 10 dk 29.02 436(v) 23.03.2007 eS- ,yfEcd ,fjFkzksflu500 fexzk- csl@xksfy;ka iRrk@fCyLVj eS- bidk ,YVksflu

eS- Qkjesfl;k ,p ,fjFkzksflueS- ,ydse ,fjFkzksekbflu

22. ,fjFkzksekbflu bLVh;jsV lLisUlu 60 fefy dh 14.88 1340(v) 16.09.2005 eS- ,yfEcd ,fjFkzksflu100 fexzk- csl@ 5 fefy cksry ,e- di lfgr

23. ,fjFkzksekbflu bLVh;jsV lLisUlu 30 fefy dh 10.54 436(v) 23.03.2007 eS- fudksYl fijkey ,eFkzksflu125 fexzk- csl@ 5 fefy cksry ,e- di lfgr

24. ,fjFkzksekbflu xzsU;wy@flji@lLisUlu 60 fefy dh 16.52 1642(v) 27.09.2007 eS- fudksYl fijkey ,eFkzksflu125 fexzk- ¼,fjFkzksekbflu LVh;jsV cksry ,e- di lfgrds leku½@ 5 fefy

25. ,fjFkzksekbflu bLVh;jsV isfM;fVªd Mªksi 10 fefy dh 10.50 1340(v) 16.09.2005 eS- ,yfEcd ,yFkzksflu100 fexzk- csl@ 5 fefy cksry Mªksij lfgr

26. ,fjFkzksekbflu bFkk;y 45fefy dh cksry 16.10 1341(v) 16.09.2005lDlhusV MªkbZ flji ,e- di lfgr,fjFkzksekbflu bFkk;y lDlhusV,fjFkzksekbflu&125 fexzk- csl ds leku @ 5 fefy

27. ,fjFkzksekbflu bFkk;y 30 fefy dh 11.42 1341(v) 16.09.2005lDlhusV xzsU;wyl@MªkbZ flji cksry ,e- di,fjFkzksekbflu&125 fexzk- lfgr¼,fjFkzksekbflu bFkk;ylDlhusV ds leku½ @ 5 fefy

28. ,fjFkzksekbflu bFkk;y lDlhusV xksfy;ka 10 dk 32.60 1341(v) 16.09.2005 eS- ,cksV b-b-,l 400400 fexzk- iRrk@fCyLVj¼,fjFkzksekbflu bFkk;y lDlhusV esa½

Page 90: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 71 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

29. ,fjFkzksekbflu bFkk;y 4x1.9 xzk- lspV 8.96 1341(v) 16.09.2005lDlhusV xzsU;wyl,fjFkzksekbflu&200 fexzk-¼,fjFkzksekbflu bFkk;y lDlhusV ds leku ½@ikmp

30. ,fjFkzksekbflu bFkk;y 10 dk 44.58 436(v) 23.03.2007lDlhusV xksfy;ka iRrk@fCyLVj,fjFkzksekbflu bFkk;y lDlhusV,fjFkzksekbflu 600 fexzk-csl ds cjkcj @ xksfy;ka

31. ,fjFkzksekbflu bFkk;y 10 dk 11.04 1341(v) 16.09.2005lDlhusV xksfy;ka ,,y_fCyLVj,fjFkzksekbflu bFkk;y lDlhusVbjkbFkjksekbflu 125 fexzk-csl ds cjkcj @ ?kqyu’khu xksfy;ka

32. ,fjFkzksekbflu Mªksi 15 fefy dh cksry 13.18 1073(v) 11.07.2006,fjFkzksekbflu&100 fexzk- Mªksij lfgr

33. ,fjFkzksekbflu Øhe 30 xzke dh V~;wc 13.38 1685(v) 03.10.2006,fjFkzksekbflu&3% MCY;w@MCY;w @xzke

34. ,fjFkzksekbflu xksfy;ka 10 dk 19.08 1919(v) 08.11.2006izR;sd ,afVªd fyfir xksfy;ksa esa iRrk@fCyLVj,fjFkzksekbflu csl&333 fexzk-

35. ,fjFkzksekbflu $ftad ,sflVsV 15 xzke dh V~;wc 8.98 442(v) 23.03.2007tWy@vkW;UVesUV@Øhe,fjFkzksekbflu & 4%ftad ,sflVsV & 2%

36. ,fjFkzksekbflu vk¡[kksa dk vkW;uVesUV 5 xzke dh V~;wc 4.26 2044(v) 30.11.2007,fjFkzksekbflu&5 fexzk-@xzke

37. ,fjFkzksekbflu $ftad ,sflVsV yks’ku 15 xzke dh 8.98 178(v) 29.01.2008,fjFkzksekbflu & 4.00% MCY;w@MCY;w yks’ku V~;wcftad ,sflVsV & 2.00% MCY;w@MCY;w

38. ,sQsMjhu$esUFkksy$dsEQj$ 10 fefy dk 5.46 1341(v) 19.11.2003 eS- ok;Fk ,uMªhub;wdsfyiVksy$dslVkWj vkW;y Mªksi ok;y,sQsMjhu ,plh,y 0.75%esUFkksy 0.5%, dsEQj 0.5%b;wdsfyiVksy 0.5%, dslVkWj vkW;y 0.5%@fefy

39. ,sQsMjhu$dsEQj$b;wdsfyiVksy$ 10 fefy dk 5.32 1341(v) 19.11.2003 eS- ok;Fk ,uMªhu feYMdslVkWj vkW;y Mªksi ok;y,sQsMjhu ,plh,y 0.75%dsEQj 0.5%, b;wdsfyiVksy 0.5%,dslVkWj vkW;y 0.5%@fefy

Page 91: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 72 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

40. ,sQsMjhu$DyksjQsfujkekbu esfy,V$ 60 fefy dh 8.28 1326(v) 19.11.2003ik;fjykekbu esfy,V$MkbZQsfuMªkekbu cksry$,eksfu;e DyksjkbM$lksfM;elkbVªsV$esUFkksy$,YdksgWy ,fyDlj,sQsMjhu ,plh,y 5 fexzk-DyksjQsfujkekbu esfy,V 1 fexzk-ik;fjykekbu esfy,V 5 fexzk-MkbZQsfuMªkekbu ,plh,y 5 fexzk-,eksfu;e DyksjkbM 90 fexzk-lksfM;e lkbVªsV 40 fexzk-] esUFkksy 0.75 fexzk-,YdksgWy ,fyDlj 4.3% oh@oh @ 4 fefy

41. ,sQsMjhu$DyksjQsfujkekbu esfy,V$ 110 fefy dh 11.88 1326(v) 19.11.2003ik;fjykekbu esfy,V$MkbZQsfuMªkekbu cksry$,eksfu;e DyksjkbM$lksfM;elkbVªsV$esUFkksy$,YdksgWy ,fyDlj,sQsMjhu ,plh,y 5 fexzk-DyksjQsfujkekbu esfy,V 1 fexzk-ik;fjykekbu esfy,V 5 fexzk-MkbZQsfuMªkekbu ,plh,y 5 fexzk-,eksfu;e DyksjkbM 90 fexzk-lksfM;e lkbVªsV 40 fexzk-] esUFkksy 0.75 fexzk-,YdksgWy ,fyDlj 4.3% oh@oh @ 4 fefy

42. ,sQsMjhu$fVªiyksfMu flji 115 fefy dh 17.32 1326(v) 19.11.2003,sQsMjhu ,plh,y&15 fexzk- cksryfVªiyksfMu ,plh,y&2.5 fexzk-@5fefy

43. ,sQsMjhu$fFk;ksQkbfyu$ 200 fefy dh 24.88 1326(v) 19.11.2003QsuksckjfcVksu$X;wQSUlhu$ cksry,YdksgWy ,fyDlj,sQsMjhu ,plh,y&12 fexzk-fiijktkbu&80 fexzk- dk fFk;ksQkbfyu bFkksusVQsuksckjfcVksu&4 fexzk-X;wQSUlhu&50 fexzk-,YdksgWy&0.55 fefy@5 fefy

44. ,sQsMjhu$fFk;ksQkbfyu$ 100 fefy dh 26.24 182(v) 07.02.2006QsuksckjfcVksu fyfDoM cksry,sQsMjhu ,plh,y&10 fexzk-fFk;ksQkbfyu ,Ugkb- &100 fexzk-QsuksckjfcVksu &10 fexzk-@5 fefy

45. ,sQsMjhu$DyksjQsfujkekbu esfy,V$ 100 fefy dh 10.82 1326(v) 19.11.2003X;wQSUlhu$lksfM;e lkbVªsV$ cksryesUFkksy flji,sQsMjhu ,plh,y&5 fexzk-DyksjQsfujkekbu esfy,V&2 fexzk-X;wQSUlhu&5 fexzk-lksfM;e lkbVªsV&150 fexzk-esUFkksy&0.1 fexzk-@5 fefy

Page 92: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 73 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

46. ,sQsMjhu$DyksjQsfujkekbu esfy,V$ 60 fefy dh 8.72 1326(v) 19.11.2003MsDLVªksfeFkksjQsu gkbMªksczksekbM$ cksryczkseksgsDlhu flji,sQsMjhu ,plh,y&5 fexzk-DyksjQsfujkekbu esfy,V&1 fexzk-MsDLVªksfeFkksjQsu gkbMªksczksekbM&5 fexzk-czkseksgsDlhu&2.7 fexzk-@5 fefy

47. ,sQsMjhu$DyksjQsfujkekbu esfy,V$ 60 fefy dh 16.20 1326(v) 19.11.2003dksfMu QksLQsV flji cksry,sQsMjhu ,plh,y&7 fexzk-DyksjQsfujkekbu esfy,V&4 fexzk-dksfMu QksLQsV&10 fexzk-@5 fefy

48. ,sQsMjhu$lksfM;e lkbVªsV$ 100 fefy dh 10.94 1326(v) 19.11.2003MkbZQsfujkekbu$,eksfu;e DyksjkbM$ cksryesUFkksy flji,sQsMjhu ,plh,y&8 fexzk-lksfM;e lkbVªsV&50 fexzk-MkbZQsfujkekbu ,plh,y&14 fexzk-,eksfu;e DyksjkbM&100 fexzk-esUFkksy&1 fexzk-@5 fefy

49. ,sQsMjhu$DyksjQsfujkekbu esfy,V$ 100 fefy dh 11.00 1326(v) 19.11.2003,eksfu;e DyksjkbM$ cksrylksfM;e lkbVªsV$esUFkksy flji,sQsMjhu ,plh,y&10 fexzk-DyksjQsfujkekbu esfy,V&4 fexzk-,eksfu;e DyksjkbM&125 fexzk-lksfM;e lkbVªsV&62.5 fexzk-esUFkksy&1 fexzk-@5 fefy

50. ,sQsMjhu$DyksjQsfujkekbu esfy,V$ 400 fefy dh 33.34 1326(v) 19.11.2003,eksfu;e DyksjkbM$ cksrylksfM;e lkbVªsV$esUFkksy flji,sQsMjhu ,plh,y&10 fexzk-DyksjQsfujkekbu esfy,V&4 fexzk-,eksfu;e DyksjkbM&125 fexzk-lksfM;e lkbVªsV&62.5 fexzk-esUFkksy&1 fexzk-@5 fefy

51. fl;wMks,sQsMjhu$isjkflVkeksy xksfy;ka 10 dk 4.10 1016(v) 03.09.200330 fexzk-$500 fexzk-@xksfy;ka iRrk@fCyLVj

52. fl;wMks,sQsMjhu$fVªiyksfMu xksfy;ka 10 dk 5.98 773(v) 19.05.200660 fexzk-$ 2.5 fexzk-@xksfy;ka ,,y_iRrk

53. fl;wMks,sQsMjhu$fVªiyksfMu xksfy;ka 10 dk 5.76 1016(v) 03.09.200360 fexzk-$ 2.5 fexzk-@xksfy;ka ,,y_iRrk

Page 93: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 74 -

54. fl;wMks,sQsMjhu$isjkflVkeksy$ 10 dk 4.46 1016(v) 03.09.2003lhih,e$dSfQu xksfy;ka iRrk@fCyLVjfl;wMks,sQsMjhu ,plh,y 30 fexzk-isjkflVkeksy 500 fexzk-lhih,e 2 fexzk-dSfQu 30 fexzk-@xksfy;ka

55. fl;wMks,sQsMjhu$ 10 dk 6.42 773(v) 19.05.2006 eS- ck;ksyksft+dy bZ ,ydksYMflVªhft+u ,plh,y xksfy;ka iRrk@fCyLVj eS- lu QkekZ flVªhtsV&Mh120 fexzk- $ 5 fexzk-@xksfy;ka

56. fl;wMks,sQsMjhu$,sflVkfeuksQsu$ 10 dk 6.24 1016(v) 03.09.2003MsDlVªksfeFkksjQsu ,pchvkj xksfy;ka iRrk@fCyLVjfl;wMks,sQsMjhu ,plh,y 30 fexzk-,sflVkfeuksQsu 500 fexzk-MsDlVªksfeFkksjQsu ,pchvkj 15 fexzk-@xksfy;ka

57. fl;wMks,sQsfMjhu$ 10 dk 23.00 773(v) 19.05.2006QsDlksQsukMhu xksfy;ka ,,y_iRrkfl;wMk,sQsfMjhu ,plh,y&120 fexzk-QsDlksQsukMhu&60 fexzk-

58. fl;wMks,sQsfMjhu$ 10 dk 22.68 773(v) 19.05.2006QsDlksQsukMhu xksfy;ka ,,y_fCyLVjfl;wMk,sQsfMjhu ,plh,y&120 fexzk-QsDlksQsukMhu&60 fexzk-

59. fl;wMks,sQsMjhu$isjkflVkeksy$ 10 dk 5.98 145(v) 31.01.2002 eS- ,Fkuksj jslizsuDyksjQsfujkekbu esfy,V$ ,,y_iRrkMsDlVªksfeFkksjQsu xksfy;kafl;wMks,sQsMjhu ,plh,y 30 fexzk-isjkflVkeksy 325 fexzk-DyksjQsfujkekbu esfy,V 2 fexzk-MsDlVªksfeFkksjQsu ,pchvkj 15 fexzk-@ xksfy;ka

60. fl;wMks,sQsMjhu$isjkflVkeksy$ 10 dk 5.60 145(v) 31.01.2002 eS- ,Fkuksj jslizsuDyksjQsfujkekbu esfy,V$ ,,y_fCyLVjMsDlVªksfeFkksjQsu xksfy;kafl;wMks,sQsMjhu ,plh,y 30 fexzk-isjkflVkeksy 325 fexzk-DyksjQsfujkekbu esfy,V 2 fexzk-MsDlVªksfeFkksjQsu ,pchvkj 15 fexzk-@ xksfy;ka

61. fl;wMks,sQsMjhu$VjQsukfMu xksfy;ka 10 dk 11.82 773(v) 19.05.2006 eS- izksVsd VsjQsM&Mhfl;wMks,sQsMjhu ,plh,y 120 fexzk- ,,y_iRrkVjQsukfMu 60 fexzk-@,lvkj@bZvkj xksfy;ka

62. fl;wMks,sQsMjhu$VjQsukfMu xksfy;ka 10 dk 11.38 773(v) 19.05.20063 eS- izksVsd VsjQsM&Mhfl;wMks,sQsMjhu ,plh,y 120 fexzk- ,,y_fCyLVjVjQsukfMu 60 fexzk-@,lvkj@bZvkj xksfy;ka

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 94: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 75 -

63. fl;wMks,sQsMjhu$flVªhft+u xksfy;ka 10 dk 7.08 773(v) 19.05.2006 eS- ,eD;wj vkbZds,fl;wMks,sQsMjhu ,plh,y 120 fexzk- ,,y_iRrkflVªhft+u MkbZ ,plh,y 5 fexzk-@,lvkj@bZvkj xksfy;ka

64. fl;wMks,sQsMjhu$flVªhft+u xksfy;ka 10 dk 6.54 773(v) 19.05.2006 eS- ,eD;wj vkbZds,fl;wMks,sQsMjhu ,plh,y 120 fexzk- ,,y_fCyLVjflVªhft+u MkbZ ,plh,y 5 fexzk-@,lvkj@bZvkj xksfy;ka

65. fl;wMks,sQsMjhu$DyksjQsfujkekbu 60 fefy dh 8.92 773(v) 05.07.2001esfy,V$MsDlVªksfeFkksjQsu $ cksryisjkflVkeksy fljiizR;sd 5 fefy esafl;wMks,sQsMjhu ,plh,y 10 fexzk-DyksjQsfujkekbu esfy,V 1 fexzk-MsDlVªksfeFkksjQsu ,pchvkj 5 fexzk-isjkflVkeksy 125 fexzk-

66. fl;wMks,sQsMjhu$,sflVkfeuksQsu$ 60 fefy dh 8.28 145(v) 31.01.2002dkfcZuksDlkekbu$MsDlVªksfeFkksjQsu cksryfyfDoMfl;wMks,sQsMjhu ,plh,y 10 fexzk-,sflVkfeuksQsu 125 fexzk-dkfcZuksDlkekbu esfy,V 1 fexzk-MsDlVªksfeFkksjQsu ,pchvkj 5 fexzk-@5 fefy

67. fl;wMks,sQsMjhu$,sflVkfeuksQsu$ 60 fefy dh 8.76 145(v) 31.01.2002dkfcZuksDlkekbu$MsDlVªksfeFkksjQsu cksryfyfDoM ,e- di lfgrfl;wMks,sQsMjhu ,plh,y 10 fexzk-,sflVkfeuksQsu 125 fexzk-dkfcZuksDlkekbu esfy,V 1 fexzk-MsDlVªksfeFkksjQsu ,pchvkj 5 fexzk-@5 fefy

68. ,sQsMjhu$fFk;ksQkbfyu xksfy;ka 10 dk 3.18 773(v) 19.05.2006,sQsMjhu ,plh,y 24 fexzk- iRrk@fCyLVjfFk;ksQkbfyu 130 fexzk-

69. ,sQsfMjhu$fFk;ksQkbfyu$ 10 dk 5.06 773(v) 19.05.2006QsuksckjfcVksu$fxy;lfjy iRrk@fCyLVjx;wdksysV xksfy;ka,sQsfMjhu ,plh,y&48 fexzk-fFk;ksQkbfyu&130 fexzk-QsuksckjfcVksu&8 fexzk-fxy;lfjy x;wdksysV&100 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 95: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 76 -

70. ,sQsfMjhu$fFk;ksQkbfyu$ 10 dk 4.26 773(v) 19.05.2006QsuksckjfcVksu xksfy;ka iRrk@fCyLVj,sQsfMjhu ¼jsflusV ds #i esa½&50 fexzk-fFk;ksQkbfyu ,UgkbMªsl&65 fexzk-QsuksckjfcVksu&30 fexzk-

71. fFk;ksQkbfyu$,sQsfMjhu$ 10 dk 3.08 773(v) 19.05.2006QsuksckjfcVksu xksfy;ka iRrk@fCyLVjfFk;ksQkbfyu ,UgkbMªsl&100 fexzk-,sQsfMjhu ,plh,y&20 fexzk-QsuksckjfcVksu&15 fexzk-

72. ,sQsMjhu$fFk;ksQkbfyu$QsuksckjfcVksu 10 dk 6.20 773(v) 19.05.2006 eS- ikdZ Msfol VsMjy ,l,lLVsaM ,D’ku ¼,l,½ xksfy;ka iRrk@fCyLVj,sQsMjhu ,plh,y 48 fexzk-fFk;ksQkbfyu 198 fexzk-QsuksckjfcVksu 25 fexzk-

73. ,sQsMjhu$fFk;ksQkbfyu$ 20 dk 16.26 182(v) 07.02.2006gkbMªksDlht+kbu dSilwy iRrk@fCyLVj,sQsMjhu ,plh,y 25 fexzk-fFk;ksQkbfyu 130 fexzk-gkbMªksDlht+kbu ,plh,y 10 fexzk-

74. fl;wMks,sQsMjhu$,sflVkfeuksQsu$ 8 dk 4.58 773(v) 19.05.2006 eS- vkjihth fjuksLVsVDyksjQsfujkekbu esfy,V xksfy;ka iRrk@fCyLVj ykbQlablfl;wMks,sQsMjhu ,plh,y 60 fexzk-,sflVkfeuksQsu 500 fexzk-DyksjQsfujkekbu esfy,V 4 fexzk-@xksfy;ka

75. fl;wMks,sQsMjhu$flVªhft+u$ 10 dk 6.56 1358(v) 16.09.2005 eS- lu QkekZ jsfyQisjkflVkeksy xksfy;ka iRrk@fCyLVjfl;wMks,sQsMjhu ,plh,y 60 fexzk-flVªhft+u 5 fexzk-isjkflVkeksy 500 fexzk-@xksfy;ka

76. fl;wMks,sQsMjhu$MsDlVªksfeFkksjQsu$ 100 fefy dh 17.40 447(v) 29.03.2006fVªiyksfMu$esUFkksy flji cksryfl;wMks,sQsMjhu ,plh,y 30 fexzk-MsDlVªksfeFkksjQsu ,pchvkj 10 fexzk-fVªiyksfMu ,plh,y 1.25 fexzk-esUFkksy 1.5 fexzk-@ 5 fefy

77. fl;wMks,sQsMjhu$MsDlVªksfeFkksjQsu$ 100 fefy dh 17.90 447(v) 29.03.2006fVªiyksfMu$esUFkksy flji cksry ,e- di lfgrfl;wMks,sQsMjhu ,plh,y 30 fexzk-MsDlVªksfeFkksjQsu ,pchvkj 10 fexzk-fVªiyksfMu ,plh,y 1.25 fexzk-esUFkksy 1.5 fexzk-@ 5 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 96: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 77 -

78. fl;wMks,sQsMjhu$MsDlVªksfeFkksjQsu$ 100 fefy dh 19.58 1358(v) 16.09.2005flVªhft+u flji cksry ,e- di lfgrfl;wMks,sQsMjhu ,plh,y 60 fexzk-MsDlVªksfeFkksjQsu ,pchvkj 10 fexzk-flVªhft+u ,plh,y 5 fexzk-@ 5 fefy

79. ,sQsfMjhu$fFk;ksQkbfyu$ 100 dh cksry 26.12 1080(v) 11.07.2006QsuksckjfcVksu xksfy;ka,sQsfMjhu ,plh,y&10 fexzk-fFk;ksQkbfyu&100 fexzk-QsuksckjfcVksu&10 fexzk-

80. ,sQsfMjhu$fFk;ksQkbfyu$ 10 dk 2.88 1080(v) 11.07.2006QsuksckjfcVksu xksfy;ka iRrk@fCyLVj,sQsfMjhu ,plh,y&15 fexzk-fFk;ksQkbfyu&100 fexzk-QsuksckjfcVksu&10 fexzk-

81. fl;wMks ,sQsfMjhu$isjkflVkeksy$ 60 fefy dh 10.24 1082(v) 11.07.2006DyksjQsfujkekbu esfy,V flji cksryfl;wMks ,sQsfMjhu ,plh,y&30 fexzk-isjkflVkeksy&125 fexzk-DyksjQsfujkekbu esfy,V&2 fexzk-@5 fefy

82. fl;wMks ,sQsfMjhu$czkseksgDlhu$ 60 fefy dh 9.92 1082(v) 11.07.2006DyksjQsfujkekbu esfy,V flji cksryfl;wMks ,sQsfMjhu ,plh,y&60 fexzk-czkseksgDlhu ,plh,y&8 fexzk-DyksjQsfujkekbu esfy,V&4 fexzk-@10 fefy

83. fl;wMks ,sQsfMjhu$czkseksgDlhu$ 100 fefy dh cksry 13.30 1082(v) 11.07.2006DyksjQsfujkekbu esfy,V fljifl;wMks ,sQsfMjhu ,plh,y&60 fexzk-czkseksgDlhu ,plh,y&8 fexzk-DyksjQsfujkekbu esfy,V&4 fexzk-@10fefy

84. fl;wMks,sQsMjhu$MsDlVªksfeFkksjQsu$ 10 dk 4.96 1688(v) 03.10.2006fQuk;y,sQjhu$MkbZQsfuMªkekbu iRrk@fCyLVj,plh,y$isjkflVkeksy xksfy;kafl;wMks,sQsMjhu gkbMªksDyksjkbM&30 fexzk-MsDlVªksfeFkksjQsu gkbMªksczksekbM&5 fexzk-fQuk;y,sQjhu gkbMªksDyksjkbM&5 fexzk-MkbZQsfuMªkekbu ,plh,y&15 fexzk-isjkflVkeksy&500 fexzk-

85. fl;wMks,sQsMjhu$DyksjkQsfujkekbu 10 dk 5.64 1688(v) 03.10.2006esfy,sV$isjkflVkeksy$dSfQu xksfy;ka iRrk@fCyLVjfl;wMks,sQsMjhu&60 fexzk-DyksjkQsfujkekbu esfy,sV&2 fexzk-isjkflVkeksy&500 fexzk-dSfQu&30 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 97: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 78 -

86. ,sQsMjhu$ 10 dk 1.76 1688(v) 03.10.2006DyksjkQsfujkekbu esfy,sV$ iRrk@fCyLVjuksLdsfiu xksfy;ka,sQsMjhu ,plh,y&10 fexzk-DyksjkQsfujkekbu esfy,sV&4 fexzk-uksLdsfiu&10 fexzk-

87. fl;wMks,sQsMjhu$ 10 dk 4.42 1688(v) 03.10.2006,sflVkfeuksQsu$flVªhft+u iRrk@fCyLVjMkbZgkbMªksDyksjkbM xksfy;kafl;wMks,sQsMjhu ,plh,y&30 fexzk-,sflVkfeuksQsu&500 fexzk-flVªhft+u MkbZgkbMªksDyksjkbM&5 fexzk-

88. fl;wMks,sQsMjhu$ 15 dk 5.00 1688(v) 03.10.2006czkseksgSDl+hu ,plh,y xksfy;ka iRrk@fCyLVjfl;wMks,sQsMjhu ,plh,y&60 fexzk-czkseksgSDl+hu ,plh,y&8 fexzk-

89. ,sQsMjhu$DyksjkQsfujkekbu 10 dk 3.80 1688(v) 03.10.2006esfy,sV$isjkflVkeksy$X;wQSulhu$ iRrk@fCyLVjczkseksgSDl+hu ,plh,y xksfy;ka,sQsMjhu ,plh,y&5 fexzk-DyksjkQsfujkekbu esfy,sV&2 fexzk-isjkflVkeksy&500 fexzk-X;wQSulhu&50 fexzk-czkseksgSDl+hu ,plh,y&4 fexzk-

90. fl;wMks,sQsMjhu$DyksjkQsfujkekbu 10 dk 6.52 1688(v) 03.10.2006esfy,sV$isjkflVkeksy$X;wQSulhu$ iRrk@fCyLVjczkseksgSDl+hu ,plh,y$lsjkfV;ksisifVMst+ xksfy;kafl;wMks,sQsMjhu ,plh,y&60 fexzk-DyksjkQsfujkekbu esfy,sV&2 fexzk-isjkflVkeksy&325 fexzk-X;wQSulhu&50 fexzk-czkseksgSDl+hu ,plh,y&4 fexzk-lsjkfV;ksisifVMst&5 fexzk-+

91. fl;wMks,sQsMjhu$DyksjkQsfujkekbu 10 dk 4.28 1688(v) 03.10.2006esfy,sV$isjkflVkeksy xksfy;ka iRrk@fCyLVjfl;wMks,sQsMjhu ,plh,y&30 fexzk-DyksjkQsfujkekbu esfy,sV&2 fexzk-isjkflVkeksy&500 fexzk-

92. fl;wMks,sQsMjhu$DyksjkQsfujkekbu 10 dk 4.30 1688(v) 03.10.2006esfy,sV$isjkflVkeksy xksfy;ka iRrk@fCyLVjfl;wMks,sQsMjhu ,plh,y&30 fexzk-DyksjkQsfujkekbu esfy,sV&4 fexzk-isjkflVkeksy&500 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 98: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 79 -

93. fl;wMks,sQsMjhu$DyksjkQsfujkekbu 100 fefy dh 15.64 1688(v) 03.10.2006esfy,sV$,EczksDlksy$X;wQSulhu cksry,eksfu;e DyksjkbM$eSUFkkWy fljifl;wMks,sQsMjhu ,plh,y&30 fexzk-DyksjkQsfujkekbu esfy,sV&2 fexzk-,EczksDlksy ,plh,y&15 fexzk-X;wQSulhu&50 fexzk-,eksfu;e DyksjkbM&100 fexzk-eSUFkkWy&1 fexzk-@5 fefy

94. fl;wMks,sQsMjhu$DyksjkQsfujkekbu 60 fefy dh cksry 10.60 1688(v) 03.10.2006esfy,sV$isjkflVkeksy$lksfM;elkbVªsV$eSUFkkWy fljifl;wMks,sQsMjhu ,plh,y&30 fexzk-DyksjkQsfujkekbu esfy,sV&2 fexzk-isjkflVkeksy&125 fexzk-] lksfM;e lkbVªsV&60 fexzk-eSUFkkWy&1 fexzk-@5 fefy

95. fl;wMks,sQsMjhu$DyksjkQsfujkekbu 100 fefy dh cksry 14.44 1688(v) 03.10.2006esfy,sV$isjkflVkeksy$lksfM;elkbVªsV$eSUFkkWy fljifl;wMks,sQsMjhu ,plh,y&30 fexzk-DyksjkQsfujkekbu esfy,sV&2 fexzk-isjkflVkeksy&125 fexzk-lksfM;e lkbVªsV&60 fexzk-eSUFkkWy&1 fexzk-@5 fefy

96. fl;wMks,sQsMjhu$DyksjkQsfujkekbu 60 fefy dh 10.40 1688(v) 03.10.2006esfy,sV$MsDlVªksfeFkksjQsu ,pchvkj$ cksryczkseksgSDl+hu fljifl;wMks,sQsMjhu ,plh,y&30 fexzk-DyksjkQsfujkekbu esfy,sV&1 fexzk-MsDlVªksfeFkksjQsu ,pchvkj&5 fexzk-czkseksgSDl+hu ,plh,y&2.7 fexzk-@5 fefy

97. fl;wMks,sQsMjhu$DyksjkQsfujkekbu 100 fefy dh 14.10 1688(v) 03.10.2006esfy,sV$MsDlVªksfeFkksjQsu ,pchvkj$ cksryczkseksgSDl+hu fljifl;wMks,sQsMjhu ,plh,y&30 fexzk-DyksjkQsfujkekbu esfy,sV&1 fexzk-MsDlVªksfeFkksjQsu ,pchvkj&5 fexzk-czkseksgSDl+hu ,plh,y&2.7 fexzk-@5 fefy

98. fl;wMks,sQsMjhu$MsDlVªksfeFkksjQsu 60 fefy dh 13.18 1688(v) 03.10.2006,pchvkj$fVªizksfyfMu ,plh,y$ cksryeSUFkkWy fljifl;wMks,sQsMjhu ,plh,y&30 fexzk-MsDlVªksfeFkksjQsu ,pchvkj&10 fexzk-fVªizksfyfMu ,plh,y&1.25 fexzk-eSUFkkWy&1.5 fexzk-@5 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 99: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 80 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

99. fl;wMks,sQsMjhu$MsDlVªksfeFkksjQsu 100 fefy dh cksry 18.74 1688(v) 03.10.2006,pchvkj$fVªizksfyfMu ,plh,y$eSUFkkWy fljifl;wMks,sQsMjhu ,plh,y&30 fexzk-MsDlVªksfeFkksjQsu ,pchvkj&10 fexzk-fVªizksfyfMu ,plh,y&1.25 fexzk-eSUFkkWy&1.5 fexzk-@5 fefy

100. fl;wMks,sQsMfju$DyksjQsfujkekbu 60 fefy dh 12.32 203(v) 14.02.2007esfy,V$isjkflVkeksy flji cksry ,e- di lfgrfl;wMks,sQsMfju&15 fexzk-DyksjQsfujkekbu esfy,V&1 fexzk-isjkflVkeksy&125 fexzk- @5 fefy

101. fl;wMks,sQsMjhu$DyksjkQsfujkekbu 60 fefy dh cksry 9.88 1688(v) 03.10.2006esfy,sV$,sflVkfeuksQsu fljifl;wMks,sQsMjhu ,plh,y&15 fexzk-DyksjkQsfujkekbu esfy,sV&2 fexzk-,sflVkfeuksQsu&125 fexzk-@5 fefy

102. fl;wMks,sQsMjhu$DyksjkQsfujkekbu 50 fefy dh cksry 8.54 1688(v) 03.10.2006esfy,sV$,sflVkfeuksQsu fljifl;wMks,sQsMjhu ,plh,y&15 fexzk-DyksjkQsfujkekbu esfy,sV&2 fexzk-,sflVkfeuksQsu&125 fexzk-@5 fefy

103. fl;wMks,sQsMjhu$flVªhft+u xksfy;ka 10 dk 2.94 224(v) 14.02.2007fl;wMks,sQsMjhu ,plh,y-30 fexzk- iRrk@fCyLVjflVªhft+u MkbZ gkbZMªksDyksjkbM-10 fexzk-

104. fl;wMks,sQsMjhu$flVªhft+u xksfy;ka 10 dk 3.80 224(v) 14.02.2007fl;wMks,sQsMjhu ,plh,y-60 fexzk- iRrk@fCyLVjflVªhft+u -5 fexzk-

105. fl;wMks,sQsMjhu$czkseksgsDlhu$ 100 fefy dh 17.80 224(v) 14.02.2007DyksjQsfujkekbu esfy,sV ,DlisDVkjsUV cksryfl;wMks,sQsMjhu ,plh,y-80 fexzk-czkseksgsDlhu ,plh,y-4 fexzk-DyksjQsfujkekbu esfy,sV -2 fexzk-@5 fefy

106. fl;wMks,sQsMjhu$isjkflVkeksy$ 60 fefy dh cksry 11.08 224(v) 14.02.2007DyksjQsfujkekbu esfy,sV flji ,e- di lfgrfl;wMks,sQsMjhu ,plh,y-30 fexzk-isjkflVkeksy-125 fexzk-DyksjQsfujkekbu esfy,sV -1 fexzk@5 fefy

107. fl;wMks,sQsMjhu$a 10 dk 41.38 439(v) 23.03.2007QsDlksfQukfMu xksfy;k iRrk@fCyLVjfl;wMks,sQsMjhu lYQsV-180 fexzk-QsDlksfQukfMu gkbMªksDyksjkbM-120 fexzk-a

Page 100: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 81 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

108 fl;wMks,sQsMjhu$MkbZQsfuMªkekbu 50 fefy dh 9.10 1336(v) 01.08.2007esfy,sV$,eksfu;e DyksjkbM$eSUFkksy$ cksrylksfM;e lkbVªsV ,DliSDVksjsUVfl;wMks,sQsMjhu ,plh,y-30 fexzk-MkbZQsfuMªkekbu ,plh,y -20fexzk-,eksfu;e DyksjkbM -125 fexzk-eSUFkksy -2 fexzk-lksfM;e lkbVªsV - 55 fexzk-@ 5 fefy

109 fl;wMks,sQsMjhu$MkbZQsfuMªkekbu 100 fefy dh 14.33 1336(v) 01.08.2007esfy,sV$,eksfu;e DyksjkbM$eSUFkksy$ cksrylksfM;e lkbVªsV ,DliSDVksjsUVfl;wMks,sQsMjhu ,plh,y-30 fexzk-MkbZQsfuMªkekbu ,plh,y -20fexzk-,eksfu;e DyksjkbM -125 fexzk-] eSUFkksy -2 fexzk-lksfM;e lkbVªsV - 55 fexzk-@ 5 fefy

110. fl;wMks,sQsMjhu$fVªiyksfMu 15 fefy dh 6.60 1336(v) 01.08.2007,plh,y$isjkflVkeksy lLisUlu cksryfl;wMks,sQsMjhu ,plh,y -30 fexzk-fVªiyksfMu ,plh,y - 0.625fexzk-isjkflVkeksy - 125 fexzk-@ 5 fefy

111. fl;wMks,sQsMjhu$isjkflVkeksy$ 60 fefy dh 11.66 1336(v) 01.08.2007eSUFkksy$lksfM;e lkbVªsV ,DliSDVksjsUV cksryfl;wMks,sQsMjhu ,plh,y -30 fexzk-isjkflVkeksy - 125 fexzk-] eSUFkksy - 1 fexzk-lksfM;e lkbVªsV - 60 fexzk- @ 5 fefy

112. fl;wMks,sQsMjhu$MsDlVªksfeFkksjQsu$ 60 fefy dh 12.48 1336(v) 01.08.2007flVªhft+u$eSUFkksy flji cksryfl;wMks,sQsMjhu ,plh,y -30 fexzk-MsDlVªksfeFkksjQsu ,pchvkj- 10 fexzk-flVªhft+u - 5 fexzk-eSUFkksy - 1.5 fexzk-@ 5 fefy

113. fl;wMks,sQsMjhu$MsDlVªksfeFkksjQsu$ 100 fefy dh 16.48 1336(v) 01.08.2007flVªhft+u$eSUFkksy flji cksryfl;wMks,sQsMjhu ,plh,y -30 fexzk-MsDlVªksfeFkksjQsu ,pchvkj- 10 fexzk-flVªhft+u - 5 fexzk-eSUFkksy - 1.5 fexzk-@ 5 fefy

114. fl;wMks,sQsMjhu$isjkflVkeksy$ 60 fefy dh 10.96 1336(v) 01.08.2007Qsfujkekbu esfy,sV$lksfM;e cksrylkbVªsV$eSUFkksy ,DliSDVksjsUVfl;wMks,sQsMjhu ,plh,y -15 fexzk-isjkflVkeksy - 125 fexzk-Qsfujkekbu esfy,sV - 1 fexzk-lksfM;e lkbVªsV - 60 fexzk-eSUFkksy - 1 fexzk-@ 5 fefy

Page 101: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 82 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

115. fl;wMks,sQsMjhu$DyksjQsfujkekbu 30 fefy dh 7.70 1336(v) 01.08.2007esfy,sV$eSUFkksy flji cksryfl;wMks,sQsMjhu ,plh,y -30 fexzk-DyksjQsfujkekbu esfy,sV -2 fexzk-eSUFkksy - 1 fexzk-@ 5 fefy

116. fl;wMks,sQsMjhu$DyksjQsfujkekbu 60 fefy dh 11.18 1336(v) 01.08.2007esfy,sV$eSUFkksy flji cksryfl;wMks,sQsMjhu ,plh,y -30 fexzk-DyksjQsfujkekbu esfy,sV -2 fexzk-eSUFkksy - 1 fexzk-@ 5 fefy

117. fl;wMks,sQsMjhu$isjkflVkeksy$ 60 fefy dh 12.26 1336(v) 01.08.2007flVªht+u lLisUlu cksryfl;wMks,sQsMjhu ,plh,y -15 fexzk-isjkflVkeksy -125 fexzk-flVªht+u ,plh,y - 2 fexzk-@ 5 fefy

118. fl;wMks,sQsMjhu$fVªiyksfMu 50 fefy dh 10.22 1336(v) 01.08.2007,plh,y flji cksryfl;wMks,sQsMjhu ,plh,y -60 fexzk-fVªiyksfMu ,plh,y -250 fexzk-eSUFkksy - 1 fexzk-@ 10 fefy

119. fl;wMks,sQsMjhu$flVªht+u xksfy;ka 10 dk 3.10 1336(v) 01.08.2007fl;wMks,sQsMjhu ,plh,y -30 fexzk- iRrk@fCyLVjflVªht+u MkbZgkbMªksDyksjkbM- 10 fexzk-@ fQYe fyfir

120. fl;wMks,sQsMjhu$isjkflVkeksy$ 60 fefy dh 12.32 2046(v) 30.11.2007flVªht+u lLisUlu cksry ,e- difl;wMks,sQsMjhu ,plh,y-15 fexzk- lfgrisjkflVkeksy-125 fexzk-flVªht+u MkbZgkbMªksDyksjkbM-2 fexzk-@5 fefy

121. fl;wMks,sQsMjhu$isjkflVkeksy$ 10 dk 5.88 2046(v) 30.11.2007DyksjksQsfujkekbu$dSfQu xksfy;ka iRrk@fCyLVjfl;wMks,sQsMjhu-60 fexzk-isjkflVkeksy-500 fexzk-DyksjksQsfujkekbu-4 fexzk-dSfQu -30 fexzk-

122. fl;wMks,sQsMjhu$yksjkfVfMu$dSfQu$ 10 dk 6.80 171(v) 29.01.2008MsDlVªksfeFkzksQsu$,sflVkfeuksQsu xksfy;ka iRrk@fCyLVjfl;wMks,sQsMjhu ,plh,y -80 fexzk-yksjkfVfMu- 5 fexzk-dSfQu- 30 fexzk-MsDlVªksfeFkzksQsu ,pchvkj- 10 fexzk-,sflVkfeuksQsu - 50 fexzk-@fVfd;k

Page 102: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 83 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

123. bVksQkbfyu$czkseksgsDlhu 10 dk 4.30 448(v) 29.03.2006lsyC;wVkseksy xksfy;ka iRrk@fCyLVjbVksQkbfyu&200 fexzk-lsyC;wVkeksy &4 fexzk-czkseksgsDlhu ,plh,y&16 fexzk-

124. bVksQkbfyu $czkseksgsDlhu 10 dk 2.64 448(v) 29.03.2006lsyC;wVkseksy xksfy;ka iRrk@fCyLVjlsyC;wVkeksy lYQsV2 fexzk- lsyC;wVkeksy ds cjkcjczkseksgsDlhu ,plh,y&8 fexzk-bVksQkbfyu&100 fexzk-

125. bVksQkbfyu$lsyC;wVkseksy xksfy;ka 10 dk 2.48 448(v) 29.03.2006bVksQkbfyu&100 fexzk- iRrk@fCyLVjlsyC;wVkeksy &2 fexzk-

126. bVksQkbfyu$lsyC;wVkseksy$ 10 dk 3.26 448(v) 29.03.2006X;wQSulhu xksfy;ka iRrk@fCyLVjbVksQkbfyu&100 fexzk-lsyC;wVkeksy &2 fexzk-X;wQSulhu&100 fexzk-

127. bVksQkbfyu $lsyC;wVkseksy$ 10 dk 4.22 448(v) 29.03.2006czkseksgsDlhu xksfy;ka iRrk@fCyLVjbVksQkbfyu&200 fexzk-lsyC;wVkeksy &4 fexzk-czkseksgsDlhu ,plh,y&8 fexzk-

128. bVksQkbfyu$fFk;ksQkbfyu ,Ei;wy 2 fefy dk ,Ei;wy 2.98 449(v) 29.03.2006bVksQkbfyu&84.7 fexzk-fFk;ksQkbfyu ,ugkbMªsl25.3 fexzk- fFk;ksQkbfyu gkbMªsVds cjkcj@fefy

129. bVksQkbfyu$fFk;ksQkbfyu flji 100 fefy dh 12.29 449(v) 29.03.2006bVksQkbfyu&46.5 fexzk- cksryfFk;ksQkbfyu ,ugkbMªsl14 fexzk- fFk;ksQkbfyu gkbMªsVds cjkcj@5 fefy

130. fFk;ksQkbfyu$ 100 fefy dh 11.92 449(v) 29.03.2006bVksQkbfyu flji cksrybVksQkbfyu&77 fexzk-fFk;ksQkbfyu ,ugkbMªsl23 fexzk- fFk;ksQkbfyu gkbMªsVds cjkcj@5 fefy

Page 103: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 84 -

131. fFk;ksQkbfyu$ 10 dk 2.46 449(v) 29.03.2006bVksQkbfyu xksfy;ka iRrk@fCyLVjbVksQkbfyu&77.0 fexzk-fFk;ksQkbfyu ,ugkbMªsl23.0 fexzk- fFk;ksQkbfyu gkbMªsV ds cjkcj

132. fFk;ksQkbfyu$ 250 dh cksry 48.65 449(v) 29.03.2006bVksQkbfyu xksfy;kabVksQkbfyu&77.0 fexzk-fFk;ksQkbfyu ,ugkbMªsl23.0 fexzk- fFk;ksQkbfyu gkbMªsV ds cjkcj

133. fFk;ksQkbfyu$bVksQkbfyu xksfy;ka 10 dk 4.06 449(v) 29.03.2006bVksQkbfyu&115 fexzk- iRrk@fCyLVjfFk;ksQkbfyu ,ugkbMªsl35 fexzk- fFk;ksQkbfyu gkbMªsV ds cjkcj¼,lvkj@lhvkj@Vhvkj@ fjVkMZ fVfd;k½

134. bVksQkbfyu $fFk;ksQkbfyu xksfy;ka 10 dk 6.12 449(v) 29.03.2006bVksQkbfyu&231 fexzk- iRrk@fCyLVjfFk;ksQkbfyu ,ugkbMªsl69 fexzk- fFk;ksQkbfyu gkbMªsV ds cjkcj¼,lvkj@lhvkj@Vhvkj@ fjVkMZ fVfd;k½

135. bVksQkbfyu $fFk;ksQkbfyu xksfy;ka 10 dk 7.82 449(v) 29.03.2006bVksQkbfyu&346 fexzk- iRrk@fCyLVjfFk;ksQkbfyu ,ugkbMªsl104 fexzk- fFk;ksQkbfyu gkbMªsV ds cjkcj¼,lvkj@lhvkj@Vhvkj@ fjVkMZ fVfd;k½

136. bVksQkbfyu$lsyC;wVkeksy xksfy;ka 10 dk 3.68 1065(v) 11.07.2006bVksQkbfyu&200 fexzk- iRrk@fCyLVjlsyC;wVkeksy lYQsVlsyC;wVkeksy &4 fexzk- ds cjkcj@fVfd;k

137. bVksQkbfyu$lsyC;wVkeksy flji 100 fefy dh 12.40 1065(v) 11.07.2006bVksQkbfyu&50 fexzk- cksrylsyC;wVkeksy lYQsVlsyC;wVkeksy &1 fexzk- ds cjkcj@5 fefy

138. bVksQkbfyu$lsyC;wVkeksy flji 100 fefy dh 12.66 1065(v) 11.07.2006bVksQkbfyu&50 fexzk- cksrylsyC;wVkeksy lYQsVlsyC;wVkeksy &2 fexzk- ds cjkcj@5 fefy

139. bVksQkbfyu$lsyC;wVkeksy$ 100 fefy dh 13.10 1932(v) 08.11.2006Xykblzksy xw;sdksy ,Fkj flji cksrybVksQkbfyu&50 fexzk-lsyC;wVkeksy lYQsV1 fexzk- lsyC;wVkeksy ds cjkcjXykblzksy xw;sdksy ,Fkj&50 fexzk-@5 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 104: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 85 -

140. bVksQkbfyu$VjC;wVsfyu 100 fefy dh 13.64 1650(v) 27.09.2007lYQsV flji@lLisUlu cksrybVksQkbfyu&50 fexzk-VjC;wVsfyu lYQsV&1.25 fexzk-@ 5 fefy

141. bVksQkbfyu $fFk;ksQkbfyu xksfy;ka 10 dk 8.14 196(v) 29.01.2008bVksQkbfyu-462 fexzk- iRrk@fCyLVjfFk;ksQkbfyu-138 fexzk-@fVfd;k

142. bVksQkbfyu$VjC;wVsfyu lYQsV xksfy;ka 10 dk 3.06 196(v) 29.01.2008bVksQkbfyu&100 fexzk- iRrk@fCyLVjVjC;wVsfyu lYQsV&2.5 fexzk-@ fVfd;k

143. bVksQkbfyu$VjC;wVsfyu$ 10 dk 3.16 196(v) 29.01.2008czkseksgsDlhu xksfy;ka iRrk@fCyLVjbVksQkbfyu&100 fexzk-VjC;wVsfyu lYQsV&2.5 fexzk-czkseksgsDlhu &4 fexzk-@ fVfd;k

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 105: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 86 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

,Q (F)1. QseksfVfMu xksfy;ka&10 14 dk 2.38 1018(v) 03.09.2003 eS- VksjsUV VksiflM xksfy;ka

10 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj eS- bUVkl QsflM xksfy;kaeS- lksekfVdks iksfyQse xksfy;ka

2. QseksfVfMu xksfy;ka&20 14 dk 1.98 2036(v) 30.11.2007 eS- ,uvkbZih,y QseVsd xksfy;ka20 fexzk-@xksfy;ka iRrk@fCyLVj eS- VksjsUV VksiflM xksfy;ka

eS- lu QkekZ QseksflM xksfy;kaeS- ;w,loh QseksfVu xksfy;kaeS- ,fjLVks QsfMu xksfy;ka

3. QseksfVfMu xksfy;ka&30 14 dk 3.28 771(v) 19.05.200630 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj

4. QseksfVfMu xksfy;ka&40 14 dk 2.60 2036(v) 30.11.2007 eS- ,uvkbZih,y QseVsd xksfy;ka40 fexzk-@xksfy;ka iRrk@fCyLVj eS- VksjsUV VksiflM xksfy;ka

eS- lu QkekZ QseksflM xksfy;kaeS- ;w,loh QseksfVu xksfy;kaeS- ,fjLVks QsfMu xksfy;ka

4. QseksfVfMu xksfy;ka&40 14 dk 4.46 176(v) 29.01.200840 fexzk-@tsysfVu fyfir xksfy;ka iRrk@fCyLVj

5. QseksfVfMu bUtsD’ku&20 2 fefy dk 2.14 840(v) 09.12.1997 eS- bUVkl QsflM bUtsD’ku20 fexzk-@ 2 fefy ,Ei;wy ,Ei;wy

6. QseksfVfMu$MkseisjhMksu xksfy;ka 10 dk 2.62 771(v) 19.05.200620 fexzk-$10 fexzk-@ xksfy;ka iRrk@fCyLVj

7. QseksfVfMu$ 10 dk 2.18 1074(v) 11.07.2006fMdyksQsusd lksfM;e xksfy;ka iRrk@fCyLVj20 fexzk-$50 fexzk-@ xksfy;ka

8. zQsfelsVhu$MsDlkfeFkkt+ksu 15 xzke dh V~;wc 17.88 1330(v) 01.08.2007,sflVsV$DyksfVªekt+ksy Øhe zQsfelsVhu lYQsV -1% MCY;w@MCY;wMsDlkfeFkkt+ksu ,sflVsV -0.1% MCY;w@MCY;wDyksfVªekt+ksy -1% MCY;w@MCY;wfeFkk;y isjkcsu -0.08% MCY;w@MCY;wizksfiy isjkcsu -0.04% MCY;w@MCY;w

9. zQsfelsfVu$gkbMªksdksfVZlksu$ 10 xzke dh 17.22 1330(v) 01.08.2007 eS- lsuksQh ,ofUVl izksDVkslsMk;ygsfizu$,lD;wykslkbM$bFkk;y vkSj V~;wccwVk;y ,feukscsUtq,V vkW;UVesaV zQsfelsfVu lYQsV 10 fexzk-gkbMªksdksfVZlksu ,flVsV 5.58 fexzk-gsfizu 100 ;wfuV] ,lD;wykslkbM 10 fexzk-bFkk;y ,feukscsUtq,V 10 fexzk-cwVk;y ,feukscsUtq,V 10 fexzk-@xzke

Page 106: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 87 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

10. zQsfelsVhu Øhe 20 xzke dh V~;wc 14.94 1330(v) 01.08.2007 zQsfelsVhu lYQsV -1% MCY;w@MCY;wfeFkk;y isjkcsu -0.08% MCY;w@MCY;wizksfiy isjkcsu -0.04% MCY;w@MCY;w

11. zQsfelsVhu$MsDlkfeFkkt+ksu 20 xzke dh V~;wc 20.54 1330(v) 01.08.2007,sflVsV Øhe zQsfelsVhu lYQsV -1% MCY;w@MCY;wMsDlkfeFkkt+ksu ,sflVsV -0.1% MCY;w@MCY;w

12. zQsfelsVhu vkW;UVesUV 5 xzke dh V~;wc 5.64 1330(v) 01.08.2007 zQsfelsVhu lYQsV -0.5% MCY;w@MCY;w

13. zQsfelsVhu$MsDlkfeFkkt+ksu Mªksi 5 fefy dh cksry 14.18 1330(v) 01.08.2007 zQsfelsVhu-1% MCY;w@MCY;w Mªksij vkSj dkVZuMsDlkfeFkkt+ksu lksfM;e lfgresVklYQks csUtq,sV -0.116% @fefy

14. zQsfelsVhu$gkbMªksdksfVZlksu 5 fefy dh cksry 12.28 1330(v) 01.08.2007,sflVsV vk¡[k@dku dk Mªksi Mªksij vkSj dkVZu zQsfelsVhu lYQsV -1% lfgrgkbMªksdksfVZlksu ,sflVsV-1%@fefy

15. zQsfelsVhu vk¡[k dk Mªksi 5 fefy dh cksry 7.15 1330(v) 01.08.2007 zQsfelsVhu lYQsV -0.5%@fefy Mªksij vkSj dkVZu lfgr

16. zQsfelsVhu Øhe 30 xzke dh 20.54 2028(v) 30.11.2007izR;sd xzke esa vuysdMZ V~;wc zQsfelsVhu lYQsV -1%MCY;w@MCY;wfeFkk;y isjkcsu -0.08%MCY;w@MCY;wizksfiy isjkcsu -0.04%MCY;w@MCY;w

17. zQsfelsVhu Øhe 30 xzke dh 20.70 2028(v) 30.11.2007izR;sd xzke esa ysdMZ V~;wc zQsfelsVhu lYQsV -1%MCY;w@MCY;wfeFkk;y isjkcsu -0.08%MCY;w@MCY;wizksfiy isjkcsu -0.04%MCY;w@MCY;w

18. zQwlkekbM bUtsD’ku 2 fefy ,Ecj 2.81 434(v) 29.03.2006 eS- ,ofUVl ysflDl10 fexzk-@ fefy ,Ei;wy eS- usVdks QsflDl

eS- jsucsDlh yk;fjUteS- fliyk zQwflDleS- baM&LohQ~V zQw

19. zQwlkekbM xksfy;ka 10 dk 4.12 1329(v) 01.08.2007 eS- ,ofUVl ysflDl40 fexzk-@ xksfy;ka iRrk@fCyLVj eS- ftuks zQwlsusDl

eS- usVdks QsflDleS- jsucsDlh yk;fjUteS- bUVkl ;wfjDl

Page 107: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 88 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

20. zQwlkekbM xksfy;ka 10 dk 3.82 390(v) 02.04.2003 eS- ftuks zQwlsusDl40 fexzk-@ xksfy;ka ,,y_fCyLVj

21. zQwlkekbM xksfy;ka 10 dk 4.46 1075(v) 11.07.2006100 fexzk-@ xksfy;ka iRrk@fCyLVj

22. zQwlkekbM$fLizsuksysDVksu xksfy;ka 10 dk 23.60 1061(v) 11.07.2006 eS- ,ofUVl ysflysDVksu zQwlkekbM 20 fexzk- ,,y_iRrk eS- Y;wfiu zQwlsysdfLizsuksysDVksu 50 fexzk-@ xksfy;ka ¼lknh½ eS- vkjihth ykbQlkabl fLizksekbM

eS- ,yMj ,eh zQweS- th,lds zQwlsfeu

23. zQwlkekbM$fLizsuksysDVksu xksfy;ka 10 dk 23.20 1061(v) 11.07.2006 eS- Y;wfiu zQwlsysd zQwlkekbM 20 fexzk- ,,y_fCyLVj eS- lsuksQh ,ofUVl ysflysDVksufLizsuksysDVksu 50 fexzk-@ xksfy;ka ¼lknh½ eS- vkjihth ykbQlkabl fLizksekbM

24. zQwlkekbM$fLizsuksysDVksu xksfy;ka 10 dk 24.52 1332(v) 01.08.2007 eS- Y;wfiu zQwlsysd zQwlkekbM 20 fexzk- iRrk@fCyLVj eS- lsuksQh ,ofUVl ysflysDVksufLizsuksysDVksu 50 fexzk-@ xksfy;ka ¼fyfir½ eS- vkjihth ykbQlkabl fLizksekbM

25. zQwlkekbM$,feyksjkbM xksfy;ka 10 dk 5.18 453(v) 29.03.2006 eS- ,yMj ,eh zQw zQwlkekbM 40 fexzk- iRrk@fCyLVj eS- ftuks zQwehy,feyksjkbM 5 fexzk-@ xksfy;ka eS- ekbØks ysc ,Dluk&ds

eS- ,ofUVl ysfljkbM

26. zQwlkekbM$fLizuksySDVksu xksfy;ka 10 dk 24.68 1332(v) 01.08.2007 zQwlkekbM&40 fexzk- iRrk@fCyLVjfLizuksySDVksu&50 fexzk-@fQYe fyfir xksfy;ka

27. zQwlkekbM$ 10 dk 2.38 1927(v) 08.11.2006iksVkf’k;e DyksjkbM xksfy;ka iRrk@fCyLVj zQwlkekbM&20 fexzk-iksVkf’k;e DyksjkbM&300 fexzk-@xksfy;ka

28. zQwlkekbM$ 10 dk 3.60 1927(v) 08.11.2006iksVkf’k;e DyksjkbM xksfy;ka iRrk@fCyLVj zQwlkekbM&40 fexzk-iksVkf’k;e DyksjkbM&600 fexzk-@xksfy;ka

29. z QwlkekbM$VªkbZfeVsjsu xksfy;ka 10 dk 3.12 219(v) 14.02.2007 z QwlkekbM -20 fexzk- iRrk@fCyLVjVªkbZfeVsjsu -50 fexzk-@xksfy;ka

30. z QwlkekbM$VªkbZfeVsjsu xksfy;ka 10 dk 3.34 219(v) 14.02.2007 z QwlkekbM -40 fexzk- iRrk@fCyLVjVªkbZfeVsjsu -50 fexzk-

31. zQwlkekbM bUtSD’ku 25 fefy dk 6.11 1662(v) 27.09.200710 fexzk-@ fefy ok;y

Page 108: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 89 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

32. ¶;wjkt+ksfyMksu xksfy;ka 10 dk 1.80 1333(v) 01.08.2007 eS- yscksjsV QkekZ ¶;wjkt+ksy100 fexzk-@xksfy;ka iRrk@fCyLVj eS- luh MªXl ¶;wjkt+ksy

eS- jsdohuk MhvkbZ,eeS- th,lds ¶;wjkDlksueS- osyD;wj MªXl ¶;wjkt+ksfyMksu

33. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy dSilwy 10 dk 8.00 1333(v) 01.08.2007 eS- Ms~l ,UVªks¶;wjse&,e¶;wjkt+ksfyMksu 100 fexzk- vkSj ,,y_iRrkeSVªksfuMkt+ksy 300 fexzk-@dSilwy

34. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy dSilwy 10 dk 7.46 1105(v) 08.12.2000 eS- Ms~l ,UVªks¶;wjse&,e¶;wjkt+ksfyMksu 100 fexzk- vkSj ,,y_fCyLVjeSVªksfuMkt+ksy 300 fexzk-@dSilwy

35. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy xksfy;ka 10 dk 4.72 176(v) 09.03.1998 eS- baM&LohQ~V ,ehcsDl¶;wjkt+ksfyMksu 100 fexzk- vkSj iRrk@fCyLVj eS- yscksjsV QkW ¶;wjkt+ksyeSVªksfuMkt+ksy 300 fexzk-@xksfy;ka eS- th,lds fMisUMy&,e

eS- ,YMs esMh bEi fMt+ksy&,e,Q

36. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy xksfy;ka 10 dk 6.82 942(v) 30.10.1998¶;wjkt+ksfyMksu 100 fexzk- vkSj ,,y_iRrkeSVªksfuMkt+ksy 400 fexzk-@xksfy;ka

37. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy xksfy;ka 10 dk 6.44 942(v) 30.10.1998¶;wjkt+ksfyMksu 100 fexzk- vkSj ,,y_fCyLVjeSVªksfuMkt+ksy 400 fexzk-@xksfy;ka

38. ¶;wjkt+ksfyMksu$yksizkekbM dSilwy 4 dk 2.36* 613(v) 29.06.2001100 fexzk-$ 2 fexzk-@dSilwy iRrk@fCyLVj

39. ¶;wjkt+ksfyMksu$yksizkekbM xksfy;ka 10 dk 2.40* 613(v) 29.06.2001 eS- txluiky Mk;jyksi Iyl100 fexzk-$ 2 fexzk-@xksfy;ka iRrk@fCyLVj

40. ¶;wjkt+ksfyMksu$MkbZQsuksDlhysV$ 10 dk 2.08 612(v) 29.06.2001 eS- jkihth ykbQlkbalykseksQsu,Vªksikbu xksfy;ka ihohlh QkW;y50 fexzk-$ 2.5 fexzk-$ 0.025 fexzk-@xksfy;ka

41. ¶;wjktksfyMksu$eSVªksfuMkt+ksy$ 10 dk 5.88 1333(v) 01.08.2007csjcsjhu ,plh,y iRrk@fCyLVjcsykMksuk ,sYdkyksbM xksfy;ka¶;wjktksfyMksu&100 fexzk-eSVªksfuMkt+ksy&200 fexzk-csjcsjhu ,plh,y&20 fexzk-csykMksuk ,sYdkyksbM&125 fexzk-@xksfy;ka

42. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 10 dk 6.66 142(v) 31.01.2002 eS- tkWulu ,aM tkWulu¶;wesfMyMkbZlkbDyksekbu dSilwy ,,y_iRrk¶;wjkt+ksfyMksu 50 fexzk-eSVªksfuMkt+ksy 200 fexzk-MkbZlkbDyksekbu ,plh,y 10 fexzk-@dSilwy

Page 109: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 90 -

43. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 10 dk 6.14 142(v) 31.01.2002 eS- tkWulu ,aM tkWulu¶;wesfMyMkbZlkbDyksekbu dSilwy ,,y_fCyLVj¶;wjkt+ksfyMksu 50 fexzk-eSVªksfuMkt+ksy 200 fexzk-MkbZlkbDyksekbu ,plh,y 10 fexzk-@dSilwy

44. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 60 fefy dh 7.82 1234(v) 19.12.2001 eS- th,lds fMisuMy&,ecsUtq,V flji@lLisUlu cksry eS- dsfMyk QkekZ ¶;wesLVkj25 fexzk-$ eSVªksfuMkt+ksy 75 fexzk-¼ds cjkcj csUtq,V esa½ @ 5 fefy

45. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 60 fefy dh cksry 8.30 1234(v) 19.12.2001 eS- th,lds fMisuMy&,ecsUtq,V flji@lLisUlu ,e- di lfgr eS- dsfMyk QkekZ ¶;wesLVkj25 fexzk-$ eSVªksfuMkt+ksy 75 fexzk-¼ds cjkcj csUtq,V esa½ @ 5 fefy

46. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 50 fefy dh 7.18 1234(v) 19.12.2001 eS- baMksdks estk;y&,QcsUtq,V flji@lLisUlu cksry30/35 fexzk-$ eSVªksfuMkt+ksy 100 fexzk-¼ds cjkcj csUtq,V esa½ @ 5 fefy

47. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 50 fefy dh cksry 7.66 1234(v) 19.12.2001 eS- baMksdks estk;y&,QcsUtq,V flji@lLisUlu ,e- di lfgr30/35 fexzk-$ eSVªksfuMkt+ksy 100 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

48. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 60 fefy dh 8.30 1234(v) 19.12.2001 eS- ,fjLVks QkekZ ,fjLVksthy&,QcsUtq,V flji@lLisUlu cksry eS- ,YMs esMh bEi- fMtksy&,e,Q30/35 fexzk-$ eSVªksfuMkt+ksy 100 fexzk- eS- ftuks ftuksthy&,Q¼ds cjkcj csUtq,V esa½ @ 5 fefy

49. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 60 fefy dh cksry 8.78 1234(v) 19.12.2001 eS- ,fjLVks QkekZ ,fjLVksthy&,QcsUtq,V flji@lLisUlu ,e- di lfgr eS- ,YMs esMh bEi- fMtksy&,e,Q30/35 fexzk-$ eSVªksfuMkt+ksy 100 fexzk eS- ftuks ftuksthy&,Q¼ds cjkcj csUtq,V esa½ @ 5 fefy

50. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 1000 fefy dh 76.42 1234(v) 19.12.2001 eS- vxzoky ¶;wjk&,ecsUtq,V flji@lLisUlu cksry30/35 fexzk-$ eSVªksfuMkt+ksy 100 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

51. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 1000 fefy dh cksry 76.90 1234(v) 19.12.2001 eS- vxzoky ¶;wjk&,ecsUtq,V flji@lLisUlu ,e- di lfgr30/35 fexzk-$ eSVªksfuMkt+ksy 100 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

52. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 60 fefy dh cksry 9.40 1234(v) 19.12.2001csUtq,V flji@lLisUlu30 fexzk-$ eSVªksfuMkt+ksy 160 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 110: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 91 -

53. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 60 fefy dh cksry 9.88 1234(v) 19.12.2001csUtq,V flji@lLisUlu ,e- di lfgr30 fexzk-$ eSVªksfuMkt+ksy 160 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

54. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 60 fefy dh cksry 7.46 1234(v) 19.12.2001csUtq,V flji@lLisUlu40 fexzk-$ eSVªksfuMkt+ksy 50 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

55. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 60 fefy dh cksry 7.94 1234(v) 19.12.2001csUtq,V flji@lLisUlu ,e- di lfgr40 fexzk-$ eSVªksfuMkt+ksy 50 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

56. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 500 fefy dh cksry 34.18 1234(v) 19.12.2001csUtq,V flji@lLisUlu40 fexzk-$ eSVªksfuMkt+ksy 50 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

57. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 500 fefy dh cksry 34.66 1234(v) 19.12.2001csUtq,V flji@lLisUlu ,e- di lfgr40 fexzk-$ eSVªksfuMkt+ksy 50 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

58. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 450 fefy dh 48.76 1333(v) 01.08.2007csUtq,V flji@lLisUlu cksry ,e-di lfgr30 fexzk-$ eSVªksfuMkt+ksy 100 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

59. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 60 fefy dh 7.52 1333(v) 01.08.2007csUtq,V flji@lLisUlu cksry ,e-di lfgr25 fexzk-$ eSVªksfuMkt+ksy 100 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

60. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 50 fefy dh 7.24 1234(v) 19.12.2001 eS- QkekZflUFk ,UVhthy&,QcsUtq,V flji@lLisUlu cksry40 fexzk-$ eSVªksfuMkt+ksy 100 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

61. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 50 fefy dh cksry 7.72 1234(v) 19.12.2001 eS- QkekZflUFk ,UVhthy&,QcsUtq,V flji@lLisUlu ,e- di lfgr40 fexzk-$ eSVªksfuMkt+ksy 100 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

62. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 60 fefy dh 9.36 1234(v) 19.12.2001csUtq,V flji@lLisUlu cksry75 fexzk-$ eSVªksfuMkt+ksy 100 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 111: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 92 -

63. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 60 fefy dh cksry 9.84 1234(v) 19.12.2001csUtq,V flji@lLisUlu ,e- di lfgr75 fexzk-$ eSVªksfuMkt+ksy 100 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

64. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 450 fefy dh 45.70 1234(v) 19.12.2001csUtq,V flji@lLisUlu cksry75 fexzk-$ eSVªksfuMkt+ksy 100 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

65. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 450 fefy dh cksry 46.18 1234(v) 19.12.2001csUtq,V flji@lLisUlu ,e- di lfgr75 fexzk-$ eSVªksfuMkt+ksy 100 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

66. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 60 fefy dh 10.80 1234(v) 19.12.2001 eS- ;wfud QkekZ eSVªkthy&,QcsUtq,V flji@lLisUlu cksry40 fexzk-$ eSVªksfuMkt+ksy 200 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

67. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 60 fefy dh cksry 11.28 1234(v) 19.12.2001 eS- ;wfud QkekZ eSVªkthy&,QcsUtq,V flji@lLisUlu ,e- di lfgr40 fexzk-$ eSVªksfuMkt+ksy 200 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

68. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 60 fefy dh 10.94 1234(v) 19.12.2001csUtq,V flji@lLisUlu cksry60 fexzk-$ eSVªksfuMkt+ksy 200 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

69. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy 60 fefy dh cksry 9.52 1234(v) 19.12.2001csUtq,V flji@lLisUlu60 fexzk-$ eSVªksfuMkt+ksy 200 fexzk¼ds cjkcj csUtq,V esa½ @ 5 fefy

70. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 60 fefy dh cksry 10.00 1234(v) 19.12.2001csUtq,V flji@lLisUlu ,e- di lfgr¶;wjkt+ksfyMksu 37.5 fexzk-eSVªksfuMkt+ksy csUtq,VeSVªksfuMkt+ksy 100 fexzk- ds cjkcjisdfVax 75 fexzk-ykbV ds;ksfyu 50 fexzk-@5 fefy

71. ¶;wjkt+ksfyMksu$eSVªksfuMkt+ksy$ 60 fefy dh cksry 10.00 1234(v) 19.12.2001csUtq,V flji@lLisUlu ,e- di lfgr¶;wjkt+ksfyMksu 37.5 fexzk-eSVªksfuMkt+ksy csUtq,VeSVªksfuMkt+ksy 100 fexzk- ds cjkcjisdfVax 75 fexzk-ykbV ds;ksfyu 50 fexzk-@5 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 112: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 93 -

72. ¶;wjktksfyMksu$eSVªksfuMkt+ksy$ 60 fefy dh cksry 12.36 749(v) 19.05.2006lkbesfFkdksu lLiSUlu ,e- di lfgr¶;wjktksfyMksu&33 fexzk-eSVªksfuMkt+ksy&100 fexzk-lkbesfFkdksu&25 fexzk-

73. ¶;wjktksfyMksu$eSVªksfuMkt+ksy$ 60 fefy dh 10.18 749(v) 19.05.2006lkbesfFkdksu flji cksry¶;wjktksfyMksu&30 fexzk-eSVªksfuMkt+ksy csUtq,V&100 fexzk-lkbesfFkdksu&20 fexzk-

74. ¶;wjkt+ksfyMksu $ 60 fefy dh cksry 10.04 1070(v) 11.07.2006eSVªksfuMkt+ksy lLiSUlu¶;wjkt+ksfyMksu&30 fexzk-eSVªksfuMkt+ksy&100 fexzk-

75. ¶;wjkt+ksfyMksu$ 10 dk 6.90 1070(v) 11.07.2006gkbMªksDyksjksgkbMªksDlhD;wuksfyu iRrk@fCyLVj¼vkbZlh,pD;w½ xksfy;ka¶;wjkt+ksfyMksu&100 fexzk-gkbMªksDyksjksgkbMªksDlhD;wuksfyu&250 fexzk-

76. ¶;wjkt+ksfyMksu$esVªksfuMkt+ksy 30 fefy dh cksry 7.46 1672(v) 03.10.2006lLisUlu@flji ,e- di lfgr¶;wjkt+ksfyMksu&30 fexzk-esVªksfuMkt+ksy&100 fexzk-

77. ¶;wjkt+ksfyMksu$esVªksfuMkt+ksy 30 fefy dh cksry 7.54 1672(v) 03.10.2006lLisUlu@flji ,e- di lfgr¶;wjkt+ksfyMksu&40 fexzk-esVªksfuMkt+ksy&200 fexzk-

78. ¶;wjkt+ksfyMksu flji@lLisUlu 1000 fefy dh 56.33 1663(v) 27.09.2007¶;wjkt+ksfyMksu&25 fexzk- cksry

79. ¶;wjkt+ksfyMksu flji@lLisUlu 60 fefy dh 5.66 1663(v) 27.09.2007¶;wjkt+ksfyMksu&25 fexzk- cksry

80. ¶;wjkt+ksfyMksu$fVfuMkt+ksy xksfy;ka 10 dk 5.24 180(v) 29.01.2008¶;wjkt+ksfyMksu&100 fexzk- iRrk@fCyLVjfVfuMkt+ksy &300 fexzk-@xksfy;ka

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 113: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 94 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

th (G)

1. tSUVkekbflu lYQsV bUtsD’ku 2 fefy dk ok;y 5.60 1928(v) 08.11.2006 eS- jsucsdlh jsuck;ksfVdtSUVkekbflu lYQsV dUoSU’kuy iSd eS- oksdkMZ tSUVkekbflu40 fexzk- tSUVkekbflu csl ds cjkcj@fefy eS- ck;ksdse xzsflu

2. tSUVkekbflu lYQsV bUtsD’ku 2 fefy dk ok;y 6.74 1323(v) 01.08.2007 eS- baM&LohQ~V tSUVkLohQ~VtSUVkekbflu lYQsV eS- Y;wfiu Y;wfitSUVk40 fexzk- tSUVkekbflu csl ds cjkcj@fefy

3. tSUVkekbflu lYQsV bUtsD’ku 2 fefy dk fdV 5.82 1643(v) 27.09.2007tSUVkekbflu lYQsV 20 fexzk-@fefy

4. tSUVkekbflu lYQsV bUtsD’ku 2 fefy dk fdV 6.22 1643(v) 27.09.2007tSUVkekbflu lYQsV 40 fexzk-@fefy

5. tSUVkekbflu bUtsD’ku isfM;fVªd&10 2 fefy dk ok;y 5.76 2034(v) 30.11.2007 eS- iysfFkdks tsuksfVd10 fexzk- csl @fefy dUoSU’kuy iSd eS- LVsjdse tsulVj

6. tSUVkekbflu bUtsD’ku isfM;fVªd&10 2 fefy dk ok;y 5.44 1928(v) 08.11.2006 eS- ck;ks,fFkdy ck;kstSUVk10 fexzk- csl @fefy VsEij&izwQ lhy iSd eS- gsVsjks ,p- ds;j yk;jkekbflu

7. tSUVkekbflu vk¡[k@dku Mªksi 3 fefy dk ok;y 4.94 67(v) 31.10.1995 eS- tSUVksM tSUVksM3 fexzk- csl@fefy ¼ 0.3% MCY;w@MCY;w½ Mªksij lfgr eS- ,QMhlh csdVhtsu

8. tSUVkekbflu vk¡[k@dku Mªksi 5 fefy dk 6.68 1022(v) 01.12.1998 eS- ,yjt+u tSUVhflu3 fexzk- csl@fefy ¼ 0.3% MCY;w@MCY;w½ ok;y Mªksij vkSj eS- tSuksifVd tSuksifVd

dkVZu lfgr eS- okjsu VsehtsueS- usVdks QkekZ tsuck;ksfVdeS- ekbØks ysc tsufVuk

9. tSUVkekbflu Vksfidy vkW;UVesaV 5 xzke dh 2.66 67(v) 31.01.1995 eS- ikjdj jksfcUlu lqijktsUV0.1% MCY;w@MCY;w V~;wc

10. tSUVkekbflu$fcVkfeFkkt+ksu 10 xzke dh 15.78 192(v) 11.03.1998 eS- foy bEiSDl fMcsDl&thMkbZizksfi;ksusV vkW;UVesaV@Øhe V~;wc eS- oaMj fMcsMeZ&thtSUVkekbflu 0.1%fcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcj

11. tSUVkekbflu$fcVkfeFkkt+ksu 15 xzke dh 22.12 192(v) 11.03.1998 eS- ekbØks csVktWy&thMkbZizksfi;ksusV vkW;UVesaV@Øhe V~;wc eS- oaMj chth ØhetSUVkekbflu 0.1% eS- cky QkekZ dksfVZMeZ&thfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcj

Page 114: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 95 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

12. tSUVkekbflu$fcVkfeFkkt+ksu MkbZizksfi;ksusV 10 xzke dh 16.00 192(v) 11.03.1998 eS- ,MhIl ,t+ksusV&thlhvkSj DyksVªhekt+ksy vkW;UVesaV@Øhe V~;wctSUVkekbflu 0.1%fcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcjDyksVªhekt+ksy 1.00%

13. tSUVkekbflu$fcVkfeFkkt+ksu MkbZizksfi;ksusV 15 xzke dh 22.46 192(v) 11.03.1998 eS- flj;k ,ihdksVZ&thlhvkSj DyksVªhekt+ksy vkW;UVesaV@Øhe V~;wctSUVkekbflu 0.1%fcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcjDyksVªhekt+ksy 1.00%

14. tSUVkekbflu$DyksfcVklksy 10 xzke dh 6.82 840(v) 15.06.2005 eS- ljos QkekZfl;wfVdylhch,l&thizksfi;ksusV vkW;UVesaV@Øhe V~;wc eS- uslVj DykscsV&thtSUVkekbflu 0.1% MCY;w@MCY;wDyksfcVklksy izksfi;ksusV 0.05% MCY;w@MCY;w

15. tSUVkekbflu$DyksfcVklksy 15 xzke dh 8.84 840(v) 15.06.2005 eS- fudksYl ykscsV&thizksfi;ksusV vkW;UVesaV@Øhe V~;wc eS- XysuekdZ ikWojtsutSUVkekbflu 0.1% MCY;w@MCY;wDyksfcVklksy izksfi;ksusV 0.05% MCY;w@MCY;w

16. tSUVkekbflu$VksYukQVsV$fcVkfeFkkt+ksu 5 xzke dh 5.52 828(v) 15.06.2005 eS- fczldksu ,lY;wosyjsV$vkbZlh,pD;w Øhe V~;wctSUVkekbflu lYQsV 1 fexzk-VksYukQVsV 10 fexzk-fcVkfeFkkt+ksu osyjsV 0.61 fexzk-vkbZlh,pD;w 10 fexzk-

17. tSUVkekbflu$VksYukQVsV$fcVkfeFkkt+ksu 10 xzke dh 8.22 828(v) 15.06.2005 eS- isut+ksu QkekZ D;w-Mh- 4osyjsV$vkbZlh,pD;w Øhe V~;wctSUVkekbflu lYQsV 1 fexzk-VksYukQVsV 10 fexzk-fcVkfeFkkt+ksu osyjsV 0.61 fexzk-vkbZlh,pD;w 10 fexzk-

18. tSUVkekbflu$VksYukQVsV$fcVkfeFkkt+ksu 5 xzke dh 5.24 828(v) 15.06.2005 eS- Mk;ukfed chbZ&,uosyjsV$vkbZlh,pD;w Øhe V~;wctSUVkekbflu lYQsV 1 fexzk-VksYukQVsV 10 fexzk-fcVkfeFkkt+ksu osyjsV 0.5 fexzk-vkbZlh,pD;w 10 fexzk-

19. tSUVkekbflu vkSj fcVkfeFkkt+ksu bZ@bZ Mªksi 5 fefy dh 3.84 76(v) 15.01.2004 eS- ,yjxu tSUVhfl&chtSUVkekbflu lYQsV 0.03% MCY;w@oh cksry Mªksij vkSj eS- tsuksfVi ch tsuksfVi chfcVkfeFkkt+ksu lksfM;e QksLQsV 0.03% MCY;w@ohdkVZu lfgr eS- csLVksdse csVkfou&th,e

Page 115: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 96 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

20. tSUVkekbflu$DyksfcVklksy 10 xzke dh 7.42 841(v) 15.06.2005 eS- ,ehnhi DyksfMi&th,eizksfi;ksusV vkW;uVesaV@Øhe V~;wc eS- MªkDV QkekZ Dykscslksy th,eizR;sd xzke esatSUVkekbflu 0.1% MCY;w@MCY;wDyksfcVklksy izksfi;ksusV 0.05% MCY;w@MCY;wfedksukt+ksy ukbVªsV 2% MCY;w@MCY;w

21. tSUVkekbflu$DyksfcVklksy 15 xzke dh 9.72 841(v) 15.06.2005 eS- ck;ksflu ,p- ds;jfluDyksc&th,eizksfi;ksusV vkW;uVesaV@Øhe V~;wc eS- esMhiksy feDykstsuizR;sd xzke esatSUVkekbflu 0.1% MCY;w@MCY;wDyksfcVklksy izksfi;ksusV 0.05% MCY;w@MCY;wfedksukt+ksy ukbVªsV 2% MCY;w@MCY;w

22. tSUVkekbflu$DyksfcVklksy 10 xzke dh 6.90 841(v) 15.06.2005 eS- fl;jk QkekZ MfeZl&thizksfi;ksusV vkW;uVesaV@Øhe V~;wcizR;sd xzke esatSUVkekbflu 0.1% MCY;w@MCY;wDyksfcVklksy izksfi;ksusV 0.05% MCY;w@MCY;wftad lYQsV 2.5% MCY;w@MCY;w

23. tSUVkekbflu$DyksfcVklksy 15 xzke dh 8.94 841(v) 15.06.2005 eS- esufVl QkekZ IyksLVsV&thizksfi;ksusV vkW;uVesaV@Øhe V~;wcizR;sd xzke esatSUVkekbflu 0.1% MCY;w@MCY;wDyksfcVklksy izksfi;ksusV 0.05% MCY;w@MCY;wftad lYQsV 2.5% MCY;w@MCY;w

24. tSUVkekbflu vkSj fcVkfeFkkt+ksu 10 xzke dh 8.44 1347(v) 16.09.2005 eS- foy bEiSDl fMcsDl&thMkbZizksfi;ksusV vkW;UVesaV@Øhe V~;wc eS- osaMj fMckMeZ&thtSUVkekbflu 0.1% MCY;w@MCY;wfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcj

25. tSUVkekbflu vkSj fcVkfeFkkt+ksu 15 xzke dh 11.26 1347(v) 16.09.2005 eS- ekbØks csVktWy&thMkbZizksfi;ksusV vkW;UVesaV@Øhe V~;wc eS- osaMj chth ØhetSUVkekbflu 0.1% MCY;w@MCY;w eS- cky QkekZ dksfVZMeZ&thfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcj

26. tSUVkekbflu vkSj fcVkfeFkkt+ksu 10 xzke dh 8.52 1347(v) 16.09.2005 eS- ,fMil ,tksusV thlhMkbZizksfi;ksusV ,oa DyksVªhekt+ksy V~;wc eS- ,elu esMhdse csVk lhthvkW;UVesaV@ØhetSUVkekbflu 0.1%fcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcjvkSj DyksVªhekt+ksy 1.00%

Page 116: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 97 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

27. tSUVkekbflu vkSj fcVkfeFkkt+ksu 15 xzke dh 11.38 1347(v) 16.09.2005 eS- flj;k ,ihdksVZ&thlhMkbZizksfi;ksusV ,oa DyksVªhekt+ksy V~;wcvkW;UVesaV@ØheizR;sd xzke esatSUVkekbflu 0.1%fcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcjvkSj DyksVªhekt+ksy 1.00%

28. tSUVkekbflu vkSj fcVkfeFkkt+ksu 10 xzke dh 9.02 1347(v) 16.09.2005 eS- edZ csVkfey&th,eMkbZizksfi;ksusV ,oa fedkukt+ksy V~;wcukbVªsV vkW;UVesaV@ØheizR;sd xzke esatSUVkekbflu 0.10%fcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% fcVkfeFkkt+ksu ds cjkcjfedkukt+ksy ukbVªsV 2%

29. tSUVkekbflu $ 5 fefy dk ok;y 8.06 217(v) 14.02.2007MsDlkfeFkkt+ksu vk¡[k@dku Mªksij vkSj dkVZu lfgrdk MªksitSUVkekbflu&0.3% MCY;w@oh¼tSUVkekbflu lYQsV ds leku½MsDlkfeFkkt+ksu&0.1% MCY;w@oh¼MsDlkfeFkkt+ksu lksfM;eQksLQsV ds leku½

30. tsUVkekbflu$fcVkfeFkkt+ksu 15 xzke dh 8.38 450(v) 29.03.2006osyjsV$VksYukQVsV$ V~;wcvkbMksDyksjksgkbMªksDlhD;wuksfyu¼vkbZlh,pD;w½ ØhetsUVkekbflu lYQsV 1 fexzk-fcVkfeFkkt+ksu osyjsV 0.61 fexzk-VksYukQVsV 10 fexzk-vkbMksDyksjksgkbMªksDlhD;wuksfyu 10 fexzk-@xzke

31. tSUVkekbflu$ 10 fefy dh ok;y 10.16 217(v) 14.02.2007MsDlkfeFkkt+ksu Mªksi Mªksij lfgrtSUVkekbflu&0.3% MCY;w@ohMsDlkfeFkkt+ksu&0.1% MCY;w@oh@fefy

32. tsUVkekbflu lYQsV$ 5 xzke dh V~;wc 5.12 1072(v) 11.07.2006fcdyksfeFkkt+ksu MkbZizksfi;ksusV$DyksVªhekt+ksy ØhetsUVkekbflu lYQsVtsUVkekbflu csl&0.1% ds cjkcjfcdyksfeFkkt+ksu MkbZizksfi;ksusV&0.025% MCY;w@MCY;wDyksVªhekt+ksy&1% MCY;w@MCY;w @ xzke

Page 117: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 98 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

33. tsUVkekbflu lYQsV$ 15 xzke dh V~;wc 9.44 1072(v) 11.07.2006fcdyksfeFkkt+ksuMkbZizksfi;ksusV$DyksVªhekt+ksy ØhetsUVkekbflu lYQsVtsUVkekbflu csl&0.1% ds cjkcjfcdyksfeFkkt+ksu MkbZizksfi;ksusV&0.025% MCY;w@MCY;wDyksVªhekt+ksy&1% MCY;w@MCY;w

34. tsUVkekbflu $ 7.5 xzke dh V~;wc 7.08 1072(v) 11.07.2006fcVkfeFkt+ksu ØhetsUVkekbflu lYQsV&1 fexzk-fcVkfeFkt+ksu MkbZizksfi;ksusV&0.64 fexzk-

35. tsUVkekbflu$fcVkfeFkt+ksu$ 5 xzke dh V~;wc 5.92 1072(v) 11.07.2006D;wuksfMDyksj$DyksVªhekt+ksy ØhetsUVkekbflu ¼lYQsV ds leku½&0.1% MCY;w@MCY;wfcVkfeFkkt+ksu osyjsV&0.061% MCY;w@MCY;wD;wuksfMDyksj&3% MCY;w@MCY;wDyksVªhekt+ksy&1% MCY;w@MCY;w

36. tSUVkekbflu bUtsD’ku 10 fefy dh ok;y 10.76 1918(v) 08.11.2006tSUVkekbflu lYQsV fQfyi vkWQ lhy80 fexzk- tSUVkekbflu ds cjkcj@2 fefy

37. tSUVkekbflu bUtsD’ku 20 fefy dh ok;y 16.00 1918(v) 08.11.2006tSUVkekbflu lYQsV fQfyi vkWQ lhy80 fexzk- tSUVkekbflu ds cjkcj@2 fefy

38. tSUVkekbflu$DyksfcVklksy 5 xzke dh V~;wc 5.72 433(v) 23.03.2007izksfi;ksusV$VksYukQVsV$vkbZMksDyksjksgkbMªksDlhD;wuksfyu$DyksfVªekt+ksy Øhe@vkW;uVeSaVtSUVkekbflu lYQsV1 fexzk- tSUVkekbflu ds cjkcjDyksfcVklksy izksfi;ksusV&0.5 fexzk-VksYukQVsV&10 fexzk-vkbZMksDyksjksgkbMªksDlhD;wuksfyu&10 fexzk-DyksfVªekt+ksy&10 fexzk-

39. tSUVkekbflu$ 15 xzke dh V~;wc 11.94 1686(v) 03.10.2006fcVkfeFkkt+ksu MkbZizksfi;ksusV$fedksukst+ksy ukbVªsV ØhetSUVkekbflu 0.1% MCY;w@MCY;wfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% MCY;w@MCY;w ds cjkcjfedksukst+ksy ukbVªsV 2% MCY;w@MCY;w

Page 118: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 99 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

40. tSUVkekbflu$ 10 xzke dh V~;wc 8.66 1686(v) 03.10.2006fcVkfeFkkt+ksu MkbZizksfi;ksusV$fedksukst+ksy ukbVªsV ØhetSUVkekbflu 0.05% MCY;w@MCY;wfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% MCY;w@MCY;w ds cjkcjfedksukst+ksy ukbVªsV 1% MCY;w@MCY;w

41. tSUVkekbflu$ 16 xzke dh V~;wc 11.90 1686(v) 03.10.2006fcVkfeFkkt+ksu MkbZizksfi;ksusV ØhetSUVkekbflu 0.1% MCY;w@MCY;wfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% MCY;w@MCY;w ds cjkcj

42. tSUVkekbflu$ 10 xzke dh V~;wc 11.36 1686(v) 03.10.2006fcVkfeFkkt+ksu MkbZizksfi;ksusV$fedksukst+ksy ukbVªsV ØhetSUVkekbflu 0.1% MCY;w@MCY;wfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.10% MCY;w@MCY;wfedksukst+ksy ukbVªsV 2% MCY;w@MCY;w

43. tSUVkekbflu$ 10 xzke dh V~;wc 6.76 1686(v) 03.10.2006fcVkfeFkkt+ksu MkbZizksfi;ksusV$bdksukt+ksy ukbVªsV ØhetSUVkekbflu 0.1% MCY;w@MCY;wfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.025% MCY;w@MCY;wbdksukt+ksy ukbVªsV 1% MCY;w@MCY;w

44. tSUVkekbflu$ 15 xzke dh V~;wc 11.94 1686(v) 03.10.2006fcVkfeFkkt+ksu MkbZizksfi;ksusV$bdksukt+ksy ukbVªsV ØhetSUVkekbflu 0.1% MCY;w@MCY;wfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.025% MCY;w@MCY;wbdksukt+ksy ukbVªsV 1% MCY;w@MCY;w

45. tSUVkekbflu$ 5 xzke dh V~;wc 8.72 1686(v) 03.10.2006fcVkfeFkkt+ksu MkbZizksfi;ksusV$vkbZMksDyksjksgkbMªksDlh&D;wuksfyu ¼vkbZlh,pD;w½ ØhetSUVkekbflu csl 0.2% MCY;w@MCY;wfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.1% MCY;w@MCY;wvkbZMksDyksjksgkbMªksDlhD;wuksfyu&2% MCY;w@MCY;w

46. fcVkfeFkkt+ksu MkbZizksfi;ksusV$ 20 fefy dh cksry 11.52 1686(v) 03.10.2006tSUVkekbflu yks’kutSUVkekbflu lYQsV 0.1% MCY;w@MCY;wfcVkfeFkkt+ksu MkbZizksfi;ksusV 0.064%0.05% MCY;w@MCY;w ds cjkcj

Page 119: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 100 -

47. tSUVkekbflu$ekbdksuktksy 5 xzke dh V~;wc 4.46 1920(v) 08.11.2006ukbVªsV$¶y;wfluksyksu,sflVksukbM Øhe@vkW;uVeSaVtSUVkekbflu&0.1% MCY;w@MCY;wekbdksuktksy ukbVªsV&2% MCY;w@MCY;w¶y;wfluksyksu ,sflVksukbM&0.01% MCY;w@MCY;w

48. tSUVkekbflu$fcdyksfeFkkt+ksu 10 xzke dh V~;wc 5.78 1920(v) 08.11.2006MkbZizksfi;ksusV$DyksVªhektksyØhe@vkW;uVeSaVtSUVkekbflu lYQsV0.1% MCY;w@MCY;w tSUVkekbflu ds cjkcjfcdyksfeFkkt+ksu MkbZizksfi;ksusV&0.025% MCY;w@MCY;wDyksVªhektksy&1% MCY;w@MCY;w

49. tSUVkekbflu$fcVkfeFkkt+ksu 10 xzke dh 7.94 433(v) 23.03.2007MkbZizksfi;ksusV$VksYukQVsV V~;wcvkbMksDyksjksgkbMªksDlh&D;wuksfyu Øhe@vkW;uVeSaVtSUVkekbflu lYQsV1 fexzk- tSUVkekbflu csl ds cjkcjfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.643 fexzk-ysfDVd ,sflM 10% MCY;w@MCY;wVksYukQVsV&10 fexzk-vkbMksDyksjksgkbMªksDlhD;wuksfyu&10 fexzk-

50. tSUVkekbflu$fcVkfeFkkt+ksu 16 xzke dh V~;wc 9.66 1923(v) 08.11.2006MkbZizksfi;ksusV$DyksfVªekt+ksyØhe@vkW;uVeSaVtSUVkekbflu lYQsV&0.1% MCY;w@MCY;wfcVkfeFkkt+ksu MkbZizksfi;ksusV0.05% MCY;w@MCY;w fcVkfeFkkt+ksu ds cjkcjDyksfVªekt+ksy&1.0% MCY;w@MCY;w

51. tSUVkekbflu$fcVkfeFkkt+ksu 7 xzke dh V~;wc 6.02 1923(v) 08.11.2006MkbZizksfi;ksusV$DyksfVªekt+ksyØhe@vkW;uVeSaVtSUVkekbflu lYQsV&0.1% MCY;w@MCY;wfcVkfeFkkt+ksu MkbZizksfi;ksusV0.05% MCY;w@MCY;w fcVkfeFkkt+ksu ds cjkcjDyksfVªekt+ksy&1.0% MCY;w@MCY;w

52. tSUVkekbflu$DykscsVklksy$ 15 xzke dh 7.18 2048(v) 30.11.2007fedksukt+ksy$DyksjksØslksy Øhe V~;wctSUVkekbflu ¼tSUVkekbflulYQsV ds leku½-0.2% MCY;w@MCY;wDykscsVklksy izksfi;ksusV-0.05% MCY;w@MCY;wfedksukt+ksy ukbVªsV-2.00% MCY;w@MCY;wDyksjksØslksy-0.1% MCY;w@MCY;w

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 120: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 101 -

53. tSUVkekbflu$DykscsVklksy Øhe 30 xzke dh 9.64 2048(v) 30.11.2007tSUVkekbflu lYQsV V~;wctSUVkekbflu -0.1% MCY;w@MCY;w ds cjkcjDykscsVklksy izksfi;ksusV-0.05% MCY;w@MCY;w

54. tSUVkekbflu$DykscsVklksy$ 10 xzke dh 6.56 2048(v) 30.11.2007fedksukt+ksy Øhe V~;wctSUVkekbflu lYQsVtSUVkekbflu -0.20% MCY;w@MCY;w ds cjkcjDykscsVklksy izksfi;ksusV-0.05% MCY;w@MCY;wfedksukt+ksy ukbVªsV-2.00% MCY;w@MCY;w

55. tSUVkekbflu$MsDlkfeFkkt+ksu$ 5 fefy dh 7.28 2048(v) 30.11.2007csUtydksfu;e DyksjkbM vk¡[k@ cksry Mªksijdku dk Mªksi lfgrtSUVkekbflu lYQsVtSUVkekbflu -0.3% MCY;w@MCY;wMsDlkfeFkkt+ksu lksfM;e QksLQsVMsDlkfeFkkt+ksu -0.1% MCY;w@MCY;w ds cjkcjcsUtydksfu;e DyksjkbM lksY;w--0.02% MCY;w@MCY;w@fefy

56. tSUVkekbflu lYQsV$ 5 fefy dh 9.46 168(v) 29.01.2008fcVkfeFkkt+ksu lksfM;e QksLQsV Mªksi IykfLVd cksrytSUVkekbflu lYQsVtSUVkekbflu ¼3000 ;wfuV@fefy½-0.3% MCY;w@ohfcVkfeFkkt+ksu lksfM;e QksLQsV-0.1% MCY;w@ohcsUtydksfu;e DyksjkbM lksY;w’ku-0.02% MCY;w@oh

57. tSUVkekbflu lYQsV$ 10 fefy dh 12.80 168(v) 29.01.2008fcVkfeFkkt+ksu lksfM;e QksLQsV Mªksi IykfLVd cksrytSUVkekbflu lYQsVtSUVkekbflu ¼3000 ;wfuV@fefy½-0.3% MCY;w@ohfcVkfeFkkt+ksu lksfM;e QksLQsV-0.1% MCY;w@ohcsUtydksfu;e DyksjkbM lksY;w’ku-0.02% MCY;w@oh

58. tSUVkekbflu lYQsV$ 15 fefy dh 15.98 168(v) 29.01.2008fcVkfeFkkt+ksu lksfM;e QksLQsV Mªksi IykfLVd cksrytSUVkekbflu lYQsVtSUVkekbflu ¼3000 ;wfuV@fefy½-0.3% MCY;w@ohfcVkfeFkkt+ksu lksfM;e QksLQsV-0.1% MCY;w@ohcsUtydksfu;e DyksjkbM lksY;w’ku-0.02% MCY;w@oh

59. tSUVkekbflu lYQsV$ 15 fefy dh 24.66 168(v) 29.01.2008fcVkfeFkkt+ksu lksfM;e QksLQsV Mªksi IykfLVd cksrytSUVkekbflu lYQsVtSUVkekbflu ¼3000 ;wfuV@fefy½-0.3% MCY;w@ohfcVkfeFkkt+ksu lksfM;e QksLQsV-0.1% MCY;w@ohcsUtydksfu;e DyksjkbM lksY;w’ku-0.02% MCY;w@oh

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 121: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 102 -

60. tSUVkekbflu lYQsV$ 5 xzke dh 6.30 203(v) 29.01.2008fcVkfeFkkt+ksu osyjsV$VksYukQVsV$ V~;wcvkbZlh,pD;w ØhetSUVkekbflu lYQsVtSUVkekbflu csl 1.00 fexzk- ds cjkcjfcVkfeFkkt+ksu osyjsV-0.61 fexzk-VksYukQVsV-15.00 fexzk-vkbZMksDyksjksgkbMªksDlhD;wuksfyu-15.00 fexzk-@xzke

61. tSUVkekbflu lYQsV$ 25 xzke dh 13.22 203(v) 29.01.2008DyksfcVklksy izksfi;ksusV Øhe V~;wctSUVkekbflu lYQsV 0.1% MCY;w@MCY;wDyksfcVklksy izksfi;ksusV-0.05% MCY;w@MCY;w

62. tSUVkekbflu lYQsV$bdksuktksy 10 xzke dh 7.28 203(v) 29.01.2008ukbVªsV$fcdyksfeFkktksu MkbZizksfi;ksusV$ V~;wcDyksjksØslksy ØhetSUVkekbflu 0.1% MCY;w@MCY;w¼tSUVkekbflu lYQsV ds leku½bdksuktksy ukbVªsV 1.0% MCY;w@MCY;wfcdyksfeFkktksu MkbZizksfi;ksusV-0.025% MCY;w@MCY;wDyksjksØslksy ¼izstjosfVo ds leku½-0.1% MCY;w@MCY;w

63. tSUVkekbflu lYQsV vkW;uVesUV 15 xzke dh V~;wc 6.40 203(v) 29.01.2008tSUVkekbflu lYQsV 0.1% MCY;w@MCY;w@xzke

64. fxfyfit+kbM xksfy;ka 10 dk 2.80 1019(v) 03.09.2003 eS- ;w,loh lseh&Xyk;usl2.5 fexzk-@xksfy;ka iRrk@fCyLVj eS- vkjihth ykbQlkbalXyk;Vksi

eS- tsusfVdk xysteS- xzsufMDl Mh&fxfyieS- LVsMesM Xyk;fti

65. fxfyfit+kbM xksfy;ka 10 dk 4.36 1019(v) 03.09.2003 eS- ;w,loh Xyk;usl5 fexzk-@xksfy;ka iRrk@fCyLVj eS- ekbØks ysc fMfctkbM

eS- tsusfVdk esVkXysteS- zQsadks bafM;u XykbMeS- vkjihth ykbQlkbalXyk;Vksi&5 ,lvkj

66. fxfyfit+kbM xksfy;ka 10 dk 6.16 1019(v) 03.09.2003 eS- tsusfVdk xyst7.5 fexzk-@xksfy;ka iRrk@fCyLVj

67. fxfyfit+kbM xksfy;ka 10 dk 7.74 1671(v) 03.10.2006 eS- ;w,loh Xyk;usl10 fexzk-@xksfy;ka iRrk@fCyLVj eS- vkjihth ykbQlkbalXyk;Vksi

eS- tsusfVdk xysteS- ekbØks ysc fMfctkbMeS- esuks th&Vªksy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 122: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 103 -

68. fxfyfit+kbM xksfy;ka 10 dk 6.82 1060(v) 11.07.2006 eS- ;w,loh Xyk;usl5 fexzk-@,lvkj@Mhvkj@lhvkj@ ,,y_iRrk eS- vkjihth ykbQlkbalXyk;VksiVhvkj@,Dlvkj xksfy;ka eS- esuks th&Vªksy

eS- eksnh eqaMh fxfyfidksufVueS- ,eD;wj ckbeksM

69. fxfyfit+kbM xksfy;ka 10 dk 6.34 1060(v) 11.07.20065 fexzk-@,lvkj@Mhvkj@lhvkj@ ,,y_fCyLVjVhvkj@,Dlvkj xksfy;ka

70. fxfyfit+kbM xksfy;ka 10 dk 12.44 1060(v) 11.07.2006 eS- ;w,loh Xyk;usl10 fexzk-@,lvkj@Mhvkj@lhvkj@ ,,y_iRrk eS- vkjihth ykbQlkbalXyk;VksiVhvkj@,Dlvkj xksfy;ka eS- eksnh eqaMh fxfyfidksufVu

eS- ,eD;wj ckbeksM

71. fxfyfit+kbM xksfy;ka 10 dk 11.86 1060(v) 11.07.200610fexzk-@,lvkj@Mhvkj@lhvkj@ ,,y_fCyLVjVhvkj@,Dlvkj xksfy;ka

72. fxfyfit+kbM$esVQksjfeu xksfy;ka 10 dk 4.46 1671(v) 03.10.2006 eS- tsusfVdk esVkXyst2.5 fexzk-$400 fexzk-@xksfy;ka iRrk@fCyLVj eS- xzsafMDl Xyk;lsIV

eS- lu QkekZ fxfyfiesVeS- esuks QkekZ fxfyQksjfeu

73. fxfyfit+kbM$esVQksjfeu xksfy;ka 10 dk 6.56 1671(v) 03.10.2006 eS- ;w,loh Xyk;usl5 fexzk-$500 fexzk-@xksfy;ka iRrk@fCyLVj eS- ekbØks ysc fMfctkbM

eS- tsusfVdk esVkXysteS- zQsadks bafM;u Xyk;esVeS- oksdkMZ ftfMfeu

74. fxfyfit+kbM$esVQksjfeu xksfy;ka 10 dk 3.42 1671(v) 03.10.2006 eS- zQsadks bafM;u Xyk;esVfxfyfit+kbM 2.5 fexzk- iRrk@fCyLVjesVQksjfeu 250 fexzk-@xksfy;ka

75. xzslks¶;wyfou xksfy;ka&125 10 dk 6.72 210(v) 14.02.2007 eS- Mk;ukfed ysc xzslks&125125 fexzk-@xksfy;ka iRrk@fCyLVj

76. xzslks¶;wyfou xksfy;ka&250 10 dk 12.56 210(v) 14.02.2007 eS- Mk;ukfed ysc xzslks&125250 fexzk-@xksfy;ka ,,y_iRrk eS- vesfjdu jsesfMt fxzl&vksMh

77. xzslks¶;wyfou xksfy;ka&250 10 dk 12.32 210(v) 14.02.2007 eS- cky QkekZ fxzlksjy250 fexzk-@xksfy;ka ,,y_fCyLVj eS- th,lds fxzlksfou&,Qih

eS- osysl osykfou

78. xzslks¶;wyfou xksfy;ka&375 10 dk 18.40 210(v) 14.02.2007 eS- MkW- jsM~Mh ysc fxzl&vksMh&375375 fexzk-@xksfy;ka ,,y_iRrk eS- cky QkekZ fxzlksjy&vksMh

79. xzslks¶;wyfou xksfy;ka&375 10 dk 18.08 210(v) 14.02.2007 eS- MkW- jsM~Mh ysc fxzl&vksMh&375375 fexzk-@xksfy;ka ,,y_fCyLVj eS- cky QkekZ fxzlksjy&vksMh

80. xzslks¶;wyfou xksfy;ka&500 10 dk 24.22 210(v) 14.02.2007 eS- fluesfMd ysc flukflu&500500 fexzk-@xksfy;ka ,,y_iRrk eS- lkbdksVªksfiDl ¼vkbZ½ekbdksukseZ

81. xzslks¶;wyfou xksfy;ka&500 10 dk 23.80 210(v) 14.02.2007 eS- fluesfMd ysc flukflu&500500 fexzk-@xksfy;ka ,,y_fCyLVj eS- lkbdksVªksfiDl ¼vkbZ½ekbdksukseZ

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 123: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 104 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

vkbZ (I)

1. bC;wizksQsu xksfy;ka&200 10 dk 3.00 1669(v) 03.10.2006 eS- ,cksV QkekZ czwQsu200 fexzk-@xksfy;ka iRrk@fYyLVj eS- fliyk bC;wtsfld

eS- dUlsiV QkekZ bC;wdksueS- edZ ,e¶yseeS- foØe ysc bC;wizksQsu

2. bC;wizksQsu xksfy;ka&300 10 dk 3.80 1351(v) 16.09.2005300 fexzk-@xksfy;ka iRrk@fYyLVj

3. bC;wizksQsu xksfy;ka&400 10 dk 5.18 1669(v) 03.10.2006 eS- ,cksV QkekZ czwQsu400 fexzk-@xksfy;ka iRrk@fYyLVj eS- fliyk bC;wtsfld

eS- ,xyksesM vkjfVQsu&vks,yMheS- txluiky bC;wikyeS- vksesxk jsesfMt czwtsfld

4. bC;wizksQsu xksfy;ka&600 10 dk 7.50 1669(v) 03.10.2006 eS- ,cksV QkekZ czwQsu600 fexzk-@xksfy;ka iRrk@fYyLVj eS- fliyk bC;wtsfld

eS- edZ ,e¶yseeS- foaxl QkekZ bC;wizksQsu

5. bC;wizksQsu ,lvkj@lhvkj dSilwy&300 10 dk 6.90 179(v) 07.02.2006 eS- fliyk bC;wtsfld ,lvkj300 fexzk-@,lvkj@lhvkj dSilwy iRrk@fYyLVj

6. bC;wizksQsu ,lvkj@lhvkj dSilwy&600 10 dk 9.42 297(v) 29.03.2001600 fexzk-@,lvkj@lhvkj dSilwy iRrk@fYyLVj

7. bC;wizksQsu lLisUlu 50 fefy dh cksry 4.80 855(v) 18.12.1997100 fexzk-@ 5 fefy ,e- di lfgr

8. bC;wizksQsu lLisUlu 60 fefy dh cksry 11.72 1660(v) 27.09.2007 eS- fliyk bC;wtsfld lLisUlu100 fexzk-@ 5 fefy ,e- di lfgr eS- XysuekdZ bu¶ysd lLisUlu

9. bC;wizksQsu lLisUlu 60 fefy dh 6.74 297(v) 29.03.2001 eS- fliyk bC;wtsfld lLisUlu100 fexzk-@ 5 fefy cksry eS- XysuekdZ bu¶ysd lLisUlu

10. bC;wizksQsu lLisUlu 112 fefy dh cksry 8.00 855(v) 18.12.1997100 fexzk-@ 5 fefy ,e- di lfgr

11. bC;wizksQsu vkSj isjkflVkeksy 10 dk 2.98 292(v) 29.03.2000 eS- flok;t+sjk gsYFkds;j fM;w¶ysefdM@?kqyu’khy xksfy;ka ,,y_iRrk eS- baMksdks bC;w¶ysej&ih100 fexzk-$ 125 fexzk-@fdM@?kqyu’khy xksfy;ka eS- MkW- jsM~Mh bC;wflu

eS- ftuks czwiyeS- lkYdl QkekZ czwQseksy

12. bC;wizksQsu vkSj isjkflVkeksy 10 dk 2.60 292(v) 29.03.2000 eS- flok;t+sjk gsYFkds;j fM;w¶ysefdM@?kqyu’khy xksfy;ka ,,y_fCyLVj eS- baMksdks bC;w¶ysej&ih100 fexzk-$ 125 fexzk-@fdM@?kqyu’khy xksfy;ka eS- MkW- jsM~Mh bC;wflu

eS- ftuks czwiyeS- lkYdl QkekZ czwQseksy

Page 124: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 105 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

13. bC;wizksQsu vkSj isjkflVkeksy xksfy;ka 10 dk 5.84# 17(v) 04.01.2005 eS- ,ofUVl dksEch¶yse400 fexzk-$ 325 fexzk-@xksfy;ka ¼lknh½ iRrk@fCyLVj eS- fliyk bC;wtsfld Iyl

eS- th,lds twij# layXud & 1 nsf[k;s eS- edZ ,e¶yse

eS- txluiky czw,l

14. bC;wizksQsu vkSj isjkflVkeksy lLisUlu 50 fefy dh cksry 6.78 297(v) 29.03.2001 eS- ejdjh ysc isjkC;wMksy100 fexzk-$ 125 fexzk-@ 5 fefy ,e- di lfgr

15. bC;wizksQsu vkSj isjkflVkeksy lLisUlu 50 fefy dh 6.30 297(v) 29.03.2001 eS- ejdjh ysc isjkC;wMksy100 fexzk-$ 125 fexzk-@ 5 fefy cksry

16. bC;wizksQsu vkSj isjkflVkeksy lLisUlu 60 fefy dh cksry 9.42 1659(v) 27.09.2007 eS- ,ycVZ MsfoM ,uk¶yse100 fexzk-$ 125 fexzk-@ 5 fefy ,e- di lfgr eS- ,xyksesM vkjfVQsu Iyl

eS- baMksdks bC;w¶ysejeS- ,yfEcd esxkMksyeS- fu;ks QkekZ ih&Qsfczu

17. bC;wizksQsu vkSj isjkflVkeksy lLisUlu 60 fefy dh 8.94 297(v) 29.03.2001 eS- ,ycVZ MsfoM ,uk¶yse100 fexzk-$ 125 fexzk-@ 5 fefy cksry eS- ,xyksesM vkjfVQsu Iyl

eS- baMksdks bC;w¶ysejeS- ,yfEcd esxkMksyeS- fu;ks QkekZ ih&Qsfczu

18. bC;wizksQsu vkSj isjkflVkeksy lLisUlu 60 fefy dh cksry 11.08 208(v) 14.02.2007 eS- XysuekdZ vkjfVtsfld100 fexzk-$ 162.5 fexzk-@ 5 fefy ,e- di lfgr eS- fliyk bC;wtsfld Iyl

eS- vksojfll ,p- ds;j izksQsueS- ekdZ bafM;k jsfM¶yse

19. bC;wizksQsu $ isjkflVkeksy vkSj 10 dk 7.40 297(v) 29.03.2001Dyksjt+ksDlkt+ksu xksfy;ka iRrk@fCyLVj¼400 fexzk-$ 325 fexzk-vkSj 250 fexzk-½@xksfy;ka

20. bC;wizksQsu $ isjkflVkeksy vkSj 10 dk 7.36 297(v) 29.03.2001Dyksjt+ksDlkt+ksu xksfy;ka iRrk@fCyLVj¼400 fexzk-$ 300 fexzk-vkSj 250 fexzk-½@xksfy;ka

21. bC;wizksQsu $ isjkflVkeksy vkSj 10 dk 6.06 1164(v) 20.10.2004dSfQu xksfy;ka iRrk@fCyLVj¼400 fexzk-$ 333 fexzk-vkSj 25 fexzk-½@xksfy;ka

22. bC;wizksQsu vkSj fVtkfufMu xksfy;ka 10 dk 5.06 1351(v) 16.09.2005 eS- Qs;jMsy fjlpZ ,d¶yse&Vh400 fexzk-$ 2 fexzk-@ xksfy;ka iRrk@fCyLVj eS- ,Mh fVftVky&ch

23. bC;wizksQsu$MsDlVªksfeFkksjQsu xksfy;ka 10 dk 6.40 1351(v) 16.09.2005200 fexzk-$ 32.5 fexzk-@ xksfy;ka iRrk@fCyLVj

Page 125: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 106 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

24. bC;wizksQsu vkSj MsDlVªksizksiksDlhQsu 10 dk 7.78 1345(v) 16.09.2005 eS- oksdkMZ bC;w&izksDlhoksu,plh,y dSilwy iRrk@fCyLVj400 fexzk-$ 65 fexzk-@ dSilwy

25. bC;wizksQsu$ikjkflVkeksy$ 10 dk iRrk@fCyLVj 6.12 175(v) 07.02.2006esxusfl;e VªkbZflfydsV xksfy;kabC;wizksQsu&400 fexzk-ikjkflVkeksy&325 fexzk-esxusfl;e VªkbZflfydsV&150 fexzk-@xksfy;ka

26. bC;wizksQsu$fVtkfuMhu dSilwy 6 dk iRrk@fCyLVj 35.36 175(v) 07.02.2006bC;wizksQsu&400 fexzk-fVtkfuMhu ,plh,y&2.288 fexzk-fVtkfuMhu csl&2 fexzk- ds cjkcj@dSilwy

27. bC;wizksQsu $isjkflVkeksy vkSj 10 dk 6.34# 1666(v) 03.10.2006vU; dh xksfy;ka iRrk@fCyLVj400 fexzk-$ 325 fexzk-@xksfy;ka

28. bC;wizksQsu tWy 30 xzke dh V~;wc 10.28 446(v) 29.03.2006bC;wizksQsu 10% @xzke

29. bC;wizksQsu$ikjkflVkeksy lLisUlu 60 fefy dh 10.30 763(v) 19.05.2006bC;wizksQsu&100 fexzk- cksryikjkflVkeksy&100 fexzk-@5 fefy

30. bC;wizksQsu$,flVkfeuksQsu lLisUlu 50 fefy dh 9.86 763(v) 19.05.2006bC;wizksQsu&100 fexzk- cksry,flVkfeuksQsu&162.5 fexzk-@5 fefy

31. bC;wizksQsu$,sflVkfeuksQsu$ 50 fefy dh cksry 10.06 763(v) 19.05.2006lkbesfFkdksu lLiSUlubC;wizksQsu&100 fexzk-,sflVkfeuksQsu&162.5 fexzk-lkbesfFkdksu&50 fexzk-@5 fefy

32. bC;wizksQsu$ikjkflVkeksy$ 20 dk iRrk@fCyLVj 16.00 763(v) 19.05.2006jsdsesfFk;ksuhu xksfy;kabC;wizksQsu&400 fexzk-ikjkflVkeksy&500 fexzk-jsdsesfFk;ksuhu&50 fexzk-

33. bC;wizksQsu lLisUlu 100 fefy dh cksry 15.06 207(v) 14.02.2007bC;wizksQsu&100 fexzk- ,e- di lfgr

34. bC;wizksQsu$ 60 fefy dh iSV 13.70 207(v) 14.02.2007isjkflVkeksy lLisUlu cksry ,e- di lfgrbC;wizksQsu&100 fexzk-isjkflVkeksy&162.5 fexzk-

Page 126: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 107 -

35. bC;wizksQsu$ 60 fefy dh iSV 14.90 207(v) 14.02.2007isjkflVkeksy lLisUlu cksry ,e- di vkSjbC;wizksQsu&100 fexzk- dkVZu lfgrisjkflVkeksy&162.5 fexzk-

36. bC;wizksQsu$isjkflVkeksy$ 60 fefy dh 12.16 1661(v) 27.09.2007isjkfeFkkft+u flji@lLisUlu cksrybC;wizksQsu&100 fexzk-isjkflVkeksy&125 fexzk-isjkfeFkkft+u&2.5 fexzk-@5fefy

37. bC;wizksQsu$fVtkfufMu 10 dk 13.68 174(v) 29.01.2008,plh,y dSilwy iRrk@fCyLVjbC;wizksQsu&400 fexzk- eksuks dkVZu esafVtkfufMu ,plh,y&2.288 fexzk-fVtkfufMu csl 2 fexzk- ds cjkcj@lkW¶V tsysfVu dSilwy

38. bC;wizksQsu$fVtkfufMu 10 dk 8.04 1661(v) 27.09.2007,plh,y dSilwy iRrk@fCyLVjbC;wizksQsu&400 fexzk-fVtkfufMu ,plh,y&2.288 fexzk-fVtkfufMu csl 2 fexzk- ds cjkcj@dSilwy

39. vkbZMks&Dyksjks&gkbMªksDlh&D;wuksfyu xksfy;ka 10 dk 4.79 941(v) 30.10.1998 eS- esudkbaM ,uVªksesDl250 fexzk-@ xksfy;ka ¼vkbZlh,pD;w½ thih@iRrk

40. vkbZMks&Dyksjks&gkbMªksDlh&D;wuksfyu 4% Øhe 25 xzke ysdMZ 8.02 828(v) 15.06.2005 eS- bZLV bafM;k MeksZfD;wuksy4% MCY;w@MCY;w ,,y_V~;wc

41. vkbZMks&Dyksjks&gkbMªksDlh&D;wuksfyu 8% Øhe 25 xzke ysdMZ 9.40 828(v) 15.06.2005 eS- bZLV bafM;k MeksZfD;wuksy8% MCY;w@MCY;w ,,y_V~;wc

42. vkbZlh,pD;w$VksYukQVsV$tSUVkekbflu 5 xzke dh 5.52 828(v) 15.06.2005 eS- QwyQksMZ DokfMZMeZfcVkfeFkkt+ksu osyjsV Øhe V~;wc eS- lh,Q,y QkekZ VksycsVizR;sd xzke esavkbZlh,pD;w 10 fexzk-VksYukQVsV 10 fexzk-tSUVkekbflu lYQsV 1 fexzk-fcVkfeFkkt+ksu osyjsV 0.61 fexzk-

43. vkbZlh,pD;w$VksYukQVsV$tSUVkekbflu 10 xzke dh 8.22 828(v) 15.06.2005 eS- QwyQksMZ DokfMZMeZfcVkfeFkkt+ksu osyjsV Øhe V~;wcizR;sd xzke esavkbZlh,pD;w 10 fexzk-VksYukQVsV 10 fexzk-tSUVkekbflu lYQsV 1 fexzk-fcVkfeFkkt+ksu osyjsV 0.61 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 127: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 108 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

44. vkbZlh,pD;w$VksYukQVsV$tSUVkekbflu 5 xzke dh 5.24 828(v) 15.06.2005 eS- txluiky D;wblfcVkfeFkkt+ksu osyjsV Øhe V~;wcizR;sd xzke esavkbZlh,pD;w 10 fexzk-VksYukQVsV 10 fexzk-tSUVkekbflu lYQsV 1 fexzk-fcVkfeFkkt+ksu osyjsV 0.5 fexzk-

45. vkbMksDyksjks& 15 xzk- dh V~;wc 8.46 828(v) 15.06.2005gkbMªksDlhD;wuksfyu¼fpuksQkWeZ½$fcDyksfeFkkt+ksuMkbZizksfi;ksusV ØhevkbMksDyksjksgkbMªksDlhD;wuksfyu¼fpuksQkWeZ½&3% MCy;w@MCy;wfcDyksfeFkkt+ksu MkbZizksfi;ksusV&0.025% MCy;w@MCy;W

46. D;wfuMksDyksj xksfy;ka 20 dk 11.04 743(v) 19.05.2006D;wfuMksDyksj 250 fexzk- iRrk@fCyLVj

47. gkbMªksDyksjksgkbMªksDlhD;wuksfyu 10 dk 6.90 1071(v) 11.07.2006¼vkbZlh,pD;w½$¶;wjkt+ksfyMksu xksfy;ka iRrk@fCyLVjgkbMªksDyksjksgkbMªksDlhD;wuksfyu&250 fexzk-¶;wjkt+ksfyMksu&100 fexzk-

48. fpuksQkWeZ ¼vkbZlh,pD;w½ $ 5 xzke dh V~;wc 2.59 221(v) 14.02.2007fcDyksfeFkkt+ksu MkbZizksfi;ksusVØhefpuksQkWeZ ¼vkbZlh,pD;w½-3% MCY;w@ohfcDyksfeFkkt+ksuMkbZizksfi;ksusV-0.025% MCY;w@oh

49. bUl;qfyu ftad lLisUlu ¼ysuVs½&40 10 fefy dk 32.16 846(v) 09.02.199740 ;wfuV@fefy ok;y

50. bUl;qfyu vkblksQsu ¼,uih,p½&40 10 fefy dk 32.50 846(v) 09.02.199740 ;wfuV@fefy ok;y

Page 128: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 109 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

,y (L)

1. ysoksMksik xksfy;ka&500 10 dk 10.56 611(v) 27.05.2003 eS- th,lds fcMksiky500 fexzk- csl@xksfy;ka ,,y_iRrk eS- osysl ysoksik

2. ysoksMksik xksfy;ka&500 10 dk 10.12 611(v) 27.05.2003 eS- th,lds fcMksiky500 fexzk- csl@xksfy;ka ,,y_fCyLVj eS- osysl ysoksik

3. ysoksMksik vkSj dkfcZMksik xksfy;ka 10 dk 10.18 611(v) 27.05.2003 eS- esfjaM fM;ksMksikysoksMksik 100 fexzk- ,,y_iRrk eS- buVkl ,ylhMhdkfcZMksik ,UgkbMªsl 10 fexzk-@xksfy;ka eS- lu QkekZ fluMksik&110

eS- VksjsUV fVMksesV ,y,l

4. ysoksMksik vkSj dkfcZMksik xksfy;ka 10 dk 9.88 611(v) 27.05.2003

ysoksMksik 100 fexzk- ,,y_fCyLVjdkfcZMksik ,UgkbMªsl 10 fexzk-@xksfy;ka

5. ysoksMksik vkSj dkfcZMksik xksfy;ka 10 dk 20.68 611(v) 27.05.2003 eS- esfjaM fM;ksMksik IylysoksMksik 100 fexzk- ,,y_iRrk eS- buVkl ,ylhMhdkfcZMksik ,UgkbMªsl 25 fexzk-@xksfy;ka eS- lu QkekZ fluMksik Iyl

eS- VksjsUV fVMksesV Iyl

6. ysoksMksik vkSj dkfcZMksik xksfy;ka 10 dk 20.34 611(v) 27.05.2003

ysoksMksik 100 fexzk- ,,y_fCyLVjdkfcZMksik ,UgkbMªsl 25 fexzk-@xksfy;ka

7. ysoksMksik vkSj dkfcZMksik xksfy;ka 10 dk 23.80 611(v) 27.05.2003 eS- buVkl ,ylhMhysoksMksik 250 fexzk- ,,y_iRrk eS- osysl ysoksik&lhdkfcZMksik ,UgkbMªsl 25 fexzk-@xksfy;ka eS- lu QkekZ fluMksik&275

eS- VksjsUV fVMksesV QksVZ

8. ysoksMksik vkSj dkfcZMksik xksfy;ka 10 dk 23.80 611(v) 27.05.2003

ysoksMksik 250 fexzk- ,,y_fCyLVjdkfcZMksik ,UgkbMªsl 25 fexzk-@xksfy;ka

9. ysoksMksik vkSj dkfcZMksik lhvkj@,lvkj xksfy;ka 10 dk 41.70 611(v) 27.05.2003 eS- lu QkekZ fluMksik lhvkjysoksMksik 200 fexzk- ,,y_iRrkdkfcZMksik ,UgkbMªsl 50 fexzk-@lhvkj@,lvkj xksfy;ka

10. ysoksMksik vkSj dkfcZMksik lhvkj@,lvkj xksfy;ka 10 dk 41.32 611(v) 27.05.2003 eS- lu QkekZ fluMksik lhvkjysoksMksik 200 fexzk- ,,y_fCyLVjdkfcZMksik ,UgkbMªsl 50 fexzk-@lhvkj@,lvkj xksfy;ka

Page 129: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 110 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

11. ysoksMksik$dkfcZMksik$ 10 dk 46.06 1665(v) 03.10.2006

,UVkdsiksu xksfy;ksa iRrk@fCyLVjysoksMksik&50 fexzk-dkfcZMksik ¼,UgkbMªsl½&12.5 fexzk-,UVkdsiksu&200 fexzk-

12. ysoksMksik$dkfcZMksik$ 10 dk 53.14 1665(v) 03.10.2006

,UVkdsiksu xksfy;ksa iRrk@fCyLVjysoksMksik&100 fexzk-dkfcZMksik ¼,UgkbMªsl½&25 fexzk-,UVkdsiksu&200 fexzk-

13. ysoksMksik$dkfcZMksik$ 10 dk 60.64 1665(v) 03.10.2006

,UVkdsiksu xksfy;ksa iRrk@fCyLVjysoksMksik&150 fexzk-dkfcZMksik ¼,UgkbMªsl½&37.5 fexzk-,UVkdsiksu&200 fexzk-

14. fyudksekblhu xksfy;ka 10 dk iRrk@fCyLVj 11.74 187(v) 07.02.2006

fyudksekblhu&250 fexzk-

15. fyudksekblhu xksfy;ka 10 dk iRrk@fCyLVj 22.34 187(v) 07.02.2006

fyudksekblhu&500 fexzk-

16. fyudksekblhu dSilwy 10 dk 14.28 744(v) 19.05.2006 eS- LohMs bafM;k fyudkslhu250 fexzk- @dSilwy iRrk@fCyLVj eS- fcusV QkekZ fy;ksM

eS- osysl yk;uDleS- Lik;j QkekZ LiykbueS- flaVks vksjxsfud Vªhdksfyu

17. fyudksekblhu dSilwy 10 dk 25.24 744(v) 19.05.2006 eS- ,lVse ,p- ds;j ,fyu500 fexzk- @dSilwy iRrk@fCyLVj eS- Mk;ukfeu fyuflu

eS- Mhihih,y fyadkseS- LohMs bafM;k fyadksflueS- ,yUts bafM;k fyulh

18. fyudksekblhu flji 60 fefy dhs cksry 21.40 744(v) 19.05.2006 eS- osysl yk;uDl125 fexzk- @ 5 fefy ,e- di vkSj

dkVZu lfgr

19. fyudksekblhu bUtSaD’ku 1 fefy dk 6.50 187(v) 07.02.2006 eS- tsdlu ysc gk;usDl300 fexzk- @ fefy ok;y eS- tksysu esMhds;j tksfyad

eS- Mh-ih-ih-,y- fyadks

Page 130: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 111 -

20. fyudksekblhu bUtSaD’ku 1 fefy dk 4.48 744(v) 19.05.2006 eS- ck;ks lkbal fyad300 fexzk- @ fefy ,Ei;wy eS- Xykscy esMhlkbal fyadk

eS- osysl yk;uDl

21. fyudksekblhu bUtSaD’ku 2 fefy dk 7.90 187(v) 07.02.2006 eS- ,lVe ,p- ds;j ,fyu300 fexzk- @ fefy ok;y eS- bUVªkflu dkslVsi&vkbZ

eS- izksgsYFk foVkfeu fgfyad

22. fyudksekblhu bUtSaD’ku 2 fefy dk 7.46 744(v) 19.05.2006 eS- tsdlu ysc gk;usDl300 fexzk- @ fefy ,Ei;wy eS- tksysu esMhds;j tksfyad

23. fyudksekblhu tWy 10 xzke dh 5.64 744(v) 19.05.2006 eS- Mh-ih-ih-,y- fyadks2% @ xzke V~;wc eS- osysl yk;uDl

24. fyudksekblhu bUtSD’ku 2 fefy dk ok;y 6.50 1644(v) 27.09.2007

300 fexzk-@ 2 fefy

25. fyudksekblhu bUtSD’ku 2 fefy dk ,Ei;wy 4.06 1644(v) 27.09.2007

300 fexzk-@ 2 fefy

26. fyudksekblhu$ 10 dk 16.86 183(v) 29.01.2008

ysfDVd ,sflM csflyl dSilwy iRrk@fCyLVjfyudksekblhu gkbMªksDyksjkbMfyudksekblhu csl -500 fexzk- ds cjkcjysfDVd ,sflM csflyl-60 fefy;u LiksZl@dSilwy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 131: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 112 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

,e (M)

1. escgkbMªksfyu usisfMlk;ysV xksfy;ka 10 dk 3.10 18(v) 07.01.1997 eS- cs;j balhMy75 fexzk-] 50 fexzk- csl ds cjkcj@xksfy;ka thih@iRrk eS- osysl ysoksik

2. feFkk;yMksik xksfy;ka&250 10 dk 11.72 894(v) 05.06.2007 eS- VªkbZMksl ,YQkMksik250 fexzk- csl@xksfy;ka ¼lknh@?kqyu’khy½ ,,y_iRrk eS- vkbZMhih,y ,eMksik

3. feFkk;yMksik xksfy;ka&250 10 dk 11.48 894(v) 05.06.2007 eS- VªkbZMksl ,YQkMksik250 fexzk- csl@xksfy;ka ¼lknh@?kqyu’khy½,,y_fCyLVj eS- vkbZMhih,y ,eMksik

4. feFkk;yMksik xksfy;ka&250 ¼fQYe fyfir½ 10 dk 18.96 2031(v) 30.11.2007 eS- VªkbZMksl ,YQkMksikfeFkk;yMksik 250 fexzk- iRrk@fCyLVj eS- vkbZMhih,y ,eMksik,UgkbMªsl feFkk;yMksik ds cjkcj

5. eSVªksfuMkt+ksy xksfy;ka&200 10 dk 3.62 206(v) 14.02.2007 eS- ;wfud QkekZ eSVªksfty200 fexzk-@xksfy;ka ¼fQYe fyfir½ iRrk@fCyLVj eS- jksgu iksysad ¶ysfty

eS- ,ydse eSVªksueS- ,fjLVks ,fjLVksftyeS- txluiky eSVfty

6. eSVªksfuMkt+ksy xksfy;ka 10 dk 3.82 749(v) 19.05.2006

eSVªksfuMkt+ksy 250 fexzk-@xksfy;ka iRrk@fCyLVj

7. eSVªksfuMkt+ksy xksfy;ka&400 10 dk 5.94 206(v) 14.02.2007 eS- ;wfud QkekZ eSVªksfty400 fexzk-@xksfy;ka ¼fQYe fyfir½ iRrk@fCyLVj eS- jksgu iksysad ¶ysfty

eS- ,ydse eSVªksueS- ,fjLVks ,fjLVksftyeS- ;wfudse ;wfuesfty

8. eSVªksfuMkt+ksy xksfy;ka 10 dk 7.46 749(v) 19.05.2006

eSVªksfuMkt+ksy 600 fexzk-@xksfy;ka iRrk@fCyLVj

9. eSVªksfuMkt+ksy$¶;wjkt+ksfyMksu xksfy;ka 10 dk 4.72 176(v) 09.03.1998 eS- th,lds fMisUMy&,e300 fexzk-$ 100 fexzk-@xksfy;ka iRrk@fCyLVj

10. eSVªksfuMkt+ksy$¶;wjkt+ksfyMksu xksfy;ka 10 dk 6.82 942(v) 30.10.1998 eS- fudksYl ¶ysfty&,Q400 fexzk-$ 100 fexzk-@xksfy;ka ¼fyfir½ ,,y_iRrk

11. eSVªksfuMkt+ksy$¶;wjkt+ksfyMksu xksfy;ka 10 dk 6.44 942(v) 30.10.1998 eS- th,lds ¶ysfty&,Q400 fexzk-$ 100 fexzk-@xksfy;ka ¼fyfir½ ,,y_fCyLVj

12. eSVªksfuMkt+ksy$MkbZyksDlkukbM ¶;wjsV xksfy;ka 6 dk 3.82 759(v) 02.09.1998 eS- fliyk Mk;jsM&,e200 fexzk-$ 250 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj eS- vkjihth D;wfty

Page 132: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 113 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

13. eSVªksfuMkt+ksy$MkbZyksDlkukbM ¶;wjsV xksfy;ka 10 dk 6.36 759(v) 02.09.1998 eS- fliyk Mk;jsM&,e200 fexzk-$ 250 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj eS- uksy ,UVkfetksy

eS- ekijk LizksV

14. eSVªksfuMkt+ksy$MkbZyksDlkukbM ¶;wjsV xksfy;ka 15 dk 19.88 206(v) 14.02.2007 eS- ,ycVZ MsfoM ,YMstksy&Mh,Q400 fexzk-$ 500 fexzk-@xksfy;ka ¼fQYe fyfir½iRrk@fCyLVj eS- ts-ch- dsfedyl eSVªksfty dEikmaM

eS- uksy ,UVkfetksy

15. eSVªksfuMkt+ksy$usfyfMfDld ,sflM xksfy;ka 10 dk 8.42 608(v) 29.06.2001 eS- CY;w ØkWl ;wfyDl&,e100 fexzk-$ 150 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj

16. eSVªksfuMkt+ksy$usfyfMfDld ,sflM xksfy;ka 10 dk 15.34 608(v) 29.06.2001 eS- Js;k ykbQ ,fcdksu200 fexzk-$ 300 fexzk-@xksfy;ka ¼fyfir½ ,,y_iRrk eS- lh,Q,y usxkfMDl&,e

eS- ekijk LizksV&,u

17. eSVªksfuMkt+ksy$usfyfMfDld ,sflM xksfy;ka 10 dk 14.90 608(v) 29.06.2001 eS- Mk;ukfed ysc vkbtksy200 fexzk-$ 300 fexzk-@xksfy;ka ¼fyfir½ ,,y_fCyLVj eS- ,xzksu csVkfMDl

18. eSVªksfuMkt+ksy$usfyfMfDld ,sflM xksfy;ka 10 dk 21.06 608(v) 29.06.2001 eS- vjksfcUnks QkekZ ,Mh&500

200 fexzk-$ 500 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj eS- uslVj xzseksusDl

19. eSVªksfuMkt+ksy$¶;wjkt+ksfyMksu dSilwy 10 dk 8.40 1105(v) 08.12.2000 eS- Msl ,UVªks¶;wjsu&,e300 fexzk-$ 100 fexzk-@dSilwy ,,y_iRrk eS- vkbZMhih,y bulsifVu&,e,Q

20. eSVªksfuMkt+ksy$¶;wjkt+ksfyMksu dSilwy 10 dk 7.46 1105(v) 08.12.2000 eS- Msl ,UVªks¶;wjsu&,e300 fexzk-$ 100 fexzk-@dSilwy ,,y_fCyLVj eS- vkbZMhih,y bulsifVu&,e,Q

21. eSVªksfuMkt+ksy$¶;wjkt+ksfyMksu$ 10 dk 6.66 142(v) 31.01.2002 eS- tkulu ,aM tkulu¶;wesfMyMkbZlkbDyksekbu dSilwy ,,y_iRrkeSVªksfuMkt+ksy 200 fexzk-¶;wjkt+ksfyMksu 50 fexzk-MkbZlkbDyksekbu ,plh,y 10 fexzk-@dSilwy

22. eSVªksfuMkt+ksy$¶;wjkt+ksfyMksu$ 10 dk 6.14 142(v) 31.01.2002 eS- tkulu ,aM tkulu¶;wesfMyMkbZlkbDyksekbu dSilwy ,,y_fCyLVjeSVªksfuMkt+ksy 200 fexzk-¶;wjkt+ksfyMksu 50 fexzk-MkbZlkbDyksekbu ,plh,y 10 fexzk-@dSilwy

23. eSVªksfuMkt+ksy$uksj¶yksDlhu xksfy;ka 10 dk 4.04 1335(v) 16.09.2005 eS- CY;w ØkWl uksjlsQ&,e100 fexzk-$ 100 fexzk-@xksfy;ka iRrk@fCyLVj eS- bZLV vQjhdu uksVh fdM

Page 133: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 114 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

24. eSVªksfuMkt+ksy$uksj¶yksDlhu xksfy;ka 10 dk 7.22 1335(v) 16.09.2005 eS- ,fjLVks QkekZ csflfty&,u200 fexzk-$ 200 fexzk-@xksfy;ka iRrk@fCyLVj eS- Js;k ykbQlkbal Dykld

eS- QkbuD;wjk Qsuhfty

25. eSVªksfuMkt+ksy$uksj¶yksDlhu xksfy;ka 10 dk 8.44 1335(v) 16.09.2005 eS- fdeks MªXl yksDlkesV300 fexzk-$ 200 fexzk-@xksfy;ka iRrk@fCyLVj

26. eSVªksfuMkt+ksy$uksj¶yksDlhu xksfy;ka 10 dk 8.88 1335(v) 16.09.2005

250 fexzk-$ 250 fexzk-@xksfy;ka iRrk@fCyLVj

27. eSVªksfuMkt+ksy$uksj¶yksDlhu xksfy;ka 10 dk 10.36 1335(v) 16.09.2005

300 fexzk-$ 300 fexzk-@xksfy;ka iRrk@fCyLVj

28. eSVªksfuMkt+ksy$uksj¶yksDlhu xksfy;ka 10 dk 13.38 766(v) 19.05.2006 eS- vkjczks QkekZ uksfdu Iyl400 fexzk-$ 400 fexzk-@xksfy;ka iRrk@fCyLVj

29. eSVªksfuMkt+ksy$uksj¶yksDlhu xksfy;ka 10 dk 15.14 431(v) 23.03.2007 eS- fudksYl psdesV500 fexzk-$ 400 fexzk-@xksfy;ka iRrk@fCyLVj eS- uksfjl ¶yksDlhuksj&,e

eS- jsDlVj xzseksfty

30. eSVªksfuMkt+ksy$uksj¶yksDlhu xksfy;ka 10 dk 15.46 766(v) 19.05.2006 eS- LVsMdse bysDVªksfty600 fexzk-$ 400 fexzk-@xksfy;ka iRrk@fCyLVj eS- QkekZflUFk uksjeksfty

eS- fdeks MªXl yksDlkesV QksVZ

31. eSVªksfuMkt+ksy$uksj¶yksDlhu$ 10 dk 4.48 1335(v) 16.09.2005

ysfDVd ,sflM csflyl xksfy;ka iRrk@fCyLVj100 fexzk-$ 100 fexzk-$60 fefy;u LiksZl@xksfy;ka

32. eSVªksfuMkt+ksy$uksj¶yksDlhu xksfy;ka 10 dk 4.14 1335(v) 16.09.2005 eS- fdeks MªXl yksDlkesV MhVh100 fexzk-$ 100 fexzk-@?kqyu’khy xksfy;kaiRrk@fCyLVj

33. eSVªksfuMkt+ksy$MkbZyksDlkukbM 10 dk iRrk@fCyLVj 11.36 749(v) 19.05.2006

¶;wjsV$MkbZlkbdyksekbu xksfy;kaeSVªksfuMkt+ksy&400 fexzk-MkbZyksDlkukbM ¶;wjsV&500 fexzk-MkbZlkbdyksekbu&10 fexzk-

34. eSVªksfuMkt+ksy$MkbZyksDlkukbM 10 dk iRrk@fCyLVj 11.26 749(v) 19.05.2006

¶;wjsV$lkbesfFkdksu xksfy;kaeSVªksfuMkt+ksy&400 fexzk-MkbZyksDlkukbM ¶;wjsV&500 fexzk-lkbesfFkdksu&100 fexzk-

Page 134: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 115 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

35. eSVªksfuMkt+ksy$MkbZyksDlkukbM 4 dk iRrk@fCyLVj 4.48 749(v) 19.05.2006

¶;wjsV$,DVhosVM MkbZfeFkk;yiksfyflyksDlse xksfy;kaeSVªksfuMkt+ksy&400 fexzk-MkbZyksDlkukbM ¶;wjsV&500 fexzk-,DVhosVM MkbZfeFkk;y iksfyflyksDlse&25 fexzk-

36. eSVªksfuMkt+ksy$MkbZyksDlkukbM 15 dk iRrk@fCyLVj 16.52 749(v) 19.05.2006

¶;wjsV$MkbZesfFkdksu xksfy;kaeSVªksfuMkt+ksy&400 fexzk-MkbZyksDlkukbM ¶;wjsV&500 fexzk-MkbZesfFkdksu&50 fexzk-

37. eSVªksfuMkt+ksy$¶;wjktksfyMksu$ 10 dk iRrk@fCyLVj 6.26 749(v) 19.05.2006

csjcsjhu ,plh,y+$csykMksuk ,sYdkyksbM xksfy;kaeSVªksfuMkt+ksy&200 fexzk-¶;wjktksfyMksu&100 fexzk-csjcsjhu ,plh,y&20 fexzk-csykMksuk ,sYdkyksbM&125 fexzk-

38. esVªksfuMkt+ksy$usfyfMfDld 10 dk iRrk@fCyLVj 16.48 1672(v) 03.10.2006

,sflM xksfy;kaesVªksfuMkt+ksy&400 fexzk-usfyfMfDld ,sflM&300 fexzk-

39. esVªksfuMkt+ksy$VsVªklkbdfyu 10 dk iRrk@fCyLVj 10.37 1672(v) 03.10.2006

,plh,y dSilwyizR;sd dSilwy esaesVªksfuMkt+ksy&400 fexzk-VsVªklkbdfyu ,plh,y&333 fexzk-

40. eSVªksfuMkt+ksy$Mk;yksDlkekbM 15 dh cksry 12.90 1672(v) 03.10.2006

¶;wjsV xksfy;kaeSVªksfuMkt+ksy&200 fexzk-Mk;yksDlkekbM ¶;wjsV&250 fexzk-@xksfy;ka

41. eSVªksfuMkt+ksy$DyksfVªekt+ksy$ 10 dk 8.08 1672(v) 03.10.2006

ysfDVd ,sflM csflyl xksfy;ka iRrk@fCyLVjizR;sd osftuy xksfy;ksa esaeSVªksfuMkt+ksy&500 fexzk-DyksfVªekt+ksy&100 fexzk-ysfDVd ,sflM csflyl&150 fefy;u LiksZl

Page 135: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 116 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

42. eSVªksfuMkt+ksy$uksj¶yksDlhu xksfy;ka 10 dk 14.46 1924(v) 08.11.2006

izR;sd ?kqyu’khy xksfy;ksa esa iRrk@fCyLVjeSVªksfuMkt+ksy&500 fexzk-uksj¶yksDlhu&400 fexzk-

43. eSVªksfuMkt+ksy$DyksfVªekt+ksy 45 xzke dh 18.02 1924(v) 08.11.2006

Øhe@vkW;uVeSaV V~;wc@tkjeSVªksfuMkt+ksy&10% MCY;w@MCY;wDyksfVªekt+ksy&2% MCY;w@MCY;w@xzke

44. eSVªksfuMkt+ksy Øhe@tWy 30 xzke dh 9.20 749(v) 19.05.2006

eSVªksfuMkt+ksy 10 fexzk-@xzke V~;wc

45. eSVªksfuMkt+ksy bUtsD’ku vkbZoh@vkbZ,e&500 100 fefy 15.70 761(v) 02.09.1998 eS- ts-ch- dsfedyl eSVªksfty IV

5 fexzk-@ fefy dk¡p dh cksry eS- oksdkMZ eSVªksfuMkt+ksy bUQleS- fliyk eSVªksflieS- ,ycVZ MsfoM ,YMstksy

46. eSVªksfuMkt+ksy bUtsD’ku vkbZoh@vkbZ,e&500 100 fefy dk 16.10 431(v) 23.03.2007 eS- dysfjl ykbQlkbaleSVªksfuMkt+ksy bUQl5 fexzk-@ fefy IykfLVd@,pMhihbZ cksry eS- csdLVj eSVªksfuMkt+ksy bUQl

47. eSVªksfuMkt+ksy csUtq,V flji@lLisUlu 30 fefy dh 5.82 1234(v) 19.12.2001 eS- ;wfud QkekZ eSVªksftyeSVªksfuMkt+ksy 100 fexzk- cksry eS- ts-ch- dsfedyl eSVªksfty¼csUtq,V ds cjkcj½ @ 5 fefy eS- ,ydse eSVªksu

48. eSVªksfuMkt+ksy csUtq,V flji@lLisUlu 60 fefy dh 6.30 1234(v) 19.12.2001

eSVªksfuMkt+ksy 100 fexzk- cksry ,e-di lfgr¼csUtq,V ds cjkcj½ @ 5 fefy

49. eSVªksfuMkt+ksy csUtq,V flji@lLisUlu 60 fefy dh 8.60 1234(v) 19.12.2001 eS- ;wfud QkekZ eSVªksftyeSVªksfuMkt+ksy 100 fexzk- cksry eS- ,ydse eSVªksu¼csUtq,V ds cjkcj½ @ 5 fefy eS- ,fjLVks ,fjLVksfty

eS- ekijk ysc LizksV&ih

50. eSVªksfuMkt+ksy csUtq,V flji@lLisUlu 60 fefy dh 9.08 1234(v) 19.12.2001 eS- ;wfud QkekZ eSVªksftyeSVªksfuMkt+ksy 100 fexzk- cksry ,e-di lfgr eS- ,ydse eSVªksu¼csUtq,V ds cjkcj½ @ 5 fefy eS- ,fjLVks ,fjLVksfty

eS- ekijk ysc LizksV&ih

51. eSVªksfuMkt+ksy csUtq,V flji@lLisUlu 30 fefy dh 6.72 853(v) 25.07.2003 eS- ;wfud QkekZ eSVªksftyeSVªksfuMkt+ksy 200 fexzk- cksry eS- jksgu iksysad ¶ysfty¼csUtq,V ds cjkcj½ @ 5 fefy eS- ,ydse eSVªksu

eS- ,fjLVks ,fjLVksftyeS- ;wfudse ;wuhestksy

Page 136: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 117 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

52. eSVªksfuMkt+ksy flji@lLisUlu 30 fefy dh 8.46 206(v) 14.02.2007 eS- ;wfud QkekZ eSVªksfty lLisUlueSVªksfuMkt+ksy 200 fexzk- cksry ,e-di lfgr eS- jksgu iksysad ¶ysfty¼csUtq,V ds cjkcj½ @ 5 fefy eS- ,ydse eSVªksu

eS- ,fjLVks ,fjLVksftyeS- ;wfudse ;wuhestksy

53. eSVªksfuMkt+ksy csUtq,V flji@lLisUlu 60 fefy dh 10.44 1234(v) 19.12.2001 eS- jksgu iksysad ¶ysftyeSVªksfuMkt+ksy 200 fexzk- cksry eS- ,ydse eSVªksu¼csUtq,V ds cjkcj½ @ 5 fefy eS- ;wfudse ;wuhestksy

eS- ;wfud QkekZ eSVªksftyeS- ,ycVZ MsfoM ,yMstksy

54. eSVªksfuMkt+ksy csUtq,V flji@lLisUlu 60 fefy dh 12.74 206(v) 14.02.2007 eS- jksgu iksysad ¶ysftyeSVªksfuMkt+ksy 200 fexzk- cksry ,e-di lfgr eS- ,ydse eSVªksu¼csUtq,V ds cjkcj½ @ 5 fefy eS- ;wfudse ;wuhestksy

eS- ;wfud QkekZ eSVªksftyeS- ,ycVZ MsfoM ,yMstksy

55. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 7.46 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksryeSVªksfuMkt+ksy 50 fexzk-¼csUtq,V ds cjkcj½ $ 40 fexzk-@ 5 fefy

56. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 7.94 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksry ,e-dieSVªksfuMkt+ksy 50 fexzk- lfgr¼csUtq,V ds cjkcj½ $ 40 fexzk-@ 5 fefy

57. eSVªksfuMkt+ksy csUtq,V$ 500 fefy dh 34.18 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksryeSVªksfuMkt+ksy 50 fexzk-¼csUtq,V ds cjkcj½ $ 40 fexzk-@ 5 fefy

58. eSVªksfuMkt+ksy csUtq,V$ 500 fefy dh 34.66 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksry ,e-dieSVªksfuMkt+ksy 50 fexzk- lfgr¼csUtq,V ds cjkcj½ $ 40 fexzk-@ 5 fefy

59. eSVªksfuMkt+ksy csUtq,V$ 50 fefy dh 6.78 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksryeSVªksfuMkt+ksy 75 fexzk-¼csUtq,V ds cjkcj½ $ 25 fexzk-@ 5 fefy

Page 137: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 118 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

60. eSVªksfuMkt+ksy csUtq,V$ 50 fefy dh 7.26 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksry ,e-di lfgreSVªksfuMkt+ksy 75 fexzk-¼csUtq,V ds cjkcj½ $ 25 fexzk-@ 5 fefy

61. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 7.82 1234(v) 19.12.2001 eS- ck;ksVsd QkekZ Mk;lQj&,e¶;wjkt+ksfyMksu flji@lLisUlu cksryeSVªksfuMkt+ksy 75 fexzk-¼csUtq,V ds cjkcj½ $ 25 fexzk-@ 5 fefy

62. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 8.30 1234(v) 19.12.2001 eS- ck;ksVsd QkekZ Mk;lQj&,e¶;wjkt+ksfyMksu flji@lLisUlu cksry ,e-di lfgreSVªksfuMkt+ksy 75 fexzk-¼csUtq,V ds cjkcj½ $ 25 fexzk-@ 5 fefy

63. eSVªksfuMkt+ksy csUtq,V$ 50 fefy dh 7.18 1234(v) 19.12.2001 eS- baMksdks eSVªksfty&,Q¶;wjkt+ksfyMksu flji@lLisUlu cksryeSVªksfuMkt+ksy 100 fexzk-¼csUtq,V ds cjkcj½ $ 30/35 fexzk-@ 5 fefy

64. eSVªksfuMkt+ksy csUtq,V$ 50 fefy dh 7.66 1234(v) 19.12.2001 eS- baMksdks eSVªksfty&,Q¶;wjkt+ksfyMksu flji@lLisUlu cksry ,e-di lfgreSVªksfuMkt+ksy 100 fexzk-¼csUtq,V ds cjkcj½ $ 30/35 fexzk-@ 5 fefy

65. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 8.30 1234(v) 19.12.2001 eS- fudksYl ¶ysfty&,Q¶;wjkt+ksfyMksu flji@lLisUlu cksry eS- dksijsu fVuh&,QeSVªksfuMkt+ksy 100 fexzk- eS- ,xyksesM fMxyks¼csUtq,V ds cjkcj½ $ 30/35 fexzk-@ 5 fefy eS- ts ,aM ts ¶;wesfMy

66. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 8.78 1234(v) 19.12.2001 eS- fudksYl ¶ysfty&,Q¶;wjkt+ksfyMksu flji@lLisUlu cksry ,e-di lfgr eS- dksijsu fVuh&,QeSVªksfuMkt+ksy 100 fexzk- eS- ,xyksesM fMxyks¼csUtq,V ds cjkcj½ $ 30/35 fexzk-@ 5 fefy eS- ts ,aM ts ¶;wesfMy

67. eSVªksfuMkt+ksy csUtq,V$ 1000 fefy dh 76.42 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksryeSVªksfuMkt+ksy 100 fexzk-¼csUtq,V ds cjkcj½ $ 30/35 fexzk-@ 5 fefy

68. eSVªksfuMkt+ksy csUtq,V$ 1000 fefy dh 76.90 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksry ,e-di lfgreSVªksfuMkt+ksy 100 fexzk-¼csUtq,V ds cjkcj½ $ 30/35 fexzk-@ 5 fefy

Page 138: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 119 -

69. eSVªksfuMkt+ksy csUtq,V$ 50 fefy dh 7.24 1234(v) 19.12.2001 eS- QkekZflUFk ,aVhfty&,Q¶;wjkt+ksfyMksu flji@lLisUlu cksryeSVªksfuMkt+ksy 100 fexzk-¼csUtq,V ds cjkcj½ $ 40 fexzk-@ 5 fefy

70. eSVªksfuMkt+ksy csUtq,V$ 50 fefy dh 7.72 1234(v) 19.12.2001 eS- QkekZflUFk ,aVhfty&,Q¶;wjkt+ksfyMksu flji@lLisUlu cksry ,e-di lfgreSVªksfuMkt+ksy 100 fexzk-¼csUtq,V ds cjkcj½ $ 40 fexzk-@ 5 fefy

71. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 9.36 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksryeSVªksfuMkt+ksy 100 fexzk-¼csUtq,V ds cjkcj½ $ 75 fexzk-@ 5 fefy

72. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 9.84 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksry ,e-di lfgreSVªksfuMkt+ksy 100 fexzk-¼csUtq,V ds cjkcj½ $ 75 fexzk-@ 5 fefy

73. eSVªksfuMkt+ksy csUtq,V$ 450 fefy dh 45.70 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksryeSVªksfuMkt+ksy 100 fexzk-¼csUtq,V ds cjkcj½ $ 75 fexzk-@ 5 fefy

74. eSVªksfuMkt+ksy csUtq,V$ 450 fefy dh 46.18 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksry ,e-di lfgreSVªksfuMkt+ksy 100 fexzk-¼csUtq,V ds cjkcj½ $ 75 fexzk-@ 5 fefy

75. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 9.40 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksryeSVªksfuMkt+ksy 160 fexzk-¼csUtq,V ds cjkcj½ $ 30 fexzk-@ 5 fefy

76. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 9.88 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksry ,e-di lfgreSVªksfuMkt+ksy 160 fexzk-¼csUtq,V ds cjkcj½ $ 30 fexzk-@ 5 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 139: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 120 -

77. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 10.80 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksryeSVªksfuMkt+ksy 200 fexzk-¼csUtq,V ds cjkcj½ $ 40 fexzk-@ 5 fefy

78. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 11.28 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksry ,e-di lfgreSVªksfuMkt+ksy 200 fexzk-¼csUtq,V ds cjkcj½ $ 40 fexzk-@ 5 fefy

79. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 10.94 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksryeSVªksfuMkt+ksy 200 fexzk-¼csUtq,V ds cjkcj½ $ 60 fexzk-@ 5 fefy

80. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 11.42 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksry ,e-di lfgreSVªksfuMkt+ksy 200 fexzk-¼csUtq,V ds cjkcj½ $ 60 fexzk-@ 5 fefy

81. eSVªksfuMkt+ksy csUtq,V$ 50 fefy dh 9.04 1234(v) 19.12.2001

MkbZyksDlkukbM ¶;wjsV flji@lLisUlu cksryeSVªksfuMkt+ksy 200 fexzk-¼csUtq,V ds cjkcj½ $ 250 fexzk-@ 10 fefy

82. eSVªksfuMkt+ksy csUtq,V$ 50 fefy dh 9.52 1234(v) 19.12.2001

MkbZyksDlkukbM ¶;wjsV flji@lLisUlu cksry ,e-di lfgreSVªksfuMkt+ksy 200 fexzk-¼csUtq,V ds cjkcj½ $ 250 fexzk-@ 10 fefy

83. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 10.52 1234(v) 19.12.2001 eS- ,cksV ,aVkfet+ksyMkbZyksDlkukbM ¶;wjsV flji@lLisUlu cksryeSVªksfuMkt+ksy 200 fexzk-¼csUtq,V ds cjkcj½ $ 250 fexzk-@ 10 fefy

84. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 11.00 1234(v) 19.12.2001 eS- ,cksV ,aVkfet+ksyMkbZyksDlkukbM ¶;wjsV flji@lLisUlu cksry ,e-di lfgreSVªksfuMkt+ksy 200 fexzk-¼csUtq,V ds cjkcj½ $ 250 fexzk-@ 10 fefy

85. eSVªksfuMkt+ksy$usfyfMfDld ,sflM lLisUlu 30 fefy 8.96 608(v) 29.06.2001 eS- th,lds ,cMksfty&,u100 fexzk- ¼csUtq,V ds cjkcj½ $ dh cksry eS- flj;k ykbQlkbal ,fcdksu150 fexzk-@ 5 fefy eS- jsucsDlh xzseksusx&,e

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 140: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 121 -

86. eSVªksfuMkt+ksy$usfyfMfDld ,sflM lLisUlu 30 fefy dh 9.44 608(v) 29.06.2001 eS- uslVj xzseksusDl&lh100 fexzk- ¼csUtq,V ds cjkcj½ $ cksry ,e-di lfgr eS- esfMdkesu esDlhfty150 fexzk-@ 5 fefy

87. eSVªksfuMkt+ksy$usfyfMfDld ,sflM lLisUlu 60 fefy 14.84 608(v) 29.06.2001 eS- ,ydse ,YMkxzke100 fexzk- ¼csUtq,V ds cjkcj½ $ dh cksry eS- fou esfMds;j csDVksesV&lh150 fexzk-@ 5 fefy

88. eSVªksfuMkt+ksy$usfyfMfDld ,sflM lLisUlu 6fefy dh 15.32 608(v) 29.06.2001 eS- jsucsdlh xzseksusx&,e100 fexzk- ¼csUtq,V ds cjkcj½ $ cksry ,e-di lfgr eS- lh,Q,y usxkfMDl&,e150 fexzk-@ 5 fefy eS- ch bZ usfyfMl

89. eSVªksfuMkt+ksy$usfyfMfDld ,sflM lLisUlu 40 fefy 10.72 608(v) 29.06.2001

100 fexzk- ¼csUtq,V ds cjkcj½ $ dh cksry150 fexzk-@ 5 fefy

90. eSVªksfuMkt+ksy$usfyfMfDld ,sflM lLisUlu 40 fefy dh 11.20 608(v) 29.06.2001

100 fexzk- ¼csUtq,V ds cjkcj½ $ cksry ,e-di lfgr150 fexzk-@ 5 fefy

91. eSVªksfuMkt+ksy$usfyfMfDld ,sflM flji 50 fefy dh 12.64 608(v) 29.06.2001 eS- Mk;ukfed ysc vkbtksy100 fexzk- $ 150 fexzk-@ 5 fefy cksry

92. eSVªksfuMkt+ksy$usfyfMfDld ,sflM flji 50 fefy dh 13.12 608(v) 29.06.2001 eS- Mk;ukfed ysc vkbtksy100 fexzk- $ 150 fexzk-@ 5 fefy cksry ,e-di lfgr

93. eSVªksfuMkt+ksy$usfyfMfDld ,sflM flji 60 fefy dh 16.44 852(v) 25.07.2003 eS- vkjihth D;wfty&,u200 fexzk- $ 150 fexzk-@ 5 fefy cksry

94. eSVªksfuMkt+ksy$usfyfMfDld ,sflM flji 60 fefy dh 16.92 852(v) 25.07.2003 eS- vkjihth D;wfty&,u200 fexzk- $ 150 fexzk-@ 5 fefy cksry ,e-di lfgr

95. eSVªksfuMkt+ksy$usfyfMfDld ,sflM flji 60 fefy dh 22.76 852(v) 25.07.2003 eS- uslVj xzseksusDl200 fexzk- $ 300 fexzk-@ 5 fefy cksry eS- fou esfMds;j csDVksesV

96. eSVªksfuMkt+ksy$usfyfMfDld ,sflM flji 60 fefy dh 23.24 852(v) 25.07.2003 eS- uslVj xzseksusDl200 fexzk- $ 300 fexzk-@ 5 fefy cksry ,e-di lfgr eS- fou esfMds;j csDVksesV

97. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 9.52 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksryeSVªksfuMkt+ksy csUtq,VeSVªksfuMkt+ksy 100 fexzk- ds cjkcj¶;wjkt+ksfyMksu 37.5 fexzk-isdfVax 75 fexzk-ykbV ds;ksfyu 50 fexzk-@ 5 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 141: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 122 -

98. eSVªksfuMkt+ksy csUtq,V$ 60 fefy dh 10.00 1234(v) 19.12.2001

¶;wjkt+ksfyMksu flji@lLisUlu cksry ,e-di lfgreSVªksfuMkt+ksy csUtq,VeSVªksfuMkt+ksy 100 fexzk- ds cjkcj¶;wjkt+ksfyMksu 37.5 fexzk-isdfVax 75 fexzk-ykbV ds;ksfyu 50 fexzk-@ 5 fefy

99. eSVªksfuMkt+ksy$MkbZyksDlkukbM 100 fefy dh 15.30 1354(v) 16.09.2005

¶;wjsV lLisUlu cksry100 fexzk- csUtq,V esa $ 125 fexzk-@5 fefy

100. eSVªksfuMkt+ksy$MkbZyksDlkukbM 100 fefy dh 15.78 1354(v) 16.09.2005

¶;wjsV lLisUlu cksry ,e-di100 fexzk- csUtq,V esa $ 125 fexzk-@5 fefy lfgr

101. eSVªksfuMkt+ksy$ 30 fefy dh cksry 10.54 431(v) 23.03.2007 eS- ,fjLVks csflfty&,uuksj¶yksDlhu lLisUlu@flji ,e- di lfgr eS- lu QkekZ Mk;ck&,e100 fexzk- csUtq,V esa $ 100 fexzk-@ 5 fefy eS- QkbuD;wj QkekZ Qsuhfty

102. eSVªksfuMkt+ksy$uksj¶yksDlhu$ 30 fefy dh cksry 9.04 1335(v) 16.09.2005 eS- ftuks QkekZ ftuksfty&,ulkbesfFkdksu lLisUlu@flji ,e- di lfgr eS- jsdLVj xzseksfty

100 fexzk- csUtq,V esa $ 100 fexzk-$10 fexzk-@ 5 fefy

103. eSVªksfuMkt+ksy$ 60 fefy dh cksry 13.90 1335(v) 16.09.2005 eS- ,fjLVks csflfty&,uuksj¶yksDlhu lLisUlu@flji ,e- di lfgr eS- fudksYl ¶ysftuksj100 fexzk- csUtq,V esa $ 100 fexzk-@ 5 fefy eS- czkWu esVuy

104. eSVªksfuMkt+ksy$ 30 fefy dh cksry 9.22 1335(v) 16.09.2005 eS- Mk;ukfed esVuksjuksj¶yksDlhu lLisUlu@flji ,e- di lfgr125 fexzk- csUtq,V esa $ 100 fexzk-@ 5 fefy

105. eSVªksfuMkt+ksy$ 30 fefy dh cksry 9.42 1335(v) 16.09.2005 eS- LVsMdse bysDVksftyuksj¶yksDlhu lLisUlu@flji ,e- di lfgr150 fexzk- csUtq,V esa $ 100 fexzk-@ 5 fefy

106. eSVªksfuMkt+ksy$ 30 fefy dh cksry 9.82 1335(v) 16.09.2005 eS- uksjfMd QkekZ yksesV Iyluksj¶yksDlhu lLisUlu@flji ,e- di lfgr200 fexzk- csUtq,V esa $ 100 fexzk-@ 5 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 142: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 123 -

107. esVªksfuMkt+ksy$uksj¶yksDlklhu 60 fefy dh cksry 15.50 1335(v) 16.09.2005

lLiSUlu@flji ,e- di lfgresVªksfuMkt+ksy ¼csUtq,sVds leku½&200 fexzk-uksj¶yksDlklhu&100 fexzk-@5 fefy

108. esVªksfuMkt+ksy$uksj¶yksDlklhu 30 fefy dh cksry 11.40 1335(v) 16.09.2005

lLiSUlu@flji ,e- di lfgresVªksfuMkt+ksy ¼csUtq,sVds leku½&400 fexzk-uksj¶yksDlklhu&100 fexzk-@5 fefy

109. esVªksfuMkt+ksy$uksj¶yksDlklhu 60 fefy dh cksry 18.68 1335(v) 16.09.2005

lLiSUlu@flji ,e- di lfgresVªksfuMkt+ksy ¼csUtq,sVds leku½&400 fexzk-uksj¶yksDlklhu&100 fexzk-@5 fefy

110. uksj¶yksDlklhu$esVªksfuMkt+ksy 30 fefy dh cksry 9.60 1335(v) 16.09.2005

lLiSUlu@flji ,e- di lfgresVªksfuMkt+ksy ¼csUtq,sVds leku½&100 fexzk-uksj¶yksDlklhu&150 fexzk-@5 fefy

111. esVªksfuMkt+ksy$uksj¶yksDlklhu 30 fefy dh cksry 10.96 1335(v) 16.09.2005

lLiSUlu@flji ,e- di lfgresVªksfuMkt+ksy ¼csUtq,sVds leku½&200 fexzk-uksj¶yksDlklhu&200 fexzk-@5 fefy

112. esVªksfuMkt+ksy$uksj¶yksDlklhu 60 fefy dh cksry 17.78 1335(v) 16.09.2005

lLiSUlu@flji ,e- di lfgresVªksfuMkt+ksy ¼csUtq,sVds leku½&200 fexzk-uksj¶yksDlklhu&200 fexzk-@5 fefy

113. esVªksfuMkt+ksy$uksj¶yksDlklhu 30 fefy dh cksry 14.86 1335(v) 16.09.2005lLiSUlu@flji ,e- di lfgresVªksfuMkt+ksy ¼csUtq,sVds leku½&400 fexzk-uksj¶yksDlklhu&400 fexzk-@5 fefy

114. eSVªksfuMkt+ksy$vks¶yksDlhu lLisUlu 30 fefy dh cksry 10.26 174(v) 07.02.2006 eS- csLVksdse csLVks¶yksDleSVªksfuMkt+ksy csUtq,V ,e- di lfgr eS- banq MªXl vksQsflu&,e,u100 fexzk- eSVªksfuMkt+ksy ds cjkcj eS- bZLV vQjhdu vksQsy&lhVhvks¶yksDlhu 50 fexzk-@ 5 fefy eS- ,xyksesM vks¶ykesM&,e,u

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 143: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 124 -

115. eSVªksfuMkt+ksy$vks¶yksDlhu lLisUlu 60 fefy dh cksry 16.14 174(v) 07.02.2006 eS- fl;jk QkekZ lsjyksDl&,eeSVªksfuMkt+ksy csUtq,V ,e- di lfgr eS- ,afMd ykbQlkbal ,aMks&,e100 fexzk- eSVªksfuMkt+ksy ds cjkcj eS- ,lsaV ysc vkslsaV&,evks¶yksDlhu 50 fexzk-@ 5 fefy eS- ,lchih gsYFkds;j vks¶yksfDlu&,e

116. eSVªksfuMkt+ksy$vks¶yksDlhu lLisUlu 30 fefy dh cksry 13.04 174(v) 07.02.2006 eS- LohQ~V esfMds;j vks¶ykLohQ~V&,eeSVªksfuMkt+ksy csUtq,V ,e- di lfgr eS- uksjfMd QkekZ vks¶yks&,e200 fexzk- eSVªksfuMkt+ksy ds cjkcj eS- izksfQd vksjxsfud vks¶Ve&,evks¶yksDlhu 100 fexzk-@ 5 fefy eS- uksjosLV vksjksesV

eS- ck;ksLVªkl vksVªkl ,e 2

117. eSVªksfuMkt+ksy$vks¶yksDlhu lLisUlu 60 fefy dh cksry 21.70 174(v) 07.02.2006

eSVªksfuMkt+ksy csUtq,V ,e- di lfgr200 fexzk- eSVªksfuMkt+ksy ds cjkcjvks¶yksDlhu 100 fexzk-@ 5 fefy

118. eSVªksfuMkt+ksy$ 60 fefy dh cksry 12.36 749(v) 19.05.2006

¶;wjktksfyMksu$ ,e- di lfgrlkbesfFkdksu lLiSUlueSVªksfuMkt+ksy&100 fexzk-¶;wjktksfyMksu&33 fexzk-lkbesfFkdksu&25 fexzk-@5 fefy

119. eSVªksfuMkt+ksy$ 60 fefy dh cksry 12.60 749(v) 19.05.2006

MkbZyksDlkukbM ¶;wjsV$ ,e- di lfgrlkbesfFkdksu lLiSUlueSVªksfuMkt+ksy&100 fexzk-MkbZyksDlkukbM ¶;wjsV&125 fexzk-lkbesfFkdksu&50 fexzk-@5 fefy

120. eSVªksfuMkt+ksy$ 60 fefy dh cksry 10.18 749(v) 19.05.2006

¶;wjktksfyMksu$lkbesfFkdksu fljieSVªksfuMkt+ksy csUtq,V&100 fexzk-¶;wjktksfyMksu&30 fexzk-lkbesfFkdksu&20 fexzk-@5 fefy

121. eSVªksfuMkt+ksy$ 60 fefy dh cksry 10.04 1070(v) 11.07.2006

¶;wjktksfyMksu lLiSUlu ,e- di lfgreSVªksfuMkt+ksy&100 fexzk-¶;wjktksfyMksu&30 fexzk-@5 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 144: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 125 -

122. eSVªksfuMkt+ksy$ 30 fefy dh cksry 7.46 1672(v) 03.10.2006¶;wjktksfyMksu lLiSUlu ,e- di lfgreSVªksfuMkt+ksy&100 fexzk-¶;wjktksfyMksu&30 fexzk-@5 fefy

123. eSVªksfuMkt+ksy$ 30 fefy dh cksry 7.54 1672(v) 03.10.2006¶;wjktksfyMksu lLiSUlu ,e- di lfgreSVªksfuMkt+ksy&200 fexzk-¶;wjktksfyMksu&40 fexzk-@5 fefy

124. esVªksfuMkt+ksy$MkbZyksDlkukbM 112 fefy dh cksry 15.28 216(v) 14.02.2007¶;wjsV lLisUlu ,e- di lfgresVªksfuMkt+ksy -100 fexzk-MkbZyksDlkukbM ¶;wjsV -125 fexzk-

125. esVªksfuMkt+ksy$MkbZyksDlkukbM 50 fefy dh cksry 8.25 216(v) 14.02.2007¶;wjsV lLisUlu ,e- di lfgresVªksfuMkt+ksy -100 fexzk-MkbZyksDlkukbM ¶;wjsV -125 fexzk-

126. esVªksfuMkt+ksy$ 450 fefy dh 60.58 445(v) 23.03.2007¶;wjktksfyMksu$,DVhosVsM cksryMkbZesfFkdksu flji@lLisUluesVªksfuMkt+ksy csUtq,sVesVªksfuMkt+ksy -100 fexzk- ds cjkcj¶;wjktksfyMksu -30 fexzk-,DVhosVsM MkbZesfFkdksu - 20 fexzk-

127. esVªksfuMkt+ksy$ 60 fefy dh cksry 20.30 445(v) 23.03.2007vks¶yksDlhu flji@lLisUluesVªksfuMkt+ksy csUtq,sVesVªksfuMkt+ksy -100 fexzk- ds cjkcjvks¶yksDlhu -100 fexzk-

128. esVªksfuMkt+ksy$Mk;yksDlkukbM ¶;wjsV$ 10 dk 6.42 1645(v) 27.09.2007iksfyMhfEFkk;y flyksDlsu xksfy;ka iRrk@fCyLVjesVªksfuMkt+ksy -200 fexzk-Mk;yksDlkukbM ¶;wjsV-250 fexzk-iksfyMhfEFkk;y flyksDlsu -25 fexzk-

129. esVªksfuMkt+ksy$¶;wjktksfyMksu$ 10 dk 4.48 1645(v) 27.09.2007Mk;lkbDyksekbu xksfy;ka iRrk@fCyLVjesVªksfuMkt+ksy -200 fexzk-¶;wjktksfyMksu-50 fexzk-Mk;lkbDyksekbu-20 fexzk-

130. esVªksfuMkt+ksy$VsVªklkbdfyu 10 dk 9.00 1645(v) 27.09.2007,plh,y xksfy;ka iRrk@fCyLVjesVªksfuMkt+ksy -400 fexzk-VsVªklkbdfyu ,plh,y -300 fexzk-izR;sd xzke esa

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 145: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 126 -

131. esVªksfuMkt+ksy$lwØksYQsV Øhe 20 xzke dh 7.90 2056(v) 30.11.2007esVªksfuMkt+ksy-1% MCY;w@MCY;w V~;wclwØksYQsV-7% MCY;w@MCY;w

132. esVªksfuMkt+ksy csUtq,sV$ 10 dk 11.94 172(v) 29.01.2008MkbZyksDlkukbM ¶;wjsV xksfy;ka iRrk@fCyLVjesVªksfuMkt+ksy csUtq,sV-400 fexzk-MkbZyksDlkukbM ¶;wjsV-500 fexzk-

133. esVªksfuMkt+ksy$MkbZyksDlkukbM ¶;wjsV$ 10 dk 12.44 172(v) 29.01.2008,sfDVosVsM feFkk;y iksfyflyksDlsu$ iRrk@fCyLVjMkbZlkbDyksekbu ,plh,y xksfy;kaesVªksfuMkt+ksy -400 fexzk-MkbZyksDlkukbM ¶;wjsV-500 fexzk-,sfDVosVsM feFkk;y iksfyflyksDlsu-25 fexzk-MkbZlkbDyksekbu ,plh,y-10 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 146: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 127 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

,u (N)

1. usfyfMfDld ,sflM xksfy;ka&125 10 dk 5.46 607(v) 29.06.2001 eS- lh,Q,y usxkfMDl125 fexzk- @xksfy;ka iRrk@fCyLVj eS- jsdfouk fMDlh

2. usfyfMfDld ,sflM xksfy;ka&150 10 dk 6.42 607(v) 29.06.2001 eS- CY;w ØkWl ;wfyDl&ih150 fexzk- @xksfy;ka iRrk@fCyLVj

3. usfyfMfDld ,sflM xksfy;ka&250 10 dk 9.96 607(v) 29.06.2001 eS- ihlhvkbZ fMDl250 fexzk- @xksfy;ka iRrk@fCyLVj

4. usfyfMfDld ,sflM xksfy;ka&300 6 dk 6.96 607(v) 29.06.2001 eS- Vªks;dk usfMDl ,D;wVsc300 fexzk- @xksfy;ka iRrk@fCyLVj

5. usfyfMfDld ,sflM xksfy;ka&500 4 dk 7.53 607(v) 29.06.2001 eS- jsucsdlh xzseksusx500 fexzk- @xksfy;ka iRrk@fCyLVj

6. usfyfMfDld ,sflM xksfy;ka&500 10 dk 18.82 607(v) 29.06.2001 eS- lh,Q,y usxkfMDl500 fexzk- @xksfy;ka iRrk@fCyLVj eS- ihlhvkbZ fMDl

6. usfyfMfDld ,sflM xksfy;ka&500 8 dk 182 182(v) 29.01.2008

500 fexzk- @?kqyu’khy xksfy;ka iRrk@fCyLVj

7. usfyfMfDld ,sflM xksfy;ka&1 xzke 4 dk 14.78 607(v) 29.06.2001 eS- ihlhvkbZ fMDl1 xzke @xksfy;ka iRrk@fCyLVj

8. usfyfMfDld ,sflM lLisUlu 30 fefy dh 14.68 619(v) 03.09.1996 eS- jsdLVj xzseksusx300 fexzk- @ 5 fefy cksry eS- txluiky Mk;jyksi lLisUlu

eS- ihlhvkbZ fMDl

9. usfyfMfDld ,sflM lLisUlu 60 fefy dh 26.86 619(v) 03.09.1996 eS- eklZ usxkesV300 fexzk- @ 5 fefy cksry eS- ihlhvkbZ fMDl

10. usfyfMfDld ,sflM flLi 30 fefy dh 11.40 443(v) 29.03.2006

300 fexzk- @ 5 fefy cksry

11. usfyfMfDld ,sflM flLi 30 fefy dh 11.88 443(v) 29.03.2006

300 fexzk- @ 5 fefy cksry ,e-di lfgr

12. usfyfMfDld ,sflM flLi 60 fefy dh 19.72 443(v) 29.03.2006

300 fexzk- @ 5 fefy cksry

Page 147: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 128 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

13. usfyfMfDld ,sflM flLi 60 fefy dh 20.20 443(v) 29.03.2006

300 fexzk- @ 5 fefy cksry ,e-di lfgr

14. usfyfMfDld ,sflM$eSVªksfuMkt+ksy xksfy;ka 10 dk 8.42 608(v) 29.06.2001 eS- CY;w ØkWl ;wfyDl&,e150 fexzk-$100 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj

15. usfyfMfDld ,sflM$eSVªksfuMkt+ksy xksfy;ka 10 dk 15.34 608(v) 29.06.2001 eS- flj;k ykbQ ,fcdksu300 fexzk-$ 200 fexzk-@xksfy;ka ¼fyfir½ ,,y_iRrk eS- ,xzksu csVkfMDl

16. usfyfMfDld ,sflM$eSVªksfuMkt+ksy xksfy;ka 10 dk 14.90 608(v) 29.06.2001 eS- Mk;ukfed ysc vkbtksy300 fexzk-$ 200 fexzk-@xksfy;ka ¼fyfir½ ,,y_fCyLVj eS- ekijk LizksV&,u

17. usfyfMfDld ,sflM$eSVªksfuMkt+ksy xksfy;ka 10 dk 21.06 608(v) 29.06.2001 eS- vjksfcUnks QkekZ ,Mh&500

500 fexzk-$ 200 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj eS- uslVj xzseksusDl

18. usfyfMfDld ,sflM$eSVªksfuMkt+ksy xksfy;ka 10 dk 16.48 1672(v) 03.10.2006

300 fexzk-$ 400 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj

19. usfyfMfDld ,sflM$eSVªksfuMkt+ksy flji 50 fefy dh 12.64 608(v) 29.06.2001 eS- Mk;ukfed ysc vkbtksy150 fexzk- $ 100 fexzk-@ 5 fefy cksry

20. usfyfMfDld ,sflM$eSVªksfuMkt+ksy flji 50 fefy dh 13.12 608(v) 29.06.2001 eS- Mk;ukfed ysc vkbtksy150 fexzk- $ 100 fexzk-@ 5 fefy cksry ,e-di lfgr

21. usfyfMfDld ,sflM$eSVªksfuMkt+ksy flji 60 fefy dh 16.44 852(v) 25.07.2003 eS- vkjihth D;wfty&,u150 fexzk- $ 200 fexzk-@ 5 fefy cksry

22. usfyfMfDld ,sflM$eSVªksfuMkt+ksy flji 60 fefy dh 16.92 852(v) 25.07.2003 eS- vkjihth D;wfty&,u150 fexzk- $ 200 fexzk-@ 5 fefy cksry ,e-di lfgr

23. usfyfMfDld ,sflM$eSVªksfuMkt+ksy flji 60 fefy dh 22.76 852(v) 25.07.2003 eS- uslVj xzseksusDl300 fexzk- $ 200 fexzk-@ 5 fefy cksry eS- fou esfMds;j csDVksesV

24. usfyfMfDld ,sflM$eSVªksfuMkt+ksy flji 60 fefy dh 23.24 852(v) 25.07.2003 eS- uslVj xzseksusDl300 fexzk- $ 200 fexzk-@ 5 fefy cksry ,e-di lfgr eS- fou esfMds;j csDVksesV

25. usfyfMfDld ,sflM$eSVªksfuMkt+ksy lLisUlu 30 fefy 8.96 608(v) 29.06.2001 eS- ,fjLVks QkekZ csflfty150 fexzk-$ dh cksry eS- ekijk ysc LizksV&,u100 fexzk- ¼csUtq,V ds cjkcj½ @ 5 fefy

Page 148: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 129 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

26. usfyfMfDld ,sflM$eSVªksfuMkt+ksy lLisUlu 30 fefy dh 9.44 608(v) 29.06.2001 eS- Js;k ykbQlkbal ,fcdksu150 fexzk-$ cksry ,e-di lfgr eS- vjfcUnks QkekZ ,Mh&500

100 fexzk- ¼csUtq,V ds cjkcj½@ 5 fefy

27. usfyfMfDld ,sflM$eSVªksfuMkt+ksy lLisUlu 60 fefy 14.84 608(v) 29.06.2001 eS- ,ydse ,YMkxzke150 fexzk-$ dh cksry eS- jsucsDlh xzseksusx&,e100 fexzk- ¼csUtq,V ds cjkcj½ @ 5 fefy

28. usfyfMfDld ,sflM$eSVªksfuMkt+ksy lLisUlu 60 fefy dh 15.32 608(v) 29.06.2001 eS- ch bZ usfyfMl150 fexzk-$ cksry ,e-di lfgr eS- lh,Q,y usxkfMDl&,e100 fexzk- ¼csUtq,V ds cjkcj½@ 5 fefy eS- ekijk LizksV&,u

29. uksj¶yksDlhu xksfy;ka 10 dk 3.09 765(v) 19.05.2006

100 fexzk-@xksfy;ka iRrk@fCyLVj

30. uksj¶yksDlhu xksfy;ka 10 dk 4.92 1335(v) 16.09.2005 eS- fu;ks QkekZ fu;ksuksDl200 fexzk-@xksfy;ka iRrk@fCyLVj eS- ,yfEcd uksjfcM

eS- fliyk uksj¶YkksDleS- MkW- jsM~Mh ysc uksfjysVeS- CY;w ØkWl uksjLisu

31. uksj¶yksDlhu xksfy;ka 10 dk 9.70 1052(v) 11.07.2006 eS- fliyk uksj¶YkksDl400 fexzk-@fyfir dSiysV xksfy;ka iRrk@fCyLVj eS- MkW- jsM~Mh ysc uksfjysV

eS- ,yfEcd uksjfcMeS- dsfMyk gsYFkds;j usxk¶yksDleS- Ms~l ,UVªks¶yksDl

32. uksj¶yksDlhu xksfy;ka 10 dk 16.66 766(v) 19.05.2006 eS- fliyk uksj¶YkksDl800 fexzk-@xksfy;ka iRrk@fCyLVj eS- ekbØks uksok fD;wuksfcM

eS- Y;wfiu ;wfVfcM

33. uksj¶yksDlhu xksfy;ka 10 dk 17.28 765(v) 19.05.2006

800 fexzk-@fQYe fyfir xksfy;ka iRrk@fCyLVj

34. uksj¶yksDlhu$fVfuMkt+ksy xksfy;ka 10 dk 6.78 1335(v) 16.09.2005 eS- IysfFkdks Dykld200 fexzk-$ 200 fexzk-@xksfy;ka iRrk@fCyLVj

35. uksj¶yksDlhu$fVfuMkt+ksy xksfy;ka 10 dk 14.12 766(v) 19.05.2006 eS- oksdkMZ dksukt+400 fexzk-$ 600 fexzk-@xksfy;ka iRrk@fCyLVj eS- lu QkekZ fM;kck

eS- vkjihth ykbQlkbalfM;ksuksjeS- Ms~l ,UVªks¶yksDl&VheS- jsucsDlh xzseksusx&Vh,e

Page 149: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 130 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

36. uksj¶yksDlhu$fVfuMkt+ksy xksfy;ka 10 dk 13.32 766(v) 19.05.2006

400 fexzk-$ 500 fexzk-@xksfy;ka iRrk@fCyLVj

37. uksj¶yksDlhu$fVfuMkt+ksy xksfy;ka 10 dk 11.48 766(v) 19.05.2006

400 fexzk-$ 300 fexzk-@xksfy;ka iRrk@fCyLVj

38. uksj¶yksDlhu$eSVªksfuMkt+ksy xksfy;ka 10 dk 4.04 1335(v) 16.09.2005 eS- fdeks MªXl yksDlkesV&MhVh100 fexzk-$ 100 fexzk-@xksfy;ka iRrk@fCyLVj eS- CY;w ØkWl uksjLisu&,e

eS- bZLV vQjhdu uksVh&fdM

39. uksj¶yksDlhu$eSVªksfuMkt+ksy xksfy;ka 10 dk 7.22 1335(v) 16.09.2005 eS- ,fjLVks QkekZ csflfty&,u200 fexzk-$ 200 fexzk-@xksfy;ka iRrk@fCyLVj eS- QkbuD;wjk Qsuhfty

eS- flj;k ykbQlkbal DykldeS- czkWu esVuy

40. uksj¶yksDlhu$eSVªksfuMkt+ksy xksfy;ka 10 dk 8.44 1335(v) 16.09.2005 eS- fdeks MªXl yksDlkesV200 fexzk-$ 300 fexzk-@xksfy;ka iRrk@fCyLVj

41. uksj¶yksDlhu$eSVªksfuMkt+ksy xksfy;ka 10 dk 8.88 1335(v) 16.09.2005

250 fexzk-$ 250 fexzk-@xksfy;ka iRrk@fCyLVj

42. uksj¶yksDlhu$eSVªksfuMkt+ksy xksfy;ka 10 dk 10.36 1335(v) 16.09.2005

300 fexzk-$ 300 fexzk-@xksfy;ka iRrk@fCyLVj

43. uksj¶yksDlhu$eSVªksfuMkt+ksy xksfy;ka 10 dk 13.38 766(v) 19.05.2006 eS- vkjczks QkekZ uksfdZu Iyl400 fexzk-$ 400 fexzk-@xksfy;ka iRrk@fCyLVj

44. uksj¶yksDlhu$eSVªksfuMkt+ksy xksfy;ka 10 dk 14.40 766(v) 19.05.2006 eS- ekijk LizksV&,u400 fexzk-$ 500 fexzk-@xksfy;ka iRrk@fCyLVj eS- fudksyl psdesV

eS- ukSfjl ¶yksDlhuksj&,eeS- jsDlVj xzseksfty

45. uksj¶yksDlhu$eSVªksfuMkt+ksy xksfy;ka 10 dk 15.46 766(v) 19.05.2006 eS- LVsMdse bysDVªksfty400 fexzk-$ 600 fexzk-@xksfy;ka iRrk@fCyLVj eS- fdeks MªXl yksDlkesV QksVZ

eS- QkekZflUFk uksjeksfty

46. uksj¶yksDlhu$eSVªksfuMkt+ksy$ 10 dk 4.48 1335(v) 16.09.2005

ysfDVd ,sflM csflyl xksfy;ka iRrk@fCyLVj100 fexzk-$ 100 fexzk-$60 fefy;u LiksZl@xksfy;ka

47. uksj¶yksDlhu$vksjfuMkt+ksy xksfy;ka 10 dk 17.22 766(v) 19.05.2006 eS- Vh,uVh ykbQlkbal ¶yksfuM&vkstsM400 fexzk-$ 500 fexzk-@xksfy;ka iRrk@fCyLVj eS- ,lDysfi;ksl jsesfMt[kksfty&,u

eS- ;wfcV uksjfcV&vksvkj

Page 150: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 131 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

48. uksj¶yksDlhu$fVfuMktksy$ 10 dk 7.98 1335(v) 16.09.2005

MkbZlkbdyksekbu ,plh,y xksfy;ka iRrk@fCyLVj200 fexzk-$ 300 fexzk-$ 10 fexzk-@xksfy;ka

49. uksj¶yksDlhu$fVfuMktksy$ 10 dk 14.32 766(v) 19.05.2006

MkbZlkbdyksekbu ,plh,y xksfy;ka iRrk@fCyLVj400 fexzk-$ 600 fexzk-$ 10 fexzk-@xksfy;ka

50. uksj¶yksDlhu xksfy;ka 10 dk 3.10 1335(v) 16.09.2005 eS- fliyk uksj¶yksDl100 @?kqyu’khy xksfy;ka iRrk@fCyLVj eS- CY;w ØkWl uksjLisu

51. uksj¶yksDlhu$eSVªksfuMkt+ksy xksfy;ka 10 dk 4.14 1335(v) 16.09.2005 eS- f’kokfyd ysc uksjfMt+ksy&MhVh100 fexzk-$ 100 fexzk-@?kqyu’khy xksfy;kaiRrk@fCyLVj eS- CY;w ØkWl uksjLisu&,e

52. uksj¶yksDlhu Mªksi 5 fefy dk ok;y 6.54 1335(v) 16.09.2005 eS- ,ydse ,y¶yksDl&Mhih,l0.3% @ok;y Mªksij lfgr eS- MkW- jsM~Mh ysc uksfjysV

eS- jsucsDlh uksjcsdfVu Mhih,leS- dsfMyk uksjMkWdeS- fliyk uksj¶yksDl

53. uksj¶yksDlhu Mªksi 10 fefy dk ok;y 7.30 1335(v) 16.09.2005 eS- fliyk uksj¶yksDl0.3% @ok;y Mªksij lfgr eS- baM&LohQ~V uksfjV Mhih,l

54. uksj¶yksDlhu vkW;uVesaV 5 xzke dh 4.28 766(v) 19.05.2006 eS- fliyk uksj¶yksDl0.3% @xzke V~;wc

55. uksj¶yksDlhu$fVfuMkt+ksy lLisUlu@flji 30 fefy dh 8.72 1335(v) 16.09.2005 eS- Vksjl ysc gkj¶yksDl&Vh100 fexzk-$ 100 fexzk-@ 5 fefy cksry ,e-di lfgr eS- U;wtsu uksjQsu&VhtsM

eS- ,ydse esxkuksjeS- dsfMyk QkekZ uksjQsu&VhtsM

56. uksj¶yksDlhu$fVfuMkt+ksy lLisUlu@flji 50 fefy dh 11.46 1335(v) 16.09.2005

100 fexzk-$ 100 fexzk-@ 5 fefy cksry ,e-di lfgr

57. uksj¶yksDlhu$fVfuMkt+ksy lLisUlu@flji 60 fefy dh 13.30 1335(v) 16.09.2005 eS- LdkbZeSDl uksjfMy&VhtsM100 fexzk-$ 75 fexzk-@ 5 fefy cksry ,e-di lfgr

58. uksj¶yksDlhu$fVfuMkt+ksy lLisUlu@flji 30 fefy dh 8.60 1335(v) 16.09.2005 eS- VkbEl MªXl ,aM QkekZ QsfluksDl&Vh100 fexzk-$ 75 fexzk-@ 5 fefy cksry ,e-di lfgr eS- ,ydse esxkuksj

eS- dspsV yksDlhfVu&ih

Page 151: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 132 -

59. uksj¶yksDlhu $ 30 fefy dh cksry 9.02 1335(v) 16.09.2005 eS- ,fjLVks csflfty&,ueSVªksfuMkt+ksy lLisUlu@flji ,e- di lfgr eS- bUVªk ysc uksfju&,etsM100 fexzk- csUtq,V esa $ 100 fexzk-@ 5 fefy eS- lu QkekZ fM;kck&,e

eS- QkbuD;wj QkekZ QsuhftyeS- ftuks QkekZ ftuksfty&,u

60. uksj¶yksDlhu$eSVªksfuMkt+ksy$ 30 fefy dh cksry 9.04 1335(v) 16.09.2005

lkbesfFkdksu lLisUlu@flji ,e- di lfgr100 fexzk-$ 100 fexzk- csUtq,V esa $10 fexzk-@ 5 fefy

61. uksj¶yksDlhu$ 60 fefy dh cksry 13.90 1335(v) 16.09.2005 eS- ,fjLVks csflfty&,ueSVªksfuMkt+ksy lLisUlu@flji ,e- di lfgr eS- fudksYl ¶ysftuksj100 fexzk-$ 100 fexzk- csUtq,V esa @ 5 fefy eS- czkWu esVuy

62. uksj¶yksDlhu$ 30 fefy dh cksry 9.22 1335(v) 16.09.2005 eS- Mk;ukfed esVuksjeSVªksfuMkt+ksy lLisUlu@flji ,e- di lfgr100 fexzk- csUtq,V esa $ 125 fexzk-@ 5 fefy

63. uksj¶yksDlhu$ 30 fefy dh cksry 9.42 1335(v) 16.09.2005 eS- LVsMdse bysDVªksftyeSVªksfuMkt+ksy lLisUlu@flji ,e- di lfgr100 fexzk- csUtq,V esa $ 150 fexzk-@ 5 fefy

64. uksj¶yksDlhu$ 30 fefy dh cksry 9.82 1335(v) 16.09.2005 eS- uksjfMd QkekZ yksesV IyleSVªksfuMkt+ksy lLisUlu@flji ,e- di lfgr 100 fexzk-$200 fexzk- csUtq,V esa @ 5 fefy

65. uksj¶yksDlhu$ 60 fefy dh cksry 15.50 1335(v) 16.09.2005

eSVªksfuMkt+ksy lLisUlu@flji ,e- di lfgr 100 fexzk-$200 fexzk- csUtq,V esa @ 5 fefy

66. uksj¶yksDlhu$ 30 fefy dh cksry 11.40 1335(v) 16.09.2005

eSVªksfuMkt+ksy lLisUlu@flji ,e- di lfgr 100 fexzk-$400 fexzk- csUtq,V esa @ 5 fefy

67. uksj¶yksDlhu$ 60 fefy dh cksry 18.68 1335(v) 16.09.2005

eSVªksfuMkt+ksy lLisUlu@flji ,e- di lfgr 100 fexzk-$400 fexzk- csUtq,V esa @ 5 fefy

68. uksj¶yksDlhu$ 30 fefy dh cksry 9.60 1335(v) 16.09.2005 eS- LVsMdse bysDVªksftyeSVªksfuMkt+ksy lLisUlu@flji ,e- di lfgr150 fexzk- csUtq,V esa $ 100 fexzk-@ 5 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 152: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 133 -

69. uksj¶yksDlhu$ 30 fefy dh cksry 10.96 1335(v) 16.09.2005 eS- LVsMdse bysDVªksftyeSVªksfuMkt+ksy lLisUlu@flji ,e- di lfgr200 fexzk- csUtq,V esa $ 200 fexzk-@ 5 fefy

70. uksj¶yksDlhu$ 60 fefy dh cksry 17.78 1335(v) 16.09.2005 eS- ,eD;wj uksjesV QksVZeSVªksfuMkt+ksy lLisUlu@flji ,e- di lfgr200 fexzk- csUtq,V esa $ 200 fexzk-@ 5 fefy

71. uksj¶yksDlhu$ 30 fefy dh cksry 14.86 1335(v) 16.09.2005 eS- ysdj QkekZ uksjesVªksftyeSVªksfuMkt+ksy lLisUlu@flji ,e- di lfgr400 fexzk- csUtq,V esa $ 400 fexzk-@ 5 fefy

72. uksj¶yksDlhu$ 30 fefy dh cksry 9.42 1335(v) 16.09.2005 eS- th&ukbu ekdsZfVax uksfjMeSVªksfuMkt+ksy lLisUlu@flji ,e- di lfgr100 fexzk- csUtq,V esa $ 125 fexzk-@ 5 fefy

73. uksj¶yksDlhu$fVfuMktksy lLisUlu 30 fefy dh cksry 9.60 1070(v) 11.07.2006

100 fexzk-$ 125 fexzk-@ 5 fefy

74. uksj¶yksDlhu vk¡[kks dk Mªksi 15 fefy dh cksry 8.27 1070(v) 11.07.2006

0.3% MCY;w@oh @ fefy

75. uksj¶yksDlhu$fVfuMktksy xksfy;ka 10 dk 6.04 1673(v) 03.10.2006

100 fexzk-$ 300 fexzk-@ xksfy;ka iRrk@fCyLVj

76. uksj¶yksDlhu$eSVªksfuMkt+ksy xksfy;ka 10 dk 14.46 1924(v) 08.11.2006

400 fexzk-$ 500 fexzk-@?kqyu’khy xksfy;kaiRrk@fCyLVj

77. uksj¶yksDlhu flji@lLisUlu 30 fefy 8.76 1339(v) 01.08.2007

100 fexzk-@5 fefy dh cksry

78. uksj¶yksDlhu xksfy;ka 10 dk 3.10 1339(v) 01.08.2007

uksj¶yksDlhu-100 fexzk- iRrk@fCyLVjcsVk &lkbDyksMsDlVªhu esa¶ysoj csl lfgr@fVfd;k

79. uksj¶yksDlhu$csUtydksfu;e 10 xzke dh 6.20 1656(v) 27.09.2007

DyksjkbM vkW;UVesUV V~;wcuksj¶yksDlhu-0.3% MCY;w@MCY;wcsUtydksfu;e DyksjkbM-0.01% MCY;w@oh

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 153: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 134 -

80. uksj¶yksDlhu$ysfDVd ,sflM 10 dk 9.30 2050(v) 30.11.2007

csflyl xksfy;ka iRrk@fCyLVjuksj¶yksDlhu-400 fexzk-ysfDVd ,sflM csflyl -120 fefy;u LiksZl

81. uksj¶yksDlhu$fVfuMkt+ksy$ 10 dk 11.86 2050(v) 30.11.2007

ysfDVd ,sflM csflyl xksfy;ka iRrk@fCyLVjuksj¶yksDlhu-400 fexzk-fVfuMkt+ksy-200 fexzk-ysfDVd ,sflM csflyl -120 fefy;u LiksZl

82. usizksDlsu xksfy;ka 10 dk 8.52 2038(v) 30.11.2007

250 fexzk-@fVfd;k iRrk@fCyLVj

83. usizksDlsu xksfy;ka 10 dk 16.18 2038(v) 30.11.2007

500 fexzk-@fVfd;k iRrk@fCyLVj

84. usizksDlsu xksfy;ka 10 dk 13.00 1338(v) 16.09.2005

250 fexzk- lksfM;e ds leku@fVfd;k iRrk@fCyLVj

85. usizksDlsu xksfy;ka 6 dk 20.84 1338(v) 16.09.2005

750 fexzk- @,lvkj@ iRrk@fCyLVjlhvkj@Mhvkj fVfd;k

86. usizksDlsu lksfM;e xksfy;ka 10 dk 11.48 2037(v) 30.11.2007

usizksDlsu lksfM;e-275 fexzk- iRrk@fCyLVjusizksDlsu-250 fexzk- ds cjkcj

87. usizksDlsu xksfy;ka 10 dk 23.62 2040(v) 30.11.2007

750 fexzk- @fVfd;k iRrk@fCyLVj

88. usizksDlsu xksfy;ka 10 dk 9.08 2040(v) 30.11.2007

250 fexzk- @fQYe fyfir fVfd;k iRrk@fCyLVj

89. usizksDlsu xksfy;ka 10 dk 16.86 2040(v) 30.11.2007

500 fexzk- @fQYe fyfir fVfd;k iRrk@fCyLVj

90. usizksDlsu xksfy;ka 10 dk 24.46 2040(v) 30.11.2007

750 fexzk- @fQYe fyfir fVfd;k iRrk@fCyLVj

91. usizksDlsu xksfy;ka 10 dk 9.54 2040(v) 30.11.2007

250 fexzk- @,lvkj@lhvkj fVfd;k iRrk@fCyLVj

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 154: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 135 -

92. usizksDlsu xksfy;ka 10 dk 17.48 2040(v) 30.11.2007

500 fexzk- @,lvkj@lhvkj fVfd;k iRrk@fCyLVj

93. usizksDlsu xksfy;ka 10 dk 25.00 2040(v) 30.11.2007

750 fexzk- @,lvkj@lhvkj fVfd;k iRrk@fCyLVj

94. usizksDlsu lksfM;e xksfy;ka 10 dk 19.32 2040(v) 30.11.2007

usizksDlsu lksfM;e 550 fexzk- iRrk@fCyLVjusizksDlsu 500 fexzk- ds cjkcj@fVfd;k

95. usizksDlsu lksfM;e xksfy;ka 10 dk 28.34 2040(v) 30.11.2007

usizksDlsu lksfM;e 825 fexzk- iRrk@fCyLVjusizksDlsu 750 fexzk- ds cjkcj@fVfd;k

96. usizksDlsu lksfM;e xksfy;ka 10 dk 20.02 2040(v) 30.11.2007

usizksDlsu lksfM;e 550 fexzk- iRrk@fCyLVjusizksDlsu 500 fexzk- ds cjkcj@fQYe fyfir fVfd;k

97. usizksDlsu lksfM;e xksfy;ka 10 dk 29.22 2040(v) 30.11.2007

usizksDlsu lksfM;e 825 fexzk- iRrk@fCyLVjusizksDlsu 750 fexzk- ds cjkcj@fQYe fyfir fVfd;k

98. usizksDlsu lksfM;e xksfy;ka 10 dk 11.12 2040(v) 30.11.2007

usizksDlsu lksfM;e 275 fexzk- iRrk@fCyLVjusizksDlsu 250 fexzk- ds cjkcj@,lvkj@lhvkj fVfd;k

99. usizksDlsu lksfM;e xksfy;ka 10 dk 20.64 2040(v) 30.11.2007

usizksDlsu lksfM;e 550 fexzk- iRrk@fCyLVjusizksDlsu 500 fexzk- ds cjkcj@,lvkj@lhvkj fVfd;k

100. usizksDlsu lksfM;e xksfy;ka 10 dk 29.74 2040(v) 30.11.2007

usizksDlsu lksfM;e 825 fexzk- iRrk@fCyLVjusizksDlsu 750 fexzk- ds cjkcj@,lvkj@lhvkj fVfd;k

101. usizksDlsu dSilwy 10 dk 10.92 2040(v) 30.11.2007

usizksDlsu 250 fexzk-@dSilwy iRrk@fCyLVj

102. usizksDlsu dSilwy 10 dk 18.20 2040(v) 30.11.2007

usizksDlsu 500 fexzk-@dSilwy iRrk@fCyLVj

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 155: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 136 -

103. usizksDlsu dSilwy 10 dk 26.16 2040(v) 30.11.2007

usizksDlsu 750 fexzk-@dSilwy iRrk@fCyLVj

104. usizksDlsu dSilwy 10 dk 12.08 2040(v) 30.11.2007

usizksDlsu 250 fexzk-@ iRrk@fCyLVj,lvkj@lhvkj dSilwy

105. usizksDlsu dSilwy 10 dk 19.42 2040(v) 30.11.2007

usizksDlsu 500 fexzk-@ iRrk@fCyLVj,lvkj@lhvkj dSilwy

106. usizksDlsu dSilwy 10 dk 27.46 2040(v) 30.11.2007

usizksDlsu 750 fexzk-@ iRrk@fCyLVj,lvkj@lhvkj dSilwy

107. usizksDlsu lksfM;e dSilwy 10 dk 12.50 2040(v) 30.11.2007

usizksDlsu lksfM;e 275 fexzk- iRrk@fCyLVjusizksDlsu 250 fexzk- ds cjkcj@dSilwy

108. usizksDlsu lksfM;e dSilwy 10 dk 21.34 2040(v) 30.11.2007

usizksDlsu lksfM;e 550 fexzk- iRrk@fCyLVjusizksDlsu 500 fexzk- ds cjkcj@dSilwy

109. usizksDlsu lksfM;e dSilwy 10 dk 30.88 2040(v) 30.11.2007

usizksDlsu lksfM;e 825 fexzk- iRrk@fCyLVjusizksDlsu 750 fexzk- ds cjkcj@dSilwy

110. usizksDlsu lksfM;e dSilwy 10 dk 13.66 2040(v) 30.11.2007

usizksDlsu lksfM;e 275 fexzk- iRrk@fCyLVjusizksDlsu 250 fexzk- ds cjkcj@,lvkj@lhvkj dSilwy

111. usizksDlsu lksfM;e dSilwy 10 dk 22.58 2040(v) 30.11.2007

usizksDlsu lksfM;e 550 fexzk- iRrk@fCyLVjusizksDlsu 500 fexzk- ds cjkcj@,lvkj@lhvkj dSilwy

112. usizksDlsu lksfM;e dSilwy 10 dk 32.22 2040(v) 30.11.2007

usizksDlsu lksfM;e 825 fexzk- iRrk@fCyLVjusizksDlsu 750 fexzk- ds cjkcj@,lvkj@lhvkj dSilwy

113. usizksDlsu tWy 20 xzke dh 14.28 2040(v) 30.11.2007

usizksDlsu csl 10% MCY;w@MCY;w V~;wc

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 156: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 137 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

vks (O)

1. vkWDldkcZts+ikbu xksfy;ka 10 dk 12.18 770(v) 19.05.2006

vkWDldkcZts+ikbu&150 fexzk- iRrk@fCyLVj

2. vkWDldkcZts+ikbu xksfy;ka 10 dk iRrk@fCyLVj 23.16 770(v) 19.05.2006

vkWDldkcZts+ikbu&300 fexzk-

3. vkWDldkcZts+ikbu xksfy;ka 10 dk iRrk@fCyLVj 34.04 770(v) 19.05.2006

vkWDldkcZts+ikbu&450 fexzk-

4. vkWDldkcZts+ikbu xksfy;ka 10 dk iRrk@fCyLVj 37.86 770(v) 19.05.2006

vkWDldkcZts+ikbu&500 fexzk-

5. vkWDldkcZts+ikbu xksfy;ka 10 dk 45.12 770(v) 19.05.2006

vkWDldkcZts+ikbu&600 fexzk- iRrk@fCyLVj

6. vkWDlhVsVªklkbdfyu ,plh,y dSilwy&250 4 dk 2.70 612(v) 27.05.2003 eS- Qkbt+j vkWDlhVsVªklkbdfyu250 fexzk- @dSilwy ,,y_iRrk

7. vkWDlhVsVªklkbdfyu ,plh,y dSilwy&250 4 dk 2.50 612(v) 27.05.2003 eS- Qkbt+j vkWDlhVsVªklkbdfyu250 fexzk- @dSilwy ,,y_fCyLVj

8. vkWDlhVsVªklkbdfyu dSilwy 10 dk 8.86 1163(v) 20.10.2004 eS- Qkbt+j vkWDlhVsVªklkbdfyuvkWDlhVsVªklkbdfyu ,plh,y 500 fexzk-@ ,,y_iRrkdSilwy

9. vkWDlhVsVªklkbdfyu dSilwy 10 dk 8.22 1163(v) 20.10.2004 eS- Qkbt+j vkWDlhVsVªklkbdfyuvkWDlhVsVªklkbdfyu ,plh,y 500 fexzk-@,,y_fCyLVjdSilwy

10. vkWDlhVsVªklkbdfyu ,plh,y 25 dh 4.70 488(v) 01.06.1995

lksY;wcy xksfy;ka - 50 cksry / iRrk50 fexzk-@xksfy;ka ¼lksY;wcy½

11. vkWDlhVsVªklkbdfyu ,plh,y 10 dh 3.76 488(v) 01.06.1995

lksY;wcy xksfy;ka - 50 cksry / iRrk50 fexzk-@xksfy;ka ¼lksY;wcy½

12. vkWDlhVsVªklkbdfyu ,plh,y xksfy;ka 1 dk 4.26 751(v) 19.05.2006

2 xzke@xksfy;ka vkscysV

Page 157: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 138 -

13. vkWDlhVsVªklkbdfyu ,plh,y bUtSD’ku 10 fefy 6.60 488(v) 01.06.1995

50 fexzk-@fefy dk ok;y

14. vkWDlhVsVªklkbdfyu ,plh,y bUtSaD’ku&50 20 fefy 10.56 845(v) 09.12.1997 eS- ,uihvkbZ,y50 fexzk- @fefy dk ok;y

15. vkWDlhVsVªklkbdfyu ,plh,y bUtSaD’ku&50 30 fefy 13.24 1638(v) 27.09.2007 eS- txluiky vkWDlhVsjkflu50 fexzk- @fefy dk ok;y

16. vkWDlhVsVªklkbdfyu ,plh,y bUtSD’ku&50 100 fefy 33.22 1638(v) 27.09.2007

50 fexzk- @fefy dk ok;y

17. vkWDlhVsVªklkbdfyu ,plh,y bUtSD’ku&50 10x2 fefy 13.63 488(v) 01.06.1995

50 fexzk- @fefy dk ,Ei;wy

18. vkWDlhVsVªklkbdfyu ,plh,y bUtSD’ku&125 10x2 fefy 17.36 488(v) 01.06.1995

125 fexzk- @fefy dk ,Ei;wy

19. vkWDlhVsVªklkbdfyu ,plh,y bUtSD’ku&250 3 fefy 2.26 488(v) 01.06.1995

250 fexzk- @fefy dk ,Ei;wy

20. vkWDlhVsVªklkbdfyu$fyMksdsu bUtSD’ku 20 fefy 11.32 2027(v) 30.11.2007

izR;sd fefy esa dk ok;yvkWDlhVsVªklkbdfyu ,UgkbMªlvkWDlhVsVªklkbdfyu & 50 fexzk- ds cjkcjfyMksdsu & 2% MCY;w@oh

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 158: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 139 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

ihs (P)

1. isjk&Dyksjks esVkDlhysuksy ¼ihlh,e,Dl½ 12x25 xzke dh 73.42 128(v) 15.02.2000 eS- jsfdV~ csudkbt+j fMVkWy Øhe,aVhlsf¶Vd Øhe 0.8% MCY;w@oh V~;wc

2. iSuhflfyu th iksVkf’k;e xksfy;ka 6 dk 3.94 1236(v) 19.12.2001 eS- fudksYl isfUVM~l2 yk[k ;wfuV @xksfy;ka iRrk@fCyLVj

3. iSuhflfyu th iksVkf’k;e xksfy;ka 6 dk 6.90 1236(v) 19.12.2001 eS- fudksYl isfUVM~l4 yk[k ;wfuV @xksfy;ka iRrk@fCyLVj

4. iSuhflfyu th iksVkf’k;e xksfy;ka 6 dk 8.46 1236(v) 19.12.2001

5 yk[k ;wfuV @xksfy;ka iRrk@fCyLVj

5. iSuhflfyu th iksVkf’k;e xksfy;ka 4 dk 8.76 1236(v) 19.12.2001 eS- fudksYl isfUVM~l8 yk[k ;wfuV @xksfy;ka iRrk@fCyLVj

6. lksfM;e csUtkby iSuhflfyu bUtsD’ku 1 ok;y 5.18 1357(v) 24.12.2002 eS- ,yfEcd csUtkby iSuhflfyu5 yk[k ;wfuV @ok;y

7. lksfM;e csUtkby iSuhflfyu bUtsD’ku 1 ok;y 6.70 1357(v) 24.12.2002 eS- gWy lksfMflfyu10 yk[k ;wfuV @ok;y eS- ,yfEcd csUtkby iSuhflfyu

8. csUtkFkhu iSuhflfyu th bUtsD’ku 1 ok;y 6.84 404(v) 10.05.2001 eS- ok;Fk isfUkM~;wj6 yk[k ;wfuV @ok;y

9. csUtkFkhu iSuhflfyu th bUtsD’ku 5 ok;y 34.20 404(v) 10.05.2001 eS- ,yfEcd isudkse6 yk[k ;wfuV @ok;y

10. csUtkFkhu iSuhflfyu th bUtsD’ku 1 ok;y 10.06 444(v) 29.03.2006 eS- ok;Fk isfuM~;wj12 yk[k ;wfuV @ok;y

11. csUtkFkhu iSuhflfyu th bUtsD’ku 5 ok;y 50.30 444(v) 29.03.2006 eS- ,yfEcd isudkse12 yk[k ;wfuV @ok;y

12. csUtkFkhu iSuhflfyu th bUtsD’ku 1 ok;y 14.02 444(v) 29.03.2006 eS- ok;Fk isfUkM~;wj24 yk[k ;wfuV @ok;y

13. csUtkFkhu csUtkby 1 ok;y 22.88 444(v) 29.03.2006

iSuhflfyu th bUtsD’ku48 yk[k ;wfuV @ok;y ¼osfV-½

Page 159: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 140 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

14. QsuksDlh feFkk;y iSuhflfyu xksfy;ka 50 dh cksry 19.92 1237(v) 19.12.2001

65 fexzk-@xksfy;ka

15. QsuksDlh feFkk;y iSuhflfyu xksfy;ka 50 dh cksry 34.20 1237(v) 19.12.2001

130 fexzk-@xksfy;ka

16. QsuksDlh feFkk;y iSuhflfyu xksfy;ka 10x10 dk 66.60 1237(v) 19.12.2001

125 fexzk-@xksfy;ka iRrk@fCyLVj

17. QsuksDlh feFkk;y iSuhflfyu xksfy;ka 10 dk 12.08 1237(v) 19.12.2001

250 fexzk-@xksfy;ka iRrk@fCyLVj

18. QsuksDlh feFkk;y iSuhflfyu xksfy;ka 10 dk 23.04 1237(v) 19.12.2001

500 fexzk-@xksfy;ka iRrk@fCyLVj

19. iSuhflfyu th xksfy;ka 4 dk 4.14 764(v) 19.05.2006

300 fexzk-@xksfy;ka iRrk@fCyLVj

20. iSuhflfyu th iksVkf’k;e xksfy;ka 6 dk 3.10 1083(v) 11.07.2006

200 fexzk-@xksfy;ka iRrk@fCyLVj

21. QsuksDlh feFkk;y iSuhflfyu xksfy;ka 8x6 dk 17.80 1237(v) 19.12.2001

65 fexzk-@xksfy;ka iRrk@fCyLVj

22. izksdsu iSuhflfyu th vkSj lksfM;e 1 Mkst+ ok;y 5.02 1355(v) 24.12.2002 eS- ,uihvkbZ,y QksfVZQkbM izksdsucsUTkkby iSuhflfyu th bUtsD’ku iSuhflfyu3 yk[k ;wfuV $ 1 yk[k ;wfuV@ok;y

23. izksdsu iSuhflfyu th vkSj lksfM;e 5 Mkst+ ok;y 9.92 444(v) 29.03.2006 eS- ,yfEcd QksfVZQkbM izksdsucsUTkkby iSuhflfyu th bUtsD’ku iSuhflfyu15 yk[k ;wfuV $ 5 yk[k ;wfuV@ok;y

24. izksdsu iSuhflfyu th vkSj lksfM;e 20 fefy dk 16.90 2039(v) 30.11.2007

csUTkkby iSuhflfyu th bUtsD’ku ok;y30 yk[k ;wfuV $ 10 yk[k ;wfuV@ok;y

25. iSuhflfyu$LVªsIVksekbflu bUtsD’ku 1 Mkst+ ok;y 10.48 610(v) 27.05.2003

izksdsu iSuhflfyu th 3 yk[k ;wfuViSuhflfyu th lksfM;e 1 yk[k ;wfuVLVªsIVksekbflu lYQsV1 fexzk- csl ds cjkcj@ok;y

Page 160: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 141 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

26. iSuhflfyu$LVªsIVksekbflu bUtsD’ku 20 fefy dk 20.34 2039(v) 30.11.2007

izksdsu iSuhflfyu th 15 yk[k ;wfuV ok;yiSuhflfyu th lksfM;e 5 yk[k ;wfuVLVªsIVksekbflu lYQsV2.5 fexzk- csl ds cjkcj@ok;y

27. iSuhflfyu$LVªsIVksekbflu lYQsV$ 30 fefy dk 34.62 2029(v) 30.11.2007

izksdsu iSuhflfyu th$ iSuhflfyu th ok;ylksfM;e bUtsD’kuizksdsu iSuhflfyu th 3000000 yk[k ;wfuViSuhflfyu th lksfM;e 2000000 yk[k ;wfuVLVªsIVksekbflu lYQsVLVªsIVksekbflu 5 fexzk- ds cjkcj@ok;y

28. iSUVktksflu bUtsD’ku&30 1 fefy dk 3.80 1331(v) 01.08.2007 eS- dsfMyk QkekZ QksjLVkjiSUVktksflu 30 fexzk-@fefy ¼ysdVsV esa½ ,Ei;wy eS- jsucsDlh QksVZfou

eS- ck;ksdse iSUVkfoueS- baM&Loh¶V tksflu

29. iSUVktksflu bUtsD’ku&30 10 fefy dk 22.46 1331(v) 01.08.2007

iSUVktksflu 30 fexzk-@fefy ¼ysdVsV esa½ ok;y

30. iSUVktksflu xksfy;ka 10 dk 13.64 1331(v) 01.08.2007

iSUVktksflu ,plh,y iRrk@fCyLVjiSUVktksflu 25 fexzk- ds cjkcj

31. iSUVktksflu$isjkflVkeksy xksfy;ka 10 dk 10.42 1331(v) 01.08.2007 eS- fou esMhds;j ,DliztsfldiSUVktksflu ,plh,y iRrk@fCyLVj eS- lsuksQh ,ofUVl QksVZtsfld15 fexzk- iSUVktksflu ds cjkcj eS- baM&Loh¶V iSUVktsuisjkflVkeksy 500 fexzk-@xksfy;ka

32. iSUVksDlhQkbfyu ,lvkj@lhvkj xksfy;ka&400 10 dk 23.60 1324(v) 19.11.2003 eS- ,ofUVl VªsUVy400 fexzk-@,lvkj@lhvkj xksfy;ka ,,y_fCyLVj eS- lu QkekZ ¶ysDlhVy

eS- fliyk fdusVyeS- lsuksQh flUFksYcks fjc¶ysDleS- fyadksYu QkekZ isUVksokl

33. iSUVksDlhQkbfyu bUtsD’ku&20 15 fefy dk 6.40 1148(v) 20.10.2004 eS- lu QkekZ ¶ysDlhVy20 fexzk-@fefy ,Ei;wy

34. iSUVksDlhQkbfyu bu¶;wt+u 15 fefy dk 6.22 1352(v) 16.09.2005 eS- ,ofUVl VªsUVy300 fexzk-@,Ei;wy ,Ei;wy

35. iSUVksDlhQkbfyu xksfy;ka 10 dk 17.46 167(v) 29.1.2008

400 fexzk-@,lvkj@lhvkj@Mhvkj@ iRrk@fCyLVjbZvkj@,yvkj@,evkj@Vhvkj fVfd;k

Page 161: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 142 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

36. Qsfujkekbu esfy,V xksfy;ka 10 dk 2.16 138(v) 31.01.2002 eS- ,ofUVl QkekZ ,foy25 fexzk-@xksfy;ka ,,y_iRrk

37. Qsfujkekbu esfy,V xksfy;ka 10 dk 1.58 138(v) 31.01.2002 eS- ,ofUVl QkekZ ,foy25 fexzk-@xksfy;ka ,,y_fCyLVj

38. Qsfujkekbu esfy,V xksfy;ka 10 dk 2.74 138(v) 31.01.2002 eS- ,ofUVl QkekZ ,foy50 fexzk-@xksfy;ka ,,y_iRrk

39. Qsfujkekbu esfy,V xksfy;ka 10 dk 2.17 138(v) 31.01.2002 eS- ,ofUVl QkekZ ,foy50 fexzk-@xksfy;ka ,,y_fCyLVj

40. Qsfujkekbu esfy,V bUtsD’ku 2 fefy dk 2.54 138(v) 31.01.2002 eS- ,ofUVl QkekZ ,foy22.75 fexzk-@fefy ,Ei;wy

41. Qsfujkekbu esfy,V bUtsD’ku 10 fefy dk 7.68 204(v) 14.02.2007 eS- ,ofUVl QkekZ ,foy22.75 fexzk-@fefy ok;y

42. Qsfujkekbu esfy,V bUtsD’ku 10 fefy dk 8.58 204(v) 14.02.2007 eS- ,ofUVl QkekZ ,foy22.75 fexzk-@fefy ok;y dkVZu lfgr

43. Qsfujkekbu esfy,V ,DlisDVksjsUV 100 fefy dh 10.86 138(v) 31.01.2002

Qsfujkekbu esfy,V 15 fexzk- cksry,eksfu;e DyksjkbM 125 fexzk-esUFkksy 1.14 fexzk-@5 fefy

44. Qsfujkekbu esfy,V ,DlisDVksjsUV 100 fefy dh 11.34 138(v) 31.01.2002

Qsfujkekbu esfy,V 15 fexzk- cksry ,e-di,eksfu;e DyksjkbM 125 fexzk- lfgresUFkksy 1.14 fexzk-@5 fefy

45. Qsfujkekbu esfy,V$,eksfu;e DyksjkbM$ 400 fefy dh 25.91 1335(v) 01.08.2007

eSUFkksy ,DlisDVksjsUV cksryQsfujkekbu esfy,V 15 fexzk-,eksfu;e DyksjkbM 125 fexzk-esUFkksy 1.14 fexzk-@fefy

46. fQuk;y cwVkt+ksu xksfy;ka&100 10 dk 1.98 430(v) 28.03.2005

100 fexzk-@xksfy;ka ,,y_iRrk

47. fQuk;y cwVkt+ksu xksfy;ka&100 10 dk 1.70 430(v) 28.03.2005

100 fexzk-@xksfy;ka ,,y_fCyLVj

48. fQuk;y cwVkt+ksu xksfy;ka&200 10 dk 3.10 430(v) 28.03.2005

200 fexzk-@xksfy;ka ,,y_iRrk

49. fQuk;y cwVkt+ksu xksfy;ka&200 10 dk 2.74 430(v) 28.03.2005

200 fexzk-@xksfy;ka ,,y_fCyLVj

Page 162: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 143 -

50. fQuk;y cwVkt+ksu lksfM;e bUtsD’ku 5x3 fefy dk 15.12 178(v) 09.03.1998

200 fexzk-$ 10 fexzk-¼fyxuksdsu½@fefy ,Ei;wy

51. izsMuhlksyksu xksfy;ka 10 dk 1.47 227(v) 14.02.2007

izsMuhlksyksu 2 fexzk-@xksfy;ka iRrk@fCyLVj

52. izsMuhlksyksu xksfy;ka 10 dk 2.64 437(v) 23.03.2007

izsMuhlksyksu ,sflVsV 2.5 fexzk-@ iRrk@fCyLVj?kqyu’khy xksfy;ka

53. izsMuhlksyksu xksfy;ka&5 10 dk 3.48 170(v) 07.02.2006 eS- esdfy;ksMl vkseusdksfVZy5 fexzk-@xksfy;ka iRrk@fCyLVj eS- ok;Fk izsMuhlksyksu

eS- fliyk izsMksueS- esMks QkekZ ,elksyksueS- teZu jsesfMt+ izsMh

54. izsMuhlksyksu xksfy;ka&5 1000 dh 375.24 948(v) 17.12.1993 eS- ykdZ ysc izsMuhlksyksu5 fexzk-@xksfy;ka cksry

55. izsMuhlksyksu xksfy;ka&10 10 dk 6.24 170(v) 07.02.2006 eS- esdfy;ksMl QkekZ vkseusdksfVZy10 fexzk-@xksfy;ka iRrk@fCyLVj eS- ok;Fk ok;lksyksu

eS- fliyk izsMksueS- esMks QkekZ ,elksyksueS- esudkbaM fu;wdksVZ

56. izsMuhlksyksu xksfy;ka&20 10 dk 11.44 170(v) 07.02.2006 eS- esdfy;ksMl QkekZ vkseusdksfVZy20 fexzk-@xksfy;ka iRrk@fCyLVj eS- ok;Fk ok;lksyksu

eS- fliyk izsMksueS- esMks QkekZ ,elksyksueS- vksojlht+ ,DVhdksVZ

57. izsMuhlksyksu xksfy;ka&25 10 dk 6.77 760(v) 19.05.2006

25 fexzk-@xksfy;ka iRrk@fCyLVj

58. izsMuhlksyksu xksfy;ka&30 10 dk 17.30 170(v) 07.02.2006 eS- esdfy;ksMl QkekZ vkseusdksfVZy30 fexzk-@xksfy;ka iRrk@fCyLVj eS- ok;Fk ok;lksyksu

eS- lkbdksVªksfiDl Msylksu

59. izsMuhlksyksu xksfy;ka&40 10 dk 22.12 170(v) 07.02.2006 eS- esdfy;ksMl QkekZ vkseusdksfVZy40 fexzk-@xksfy;ka iRrk@fCyLVj eS- ok;Fk ok;lksyksu

eS- lkbdksVªksfiDl MsylksueS- esMks QkekZ ,elksyksueS- esudkbaM fu;wdksVZ

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 163: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 144 -

60. izsMuhlksyksu flji 60 fefy dh 12.50 1350(v) 16.09.2005 eS- fliyk izsMksuizsMuhlksyksu ,sflVsV 5 fexzk-@ 5 fefy cksry ,e-di eS- jksgu iksyad fdM izsM

lfgr eS- csLVksdse cslksu

61. izsMuhlksyksu flji 60 fefy dh 19.39 437(v) 23.03.2007 eS- esdfy;ksMl QkekZ vkseusdksfVZyizsMuhlksyksu ,sflVsV 15 fexzk-@ 5 fefy cksry ,e-di eS- fliyk izsMksu

lfgr eS- jksgu iksyad fdM izsM

62. izsMuhlksyksu flji 60 fefy dh cksry 14.08 760(v) 19.05.2006

izsMuhlksyksu 5 fexzk-@ 5 fefy ,e-di lfgr

63. izsMuhlksyksu flji 60 fefy dh cksry 20.14 760(v) 19.05.2006

izsMuhlksyksu 15 fexzk-@ 5 fefy ,e-di lfgr

64. izsMuhlksyksu flji@lLisUlu 30 fefy dh cksry 8.66 437(v) 23.03.2007

izsMuhlksyksu 5 fexzk-@ 5 fefy

65. izsMuhlksyksu flji@lLisUlu 30 fefy dh cksry 9.16 437(v) 23.03.2007

izsMuhlksyksu 5 fexzk-@ 5 fefy ,e-di lfgr

66. feFkk;y izsMuhlksyksu ,sflVsV ,Ei;wy 1 fefy dk 20.02 437(v) 23.03.2007

40 fexzk-@ fefy ,Ei;wy

67. feFkk;y izsMuhlksyksu ok;y 2 fefy dk 38.10 760(v) 19.05.2006

40 fexzk-@ fefy ok;y

68. feFkk;y izsMuhlksyksu ,sflVsV bUtsD’ku 1 fefy dk 22.10 437(v) 23.03.2007

40 fexzk-@ fefy ok;y

69. izsMuhlksyksu $,YdksgWy flji 60 fefy dh cksry 16.16 227(v) 14.02.2007

izsMuhlksyksu lksfM;e QksLQsV-5 fexzk- ,e- di lfgr,YdksgWy-(95%) 5%

70. izsMuhlksyksu $,YdksgWy flji 60 fefy dh cksry 29.60 437(v) 23.03.2007

izsMuhlksyksu lksfM;e QksLQsV-15 fexzk- ,e- di lfgr,YdksgWy-(95%) 5%

71. izsMuhlksyksu lLisUlu 60 fefy dh cksry 20.40 227(v) 14.02.2007

izsMuhlksyksu lksfM;e QksLQsV ,e- di lfgrizsMuhlksyksu -5 fexzk- ds cjkcj

72. feFkk;y izsMuhlksyksu ,sflVsV bUtSD’ku 2 fefy dk lQsn 37.27 1344(v) 01.08.2007

40 fexzk-@ fefy ,Ei;wy Vªs esa

73. feFkk;y izsMuhlksyksu ,sflVsV bUtSD’ku 2 fefy dk lQsn 37.27 1344(v) 01.08.2007

40 fexzk-@ fefy ,Ei;wy fCyLVj esa

74. feFkk;y izsMuhlksyksu ,sflVsV bUtSD’ku 2 fefy dk ,Ecj 37.27 1344(v) 01.08.2007

40 fexzk-@ fefy ,Ei;wy Vªs esa

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 164: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 145 -

75. feFkk;y izsMuhlksyksu ,sflVsV bUtSD’ku 2 fefy dk ,Ecj 37.27 1344(v) 01.08.2007

40 fexzk-@ fefy ,Ei;wy fCyLVj esa

76. izsMuhlksyksu$vkW¶yksDlhu$ 5 fefy dh 10.48 2052(v) 30.11.2007csUtydksfu;e DyksjkbM vka[k@ cksrydku dk MªksiizsMuhlksyksu ,sflVsV-10 fexzk-vkW¶yksDlhu-3 fexzk-csUtydksfu;e DyksjkbM-0.02% oh@oh@fefy

77. feFkk;y izsMuhlksyksu bUtSD’ku 1 fefy dk 15.50 2052(v) 30.11.2007

feFkk;y izsMuhlksyksu-40 fexzk- ok;y

78. feFkk;y izsMuhlksyksu bUtSD’ku 2 fefy dk 25.56 2052(v) 30.11.2007feFkk;y izsMuhlksyksu ,sflVsV-40 fexzk- ok;y

79 feFkk;y izsMuhlksyksu bUtSD’ku 1 fefy dk 12.98 2052(v) 30.11.2007feFkk;y izsMuhlksyksu-40 fexzk- lQsn ,Ei;wy

fCyLVj iSd esa

80. feFkk;y izsMuhlksyksu bUtSD’ku 1 fefy dk 12.96 2052(v) 30.11.2007feFkk;y izsMuhlksyksu-40 fexzk- lQsn ,Ei;wy

Vªs iSd esa

81. feFkk;y izsMuhlksyksu bUtSD’ku 1 fefy dk 13.16 2052(v) 30.11.2007feFkk;y izsMuhlksyksu-40 fexzk- ,Ecj ,Ei;wy

fCyLVj iSd esa

82. feFkk;y izsMuhlksyksu bUtSD’ku 1 fefy dk 13.14 2052(v) 30.11.2007feFkk;y izsMuhlksyksu-40 fexzk- ,Ecj ,Ei;wy

Vªs iSd esa

83. feFkk;y izsMuhlksyksu bUtSD’ku 2 fefy dk 24.54 2052(v) 30.11.2007feFkk;y izsMuhlksyksu-40 fexzk- lQsn ,Ei;wy

fCyLVj iSd esa

84. feFkk;y izsMuhlksyksu bUtSD’ku 2 fefy dk 24.50 2052(v) 30.11.2007feFkk;y izsMuhlksyksu-40 fexzk- lQsn ,Ei;wy

Vªs iSd esa

85. feFkk;y izsMuhlksyksu bUtSD’ku 2 fefy dk 24.60 2052(v) 30.11.2007feFkk;y izsMuhlksyksu-40 fexzk- ,Ecj ,Ei;wy

fCyLVj iSd esa

86. feFkk;y izsMuhlksyksu bUtSD’ku 2 fefy dk 24.56 2052(v) 30.11.2007feFkk;y izsMuhlksyksu-40 fexzk- ,Ecj ,Ei;wy

Vªs iSd esa

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 165: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 146 -

87. feFkk;y izsMuhlksyksu ,sflVsV bUtSD’ku 1 fefy dk 12.98 2052(v) 30.11.2007feFkk;y izsMuhlksyksu ,sflVsV lQsn ,Ei;wyfeFkk;y izsMuhlksyksu -40 fexzk- ds cjkcj fCyLVj iSd esa

88. feFkk;y izsMuhlksyksu ,sflVsV bUtSD’ku 1 fefy dk 13.14 2052(v) 30.11.2007feFkk;y izsMuhlksyksu ,sflVsV lQsn ,Ei;wyfeFkk;y izsMuhlksyksu-40 fexzk- ds cjkcj Vªs iSd esa

89. feFkk;y izsMuhlksyksu ,sflVsV bUtSD’ku 1 fefy dk 13.16 2052(v) 30.11.2007feFkk;y izsMuhlksyksu ,sflVsV ,Ecj ,Ei;wyfeFkk;y izsMuhlksyksu -40 fexzk- ds cjkcj fCyLVj iSd esa

90. feFkk;y izsMuhlksyksu xksfy;ka 10 dk 42.32 177(v) 29.01.2008feFkk;y izsMuhlksyksu -16 fexzk- iRrk@fCyLVj

91 feFkk;y izsMuhlksyksu xksfy;ka 10 dk 11.40 177(v) 29.01.2008feFkk;y izsMuhlksyksu -4 fexzk- iRrk@fCyLVj

92. ik;jsUVy iseks,sV xksfy;ka&200 2 dk 2.70 194(v) 11.03.1998 eS- Qkbt+j dksEckfUVªu200 fexzk- csl@xksfy;ka ,,y_fCyLVj

93. ik;jsUVy iseks,sV xksfy;ka&200 20x2 dk 54.08 194(v) 11.03.1998 eS- Qkbt+j dksEckfUVªu200 fexzk- csl@xksfy;ka ,,y_fCyLVj

94. ik;jsUVy iseks,sV xksfy;ka&250 3 dk 6.60 194(v) 11.03.1998 eS- bidk fueksflM250 fexzk- csl@xksfy;ka ,,y_iRrk eS- b;wQksfjd ih,&ih,

95. ik;jsUVy iseks,sV xksfy;ka&250 3 dk 7.14 185(v) 07.02.2006

250 fexzk- csl@xksfy;ka iRrk@fCyLVj

96. ik;jsUVy iseks,sV flji 8 fefy dh 4.94 194(v) 11.03.1998 eS- esfjaM ,DlisUV25 fexzk- csl@fefy cksry

97. ik;jsUVy iseks,sV lLisUlu 10 fefy dh cksry 10.38 437(v) 29.03.2006 eS- esfjaM ,DlisUVik;jsUVy iseks,sV ,e- di vkSj eS- bafMdk oksjfed&,lMh250 fexzk- ik;jsUVy ds cjkcj@ 5 fefy dkVZu lfgr

98. ik;jsUVy iseks,sV$escsuMktksy xksfy;ka 2 dk 2.58 223(v) 14.02.2007

ik;jsUVy iseks,sV - 100 fexzk- iRrk@fCyLVjescsuMktksy - 150 fexzk-@ xksfy;ka

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 166: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 147 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

vkj (R)

1. jsuhfVMhu ,plh,y xksfy;ka&75 10 dk 7.52 1337(v) 16.09.2005 eS- dsfMyk ,p- ds;j vkj&yksdjsuhfVMhu ,plh,y ,,y_iRrk eS- ekbØks uksok tk;uksy75 fexzk- jsuhfVMhu ds cjkcj@xksfy;ka ¼?kqyu’khy½

2. jsuhfVMhu ,plh,y xksfy;ka&75 10 dk 7.16 1337(v) 16.09.2005 eS- dsfMyk ,p- ds;j vkj&yksdjsuhfVMhu ,plh,y ,,y_fCyLVj eS- ekbØks uksok tk;uksy75 fexzk- jsuhfVMhu ds cjkcj@xksfy;ka ¼?kqyu’khy½

3. jsuhfVMhu ,plh,y xksfy;ka&150 10 dk 4.52 205(v) 14.02.2007 eS- dsfMyk ,flyksdjsuhfVMhu ,plh,y ,,y_iRrk eS- ,cksV ,Mosus150 fexzk- jsuhfVMhu ds cjkcj@ eS- jsucsDlh fglVsdxksfy;ka ¼fyfir@lknh½

4. jsuhfVMhu ,plh,y xksfy;ka&150 10 dk 4.00 1336(v) 16.09.2005 eS- cky QkekZ jsuljjsuhfVMhu ,plh,y ,,y_fCyLVj eS- ,LVªk tsusdk fxjku150 fexzk- jsuhfVMhu ds cjkcj@xksfy;ka ¼fyfir@lknh½

5. jsuhfVMhu ,plh,y xksfy;ka&300 10 dk 7.78 205(v) 14.02.2007 eS- dsfMyk ,flyksdjsuhfVMhu ,plh,y ,,y_iRrk eS- ,cksV ,Mosus300 fexzk- jsuhfVMhu ds cjkcj@ eS- jsucsDlh fglVsdxksfy;ka ¼fyfir@lknh½

6. jsuhfVMhu ,plh,y xksfy;ka&300 10 dk 7.01 1336(v) 16.09.2005 eS- baM&Loh¶V ,tVsdjsuhfVMhu ,plh,y ,,y_fCyLVj eS- fliyk oYVsd300 fexzk- jsuhfVMhu ds cjkcj@xksfy;ka ¼fyfir@lknh½

7. jsuhfVMhu bUtsD’ku 5x2 fefy dk 14.96 205(v) 14.02.2007 eS- MhMCY;wMh QkekZ baVsdjsuhfVMhu ,plh,y ,Ei;wy50 fexzk- jsuhfVMhu ds cjkcj@fefy

8. jsuhfVMhu bUtsD’ku 2 fefy dk 2.34 1336(v) 16.09.2005 eS- baM&Loh¶V ,tVsdjsuhfVMhu ,plh,y ,Ei;wy eS- VksjsUV jsuhfVu25 fexzk- jsuhfVMhu ds cjkcj@fefy eS- Mk;ukfed ysc dksVsd

9. jsuhfVMhu bUtsD’ku 2 fefy dk 2.70 1337(v) 16.09.2005 eS- dsfMyk ,flyksdjsuhfVMhu ,plh,y ,Ei;wy eS- jsucsDlh fglVsd50 fexzk- jsuhfVMhu ds cjkcj@fefy

Page 167: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 148 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

dEchus’ku

10. jsuhfVMhu$MkbZlkbDyksekbu xksfy;ka 10 dk 4.60 1670(v) 03.10.2006 eS- fl,LVk QkekZ ,fllikljsuhfVMhu ,plh,y ,,y_iRrk eS- banw MªXl dksfyVsd150 fexzk- jsuhfVMhu ds cjkcjMkbZlkbDyksekbu 10 fexzk-@xksfy;ka¼fyfir@lknh½

11. jsuhfVMhu$MkbZlkbDyksekbu xksfy;ka 10 dk 4.24 1336(v) 16.09.2005 eS- czkWu vkjMh&jsuhfVMhu ,plh,y ,,y_fCyLVj eS- ,fDVo ,p- ds;j lkbdyksju150 fexzk- jsuhfVMhu ds cjkcj eS- vYVªkekdZ ,p- ds;j LisleksfMuMkbZlkbDyksekbu 10 fexzk-@xksfy;ka¼fyfir@lknh½

12. jsuhfVMhu$MkseisjhMksu xksfy;ka 10 dk 5.20 438(v) 29.03.2006 eS- QkbuD;wj jsusl&MhjsuhfVMhu ,plh,y ,,y_iRrk eS- bZLV vQjhdu jsfufoj&Mh150 fexzk- jsuhfVMhu ds cjkcjMkseisjhMksu 10 fexzk-@xksfy;ka¼fyfir@lknh½

13. jsuhfVMhu$MkseisjhMksu xksfy;ka 10 dk 4.85 1336(v) 16.09.2005 eS- fl,LVk QkekZ ,fllikljsuhfVMhu ,plh,y ,,y_fCyLVj eS- eSVªks QkekZ jsuhVksy&Mh150 fexzk- jsuhfVMhu ds cjkcj eS- lkbij lkbikVsd&MhMkseisjhMksu 10 fexzk-@xksfy;ka¼fyfir@lknh½

14. jsuhfVMhu$MkseisjhMksu xksfy;ka 10 dk 5.46 1337(v) 16.09.2005 eS- dsUMksj ck;ksVsd dsUMksVsdjsuhfVMhu ,plh,y iRrk@fCyLVj150 fexzk- jsuhfVMhu ds cjkcjMkseisjhMksu 20 fexzk-@xksfy;ka

15. jsuhfVMhu$MkseisjhMksu xksfy;ka 10 dk 5.16 1337(v) 16.09.2005

jsuhfVMhu ,plh,y iRrk@fCyLVj150 fexzk- jsuhfVMhu ds cjkcjMkseisjhMksu 15 fexzk-@xksfy;ka

16. jsuhfVMhu$MkseisjhMksu$esxkYMjsV xksfy;ka 10 dk 5.76 1337(v) 16.09.2005 eS- flaVks vksjxsfud MksfeV&,ejsuhfVMhu ,plh,y iRrk@fCyLVj eS- esQjks QkekZ jsfuVksy&Mh150 fexzk- jsuhfVMhu ds cjkcjMkseisjhMksu 10 fexzk-esxkYMjsV 400 fexzk-@xksfy;ka

Page 168: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 149 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

17. jsuhfVMhu$esxyMªsV xksfy;ka 10 dk 4.34 1337(v) 16.09.2005

jsuhfVMhu ,plh,y iRrk@fCyLVj150 fexzk- jsuhfVMhu ds cjkcjesxyMªsV 200 fexzk-@¼lknh@fyfir xksfy;ka½

18. jsuhfVMhu$MkbZlkbDyksekbu$ 10 dk 5.32 1337(v) 16.09.2005 eS- ,aVhtu ,p- ds;j jsulhfdfyfMfu;e czksekbM xksfy;ka iRrk@fCyLVjjsuhfVMhu ,plh,y150 fexzk- jsuhfVMhu ds cjkcjMkbZlkbDyksekbu 10 fexzk-fdfyfMfu;e czksekbM 2.5 fexzk-@xksfy;ka

19. jsuhfVMhu$MªksVkofju xksfy;ka 10 dk 11.60 1337(v) 16.09.2005 eS- gsysDl ,p- ds;j okseflM&MhohjsuhfVMhu ,plh,y iRrk@fCyLVj eS- fMldojh esudkbaMjsfulikl&Mhoh150 fexzk- jsuhfVMhu ds cjkcjMªksVkofju 40 fexzk-@xksfy;ka

20. jsuhfVMhu$vksuMsULVªksu xksfy;ka 10 dk 5.72 1337(v) 16.09.2005 eS- csLVksdse Mksjsu&vksjsuhfVMhu ,plh,y iRrk@fCyLVj eS- ,Dlds;j mMsu&vkj150 fexzk- jsuhfVMhu ds cjkcj eS- esudkbaM jsuhMkse&vksvksuMsUlVªksu 4 fexzk-@xksfy;ka eS- eksjkfll jsuksy&vks

21. jsuhfVMhu$vksuMsULVªksu bUtsD’ku 2 fefy dk 2.72 1337(v) 16.09.2005 eS- csLVksdse Mksjsu&vksjsuhfVMhu ,plh,y ,Ei;wy25 fexzk- jsuhfVMhu ds cjkcjvksuMsUlVªksu 2 fexzk-@fefy

22. jsuhfVMhu$ fllkizkbM xksfy;ka 10 dk 7.28 1336(v) 16.09.2005

jsuhfVMhu ,plh,y ,,y_iRrkjsuhfVMhu&150 fexzk- ds cjkcjfllkizkbM&10 fexzk-

23. jsuhfVMhu$MkseisfjMksu xksfy;ka 10 dk 7.00 1336(v) 16.09.2005

jsuhfVMhu ,plh,y ,,y_fCyLVjjsuhfVMhu&150 fexzk- ds cjkcjfllkizkbM&10 fexzk-

24. jsfufVMhu$MkbZDyksekbu$ 10 dk 3.58 762(v) 19.05.2006

lkbesfFkdksu xksfy;ka iRrk@fCyLVjjsfufVMhu ,plh,y&150 fexzk-MkbZDyksekbu ,plh,y&10 fexzk-lkbesfFkdksu&25 fexzk-

Page 169: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 150 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

25. jsfufVMhu$esxyMªsV$ 10 dk 6.26 762(v) 19.05.2006

MkseisfjMksu xksfy;ka iRrk@fCyLVjjsfufVMhu &150 fexzk-esxyMªsV&200 fexzk-MkseisfjMksu &10 fexzk-

26. jsfufVMhu$MkbZDyksekbu$ 2 fefy dk 3.14 1067(v) 11.07.2006

Qsuksy bUtSD’ku ,Ei;wyizR;sd 2 fefy esajsfufVMhu&25 fexzk-MkbZDyksekbu&10 fexzk-Qsuksy&0.5%

27. jsuhfVfMu$fQuk;y ,Ei;wy 5 fefy dk 5.34 2051(v) 30.11.2007jsuhfVfMu-125 fexzk- ,Ei;wyfQuk;y-0.5% MCY;w@MCY;w

28. fjQsEihflu dSilwy&150 10 dk 14.74 440(v) 29.03.2006 eS- ihlhvkbZ fjQsfDyu150 fexzk-@dSilwy iRrk@fCyLVj

29. fjQsEihflu dSilwy&150 100 dh cksry 145.08 440(v) 29.03.2006 eS- ihlhvkbZ fjQsfDyu150 fexzk-@dSilwy

30. fjQsEihflu dSilwy&300 100 dh 261.90 836(v) 15.06.2005 eS- uksokjfVl fjesdVsu300 fexzk-@dSilwy cksry

31. fjQsEihflu dSilwy&300 10 dk 26.50 440(v) 29.03.2006 eS- esdfy;ksMl esdksl300 fexzk-@dSilwy iRrk@fCyLVj eS- Y;wfiu vkj&flu

32. fjQsEihflu dSilwy&450 10 dk 38.38 440(v) 29.03.2006 eS- yk lsUVs~ ,y,y fjQ450 fexzk-@dSilwy iRrk@fCyLVj eS- Y;wfiu vkj&flu

eS- dulsIV fjQklsIVeS- ck;ksdse fjQkekbflueS- iysfFkdks eksUVksekbflu&450

33. fjQsEihflu dSilwy&600 10 dk 50.76 440(v) 29.03.2006 eS- Vksjl ysc VksfjQ600 fexzk-@dSilwy iRrk@fCyLVj

34. fjQsEihflu$vkblksfu;kt+kbM dSilwy 10 dk 41.84 440(v) 29.03.2006 eS- ,fjLVks dksDlhusDl450 fexzk-$ 300 fexzk-@dSilwy iRrk@fCyLVj eS- ykdZ ysc QsehusDl

eS- ck;ksdse vkblksfjQseeS- Y;wfiu vkj&flu

Page 170: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 151 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

35. fjQsEihflu$vkblksfu;kt+kbM$ 4 dk 10.50 837(v) 15.06.2005

ik;jkftukekbM dSilwy iRrk@fCyLVj150 fexzk-$ 100 fexzk-$ 500 fexzk-@dSilwy

36. fjQsEihflu xksfy;ka&50 10 dk 5.66 836(v) 15.06.2005

50 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj

37. fjQsEihflu xksfy;ka&100 10 dk 9.54 836(v) 15.06.2005

100 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj

38. fjQsEihflu xksfy;ka&150 10 dk 13.33 836(v) 15.06.2005 eS- Fksfel Vh&flu150 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj

39. fjQsEihflu xksfy;ka&150 100 dh 128.40 836(v) 15.06.2005

150 fexzk-@xksfy;ka ¼fyfir½ cksry

40. fjQsEihflu xksfy;ka&300 10 dk 25.00 836(v) 15.06.2005 eS- Fksfel Vh&flu300 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj

41. fjQsEihflu xksfy;ka&300 100 dh 243.76 836(v) 15.06.2005

300 fexzk-@xksfy;ka ¼fyfir½ cksry

42. fjQsEihflu xksfy;ka&450 10 dk 37.38 836(v) 15.06.2005 eS- Fksfel Vh&flu450 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj

43. fjQsEihflu xksfy;ka&600 10 dk 49.10 836(v) 15.06.2005 eS- Vksjl ysc VksfjQ600 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj

44. fjQsEihflu$vkblksfu;kt+kbM xksfy;ka 6 dk 4.38 440(v) 29.03.200660 fexzk-$ 30 fexzk-@xksfy;ka iRrk@fCyLVj

45. fjQsEihflu$vkblksfu;kt+kbM xksfy;ka 10 dk 10.26 837(v) 15.06.2005 eS- Y;wfiu vkj&lkbusDl100 fexzk-$ 50 fexzk-@xksfy;ka iRrk@fCyLVj eS- ØsLi fjfQusDl

eS- esdfy;ksMl esdksDl IyleS- iysfFkdks eksUVksusDl fdM

46. fjQsEihflu$vkblksfu;kt+kbM xksfy;ka 10 dk 11.06 440(v) 29.03.2006 eS- ;wfudse ,aVhdksDl&II fdM100 fexzk-$ 100 fexzk-@xksfy;ka iRrk@fCyLVj eS- Y;wfiu vkj&lkbusDl

eS- cky QkekZ vkj&ftMeS- isusfl;k ck;ksVsd ,DlhM&2

47. fjQsEihflu$vkblksfu;kt+kbM xksfy;ka 6 dk 9.42 440(v) 29.03.2006

150 fexzk-$ 75 fexzk-@xksfy;ka iRrk@fCyLVj

Page 171: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 152 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

48. fjQsEihflu$vkblksfu;kt+kbM xksfy;ka 10 dk 45.28 440(v) 29.03.2006 eS- ,ydse dksDlVj&2450 fexzk-$ 300 fexzk-@xksfy;ka iRrk@fCyLVj eS- vkbZMhih,y Qseflu&,p

eS- esdfy;ksMl esdksDl IyleS- ykW lsUVs~ ekbdksDleS- lqfut+ QkekZ vkj,Q dEikmaM

49. fjQsEihflu$vkblksfu;kt+kbM xksfy;ka 10 dk 54.64 440(v) 29.03.2006

600 fexzk-$ 300 fexzk-@xksfy;ka ¼fyfir½ iRrk@fCyLVj

50. fjQsEihflu$vkblksfu;kt+kbM$ 6 dk 6.24 440(v) 29.03.2006

ik;jkftukekbM xksfy;ka iRrk@fCyLVj100 fexzk-$ 50 fexzk-$ 300 fexzk-@xksfy;ka ¼fyfir½

51. fjQsEihflu$vkblksfu;kt+kbM$ 10 dk 15.34 837(v) 15.06.2005 eS- esdfy;ksMl esdksDl Iylik;jkftukekbM xksfy;ka iRrk@fCyLVj100 fexzk-$ 50 fexzk-$ 300 fexzk-@xksfy;ka ¼fyfir½

52. fjQsEihflu$vkblksfu;kt+kbM$ 10 dk 16.18 837(v) 15.06.2005 eS- ,ofUVl fjQkVjik;jkftukekbM xksfy;ka iRrk@fCyLVj eS- lqfut+ QkekZ fji120 fexzk-$ 80 fexzk-$ 250 fexzk-@xksfy;ka ¼fyfir½

53. fjQsEihflu$vkblksfu;kt+kbM$ 6 dk 12.70 838(v) 15.06.2005 eS- ykW lsUVs~ ekbD;wfjV&tsMik;jkftukekbM xksfy;ka iRrk@fCyLVj150 fexzk-$ 75 fexzk-$ 400 fexzk-@xksfy;ka ¼fyfir½

54. fjQsEihflu$vkblksfu;kt+kbM$ 10 dk 19.86 837(v) 15.06.2005

ik;jkftukekbM xksfy;ka iRrk@fCyLVj150 fexzk-$ 150 fexzk-$ 350 fexzk-@xksfy;ka ¼fyfir½

55. fjQsEihflu$vkblksfu;kt+kbM$ 6 dk 16.36 837(v) 15.06.2005

ik;jkftukekbM xksfy;ka iRrk@fCyLVj150 fexzk-$ 150 fexzk-$ 500 fexzk-@xksfy;ka ¼fyfir½

56. fjQsEihflu$vkblksfu;kt+kbM$ 10 dk 24.74 440(v) 29.03.2006 eS- lqfut+ QkekZ vkj,Q&3ik;jkftukekbM xksfy;ka iRrk@fCyLVj eS- ,ydse dksDlVj&3 ,QMh150 fexzk-$ 100 fexzk-$ 500 fexzk-@xksfy;ka ¼fyfir½ eS- QkjesM fjQkyfMuk&2

57. fjQsEihflu$vkblksfu;kt+kbM$ 10 dk 29.64 837(v) 15.06.2005 eS- lqfut+ QkekZ vkj,Q&3 QksVZik;jkftukekbM xksfy;ka iRrk@fCyLVj eS- Fksfel VªkbZdksDl225 fexzk-$ 150 fexzk-$ 500 fexzk-@xksfy;ka ¼fyfir½

58. fjQsEihflu$vkblksfu;kt+kbM$ 10 dk 35.86 440(v) 29.03.2006 eS- ykW lsUVs~ ekbdksDl&tsMik;jkftukekbM xksfy;ka iRrk@fCyLVj eS- Fksfel VªkbZdksDl&1500

225 fexzk-$ 150 fexzk-$ 750 fexzk-@xksfy;ka ¼fyfir½ eS- ck;ksyksftdy bZ ckbZusDl&tsMeS- esdfy;ksMl esdksDl&tsM,p

Page 172: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 153 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

59. fjQsEihflu$vkblksfu;kt+kbM$ 10 dk 15.28 440(v) 29.03.2006

bFkkeC;wVksy xksfy;ka iRrk@fCyLVj150 fexzk-$ 75 fexzk-$ 275 fexzk-@xksfy;ka¼fyfir½

60. fjQsEihflu$vkblksfu;kt+kbM$ 10 dk 10.26 837(v) 15.06.2005 eS- bidk bidkfluik;fjMksDlhu xksfy;ka iRrk@fCyLVj100 fexzk-$ 100 fexzk-$ 5 fexzk-@xksfy;ka ¼fyfir½

61. fjQsEihflu$vkblksfu;kt+kbM$ 10 dk 40.88 837(v) 15.06.2005 eS- dsfMyk ,p- ds;j lh,Dl&3ik;fjMksDlhu xksfy;ka iRrk@fCyLVj450 fexzk-$ 300 fexzk-$ 10 fexzk-@xksfy;ka ¼fyfir½

62. fjQsEihflu$vkblksfu;kt+kbM$ 10 dk 35.26 440(v) 29.03.2006

ik;jkftukekbM$bFkkeC;wVksy xksfy;ka iRrk@fCyLVj150 fexzk-$ 100 fexzk-$500 fexzk-$ 267 fexzk-@xksfy;ka ¼fyfir½

63. fjQsEihflu$vkblksfu;kt+kbM$ 6 dk 20.22 440(v) 29.03.2006

ik;jkftukekbM$bFkkeC;wVksy xksfy;ka iRrk@fCyLVj150 fexzk-$ 75 fexzk-$400 fexzk-$ 275 fexzk-@xksfy;ka ¼fyfir½

64. fjQsEihflu$vkblksfu;kt+kbM$ 10 dk 49.46 440(v) 29.03.2006 eS- Fksfel VsVªkdksDlik;jkftukekbM$bFkkeC;wVksy xksfy;ka ,,y_ihohMhlh225 fexzk-$ 150 fexzk-$ fCyLVj750 fexzk-$ 400 fexzk-@xksfy;ka ¼fyfir½

65. fjQsEihflu$vkblksfu;kt+kbM$ 2 dk 8.12 1356(v) 16.09.2005 eS- ;wfudse ,aVhdksDl&3bFkkeC;wVksy xksfy;ka iRrk@fCyLVj eS- ekdZ bafM;k dksDlohu&3izR;sd xksfy;ksa esafjQsEihflu 450 fexzk-vkblksfu;kt+kbM 300 fexzk-bFkkeC;wVksy 800 fexzk-

66. fjQsEihflu$vkblksfu;kt+kbM$ 5 dk 20.24 1356(v) 16.09.2005 eS- oksdkMZ oksdsDl&4 Iylik;fjMksDlhu xksfy;ka iRrk@fCyLVjizR;sd xksfy;ksa esafjQsEihflu 600 fexzk-vkblksfu;kt+kbM 300 fexzk-ik;fjMksDlhu ,plh,y 10 fexzk-

Page 173: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 154 -

67. fjQSfEiflu$vkblksfu;ktkbM$ 10 dk iRrk@fCyLVj 55.44 761(v ) 19.05.2006

ik;jkftukekbM xksfy;ka

fjQSfEiflu&450 fexzk-

vkblksfu;ktkbM&225 fexzk-ik;jkftukekbM&825 fexzk-

68. fjQSfEiflu$vkblksfu;ktkbM$ 10 dk iRrk@fCyLVj 34.61 761(v ) 19.05.2006

ik;jkftukekbM$bFkkeC;wVksy xksfy;kafjQSfEiflu&150 fexzk-vkblksfu;ktkbM&225 fexzk-ik;jkftukekbM&400 fexzk-bFkkeC;wVksy&275 fexzk-

69. fjQSfEiflu$vkblksfu;ktkbM$ 10 dk iRrk@fCyLVj 53.35 761(v ) 19.05.2006

bFkkeC;wVksy xksfy;ka

fjQSfEiflu&450 fexzk-vkblksfu;ktkbM&225 fexzk-

bFkkeC;wVksy&825 fexzk-

70. fjQSfEiflu$ 10 dk iRrk@fCyLVj 36.26 761(v ) 19.05.2006

vkblksfu;ktkbM xksfy;kafjQSfEiflu&450 fexzk-

vkblksfu;ktkbM&225 fexzk-

71. fjQSfEiflu$ 10 dk iRrk@fCyLVj 24.56 761(v ) 19.05.2006

vkblksfu;ktkbM xksfy;kafjQSfEiflu&300 fexzk-

vkblksfu;ktkbM&150 fexzk-

72. fjQSfEiflu$ 10 dk iRrk@fCyLVj 9.20 761(v ) 19.05.2006

vkblksfu;ktkbM xksfy;ka

fjQSfEiflu&100 fexzk-

vkblksfu;ktkbM&75 fexzk-

73. fjQSfEiflu$vkblksfu;ktkbM$ 10 dk iRrk@fCyLVj 8.30 761(v ) 19.05.2006

ik;jkftukekbM xksfy;ka

fjQSfEiflu&60 fexzk-

vkblksfu;ktkbM&30 fexzk-ik;jkftukekbM&100 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 174: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 155 -

74. fjQSfEiflu$vkblksfu;ktkbM$ 10 dk iRrk@fCyLVj 15.66 761(v ) 19.05.2006ik;fjMksDlhu $ik;jkftukekbM xksfy;kafjQSfEiflu&100 fexzk-vkblksfu;ktkbM&100 fexzk-ik;fjMksDlhu ,plh,y&5 fexzk-ik;jkftukekbM&300 fexzk-

75. fjQSfEiflu$ 10 dk iRrk@fCyLVj 13.74 1921(v ) 08.11.2006vkblksfu;ktkbM xksfy;kafjQSfEiflu&150 fexzk-vkblksfu;ktkbM&100 fexzk-@fdM xksfy;ka

76. fjQsEihflu flji 60 fefy dh 16.90 836(v ) 15.06.2005 eS- Y;wfiu vkj&flu100 fexzk-@ 5 fefy cksry

77. fjQsEihflu flji 60 fefy dh 17.38 836(v ) 15.06.2005 eS- Y;wfiu vkj&flu100 fexzk-@ 5 fefy cksry ,e- di lfgr

78. fjQsEihflu flji 150 fefy dh 36.08 836(v ) 15.06.2005 eS- Y;wfiu vkj&flu100 fexzk-@ 5 fefy cksry

79. fjQsEihflu flji 150 fefy dh 36.56 836(v ) 15.06.2005 eS- Y;wfiu vkj&flu100 fexzk-@ 5 fefy cksry ,e- di lfgr

80. fjQsEihflu flji 200 fefy dh 54.08 440(v ) 29.03.2006 eS- Y;wfiu vkj&flu100 fexzk-@ 5 fefy cksry

81. fjQsEihflu flji 200 fefy dh 54.58 440(v ) 29.03.2006 eS- Y;wfiu vkj&flu100 fexzk-@ 5 fefy cksry ,e- di lfgr

82. fjQsEihflu$vkblksfu;kt+kbM$ 2 xksfy;ksa@dSilwy 6.92 440(v) 29.03.2006 eS- ;wfudse ,aVhdksDl&3bFkkeC;wVksy fQDlM Mkst+ dksEch iSd esa dk dksEch iSd eS- Js;k eksuVks&3izR;sd dksEch iSd 2 xksfy;ksa@dSilwy esa ,,y@ihohMhlh&fjQsEihflu 450 fexzk- ihohlhvkblksfu;kt+kbM 300 fexzk- vkSj fCyLVjbFkkeC;wVksy ,plh,y 800 fexzk-

83. fjQsEihflu$vkblksfu;kt+kbM$ 2 xksfy;ksa@dSilwy 6.64 837(v) 15.06.2005 eS- Js;k dksuQst&3ik;fjMksDlhu$bFkkeC;wVksy dk dksEch iSdfQDlM Mkst+ dksEch iSd esa ,,y@ihohMhlh&izR;sd dksEch iSd 2 xksfy;ksa@dSilwy esa ihohlhfjQsEihflu 450 fexzk- fCyLVjvkblksfu;kt+kbM 300 fexzk-ik;fjMksDlhu 10 fexzk- vkSjbFkkeC;wVksy ,plh,y 800 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 175: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

84. fjQsEihflu$vkblksfu;kt+kbM$ 3 xksfy;ksa@dSilwy 7.18 837(v) 15.06.2005 eS- baMksdks fjQkdkse&3ik;jkftukekbM fQDlM Mkst+ dksEch iSd esa dk dksEch iSd eS- fudksyl Vj&3izR;sd dksEch iSd 3 xksfy;ksa@dSilwy esa ,,y@ihohMhlh& eS- jsdLVj fVfcfdV IylfjQsEihflu 450 fexzk- ihohlhvkblksfu;kt+kbM 300 fexzk- vkSj fCyLVjik;jkftukekbM 1500 fexzk-

85. fjQsEihflu$vkblksfu;kt+kbM$ 4 xksfy;ksa@dSilwy 9.72 440(v) 29.03.2006 eS- uksokjfVl 4 Mhik;jkftukekbM$bFkkeC;wVksy dk dksEch iSdfQDlM Mkst+ dksEch iSd esa ,,y@ihohMhlh&izR;sd dksEch iSd 4 xksfy;ksa@dSilwy esa ihohlhfjQsEihflu 450 fexzk- fCyLVjvkblksfu;kt+kbM 300 fexzk-ik;jkftukekbM 1500 fexzk- vkSjbFkkeC;wVksy ,plh,y 800 fexzk-

86. fjQsEihflu$vkblksfu;kt+kbM$ 6 dk 40.82 441(v) 29.03.2006 eS- bafMykbu QkekZ ekbdksV~;wcbFkkeC;wVksy xksfy;ka iRrk@fCyLVjizR;sd fQYe fyfir xksfy;ksa esafjQsEihflu 450 fexzk-vkblksfu;kt+kbM 300 fexzk-bFkkeC;wVksy ,plh,y 800 fexzk-

87. fjQsEihflu$vkblksfu;kt+kbM$ 4 dk fdV 18.30 1356(v) 16.09.2005 eS- esfjaM dsfoVj&,QMhik;jkftukekbM$bFkkeC;wVksyfoVkfeu ch&6 fdVizR;sd fdV esafjQsEihflu 225 fexzk-vkblksfu;kt+kbM 150 fexzk-ik;jkftukekbM 750 fexzk-bFkkeC;wVksy 400 fexzk-foVkfeu ch&6 10 fexzk-

88. fjQSfEiflu$vkblksfu;ktkbM$ 1 fdV 6.02 761(v) 19.05.2006ik;jkftukekbM fdVfjQSfEiflu&450 fexzk-vkblksfu;ktkbM&300 fexzk-ik;jkftukekbM&750 fexzk-

89. fjQSfEiflu$vkblksfu;ktkbM$ 1 fdV 9.16 761(v) 19.05.2006ik;jkftukekbM$foVkfeu ch 6$bFkkeC;wVksy fdVfjQSfEiflu&450 fexzk- dh 1 xksyhik;jkftukekbM&750 fexzk- izR;sd 2 xksfy;ksa esavkblksfu;ktkbM&300 fexzk-foVkfeu ch 6 &10 fexzk-bFkkeC;wVksy &800 fexzk- dh 1 xksyh

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 176: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 157 -

90. fjQSfEiflu$vkblksfu;ktkbM$ 1 fdV 10.26 761(v) 19.05.2006ik;jkftukekbM$foVkfeu ch 6$bFkkeC;wVksy fdVfjQSfEiflu&600 fexzk- dh 1 xksyhvkblksfu;ktkbM&300 fexzk-ik;jkftukekbM&750 fexzk- izR;sd 2 xksfy;ksa esafoVkfeu ch 6 &10 fexzk-bFkkeC;wVksy &800 fexzk- dh 1 xksyh

91. fjQSfEiflu$vkblksfu;ktkbM$ 1 fdV 9.26 761(v) 19.05.2006ik;jkftukekbM$ik;fjMksDlhu$bFkkeC;wVksy fdVfjQSfEiflu&450 fexzk-vkblksfu;ktkbM&300 fexzk-ik;fjMksDlhu ,plh,y &10 fexzk-bFkkeC;wVksy &800 fexzk- dh 1 xksyhik;jkftukekbM&1500 fexzk- ¼750 fexzk- izfr xksyh½

92. fjQSfEiflu$vkblksfu;ktkbM$ 1 fdV 9.16 761(v) 19.05.2006ik;jkftukekbM$foVkfeu ch 6$bFkkeC;wVksy fdVfjQSfEiflu&450 fexzk- dh 1 xksyhik;jkftukekbM&750 fexzk- izR;sd 2 xksfy;ksa esavkblksfu;ktkbM&300 fexzk-foVkfeu ch 6 &10 fexzk-bFkkeC;wVksy &800 fexzk- dh 1 xksyh

93. fjQSfEiflu$vkblksfu;ktkbM$ 10 dk 19.20 1342(v) 01.08.2007ik;fjMksDlhu xksfy;ka iRrk@fCyLVjfjQSfEiflu&200 fexzk-vkblksfu;ktkbM&150 fexzk-ik;fjMksDlhu gkbMªksDyksjkbM&5 fexzk-

94. fjQSfEiflu$vkblksfu;ktkbM$ 10 dk 14.88 1342(v) 01.08.2007ik;fjMksDlhu$ik;jkftukekbM xksfy;ka iRrk@fCyLVjfjQSfEiflu&100 fexzk-vkblksfu;ktkbM&75 fexzk-ik;fjMksDlhu gkbMªksDyksjkbM&2.5 fexzk-ik;jkftukekbM&250 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 177: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 158 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

,l (S)

1. lsyC;wVkeksy xksfy;ka&2 10 dk 1.22 1688(v) 03.10.2006 eS- [kaMsyoky lYekIyksu2 fexzk- csl@xksfy;ka ,,y_fCyLVj eS- fliyk ,lFksfyu

eS- ,QMhlh lYcsVksyeS- bjkst+ lsyfcMeS- foax QkekZ lsyC;wVkeksy

2. lsyC;wVkeksy xksfy;ka&4 10 dk 1.62 1688(v) 03.10.2006 eS- [kaMsyoky lYekIyksu4 fexzk- csl@xksfy;ka ,,y_fCyLVj eS- fliyk ,lFksfyu

eS- ,QMhlh lYcsVksyeS- bjkst+ lsyfcMeS- foax QkekZ lsyC;wVkeksy

3. lsyC;wVkeksy xksfy;ka&2 8x250 dk 143.66 1337(v) 01.08.20072 fexzk- @xksfy;ka ywt iSd

4. lsyC;wVkeksy xksfy;ka&4 8x250 dk 194.60 1337(v) 01.08.20074 fexzk- @xksfy;ka ywt iSd

5. lsyC;wVkeksy flji 112 fefy dh 7.76 357(v) 30.04.1997 eS- fliyk ,lFksfyu2 fexzk- csl@ 5 fefy cksry eS- ;’k QkekZ osaVhlksy

6. lsyC;wVkeksy$czkseksgsDlhu xksfy;ka 10 dk 1.26 501(v) 16.07.1997 eS- fliyk E;wdks&,lFksfyulsyC;wVkeksy 2 fexzk- ,,y_fCyLVjczkseksgsDlhu 8 fexzk-@xksfy;ka

7. lsyC;wVkeksy$czkseksgsDlhu xksfy;ka 10 dk 1.70 501(v) 16.07.1997 eS- fliyk E;wdks&,lFksfyulsyC;wVkeksy 2 fexzk- iRrk@fCyLVjczkseksgsDlhu 8 fexzk-@xksfy;ka

8. lsyC;wVkeksy$fFk;ksQkbfyu xksfy;ka 10 dk 2.02 501(v) 16.07.1997 eS- bZLV vQjhdu fFk;ksfjolsyC;wVkeksy 2 fexzk- ,,y_fCyLVj eS- lh,Q,y QkekZ czksuksdksQkby IylfFk;ksQkbfyu 100 fexzk-@xksfy;ka eS- lkbuksdse czksuksD;wj

9. lsyC;wVkeksy$fFk;ksQkbfyu xksfy;ka 10 dk 3.34 501(v) 16.07.1997 eS- fliyk fFk;ks ,lFksfyu QksVZlsyC;wVkeksy 2 fexzk- iRrk@fCyLVj eS- bZLV vQjhdu fFk;ksfjo QksVZfFk;ksQkbfyu 100 fexzk-@xksfy;ka

10. lsyC;wVkeksy lhvkj@,lvkj dSilwy&4 10 dk 6.10 186(v) 07.02.2006 eS- th,lds osUVªksfyulsyC;wVkeksy 4 fexzk-@ ,,y_iRrk eS- jsiVkdksl czsV fM;wjkslylhvkj@,lvkj dSilwy

11. lsyC;wVkeksy lhvkj@,lvkj dSilwy&4 10 dk 5.66 186(v) 07.02.2006 eS- Qkjesfl; lsyC;wlsyC;wVkeksy 4 fexzk-@ ,,y_fCyLVj eS- bjkst+ lsyfcMlhvkj@,lvkj dSilwy

Page 178: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 159 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

12. lsyC;wVkeksy lhvkj@,lvkj dSilwy&8 10 dk 7.80 186(v) 07.02.2006 eS- th,lds osUVªksfyulsyC;wVkeksy 8 fexzk-@ ,,y_iRrk eS- jsiVkdksl czsV fM;wjkslylhvkj@,lvkj dSilwy

13. lsyC;wVkeksy lhvkj@,lvkj dSilwy&8 10 dk 7.36 186(v) 07.02.2006 eS- bjkst+ lsyfcMlsyC;wVkeksy 8 fexzk-@ ,,y_fCyLVjlhvkj@,lvkj dSilwy

14. lsyC;wVkeksy$czkseksgsDlhu flji 100 fefy dh 12.78 326(v) 16.04.1998 eS- ekbØks ysc osafVªylsyC;wVkeksy 2 fexzk- cksryczkseksgsDlhu 8 fexzk-@ 5 fefy

15. lsyC;wVkeksy$czkseksgsDlhu flji 100 fefy dh 11.46 463(v) 26.05.1998 eS- fliyk E;wdksfyadlsyC;wVkeksy 2 fexzk- cksry ,e- di lfgrczkseksgsDlhu 4 fexzk-@ 5 fefy

16. lsyC;wVkeksy bUgSyj 200 ehVj Mkst+ 68.50 1113(v) 16.11.1999 eS- fliyk ,lFksfyu bUgSyjlsyC;wVkeksy 100 ,elhth@ehVj Mkst+ ,Y;wfeU;e dsu eS- th,lds osaVªksfyu

eS- Y;wfiu lsycs;jeS- teZu jsesfMt+ MsjhgsyjeS- lu QkekZ ,sjksVkWt

17. lsyC;wVkeksy$fcdyksfeFkkt+ksu 200 ehVj Mkst+ 99.08 1113(v) 16.11.1999 eS- fliyk ,jkdksVZ bUgSyjMkbZizksfi;ksusV bUgSyj ,Y;wfeU;e dsu eS- Y;wfiu lsycs;jlsyC;wVkeksy 100 ,elhth+$fcdyksfeFkkt+ksuMkbZizksfi;ksusV 50 ,elhth @ehVj Mkst

18. lsyC;wVkeksy lYQsV$fcdyksfeFkkt+ksu 30 dh cksry 17.22 1348(v) 16.09.2005 eS- fliyk ,jkdksVZMkbZizksfi;ksusV jksVkdSi eS- Y;wfiu lsycs;jlsyC;wVkeksy 200 ,elhth+$fcdyksfeFkkt+ksuMkbZizksfi;ksusV 100 ,elhth @jksVkdSi

19. lsyC;wVkeksy lYQsV$vkbZizkVªksfi;e 30 dh cksry 15.26 1348(v) 16.09.2005 eS- dksijsu osfUVizkczksekbM jksVkdSilsyC;wVkeksy 200 ,elhth+vkbZizkVªksfi;e czksekbM 100 ,elhth@jksVkdSi

20. lsyC;wVkeksy lYQsV jksVkdSi 30 dh cksry 14.06 1348(v) 16.09.2005 eS- fliyk ,lFksfyu jksVkdSilsyC;wVkeksy 400 ,elhth+@jksVkdSi

21. lsyC;wVkeksy lYQsV bUgSyj 400 ehVj Mkst+ 84.94 186(v) 07.02.2006 eS- fliyk ,lFksfyu bdksiSdlsyC;wVkeksy 100 ,elhth+@ehVj Mkst+ ¼2x200 ehVj Mkst½

22. lsyC;wVkeksy lYQsV$vkbZizkVªksfi;e 200 ehVj Mkst+ 68.28 186(v) 07.02.2006 eS- fliyk fM;ksfyuczksekbM bUgSyj eS- Y;wfiu lsycs;jlsyC;wVkeksy 100 ,elhth+ eS- teZu jsesfMt+ dksEchfeLVvkbZizkVªksfi;e czksekbM 20 ,elhth@ehVj Mkst+ eS- edZ osafVizk

Page 179: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 160 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

23. lsyC;wVkeksy lYQsV$fcdyksfeFkkt+ksu 8 dk 2.48 1348(v) 16.09.2005 eS- lu QkekZ ,jksVkbM fMLdMkbZizksfi;ksusV xksfy;ka iRrk@fCyLVjlsyC;wVkeksy 400 ,elhth+fcdyksfeFkkt+ksuMkbZizksfi;ksusV 200 ,elhth@fMLd xksfy;ka

24. lsyC;wVkeksy lYQsV xksfy;ka 8 dk 1.14 1348(v) 16.09.2005 eS- lu QkekZ ,jksVkWt fMLdlsyC;wVkeksy 200 ,elhth@fMLd xksfy;ka iRrk@fCyLVj

25. lsyC;wVkeksy lYQsV$fcdyksfeFkkt+ksu 8 dh fMLd 1.76 1348(v) 16.09.2005 eS- lu QkekZ ,jksVkbM fMLdMkbZizksfi;ksusV xksfy;kalsyC;wVkeksy 200 ,elhth+fcdyksfeFkkt+ksuMkbZizksfi;ksusV 100 ,elhth@fMLd xksfy;ka

26. lsyC;wVkeksy$czkseksgsDlhu$ 100 fefy 14.44 176(v) 07.02.2006 eS- [kaMsyoky ,DlhIyksu chvkjX;wQSulhu vkSj eSuFkksy ,DliSDVksjsUV dk¡p dh cksrylsyC;wVkeksy lYQsV1 fexzk- lsyC;wVkeksy ds cjkcjczkseksgsDlhu ,plh,y 2 fexzk-X;wQSulhu 50 fexzk-eSuFkksy 0.5 fexzk- @ 5 fefy

27. lsyC;wVkseksy$ 100 fefy dh 8.64 176(v) 07.02.2006X;wQSulhu ,DliSDVksjsUV dkap dh cksrylsyC;wVkeksy lYQsVlsyC;wVkeksy&2 fexzk- ds cjkcjX;wQSulhu&100 fexzk-

28. lsyC;wVkseksy jslikbjsVjh lksY;w’ku 3 fefy dk 3.19 448(v) 29.03.2006lsyC;wVkeksy lYQsV dkap@IykfLVdlsyC;wVkeksy&2.5 fexzk- ds cjkcj ,Ei;wyX;wQSulhu&50 fexzk-

29. lsyC;wVkseksy flji 100 fefy dh cksry 11.80 448(v) 29.03.2006lsyC;wVkeksy ¼lYQsV ds leku½&2 fexzk-

30. lsyC;wVkeksy$,EczksDlksy flji 100 fefy 12.46 1674v) 03.10.2006 eS- ,fjLVks ,EczksfMy ,llsyC;wVkeksy ¼lYQsV esa½ 1 fexzk- dh cksry,EczksDlksy ,plh,y 15 fexzk-@ 5 fefy

31. lsyC;wVkeksy$,EczksDlksy $ 100 fefy dh 16.66 1056(v) 11.07.2006 eS- fliyk ,DlsfyuX;wQSulhu vkSj eSuFkksy flji cksry eS- ,xyksesM balVsfjy&ihlsyC;wVkeksy ¼lYQsV esa½ 1 fexzk- eS- zQsadQVZ zQsadksQ,EczksDlksy ,plh,y 15 fexzk-X;wQSulhu 50 fexzk-eSuFkksy 0.5 fexzk- ls 5 fexzk-@ 5 fefy

Page 180: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 161 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

32. lsyC;wVkseksy$ 110 fefy dh 14.64 448(v) 29.03.2006czkseksgsDlhu ,DliSDVksjsUV cksrylsyC;wVkeksy ¼lYQsV ds leku½&2 fexzk-czkseksgsDlhu ,plh,y&4 fexzk-

33. lsyC;wVkeksy$dksfyu fFk;ksQk;fyusV flji 100 fefy dh 12.48 448(v) 29.03.2006 eS- fyVkdk QkekZ ,LFksykbV ihMhlsyC;wVkeksy ¼lYQsV esa½ 1 fexzk- cksry eS- dsMsDl ysc ihMh dsaVdksfyu fFk;ksQk;fyusV 50 fexzk-@ 5 fefy eS- lksekfVdks ysc lksekosaV&ihMh

eS- ;wuhekdZ QkekZ osaVhjsDl Iyl

34. lsyC;wVkeksy$czkseksgsDlhu$ 60 fefy dh 9.50 448(v) 29.03.2006 eS- Vksjl ysc foldksQ&,lX;wQSulhu vkSj eSuFkksy ,DliSDVksjsUV cksrylsyC;wVkeksy ¼lYQsV esa½ 1 fexzk-czkseksgsDlhu ,plh,y 2 fexzk-X;wQSulhu 50 fexzk-eSuFkksy 1 fexzk- ls 5 fexzk-@ 5 fefy

35. lsyC;wVkeksy$czkseksgsDlhu$ 100 fefy dh 12.60 448(v) 29.03.2006 eS- baM&LohQ~V LohdksQ&chthX;wQSulhu vkSj eSuFkksy ,DliSDVksjsUV cksrylsyC;wVkeksy ¼lYQsV esa½ 1 fexzk-czkseksgsDlhu ,plh,y 2 fexzk-X;wQSulhu 50 fexzk-eSuFkksy 1 fexzk- ls 5 fexzk-@ 5 fefy

36. lsyC;wVkeksy$czkseksgsDlhu$Dyksjks 100 fefy dh 12.04 448(v) 29.03.2006 eS- FklZ QkekZ lsofjyQsfujkekbu esfy,V$eSUFkksy ,DliSDVksjsUV cksrylsyC;wVkeksy ¼lYQsV esa½ 2 fexzk-czkseksgsDlhu ,plh,y 4 fexzk-Dyksjks Qsfujkekbu esfy,V ¼lhih,e½ 4 fexzk-eSuFkksy 0.5 fexzk- ls 5 fexzk-@ 5 fefy

37. lsyC;wVkeksy$,EczksDlksy$ 100 fefy dh 13.54 448(v) 29.03.2006 eS- ftuks QkekZ jslikbjkX;wQSulhu fyfDoM cksrylsyC;wVkeksy ¼lYQsV esa½ 1 fexzk-,EczksDlksy ,plh,y 15 fexzk-X;wQSulhu 50 fexzk-@ 5 fefy

38. lsyC;wVkeksy$,EczksDlksy flji 100 fefy dh 12.86 448(v) 29.03.2006 eS- czkWmu ysc lsyC;wVksy&,lsyC;wVkeksy ¼lYQsV esa½ 1 fexzk- cksry,EczksDlksy ,plh,y 15 fexzk-@ 5 fefy

39. lsyC;wVkeksy$czkseksgsDlhu$ 100 fefy dh 12.80 448(v) 29.03.2006 eS- D;wtsu ck;ksVsd dksfQtX;wQSulhu$eSUFkksy ,DliSDVksjsUV cksry eS- lqij LVkj ysc ,lchthlsyC;wVkeksy ¼lYQsV esa½ 2 fexzk-czkseksgsDlhu ,plh,y 4 fexzk-X;wQSulhu 50 fexzk-eSuFkksy 0.5 fexzk- @ 5 fefy

Page 181: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 162 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

40. lsyC;wVkeksy$dksfyu fFk;ksQk;fyusV fyfDoM 100 fefy 12.46 448(v) 29.03.2006 eS- dksijsu osUVlsyC;wVkeksy lYQsV dh cksry eS- ;’k QkekZ osfUVQkbfyu2 fexzk- lsyC;wVkeksy ds cjkcjdksfyu fFk;ksQk;fyusV 100 fexzk-@ 5 fefy

41. lsyC;wVkeksy$czkseksgsDlhu$ 60 fefy 8.80 448(v) 29.03.2006 eS- Qkbt+j csfuyhuX;wQSulhu ,DliSDVksjsUV dk¡p dh cksrylsyC;wVkeksy ¼lYQsV esa½ 1 fexzk-czkseksgsDlhu ,plh,y 2 fexzk-X;wQSulhu 50 fexzk-@ 5 fefy

42. lsyC;wVkeksy$czkseksgsDlhu$ 100 fefy 9.70 448(v) 29.03.2006 eS- ,xjksu jsesfMt czkslksuX;wQSulhu ,DliSDVksjsUV dh cksrylsyC;wVkeksy ¼lYQsV esa½ 2 fexzk-czkseksgsDlhu ,plh,y 4 fexzk-X;wQSulhu 100 fexzk-@ 10 fefy

43. lsyC;wVkeksy$fFk;ksQkbfyu flji 100 fefy 12.28 448(v) 29.03.2006 eS- fliyk fFk;ks ,lFksfyulsyC;wVkeksy lYQsV dh cksry2 fexzk- lsyC;wVkeksy ds cjkcjfFk;ksQkbfyu ¼,UgkbMªsl½ 100 fexzk-@ 10 fefy

43. lsyC;wVkeksy$czkseksgsDlhu$ 10 dk 2.40 448(v) 29.03.2006 eS- LVsMesM iqYeks&jsLVX;wQSulhu xksfy;ka iRrk@fCyLVj eS- dUlsIV lk;ukczksulsyC;wVkeksy 2 fexzk-czkseksgsDlhu ,plh,y 8 fexzk-X;wQSulhu 100 fexzk-@xksfy;ka

44 lsyC;wVkeksy$czkseksgsDlhu xksfy;ka 10 dk 1.46 448(v) 29.03.2006 eS- th,lds czksudksVsc&bZ,DllsyC;wVkeksy 2 fexzk- iRrk@fCyLVjczkseksgsDlhu ,plh,y 4 fexzk-@xksfy;ka

45. lsyC;wVkeksy$czkseksgsDlhu xksfy;ka 10 dk 1.62 448(v) 29.03.2006 eS- th,lds czksudksVsc&4 bZ,DllsyC;wVkeksy 4 fexzk- iRrk@fCyLVjczkseksgsDlhu ,plh,y 4 fexzk-@xksfy;ka

46. lsyC;wVkseksy$,Eczksdlksy 10 dk 3.68 448(v) 29.03.2006fFk;ksQkbfyu xksfy;ka iRrk@fCyLVjlsyC;wVkeksy &2 fexzk-,Eczksdlksy ,plh,y&30 fexzk-fFk;ksQkbfyu ¼,ugkbMªsl½&100 fexzk-

47. lsyC;wVkeksy$czkseksgsDlhu$ 10 dk 4.30 448(v) 29.03.2006 eS- jV QkekZ fcMªsDlbVksQkbfyu xksfy;ka iRrk@fCyLVj eS- flfFkadks czkslfeu QksVZlsyC;wVkeksy 4 fexzk-czkseksgsDlhu ,plh,y 16 fexzk-bVksQkbfyu 200 fexzk-@xksfy;ka

Page 182: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 163 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

48. lsyC;wVkeksy$czkseksgsDlhu$ 10 dk 2.64 448(v) 29.03.2006 eS- flfFkadks czkslfeu QksVZbVksQkbfyu xksfy;ka iRrk@fCyLVjlsyC;wVkeksy lYQsV4 fexzk- lsyC;wVkeksy ds cjkcjczkseksgsDlhu ,plh,y 8 fexzk-bVksQkbfyu 100 fexzk-@xksfy;ka

49. lsyC;wVkeksy$bVksQkbfyu xksfy;ka 10 dk 2.48 448(v) 29.03.2006 eS- usfoy MsjhosUVlsyC;wVkeksy 2 fexzk- iRrk@fCyLVjbVksQkbfyu 100 fexzk-@xksfy;ka

50. lsyC;wVkeksy$X;wQSulhu$ 10 dk 3.26 448(v) 29.03.2006 eS- usfoy MsjhosUV&bZbVksQkbfyu xksfy;ka iRrk@fCyLVjlsyC;wVkeksy 2 fexzk-X;wQSulhu 100 fexzk-bVksQkbfyu 100 fexzk-@xksfy;ka

51. lsyC;wVkeksy$czkseksgsDlhu$ 10 dk 3.44 448(v) 29.03.2006 eS- ,QMhlh bVks&lsYcsVksyfFk;ksQkbfyu xksfy;ka iRrk@fCyLVj eS- baMksdks ,QsfyulsyC;wVkeksy 2 fexzk- eS- lsokW; ck;ksVsd lk;czksuczkseksgsDlhu ,plh,y 8 fexzk- eS- fllVksfid ,lekVkbM&chvkjfFk;ksQkbfyu 200 fexzk-@xksfy;ka

52. lsyC;wVkeksy$czkseksgsDlhu$ 10 dk 4.22 448(v) 29.03.2006 eS- dsiysV bafM;k osUVsDl QksVZbVksQkbfyu xksfy;ka iRrk@fCyLVjlsyC;wVkeksy 4 fexzk-czkseksgsDlhu ,plh,y 8 fexzk-bVksQkbfyu 200 fexzk-@xksfy;ka

53. lsyC;wVkeksy$fFk;ksQkbfyu xksfy;ka 10 dk 5.46 448(v) 29.03.2006 eS- fliyk fFk;ks ,lFksfyu ,lvkjlsyC;wVkeksy 4 fexzk- iRrk@fCyLVjfFk;ksQkbfyu 300 fexzk-@,lvkj xksfy;ka

54. lsyC;wVkeksy xksfy;ka 10 dk 2.96 448(v) 29.03.2006 eS- fliyk fFk;ks ,lFksfyu ,lvkjlsyC;wVkeksy 4 fexzk-@,l, xksfy;ka iRrk@fCyLVj

55. lsyC;wVkeksy xksfy;ka 10 dk 3.26 448(v) 29.03.2006 eS- fliyk fFk;ks ,lFksfyu ,lvkjlsyC;wVkeksy 8 fexzk-@,l, xksfy;ka iRrk@fCyLVj

56. lsyC;wVkeksy jslikbjsVjh lksY;w’ku 15 fefy dk 6.76 448(v) 29.03.2006 eS- fliyk ,lFksfyulsyC;wVkeksy ¼lYQsV esa½ 5 fexzk-@fefy dk¡p@IykfLVd jslikbjsVjh lksY;w’ku

,Ei;wy

57. lsyC;wVkeksy$fcdyksfeFkkt+ksu 30 dh cksry 23.46 754(v) 19.05.2006MkbZizksfi;ksusV dSilwylsyC;wVkeksy&400 ,elhthfcdyksfeFkkt+ksu MkbZizksfi;ksusV&200 ,elhth

Page 183: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 164 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

58. lsyC;wVkeksy$ 10 dk 3.68 1065(v) 11.07.2006bVksQkbfyu xksfy;ka iRrk@fCyLVjlsyC;wVkeksy lYQsVlsyC;wVkeksy&4 fexzk- ds cjkcjbVksQkbfyu&200 fexzk-

59. lsyC;wVkeksy$,EczksDlksy 10 dk 3.04 1065(v) 11.07.2006X;wQsuflu xksfy;ka iRrk@fCyLVjlsyC;wVkeksy lYQsVlsyC;wVkeksy&2 fexzk- ds cjkcj,EczksDlksy ,plh,y&15 fexzk-X;wQsuflu&100 fexzk-

60. lsyC;wVkeksy jksVkdSi 30 dk jksVkdSi 13.28 1065(v) 11.07.2006lsyC;wVkeksy&200 ,elhth

61. ysokslsyC;wVkeksy jksVkdSi 30 dk jksVkdSi 13.22 1065(v) 11.07.2006ysokslsyC;wVkeksy&100 ,elhth

62. ysokslsyC;wVkeksy bUgsyj 200 ehVj Mkst 59.36 1065(v) 11.07.2006izR;sd ehVj Mkst esaysokslsyC;wVkeksy&50 ,elhth

63. lsyC;wVkeksy fMLd 14 fMLd x 4 dk 8.64 1065(v) 11.07.2006izR;sd fMLd gksYMj esa fCyLVj 1 fMLd gksYMjlsyC;wVkeksy&50 ,elhthft+ukQks,sV ds leku

64. lsyC;wVkeksy$,EczksDlksy 2.5 fefy dk iSd 3.26 1065(v) 11.07.2006lksY;w’kuizR;sd 2.5 fefy esalsyC;wVkeksy&2.5 fexzk-,EczksDlksy ,plh,y&1.5 fexzk-vkblksVksfud lksY;w’ku esa

65. lsyC;wVkeksy lksY;w’ku 2.5 fefy dk iSd 3.06 1065(v) 11.07.2006lsyC;wVkeksy&2.5 fexzk-

66. ysokslsyC;wVkeksy lksY;w’ku 2.5 fefy dk iSd 2.71 1065(v) 11.07.2006lsyC;wVkeksy&0.31 fexzk-

67. ysokslsyC;wVkeksy lksY;w’kulsyC;wVkeksy&0.63 fexzk- 2.5 fefy dk iSd 3.12 1065(v) 11.07.2006

68. ysokslsyC;wVkeksy lksY;w’ku 2.5 fefy dk iSd 3.14 1065(v) 11.07.2006lsyC;wVkeksy&1.25 fexzk-

Page 184: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 165 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

69. lsyC;wVkeksy$vkbizkVªksfi;e 2.5 fefy dk iSd 3.88 1065(v) 11.07.2006czksekbM jslik;jsVjh lksY;w’kulsyC;wVkeksy¼,ugkbMªsl ds leku½&2.5 fexzk-vkbizkVªksfi;e czksekbM jslik;jsVjh&500 ,elhth

70. lsyC;wVkeksy$cqMslqukbM lksY;w’ku 2.5 fefy dk iSd 4.38 1065(v) 11.07.2006lsyC;wVkeksy&2.5 fexzk-cqMslqukbM&1 fexzk-

71. lsyC;wVkeksy$bVksQkbfyu flji 100 fefy dh 12.40 1065(v) 11.07.2006izR;sd 5 fefy esa cksrylsyC;wVkeksy lYQsVlsyC;wVkeksy &1 fexzk- ds cjkcjbVksQkbfyu&50 fexzk-

72. lsyC;wVkeksy$bVksQkbfyu flji 100 fefy dh 12.66 1065(v) 11.07.2006lsyC;wVkeksy lYQsV cksrylsyC;wVkeksy &2 fexzk- ds cjkcjbVksQkbfyu&50 fexzk-

73. lsyC;wVkeksy$,EczksDlksy$ 100 fefy dh 14.80 1065(v) 11.07.2006X;wQsuflu flji cksrylsyC;wVkeksy lYQsVlsyC;wVkeksy&1 fexzk- ds cjkcj,EczksDlksy ,plh,y&30 fexzk-X;wQsuflu&50 fexzk-

74. lsyC;wVkeksy$czkseksgDl+hu 60 fefy dh 8.60 1065(v) 11.07.2006,plh,y$X;wQsuflu cksrylLiSUlu@fljilsyC;wVkeksy lYQsV&1 fexzk-czkseksgDl+hu ,plh,y&2 fexzk-X;wQsuflu&25 fexzk-

75. lsyC;wVkeksy$czkseksgDl+hu 50 fefy dh 7.66 1065(v) 11.07.2006,plh,y$X;wQsuflu cksrylLiSUlu@fljilsyC;wVkeksy lYQsV&1 fexzk-czkseksgDl+hu ,plh,y&2 fexzk-X;wQsuflu&50 fexzk-

76. lsyC;wVkeksy$,EczksDlhy 60 fefy dh 9.90 1065(v) 11.07.2006,plh,y$X;wQsuflu$ cksryeSUFkksy flji@,DliSDVksjsUVlsyC;wVkeksy lYQsV&1 fexzk-X;wQsuflu&50 fexzk-eSUFkksy&1 fexzk-

Page 185: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 166 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

77. lsyC;wVkeksy$czkseksgDl+hu$ 100 fefy dh 9.80 1065(v) 11.07.2006X;wQsuflu$eSUFkksy flji cksryizR;sd 10 fefy esalsyC;wVkeksy lYQsVlsyC;wVkeksy&2 fexzk- ds cjkcjczkseksgDl+hu gkbMªksczksekbM&8 fexzk-X;wQsuflu&100 fexzk-eSUFkksy&0.5 fexzk-

78. lsyC;wVkeksy$czkseksgDl+hu$ 100 fefy dh 11.70 1065(v) 11.07.2006,feuksDyksjkbM$eSUFkksy flji cksrylsyC;wVkeksy lYQsV&2 fexzk-czkseksgDl+hu&4 fexzk-,feuksDyksjkbM&100 fexzk-eSUFkksy&1.5 fexzk-

79. lsyC;wVkeksy$dksfyu 60 fefy dh cksry 9.32 1675(v) 03.10.2006fFk;ksQkbfyusV fljiizR;sd 5 fefy esalsyC;wVkeksy&1 fexzk-¼lsyC;wVkeksy lYQsV ds leku½dksfyu fFk;ksQkbfyusV&50 fexzk-

80. lsyC;wVkeksy$X;wQSUlhu 120 fefy dh cksry 11.16 1675(v) 03.10.2006,DliSDVksjsUVizR;sd 10 fefy esalsyC;wVkeksy ¼lYQsV ds leku½&2 fexzk-X;wQSUlhu&100 fexzk-

81. lsyC;wVkeksy$bVksQkbfyu$ 100 fefy dh 13.10 1932(v) 08.11.2006Xykblzksy xw;sdksy ,Fkj flji cksryizR;sd 5 fefy esalsyC;wVkeksy lYQsV1 fexzk- lsyC;wVkeksy ds cjkcjbVksQkbfyu&50 fexzk-Xykblzksy xw;sdksy ,Fkj&50 fexzk-

82. lsyC;wVkeksy$,EczksDlksy flji 50 fefy dh 9.16 1932(v) 08.11.2006lsyC;wVkeksy lYQsV cksry2 fexzk- lsyC;wVkeksy ds cjkcj,EczksDlksy gkbMªksDyksjkbM&30 fexzk-

83. lsyC;wVkeksy$,EczksDlksy$ 100 fefy dh 15.30 1932(v) 08.11.2006X;wQSulhu flji cksrylsyC;wVkeksy lYQsV2 fexzk- lsyC;wVkeksy ds cjkcj,EczksDlksy gkbMªksDyksjkbM&30 fexzk-X;wQSulhu&50 fexzk-

Page 186: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 167 -

84. lsyC;wVkeksy$,EczksDlksy$ 60 fefy dh 9.90 1932(v) 08.11.2006X;wQSulhu$eSUFkksy cksryflji@,DliSDVksjsUVlsyC;wVkeksy lYQsV&1 fexzk-,EczksDlksy&15 fexzk-X;wQSulhu&50 fexzk-eSUFkksy&0.5 fexzk-

85. lsyC;wVkeksy$czkseksgsDlhu$ 60 fefy dh 9.50 1932(v) 08.11.2006X;wQSulhu$eSUFkksy flji cksryizR;sd 10 fefy esalsyC;wVkeksy lYQsV2 fexzk- lsyC;wVkeksy ds cjkcjczkseksgsDlhu&4 fexzk-X;wQSulhu&100 fexzk-eSUFkksy&1 fexzk-

86. lsyC;wVkeksy lksY;w’ku 3 fefy dk lksY;w- 3.19 211(v) 14.02.2007izR;sd 3 fefy esa ,Ei;wylsyC;wVkeksy lYQsVlsyC;wVkeksy&2.5 fexzk- ds cjkcj

87. lsyC;wVkeksy ,DlisDVksjsUV@flji 56 fefy dh cksry 4.83 211(v) 14.02.2007lsyC;wVkeksy&2 fexzk-@5 fefy

88. lsyC;wVkeksy$czkseksgsDlhu 100 fefy dh cksry 11.72 211(v) 14.02.2007,plh,y ,DlisDVksjsUV@fljilsyC;wVkeksy&1 fexzk-czkseksgsDlhu ,plh,y&4 fexzk-

89. lsyC;wVkeksy$X;wQSUlhu 110 fefy dh cksry 6.47 211(v) 14.02.2007,DlisDVksjsUV@fljilsyC;wVkeksy&2 fexzk-X;wQSUlhu&100 fexzk-

90. lsyC;wVkeksy$ 10 dk 4.46 211(v) 14.02.2007fFk;ksQkbfyu xksfy;ka iRrk@fCyLVjlsyC;wVkeksy lYQsV&4 fexzk-fFk;ksQkbfyu ¼,UgkbMªsl½&200 fexzk-¼lhvkj@,lvkj@Mhvkj@Vhvkj fVfd;k½

91. lsyC;wVkeksy$ 10 dk 6.58 211(v) 14.02.2007fFk;ksQkbfyu dSilwy iRrk@fCyLVjlsyC;wVkeksy lYQsV&4 fexzk-fFk;ksQkbfyu ¼,UgkbMªsl½&200 fexzk-¼lhvkj@,lvkj@Mhvkj@Vhvkj dSilwy½

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 187: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 168 -

92. lsyC;wVkeksy$ 20 dk 10.88 211(v) 14.02.2007fcDyksfeFkkt+ksu dSilwy iRrk@fCyLVjlsyC;wVkeksy &200 ,elhthfcDyksfeFkkt+ksu&100 ,elhth¼dSilwy@bUgsys’ku ds fy, dSilwy½

93. lsyC;wVkeksy$X;wQSUlhu 60 fefy dh 9.94 443(v) 23.03.2007czkseksgsDl+hu$eSUFkksy flji@lLisUlu cksryizR;sd 5 fefy esalsyC;wVkeksy -1 fexzk-X;wQSUlhu -5 fexzk-czkseksgsDl+hu -2 fexzk-eSUFkksy - 0.5 fexzk-

94. lsyC;wVkeksy$X;wQSUlhu 120 fefy dh 14.98 443(v) 23.03.2007czkseksgsDl+hu$eSUFkksy flji@lLisUlu cksrylsyC;wVkeksy -1 fexzk-X;wQSUlhu -5 fexzk-czkseksgsDl+hu -2 fexzk-eSUFkksy - 0.5 fexzk-

95. lsyC;wVkeksy$X;wQSUlhu 450 fefy dh 37.78 443(v) 23.03.2007czkseksgsDl+hu$eSUFkksy flji@lLisUlu cksrylsyC;wVkeksy -1 fexzk-X;wQSUlhu -5 fexzk-czkseksgsDl+hu -2 fexzk-eSUFkksy - 0.5 fexzk-

96. lsyC;wVkeksy lYQsV$fcdyksfeFkkt+ksu 200 ehVj Mkst+ 127.46 1321(v) 01.08.2007MkbZizksfi;ksusV lh,Qlh zQh bUgSyjlsyC;wVkeksy lYQsVlsyC;wVkeksy 100 ,elhth+ ds cjkcjfcdyksfeFkkt+ksu MkbZizksfi;ksusV 50 ,elhthizksisysUV esa lLisUMsM ,p,Q,-134, lkexzh,ClksY;wV ,YdksgWy 3.75% oh@oh

97. lsyC;wVkeksy$cqMslqukbM jslI;wy 2.5 fefy 4.10 1337(v) 01.08.2007lsyC;wVkeksy&2.5 fexzk- jslI;wy@,Ei;wycqMslqukbM&0.5 fexzk-

98. lsyC;wVkeksy lYQsV$ 60 fefy 10.49 1337(v) 01.08.2007,EczksDlksy ,plh,y flji dh cksrylsyC;wVkeksy lYQsV&2 fexzk-,EczksDlksy gkbMªksDyksjkbM&30 fexzk-@fefy

99. lsyC;wVkeksy $X;wQSUlhu ,DliSDVksjsUV 100 fefy 8.17 1337(v) 01.08.2007lsyC;wVkeksy &1 fexzk- dh cksryX;wQSUlhu &50 fexzk-@ 5 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 188: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 169 -

100. ysokslsyC;wVkeksy $ 30 dk jksVkdSi 14.88 1651(v) 27.09.2007vkbizsVªksfi;e czksekbM jksVkdSiysokslsyC;wVkeksy&100 ,elhthvkbizsVªksfi;e czksekbM&40 ,elhth

101. ysokslsyC;wVkeksy flji@lLisUlu 100 fefy dh cksry 11.58 1651(v) 27.09.2007ysokslsyC;wVkeksy&1 fexzk-@ 5 fefy

102. ysokslsyC;wVkeksy $ 100 fefy 6.99 1651(v) 27.09.2007X;wQSUlhu ,DliSDVksjsUV dh cksryysokslsyC;wVkeksy&1 fexzk-X;wQSUlhu&50 fexzk-@ 5 fefy

103. ysokslsyC;wVkeksy $ 60 fefy 9.16 1651(v) 27.09.2007czkseksgsDlhu ,DliSDVksjsUV dh cksryysokslsyC;wVkeksy&2 fexzk-czkseksgsDlhu&4 fexzk-@ 5 fefy

104. ysokslsyC;wVkeksy $ 2.5 fefy dk 3.78 1651(v) 27.09.2007vkbizsVªksfi;e czksekbM jslI;wy@,Ei;wy jslI;wy@,Ei;wyysokslsyC;wVkeksy&1.25 fexzk-vkbizsVªksfi;e czksekbM&500 ,elhth@ 2.5 fefy

105. lsyC;wVkeksy$czkseksgsDlhu$ 50 fefy dh 8.38 2045(v) 30.11.2007X;wQSUlhu$eSUFkksy flji cksrylsyC;wVkeksy lYQsV-1 fexzk-czkseksgsDlhu ,plh,y-2 fexzk-X;wQSUlhu-50 fexzk-eSUFkksy -0.5 fexzk-@5 fefy

106. lsyC;wVkeksy$czkseksgsDlhu$ 10 dk 2.14 2045(v) 30.11.2007X;wQSUlhu xksfy;ka iRrk@fCyLVjlsyC;wVkeksy lYQsV-4 fexzk-czkseksgsDlhu ,plh,y-8 fexzk-X;wQSUlhu-30 fexzk-@fVfd;k

107. lsyC;wVkeksy$czkseksgsDlhu$ 10 dk 3.96 2045(v) 30.11.2007bVksQkbfyu xksfy;ka iRrk@fCyLVjlsyC;wVkeksy lYQsV-4 fexzk-czkseksgsDlhu ,plh,y-8 fexzk-bVksQkbfyu-200 fexzk-

108. ysokslsyC;wVkeksy xksfy;ka 10 dk 1.20 190(v) 29.01.2008ysokslsyC;wVkeksy&1 fexzk-@fVfd;k iRrk@fCyLVj

109. ysokslsyC;wVkeksy xksfy;ka 10 dk 1.30 190(v) 29.01.2008ysokslsyC;wVkeksy&2 fexzk-@fVfd;k iRrk@fCyLVj

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 189: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 170 -

110. lsyC;wVkeksy$czkseksgsDlhu flji 50 fefy dh 10.16 197(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksry ,e-di lfgrczkseksgsDlhu-4 fexzk-@5 fefy

111. lsyC;wVkeksy$czkseksgsDlhu flji 10 fefy dh 5.67 197(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksry ,e-di lfgrczkseksgsDlhu-4 fexzk-@5 fefy

112. lsyC;wVkeksy$czkseksgsDlhu flji 20 fefy dh 6.39 197(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksry ,e-di lfgrczkseksgsDlhu-4 fexzk-@5 fefy

113. lsyC;wVkeksy$czkseksgsDlhu flji 30 fefy dh 7.18 197(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksry ,e-di lfgrczkseksgsDlhu-4 fexzk-@5 fefy

114. lsyC;wVkeksy$czkseksgsDlhu flji 100 fefy dh 12.59 197(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksry ,e-di lfgrczkseksgsDlhu-4 fexzk-@5 fefy

115. lsyC;wVkeksy$czkseksgsDlhu flji 150 fefy dh 17.17 197(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksry ,e-di lfgrczkseksgsDlhu-4 fexzk-@5 fefy

116. lsyC;wVkeksy$czkseksgsDlhu flji 200 fefy dh 20.64 197(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksry ,e-di lfgrczkseksgsDlhu-4 fexzk-@5 fefy

117. lsyC;wVkeksy$czkseksgsDlhu flji 250 fefy dh 24.28 197(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksry ,e-di lfgrczkseksgsDlhu-4 fexzk-@5 fefy

118. lsyC;wVkeksy$czkseksgsDlhu flji 500 fefy dh 43.33 197(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksry ,e-di lfgrczkseksgsDlhu-4 fexzk-@5 fefy

119. lsyC;wVkeksy$czkseksgsDlhu flji 60 fefy dh 9.66 210(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksryczkseksgsDlhu-4 fexzk-@5 fefy

120. lsyC;wVkeksy$czkseksgsDlhu flji 10 fefy dh 5.17 210(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksryczkseksgsDlhu-4 fexzk-@5 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 190: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 171 -

121. lsyC;wVkeksy$czkseksgsDlhu flji 20 fefy dh 5.87 210(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksryczkseksgsDlhu-4 fexzk-@5 fefy

122. lsyC;wVkeksy$czkseksgsDlhu flji 30 fefy dh 6.68 210(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksryczkseksgsDlhu-4 fexzk-@5 fefy

123. lsyC;wVkeksy$czkseksgsDlhu flji 50 fefy dh 8.10 210(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksryczkseksgsDlhu-4 fexzk-@5 fefy

124. lsyC;wVkeksy$czkseksgsDlhu flji 100 fefy dh 12.09 210(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksryczkseksgsDlhu-4 fexzk-@5 fefy

125. lsyC;wVkeksy$czkseksgsDlhu flji 150 fefy dh 16.67 210(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksryczkseksgsDlhu-4 fexzk-@5 fefy

126. lsyC;wVkeksy$czkseksgsDlhu flji 200 fefy dh 20.14 210(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksryczkseksgsDlhu-4 fexzk-@5 fefy

127. lsyC;wVkeksy$czkseksgsDlhu flji 250 fefy dh 23.78 210(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksryczkseksgsDlhu-4 fexzk-@5 fefy

128. lsyC;wVkeksy$czkseksgsDlhu flji 500 fefy dh 42.83 210(v) 29.01.2008lsyC;wVkeksy -2 fexzk- cksryczkseksgsDlhu-4 fexzk-@5 fefy

129. fLizuksySDVksu xksfy;ka&25 10 dk 12.08 1332(v) 01.08.2007 eS- vkjihth ykbQlkbal,YMsDVksu25 fexzk-@xksfy;ka iRrk@fCyLVj

130. fLizuksySDVksu xksfy;ka&50 10 dk 23.04 1320(v) 01.08.200750 fexzk-@xksfy;ka iRrk@fCyLVj

131. fLizuksySDVksu xksfy;ka&100 10 dk 45.82 1332(v) 01.08.2007 eS- vkjihth ykbQlkbal,YMsDVksu100 fexzk-@xksfy;ka iRrk@fCyLVj

132. fLizuksySDVksu$ zQwlkekbM xksfy;ka 10 dk 23.60 1061(v) 11.07.2006 eS- loZosVl ,YMkslfVDlfLizuksySDVksu 50 fexzk- ,,y_iRrk eS- Y;wfiu zQwlsysd zQwlkekbM 20 fexzk-@xksfy;ka ¼lknh½ eS- vkjihth ykbQlkbalfLizksekbM

eS- lsuksQh ,ofUVl ysflysDVksu

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 191: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 172 -

133. fLizuksySDVksu$ zQwlkekbM xksfy;ka 10 dk 23.20 1061(v) 11.07.2006 eS- loZosVl ,YMkslfVDlfLizuksySDVksu 50 fexzk- ,,y_fCyLVj eS- Y;wfiu zQwlsysd zQwlkekbM 20 fexzk-@xksfy;ka ¼lknh½ eS- vkjihth ykbQlkbalfLizksekbM

eS- lsuksQh ,ofUVl ysflysDVksu

134. fLizuksySDVksu $ 10 dk 11.44 1061(v) 11.07.2006 eS- vkjihth ykbQlkbal,YMsfDVMgkbMªks¶y;wfeFkk;ktkbM xksfy;ka iRrk@fCyLVjfLizuksySDVksu 25 fexzk-gkbMªks¶y;wfeFkk;ktkbM 25 fexzk-@xksfy;ka

135. fLizuksySDVksu$ zQwlkekbM xksfy;ka 10 dk 24.52 1332(v) 01.08.2007 eS- lsuksQh ,ofUVl ysflysDVksufLizuksySDVksu 50 fexzk- iRrk@fCyLVj zQwlkekbM 20 fexzk-@xksfy;ka ¼fQYe fyfir½

136. fLizuksySDVksu$ zQwlkekbM xksfy;ka 10 dk 24.68 1332(v) 01.08.2007 eS- lsuksQh ,ofUVl ysflysDVksufLizuksySDVksu 50 fexzk- iRrk@fCyLVj zQwlkekbM 40 fexzk-@xksfy;ka ¼fQYe fyfir½

137. LVªsIVksekbflu lYQsV 1xzke bUtsD’ku 1 ok;y 9.46 609(v) 27.05.2003 eS- fudksYl fijkey ,EchLVªhu&,lLVªsIVksekbflu lYQsV eS- esfjaM ejLVªsi1 xzke LVªsIVksekbflu csl ds cjkcj@ok;y

138. LVªsIVksekbflu lYQsV 0.75xzke bUtsD’ku 1 ok;y 7.86 609(v) 27.05.2003 eS- fudksYl fijkey ,EchLVªhu&,lLVªsIVksekbflu lYQsV0.75 xzke LVªsIVksekbflu csl ds cjkcj@ok;y

139. LVªsIVksekbflu$izksdsu iSuhflfyu$ 1 Mkst+@ok;y 7.74 630(v) 02.09.1997 eS- ,yfEcd fclVªsisulksfM;e iSuhflfyu th bUtSaD’ku ¼5 fefy ok;y½¼ 0.5 xzke $ 3 yk[k $ 1 yk[k@Mkst+½

140. LVªsIVksekbflu$iSuhflfyu bUtsD’ku 1 Mkst+ ok;y 10.48 610(v) 27.05.2003 eS- fudksYl ,Q-,Q-ihLVªsIVksekbflu lYQsV1 xzke csl ds cjkcjizksdsu iSuhflfyu th 3 yk[k ;wfuViSuhflfyu th lksfM;e 1 yk[k ;wfuV½

141. LVªsIVksekbflu$izksdsu iSuhflfyu$ 1 Mkst+@ok;y 6.06 630(v) 02.09.1997 eS- ,yfEcd fclVªsisu QksVZlksfM;e iSuhflfyu th bUtsD’ku ¼5 fefy ok;y½¼0.25xzke $ 3yk[k $ 1 yk[k@Mkst+½ iSfM;fVªd

142. LVªsIVksekbflu$iSuhflfyu bUtsD’ku 20 fefy dk ok;y 20.34 2039(v) 30.11.2007 eS- fudksYl ,Q-,Q-ihLVªsIVksekbflu lYQsV2.5 xzke csl ds cjkcjizksdsu iSuhflfyu th 15 yk[k ;wfuViSuhflfyu th lksfM;e 5 yk[k ;wfuV½

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 192: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 173 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

143. iSuhflfyu$LVªsIVksekbflu lYQsV$ 30 fefy dk 34.62 2029(v) 30.11.2007

izksdsu iSuhflfyu th$ iSuhflfyu th ok;ylksfM;e bUtsD’kuizksdsu iSuhflfyu th 3000000 yk[k ;wfuViSuhflfyu th lksfM;e 2000000 yk[k ;wfuVLVªsIVksekbflu lYQsVLVªsIVksekbflu 5 fexzk- ds cjkcj@ok;y

144. lYQkfM;kft+u vkSj VªkbZfeFkksfize xksfy;ka 10x10 dk 60.10 1055(v) 11.07.2006 eS- uksokjfVl vfczy410 fexzk-$ 90 fexzk-@xksfy;ka iRrk@fCyLVj eS- ck;ksyksftdy bZ flfytk+bu

145. lYQkMkbZt+hu$VªkbZesFkksfize xksfy;ka 6 dk ,,y_iRrk 6.98 1055(v) 11.07.2006lYQkMkbZt+hu&820 fexzk-VªkbZesFkksfize&180 fexzk-

146. lYQkMkbZt+hu$VªkbZesFkksfize xksfy;ka 6 dk ,,y_fCyLVj 6.68 1055(v) 11.07.2006lYQkMkbZt+hu&820 fexzk-VªkbZesFkksfize&180 fexzk-

147. flyoj lYQkMkbft+u Øhe 25 xzke dh V~;wc 10.72 1066(v) 11.07.2006flyoj lYQkMkbft+u&1.0% MCY;w@MCY;w

148. flyoj lYQkMkbft+u Øhe 500 xzke tkj 163.76 1066(v) 11.07.2006flyoj lYQkMkbft+u&1.0% MCY;w@MCY;w

149. flyoj lYQkMkbft+u Øhe 15 xzke dk iSd 7.36 1334(v) 01.08.2007flyoj lYQkMkbft+u&1% MCY;w@MCY;w

150. flyoj lYQkMkbft+u Øhe 20 xzke dk iSd 8.23 1334(v) 01.08.2007flyoj lYQkMkbft+u&1% MCY;w@MCY;w

151. flyoj lYQkMkbft+u Øhe 30 xzke dk iSd 11.74 1334(v) 01.08.2007flyoj lYQkMkbft+u&1% MCY;w@MCY;w

152. flyoj lYQkMkbft+u Øhe 250 xzke dk iSd 63.40 1334(v) 01.08.2007flyoj lYQkMkbft+u&1% MCY;w@MCY;w

153. flyoj lYQkMkbft+u$ 5 xzke dk iSd 4.56 1334(v) 01.08.2007DyksjgsDlhfMu Xyw;dksusV Øheflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu Xyw;dksusV& 0.2% MCY;w@MCY;w

154. flyoj lYQkMkbft+u$ 10 xzke dk iSd 6.06 1334(v) 01.08.2007DyksjgsDlhfMu Xyw;dksusV Øheflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu Xyw;dksusV& 0.2% MCY;w@MCY;w

155. flyoj lYQkMkbft+u$ 15 xzke dk iSd 7.38 1334(v) 01.08.2007DyksjgsDlhfMu Xyw;dksusV Øheflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu Xyw;dksusV& 0.2% MCY;w@MCY;w

Page 193: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 174 -

156. flyoj lYQkMkbft+u$ 20 xzke dk iSd 8.82 1334(v) 01.08.2007DyksjgsDlhfMu Xyw;dksusV Øheflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu Xyw;dksusV& 0.2% MCY;w@MCY;w

157. flyoj lYQkMkbft+u$ 25 xzke dk iSd 10.30 1334(v) 01.08.2007DyksjgsDlhfMu Xyw;dksusV Øheflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu Xyw;dksusV& 0.2% MCY;w@MCY;w

158. flyoj lYQkMkbft+u$ 100 xzke dk iSd 35.92 1334(v) 01.08.2007DyksjgsDlhfMu Xyw;dksusV Øheflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu Xyw;dksusV& 0.2% MCY;w@MCY;w

159. flyoj lYQkMkbft+u$ 250 xzke dk iSd 87.04 1334(v) 01.08.2007DyksjgsDlhfMu Xyw;dksusV Øheflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu Xyw;dksusV& 0.2% MCY;w@MCY;w

160. flyoj lYQkMkbft+u$ 15 xzke dk iSd 8.16 1334(v) 01.08.2007DyksjgsDlhfMu Xyw;dksusV vkW;UVesUVflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu Xyw;dksusV& 0.2% MCY;w@MCY;w

161. flyoj lYQkMkbft+u$ 10 xzke dk iSd 6.86 1334(v) 01.08.2007DyksjgsDlhfMu ,plh,y ikmMjflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu ,plh,y& 0.5% MCY;w@MCY;w

162. flyoj lYQkMkbft+u$ 10 xzke dk iSd 6.08 1334(v) 01.08.2007DyksjgsDlhfMu ,plh,y Øheflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu ,plh,y& 0.5% MCY;w@MCY;w

163. flyoj lYQkMkbft+u$ 15 xzke dk iSd 7.40 1334(v) 01.08.2007DyksjgsDlhfMu ,plh,y Øheflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu ,plh,y& 0.5% MCY;w@MCY;w

164. flyoj lYQkMkbft+u$ 100 xzke dk iSd 36.10 1334(v) 01.08.2007DyksjgsDlhfMu ,plh,y Øheflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu ,plh,y& 0.5% MCY;w@MCY;w

165. flyoj lYQkMkbft+u$ 25 xzke dk iSd 10.42 1334(v) 01.08.2007DyksjgsDlhfMu Xyw;dksusV Øheflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu Xyw;dksusV& 0.1% MCY;w@MCY;w

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 194: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 175 -

166. flyoj lYQkMkbft+u$ 30 xzke dk iSd 12.18 1334(v) 01.08.2007DyksjgsDlhfMu Xyw;dksusV$eSVªksfuMkt+ksy$ftad vkWDlkbM tWyflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu Xyw;dksusV& 0.2% MCY;w@MCY;weSVªksfuMkt+ksy& 1% MCY;w@MCY;wftad vkWDlkbM& 2.5% MCY;w@MCY;w

167. flyoj lYQkMkbft+u$ 20 xzke dk iSd 9.48 1334(v) 01.08.2007DyksjgsDlhfMu Xyw;dksusV$,yks;$,yuVkf;u Øhe@vkW;UVesUVflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu Xyw;dksusV& 0.2% MCY;w@MCY;w,yks;& 15% MCY;w@MCY;w,yuVkf;u& 0.1% MCY;w@MCY;w

168. flyoj lYQkMkbft+u$ 30 xzke dk iSd 12.78 1334(v) 01.08.2007DyksjgsDlhfMu Xyw;dksusV$,yks;$,yuVkf;u Øhe@vkW;UVesUVflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu Xyw;dksusV& 0.2% MCY;w@MCY;w,yks;& 15% MCY;w@MCY;w,yuVkf;u& 0.1% MCY;w@MCY;w

169. flyoj lYQkMkbft+u$ 250 xzke dk iSd 95.28 1334(v) 01.08.2007DyksjgsDlhfMu Xyw;dksusV$,yks;$,yuVkf;u Øhe@vkW;UVesUVflyoj lYQkMkbft+u&1% MCY;w@MCY;wDyksjgsDlhfMu Xyw;dksusV& 0.2% MCY;w@MCY;w,yks;& 15% MCY;w@MCY;w,yuVkf;u& 0.1% MCY;w@MCY;w

170. flYoj lYQkMk;ftu$DyksjksgsDlhfMu$ 10 xzke dh 6.42 2054(v) 30.11.2007,yks osjk$,yksuVksf;u$DyksjksØslksy Øhe V~;wcflYoj lYQkMk;ftu -0.01xzk-¼1% MCY;w@MCY;w½DyksjksgsDlhfMu XywdksusV lksY;w’kuDyksjksgsDlhfMu XywdksusV-0.002 xzk- ds cjkcj ¼0.2% MCY;w@MCY;w½,yks osjk-0.15 xzk- ¼15% MCY;w@MCY;w½,yksuVksf;u-0.001 xzk- ¼0.1% MCY;w@MCY;w½DyksjksØslksy&0.1% MCY;w@MCY;w

171. lYQkMksDlhu$ik;fjfeFkkekbu xksfy;ka 2 dk 2.82 614(v) 27.05.2003 eS- bafVek¼bidk½ ysfjMksDl500 fexzk-$ 25 fexzk-@xksfy;ka ,,y_iRrk eS- dksijsu vksufy&2

eS- VksjsUV esyksflM

172. lYQkMksDlhu$ik;fjfeFkkekbu xksfy;ka 2 dk 3.48 2032(v) 30.11.2007 eS- Js;k jsft+t500 fexzk-$ 25 fexzk-@xksfy;ka iRrk@fCyLVj eS- Y;wfiu ik;jyfQu

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 195: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 176 -

173. lYQkMksDlhu$ 2 dk 3.98 614(v) 27.05.2003 eS- bafVek¼bidk½ ysfjMksDl QksVZik;fjfeFkkekbu Mh,l xksfy;ka ,,y_fCyLVj eS- Y;wfiu ik;jyfQu QksVZ750 fexzk-$ 37.5 fexzk-@xksfy;ka ¼QksVZ xksfy;ka½ eS- flj;k jsft+t QksVZ

174. lYQkMksDlhu$ 2 dk 4.88 2032(v) 30.11.2007 eS- ,,QMh fjeksMj QksVZik;fjfeFkkekbu Mh,l xksfy;ka iRrk@fCyLVj750 fexzk-$ 37.5 fexzk-@xksfy;ka ¼QksVZ xksfy;ka½

175. lYQkMksDlhu$ 1 dk 3.20 1926(v) 08.11.2006ik;fjfeFkkekbu xksfy;ka iRrk@fCyLVj1000 fexzk-$ 50 fexzk-@xksfy;ka

176. lYQkMksDlhu$ 10 fefy dh 5.36 1926(v) 08.11.2006ik;fjfeFkkekbu flji cksry125 fexzk-$ 62.5 fexzk-@5 fefy

177. lYQkMksDlhu$ik;fjfeFkkekbu lLisUlu 10 fefy dh 7.70 2032(v) 30.11.2007 eS- bafVek¼bidk½ ysfjMksDl QksVZ250 fexzk-$ 12.5 fexzk-@ 5 fefy dkap dh cksry eS- lkbjk lsfyxks

,e- di vkSj dkVZu lfgr eS- flj;k jsft+t

178. lYQkfeFkkDlkt+ksy$VªkbZfeFkksfize xksfy;ka 10x10 dk 53.38 1017(v) 03.09.2003 eS- fudksYl ,fUVªek400 fexzk-$ 80 fexzk-@ xksfy;ka iRrk@fCyLVj eS- bZLV bafM;k dksfyt+ksy

eS- Ms~l dksefcukeS- vkjihth ykbQlkbaluksysIleS- ftuks lsifVfuDl

179. lYQkfeFkkDlkt+ksy$VªkbZfeFkksfize xksfy;ka 10x10 dk 16.16 1017(v) 03.09.2003 eS- th,lds lsiVªsu100 fexzk-$ 20 fexzk-@ xksfy;ka iRrk@fCyLVj eS- teZu jsesfMt+ lqfizLVksy

eS- flj;k fVfet+ksy

180. lYQkfeFkkDlkt+ksy vkSj 1000 dk fVu 511.79 184(v) 07.02.2006 eS- fudksYl ,fUVªekVªkbZfeFkksfize xksfy;ka eS- fliyk flifyu400 fexzk-$ 80 fexzk-@xksfy;ka¼O;Ld½ eS- bZLV bafM;k dksfyt+ksy

181. lYQkfeFkkDlkt+ksy vkSj 50 fefy 8.30 1017(v) 03.09.2003 eS- fudksYl ,fUVªekVªkbZfeFkksfize lLisUlu dh cksry eS- fliyk flifyu200 fexzk-$ 40 fexzk-@ 5 fefy lLisUlu eS- bZLV bafM;k dksfyt+ksy

182. lYQkfeFkkDlkt+ksy vkSj 50 fefy dh 10.08 1054(v) 11.07.2006 eS- Ms~l dksefcukVªkbZfeFkksfize lLisUlu cksry eS- tk;Ml dsfMyk vksfjfize200 fexzk-$ 40 fexzk-@ 5 fefy lLisUlu ,e-di lfgr

183. lYQkfeFkkDlkt+ksy vkSj 100 fefy dh 13.46 718(v) 01.08.2000VªkbZfeFkksfize lLisUlu cksry200 fexzk-$ 40 fexzk-@ 5 fefy lLisUlu ,e-di lfgr

184. lYQkfeFkkDlkt+ksy$VªkbZfeFkksfize lLisUlu 60 fefy dh 9.84 718(v) 01.08.2000 eS- ftuks lsifVfuDl200 fexzk-$ 40 fexzk-@ 5 fefy lLisUlu cksry eS- flj;k fVfet+ksy

,e-di lfgr eS- zQsadfyu ysc VªkbZesDl

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 196: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 177 -

185. lYQkfeFkkDlkt+ksy vkSj 10 dk 10.04 1054(v) 11.07.2006 eS- ,ycVZ MsfoM ,Ydksfje&,QVªkbZfeFkksfize xksfy;ka iRrk@fCyLVj eS- fudksYl fijkey csfDVªe800 fexzk-$ 160 fexzk-@xksfy;ka eS- bZLV bafM;k dksfyt+ksy

eS- CY;w ØkWl dkslYQ&iheS- Mk;kufed Mk;fVªe Mh,l

186. lYQkfeFkkDlkt+ksy vkSj 5x3 fefy dk 17.55 1353(v) 16.09.2005VªkbZfeFkksfize bUtsD’ku ,Ei;wy800 fexzk-$ 160 fexzk-@ ,Ei;wy

187. lYQkfeFkkDlkt+ksy vkSj 2 dk 1.44 756(v) 19.05.2006ik;jkfeFkkekbu xksfy;ka iRrk@fCyLVj500 fexzk-$ 25 fexzk-@ xksfy;ka

188. lYQkfeFkkDlkt+ksy vkSj 10 dk 3.38 756(v) 19.05.2006VªkbZfeFkksfize xksfy;ka iRrk@fCyLVj200 fexzk-$ 40 fexzk-@ xksfy;ka

189. lYQkfeFkkDlkt+ksy vkSj 15 fefy dh 8.04 1925(v) 08.11.2006VªkbZfeFkksfize Mªksi cksry Mªksij vkSj100 fexzk-$ 20 fexzk-@ fefy dkVZu lfgr

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 197: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 178 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Vh (T)

1. VsVªklkbdfyu ,plh,y dSilwy 10 dk 5.36 613(v) 27.05.2003125 fexzk- @dSilwy iRrk@fCyLVj

2. VsVªklkbdfyu ,plh,y dSilwy 10 dk 7.20 72(v) 15.01.2004 eS- ok;Fk ,Øksekbflu250 fexzk- @dSilwy ,,y_iRrk eS- fudksyl jsLVsfDyu

eS- Ms~l lqckekbflu

3. VsVªklkbdfyu ,plh,y dSilwy 10 dk 6.66 72(v) 15.01.2004 eS- ,ofUVl gksLVklkbdfyu250 fexzk- @dSilwy ,,y_fCyLVj eS- vkbZMhih,y vkbZfMflu

4. VsVªklkbdfyu ,plh,y dSilwy 100 dh 62.00 613(v) 27.05.2003 eS- txluiky Vsjkiy250 fexzk- @dSilwy cksry

5. VsVªklkbdfyu ,plh,y dSilwy 400 dh 236.42 613(v) 27.05.2003 eS- ok;Fk ,Øksekbflu250 fexzk- @dSilwy cksry

6. VsVªklkbdfyu ,plh,y dSilwy 1000 dh 570.96 613(v) 27.05.2003 eS- vkbZMhih,y VsVªklkbdfyu250 fexzk- @dSilwy fVu@cksry

7. VsVªklkbdfyu ,plh,y dSilwy 6 dk iRrk 4.64 613(v) 27.05.2003 eS- vkbZMhih,y VsVªklkbdfyu333 fexzk- @dSilwy

8. VsVªklkbdfyu ,plh,y dSilwy 10 dk 10.74 75(v) 15.01.2004 eS- ,ofUVl gksLVklkbdfyu500 fexzk- @dSilwy iRrk@fCyLVj eS- txluiky Vsjkiy

9. VsVªklkbdfyu ,plh,y dSilwy 200 dh 195.34 613(v) 27.05.2003500 fexzk- @dSilwy cksry

10. VsVªklkbdfyu ,plh,y dSilwy 400 dh 386.86 613(v) 27.05.2003500 fexzk- @dSilwy cksry

11. VsVªklkbdfyu ,plh,y xksfy;ka 10 dk 1.56 613(v) 27.05.2003 eS- Ms~l lqckekbflu50 fexzk- @xksfy;ka ¼fyfir½ iRrk@fCyLVj

12. VsVªklkbdfyu ,plh,y xksfy;ka 10 dk 4.44 613(v) 27.05.2003 eS- ,ofUVl gksLVklkbdfyu250 fexzk- @xksfy;ka ¼fyfir½ iRrk@fCyLVj

13. VsVªklkbdfyu xksfy;ka 500 dk tkj 297.00 1338(v) 01.08.2007250 fexzk- @xksfy;ka

14. VsVªklkbdfyu ,plh,y xksfy;ka 10 dk 5.98 613(v) 27.05.2003 eS- ejdjh ykbuesV~V333 fexzk- @xksfy;ka ¼fyfir½ iRrk@fCyLVj

15. VsVªklkbdfyu ,plh,y xksfy;ka 10 dk 9.08 1053(v) 11.07.2006 eS- ,ofUVl gksLVklkbdfyu500 fexzk- @xksfy;ka ¼fyfir½ ,,y_iRrk

16. VsVªklkbdfyu ,plh,y xksfy;ka 10 dk 8.60 1053(v) 11.07.2006 eS- ,ofUVl gksLVklkbdfyu500 fexzk- @xksfy;ka ¼fyfir½ ,,y_fCyLVj

Page 198: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 179 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

17. VsVªklkbdfyu ,plh,y$ 10 dk 10.37 1672(v) 03.10.2006eSVªksfuMkt+ksy dSilwy iRrk@fCyLVjVsVªklkbdfyu ,plh,y 300 fexzk-eSVªksfuMkt+ksy 400 fexzk-@dSilwy

18. fFk;ksQkbfyu xksfy;ka&100 10 dk 1.58 885(v) 06.11.1995 eS- th,lds fFk;ks&ih,100 fexzk- @xksfy;ka ,,y@fCyLVj@iRrk

19. fFk;ksQkbfyu xksfy;ka&100 10 dk 2.94 182(v) 07.02.2006100 fexzk-@,lvkj@lhvkj xksfy;ka ,,y_iRrk

20. fFk;ksQkbfyu xksfy;ka&100 10 dk 2.72 182(v) 07.02.2006100 fexzk-@,lvkj@lhvkj xksfy;ka ,,y_fCyLVj

21. fFk;ksQkbfyu xksfy;ka&200 10 dk 2.30 885(v) 06.11.1995 eS- th,lds fFk;ks&ih,200 fexzk- @xksfy;ka ,,y@fCyLVj@iRrk eS- oksdkMZ Qk;yksfcM

eS- Xyksl QkekZ VhXyks

22. fFk;ksQkbfyu lhvkj@,lvkj xksfy;ka 10 dk 2.80 885(v) 06.11.1995 eS- csLVksdse Vh,lvkj200 fexzk-@lhvkj@,lvkj xksfy;ka ,,y@fCyLVj@iRrk eS- ;’k QkekZ yaxQkW;y

eS- ,yfEcd fFk;ks ,lvkjeS- ;w,loh lsusosVs czksedksfMZy&,Dl,yeS- LVsuds;j fFk;ksLVsu lhvkj

23. fFk;ksQkbfyu xksfy;ka&300 10 dk 3.04 885(v) 06.11.1995 eS- ,eD;wj fczFk300 fexzk- @xksfy;ka ,,y@fCyLVj@iRrk eS- th,lds fFk;ks&ih,

24. fFk;ksQkbfyu ,lvkj xksfy;ka&300 10 dk 6.02 561(v) 09.08.1996 eS- oksdkMZ Qk;yksfcM300 fexzk- @,lvkj xksfy;ka ,,y_iRrk

25. fFk;ksQkbfyu ,lvkj xksfy;ka&300 10 dk 5.54 561(v) 09.08.1996 eS- ,eD;wj fczFk300 fexzk- @,lvkj xksfy;ka ,,y_fCyLVj

26. fFk;ksQkbfyu ,lvkj xksfy;ka&300 15 dk 8.86 423(v) 03.06.1997 eS- izksVsd fFk;ksfcM 300 ,lvkj300 fexzk- @,lvkj xksfy;ka ,,y_iRrk

27. fFk;ksQkbfyu ,lvkj xksfy;ka&300 15 dk 8.14 423(v) 03.06.1997 eS- izksVsd fFk;ksfcM 300 ,lvkj300 fexzk- @,lvkj xksfy;ka ,,y_fCyLVj

28. fFk;ksQkbfyu xksfy;ka 200 dh 116.86 1080(v) 11.07.2006400 fexzk-@ ,lvkj@lhvkj@ cksryMhvkj@bZvkj@Vhvkj xksfy;ka

29. fFk;ksQkbfyu xksfy;ka 10 dk 6.40 1080(v) 11.07.2006400 fexzk-@ ,lvkj@lhvkj@ iRrk@fCyLVjMhvkj@bZvkj@Vhvkj xksfy;ka

30. fFk;ksQkbfyu xksfy;ka 10 dk 8.96 1080(v) 11.07.2006600 fexzk-@ ,lvkj@lhvkj@ iRrk@fCyLVjMhvkj@bZvkj@Vhvkj xksfy;ka

Page 199: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 180 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

31. fFk;ksQkbfyu xksfy;ka 10 dk 4.78 182(v) 07.02.2006 eS- lu QkekZ vksMh Qk;fyu400 fexzk- @xksfy;ka iRrk@fCyLVj eS- th ysc Qk;fu&400

eS- oksdkMZ Qk;yksMseS- vkscljft+y ck;ksVsdQk;fyu&1

32. fFk;ksQkbfyu xksfy;ka 10 dk 7.36 1349(v) 16.09.2005 eS- oksdkMZ Qk;yksMs600 fexzk- @xksfy;ka iRrk@fCyLVj eS- lu QkekZ vksMh Qk;fyu

eS- izksVsd fFk;ksMs

33. fFk;ksQkbfyu lhvkj@,lvkj dSilwy 10 dk 5.80 2053(v) 30.11.2007125 fexzk-@lhvkj@,lvkj dSilwy ,,y_iRrk

34. fFk;ksQkbfyu lhvkj@,lvkj dSilwy 10 dk 5.38 2053(v) 30.11.2007125 fexzk-@lhvkj@,lvkj dSilwy ,,y_fCyLVj

35. fFk;ksQkbfyu flji 100 fefy dh 9.70 1080(v) 11.07.200680 fexzk- @ 5 fefy cksry

36. fFk;ksQkbfyu flji 100 fefy dh 9.66 1349(v) 16.09.2005 eS- eksnh eqaMh ;wfudksfUVu100 fexzk- @ 5 fefy cksry ,e-di lfgr

37. fFk;ksQkbfyu$lsyC;wVkeksy xksfy;ka 10 dk 2.02 501(v) 16.07.1997 eS- fliyk fFk;ks&,lFksfyufFk;ksQkbfyu 100 fexzk- ,,y_fCyLVj eS- lh,Q,y czksUdksQk;y IyllsyC;wVkeksy 2 fexzk-@ 5 fefy eS- th,lds czksUdks Iyl

eS- bjkst+ QkekZ fFk;kslsyfcMeS- lqfut+ QkekZ lsyC;wflu&Vh

38. fFk;ksQkbfyu$lsyC;wVkeksy xksfy;ka 10 dk iRrk 3.34 501(v) 16.07.1997 eS- th,lds czksUdks Iyl QksVZfFk;ksQkbfyu 200 fexzk- eS- fliyk fFk;ks&,lFksfyulsyC;wVkeksy 4 fexzk-@ 5 fefy eS- ;’k QkekZ osfUVQkbfyu

39. fFk;ksQkbfyu$,sQsMjhu xksfy;ka 10 dk 3.32 182(v) 07.02.2006 eS- Qkbt+j VsMjkyfFk;ksQkbfyu 130 fexzk- iRrk@fCyLVj,sQsMjhu ,plh,y 24 fexzk-

40. fFk;ksQkbfyu$,sQsMjhu$QsuksckjfcVksu$ 10 dk 5.20 1326(v) 19.11.2003 eS- Qkbt+j VsMjky&bZfxfylfjy X;wdkysV xksfy;ka iRrk@fCyLVjfFk;ksQkbfyu 130 fexzk-,sQsMjhu ,plh,y 48 fexzk-QsuksckjfcVksu 8 fexzk-fxfylfjy X;wdkysV 100 fexzk-

41. fFk;ksQkbfyu$,sQsMjhu$ 10 dk 4.54 182(v) 07.02.2006 eS- fudksYl ,LekisDl fMiksVQsuksckjfcVksu xksfy;ka iRrk@fCyLVjfFk;ksQkbfyu ,UgkbMªsl 65 fexzk-,sQsMjhu ¼jsflusV esa½ 50 fexzk-QsuksckjfcVksu 30 fexzk-

Page 200: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 181 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

42. fFk;ksQkbfyu$,sQsMjhu$ 10 dk 3.20 182(v) 07.02.2006 eS- fliyk ,yjft+uQsuksckjfcVksu xksfy;ka iRrk@fCyLVjfFk;ksQkbfyu ,UgkbMªsl 100 fexzk-,sQsMjhu ,plh,y 20 fexzk-QsuksckjfcVksu 15 fexzk-

43. fFk;ksQkbfyu$,sQsMjhu$QsuksckjfcVksu 10 dk 6.48 182(v) 07.02.2006lLVsUM ,D’ku ¼,l,½ xksfy;ka iRrk@fCyLVjfFk;ksQkbfyu 198 fexzk-,sQsMjhu ,plh,y 48 fexzk-QsuksckjfcVksu 25 fexzk-

44. fFk;ksQkbfyu$,sQsMjhu$ 20 dk 16.26 182(v) 07.02.2006 eS- ;wuhesM ¼Qkbt+j½ ekjsDlgkbMªksDlht+hu dSilwy iRrk@fCyLVjfFk;ksQkbfyu 130 fexzk-,sQsMjhu ,plh,y 25 fexzk-gkbMªksDlht+hu ,plh,y 10 fexzk-

45. fFk;ksQkbfyu$,sQsMjhu$QsuksckjfcVksu$ 200 fefy dh 24.88 1326(v) 19.11.2003 eS- dsfMyk ,p- ds;j dsfMQk;ysVX;wQSUlhu$,YdksgWy ,fyDlj cksryfFk;ksQkbfyu bFkksusV vkWQ fiijkftu 80 fexzk-,sQsMjhu ,plh,y 12 fexzk-QsuksckjfcVksu 4 fexzk-X;wQSUlhu 50 fexzk-,YdksgWy 0.55 fefy@ 5 fefy

46. fFk;ksQkbfyu$,sQsMjhu$ 100 fefy dh 26.24 182(v) 07.02.2006 eS- txluiky ,LFkfeuksQsuksckjfcVksu fyfDoM cksryfFk;ksQkbfyu ,UgkbMªsl 100 fexzk-,sQsMjhu ,plh,y 10 fexzk-QsuksckjfcVksu 10 fexzk-@ 5 fefy

47. fFk;ksQkbfyu$lsyC;wVkeksy flji 100 fefy dh 12.28 448(v) 29.03.2006 eS- ;’k QkekZ osUVsQkbfyufFk;ksQkbfyu ,UgkbMªsl 100 fexzk- cksry eS- th,lds czksUdksIyllsyC;wVkeksy lYQsV eS- fliyk fFk&,LFksfyu2 fexzk- lsyC;wVkeksy ds cjkcj@ 10 fefy eS- ØsLi osUV

48. fFk;ksQkbfyu$lsyC;wVkeksy $ 10 dk 3.68 448(v) 29.03.2006 eS- tsusdk ,p- ds;j ,ldse,EczksDlksy xksfy;ka iRrk@fCyLVj eS- Mk;ukfed tksyhufFk;ksQkbfyu ,UgkbMªsl 100 fexzk-lsyC;wVkeksy 2 fexzk-,EczksDlksy ,plh,y 30 fexzk-@xksfy;ka

49. fFk;ksQkbfyu$lsyC;wVkeksy xksfy;ka 10 dk 5.46 448(v) 29.03.2006fFk;ksQkbfyu 300 fexzk- iRrk@fCyLVjlsyC;wVkeksy 4 fexzk-@,lvkj xksfy;ka

Page 201: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 182 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

50. fFk;ksQkbfyu$bVksQkbfyu ,Ei;wy 2 fefy dk 2.98 449(v) 29.03.2006 eS- ikdlUl lqQkbfyufFk;ksQkbfyu ,UgkbMªsl ,Ei;wy25.3 fexzk- fFk;ksQkbfyu gkbMªsV ds cjkcjbVksQkbfyu 84.7 fexzk- @fefy

51. fFk;ksQkbfyu$bVksQkbfyu flji 100 fefy dh 12.29 449(v) 29.03.2006 eS- esMhikWy QkekZ czksUdksesM Iyl ekbujfFk;ksQkbfyu ,UgkbMªsl cksry eS- teZu jsesfMt MsfjQkbfyu14 fexzk- fFk;ksQkbfyu gkbMªsV ds cjkcjbVksQkbfyu 46.5 fexzk- @ 5 fefy

52. fFk;ksQkbfyu$bVksQkbfyu flji 100 fefy dh 11.92 449(v) 29.03.2006 eS- teZu jsesfMt MsfjQkbfyufFk;ksQkbfyu ,UgkbMªsl cksry23 fexzk- fFk;ksQkbfyu gkbMªsV ds cjkcjbVksQkbfyu 77 fexzk- @ 5 fefy

53. fFk;ksQkbfyu$bVksQkbfyu xksfy;ka 10 dk 2.46 449(v) 29.03.2006 eS- ,xzksu jsesfMt ,xzksQkbfyufFk;ksQkbfyu ,UgkbMªsl iRrk@fCyLVj eS- teZu jsesfMt MsfjQkbfyu23 fexzk- fFk;ksQkbfyu gkbMªsV ds cjkcjbVksQkbfyu 77 fexzk- @ xksfy;ka

54. fFk;ksQkbfyu$bVksQkbfyu xksfy;ka 250 dh 48.65 449(v) 29.03.2006 eS- teZu jsesfMt MsfjQkbfyufFk;ksQkbfyu ,UgkbMªsl cksry23 fexzk- fFk;ksQkbfyu gkbMªsV ds cjkcjbVksQkbfyu 77 fexzk- @xksfy;ka

55. fFk;ksQkbfyu$bVksQkbfyu xksfy;ka 10 dk 4.06 449(v) 29.03.2006 eS- teZu jsesfMt MsfjQkbfyu fjVkMZfFk;ksQkbfyu ,UgkbMªsl iRrk@fCyLVj35 fexzk- fFk;ksQkbfyu gkbMªsV ds cjkcjbVksQkbfyu 115 fexzk- @xksfy;ka

56. fFk;ksQkbfyu$bVksQkbfyu xksfy;ka 10 dk 6.12 449(v) 29.03.2006 eS- teZu jsesfMt MsfjQkbfyu fjVkMZfFk;ksQkbfyu ,UgkbMªsl iRrk@fCyLVj69 fexzk- fFk;ksQkbfyu gkbMªsV ds cjkcjbVksQkbfyu 231 fexzk- @xksfy;ka

57. fFk;ksQkbfyu$bVksQkbfyu xksfy;ka 10 dk 7.82 449(v) 29.03.2006 eS- teZu jsesfMt MsfjQkbfyu fjVkMZfFk;ksQkbfyu ,UgkbMªsl iRrk@fCyLVj104 fexzk- fFk;ksQkbfyu gkbMªsV ds cjkcjbVksQkbfyu 346 fexzk- @xksfy;ka

58. fFk;ksQkbfyu$ 10 dk iRrk@fCyLVj 2.78 1058(v) 11.07.2006VjC;wVkfyu xksfy;kafFk;ksQkbfyu ,ugkbMªsl&100 fexzk-VjC;wVkfyu lYQsV&2.5 fexzk-

59. fFk;ksQkbfyu$ 10 dk ,,y_iRrk 7.18 1058(v) 11.07.2006VjC;wVkfyu xksfy;kafFk;ksQkbfyu ,ugkbMªsl&300 fexzk-VjC;wVkfyu lYQsV&5 fexzk-@,lvkj xksfy;ka

Page 202: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 183 -

60. fFk;ksQkbfyu$ 10 dk ,,y_fCyLVj 6.78 1058(v) 11.07.2006VjC;wVkfyu xksfy;kafFk;ksQkbfyu ,ugkbMªsl&300 fexzk-VjC;wVkfyu lYQsV&5 fexzk-

61. gkbMªksDlh bFkk;y 2 fefy dk 2.55 746(v) 19.05.2006fFk;ksQkbfyu bUtSaD’ku ,Ei;wygkbMªksDlh bFkk;yfFk;ksQkbfyu&113 fexzk-@fefy

62. fFk;ksQkbfyu$czkseksgsDlhu$ 10 dk iRrk@fCyLVj 3.68 1080(v) 11.07.2006,yC;wVsuksy ¼lYQsV½ xksfy;kafFk;ksQkbfyu&200 fexzk-czkseksgsDlhu ,plh,y&8 fexzk-,yC;wVsuksy ¼lYQsV½&4 fexzk-

63. fFk;ksQkbfyu$,sQsfMjhu$ 100 dh cksry 26.12 1080(v) 11.07.2006QsuksckjfcVksu xksfy;kafFk;ksQkbfyu&100 fexzk-,sQsfMjhu ,plh,y&10 fexzk-QsuksckjfcVksu&10 fexzk-

64. fFk;ksQkbfyu$,sQsfMjhu$ 10 dk iRrk@fCyLVj 2.88 1080(v) 11.07.2006QsuksckjfcVksu xksfy;kafFk;ksQkbfyu&100 fexzk-,sQsfMjhu ,plh,y&15 fexzk-QsuksckjfcVksu&10 fexzk-

65. fFk;ksQkbfyu xksfy;ka 10 dk iRrk@fCyLVj 2.80 1678(v) 03.10.2006fFk;ksQkbfyu &200 fexzk-@lhvkj@,lvkj xksfy;ksa

66. fFk;ksQkbfyu xksfy;ka 10 dk iRrk@fCyLVj 4.51 1678(v) 03.10.2006fFk;ksQkbfyu &300 fexzk-

67. fFk;ksQkbfyu dSilwy 10 dk iRrk@fCyLVj 9.62 1678(v) 03.10.2006fFk;ksQkbfyu&400 fexzk-@lhvkj@,lvkj dSilwy

68. fFk;ksQkbfyu$dsVksfVQsu xksfy;ka 10 dk 7.26 1325(v) 01.08.2007fFk;ksQkbfyu ¼,UgkbMªsl½&200 fexzk- iRrk@fCyLVjdsVksfVQsu& ¶;wejsVdsVksfVQsu&1 fexzk- ds cjkcj

69. fFk;ksQkbfyu$lsyC;wVkeksy xksfy;ka 10 dk 4.46 211(v) 14.02.2007lsyC;wVkeksy lYQsV&4 fexzk- iRrk@fCyLVjfFk;ksQkbfyu ¼,UgkbMªsl½&200 fexzk-lhvkj@,lvkj@Mhvkj@Vhvkj fVfd;k

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 203: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 184 -

70. fFk;ksQkbfyu$lsyC;wVkeksy dSilwy 10 dk 6.58 211(v) 14.02.2007lsyC;wVkeksy lYQsV&4 fexzk- iRrk@fCyLVjfFk;ksQkbfyu ¼,UgkbMªsl½&200 fexzk-@lhvkj@,lvkj@Mhvkj@Vhvkj dSilwy

71. fFk;ksQkbfyu$,sQsfMjhu ,plh,y$ 200 fefy dh 25.00 1341(v) 01.08.2007lksfM;e vk;ksMkbM flji cksryfFk;ksQkbfyu&50 fexzk-,sQsfMjhu ,plh,y&15 fexzk-lksfM;e vk;ksMkbM &25 fexzk-@ 5fefy

72. fFk;ksQkbfyu$,sQsfMjhu 60 fefy dh 10.28 1341(v) 01.08.2007,plh,y fyfDoM cksryfFk;ksQkbfyu ,UgkbMªsl&30 fexzk-,sQsfMjhu ,plh,y&6 fexzk-@ 5fefy

73. fFk;ksQkbfyu$,sQsfMjhu 10 dk 3.30 1341(v) 01.08.2007,plh,y$czkseksgsDlhu xksfy;ka iRrk@fCyLVjfFk;ksQkbfyu ,UgkbMªsl&125 fexzk-,sQsfMjhu ,plh,y&20 fexzk-czkseksgsDlhu&8 fexzk-@ fVfd;k

74. fFk;ksQkbfyu dSilwy 10 dk 6.68 1341(v) 01.08.2007fFk;ksQkbfyu &200 fexzk- iRrk@fCyLVj

75. fFk;ksQkbfyu$,sQsfMjhu ,plh,y$ 200 fefy 25.88 1652(v) 27.09.2007X;wQSUlhu$,YdksgWy ,fyDlj dkap dh cksryfFk;ksQkbfyu bFkksusV dkfiijkt+kbu&80 fexzk-,sQsfMjhu ,plh,y&12 fexzk-X;wQSUlhu&50 fexzk-,YdksgWy&0.55 fefy@ 5 fefy

76. fFk;ksQkbfyu$,sQsfMjhu ,plh,y$ 200 fefy 28.16 1652(v) 27.09.2007X;wQSUlhu$,YdksgWy ,fyDlj IykfLVd dh cksryfFk;ksQkbfyu bFkksusV dkfiijkt+kbu&80 fexzk-,sQsfMjhu ,plh,y&12 fexzk-X;wQSUlhu&50 fexzk-,YdksgWy&0.55 fefy@ 5 fefy

77. fFk;ksQkbfyu$,sQsfMjhu 10 dk 2.82 1652(v) 27.09.2007,plh,y xksfy;ka iRrk@fCyLVjfFk;ksQkbfyu ,UgkbMªsl&120 fexzk-,sQsfMjhu ,plh,y&15 fexzk-@ fVfd;k

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 204: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 185 -

78. fFk;ksQkbfyu ,UgkbMªl$ 110 fefy dh 14.86 170(v) 29.01.2008lsyC;wVkeksy lYQsV flji cksryfFk;ksQkbfyu ,UgkbMªl -100 fexzk-lsyC;wVkeksy lYQsVlsyC;wVkeksy-2 fexzk- ds cjkcj

79. fFk;ksQkbfyu ,UgkbMªl$ 10 fefy dh 5.22 170(v) 29.01.2008lsyC;wVkeksy lYQsV flji cksryfFk;ksQkbfyu ,UgkbMªl -100 fexzk-lsyC;wVkeksy lYQsVlsyC;wVkeksy-2 fexzk- ds cjkcj

80. fFk;ksQkbfyu ,UgkbMªl$ 20 fefy dh 6.01 170(v) 29.01.2008lsyC;wVkeksy lYQsV flji cksryfFk;ksQkbfyu ,UgkbMªl -100 fexzk-lsyC;wVkeksy lYQsVlsyC;wVkeksy-2 fexzk- ds cjkcj

81. fFk;ksQkbfyu ,UgkbMªl$ 30 fefy dh 6.85 170(v) 29.01.2008lsyC;wVkeksy lYQsV flji cksryfFk;ksQkbfyu ,UgkbMªl -100 fexzk-lsyC;wVkeksy lYQsVlsyC;wVkeksy-2 fexzk- ds cjkcj

82. fFk;ksQkbfyu ,UgkbMªl$ 50 fefy dh 8.37 170(v) 29.01.2008lsyC;wVkeksy lYQsV flji cksryfFk;ksQkbfyu ,UgkbMªl -100 fexzk-lsyC;wVkeksy lYQsVlsyC;wVkeksy-2 fexzk- ds cjkcj

83. fFk;ksQkbfyu ,UgkbMªl$ 100 fefy dh 12.65 170(v) 29.01.2008lsyC;wVkeksy lYQsV flji cksryfFk;ksQkbfyu ,UgkbMªl -100 fexzk-lsyC;wVkeksy lYQsVlsyC;wVkeksy-2 fexzk- ds cjkcj

84. fFk;ksQkbfyu ,UgkbMªl$ 150 fefy dh 17.50 170(v) 29.01.2008lsyC;wVkeksy lYQsV flji cksryfFk;ksQkbfyu ,UgkbMªl -100 fexzk-lsyC;wVkeksy lYQsVlsyC;wVkeksy-2 fexzk- ds cjkcj

85. fFk;ksQkbfyu ,UgkbMªl$ 200 fefy dh 21.26 170(v) 29.01.2008lsyC;wVkeksy lYQsV flji cksryfFk;ksQkbfyu ,UgkbMªl -100 fexzk-lsyC;wVkeksy lYQsVlsyC;wVkeksy-2 fexzk- ds cjkcj

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 205: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 186 -

86. fFk;ksQkbfyu ,UgkbMªl$ 250 fefy dh 25.17 170(v) 29.01.2008lsyC;wVkeksy lYQsV flji cksryfFk;ksQkbfyu ,UgkbMªl -100 fexzk-lsyC;wVkeksy lYQsVlsyC;wVkeksy-2 fexzk- ds cjkcj

87. fFk;ksQkbfyu ,UgkbMªl$ 500 fefy dh 45.62 170(v) 29.01.2008lsyC;wVkeksy lYQsV flji cksryfFk;ksQkbfyu ,UgkbMªl -100 fexzk-lsyC;wVkeksy lYQsVlsyC;wVkeksy-2 fexzk- ds cjkcj

88. fFk;ksQkbfyu $bVksQkbfyu xksfy;ka 10 dk 8.14 196(v) 29.01.2008fFk;ksQkbfyu-138 fexzk- iRrk@fCyLVjbVksQkbfyu-462 fexzk-@fVfd;k

89. fFk;ksQkbfyu ,UgkbMªl lhvkj xksfy;ka 10 dk 11.42 196(v) 29.01.2008fFk;ksQkbfyu ,UgkbMªl-800 fexzk- iRrk@fCyLVj

90. fFk;ksQkbfyu $ 10 dk 8.14 196(v) 29.01.2008czksekgsDlhu ,plh,y dSilwy iRrk@fCyLVjfFk;ksQkbfyu ds isysV ds cjkcjfFk;ksQkbfyu ¼,UgkbMªl½-400 fexzk-czksekgsDlhu ,plh,y ds isysV-8 fexzk-@dSilwy

91. fFk;ksQkbfyu $lsyC;wVkeksy xksfy;ka 10 dk 3.60 196(v) 29.01.2008fFk;ksQkbfyu ,UgkbMªl-200 fexzk- iRrk@fCyLVjlsyC;wVkeksy-2 fexzk-@fVfd;k

92. fFk;ksQkbfyu $lsyC;wVkeksy$ 10 dk 6.12 196(v) 29.01.2008,EczksDlksy ,plh,y xksfy;ka iRrk@fCyLVjfFk;ksQkbfyu-200 fexzk-lsyC;wVkeksy-4 fexzk-,EczksDlksy ,plh,y-60 fexzk-@fVfd;k

93. fFk;ksQkbfyu ,UgkbMªl$MkbZbFkk;y 10 dk 3.04 196(v) 29.01.2008dkckZest+kbu lkbVªsV xksfy;ka iRrk@fCyLVjfFk;ksQkbfyu ,UgkbMªl-80 fexzk-MkbZbFkk;y dkckZest+kbu lkbVªsV-100 fexzk-

94. Fkk;feu izksfiy MkbZ lYQsV xksfy;ka 10 dk 3.98 1655(v) 27.09.2007Fkk;fefu izksfiy MkbZ lYQsV&75 fexzk- iRrk@fCyLVj

95. VksYukQVsV Øhe@vkW;UVesUV&1% 5 xzke dh 3.86 628(v) 02.09.1997VksYukQVsV 10 fexzk-@xzke V~;wc

96. VksYukQVsV Øhe@vkW;UVesUV&1% 10 xzke dh 5.20 827(v) 15.06.2005VksYukQVsV 10 fexzk-@xzke V~;wc

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 206: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 187 -

97. VksYukQVsV Øhe@vkW;UVesUV&1% 30 xzke dh 10.34 827(v) 15.06.2005VksYukQVsV 10 fexzk-@xzke V~;wc

98. VksYukQVsV yks’ku@lksY;w’ku&1% 10 fefy dh 6.62 433(v) 23.03.2007 eS- txluiky VksylksyVksYukQVsV 10 fexzk-@fefy cksry

99. VksYukQVsV yks’ku@lksY;w’ku&1% 15 fefy dh 7.76 433(v) 23.03.2007VksYukQVsV 10 fexzk-@fefy cksry

100. VksYukQVsV$tSUVkekbflu$fcVkfeFkkt+ksu 5 xzke dh 5.52 828(v) 15.06.2005 eS- lh,Q,y QkekZ VksycsVosyjsV$vkbZlh,pD;w Øhe V~;wc eS- fudksYl fijkey ,lftMeZizR;sd xzke esa eS- ,eD;wj ,chlh MeZVksYukQVsV 10 fexzk-tSUVkekbflu lYQsV 1 fexzk-fcVkfeFkkt+ksu osyjsV 0.61 fexzk-vkbZlh,pD;w 10 fexzk-

101. VksYukQVsV$tSUVkekbflu$fcVkfeFkkt+ksu 10 xzke dh 8.22 828(v) 15.06.2005 eS- isut+ksu QkekZ D;w-Mh- 4osyjsV$vkbZlh,pD;w Øhe V~;wcizR;sd xzke esaVksYukQVsV 10 fexzk-tSUVkekbflu lYQsV 1 fexzk-fcVkfeFkkt+ksu osyjsV 0.61 fexzk-vkbZlh,pD;w 10 fexzk-

102. VksYukQVsV$tSUVkekbflu$fcVkfeFkkt+ksu 5 xzke dh 5.24 828(v) 15.06.2005 eS- txluiky fD;wlosyjsV$vkbZlh,pD;w Øhe V~;wc eS- QwyQksMZ D;wMfjMeZizR;sd xzke esaVksYukQVsV 10 fexzk-tSUVkekbflu lYQsV 1 fexzk-fcVkfeFkkt+ksu osyjsV 0.5 fexzk-vkbZlh,pD;w 10 fexzk-

103. vkbMksDyksjks&gkbMªksDlhD;wuksfyu$ 15 xzk- dh V~;wc 10.12 828(v) 15.06.2005VksYukQVsV$tsUVkekbflu$fcVkfeFkkt+ksu osyjsV ØhevkbMksDyksjksgkbMªksDlhD;wuksfyu&10 fexzk-VksYukQVsV&10 fexzk-tsUVkekbflu lYQsV&1 fexzk-fcVkfeFkkt+ksu osyjsV&0.5 fexzk-

104. VksYukQVsV$tsUVkekbflu$ 5 xzk- dh V~;wc 4.88 828(v) 15.06.2005vkbMksDyksjksgkbMªksDlhD;wuksfyu$fcDyksfeFkkt+ksu MkbZizksfi;ksusV ØheVksYukQVsV&10 fexzk-tsUVkekbflu lYQsV&1 fexzk-vkbMksDyksjksgkbMªksDlhD;wuksfyu&10 fexzk-fcDyksfeFkkt+ksu MkbZizksfi;ksusV&0.25 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 207: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 188 -

105. VksYukQVsV$tsUVkekbflu$ 10 xzk- dh V~;wc 6.96 828(v) 15.06.2005vkbMksDyksjksgkbMªksDlhD;wuksfyu$fcDyksfeFkkt+ksu MkbZizksfi;ksusV ØhevkbMksDyksjksgkbMªksDlhD;wuksfyu&10 fexzk-VksYukQVsV&10 fexzk-tsUVkekbflu lYQsV&1 fexzk-fcDyksfeFkkt+ksu MkbZizksfi;ksusV&0.25 fexzk-

106. VksYukQVsV$tsUVkekbflu$ 15 xzke dh 8.38 450(v) 29.03.2006fcVkfeFkkt+ksu osyjsV$ V~;wcvkbMksDyksjksgkbMªksDlhD;wuksfyu¼vkbZlh,pD;w½ ØheVksYukQVsV 10 fexzk-tsUVkekbflu lYQsV 1 fexzk-fcVkfeFkkt+ksu osyjsV 0.61 fexzk-vkbMksDyksjksgkbMªksDlhD;wuksfyu 10 fexzk-

107. VksYukQVsV$tSUVkekbflu$ 5 xzke dh V~;wc 6.28 1686(v) 03.10.2006DyksfcVklksy izksfi;ksusV$vkbZMksDyksjksgkbMªksDlhD;wuksfyu$DyksfVªekt+ksy ØheVksYukQVsV&10 fexzk-tSUVkekbflu lYQsV1 fexzk- tSUVkekbflu ds cjkcjDyksfcVklksy izksfi;ksusV&0.5 fexzk-vkbZMksDyksjksgkbMªksDlhD;wuksfyu&10 fexzk-DyksfVªekt+ksy&10 fexzk-

108. VksYukQVsV$tSUVkekbflu$ 10 xzke dh 8.08 1923(v) 08.11.2006fcVkfeFkkt+ksu MkbZizksfi;ksusV$ V~;wcvkbMksDyksjksgkbMªksDlhD;wuksfyuØhe@vkW;uVeSaVVksYukQVsV&10 fexzk-tSUVkekbflu lYQsV1 fexzk- tSUVkekbflu csl ds cjkcjfcVkfeFkkt+ksu MkbZizksfi;ksusV-0.643 fexzk-vkbMksDyksjksgkbMªksDlhD;wuksfyu&10 fexzk-

109. VksYukQVsV lksY;w’ku 12 fefy dh 8.30 1657(v) 27.09.2007VksYukQVsV&10 fexzk-@fefy cksry

110. VªkbZfeFkksfize xksfy;ka 10 dk 2.07 220(v) 14.02.2007100 fexzk-@xksfy;ka iRrk@fCyLVj

111. VªkbZfeFkksfize vkSj 10x10 dk 53.8 1017(v) 03.09.2003lYQkfeFkkDlkt+ksy xksfy;ka iRrk@fCyLVj80 fexzk-$ 400 fexzk-@xksfy;ka

112. VªkbZfeFkksfize vkSj 10x10 dk 16.16 1017(v) 03.09.2003lYQkfeFkkDlkt+ksy xksfy;ka iRrk@fCyLVj20 fexzk-$ 100 fexzk-@xksfy;ka

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 208: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 189 -

113. VªkbZfeFkksfize vkSj 1000 dk fVu 511.79 184(v) 07.02.2006lYQkfeFkkDlkt+ksy xksfy;ka80 fexzk-$400 fexzk-@xksfy;ka¼O;Ld½

114. VªkbZfeFkksfize vkSj 50 fefy 8.30 1017(v) 03.09.2003lYQkfeFkkDlkt+ksy lLisUlu dh cksry40 fexzk-$ 200 fexzk-@ 5 fefy lLisUlu

115. VªkbZfeFkksfize vkSj 50 fefy dh 10.08 1054(v) 11.07.2006lYQkfeFkkDlkt+ksy lLisUlu cksry40 fexzk-$ 200 fexzk-@ 5 fefy lLisUlu ,e-di lfgr

116. lYQkfeFkkDlkt+ksy vkSj 100 fefy dh 13.46 718(v) 01.08.2000VªkbZfeFkksfize lLisUlu cksry200 fexzk-$ 40 fexzk-@ 5 fefy lLisUlu ,e-di lfgr

117. VªkbZfeFkksfize$lYQkfeFkkDlkt+ksy lLisUlu 60 fefy dh 9.84 718(v) 01.08.200040 fexzk-$ 200 fexzk-@ 5 fefy lLisUlu cksry

,e-di lfgr

118. VªkbZfeFkksfize vkSj 10 dk 10.04 1054(v) 11.07.2006lYQkfeFkkDlkt+ksy xksfy;ka iRrk@fCyLVj160 fexzk-$ 800 fexzk-@xksfy;ka

119. VªkbZfeFkksfize vkSj 5 fefy dk 2.90 562(v) 21.06.1995lYQkfeFkkDlkt+ksy bUtsD’ku ,Ei;wy16 fexzk-$ 80 fexzk-@fefy ,Ei;wy¼80+400 fexzk-@5 fefy½

120. VªkbZfeFkksfize vkSj 10x10 dk 60.10 1055(v) 11.07.2006lYQkfM;kft+u xksfy;ka iRrk@fCyLVj90 fexzk-$ 410 fexzk-@xksfy;ka

121. VªkbZfeFkksfize vkSj 6 dk 6.98 1055(v) 11.07.2006lYQkfM;kft+u xksfy;ka ,,y_iRrk180 fexzk-$ 820 fexzk-@xksfy;ka

122. VªkbZfeFkksfize vkSj 6 dk 6.68 1055(v) 11.07.2006lYQkfM;kft+u xksfy;ka ,,y_fCyLVj180 fexzk-$ 820 fexzk-@xksfy;ka

123. VªkbZfeFkksfize vkSj 5x3 fefy dk 17.55 1353(v) 16.09.2005lYQkfeFkkDlkt+ksy bUtsD’ku ,Ei;wy160 fexzk-$ 800 fexzk-@,Ei;wy

124. VªkbZfeFkksfize vkSj 10 dk 3.38 756(v) 19.05.2006lYQkfeFkkDlkt+ksy xksfy;ka iRrk@fCyLVj40 fexzk-$ 200 fexzk-@xksfy;ka

125. VªkbZfeFkksfize vkSj 15 fefy dh 9.40 1324(v) 01.08.2007lYQkfeFkkDlkt+ksy Mªksi cksry Mªksij vkSj20 fexzk-$ 100 fexzk-@fefy dkVZu lfgr

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 209: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 190 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

oh (V)

1. osjkikfey ,plh,y xksfy;ka&40 10 dk 6.24 944(v) 30.10.1998 eS- fudksyl fijkey dsykfIVu40 fexzk- @xksfy;ka ,,y_iRrk eS- VksjsUV oslksiVsu

2. osjkikfey ,plh,y xksfy;ka&40 10 dk 5.94 944(v) 30.10.1998 eS- Fksfel dsfedyl osjkfey40 fexzk- @xksfy;ka ,,y_fCyLVj

3. osjkikfey ,plh,y xksfy;ka&80 10 dk 11.90 944(v) 30.10.1998 eS- fudksyl fijkey dsykfIVu80 fexzk- @xksfy;ka ,,y_iRrk eS- VksjsUV oslksiVsu

4. osjkikfey ,plh,y xksfy;ka&80 10 dk 11.52 944(v) 30.10.1998 eS- Fksfel dsfedyl osjkfey80 fexzk- @xksfy;ka ,,y_fCyLVj

5. osjkikfey ,plh,y ,l-vkj xksfy;ka&120 10 dk 19.64 944(v) 30.10.1998 eS- fudksyl fijkey dsykfIVu ,l-vkj-120 fexzk- @,l-vkj- xksfy;ka ,,y_iRrk eS- VksjsUV oslksiVsu ,l-vkj-

6. osjkikfey ,plh,y ,l-vkj xksfy;ka&120 10 dk 19.26 944(v) 30.10.1998 eS- fudksyl fijkey dsykfIVu ,l-vkj-120 fexzk- @,l-vkj- xksfy;ka ,,y_fCyLVj eS- VksjsUV oslksiVsu ,l-vkj-

7. osjkikfey ,plh,y ,l-vkj xksfy;ka&240 10 dk 37.50 944(v) 30.10.1998 eS- fudksyl fijkey dsykfIVu ,l-vkj-240 fexzk- @,l-vkj- xksfy;ka ,,y_iRrk

8. osjkikfey ,plh,y ,l-vkj xksfy;ka&240 10 dk 37.08 944(v) 30.10.1998 eS- fudksyl fijkey dsykfIVu ,l-vkj-240 fexzk- @,l-vkj- xksfy;ka ,,y_fCyLVj

9. osjkikfey ,plh,y bUtsD’ku&5 2 fefy dk 2.26 82(v) 05.02.1999

2.5 fexzk- @fefy ,Ei;wy

10. osjkikfey ,plh,y bUtsD’ku&5 5x2 fefy dk 11.30 82(v) 05.02.1999

2.5 fexzk- @fefy ,Ei;wy

11. foVkfeu , dSilwy 100 dh 28.48 819(v) 05.11.1992

24000 vkbZ;w @dSilwy cksry

12. foVkfeu , dSilwy 10 dk 5.96 301(v) 04.03.2004

50000 vkbZ;w @dSilwy iRrk@fCyLVj

13. foVkfeu , dSilwy 30 dh 19.32 301(v) 04.03.2004 eS- ;w,loh ,Doklksy&,50000 vkbZ;w @dSilwy cksry

Page 210: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 191 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

14. foVkfeu , dSilwy 250 dh 81.69 55(v) 17.01.1992

50000 vkbZ;w @uje dSilwy cksry

15. foVkfeu , xksfy;ka 10 dk 6.20 301(v) 04.03.2004 eS- fudksYl foVkfeu&,50000 vkbZ;w @xksfy;ka iRrk@fCyLVj eS- esfMdkesu fxt+fy

eS- bZLV vQjhdu foVfjo&,

16. foVkfeu , dSilwy 30 dh 16.92 13(v) 04.01.2005

foVkfeu , 50000 vkbZ;w ¼ikfeVsV ds cksryleku½@uje tsysfVu dSilwy

17. foVkfeu , vkSj Mh dSilwy 1000 dh 76.68 1690(v) 03.10.2006

foVkfeu , 1600 vkbZ;w dSi cksryfoVkfe Mh&3 100 vkbZ;w@dSilwy

18. foVkfeu , $ foVkfeu bZ dSilwy 10 dk 6.52 757(v) 19.05.2006

foVkfeu , 50000 vkbZ;w iRrk@fCyLVjfoVkfe bZ 25 vkbZ;w@dSilwy

19. foVkfeu , bUtsD’ku 2 fefy dk 3.02 301(v) 04.03.2004

100000 vkbZ;w @ 2 fefy ,Ei;wy

20. foVkfeu , bUtsD’ku 3x1 fefy dk 6.24 301(v) 04.03.2004

100000 vkbZ;w @ 1 fefy ,Ei;wy ,Ei;wy

21. foVkfeu , bUtsD’ku 6x1 fefy dk 19.92 819(v) 05.11.1992

300000 vkbZ;w @ 1 fefy ,Ei;wy ,Ei;wy

22. foVkfeu , bUtsD’ku 2.5 fefy dk 4.18 209(v) 14.02.2007

foVkfeu , 4000000 vkbZ;w ¼ikfeVsV ,Ecj ,Ei;wyds leku½@ fefy

23. foVkfeu , bUtsD’ku 2.5 fefy 3.88 1081(v) 11.07.2006

foVkfeu , 5000000 vkbZ;w ¼ikfeVsV

24. foVkfeu ch 1 xksfy;ka 10 dk 2.98 775(v) 19.05.2006

75 fexzk-@xksfy;ka iRrk@fCyLVj

25. fjcw¶ysfou xksfy;ka 10 dk 1.50 2033(v) 30.11.2007

10 fexzk-@xksfy;ka iRrk@fCyLVj

Page 211: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 192 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

26. foVkfeu lh xksfy;ka&50 100 dk 11.74 1343(v) 16.09.2005

50 fexzk-@xksfy;ka cksry

27. foVkfeu lh xksfy;ka&100 100 dk 17.62 1641(v) 27.09.2007

100 fexzk-@xksfy;ka cksry

28. foVkfeu lh xksfy;ka&100 1000 dk 141.40 1641(v) 27.09.2007 eS- th,lds flfyu100 fexzk-@xksfy;ka cksry

29. foVkfeu lh xksfy;ka&200 100 dk 26.98 1641v) 27.09.2007

200 fexzk-@xksfy;ka cksry

30. foVkfeu lh xksfy;ka&250 100 dk 31.24 1641v) 27.09.2007

250 fexzk-@xksfy;ka cksry

31. foVkfeu lh xksfy;ka 10 dk 6.36 1641(v) 27.09.2007 eS- th,lds flfyu500 fexzk-@xksfy;ka ,,y_iRrk eS- fudksYl lsy&lh

32. foVkfeu lh xksfy;ka 10 dk 5.92 1641(v) 27.09.2007 eS- bZLVj vQjhdu foVfjo&lh500 fexzk-@xksfy;ka ,,y_fCyLVj

33. foVkfeu lh xksfy;ka 10 dk 12.66 1641(v) 27.09.2007

¼Mhvkj@lhvkj@,lvkj@ykWax ,fDVax½ iRrk@fCyLVj500 fexzk-@xksfy;ka

34. foVkfeu lh pckus okyh xksfy;ka 10 dk 7.72 189(v) 29.01.2008 eS- th,lds flfyu,ldksjfcd ,sflM 200 fexzk- iRrk@fCyLVj eS-,uihvkbZ,y foVkfeu lhlksfM;e ,LdksjcsV 338 fexzk- 0.04 fefe eS- vkbZMhih,y ldfl300 fexzk- ,ldksjfcd ,sflM ds cjkcj@xksfy;ka

35. foVkfeu lh pckus okyh xksfy;ka 10 dk 6.98 1641(v) 27.09.2007 eS-,uihvkbZ,y fyElh,ldksjfcd ,sflM 100 fexzk- iRrk@fCyLVj eS- QkjesM flVjkfoVlksfM;e ,LdksjcsV 450 fexzk-400 fexzk- ,ldksjfcd ,sflM ds cjkcj@xksfy;ka

36. foVkfeu lh$ flVjl 10 dk 16.84 1063(v) 11.07.2006 eS- LVjfyax ysc lhohih dSilwyfcQysoksukbM dEikÅaM dSilwy ,,y_iRrk100 fexzk-$ 100 fexzk- @dSilwy

37. foVkfeu lh$ flVjl 10 dk 16.40 1063(v) 11.07.2006 eS- LVjfyax ysc lhohih dSilwyfcQysoksukbM dEikÅaM dSilwy ,,y_fCyLVj100 fexzk-$ 100 fexzk- @dSilwy

Page 212: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 193 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

38. foVkfeu lh$ flVjl 10 dk 43.98 1063(v) 11.07.2006 eS- LVjfyax ysc lhohih dSilwyfcQysoksukbM dEikÅaM dSilwy ,,y_iRrk300 fexzk-$ 300 fexzk- @dSilwy

39. foVkfeu lh$ flVjl 10 dk 43.44 1063(v) 11.07.2006 eS- LVjfyax ysc lhohih dSilwyfcQysoksukbM dEikÅaM dSilwy ,,y_fCyLVj300 fexzk-$ 300 fexzk- @dSilwy

40. foVkfeu lh$ flVjl fcQysoksukbM 10 dk 23.44 1063(v) 11.07.2006 eS- LVjfyax ysc X;kus lhohih dSilwydEikÅaM vkSj vU; dSilwy ,,y_iRrkfoVkfeu lh 75 fexzk-flVjl fcQysoksukbM dEikÅaM 150 fexzk-esukfM;wu 0.66 fexzk-Qsjl XywdksusV 67 fexzk-VªkbZ csfld dsfY’k;e QksLQsV 144.43 fexzk-@dSilwy

41. foVkfeu lh$ flVjl fc¶ysoksukbM 10 dk 22.90 1063(v) 11.07.2006 eS- LVjfyax ysc X;kus lhohih dSilwydEikÅaM vkSj vU; dSilwy ,,y_fCyLVjfoVkfeu lh 75 fexzk-flVjl fc¶ysoksukbM dEikÅaM 150 fexzk-esukfM;wu 0.66 fexzk-Qsjl XywdksusV 67 fexzk-VªkbZ csfld dsfY’k;e QksLQsV 144.43 fexzk-@dSilwy

42. foVkfeu lh bUtsD’ku 50x2 fefy dk 86.78 1343(v) 16.09.2005 eS- fijkey gsYFkds;j foVkfeu lh bUtsD’ku100 fexzk-@ 2 fefy ,Ei;wy ,Ei;wy

43. foVkfeu lh bUtsD’ku 25x5 fefy dk 67.84 1343(v) 16.09.2005 eS- fijkey gsYFkds;j foVkfeu lh bUtsD’ku500 fexzk-@ 5 fefy ,Ei;wy ,Ei;wy

44. foVkfeu lh ¼,ldkWfcZd ,sflM½ Mªksi 15 fefy dh 7.62 1343(v) 16.09.2005 eS- ,cksV foVkfeu lh Mªksi100 fexzk-@ fefy cksry Mªksij lfgr

45. foVkfeu lh ¼,ldkWfcZd ,sflM½ Mªksi 30 fefy dh 10.93 1343(v) 16.09.2005 eS- ,cksV foVkfeu lh Mªksi100 fexzk-@ fefy cksry Mªksij lfgr

46. foVkfeu lh $ foVkfeu bZ xksfy;ka 10 dk 4.98 1679(v) 03.10.2006 eS- ;w,loh dksfoVk IylfoVkfeu bZ 200 vkbZ;w iRrk@fCyLVjfoVkfeu lh 150 fexzk-@xksfy;ka

Page 213: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 194 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

47. foVkfeu lh $ foVkfeu bZ xksfy;ka 10 dk 8.08 1679(v) 03.10.2006 eS- ;w,loh dksfoVk IylfoVkfeu bZ 400 vkbZ;w iRrk@fCyLVjfoVkfeu lh 150 fexzk-@xksfy;ka

48. foVkfeu lh $ foVkfeu bZ dSilwy 10 dk 8.84 1641(v) 27.09.2007

foVkfeu bZ ,sflVsV 200 vkbZ;w iRrk@fCyLVjfoVkfeu lh 150 fexzk-@dSilwy

49. foVkfeu lh$foVkfeu bZ$ 10 dk 17.28 1641(v) 27.09.2007

Xy;wdkslkekbu lYQsV iRrk@fCyLVjlksfM;e dSilwyfoVkfeu bZ ,sflVsV&25 fexzk-¼foVkfeu bZ ,sflVsV MªkbZikmMj 50% ds leku½foVkfeu lh ¼fyfir½&50 fexzk-Xy;wdkslkekbu lYQsV lksfM;e&750 fexzk-

50. foVkfeu lh $ dksftd ,sflM Øhe 15 xzke dh 9.94 191(v) 29.01.2008

foVkfeu lh 25% MCY;w@MCY;w V~;wcdksftd ,sflM 2.0% MCY;w@MCY;@xzke

51. foVkfeu bZ ,sflVsV dSilwy 10 dk 5.34 1680(v) 03.10.2006 eS- edZ ,fo;ksu dSilwy100 fexzk- @uje tsysfVu dSilwy ,,y_fCyLVj

52. foVkfeu bZ ,sflVsV dSilwy 30 dh 17.82 1342(v) 16.09.2005 eS- edZ ,fo;ksu dSilwy100 fexzk- @uje tsysfVu dSilwy cksry

53. foVkfeu bZ ,sflVsV dSilwy 10 dk 8.62 1680(v) 03.10.2006 eS- edZ ,fo;ksu dSilwy200 fexzk- @uje tsysfVu dSilwy ,,y_fCyLVj eS- ,yfEcd ,fouky dSilwy

eS- VksjsUV VksdksQj dSilwyeS- dsfMyk bZbZbZ dSilwyeS- xysuekdZ bdsi dSilwy

54. foVkfeu bZ ,sflVsV dSilwy 30 dh 28.86 1680(v) 03.10.2006 eS- edZ ,fo;ksu dSilwy200 fexzk- @uje tsysfVu dSilwy cksry eS- ,cksV ,foV dSilwy

55. foVkfeu bZ ,sflVsV dSilwy 10 dk 14.50 1680(v) 03.10.2006 eS- edZ ,fo;ksu dSilwy400 fexzk- @uje tsysfVu dSilwy ,,y_fCyLVj eS- ,yfEcd ,fouky dSilwy

eS- VksjsUV VksdksQj dSilwyeS- ,YMj foVkfeu bZeS- dsfMyk bZbZbZ dSilwyeS- xysuekdZ bdsi dSilwy

Page 214: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 195 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

56. foVkfeu bZ ,sflVsV dSilwy 30 dh 46.08 1680(v) 03.10.2006 eS- tk;Ml dsfMyk foVkfeu bZ dSilwy400 fexzk- @uje tsysfVu dSilwy cksry eS- ,cksV ,foy dSilwy

57. foVkfeu bZ ,sflVsV dSilwy 10 dk 19.10 434(v) 23.03.2007 eS- edZ ,fo;ksu dSilwy600 fexzk- @uje tsysfVu dSilwy ,,y_fCyLVj eS- fudksyl bQk;uy dSilwy

58. foVkfeu bZ ,sflVsV dSilwy 30 dh 60.10 1680(v) 03.10.2006 eS- edZ ,fo;ksu dSilwy600 fexzk- @uje tsysfVu dSilwy cksry

59. foVkfeu bZ ¼izkd‘frd½ dSilwy 10 dk 5.70 1680(v) 03.10.2006 eS- zQsadks bafM;u usfVo dSilwyfoVkfeu bZ ¼izkd‘frd½ 100 vkbZ;w ,,y_iRrk eS- VªkWf;dk QkekZ ,Dok&bZ dSilwy67.10 fexzk- Mh&,YQk VksdksQsjksy eS- ;w,loh dksfoVk dSilwyds cjkcj@uje tsysfVu dSilwy

60. foVkfeu bZ ¼izkd‘frd½ dSilwy 10 dk 5.32 1680(v) 03.10.2006 eS- zQsadks bafM;u usfVo dSilwyfoVkfeu bZ ¼izkd‘frd½ 100 vkbZ;w ,,y_fCyLVj eS- VªkWf;dk QkekZ ,Dok&bZ dSilwy67.10 fexzk- Mh&,YQk VksdksQsjksy eS- ;w,loh dksfoVk dSilwyds cjkcj@uje tsysfVu dSilwy

61. foVkfeu bZ ¼izkd‘frd½ dSilwy 30 dh 19.22 1680(v) 03.10.2006 eS- zQsadks bafM;u usfVo dSilwyfoVkfeu bZ ¼izkd‘frd½ 100 vkbZ;w cksry eS- MkW- jsM~Mh ck;ks&bZ dSilwy67.10 fexzk- Mh&,YQk VksdksQsjksyds cjkcj@uje tsysfVu dSilwy

62. foVkfeu bZ ¼izkd‘frd½ dSilwy 10 dk 7.70 1680(v) 03.10.2006 eS- zQsadks bafM;u usfVo dSilwyfoVkfeu bZ ¼izkd‘frd½ 200 vkbZ;w ,,y_iRrk eS- MkW- jsM~Mh ck;ks&bZ dSilwy134.2 fexzk- Mh&,YQk VksdksQsjksy eS- VªkWf;dk QkekZ ,Dok&bZ dSilwyds cjkcj@uje tsysfVu dSilwy eS- dspsV ,ubZ dSilwy

,YMj ,t+ dSilwy

63. foVkfeu bZ ¼izkd‘frd½ dSilwy 10 dk 7.32 1680(v) 03.10.2006 eS- zQsadks bafM;u usfVo dSilwyfoVkfeu bZ ¼izkd‘frd½ 200 vkbZ;w ,,y_fCyLVj eS- MkW- jsM~Mh ck;ks&bZ dSilwy134.2 fexzk- Mh&,YQk VksdksQsjksy eS- VªkWf;dk QkekZ ,Dok&bZ dSilwyds cjkcj@uje tsysfVu dSilwy eS- dspsV ,ubZ dSilwy

,YMj ,t+ dSilwy

64. foVkfeu bZ ¼izkd‘frd½ dSilwy 30 dh 25.02 1680(v) 03.10.2006 eS- zQsadks bafM;u usfVo dSilwyfoVkfeu bZ ¼izkd‘frd½ 200 vkbZ;w cksry eS- MkW- jsM~Mh ck;ks&bZ dSilwy134.2 fexzk- Mh&,YQk VksdksQsjksy eS- esdfy;ksMl ,Ul;wYl dSilwyds cjkcj@uje tsysfVu dSilwy

65. foVkfeu bZ ¼izkd‘frd½ dSilwy 10 dk 12.82 1680(v) 03.10.2006 eS- zQsadks bafM;u usfVo dSilwyfoVkfeu bZ ¼izkd‘frd½ 400 vkbZ;w ,,y_iRrk eS- MkW- jsM~Mh ck;ks&bZ dSilwy268.4 fexzk- Mh&,YQk VksdksQsjksy eS- VªkWf;dk QkW ,Dok&bZ dSilwyds cjkcj@uje tsysfVu dSilwy eS- dspsV ,ubZ dSilwy

,yMj ,t+ dSilwy

Page 215: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 196 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

66. foVkfeu bZ ¼izkd‘frd½ dSilwy 10 dk 12.38 1680(v) 03.10.2006 eS- zQsadks bafM;u usfVo dSilwyfoVkfeu bZ ¼izkd‘frd½ 400 vkbZ;w ,,y_fCyLVj eS- MkW- jsM~Mh ck;ks&bZ dSilwy268.4 fexzk- Mh&,YQk VksdksQsjksy eS- VªkWf;dk QkW ,Dok&bZ dSilwyds cjkcj@uje tsysfVu dSilwy eS- dspsV ,ubZ dSilwy

,yMj ,t+ dSilwy

67. foVkfeu bZ ¼izkd‘frd½ dSilwy 30 dh 40.12 1680(v) 03.10.2006 eS- zQsadks bafM;u usfVo dSilwyfoVkfeu bZ ¼izkd‘frd½ 400 vkbZ;w cksry eS- MkW- jsM~Mh ck;ks&bZ dSilwy268.4 fexzk- Mh&,YQk VksdksQsjksy eS- esdfy;ksMl ,Ul;wYl dSilwyds cjkcj@uje tsysfVu dSilwy

68. foVkfeu bZ $ foVkfeu lh xksfy;ka 10 dk 5.98 1679(v) 03.10.2006 eS- ;w,loh dksfoVk Iyl xksfy;kafoVkfeu bZ 200 vkbZ;w iRrk@fCyLVjfoVkfeu lh 150 fexzk-@xksfy;ka

69. foVkfeu bZ $ foVkfeu lh xksfy;ka 10 dk 8.08 1679(v) 03.10.2006 eS- ;w,loh dksfoVk Iyl xksfy;kafoVkfeu bZ 400 vkbZ;w iRrk@fCyLVj eS- dspsV QkekZ ,ubZ&200 IylfoVkfeu lh 150 fexzk-@xksfy;ka

70. foVkfeu bZ $ foVkfeu lh dSilwy 10 dk 8.84 1641(v) 27.09.2007 eS- fudksYl ,fyElh dSilwyfoVkfeu bZ ,sflVsV 200 vkbZ;w iRrk@fCyLVj eS- ;w,loh dksfoVk Iyl xksfy;kafoVkfeu lh 150 fexzk-@dSilwy eS- dspsV ,ubZ&200 Iyl

71. foVkfeu bZ $ dksM fyoj vkW;y xksfy;ka 10 dk 9.98 434(v) 23.03.2007

foVkfeu bZ ,sflVsV 400 vkbZ;w iRrk@fCyLVjdksM fyoj vkW;y 300 fexzk-@xksfy;ka

72. foVkfeu bZ $ foVkfeu , dSilwy 10 dk 6.52 757(v) 19.05.2006

foVkfeu bZ 25 fexzk- iRrk@fCyLVjfoVkfeu , 50000 vkbZ;w@dSilwy

73. foVkfeu bZ$ 50 xzke dk tkj 21.16 1915(v) 08.11.2006

,yks;$Ldosfyu ØhefoVkfeu bZ ,sflVsV&1%MCY;w@MCY;w,yks;&5% MCY;w@MCY;wLdosfyu&3% MCY;w@MCY;w

74. foVkfeu bZ$ 50 xzke dk tkj 11.86 1915(v) 08.11.2006

,yks;$Ldosfyu ØhefoVkfeu bZ ,sflVsV&1%MCY;w@MCY;w,yks;&5% MCY;w@MCY;wLdosfyu&3% MCY;w@MCY;w

Page 216: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 197 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

75. foVkfeu bZ $ dksM fyoj vkW;y dSilwy 10 dk 11.70 1929(v) 08.11.2006

foVkfeu bZ ,sflVsV 400 fexzk-@vkbZ;w iRrk@fCyLVjdksM fyoj vkW;y 300 fexzk-@dSilwy

76. foVkfeu bZ$foVkfeu lh$ 10 dk 17.28 1641(v) 27.09.2007

Xy;wdkslkekbu lYQsV lksfM;e dSilwy iRrk@fCyLVjfoVkfeu bZ ,sflVsV&25 fexzk-¼foVkfeu bZ ,sflVsV MªkbZikmMj 50% ds leku½foVkfeu lh ¼fyfir½&50 fexzk-Xy;wdkslkekbu lYQsV lksfM;e&750 fexzk-

77. ,YQk VksdksQsjksy ,sflVsV $ 10 dk 13.18 2055(v) 30.11.2007bdkslisUVh;ksfud$ iRrk@fCyLVjMksdkslgsDlh;ksfud dSilwy,YQk VksdksQsjksy ,sflVsV-400fexzk-bdkslisUVh;ksfud ,asflM-90fexzk-MksdkslgsDlh;ksfud ,sflM-60fexzk-@lkW¶V tsysfVu dsilwy

78. foVkfeu bZ $ ,yksosjk yks’ku 100 fefy dh 12.20 192(v) 29.01.2008

foVkfeu bZ 0.5% MCY;w@oh cksry,yksosjk 10% MCY;w@oh

79. foVkfeu ch dkEiysDl vkSj 10 dk 7.90 260(v) 13.04.1999 eS- vkseuhizksVsd fcdksL;wyfoVkfeu lh lfgr dSilwy ¼Fksjkfi;wfVd½ iRrk@fCyLVj Mªx@Qkbt+jizR;sd dSilwy dh jsat esafoVkfeu ch&1 4.5 fexzk- ls 10 fexzk-foVkfeu ch&2 5 fexzk- ls 10 fexzk-foVkfeu ch&6 1.5 fexzk- ls 3 fexzk-foVkfeu ch&12 5 ,elhth- ls 15 ,elhthfu;kflukekbM 45 fexzk- ls 60 fexzk-dSfY’k;e iSUVksfFkusV@Mh isfUFkuksy 5 fexzk- ls 15 fexzk-Qksfyd ,sflM 1 fexzk- ls 1.5 fexzk-foVkfeu lh 75 fexzk- ls 150 fexzk-

Page 217: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 198 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

80. foVkfeu ch dkWEIysDl vkSj 10 dk 8.58 260(v) 13.04.1999 eS- jsfeMsDl QkekZ tsfoVfoVkfeu lh] bZ vkSj fatd lfgr iRrk@fCyLVj @fLeFkdykbu chpsedSilwy ¼Fksjkfi;wfVd½izR;sd dSilwy dh jsat esafoVkfeu ch&1 4.5 fexzk- ls 10 fexzk-foVkfeu ch&2 5 fexzk- ls 10 fexzk-foVkfeu ch&6 1.5 fexzk- ls 3 fexzk-foVkfeu ch&12 5 ,elhth- ls 15 ,elhthfu;kflukekbM 45 fexzk- ls 60 fexzk-dSfY’k;e iSUVksfFkusV@Mh isfUFkuksy 5 fexzk- ls 15 fexzk-foVkfeu bZ 15 fexzk-foVkfeu lh 75 fexzk- ls 150 fexzk-ftad lYQsV 22.5 fexzk- ftad ,fyesUV ds cjkcj

81. eYVhfoVkfeu xksfy;ka lsysfu;e lfgr 10 dk 4.88 387(v) 02.04.2003

izR;sd fQYe fyfir fVfd;k esa ,,y_ihohMhlhfoVkfeu , 2500 vkbZ;w ¼,sflVsV esa feJ.k½ fCyLVj,ldksjfcd ,sflM 50 fexzk-foVkfeu bZ ,sflVsV 10 vkbZ;wik;fjMksDlhu ,plh,y 1.5 fexzk-foVkfeu ch12 - 1 ,elhth ¼esfuuVksy VªkbZVw;jsV esa feJ.k½Qksfyd ,sflM 300 ,elhthlsysfu;e MkbZvkWDlkbM eksuksgkbMªsV100 ,elhth ,sfyesuVy lsysfu;e ds cjkcj

82. eYVhfoVkfeu xksfy;ka lsysfu;e lfgr 10 dk 4.64 387(v) 02.04.2003

izR;sd fQYe fyfir fVfd;k esa iRrk@fCyLVjfoVkfeu , 2500 vkbZ;w ¼,sflVsV esa feJ.k½,ldksjfcd ,sflM 50 fexzk-foVkfeu bZ ,sflVsV 10 vkbZ;wik;fjMksDlhu ,plh,y 1.5 fexzk-foVkfeu ch12 - 1 ,elhth ¼esfuuVksy VªkbZVw;jsV esa feJ.k½Qksfyd ,sflM 300 ,elhthlsysfu;e MkbZvkWDlkbM eksuksgkbMªsV100 ,elhth ,sfyesuVy lsysfu;e ds cjkcj

Page 218: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 199 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

83. eYVhfoVkfeu xksfy;ka lsysfu;e lfgr 10 dk 4.86 387(v) 02.04.2003

izR;sd fQYe fyfir fVfd;k esa ,,y_ihohMhlhfoVkfeu , 2500 vkbZ;w ¼,sflVsV esa feJ.k½ fCyLVj,ldksjfcd ,sflM 50 fexzk-foVkfeu bZ ,sflVsV 10 vkbZ;wik;fjMksDlhu ,plh,y 1.5 fexzk-foVkfeu ch12 - 1 ,elhth ¼esfuuVksy VªkbZVw;jsV esa feJ.k½Qksfyd ,sflM 300 ,elhthlsysfu;e MkbZvkWDlkbM eksuksgkbMªsV55 ,elhth ,sfyesuVy lsysfu;e ds cjkcj

84. eYVhfoVkfeu xksfy;ka lsysfu;e lfgr 10 dk 4.62 387(v) 02.04.2003

izR;sd fQYe fyfir fVfd;k esa iRrk@fCyLVjfoVkfeu , 2500 vkbZ;w ¼,sflVsV esa feJ.k½,ldksjfcd ,sflM 50 fexzk-foVkfeu bZ ,sflVsV 10 vkbZ;wik;fjMksDlhu ,plh,y 1.5 fexzk-foVkfeu ch12 - 1 ,elhth ¼esfuuVksy VªkbZVw;jsV esa feJ.k½Qksfyd ,sflM 300 ,elhthlsysfu;e MkbZvkWDlkbM eksuksgkbMªsV100 ,elhth ,sfyesuVy lsysfu;e ds cjkcj

85. foVkfeu xksfy;ka 10 dk 2.54 778(v) 09.07.2003ysfDVd ,sflM csflyl lfgr ,,y_iRrkizR;sd ?kqyu’khy fVfd;k esafoVkfeu ch1 eksuksukbVªsV & 2 fexzk-foVkfeu ch2 & 2.5 fexzk-foVkfeu ch6 & 1.5 fexzk-fu;kflukekbM & 20 fexzk-ysfDVd ,sflM csflyl & 40 fefy;u LiksZl

86. foVkfeu xksfy;ka 10 dk 2.16 778(v) 09.07.2003ysfDVd ,sflM csflyl lfgr ,,y_fCyLVjizR;sd ?kqyu’khy fVfd;k esafoVkfeu ch1 eksuksukbVªsV & 2 fexzk-foVkfeu ch2 & 2.5 fexzk-foVkfeu ch6 & 1.5 fexzk-fu;kflukekbM & 20 fexzk-ysfDVd ,sflM csflyl & 40 fefy;u LiksZl

Page 219: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 200 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

87. gsesfVfud vk;ju dEchus’ku xksfy;ka 30 dk 11.70 617(v) 29.06.2001 eS- ,u-vkj- tsV jsfjdsi dksEch iSd¼d½ izR;sd 15 fyfir@lknh xksfy;ksa esa iRrk@fCyLVj baVjizkbtslQsjl dSfY’k;e flVªsV dkWEIysDl¼25 fexzk- vk;ju vkSj85 fexzk- dSfY’k;e½ ds cjkcjfoVkfeu ch&2 2 fexzk-foVkfeu ch&6 1 fexzk-foVkfeu lh 35 fexzk-foVkfeu ch&12 1 ,elhth-Qksfyd ,sflM 0.3 fexzk-¼[k½ izR;sd 15 fyfir@lknh xksfy;ksa esadSfY’k;e dkcksZusV vkbZih 1107 fexzk-MkbZcsfld dSfY’k;e QksLQsV vkbZih 200 fexzk- ¼,UgkbMªsl½foVkfeu Mh&3 200 vkbZ;wesxusf’k;e 90 fexzk-

88. gsesfVfud vk;ju dEchus’ku dSilwy 30 dk 20.76 618(v) 29.06.2001 eS- ,u-vkj- tsV jsfjdsi tsM,uizR;sd dSilwy esa ,,y_iRrk baVjizkbtslftad] ftad lYQsV eksuksgkbMªsV 25fexzk- esaQsjl dSfY’k;e flVªsV dkWEIysDl¼50 fexzk- vk;ju vkSj72 fexzk- dSfY’k;e½&556 fexzk- ds cjkcjfoVkfeu ch&2 2 fexzk-foVkfeu ch&6 1 fexzk-foVkfeu lh 35 fexzk-foVkfeu ch&12 1 ,elhth-Qksfyd ,sflM 0.3 fexzk-

89. gsesfVfud vk;ju dEchus’ku dSilwy 30 dk 19.20 618(v) 29.06.2001 eS- ,u-vkj- tsV jsfjdsi tsM,uizR;sd dSilwy esa ,,y_fCyLVj baVjizkbtslftad] ftad lYQsV eksuksgkbMªsV 25fexzk- esaQsjl dSfY’k;e flVªsV dkWEIysDl¼50 fexzk- vk;ju vkSj72 fexzk- dSfY’k;e½&556 fexzk- ds cjkcjfoVkfeu ch&2 2 fexzk-foVkfeu ch&6 1 fexzk-foVkfeu lh 35 fexzk-foVkfeu ch&12 1 ,elhth-Qksfyd ,sflM 0.3 fexzk-

Page 220: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 201 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

90. gsesfVfud vk;ju dEchus’ku dSilwy 30 dh 21.48 618(v) 29.06.2001 eS- ,u-vkj- tsV jsfjdsi tsM,uizR;sd dSilwy esa cksry baVjizkbtslftad] ftad lYQsV eksuksgkbMªsV 25fexzk- esaQsjl dSfY’k;e flVªsV dkWEIysDl¼50 fexzk- vk;ju vkSj72 fexzk- dSfY’k;e½&556 fexzk- ds cjkcjfoVkfeu ch&2 2 fexzk-foVkfeu ch&6 1 fexzk-foVkfeu lh 35 fexzk-foVkfeu ch&12 1 ,elhth-Qksfyd ,sflM 0.3 fexzk-

91. gsesfVfud vk;ju dEchus’ku QksVZ xksfy;ka 30 dk 12.36 618(v) 29.06.2001 eS- ,u-vkj- tsV jsfjdsi QksVZizR;sd xksfy;ksa esa ,,y_fCyLVj baVjizkbtslQsjl dSfY’k;e flVªsV dkWEIysDl¼50 fexzk- vk;ju vkSj72 fexzk- dSfY’k;e½&556 fexzk- ds cjkcjfoVkfeu ch&2 2 fexzk-foVkfeu ch&6 1 fexzk-foVkfeu lh 35 fexzk-foVkfeu ch&12 1 ,elhth-Qksfyd ,sflM 0.3 fexzk-

92. gsesfVfud vk;ju dEchus’ku QksVZ xksfy;ka 30 dh 13.86 618(v) 29.06.2001 eS- ,u-vkj- tsV jsfjdsi QksVZizR;sd xksfy;ksa esa dk¡p dh cksry baVjizkbtslQsjl dSfY’k;e flVªsV dkWEIysDl¼50 fexzk- vk;ju vkSj72 fexzk- dSfY’k;e½&556 fexzk- ds cjkcjfoVkfeu ch&2 2 fexzk-foVkfeu ch&6 1 fexzk-foVkfeu lh 35 fexzk-foVkfeu ch&12 1 ,elhth-Qksfyd ,sflM 0.3 fexzk-

93. vk;ju xksfy;ka foVkfeu vkSj 40 dk 16.62 136(v) 31.01.2002 eS- ,u-vkj- tsV jsfjdsidSfY’k;e lfgr ,,y_iRrk baVjizkbtslizR;sd fyfir xksfy;ksa esaQsjl dSfY’k;e flVªsV dkWEIysDl 278 fexzk-¼25 fexzk- vk;ju vkSj 36 fexzk- dSfY’k;e½ ds cjkcjfoVkfeu ch&2 2 fexzk-foVkfeu ch&6 1 fexzk-foVkfeu lh 35 fexzk-foVkfeu ch&12 1 ,elhth-Qksfyd ,sflM 0.3 fexzk-

Page 221: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 202 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

94. vk;ju xksfy;ka foVkfeu vkSj 40 dk 14.70 136(v) 31.01.2002 eS- ,u-vkj- tsV jsfjdsidSfY’k;e lfgr ,,y_fCyLVj baVjizkbtslizR;sd fyfir xksfy;ksa esaQsjl dSfY’k;e flVªsV dkWEIysDl 278 fexzk-¼25 fexzk- vk;ju vkSj 36 fexzk- dSfY’k;e½ ds cjkcjfoVkfeu ch&2 2 fexzk-foVkfeu ch&6 1 fexzk-foVkfeu lh 35 fexzk-foVkfeu ch&12 1 ,elhth-Qksfyd ,sflM 0.3 fexzk-

95. vk;ju xksfy;ka foVkfeu vkSj 40 dh 14.50 1640(v) 27.09.2007 eS- ,u-vkj- tsV jsfjdsidSfY’k;e lfgr dk¡p dh cksry baVjizkbtslizR;sd fyfir xksfy;ksa esaQsjl dSfY’k;e flVªsV dkWEIysDl 278 fexzk-¼25 fexzk- vk;ju vkSj 36 fexzk- dSfY’k;e½ ds cjkcjfoVkfeu ch&2 2 fexzk-foVkfeu ch&6 1 fexzk-foVkfeu lh 35 fexzk-foVkfeu ch&12 1 ,elhth-Qksfyd ,sflM 0.3 fexzk-

96. vk;ju xksfy;ka foVkfeu] ftad vkSj 30 dk 16.40 136(v) 31.01.2002 eS- ,u-vkj- tsV jsfjdsi tsM,udSfY’k;e lfgr ,,y_iRrk baVjizkbtslizR;sd fyfir xksfy;ksa esaQsjl dSfY’k;e flVªsV dkWEIysDl 556 fexzk-¼50 fexzk- vk;ju vkSj 72 fexzk- dSfY’k;e½ ds cjkcjftad ¼ftad lYQsV eksuksgkbMªsV ;w,lih esa½ 25 fexzk-foVkfeu ch&2 2 fexzk-foVkfeu ch&6 1 fexzk-foVkfeu lh 35 fexzk-foVkfeu ch&12 ¼feUVksy esa½ 1 ,elhth-Qksfyd ,sflM 0.3 fexzk-

97. vk;ju xksfy;ka foVkfeu] ftad vkSj 30 dk 14.84 136(v) 31.01.2002 eS- ,u-vkj- tsV jsfjdsi tsM,udSfY’k;e lfgr ,,y_fCyLVj baVjizkbtslizR;sd fyfir xksfy;ksa esaQsjl dSfY’k;e flVªsV dkWEIysDl 556 fexzk-¼50 fexzk- vk;ju vkSj 72 fexzk- dSfY’k;e½ ds cjkcjftad ¼ftad lYQsV eksuksgkbMªsV ;w,lih esa½ 25 fexzk-foVkfeu ch&2 2 fexzk-foVkfeu ch&6 1 fexzk-foVkfeu lh 35 fexzk-foVkfeu ch&12 ¼feUVksy esa½ 1 ,elhth-Qksfyd ,sflM 0.3 fexzk-

Page 222: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 203 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

98. vk;ju xksfy;ka foVkfeu] ftad vkSj 30 dh 16.06 1640(v) 27.09.2007 eS- ,u-vkj- tsV jsfjdsi tsM,udSfY’k;e lfgr dk¡p dh cksry baVjizkbtslizR;sd fyfir xksfy;ksa esaQsjl dSfY’k;e flVªsV dkWEIysDl 556 fexzk-¼50 fexzk- vk;ju vkSj 72 fexzk- dSfY’k;e½ ds cjkcjftad ¼ftad lYQsV eksuksgkbMªsV ;w,lih esa½ 25 fexzk-foVkfeu ch&2 2 fexzk-foVkfeu ch&6 1 fexzk-foVkfeu lh 35 fexzk-foVkfeu ch&12 ¼feUVksy esa½ 1 ,elhth-Qksfyd ,sflM 0.3 fexzk-

99. csVkdsjksfVu$foVkfeu xksfy;ka 10 dk 11.22 300(v) 04.03.2004 eS- flMeSd yscksjsfVªt csVkdsjksfVu$izR;sd fQYe fyfir xksfy;ksa esa ,,y_iRrk foVkfeu xksfy;kacsVkdsjksfVu&10 fexzk-¼20%-50 fexzk- ds leku feyk;k½foVkfeu ,&5000 vkbZ-;w- ¼,sflVsV ds leku½foVkfeu lh&150 fexzk-foVkfeu bZ ,sflVsV&25 vkbZ-;w-¼50%-50 fexzk- ds leku feyk;k½ftad lYQsV eksuksgkbMªsV&27.45 fexzk-eksuksgkbMªsV lsysfu;e MkbZvkWDlkbM&70.0 fexzk-

100. csVkdsjksfVu$foVkfeu xksfy;ka 10 dk 10.84 300(v) 04.03.2004 eS- flMeSd yscksjsfVªt csVkdsjksfVu$izR;sd fQYe fyfir xksfy;ksa esa ,,y_fCyLVj foVkfeu xksfy;kacsVkdsjksfVu&10 fexzk-¼20%-50 fexzk- ds leku feyk;k½foVkfeu ,&5000 vkbZ-;w- ¼,sflVsV ds leku½foVkfeu lh&150 fexzk-foVkfeu bZ ,sflVsV&25 vkbZ-;w-¼50%-50 fexzk- ds leku feyk;k½ftad lYQsV eksuksgkbMªsV&27.45 fexzk-eksuksgkbMªsV lsysfu;e MkbZvkWDlkbM&70.0 fexzk-

101. eYVhfoVkfeu vkSj feujy xksfy;ka 10 dk 11.22 1165(v) 20.10.2004

izR;sd fyfir fVfd;k esa iRrk@fCyLVjfoVkfeu , ,sflVsV&5000 vkbZ-;w-]foVkfeu Mh 3 & 400 vkbZ-;w-]foVkfeu bZ&15 vkbZ-;w-]Fkk;feu eksuksukbVªsV&10 fexzk-]f jcks¶ysfou&10 fexzk-]ik;fjMksDlhu ,plh,y&2 fexzk-]lkbuksdksckykfeu&7.5 ,elhth]fu;kflukekbM&25 fexzk-] dSfY’k;e iSUFkksfFkusV&10 fexzk-],Ldksjfcd ,sflM&75 fexzk-] eSxfu’k;e vkWDlkbM&30 fexzk-]eSxfulh lYQsV&2.8 fexzk-] dkWij lYQsV&2.0 fexzk-]ftad lYQsV eksuksgkbMªsV&63 fexzk-] lsysfu;e MkbZ&vkWDlkbM&70 ,elhth

Page 223: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 204 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

102. eYVhfoVkfeu vkSj feujy xksfy;ka 10 dk 9.24 1165(v) 20.10.2004

izR;sd fyfir fVfd;k esa iRrk@fCyLVjfoVkfeu , ,sflVsV&2500 vkbZ-;w-]foVkfeu ch1 eksuksukbVªsV&1 fexzk-foVkfeu ch2-1.5 fexzk-] foVkfeu ch6&1fexzk-]foVkfeu ch12 &1 ,elhth] foVkfeu lh&50 fexzk-]foVkfeu Mh3&200 vkbZ-;w-] foVkfeu bZ&7.5 fexzk-]dSfY’k;e Mh&iSUFkksfFkusV&5 fexzk-] Qksfyd ,sflM&0.15 fexzk-]fudksfVukekbM&20 fexzk-] ckW;fVu&30 ,elhth]ftad vkWDlkbM ftad&15 fexzk- ds cjkcj]iksVkf’k;e vk;ksMkbM vk;ksfMu&0.15 fexzk- ds cjkcj]Qsjl ¶;wejsV vk;ju&10 fexzk- ds cjkcj]eSxfu’k;e vkWDlkbM ykbV eSxfu’k;e&100 fexzk- ds cjkcjD;wifjd vkWDlkbM dkWij&2 fexzk- ds cjkcj]dSfY’k;e QkLQsV MkbZcsfld dSfY’k;e&162 fexzk- ds cjkcj]QkslQksjl&125 fexzk-] iksVkf’k;e DyksjkbMiksVkf’k;e&40 fexzk- ds cjkcj] Djksfed DyksjkbMDjksfe;e&25 ,elhth ds cjkcj] lksfM;e eksfycMsVeksfycMsue&25 ,elhth ds cjkcj] lksfM;e lsysusVlsysfu;e&30 ,elhth ds cjkcj] fudsy lksfM;efudsy&5 ,elhth ds cjkcj] LVsul DyksjkbMfVu&10 ,elhth ds cjkcj] dksyksbMy flfydkWuMkbZvkWDlkbM flfydkWu&2 ,elhth ds cjkcj]lksfM;e esVk osusMsV osusfM;e&10 ,elhth ds cjkcj]lksfM;e cksjsV cksjksu&50 ,elhth ds cjkcj

103. eYVhfoVkfeu xksfy;ka 10 dk 7.10 1359(v) 16.09.2005

izR;sd fyfir fVfd;k esa iRrk@fCyLVjfoVkfeu , ¼,sflVsVds leku½&5000 vkbZ;wfoVkfeu bZ ,sflVsV&25 vkbZ;w,Ldksjfcd ,sflM&100 fexzk-]Fkk;feu eksuksukbV�ªsV&10 fexzk-fjcwQsysfou&10 fexzk-] ik;fjMksDlhu ,plh,y&3 fexzk-]lkbuksdksckykekbu&5 ,elhth]fu;kflukekbM&50 fexzk-] Qksfyd ,sflM&1 fexzk-]dSfY’k;e isUVksfFkusV&12.5 fexzk-]ftad vkWDlkbM ,sfyesUVy ftad&15 fexzk- ds cjkcj]D;wifjd vkWDlkbM ,sfyesUVy dksij&2.5 fexzk- ds cjkcjlksfM;e lk;fyusV ,sfyesUVy lsysfu;e&60 ,elhth ds cjkcjesxusfll DyksjkbM ,sfyesUVy esxusfll&1.4 fexzk- ds cjkcjØksfe;e DyksjkbM ,sfyesUVy Øksfe;e&65 ,elhth ds cjkcj

Page 224: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 205 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

104. eYVhfoVkfeu xksfy;ka 10 dk 1.84 1359(v) 16.09.2005izR;sd fVfd;k esa iRrk@fCyLVjfoVkfeu ch 1&2 fexzk-foVkfeu ch 2&2.5 fexzk-foVkfeu ch 6&1.5 fexzk-ysDVkscsflyl&6 LiksjkstsUl 40x10fudksfVukekbM&20 fexzk-

105. eYVhfoVkfeu dSilwy 10 dk 13.94 1359(v) 16.09.2005izR;sd uje tsysfVu dSilwy esa iRrk@fCyLVjfoVkfeu , ¼csVk dsjksVhuds leku½ &30% fMlilZubdkslsisuVkuksbl ,sflM& 90 fexzk-MksdkslkgsDlksfud ,sflM& 60 fexzk-esxusfll ¼esxusfll lYQsV ds leku½& 2 fexzk-Øksfe;e ¼Øksfe;e fidksfyusV ds leku½& 100 ,elhthlsysfu;e ¼lsysfu;e MkbZvkWDlkbM ds leku½& 40 fexzk-foVkfeu lh& 100 fexzk-] foVkfeu bZ& 200 fexzk-Qksfyd ,sflM& 2.5 fexzk-] ftad lYQsV& 7.5 fexzk-

106. eYVhfoVkfeu dSilwy 10 dk 3.98 1359(v) 16.09.2005izR;sd dSilwy esa iRrk@fCyLVjfoVkfeu ch 1&3 fexzk-foVkfeu ch 2&3 fexzk-foVkfeu ch 6&1 fexzk-ysDVkscsflyl&40 fefy;u LiksZlfudksfVukekbM&25 fexzk-

107. eYVhfoVkfeu dSilwy 10 dk 19.24 1359(v) 16.09.2005izR;sd dSilwy esa iRrk@fCyLVjfoVkfeu ch 6&12 fexzk-foVkfeu ch 12&10 ,elhthyk;dksfiu&3 fexzk-]Qksfyd ,sflM&375 fexzk-] Mh,y&esFkksuhu&25 fexzk-dksfyu&5 fexzk-] foVkfeu lh&150 fexzk-foVkfeu bZ&9.3 fexzk-] lsysfu;e&25 ,elhthjsM cq’k Vh ,DlVªsDV&125 fexzk-

108. eYVhfoVkfeu dSilwy 30 dk 15.74 1359(v) 16.09.2005MªkbZM Qsjl lYQsV ¼50 fexzk- iRrk@fCyLVj,sfyesUVy vk;ju ds cjkcj½&155 fexzk-ik;fjMksDlhu ,plh,y&3 fexzk-lkbuksdksckykekbu&15 ,elhth,Ldksjfcd ,sflM&7.5 fexzk-] Qksfyd ,sflM&1.5 fexzk-ftad&20 fexzk-] dksij&2.5 fexzk-] lsysfu;e&65 ,elhthvk;ksfMu&150 ,elhth] esxusfll&2.5 fexzk-

Page 225: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 206 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

109. eYVhfoVkfeu dSilwy 6x3 dk 8.44 1359(v) 16.09.2005

MªkbZM Qsjl lYQsV ¼50 fexzk- iRrk@fCyLVj,sfyesUVy vk;ju ds cjkcj½&155 fexzk-Qksfyd ,sflM&0.53 fexzk-,d lQsn jax dh fVfd;k ,sfyesUVy dSfY’k;e&500 fexzk-foVkfeu Mh 3&225 vkbZ;w

,d larjh jax dk dSilwy foVkfeu lh&50 fexzk-

ftad lYQsV eksuksgkbMªsV&25 fexzk-foVkfeu bZ ,sflVsV&10 fexzk-Fkk;feu eksuksukbVªsV ¼foVkfeu ch 2½& 2 fexzk-]foVkfeu ch 6&1.6 fexzk-]foVkfeu ch 12 ¼lkbuksdksckykekbu½&1 ,elhth

110. eYVhfoVkfeu ¼osV½ 300 dh cksry 117.39 748(v) 19.05.2006

izR;sd fQYe fyfir fVfd;k esaFkk;feu eksuksukbVªsV - 10 fexzk-fjcwQysfou -10 fexzk-ik;fjMksDlhu gkbMªksDyksjkbM -3 fexzk-fudksfVukekbM -50 fexzk-lkbuksdksckykekbu -5 ,elhthMªkbM f;LV -50 fexzk-dSfY’k;e iSUVksfFkusV -10 fexzk-

111. eYVhfoVkfeu dSilwy 10 iRrk@fCyLVj 1.52 748(v) 19.05.2006

ysfDVd ,sflM csflyl lfgrizR;sd ?kqyu’khy xksfy;ksa esaFkk;feu ,plh,y&2 fexzk-fjcw¶ysfou&2.5 fexzk-ik;fjMksDlhu ,plh,y&1.5 fexzk-fu;kflukekbM&20 fexzk-ysfDVd ,sflM csflyl&40x106 ok;cy LiksZl

112. eYVhfoVkfeu dSilwy 10 iRrk@fCyLVj 3.64 748(v) 19.05.2006

ysfDVd ,sflM csflyl lfgrizR;sd dSilwy esaFkk;feu ,plh,y&3 fexzk-fjcw¶ysfou&3 fexzk-ik;fjMksDlhu ,plh,y&1 fexzk-fu;kflukekbM&25 fexzk-ysfDVd ,sflM csflyl&40x106 ok;cy LiksZl

Page 226: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 207 -

113. eYVhfoVkfeu dSilwy 10 dk iRrk@fCyLVj 12.92 748(v) 19.05.2006izR;sd dSilwy esa,y&Y;wflu -18.3 fexzk-,y&vkblksY;wflu -5.9 fexzk-,y&Fksjksukbu -8.3 fexzk-,y&ykbflu ,plh,y -25 fexzk-,y&fQuk;y ,sykekbu -5 fexzk-,y&oksfyu -6.7 fexzk-] ,y&VªkbIVksQsu -10.1 fexzk-,y&esfFk;ksfuu -18.4 fexzk-] foVkfeu , - 2500 vkbZ;w ]foVkfeu Mh 3 -200 vkbZ;w] foVkfeu ch 1 -5 fexzk-]foVkfeu ch 2 - 3 fexzk-]] foVkfeu ch 6 -3 fexzk-]foVkfeu ch 12 - 2.5 fexzk-] fudksfVukekbM - 25 fexzk-]Qksfyd ,sflM - 0.5 fexzk-]dSfY’k;e iSUVksfFkusV - 5 fexzk-]foVkfeu lh - 37.5 fexzk-] foVkfeu bZ - 7.5 vkbZ;w ]5&gkbMªksDlh,sUFkzksfufyd ,sflM - 0.2 fexzk-]

114. eYVhfoVkfeu dSilwy 10 dk iRrk@fCyLVj 13.00 748(v) 19.05.2006

foVkfeu , - 5000 vkbZ;wfoVkfeu lh - 100 fexzk-foVkfeu bZ - 25 vkbZ;w ]csVk dsjksfVu - 25 fexzk-ftad - 27.45 fexzk-lsysfu;e - 75 ,elhthesxsuhl - 1.5 fexzk-

115. eYVhfoVkfeu dSilwy 10 dk iRrk@fCyLVj 17.92 748(v) 19.05.2006

Likb#fyuk - 500 fexzk-foVkfeu ch 1 - 1.5 fexzk- ]foVkfeu ch 2 - 2 fexzk-foVkfeu ch 12 - 2 fexzk-]foVkfeu Mh 3 - 200 vkbZ;w ]foVkfeu lh - 50 fexzk-]Qksfyd ,sflM - 200 ,elhthØksfe;e DyksjkbM 50 fexzk- Øksfe;e ds cjkcjiksVkf’k;e vk;ksMkbM 0.15 fexzk- vk;ksMhu ds cjkcjiksVkf’k;e DyksjkbM 40 fexzk- iksVkf’k;e ds cjkcjlksfM;e eksfycsV 75 ,elhth eksfyfcMsue ds cjkcjlksfM;e lsfyusV 30 ,elth lsysfu;e ds cjkcjfudy lYQsV 5 ,elth fudy ds cjkcjLVsul DyksjkbM 10 ,elth fVu ds cjkcjdksyksbMy flfydksu MkbZvkWDlkbM 2 fexzk- flfydksu ds cjkcjDyksjkbM 36.3 fexzk-] ck;ksfVu 30 ,elhthlksfM;e esVkosuMsV 10 ,elth osusfM;e ds cjkcjlksfM;e cksjsV 15 ,elth cksjksu ds cjkcj

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 227: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 208 -

116. eYVhfoVkfeu dSilwy 30 dh cksry 21.04 748(v) 19.05.2006

ftad lYQsV - 61.8 fexzk-foVkfeu bZ - 25 fexzk-]izkd‘frd csVk dsjksfVu¼10% esa½ - 10 fexzk-esxful lYQsV - 2 fexzk-] dksij lYQsV - 1 fexzk-lsysfu;e MkbZvkWDlkbM eksuksgkbMªsV - 75 ,elhth]foVkfeu , - 2500 vkbZ;w

117. eYVhfoVkfeu dSilwy 30 dh cksry 24.66 1640(v) 27.09.2007

foVkfeu , - 10,000 vkbZ;wfoVkfeu Mh 3 - 500 vkbZ;wfoVkfeu ch 1 - 10 fexzk- ]foVkfeu ch 2 - 5 fexzk-foVkfeu ch 6 - 3 fexzk-Qksfyd ,sflM - 1.5 fexzk-dSfY’k;e iSUVksfFkusV - 10 fexzk-fudksfVukekbM -150 fexzk-foVkfeu lh - 50 fexzk- ]foVkfeu bZ - 15 fexzk- ]

118. eYVhfoVkfeu xksfy;ka 30 fefy dh cksry 15.38 1069(v) 11.07.2006

izR;sd fQYe fyfir fVfd;k esacsVk dsjksfVu&20% fMl-&10 fexzk-foVkfeu bZ ,sflVsV&25 fexzk-foVkfeu lh&100 fexzk-lsysfu;e MkbZvkWDlkbM&150 fexzk-dkWij lYQsV&3.39 fexzk- dkWij&1 fexzk- ds cjkcjeSxusfll DyksjkbM&5.4 fexzk-ftad lYQsV&33 fexzk- ftad&7.5 fexzk- ds cjkcj

119. eYVhfoVkfeu dSilwy 10 dk iRrk@fCyLVj 5.52 1069(v) 11.07.2006

izR;sd dBksj@uje tsysfVu dSilwy esaQsjl ¶;wekjsV&200 fexzk-lkbukdksckykekbu&5 ,elhthQksfyd ,sflM&1.5 fexzk-,ldksjfcd ,sflM&75 fexzk-Fkk;feu eksuksukbVªsV&5 fexzk-fjcw¶ysfou&5 fexzk-ik;fjMksDlhu ,plh,y&1.5 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 228: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 209 -

120. eYVhfoVkfeu dSilwy 10 dk iRrk@fCyLVj 21.82 1069(v) 11.07.2006

foVkfeu bZ ,sflVsV&4 fexzk-¼foVkfeu bZ ,sflVsV MªkbZ ikmMj 50% ds leku½foVkfeu lh ¼fyfir½&25 fexzk-,ldksjfcd ,sflM&75 fexzk-Fkk;feu eksuksukbVªsV&5 fexzk-eSxusfll lYQsV eSxusfll&10 fexzk- ds cjkcjXywdkslkekbu lYQsV lksfM;e&250 fexzk-dksuMªksfVu lYQsV lksfM;e&200 fexzk-

121. eYVhfoVkfeu cksyl 2 dk ,,y_iRrk 2.16 748(v) 19.05.2006

izR;sd cksyl esadksckYV lYQsV ch- osV- lh-100 fexzk-MªkbM Qsjl lYQsV -200 fexzk-Fkk;feu eksuksukbVªsV -50 fexzk-foVkfeu ch 12 -40 ,elhthdksfyu ckbVªkVªsV -18.2 fexzk-

122. eYVhfoVkfeu ¼osV½ 250 xzke dk ikmp 195.42 748(v) 19.05.2006

izR;sd 100 xzke esafoVkfeu ch 12 - 440 ,elhth¼foVkfeu ch 12 esfuuVksy VªkbV;wjsV 1:1000 esa½esukfM;ksu lksfM;e ckblYQkbV -0.141 xzk-foVkfeu Mh 3 & 22000 vkbZ;wfoVkfeu bZ ,sflVsV 33 vkbZ;w¼Mh&,YQk VksdksQsjksy ,sflVsV½ fjcwQysfou -0.176 xzk-fu;kflukekbM -0.881 xzk-Mh&dSfY’k;e iSUVksfFkusV -0.359 xzk-fu;ksekbflu lYQsV -5.506 xzk-3.854 xzk- fu;ksekbflu csl ds cjkcj

123. eYVhfoVkfeu xksfy;ka ,Ut+kbe lfgr 10 dk 8.75 1933(v) 08.11.2006izR;sd xksfy;ksa esa iRrk@fCyLVjisilhu (1 : 3000) 12.5 fexzk-Fkk;feu eksuksukbVªsV 2 fexzk-QUxy fM;kLVsl (1 : 50) 750 fexzk-fjcksQysfou ¼fjcksQysfou QksLQsVlksfM;e ds leku½ 1 fexzk-ik;fjMksDlhu ,plh,y 1.5 fexzk-lk;ukdksckykekbu 1 ,elhthMh&dSfY’k;e iSUVksfFkusV 2.5 fexzk-fu;kflukekbM 15 fexzk-ckby LysV chihlh 40 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 229: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 210 -

124. eYVhfoVkfeu xksfy;ka 10 dk 5.96 1933(v) 08.11.2006

izR;sd fQYe fyfir xksfy;ksa esa iRrk@fCyLVjFkk;jksbM 85' & 15 fexzk-VksdksQsjksy ,sflVsV&10 fexzk-Fkk;feu eksuksukbVªsV 2.5 fexzk-fjcksQysfou 2.5 fexzk-dSfY’k;e iSUVksfFkusV 5 fexzk-fudksfVukekbM 25 fexzk-ik;fjMksDlhu ,plh,y 1 fexzk-

125. eYVhfoVkfey xksfy;ka 10 dk 4.76 1933(v) 08.11.2006

izR;sd fVfd;k esa iRrk@fCyLVjfoVkfeu , - 2500 vkbZ;wfoVkfeu lh - 100 fexzk-foVkfeu bZ - 25 vkbZ;wcsVkdsjksfVu - 6 fexzk-lksfM;e lsysusV - 55 ,elhtheksfycsuMe - 25 ,elhth

126. eYVhfoVkfey dSilwy 15 dk 8.06 1933(v) 08.11.2006

izR;sd dSilwy esa iRrk@fCyLVjMªkbZ Qsjl lYQsV - 60 fexzk-¼Vkbe fjfyt+½Qksfyd ,sflM - 1.5 fexzk-,Ldksjfcd ,sflM - 75 fexzk-ik;fjMksDlhu ,plh,y - 1.5 fexzk-lk;ukdksckykekbu - 15 ,elhth

127. eYVhfoVkfeu vkSj feujy xksfy;ka 10 dk 7.32** 1665(v) 27.09.2007 eS- fudksYl fijkey lqizkfMuizR;sd fyfir xksfy;ksa esa iRrk@fCyLVj ¼dEiksft+f’ku dh eS- fudksYl fijkey fcdkst+kbefoVkfeu , ,sflVsV&5000 vkbZ;w ek=kk esa osfj,’ku eS- bZ edZ fu;wjksfc;ksu QksVZfoVkfeu Mh 3 &400 vkbZ;w ds fy, layXud&2 eS- fudksYl fijkey csflVksu QksVZfoVkfeu bZ &15 vkbZ;w@fexzk- dks nsf[k;sa½ eS- ,cksV ljcsDlFkk;feu eksuksukbVªsV&10 fexzk-fjcksQysfou&10 fexzk-]ik;fjMksDlhu ,plh,y&2 fexzk-lk;uksdksckykekbu&7.5 ,elhth] fu;kflukekbM&50 fexzk-dSfY’k;e iSUVksfFkusV&10 fexzk-] ,ldksjfcd ,sflM&75 fexzk-gsoh esxusf’k;e vkWDlkbM&30 fexzk-esxuhl lYQsV eksuksgkbMªsV&2.8 fexzk-]dkWij lYQsV&2.0 fexzk-] ftad lYQsV eksuksgkbMªsV&63 fexzk-lsysfu;e MkbZvkDlkbM&70 ,elhth

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 230: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 211 -

128. eYVhfoVkfeu vkSj feujy dSilwy 10 dk 8.80** 1665(v) 27.09.2007 eS- Qkbt+j fcdkfL;wyizR;sd dBksj@uje tsysfVu dSilwy esa iRrk@fCyLVj ¼dEiksft+f’ku dh eS- th,lds dksckMsDlfoVkfeu , ,sflVsV&5000 vkbZ;w ek=kk esa osfj,’ku eS- bZ-edZ iksfy;ksfc;ksufoVkfeu ch 1 eksuksukbVªsV &10 fexzk- ds fy, layXud&2 eS- ok;Fk LVªsl dSifoVkfeu ch 2 ¼fjcksQysfou½&10 fexzk- dks nsf[k;sa½foVkfeu ch 6 ¼ik;fjMksDlhu ,plh,y½&2 fexzk-foVkfeu ch 12 ¼lk;ukdksckykekbu½&7.5 ,elhthfoVkfeu lh &75 fexzk-] foVkfeu Mh 3 & 400 vkbZ;wfoVkfeu bZ ,sflVsV &15 vkbZ;w@fexzk-dSfY’k;e iSUVksfFkusV&10 fexzk-] Qksfyd ,sflM&1 fexzk-fu;kflukekbM&50 fexzk-] ck;ksfVu Mh&150 ,elhthftad lYQsV eksuksgkbMªsV&63 fexzk-iksVkf’k;e vk;ksMkbM gsoh&30 ,elhthesxusf’k;e vkWDlkbM gsoh&30 fexzk-] dkWij lYQsV&2 fexzk-]Øksfe;e fidksfyusV 25 fexzk- Øksfe;e ds cjkcjlsysfu;e MkbZvkWDlkbM eksuksgkbMªsV 70 ,elhth lsysfu;e ds cjkcjlksfM;e eksfycMsV MkbZgkbMªsV 25 ,elhth eksfycMsue ds cjkcjdksfyMy flfydksu MkbZvkWDlkbM 1 fexzk- flfydksu ds cjkcjlksfM;e cksjsV 150 ,elhth cksjksu ds cjkcjesxuhl lYQsV eksuksgkbMªsV&2.8 fexzk-]

129. fgesfVfud vk;ju dEchus’ku fyfDoM 200 fefy dh 24.36 302(v) 04.03.2004 eS- flMeSd yscksjsfVªtizR;sd 5 fefy esa cksryQsjl dsfY’k;e flVjsV dkWEIysDl¼ekbØksQkbUM½&500 fexzk-¼ds cjkcj vk;ju-25 fexzk- vkSjdsfY’k;e-85 fexzk-½] foVkfeu ,¼ikfeVsV ds leku½- 2000 vkbZ-;w-]dksYdsfY’kQsjksy ¼Mh3½ - 150 vkbZ-;w-]Fkk;feu eksuksukbVªsV¼ch1½- 1.5 fexzk-foVkfeu ch2 - 2.0 fexzk-] fudksfVukekbM -20.0 fexzk-yk;flu ,plh,y-200.0 fexzk-

130. fgesfVfud vk;ju dEchus’ku fyfDoM 200 fefy dh 24.84 302(v) 04.03.2004 eS- flMeSd yscksjsfVªtizR;sd 5 fefy esa cksry ,e-di lfgrQsjl dsfY’k;e flVjsV dkWEIysDl¼ekbØksQkbUM½&500 fexzk-¼ds cjkcj vk;ju-25 fexzk- vkSjdsfY’k;e-85 fexzk-½] foVkfeu ,¼ikfeVsV ds leku½- 2000 vkbZ-;w-]dksYdsfY’kQsjksy ¼Mh3½ - 150 vkbZ-;w-]Fkk;feu eksuksukbVªsV¼ch1½- 1.5 fexzk-foVkfeu ch2 - 2.0 fexzk-] fudksfVukekbM -20.0 fexzk-yk;flu ,plh,y-200.0 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 231: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 212 -

131. fgesfVfud vk;ju dEchus’ku fyfDoM 100 fefy dh 13.96 302(v) 04.03.2004 eS- flMeSd yscksjsfVªtizR;sd 5 fefy esa cksryQsjl dsfY’k;e flVjsV dkWEIysDl¼ekbØksQkbUM½&500 fexzk-¼ds cjkcj vk;ju-25 fexzk- vkSjdsfY’k;e-85 fexzk-½] foVkfeu ,¼ikfeVsV ds leku½- 2000 vkbZ-;w-]dksYdsfY’kQsjksy ¼Mh3½ - 150 vkbZ-;w-]Fkk;feu eksuksukbVªsV¼ch1½- 1.5 fexzk-foVkfeu ch2 - 2.0 fexzk-] fudksfVukekbM -20.0 fexzk-yk;flu ,plh,y-200.0 fexzk-

132. fgesfVfud vk;ju dEchus’ku fyfDoM 100 fefy dh 14.44 302(v) 04.03.2004 eS- flMeSd yscksjsfVªtizR;sd 5 fefy esa cksry ,e-di lfgrQsjl dsfY’k;e flVjsV dkWEIysDl¼ekbØksQkbUM½&500 fexzk-¼ds cjkcj vk;ju-25 fexzk- vkSjdsfY’k;e-85 fexzk-½] foVkfeu ,¼ikfeVsV ds leku½- 2000 vkbZ-;w-]dksYdsfY’kQsjksy ¼Mh3½ - 150 vkbZ-;w-]Fkk;feu eksuksukbVªsV¼ch1½- 1.5 fexzk-foVkfeu ch2 - 2.0 fexzk-] fudksfVukekbM -20.0 fexzk-yk;flu ,plh,y-200.0 fexzk-

133. fgesfVfud vk;ju dEchus’ku VkWfud 200 fefy dh 24.16 302(v) 04.03.2004 eS- flMeSd yscksjsfVªtizR;sd 5 fefy esa cksryQsjl dsfY’k;e flVjsV dkWEIysDl¼ekbØksQkbUM½&500 fexzk-¼ds cjkcj vk;ju-25 fexzk- vkSjdsfY’k;e-85 fexzk-½] foVkfeu ,¼ikfeVsV ds leku½- 2000 vkbZ-;w-]dksYdsfY’kQsjksy - 150 vkbZ-;w-]Fkk;feu eksuksukbVªsV - 1.5 fexzk-foVkfeu ch2 - 2 fexzk-]fudksfVukekbM -20 fexzk-Qksfyd ,sflM-0.3 fexzk-

134. fgesfVfud vk;ju dEchus’ku VkWfud 200 fefy dh 24.64 302(v) 04.03.2004 eS- flMeSd yscksjsfVªtizR;sd 5 fefy esa cksry ,e-di lfgrQsjl dsfY’k;e flVjsV dkWEIysDl¼ekbØksQkbUM½&500 fexzk-¼ds cjkcj vk;ju-25 fexzk- vkSjdsfY’k;e-85 fexzk-½] foVkfeu ,¼ikfeVsV ds leku½- 2000 vkbZ-;w-]dksYdsfY’kQsjksy - 150 vkbZ-;w-]Fkk;feu eksuksukbVªsV - 1.5 fexzk-foVkfeu ch2 - 2 fexzk-]fudksfVukekbM -20 fexzk-Qksfyd ,sflM-0.3 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 232: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 213 -

135. fgesfVfud vk;ju dEchus’ku VkWfud 100 fefy dh 13.86 302(v) 04.03.2004 eS- flMeSd yscksjsfVªtizR;sd 5 fefy esa cksryQsjl dsfY’k;e flVjsV dkWEIysDl¼ekbØksQkbUM½&500 fexzk-¼ds cjkcj vk;ju-25 fexzk- vkSjdsfY’k;e-85 fexzk-½] foVkfeu ,¼ikfeVsV ds leku½- 2000 vkbZ-;w-]dksYdsfY’kQsjksy - 150 vkbZ-;w-]Fkk;feu eksuksukbVªsV - 1.5 fexzk-foVkfeu ch2 - 2 fexzk-]fudksfVukekbM -20 fexzk-Qksfyd ,sflM-0.3 fexzk-

136. fgesfVfud vk;ju dEchus’ku VkWfud 100 fefy dh 14.34 302(v) 04.03.2004 eS- flMeSd yscksjsfVªtizR;sd 5 fefy esa cksry ,e-di lfgrQsjl dsfY’k;e flVjsV dkWEIysDl¼ekbØksQkbUM½&500 fexzk-¼ds cjkcj vk;ju-25 fexzk- vkSjdsfY’k;e-85 fexzk-½] foVkfeu ,¼ikfeVsV ds leku½- 2000 vkbZ-;w-]dksYdsfY’kQsjksy - 150 vkbZ-;w-]Fkk;feu eksuksukbVªsV - 1.5 fexzk-foVkfeu ch2 - 2 fexzk-]fudksfVukekbM -20 fexzk-Qksfyd ,sflM-0.3 fexzk-

137. eYVhfoVkfeu flji 100 fefy dh 14.70 1640(v) 27.09.2007 eS- flMeSd yscksjsfVªtizR;sd 5 fefy esa cksryfoVkfeu , ikfeVsV&5000 vkbZ-;w-foVkfeu ch1 ,plh,y&3.75 fexzk-foVkfeu ch2-5 QksLQsVfoVkfeu ch2-3.75 fexzk- ds cjkcjfoVkfeu ch6 ,plh,y&1.25 fexzk-foVkfeu ch12 ,plh,y&5 ,elhthfoVkfeu lh&62.5 fexzk-] foVkfeu Mh3&400 vkbZ-;w-fu;kflukekbM&25 fexzk-] Mh&iSUVksfFkuksy&6.25 fexzk-

138. eYVhfoVkfeu flji 100 fefy dh 15.20 1640(v) 27.09.2007 eS- flMeSd yscksjsfVªtizR;sd 5 fefy esa cksry ,e-di lfgrfoVkfeu , ikfeVsV&5000 vkbZ-;w-foVkfeu ch1 ,plh,y&3.75 fexzk-foVkfeu ch2-5 QksLQsVfoVkfeu ch2-3.75 fexzk- ds cjkcjfoVkfeu ch6 ,plh,y&1.25 fexzk-foVkfeu ch12 ,plh,y&5 ,elhthfoVkfeu lh&62.5 fexzk-] foVkfeu Mh3&400 vkbZ-;w-fu;kflukekbM&25 fexzk-] Mh&iSUVksfFkuksy&6.25 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 233: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 214 -

139. eYVhfoVkfeu Mªksi 15 fefy dh 9.88 949(v) 09.09.2002 eS- ikjd Msfol ,chMhbZlhizR;sd 0.3 fefy ¼yxHkx 10 cwan½ esa cksry Mªksij lfgrfoVkfeu , ikfeVsV&2500 vkbZ-;w-foVkfeu ch1 ,plh,y&0.5 fexzk-foVkfeu ch2 ¼lksfM;e QksLQsVds leku½-0.5 fexzk-foVkfeu lh&25 fexzk-]dksYdsfY’kQsjksy ¼foVkfeu Mh3½&200 vkbZ-;w-fu;kflukekbM&5 fexzk-] Mh&iSUVksfFkuksy&1.5 fexzk-

140. eYVhfoVkfeu flji 100 fefy dh 14.72 1640(v) 27.09.2007 eS- ikjd Msfol ,chMhbZlhizR;sd 5 fefy esa cksryfoVkfeu ,¼ikfeVsV ds leku½&5000 vkbZ-;w-foVkfeu ch1 ,plh,y&3.75 fexzk-foVkfeu ch2-5 QksLQsVfoVkfeu ch2-3.75 fexzk- ds cjkcjfoVkfeu ch6 ,plh,y&1.25 fexzk-foVkfeu ch12 ,plh,y&5 ,elhthfoVkfeu lh&62.5 fexzk-] foVkfeu Mh3&400 vkbZ-;w-fu;kflukekbM&25 fexzk-] lksfM;e iSUVksfFkusV&6.25 fexzk-

141. eYVhfoVkfeu flji 100 fefy dh 15.22 1640(v) 27.09.2007 eS- ikjd Msfol ,chMhbZlhizR;sd 5 fefy esa cksry ,e-di lfgrfoVkfeu ,¼ikfeVsV ds leku½&5000 vkbZ-;w-foVkfeu ch1 ,plh,y&3.75 fexzk-foVkfeu ch2-5 QksLQsVfoVkfeu ch2-3.75 fexzk- ds cjkcjfoVkfeu ch6 ,plh,y&1.25 fexzk-foVkfeu ch12 ,plh,y&5 ,elhthfoVkfeu lh&62.5 fexzk-] foVkfeu Mh3&400 vkbZ-;w-fu;kflukekbM&25 fexzk-] lksfM;e iSUVksfFkusV&6.25 fexzk-

142. eYVhfoVkfeu Mªksi 15 fefy dh 10.00 1640(v) 27.09.2007 eS- ikjd Msfol ,chMhbZlhizR;sd 0.3 fefy ¼yxHkx 10 cwan½ esa cksry Mªksij vkSjfoVkfeu , dkVZu lfgr¼ikfeVsV ds leku½&2500 vkbZ-;w-foVkfeu ch1 ,plh,y&0.5 fexzk-foVkfeu ch2 ¼lksfM;e QksLQsV ds leku½-0.5 fexzk-foVkfeu lh&25 fexzk-]dksYdsfY’kQsjksy ¼foVkfeu Mh3½&200 vkbZ-;w-fu;kflukekbM&5 fexzk-] lksfM;e iSUVksfFkusV&1.5 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 234: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 215 -

143. fgesfVfud vk;ju dEchus’ku Mªksi 20 fefy dk¡p 6.96 302(v) 04.03.2004 eS- flMeSd yscksjsfVªtizR;sd fefy esa dh cksryQsjl dsfY’k;e flVjsV dkWEiysDl Mªksij lfgr¼ekbØksQkbUM½&500 fexzk-¼ds cjkcj vk;ju-5 fexzk- vkSj dsfY’k;e-17 fexzk-½]foVkfeu , ¼ikfeVsV ds leku½- 750 vkbZ-;w-]dksYdsfY’kQsjksy - 200 vkbZ-;w-]Fkk;feu eksuksukbVªsV - 0.5 fexzk-foVkfeu ch2 - 0.5 fexzk-] foVkfeu ch6 - 0.5 fexzk-]fudksfVukekbM -20 fexzk-] yk;flu ,plh,y-40.0 fexzk-

144. eYVhfoVkfeu Mªksi 15 fefy dh 9.76 1361(v) 24.12.2002 eS- ,fo,V dsfedy foflusjyizR;sd 0.6 fefy esa cksry Mªksij vkSjfoVkfeu , dkVZu lfgr¼ikfeVsV ds leku½&3000 vkbZ-;w-foVkfeu Mh3&400 vkbZ;w,ldksjfcd ,sflM&40 fexzk-foVkfeu ch1 -2 fexzk-fjcw¶ysfou lksfM;e QksLQsV1 fexzk- fjcw¶ysfou ds cjkcjfudksfVukekbM&10 fexzk-]foVkfeu ch6 ,plh,y -1 fexzk-Mh&iSUVksfFkuksy &3 fexzk-VksdksQsfjy ,sflVsV&5 vkbZ;w

145. foVkfeu ch dkWEIysDl ,fyfDlj 170 fefy dh 16.32 1327(v) 19.11.2003 eS- ck;ksLVkj csVksfuuizR;sd 15 fefy esa cksryfoVkfeu ch1 -4.5 fexzk-fjcw¶ysfou &3.0 fexzk-foVkfeu ch6 -1.5 fexzk-Mh&iSUVksfFkuksy &6 fexzk-fudksfVukekbM&45 fexzk-]lk;uksdksckykekbu 3 ,elhth,YdksgWy&1.425 fefy

146. foVkfeu ch dkWEIysDl ,fyfDlj 400 fefy dh 33.18 1327(v) 19.11.2003 eS- ck;ksLVkj csVksfuuizR;sd 15 fefy esa cksryfoVkfeu ch1 -4.5 fexzk-fjcw¶ysfou &3.0 fexzk-foVkfeu ch6 -1.5 fexzk-Mh&iSUVksfFkuksy &5 fexzk-fudksfVukekbM&45 fexzk-]lk;uksdksckykekbu 3 ,elhth,YdksgWy&1.425 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 235: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 216 -

147. eYVhfoVkfeu MªkbZ flji 60 fefy dh cksry 8.68 1359(v) 16.09.2005

izR;sd 5 fefy esa ,e- di lfgr

foVkfeu ch 1 & 2 fexzk-foVkfeu ch 2 &2.5 fexzk-foVkfeu ch 6 &1.5 fexzk-ysDVkscsflyl&40 fefy;u LiksZl

fudksfVukekbM&20 fexzk-

148. eYVhfoVkfeu flji 120 fefy dh cksry 14.28 1359(v) 16.09.2005

foVkfeu , ikfeVsV&800 vkbZ;w ,e- di lfgr

dsyksdsYlhQsjksy&50 vkbZ;w

Fkkbfeu ,plh,y&0.60 fexzk-fjcwQsysfou&1 fexzk-] ik;fjMksDlhu ,plh,y&0.5 fexzk-]fudksfVukekbM&8 fexzk-] Mh&iSUFksuksy&1.5 fexzk-]foVkfeu lh&15 fexzk-] foVkfeu bZ ,sflVsV&2.5 fexzk-]Qksfyd ,sflM&100 ,elhth] ftad&2.75 fexzk-]buksflVksy&10 fexzk-] ck;ksVhu&30 ,elhth]

dksfyu DyksjkbM&30 fexzk-

149. eYVhfoVkfeu flji 200 fefy dh cksry 20.20 1359(v) 16.09.2005

foVkfeu , ikfeVsV&800 vkbZ;w ,e- di lfgrdsyksdsYlhQsjksy&50 vkbZ;w

Fkkbfeu ,plh,y&0.60 fexzk-fjcwQsysfou&1 fexzk-] ik;fjMksDlhu ,plh,y&0.5 fexzk-]fudksfVukekbM&8 fexzk-] Mh&iSUFksuksy&1.5 fexzk-]foVkfeu lh&15 fexzk-] foVkfeu bZ ,sflVsV&2.5 fexzk-]Qksfyd ,sflM&100 ,elhth] ftad&2.75 fexzk-]buksflVksy&10 fexzk-] ck;ksVhu&30 ,elhth]

dksfyu DyksjkbM&30 fexzk-] ,sfyesUVy vk;ju lfgr

150. eYVhfoVkfeu Mªksi 15 fefy dh ok;y 10.36 1359(v) 16.09.2005

izR;sd fefy esa Mªksij vkSj dkVZu lfgrfoVkfeu , ikfeVsV&1250 vkbZ;wdsyksdsYlhQsjksy&330 vkbZ;wFkkbfeu ,plh,y&1 fexzk-fjcwQsysfou QksLQsV lksfM;e&1.37 fexzk-]ik;fjMksDlhu ,plh,y&1 fexzk-] fudksfVukekbM&10 fexzk-]Mh&iSUFksuksy&1.5 fexzk-] foVkfeu bZ ,sflVsV&8 fexzk-]ftad lYQsV&11 fexzk-] Qksfyd ,sflM&100 ,elhth]buksflVksy&15 fexzk-] ck;ksVhu&50 ,elhth]dksfyu DyksjkbM&50 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 236: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 217 -

151. eYVhfoVkfeu Mªksi 15 fefy dh ok;y 9.88 1640(v) 27.09.2007izR;sd 0.6 fefy esa Mªksij vkSj dkVZu lfgrfoVkfeu , & 3000 vkbZ;wfoVkfeu Mh & 400 vkbZ;wfoVkfeu bZ& 5 fexzk-]foVkfeu ch 1 & 2 fexzk-] foVkfeu ch 2 & 1 fexzk-]foVkfeu ch 3 & 10 fexzk-] foVkfeu ch 5 & 5 fexzk-]foVkfeu ch 6 & 3 fexzk-] foVkfeu lh& 40 fexzk-

152. eYVhfoVkfeu Mªksi 20 fefy dh ok;y 11.16 1640(v) 27.09.2007foVkfeu , & 3000 vkbZ;w Mªksij vkSj dkVZu lfgrfoVkfeu Mh & 400 vkbZ;wfoVkfeu bZ& 5 fexzk-]foVkfeu ch 1 & 2 fexzk-] foVkfeu ch 2 & 1 fexzk-]foVkfeu ch 3 & 10 fexzk-] foVkfeu ch 5 & 5 fexzk-]foVkfeu ch 6 & 3 fexzk-] foVkfeu lh& 40 fexzk-

153. eYVhfoVkfeu$izksVhu 200 fefy dh 25.08 177(v) 07.02.2006 eS- t;iqj MsDlfoVk&,QbZgkbMªksyk;lsV$ftad VkWfud cksry QkekZfl;wfVdy LVªsUFk VkWfudizR;sd 5 fefy esaQsjl XywdksusV ¼20 fexzk- ,sfyesUVyvk;ju ds cjkcj½- 173 fexzk-izksVhu gkbMªksyk;lsV¼20%½-0.33 xzk-Qksfyd ,sflM - 0.5 fexzk-foVkfeu ch 1 - 2.25 fexzk-foVkfeu ch 2 - 2.5 fexzk-] foVkfeu ch 6 - 0.75 fexzk-]foVkfeu ch 12 - 2.5 ,elhth] ftad lYQsV - 5.0 fexzk-

154. eYVhfoVkfeu$izksVhu 200 fefy dh 27.58 177(v) 07.02.2006 eS- t;iqj MsDlfoVk&,QbZgkbMªksyk;lsV$ftad VkWfud cksry ,e-di lfgr QkekZfl;wfVdy LVªsUFk VkWfudizR;sd 5 fefy esaQsjl XywdksusV ¼20 fexzk- ,sfyesUVyvk;ju ds cjkcj½- 173 fexzk-izksVhu gkbMªksyk;lsV¼20%½-0.33 xzk-Qksfyd ,sflM - 0.5 fexzk-] foVkfeu ch 1 - 2.25 fexzk-foVkfeu ch 2 - 2.5 fexzk-] foVkfeu ch 6 - 0.75 fexzk-]foVkfeu ch 12 - 2.5 ,elhth] ftad lYQsV - 5.0 fexzk-

155. eYVhfoVkfeu ,sfyDlj 200 fefy dh 19.26 177(v) 07.02.2006 eS- VªkW;Mksl chth QksVZizR;sd 15 fefy ,fyDlj esa cksryFkk;feu ,plh,y ¼foVkfeu ch1½-2.5fexzk-fjcksQysfou ¼foVkfeu ch2½-2.5fexzk-foVkfeu ch 6 - 1.0 fexzk-lk;uksdksckykekbu - 5.0 ,elhthfu;kflukekbM - 25 fexzk-] ,YdksgkWy - 1.58 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 237: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 218 -

156. eYVhfoVkfeu ,sfyDlj 450 fefy dh 38.18 177(v) 07.02.2006 eS- VªkW;Mksl chth QksVZizR;sd 15 fefy ,fyDlj esa cksryFkk;feu ,plh,y ¼foVkfeu ch1½-2.5fexzk-fjcksQysfou ¼foVkfeu ch2½-2.5fexzk-foVkfeu ch 6 - 1.0 fexzk-lk;uksdksckykekbu - 5.0 ,elhthfu;kflukekbM - 25 fexzk-] ,YdksgkWy - 1.58 fefy

157. eYVhfoVkfeu flji 250 fefy dh cksry 31.23 748(v) 19.05.2006izR;sd 5 fefy esaFkk;feu gkbMªksDyksjkbM- 2 fexzk-fjcwQysfou lksfM;e QksLQsV - 2.5 fexzk-ik;fjMksDlhu ,plh,y- 0.75 fexzk-fudksfVukekbM - 0.75 fexzk-Mh&iSufFkuksy - 3 fexzk-lkbuksdksckykekbu- 2 ,elhth

158. eYVhfoVkfeu flji 200 fefy dh cksry 27.06 748(v) 19.05.2006izR;sd 5 fefy esafoVkfeu ch 1 - 2.5 fexzk-foVkfeu ch 2 - 2.5 fexzk-foVkfeu ch 6 - 0.75 fexzk-fu;kflukekbM - 25 fexzk-foVkfeu ch 12 - 3 ,elhthMh iSufFkuksy - 5 fexzk-

159. eYVhfoVkfeu flji 200 fefy dh cksry 26.82 748(v) 19.05.2006izR;sd 5 fefy esafoVkfeu ,-1250 vkbZ;w ¼ikfeVsV es½foVkfeu Mh 3 - 125 vkbZ;wfoVkfeu ch 1 - 2 fexzk-foVkfeu ch 6 - 0.5 fexzk-fu;kflukekbM - 12.5 fexzk-iksVsf’k;e X;wykdksy lYQksusV - 20 fexzk-dsjslks,j ;w-,l-,u-,Q- 0.003 fefydSfY’k;e gkbZiksQksLikbV - 10 fexzk-lksfM;e gkbZiksQksLikbV - 10 fexzk-

160. eYVhfoVkfeu flji 200 fefy dh cksry 26.82 748(v) 19.05.2006izR;sd 5 fefy esafoVkfeu ,-1250 vkbZ;w ¼ikfeVsV es½foVkfeu Mh 3 - 125 vkbZ;wfoVkfeu ch 1 - 2 fexzk-foVkfeu ch 6 - 0.5 fexzk-fu;kflukekbM - 12.5 fexzk-iksVsf’k;e X;wykdksy lYQksusV - 20 fexzk-dsjslks,j ;w-,l-,u-,Q- 0.003 fefydSfY’k;e gkbZiksQksLikbV - 10 fexzk-lksfM;e gkbZiksQksLikbV - 10 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 238: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 219 -

161. eYVhfoVkfeu flji 450 fefy dh cksry 47.40 748(v) 19.05.2006

foVkfeu ,-1000 vkbZ;qwfoVkfeu Mh - 75 vkbZ;wFkk;feu gkbMªksDyksjkbM - 0.75 fexzk-fjcwQysfou - 0.75 fexzk-Qsfjd ,eksfu;e lkbVªsV - 47.50 fexzk-fu;kflukekbM - 10 fexzk-

162. eYVhfoVkfeu flji 200 fefy dh cksry 21.96 748(v) 19.05.2006

ykbflu gkbMªksDyksjkbM-200 fexzk-Fkk;feu gkbMªksDyksjkbM -5 fexzk-fjcwQysfou QksLQsV lksfM;e2.5 fexzk- fjcwQysfou ds cjkcjftad lYQsV - 16.5 fexzk-¼3.75 fexzk- ,sfyesUVy ftad ds cjkcj½

163. eYVhfoVkfeu flji 100 fefy dh cksry 15.20 748(v) 19.05.2006foVkfeu ch 1 - 2 fexzk-foVkfeu ch 2 - 2.5 fexzk-fudksfVukekbM - 15 fexzk-foVkfeu ch 12 - 2 ,elhthfoVkfeu ch 6 - 0.75 fexzk-iSUFkksfFkuk;y ,YdksgWy - 3 fexzk-

164. eYVhfoVkfeu flji 200 fefy 24.60 1640(v) 27.09.2007foVkfeu , - 2500 vkbZ;w dh cksryfoVkfeu Mh - 200 vkbZ;wfoVkfeu ch 1 - 2 fexzk-foVkfeu ch 2 - 1 fexzk-foVkfeu ch 6 - 1 fexzk-fudksfVukekbM - 15 fexzk-foVkfeu lh - 50 fexzk-Mh&iSufFkuksy - 2.5 fexzk-foVkfeu ch 12 - 1 fexzk-lkbVªl ckbQysfouks;M dEikmUM - 5 fexzk-

165. eYVhfoVkfeu Mªksi 15 fefy dh cksry 8.80 748(v) 19.05.2006izR;sd fefy esafoVkfeu , - 8330 vkbZ;wfoVkfeu Mh - 667 vkbZ;wfoVkfeu ch 1 - 1.67 fexzk-foVkfeu ch 2 - 1.67 fexzk-foVkfeu ch 3 - 1.67 fexzk-foVkfeu ch 5 - 5 fexzk-foVkfeu ch 6 - 1.67 fexzk-foVkfeu lh - 83 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 239: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 220 -

166. eYVhfoVkfeu Mªksi 15 fefy dh cksry 8.08 1640(v) 27.09.2007

foVkfeu , - 2500 vkbZ;wfoVkfeu Mh -200 vkbZ;wfoVkfeu bZ - 2.5 vkbZ;w ]foVkfeu ch 1 - 0.5 fexzk-foVkfeu ch 2 - 0.5 fexzk- ]foVkfeu ch 6 - 0.5 fexzk-fudksfVukekbM - 1.5 fexzk-] foVkfeu lh - 25 fexzk-ftad - 2.5 fexzk-] lksfM;e iSUVksfFkusV - 1.5 fexzk-

167. eYVhfoVkfeu flji 400 fefy dh cksry 48.86 748(v) 19.05.2006

foVkfeu ch 1 - 2 fexzkfoVkfeu ch 2 - 2.5 fexzk-foVkfeu ch 5 - 3 fexzk-foVkfeu ch 6 - 0.75 fexzk-foVkfeu ch 12 - 2 ,elhthfudksfVukekbM - 15 fexzk-

168. eYVhfoVkfeu flji 100 fefy dh cksry 14.94 1640(v) 27.09.2007

foVkfeu , - 3000 vkbZ;wfoVkfeu Mh - 400 vkbZ;wfoVkfeu ch 1 - 1.5 fexzk- ]foVkfeu ch 2 - 1.2 fexzk-foVkfeu ch 6 - 1 fexzk- ]foVkfeu ch 12 - 3 ,elhthfoVkfeu lh - 50 fexzk- ],y&ykbflu ,plh,y -300 fexzk-dksfyu fcVkjVªsM - 5 fexzk-] buksflVksy - 5 fexzk-fudksfVukekbM -10 ,elhth

169. eYVhfoVkfeu flji 120 fefy dh cksry 14.88 1640(v) 27.09.2007

izR;sd 15 fefy esafoVkfeu , - 4000 vkbZ;wfoVkfeu Mh - 400 vkbZ;wFkk;feu eksuksukbVªsV -3 fexzk-fjcwQysfou lksfM;e QksLQsV -1.2 fexzk-fudksfVukekbM - 25 fexzk-Mh&iSufFkuksy - 5 fexzk-ik;fjMksDlhu ,plh,y - 1 fexzk- ],ldksjfcd ,sflM - 50 fexzk-lkbuksdksckykekbu - 3 ,elhth

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 240: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 221 -

170. eYVhfoVkfeu fyfDoM 100 fefy dh cksry 14.43 1069(v) 11.07.2006

izR;sd 5 fefy esaFkk;feu ,plh,y&2 fexzk-fjcw¶ysfou&2 fexzk-ik;fjMksDlhu&1 fexzk-fu;kflukekbM&20 fexzk-Mh&iSfUFkuksy&4 fexzk-

171. eYVhfoVkfeu fyfDoM 30 fefy dh cksry 7.64 1069(v) 11.07.2006

izR;sd 5 fefy esa ,e- di lfgr

foVkfeu ,&750 vkbZ;w

foVkfeu Mh 3&200 vkbZ;w

foVkfeu ch 1&0.5 fexzk-] foVkfeu ch 2&0.5 fexzk-fu;kflukekbM&5 fexzk-] foVkfeu ch 6&0.5 fexzk-dksfyu DyksjkbM&3.46 fexzk-]ftad XywdksusV&2.5 fexzk-

172. eYVhfoVkfeu fyfDoM 30 fefy dh cksry 7.78 1069(v) 11.07.2006

ftad lYQsV&11.0 fexzk- ,e- di lfgr

¼2.5 fexzk- ,sfyesUVy ftad ds cjkcj½

foVkfeu , ikfeVsV&750 vkbZ;w

dksysdSfY’kQsjksy&0.5 fexzk-Fkk;feu gkbMªksDyksjkbM&0.5 fexzk-]fjcw¶ysfou&0.5 fexzk-] fudksfVukekbM&5.0 fexzk-]ik;fjMksDlhu gkbMªksDyksjkbM&0.5 fexzk-buksflVksy&7.5 fexzk-] dksfyu DyksjkbM&3.46 fexzk-]

173. eYVhfoVkfeu 10 fefy dh cksry 8.36 1640(v) 27.09.2007

izR;sd fefy esa Mªksij vkSj dkVZu lfgr

foVkfeu ,&3000 vkbZ;w]

foVkfeu Mh 3&400 vkbZ;w

foVkfeu bZ&5 vkbZ;w

foVkfeu ch 1&2 fexzk-]foVkfeu ch 2&1 fexzk-]foVkfeu ch 6&1 fexzk-] foVkfeu lh&40 fexzk-]Mh&iSfUFkuksy &3 fexzk-] fudksfVukekbM &10 fexzk-ftad&2.5 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 241: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 222 -

174. eYVhfoVkfeu fyfDoM 10 fefy dh cksry 9.10 1069(v) 11.07.2006

izR;sd fefy esa

foVkfeu ch 1 & 33 fexzk-foVkfeu ch 6 & 33 fexzk-foVkfeu ch 12&500 ,elhth

csUtkby ,YdksgWy&2% oh@oh

175. eYVhfoVkfeu fyfDoM 10 fefy dh cksry 9.00 1069(v) 11.07.2006

foVkfeu ch 1&30 fexzk-]foVkfeu ch 6&13.75 fexzk-foVkfeu ch 12&500 ,elhth

csUtkby ,YdksgWy&2% oh@oh

176. eYVhfoVkfeu$vk;ju flji 200 fefy dh cksry 19.32 1687(v) 03.10.2006

izR;sd 5 fefy esaQsjl XywdksusV&50 fexzk-foVkfeu ch1&1 fexzk-foVkfeu ch2&1 fexzk-fu;kflukekbM&12.5 fexzk-foVkfeu ch6&0.25 fexzk-

177. eYVhfoVkfeu flji 200 fefy dh cksry 18.64 1687(v) 03.10.2006

Fkk;feu ,plh,y&0.33 fexzk-fjcw¶ysfou&0.34 fexzk-ik;fjMksDlhu ,plh,y&0.17 fexzk-Mh&iSUFkhuksy&0.34 fexzk-fu;kflukekbM&3.34 fexzk-,Ldksjfcd ,sflM&8.33 fexzk-

178. eYVhfoVkfeu$vk;ju$izksfVu flji 200 fefy dh cksry 18.62 1687(v) 03.10.2006

izksfVu gkbMªksyk;lsV(15% lksY;w’ku½ 0.34 fexzk-Qsjl XywdksusV&13.33 fexzk-Qksfyd ,sflM&50 fexzk-Fkk;feu ,plh,y&0.33 fexzk-fjcw¶ysfou&0.17 fexzk-fu;kflukekbM&3.34 fexzk-ik;fjMksDlhu ,plh,y&0.17 fexzk-lk;uksdksckykekbu¼foVkfeu ch12½&0.16 ,elhth

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 242: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 223 -

179. eYVhfoVkfeu flji 200 fefy dh cksry 18.78 1687(v) 03.10.2006

Fkk;feu ,plh,y&0.50 fexzk-fjcw¶ysfou&1.00 fexzk-ik;fjMksDlhu ,plh,y&0.75 fexzk-fu;kflukekbM&15 fexzk-Mh&iSUFkhuksy&1.5 fexzk-

180. eYVhfoVkfeu$vk;ju$izksfVu flji 200 fefy dh cksry 26.77 1687(v) 03.10.2006

izR;sd 15 fefy esaizksfVu gkbMªksyk;lsV (15% lksY;w’ku½ 1 xzkeQsjl XywdksusV&50 fexzk-Qksfyd ,sflM&100 fexzk-foVkfeu ch1&1 fexzk-foVkfeu ch2&1 fexzk-foVkfeu ch6&0.5 fexzk-lk;uksdksckykekbu¼foVkfeu ch12½&0.5 ,elhthdkcksZgkbMªsV&7.5 xzkeikysVscy csl D;w-,l-

181. eYVhfoVkfeu flji 200 fefy dh 20.76 1933(v) 08.11.2006

,Ut+kbe lfgr cksryizR;sd 5 fefy esaisilhu (1 : 3000) 12.5 fexzk-QUxy fM;kLVsl (1 : 2000) 18.75 fexzk-Fkk;feu ,plh,y 2 fexzk-fjcksQysfou ¼fjcksQysfou QksLQsVlksfM;e ds leku½ 1 fexzk-ik;fjMksDlhu ,plh,y 1.5 fexzk-Mh&iSfUFkuksy 1.5 fexzk-fu;kflukekbM 15 fexzk-

182. eYVhfoVkfeu flji 100 fefy dh 12.56 1933(v) 08.11.2006

,Ut+kbe lfgr cksryisilhu (1 : 3000) 12.5 fexzk-QUxy fM;kLVsl (1 : 2000) 18.75 fexzk-Fkk;feu ,plh,y 2 fexzk-fjcksQysfou ¼fjcksQysfou QksLQsVlksfM;e ds leku½ 1 fexzk-ik;fjMksDlhu ,plh,y 1.5 fexzk-Mh&iSfUFkuksy 1.5 fexzk-fu;kflukekbM 15 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 243: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 224 -

183. eYVhfoVkfeu flji 100 fefy dh 11.60 1933(v) 08.11.2006

Fkk;feu 2 fexzk- cksryfjcksQysfou 2.5 fexzk-ik;fjMksDlhu 0.75 fexzk-fu;kflukekbM 1.5 fexzk-Mh&iSfUFkuksy 3 fexzk-lk;ukdksckykekbu 1 ,elhth

184. eYVhfoVkfeu flji 200 fefy dh 18.86 1933(v) 08.11.2006Fkk;feu 2 fexzk- cksryfjcksQysfou 2.5 fexzk-ik;fjMksDlhu 0.75 fexzk-fu;kflukekbM 1.5 fexzk-Mh&iSfUFkuksy 3 fexzk-lk;ukdksckykekbu 1 ,elhth

185. eYVhfoVkfeu VkWfud 200 fefy dh cksry 18.90 1933(v) 08.11.2006

foVkfeu , ¼ikfeVsV ds leku½ 800 vkbZ;wdksydsfY’kQsjksy 100 vkbZ;wfoVkfeu bZ 2.5 vkbZ;w¼Mh,y&,YQk VksdksQsjksy ,sflVsV ds leku½Fkk;feu ,plh,y 0.75 fexzk-fjcksQysfou QksLQsV lksfM;e 0.75 fexzk-ik;fjMksDlhu ,plh,y 0.5 fexzk-lk;ukdksckykekbu 0.5 ,elhthMh&iSfUFkuksy 0.5 fexzk-fudksfVukekbM 7.5 fexzk-,y&yk;flu eksuksgkbMªksDyksjkbM 5 fexzk-iksVkf’k;e vk;ksMkbM 50 ,elhthdksij lYQsV 100 ,elhthftad lYQsV 22.2 fexzk-

186. eYVhfoVkfeu Mªksi ,Ut+kbe lfgr 15 fefy dh cksry 7.46 1933(v) 08.11.2006

izR;sd fefy esa Mªksij vkSj dkVZufM;kLVsl 1 : 5400 - 6 fexzk- lfgr¼MkbtsLVk 50 fexzk dk dwdM LVkpZ½isilhu 5 fexzk-] Fkk;feu ,plh,y 1 fexzk-fjcksQysfou 1 fexzk-¼ 5-QksLQsV lksfM;e ds leku½ik;fjMksDlhu ,plh,y 1 fexzk-lk;ukdksckykekbu 1 ,elhthlkbizksgsIVkMkbu ,plh,y 0.5 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 244: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 225 -

187. eYVhfoVkfeu fyfDoM 150 fefy dh 16.94 1933(v) 08.11.2006izR;sd 15 fefy esa cksryfoVkfeu , ¼ikfeVsV ds leku½ 2500 vkbZ;wFkk;feu gkbMªksDyksjkbM 1.5 fexzk-fjcksQysfou lksfM;e QksLQsV1.7 fexzk- fjcksQysfou ds cjkcjik;fjMksDlhu gkbMªksDyksjkbM 1.5 fexzk-foVkfeu ch&12 1 ,elhth] foVkfeu bZ ,sflVsV 10 vkbZ;wfoVkfeu lh 50 fexzk-] foVkfeu Mh&3 200 vkbZ;wfu;kflukekbM 20 fexzk-] Mh&iSfUFkuksy 5 fexzk-ck;ksfVu 300 ,elhth]ftad ¼ftad XywdksusV ds leku½ 3 fexzk-vk;ksfMu ¼iksVkf’k;e vk;ksfMu ds leku½ 150 ,elhthvk;ju ¼Qsjl XywdksusV ds leku½ 9 fexzk-esxuhl ¼esxuhl DyksjkbM ds leku½ 2.5 fexzk-Øksfe;e ¼Øksfe;e DyksjkbM ds leku½ 25 ,elhtheksfycMsue ¼lksfM;e eksfycMsV ds leku½ 25 ,elhth,Fkuksy (95%) vkbZih 5.4% MCY;w@oh ,Fkuksy ds cjkcj

188. eYVhfoVkfeu VkWfud 200 fefy dh 19.22 1933(v) 08.11.2006Fkk;feu ,plh,y 2.5 fexzk- cksryfjcksQysfou QksLQsV lksfM;e 2.5 fexzk-ik;fjMksDlhu ,plh,y 1 fexzk-lk;ukdksckykekbu 6.75 ,elhthMh&iSfUFkuksy 3 fexzk-fudksfVukekbM 25 fexzk-Qsjl XywdksusV 0.1 xzkef;LV dulsUVªsV 25 fexzk-

189. eYVhfoVkfeu Mªksi 15 fefy dh cksry 8.14 1640(v) 27.09.2007

izR;sd fefy esa Mªksij vkSj dkVZu lfgrfoVkfeu , ¼ikfeVsV ds leku½ 1250 vkbZ;wfoVkfeu Mh&3 200 vkbZ;wfoVkfeu bZ ,sflVsV 3 fexzk-Fkk;feu gkbMªksDyksjkbM 0.5 fexzk-fjcksQysfou lksfM;e QksLQsV0.5 fexzk- fjcksQysfou ds cjkcjfu;kflukekbM 5 fexzk-ik;fjMksDlhu gkbMªksDyksjkbM 0.5 fexzk-foVkfeu lh 25 fexzk-]ftad ¼ftad lYQsV ds leku½ 2.5 fexzk-vk;ju ¼Qsjl XywdksusV ds leku½ 5 fexzk-Mh&iSfUFkuksy 3 fexzk-yk;flu ,plh,y 10 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 245: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 226 -

190. eYVhfoVkfeu Mªksi 10 dk 8.16 218(v) 14.02.2007

izR;sd fefy esa iRrk@fCyLVjfoVkfeu ,-750 vkbZ;w ¼foVkfeu ,dkWUlsUVªsV vkW;yh QkWeZ ds leku½dksydsfY’kQsjksy-200 vkbZ;wfjcw¶ysfou-0.5 fexzk-Fkk;feu gkbMªksDyksjkbM-0.5 fexzk-ik;fjMksDlhu gkbMªksDyksjkbM-0.5 fexzk-ftad lYQsV-11.0 fexzk-¼2.5 fexzk- ,fyesUVy ftad ds cjkcj½fudksfVukekbM-5.0 fexzk-buksflVksy-7.5 fexzk-dksfyu DyksjkbM-3.46 fexzk-

191. eYVhfoVkfeu bUtsD’ku 100 fefy dk 6.12 1362(v) 24.12.2002 eS- ,uchtsM QkekZizR;sd fefy esa ,Ecj ,Ei;wyfoVkfeu ,¼ikfeVsV ds leku½&1100 vkbZ-;w-,YQk VksdksfQjk;y ,sflVsV&0.50 fexzk-Fkk;feu ,plh,y-5fexzk-ik;fjMksDlhu ,plh,y-1.65 fexzk-fjcksQysfou QksLQsV lksfM;e-1.40 fexzk-,ldksjfcd ,sflM&50 fexzk-] fudksfVukekbM&10 fexzk-Mh iSUVksfFkuksy&2.5 fexzk-] csUtkby ,YdksgWy&1% MCY;w@oh

192. eYVhfoVkfeu bUtsD’ku 100 fefy dk 5.48 1362(v) 24.12.2002 eS- ,uchtsM QkekZizR;sd fefy esa lQsn ,Ei;wyfoVkfeu ,¼ikfeVsV ds leku½&1100 vkbZ-;w-,YQk VksdksfQjk;y ,sflVsV&0.50 fexzk-Fkk;feu ,plh,y-5fexzk-ik;fjMksDlhu ,plh,y-1.65 fexzk-fjcksQysfou QksLQsV lksfM;e-1.40 fexzk-,ldksjfcd ,sflM&50 fexzk-fudksfVukekbM&10 fexzk-] Mh iSUVksfFkuksy&2.5 fexzk-csUtkby ,YdksgWy&1% MCY;w@oh

193. eYVhfoVkfeu bUtsD’ku 2 fefy dk 4.86 616(v) 29.06.2001 eS- ,axyks zQsap Mªx ckjkIysDl QksVZizR;sd 2 fefy esa ,Ei;wy fCyLVj lfgrFkk;feu ,plh,y-100fexzk-ik;fjMksDlhu ,plh,y-100 fexzk-fu;kflukekbM&100 fexzk-] Mh iSUVksfFkuksy&50 fexzk-lk;uksdksckykekbu&1000 ,elhth

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 246: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 227 -

194. eYVhfoVkfeu bUtsD’ku 2 fefy dk 4.64 616(v) 29.06.2001 eS- ,axyks zQsap Mªx ckjkIysDl QksVZizR;sd 2 fefy esa ,Ei;wyFkk;feu ,plh,y-5fexzk-ik;fjMksDlhu ,plh,y-100 fexzk-fu;kflukekbM&100 fexzk-] Mh iSUVksfFkuksy&50 fexzk-lkbukdksCykfeu&1000 ,elhth

195. eYVhfoVkfeu bUtsD’ku dksEch iSd 6.94 1640(v) 16.08.2001 eS- teZu jsesfMt+ U;wjksVªsVizR;sd 1.5 fefy ¼Hkkx&I½ esa bUtSaD’ku ds fy,,ldksjfcd ,sflM-150 fexzk- fCyLVj iSfdax esacsUTkkby ,YdksgWy-2.0% MCY;w@ohizR;sd 1 fefy ¼Hkkx&II½ esalk;uksdksckykekbu&2500 ,elhthQksfyd ,sflM&0.70 fexzk-] fudksfVukekbM&12 fexzk-csUTkkby ,YdksgWy-2.0% MCY;w@oh

196. eYVhfoVkfeu bUtsD’ku dksEch iSd 6.88 1640(v) 27.09.2007 eS- teZu jsesfMt+ U;wjksVªsVizR;sd 1.5 fefy ¼Hkkx&I½ esa bUtSaD’ku ds fy,,ldksjfcd ,sflM-150 fexzk-csUTkkby ,YdksgWy-2.0% MCY;w@ohizR;sd 1 fefy ¼Hkkx&II½ esalk;uksdksckykekbu&2500 ,elhthQksfyd ,sflM&0.70 fexzk-] fudksfVukekbM&12 fexzk-csUTkkby ,YdksgWy-2.0% MCY;w@oh

197. eYVhfoVkfeu bUtsD’ku 3 fefy dk 4.75 781(v) 09.07.2003 eS- bZ edZ U;wjksfc;ksu QksVZizR;sd 3 fefy esa ,Ecj ,Ei;wyFkk;feu ,plh,y-100fexzk-fjcksQysfou lksfM;e QksLQsV-5 fexzk-ik;fjMksDlhu ,plh,y-100 fexzk-lk;uksdksckykekbu&1000 ,elhthfudksfVukekbM&100 fexzk-] Mh iSUVksfFkuksy&50 fexzk-csUTkkby ,YdksgWy-1% MCY;w@oh

198. eYVhfoVkfeu bUtsD’ku 3 fefy dk 4.97 781(v) 09.07.2003 eS- bZ edZ U;wjksfc;ksu QksVZizR;sd 3 fefy esa ,Ecj ,Ei;wyFkk;feu ,plh,y-100fexzk- fCyLVj lfgrfjcksQysfou lksfM;e QksLQsV-5 fexzk-ik;fjMksDlhu ,plh,y-100 fexzk-lk;uksdksckykekbu&1000 ,elhthfudksfVukekbM&100 fexzk-] Mh iSUVksfFkuksy&50 fexzk-csUTkkby ,YdksgWy-1% MCY;w@oh

199. eYVhfoVkfeu bUtSaD’ku 5 fefy dk 5.90 1359(v) 16.09.2005foVkfeu ch 1 & 100 fexzk- ,Ei;wyfoVkfeu ch 6 & 50 fexzk-foVkfeu ch 12 & 1000 ,elhth

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 247: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 228 -

200. eYVhfoVkfeu bUtSaD’ku 10 fefy dk 5.67 1359(v) 16.09.2005

foVkfeu , & 1000 vkbZ;w ,Ei;wyfoVkfeu Mh 3 & 100 vkbZ;wfoVkfeu ch 12 & 1000 ,elhthFkkbfeu ,plh,y&5 fexzk-] fjcwQsysfou&1.4 fexzk-]ik;fjMksDlhu ,plh,y&1.5 fexzk-] foVkfeu bZ&0.5 fexzk-]fudksfVukekbM&10 fexzk-] Mh&iSUFksuksy&2.5 fexzk-

201. eYVhfoVkfeu bUtsD’ku 10 fefy dh cksry 7.60 200(v) 14.02.2007

foVkfeu ch 1&10 fexzk-]foVkfeu ch 2&2 fexzk-]foVkfeu ch 6&2 fexzk-] Mh&iSfUFkuksy &5 fexzk-fudksfVukekbM &100 ,elhthcsUtkby ,YdksgWy&1.55% MCy;w@oh

202. eYVhfoVkfeu bu¶;wt+u 10 fefy dk 8.86 195(v) 29.01.2008

¼,feuks ,sflM lfgr½ fQfyUV ,Ei;wyizR;sd fefy bu¶;wt+u esa gksyksxzke lfgrfoVkfeu ,¼ikfeVsV ds leku½&1000 vkbZ;wFkk;feu ,plh,y&5 fexzk-dksydsfY’kQsjksy&100 vkbZ;wfjcwQysfou QksLQsV&1.4 fexzk-ik;fjMksDlhu ,plh,y&1.5 fexzk-Mh&iSfUFkuksy&2.5 fexzk-] fudksfVukekbM&10 fexzk-,Ldksjfcd ,sflM&50 fexzk-,YQk VksdksQsfjy ,sflVsV&0.5 fexzk-,y&vkjfxfuu ,plh,y&6.5 fexzk-,y&fgLVhfMu ,plh,y eksuks&3 fexzk-,y&vkblksY;wflu&5.5 fexzk-] ,y&Y;wflu&12.3 fexzk-,y&ykbflu ,plh,y&17.0 fexzk-],y&esF;ksfuu&6 fexzk-] ,y&Qsfuykysfuu&8.7 fexzk-,y&Fkzksfuu &5.4 fexzk-] ,y&osfyu&6.1 fexzk-Xyk;flu&10 fexzk-MkbZ lksfM;e ,sfMMsVlksfM;e gkbMªksDlkbM

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 248: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 229 -

203. eYVhfoVkfeu bu¶;wt+u 10 fefy dk 8.60 1640(v) 27.09.2007

¼,feuks ,sflM lfgr½ ,Ei;wyfoVkfeu , gksyksxzke lfgr¼ikfeVsV ds leku½&1000 vkbZ;wdksydsfY’kQsjksy&100 vkbZ;wfjcwQysfou QksLQsV&1.4 fexzk-Fkk;feu ,plh,y&5 fexzk-ik;fjMksDlhu ,plh,y&1.5 fexzk-Mh&iSfUFkuksy&2.5 fexzk-] fudksfVukekbM&10 fexzk-,Ldksjfcd ,sflM&50 fexzk-,YQk VksdksQsfjy ,sflVsV&0.5 fexzk-,y&vkjfxfuu ,plh,y&6.5 fexzk-,y&fgLVhfMu ,plh,y eksuks&3 fexzk-,y&vkblksY;wflu&5.5 fexzk-] ,y&Y;wflu&12.3 fexzk-,y&ykbflu ,plh,y&17.0 fexzk-],y&esF;ksfuu&6 fexzk-] ,y&Qsfuykysfuu&8.7 fexzk-,y&Fkzksfuu &5.4 fexzk-] ,y&osfyu&6.1 fexzk-Xyk;flu&10 fexzk-

204. eYVhfoVkfeu dSilwy 10 dk ,,y_iRrk 12.50 1653(v) 27.09.2007Y;wfVu- 6.4 fexzk-¼tsDlufFku-512 ekbØks xzke lkexzh½,y&XywFksfFk;ksu-5 fexzk-foVkfeu bZ ,sflVsV - 25 vkbZ;wfoVkfeu lh - 150 fexzk-dksij ¼D;wiksfjd vkWDlkbM ds leku½ - 1 fexzk-ftad ¼ftad vkWDlkbM ds leku½ - 40 fexzk-

205. eYVhfoVkfeu dSilwy 10 dk iRrk@fCyLVj 10.18 1654(v) 27.09.2007foVkfeu lh-50 fexzk-,dkslkisUVksfud ,sflM-150 fexzk-MksdkslgsDlksfud ,sflM-100 fexzk-foVkfeu ,-2500 vkb;wdksij-1 fexzk-]Øksfe;e-0.1 fexzk-Qksfyd ,sflM-0.3 fexzk-esxful lYQsV eksuksgkbMªsV -2.0 fexzk-ik;fjMksDlhu ,plh,y-1.0 fexzk-lsysfu;e-0.04 fexzk-]foVkfeu bZ -10 fexzk-ftad lYQsV eksuksgkbMªsV -7.5 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 249: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 230 -

206. eYVhfoVkfeu Mªksi 15 fefy dkap dh 9.12 1654(v) 27.09.2007foVkfeu lh-40.0 fexzk- cksry Mªksij vkSj dkVZufu;kflukekbM-10.0 fexzk- lfgrMh&iSfUFkuksy-3.0 fexzk-ftad XywdksusV ftad 2.5 fexzk- ds cjkcjfoVkfeu ch1-12.0 fexzk-foVkfeu bZ -1.5 fexzk-foVkfeu ch2-1.0 fexzk-foVkfeu ch6-1.0 fexzk-foVkfeu ,-1000 vkb;wfoVkfeu Mh2-400 vkbZ;wck;ksfVu-20 ,elhth,UjVh 3.190 dsy-dkcksZgkbMªsV 940 fexzk-QsV-10 fexzk-

207 eYVhfoVkfeu Mªksi 15 fefy dkap dh 8.98 1654(v) 27.09.2007foVkfeu lh-40.0 fexzk- cksry Mªksij vkSj dkVZufu;kflukekbM-10.0 fexzk- lfgrMh&iSfUFkuksy-3.0 fexzk-foVkfeu ch1-12.0 fexzk-VksdksQsjksy ,sflVsV -1.5 fexzk-foVkfeu ch2-1.0 fexzk-foVkfeu ch6-1.0 fexzk-foVkfeu ,-1000 vkb;wfoVkfeu Mh2-400 vkbZ;wck;ksfVu-20 ,elhth,UjVh 3.245 dsy-dkcksZgkbMªsV 957 fexzk-QsV-10 fexzk-

208. eYVhfoVkfeu flji 120 fefy 16.50 1654(v) 27.09.2007foVkfeu , dulsUVªsV dh cksry¼vk;fy QkWeZ½-2500vkbZ;wdksydSfY’kQsjksy¼foVkfeu Mh3 -200 vkbZ;wVksdksQsjksy ,sflVsV -5 fexzk-Fkk;feu ,plh,y -2 fexzk-fjcw¶ysfou -1.2 fexzk-ik;fjMksDlhu ,plh,y-1 fexzk-Mh iSfUFkuksy-2.5 fexzk-lk;uksdksckykekbu-1 ,elhthfudksfVukekbM 20 fexzk-,ldksjfcd ,sflM 50 fexzk-ftad lYQsV-22.2 fexzk-¼,fyesUVy ftad 5 fexzk- ds cjkcj½

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 250: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 231 -

209. eYVhfoVkfeu Mªksi 15 fefy 8.60 1654(v) 27.09.2007foVkfeu , dulsUVªsV dh cksry¼vk;fy QkWeZ½-2750vkbZ;wdksydSfY’kQsjksy¼foVkfeu Mh3 -250 vkbZ;wVksdksQsjksy ,sflVsV -5 fexzk-Fkk;feu ,plh,y -1 fexzk-] fjcw¶ysfou -1 fexzk-ik;fjMksDlhu ,plh,y-1 fexzk-Mh iSfUFkuksy-2.5 fexzk-fudksfVukekbM 10 fexzk-,ldksjfcd ,sflM 40 fexzk-ftad lYQsV-13.3 fexzk-¼,fyesUVy ftad 3 fexzk- ds cjkcj½@1 fefy

210. eYVhfoVkfeu bUtSD’ku 5 fefy 11.22 1654(v) 27.09.2007gkbªkslksdksckykekbu-1000,elhth dk ok;yFkk;feu ,plh,y -0.1 xzkeik;fjMksDlhu ,plh,y-50 fexzk-fjcw¶ysfou -1 fexzk-Mh iSfUFkuksy-50 fexzk-] feFkk;y isjkcsu-0.1%izksfiy isjkcsu-0.02%

211. eYVhfoVkfeu flji 200 fefy dh 21.36 2042(v) 30.11.2007Fkk;feu ,plh,y- 2 fexzk- cksryfjcw¶ysfou-1.80 fexzk-ik;fjMksDlhu ,plh,y-0.75 fexzk-Mh&iSfUFkuksy - 3 fexzk-fu;kflukekbM - 15 fexzk-dksfyu MkbZgkbMªkstu lkbVªsV - 87.5 fexzk-yk;flu ,plh,y - 70 fexzk- -@5 fefy

212. eYVhfoVkfeu flji 100 fefy dh 12.98 2042(v) 30.11.2007,ujth- 17.840 dSfY’k- cksrydkcksZgkbMªsV-5.4 xzk-QsV-10 fexzk-,ldksjfcd ,sflM - 50 fexzk-fu;kflukekbM - 15 fexzk-ftad XywdksusV ,fyesUVy ftad - 5 fexzk- ds cjkcjMh&iSfUFkuksy - 2.5 fexzk-Fkk;feu ,plh,y- 2 fexzk-fjcw¶ysfou-1 fexzk-ik;fjMksDlhu ,plh,y-1 fexzk-foVkfeu ,-1000 vkbZ;w-@5 fefy,jxksdSfY’kQsjksy-200 vkbZ;wck;ksfVu-30 ,elhthlk;uksdksckykekbu-1 ,elhth-@5 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 251: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 232 -

213. eYVhfoVkfeu flji 200 fefy dh 20.98 2042(v) 30.11.2007isiflu (1:3000) - 20 fexzk-Fkk;feu ,plh,y- 1 fexzk- cksryfjcw¶ysfou-1 fexzk-ik;fjMksDlhu ,plh,y-0.5 fexzk-fu;kflukekbM-10 fexzk-@5 fefy

214. eYVhfoVkfeu dSilwy 10 dk 5.08 2042(v) 30.11.2007Fkk;feu eksuksukbVªsV- 5 fexzk-fjcw¶ysfou-1 fexzk- iRrk@fCyLVjik;fjMksDlhu ,plh,y-0.5 fexzk-lk;ukdksckykekbu-2.5 ,elhthQsjl ¶;wejsV-150 fexzk-,y&fglVhfMu ,plh,y-4 fexzk-,y&yk;flu ,plh,y-25 fexzk-xyk;flu-10 fexzk-Qksfyd ,sflM-0.5 fexzk-,ldksjfcd ,sflM-40 fexzk-ftad lYQsV-50 fexzk-@dSilwy

215. eYVhfoVkfeu dSilwy 10 dk 11.32 2042(v) 30.11.2007foVkfeu bZ- 200 fexzk-foVkfeu lh-100 fexzk- iRrk@fCyLVjbdksl,sfi;ksfVfud ,sflM-90 fexzk-ftad lYQsV-7.5 fexzk-MksdkslgsDlh;ksfud ,sflM-60 fexzk-Qksfyd ,sflM-2.5 fexzk-esxful ¼esxful lYQsV ds leku½-2 fexzk-foVkfeu , ¼csVkdsjksfVu 30% fMlilZu½-2500 vkbZ;wØksfe;e ¼Øksfe;e fidksfyusV½-100 ,elhthlsysfu;e ¼lsysfu;e Mk;vkWDlkbM ds leku½-40 ,elhthdksij dksij lYQsV ds leku-1 fexzk-@dSilwyfoVkfeu ch6 -1 fexzk-

216. eYVhfoVkfeu dSilwy 10 dk 7.16 2042(v) 30.11.2007,y-Y;wflu 25 fexzk-,y-vkblksY;wflu 8 fexzk- iRrk@fCyLVj,y-yk;flu 25 fexzk-,y-Qsfuykykukbu 5 fexzk-,y-fFkz;ksfuu 8.3 fexzk-,y-osfyu 9.1 fexzk-,y-VªkbZIVksQsu 10.1 fexzk-] ,y-feFk;ksuhu 18.4 fexzk-,y-vkjxhuhu 18.3 fexzk-foVkfeu , ,sflVsV 2500 vkbZ;wfoVkfeu Mh 3 - 200 vkbZ;wfoVkfeu bZ ,sflVsV 7.5 vkbZ;wlsysfu;e ¼lsysfu;e vkWDlkbM ds leku½ 0.084 fexzk-Øksfe;e ¼Øksfe;e fidksfyusV½ 0.522 fexzk-Qksfyd ,sflM 0.5 fexzk-os izksfVu vkblksysV 350 fexzk-@dSilwy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 252: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 233 -

217. eYVhfoVkfeu dSilwy 30 dk 19.44 2042(v) 30.11.2007Qsjl ¶;wejsV 150 fexzk-ftad lYQsV 50 fexzk- iRrk@fCyLVj,y-fglhfVfMu ,plh,y ,pvks2 - 4 fexzk-,y-yk;flu ,plh,y 25 fexzk-xyk;flu 10 fexzk-Fkk;feu eksuksgkbMªsV 5 fexzk-fjcw¶ysfou 3 fexzk-ik;fjMksDlhu ,plh,y 1.5 fexzk-feFkk;ydksckykekbu 500 ,elhthQksfyd ,sflM 0.5 fexzk-,ldksjfcd ,sflM 40 fexzk-@dSilwy

218. eYVhfoVkfeu dSilwy 2x10 dk 22.18 2042(v) 30.11.2007,y-vkjfxfuu 13.28 fexzk-,y-fglhfVfMu ,plh,y iRrk@fCyLVj,p2vks 3.71 fexzk-,y-vkblksY;wflu 5.9 fexzk-,y-Y;wflu 183 fexzk-,y-yk;flu ,plh,y 25 fexzk-Mh,y-feFk;ksuhu 18.4 fexzk-,y-fFkz;ksfuu 4.2 fexzk-,y-Vªk;IVksQsu 12 fexzk-,y-osfyu 6.7 fexzk-5 gkbMªksDlh ,UFkzkfufyd ,sflM ,plh,y 0.2 fexzk-foVkfeu , dksUlhUVªsV 2500 vkbZ;wdksydSfY’kQsjksy 200 vkbZ;wVksdksQsjksy ,sflVsV 7.5 vkbZ;wFkk;feu eksuksgkbMªsV 5 fexzk-fjcw¶ysfou 3 fexzk-fudksfVukekbM 25 fexzk-dSfY’k;e iSUVksfFkusV 5 fexzk-ik;fjMksDlhu ,plh,y 1.5 fexzk-lk;ukdksckykekbu 2.5 ,elhth,ldksjfcd ,sflM 40 fexzk-Qksfyd ,sflM 0.75 fexzk-@dSilwyftad lYQsV 50 fexzk-

219. eYVhfoVkfeu dSilwy 10 dk 6.78 2042(v) 30.11.2007csVk dsjksfVu 6 fexzk-foVkfeu lh 150 fexzk- iRrk@fCyLVjfoVkfeu bZ ,sflVsV 25 fexzk-ftad 40 fexzk-lsysfu;e 40 ,elhthdksij 2 fexzk-esxful 5 fexzk-@dSilwy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 253: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 234 -

220. eYVhfoVkfeu dSilwy 10 dk 20.72 2042(v) 30.11.2007foVkfeu , iRrk@fCyLVj¼,sflVs ds leku½ 5000 vkbZ;w,ldksjfcd ,sflM 75 fexzk-foVkfeu bZ 15 vkbZ;wftad 7.5 fexzk-dksij 1 fexzk-csVk dsjksfVu 10 fexzk-@ gkMZ tsysfVu dSilwy

221. eYVhfoVkfeu dSilwy 15 dk 14.16 2042(v) 30.11.2007izkd‘frd csVkdsjksfVu vU; iRrk@fCyLVjfeDlM dsjksfVuksf;Ml lfgrfoVkfeu , dksUlhUVªsV 5000 vkbZ;wfoVkfeu bZ 25 vkbZ;wik;fjMksDlhu ,plh,y 3 fexzk-,ldksjfcd ,sflM 75 fexzk-,y&lkbflfVu ,plh,y 46.37 fexzk-,y&Xyw;kVkfed ,sflM 40 fexzk-xyk;flu 25 fexzk-ftad lYQsV 27.45 fexzk-esxfufl;e lYQsV 11.5 fexzk-esxful lYQsV 1.12 fexzk-dksij lYQsV 0.8 fexzk-Øksfe;e fidksfyusV 0.2 fexzk-lksfM;e lsfyusV 0.1 fexzk-fLiz;wfyuk 175 fexzk-@lkW¶V tsysfVu dSilwy

222. eYVhfoVkfeu dSilwy 10 dk 9.90 2042(v) 30.11.2007foVkfeu bZ ,sflVsV 200 fexzk- iRrk@fCyLVjfoVkfeu lh 150 fexzk-vksesxk 3 QsVh ,sflMbZih, 90 fexzk- ds cjkcjMh,p, 60 fexzk-ftad 15 fexzk-Øksfe;e 65 ,elhthlsysfu;e 60 ,elhth@lkW¶V tsysfVu dSilwy

223. eYVhfoVkfeu dSilwy 10 dk iRrk@fCyLVj 6.96 2042(v) 30.11.2007yk;dksfiu 2000 ,elhthfeFkk;y dksckykekbu 500 ,elth,y - ,jfxfuu 50 fexzk-Mh - ,YQk VksdksQsjksy 25 vkbZ;w,y - lsysfu;e eksuks feFk;ksfuu 50 ,elhthftad ,LdksjcsV 50 fexzk-@lkW¶V tsysfVu dSilwy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 254: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 235 -

224. eYVhfoVkfeu xksfy;ka 10 dk iRrk@fCyLVj 2.54 2042(v) 30.11.2007foVkfeu , ¼,sflVsVds leku½ 10000 vkbZ;wdksydSfY’kQsjksy ¼foVkfeu Mh3 1000 vkbZ;wFkk;feu eksuksukbVªsV 10 fexzk-@phuh fyfir fVfd;k

225. eYVhfoVkfeu dSilwy 30 dh dkap 20.18 166(v) 29.01.2008izR;sd lkW¶V tsysfVu dSilwy esa dh cksryfoVkfeu , -5000 vkbZ;wfoVkfeu Mh3 ¼dksydSfY’kQsjksy½ 200 vkbZ;wfoVkfeu bZ 7.5 fexzk-foVkfeu ch Z1 2.5 fexzk-foVkfeu chZ2 2.5 fexzk-fudksfVukekbM- 25 fexzk-Mh&iSfUFkuksy- 2.5 fexzk-foVkfeu ch6- 1 fexzk-foVkfeu lh- 40 fexzk-Qksfyd ,sflM- 500 ,elhthfoVkfeu ch12- 2.5 ,elhthMkbZcsfld dSfY’k;e QksLQsV- 35 fexzk-dksij lYQsV- 0.1 fexzk-eSuxsfut+ lYQsV- 0.01 fexzk-ftad lYQsV MªkbZMftad lYQsV- 50 fexzk- ds cjkcjiksVkf’k;e vk;ksMkbM- 0.025 fexzk-eSxusf’k;e vkWDlkbM- 0.15 fexzk-

226. eYVhfoVkfeu MªkbZ ikmMj 60 fefy dh 7.56 166(v) 29.01.2008?kqyus ds ckn izR;sd 5 fefy esa cksry ,e-di lfgrysfDVd ,sflM csflyl-60x1000000Fkk;feu eksuksgkbMªsV-1.5 fexzk-fjcw¶ysfou lksfM;e QksLQsV-2.0 fexzk-ik;fjMksDlhu gkbMªksDyksjkbM-1.0 fexzk-fudksfVukekbM-15 fexzk-

227. eYVhfoVkfeu dSilwy 10 dk 7.48 166(v) 29.01.2008izR;sd gkMZ tsysfVu dSilwy esa iRrk@fCyLVjfeFkk;ydkscykfeu-500 ,elhth,y&XY;wVsfed ,sflM-100 fexzk-foVkfeu bZ ¼,sflVsV½-25 fexzk-foVkfeu ch1 -10 fexzk-foVkfeu ch2 -3 fexzk-foVkfeu ch6 -1.5 fexzk-dSfY’k;e iSUVksfFkusV-50 fexzk-Qksfyd ,sflM-1 fexzk-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 255: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 236 -

228. eYVhfoVkfeu dSilwy 10 dk 10.86 166(v) 29.01.2008izR;sd gkMZ tsysfVu dSilwy esa iRrk@fCyLVjfeFkk;ydkscykfeu-1500 ,elhth,y&XY;wVsfed ,sflM-100 fexzk-foVkfeu bZ ¼,sflVsV½-25 fexzk-foVkfeu ch1 -10 fexzk-] foVkfeu ch2 -3 fexzk-foVkfeu ch6 -1.5 fexzk-] dSfY’k;e iSUVksfFkusV-50 fexzk-Qksfyd ,sflM-1 fexzk-

229. eYVhfoVkfeu xksfy;ka feujy lfgr 15 dh 12.32 166(v) 29.01.2008izR;sd fVfd;k esa IykfLVd cksryfoVkfeu , ikfYeVsV-2500 vkbZ;wfoVkfeu Mh3 -200 vkbZ;w] foVkfeu bZ -10 fexzk-Fkk;feu eksuksukbVªsV -2 fexzk-] fjcw¶ysfou -3 fexzk-ik;fjMksDlhu ,plh,y -1.5 fexzk-LVscykbTM lk;ukdksckykekbu -1 fexzk-fu;kflukekbM -26 fexzk-] dSfY’k;e iSUVksfFkusV -5 fexzk-,ldksjfcd ,sflM -50 fexzk-eSxusf’k;e lYQsV eksuksgkbMªsV ftad-15 fexzk-eSxusf’k;e-100 fexzk-] dksij-2 fexzk-lksfM;e eksfycMsVeksfycsMsue-25 ,elhth ds cjkcjQksfyd ,sflM-0.3 fexzk-] foVkfeu ds -10 ,elhthck;ksfVu-30 ,elhth] vk;ksfMu -0.15 ,elhthvk;ju ¼Qsjl Xy;wdksusV½-9 fexzk-eSxful-2.5 fexzk-] dSfY’k;e-162 fexzk-QkslQksjl-125 fexzk-] iksVkf’k;e-40 fexzk-DyksjkbM-36.3 fexzk-] Øksfe;e ¼Øksfe;e DyksjkbM½-100 ,elhthlsysfu;e-25 ,elhth] fudy-5 ,elhthflfydksu-10 ,elhth] osusfM;e-10 ,elhth

230. eYVhfoVkfeu xksfy;ka feujy lfgr 15 dh 12.74 166(v) 29.01.2008izR;sd fVfd;k esa IykfLVd cksryfoVkfeu , ,sflVsV-2500 vkbZ;wfoVkfeu Mh3 -200 vkbZ;w] foVkfeu bZ -7.5 fexzk-Fkk;feu eksuksukbVªsV -1 fexzk-] fjcw¶ysfou -1.5 fexzk-ik;fjMksDlhu ,plh,y -1 fexzk-LVscykbTM lk;ukdksckykekbu -1 ,elhthfu;kflukekbM -20 fexzk-] dSfY’k;e iSUVksfFkusV -5 fexzk-,ldksjfcd ,sflM -50 fexzk-ftad-15 fexzk-] lsysfu;e MkbZvkWDlkbM-55 ,elhtheSxusf’k;e-100 fexzk-] eSxusf’k;e lYQsV eksuksgkbMªsV dksij-2 fexzk-lksfM;e eksfycMsV] eksfycsMsue-25 ,elhth ds cjkcjQksfyd ,sflM-0.15 fexzk-] foVkfeu ds -10 ,elhthck;ksfVu-30 ,elhth] vk;ksfMu -0.15 ,elhthvk;ju ¼Qsjl Xy;wdksusV½-10 fexzk-eSxful-2.5 fexzk-] dSfY’k;e-162 fexzk-QkslQksjl-125 fexzk-] iksVkf’k;e-40 fexzk-DyksjkbM-36.3 fexzk-] Øksfe;e ¼Øksfe;e DyksjkbM½-25 ,elhthlsysfu;e-25 ,elhth] fudy-5 ,elhth] fVu -10 ,elhthflfydksu-2 ,elhth] osusfM;e-10 ,elhth] cksjksu -150 ,elhth

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 256: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 237 -

231. eYVhfoVkfeu flji 250 fefy dh 26.04 193(v) 29.01.2008Fkk;feu gkbMªksDyksjkbM-2 fexzk- cksryfjcw¶ysfou lksfM;e QksLQsV-2.5 fexzk-ik;fjMksDlhu gkbMªksDyksjkbM -0.75 fexzk-fudksfVukekbM -15 fexzk-lk;ukdksckykekbu -2 ,elhthlksjfcVksy lksY;w’ku -(70%) / 5 fefy

232. eYVhfoVkfeu flji 100 fefy dh 13.40 194(v) 29.01.2008foVkfeu , ¼ikfeVsV cksryds leku½-2500 vkbZ;wfoVkfeu bZ ,sflVsV -5 vkbZ;wdksydSfY’kQsjksy-200 vkbZ;wFkk;feu gkbMªksDyksjkbM-1 fexzk-fjcw¶ysfou lksfM;e QksLQsVfjcw¶ysfou-1 fexzk- ds cjkcjik;fjMksDlhu gkbMªksDyksjkbM - 1 fexzk-fu;kflukekbM - 15 fexzk-lk;uksdksckykekbu - 1 ,elhthMh&iSUFkhuksy - 2.5 fexzk-ftad ¼ftad lYQsV ds leku½ - 3 fexzk-vk;ksfMu ¼iksVkf’k;e vk;ksMkbM ds leku½ - 50 ,elhthesxful ¼esxful DyksjkbM ds leku½ - 0.8 fexzk-

233. eYVhfoVkfeu flji 10 fefy dh 5.30 194(v) 29.01.2008Ø-l- 232 ds leku izcyrk cksry

234. eYVhfoVkfeu flji 20 fefy dh 6.15 194(v) 29.01.2008Ø-l- 232 ds leku izcyrk cksry

235. eYVhfoVkfeu flji 30 fefy dh 7.07 194(v) 29.01.2008Ø-l- 232 ds leku izcyrk cksry

236. eYVhfoVkfeu flji 50 fefy dh 8.75 194(v) 29.01.2008Ø-l- 232 ds leku izcyrk cksry

237. eYVhfoVkfeu flji 150 fefy dh 18.62 194(v) 29.01.2008Ø-l- 232 ds leku izcyrk cksry

238. eYVhfoVkfeu flji 200 fefy dh 22.74 194(v) 29.01.2008Ø-l- 232 ds leku izcyrk cksry

239. eYVhfoVkfeu flji 250 fefy dh 27.03 194(v) 29.01.2008Ø-l- 232 ds leku izcyrk cksry

240. eYVhfoVkfeu flji 500 fefy dh 49.33 194(v) 29.01.2008Ø-l- 232 ds leku izcyrk cksry

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 257: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 238 -

241. eYVhfoVkfeu flji 200 fefy dh 24.56 198(v) 29.01.2008foVkfeu ,-3000 vkbZ;w cksryfoVkfeu Mh3 -400 vkbZ;wfoVkfeu ch1-1.5 fexzk-foVkfeu ch2-1.2 fexzk-foVkfeu lh -50 fexzk-fudksfVukekbM-10 fexzk-foVkfeu ch6 - 1 fexzk-foVkfeu ch12 - 3 fexzk-@5 fefy

242. eYVhfoVkfeu flji 10 fefy dh 5.39 198(v) 29.01.2008Ø-l- 241 ds leku izcyrk cksry

243. eYVhfoVkfeu flji 20 fefy dh 6.34 198(v) 29.01.2008Ø-l- 241 ds leku izcyrk cksry

244. eYVhfoVkfeu flji 30 fefy dh 7.34 198(v) 29.01.2008Ø-l- 241 ds leku izcyrk cksry

245. eYVhfoVkfeu flji 50 fefy dh 9.20 198(v) 29.01.2008Ø-l- 241 ds leku izcyrk cksry

246. eYVhfoVkfeu flji 100 fefy dh 14.30 198(v) 29.01.2008Ø-l- 241 ds leku izcyrk cksry

247. eYVhfoVkfeu flji 150 fefy dh 19.98 198(v) 29.01.2008Ø-l- 241 ds leku izcyrk cksry

248. eYVhfoVkfeu flji 250 fefy dh 29.30 198(v) 29.01.2008Ø-l- 241 ds leku izcyrk cksry

249. eYVhfoVkfeu flji 500 fefy dh 53.88 198(v) 29.01.2008Ø-l- 241 ds leku izcyrk cksry

250. eYVhfoVkfeu VkWfud 200 fefy dh 56.48 199(v) 29.01.2008ysoksdkfuZfVu-50 fexzk- cksry dkVZu lfgrFkk;feu ,plh,y-1 fexzk-fjcw¶ysfou-1 fexzk-ik;fjMksDlhu ,plh,y - 0.75 fexzk-lk;uksdksckykekbu - 0.5 ,elhthfu;kflukekbM - 1.5 fexzk-lksjfcVksy 70% lksY;w’ku ¼ukWu fØlVkfyu½@ 5 fefy

251. eYVhfoVkfeu VkWfud 10 fefy dh 6.98 199(v) 29.01.2008Ø-l- 250 ds leku izcyrk cksry dkVZu lfgr

252. eYVhfoVkfeu VkWfud 20 fefy dh 9.53 199(v) 29.01.2008Ø-l- 250 ds leku izcyrk cksry dkVZu lfgr

253. eYVhfoVkfeu VkWfud 30 fefy dh 12.13 199(v) 29.01.2008Ø-l- 250 ds leku izcyrk cksry dkVZu lfgr

254. eYVhfoVkfeu VkWfud 50 fefy dh 17.18 199(v) 29.01.2008Ø-l- 250 ds leku izcyrk cksry dkVZu lfgr

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 258: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 239 -

255. eYVhfoVkfeu VkWfud 100 fefy dh 30.26 199(v) 29.01.2008Ø-l- 250 ds leku izcyrk cksry dkVZu lfgr

256. eYVhfoVkfeu VkWfud 150 fefy dh 43.92 199(v) 29.01.2008Ø-l- 250 ds leku izcyrk cksry dkVZu lfgr

257. eYVhfoVkfeu VkWfud 250 fefy dh 69.20 199(v) 29.01.2008Ø-l- 250 ds leku izcyrk cksry dkVZu lfgr

258. eYVhfoVkfeu VkWfud 500 fefy dh 133.68 199(v) 29.01.2008Ø-l- 250 ds leku izcyrk cksry dkVZu lfgr

259. eYVhfoVkfeu VkWfud 200 fefy dh 59.48 200(v) 29.01.2008ysoksdkfuZfVu-50 fexzk- cksry ,e-di vkSjFkk;feu ,plh,y-1 fexzk- dkVZu lfgrfjcw¶ysfou-1.5 fexzk-ik;fjMksDlhu ,plh,y - 0.75 fexzk-lk;uksdksckykekbu - 0.5 ,elhthfu;kflukekbM - 1.5 fexzk-lksjfcVksy 70% lksY;w’ku ¼ukWu fØlVkfyu½@ 5 fefy

260. eYVhfoVkfeu VkWfud 10 fefy dh 8.38 200(v) 29.01.2008Ø-l- 259 ds leku izcyrk cksry ,e-di vkSj dkVZu lfgr

261. eYVhfoVkfeu VkWfud 20 fefy dh 10.93 200(v) 29.01.2008Ø-l- 259 ds leku izcyrk cksry ,e-di vkSj dkVZu lfgr

262. eYVhfoVkfeu VkWfud 30 fefy dh 13.53 200(v) 29.01.2008Ø-l- 259 ds leku izcyrk cksry ,e-di vkSj dkVZu lfgr

263. eYVhfoVkfeu VkWfud 50 fefy dh 18.88 200(v) 29.01.2008Ø-l- 259 ds leku izcyrk cksry ,e-di vkSj dkVZu lfgr

264. eYVhfoVkfeu VkWfud 100 fefy dh 32.26 200(v) 29.01.2008Ø-l- 259 ds leku izcyrk cksry ,e-di vkSj dkVZu lfgr

265. eYVhfoVkfeu VkWfud 150 fefy dh 46.92 200(v) 29.01.2008Ø-l- 259 ds leku izcyrk cksry ,e-di vkSj dkVZu lfgr

266. eYVhfoVkfeu VkWfud 250 fefy dh 72.20 200(v) 29.01.2008Ø-l- 259 ds leku izcyrk cksry ,e-di vkSj dkVZu lfgr

267. eYVhfoVkfeu VkWfud 500 fefy dh 137.66 200(v) 29.01.2008Ø-l- 259 ds leku izcyrk cksry ,e-di vkSj dkVZu lfgr

268. eYVhfoVkfeu fyfDoM 200 fefy dh 19.80 201(v) 29.01.2008fM;kLVsl ¼Qaxy½-20 fexzk- cksryisiflu-20 fexzk-Fkk;feu eksuksukbVªsV-1 fexzk-fjcw¶ysfou-1 fexzk-ik;fjMksDlhu ,plh,y - 0.50 fexzk-fu;kflukekbM - 15 fexzk-Mh&iSfUFkuksy - 2 fexzk-lk;uksdksckykekbu - 0.50 ,elhth@15 fefy

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 259: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 240 -

269. eYVhfoVkfeu fyfDoM 10 fefy dh 5.15 201(v) 29.01.2008Ø-l- 268 ds leku izcyrk cksry

270. eYVhfoVkfeu fyfDoM 20 fefy dh 5.86 201(v) 29.01.2008Ø-l- 268 ds leku izcyrk cksry

271. eYVhfoVkfeu fyfDoM 30 fefy dh 6.63 201(v) 29.01.2008Ø-l- 268 ds leku izcyrk cksry

272. eYVhfoVkfeu fyfDoM 50 fefy dh 8.01 201(v) 29.01.2008Ø-l- 268 ds leku izcyrk cksry

273. eYVhfoVkfeu fyfDoM 100 fefy dh 11.92 201(v) 29.01.2008Ø-l- 268 ds leku izcyrk cksry

274. eYVhfoVkfeu fyfDoM 150 fefy dh 16.41 201(v) 29.01.2008Ø-l- 268 ds leku izcyrk cksry

275. eYVhfoVkfeu fyfDoM 250 fefy dh 23.35 201(v) 29.01.2008Ø-l- 268 ds leku izcyrk cksry

276. eYVhfoVkfeu fyfDoM 500 fefy dh 41.98 201(v) 29.01.2008Ø-l- 268 ds leku izcyrk cksry

277. eYVhfoVkfeu fyfDoM 150 fefy 17.94 194(v) 29.01.2008foVkfeu , ¼ikfeVsV dkap dh cksryds leku½-2500 vkbZ;wFkk;feu ,plh,y-1.5 fexzk-fjcw¶ysfou-1.7 fexzk-ik;fjMksDlhu ,plh,y - 1.5 fexzk-foVkfeu ch12 -1 ,elhthfoVkfeu lh -50 fexzk-foVkfeu Mh3 -200 vkbZ;wfoVkfeu bZ -10 vkbZ;wfu;kflukekbM - 20 fexzk-Mh iSfUFkuksy-5 fexzk-ck;ksfVu - 30 ,elhthftad ¼ftad XywdksusV½ - 3 fexzk-vk;ksfMu ¼iksVkf’k;e vk;ksfMu½ - 150 ,elhthvk;ju ¼Qsjl XywdksusV½ - 9 fexzk-esxful ¼esxful DyksjkbM½ - 2.5 fexzk-Øksfe;e ¼Øksfe;e DyksjkbM½ - 25 ,elhtheksfyfcfMue ¼lksfM;e eksfycMsV½ - 25 ,elhth@15 fefy

278. eYVhfoVkfeu fyfDoM 10 fefy 5.72 202(v) 29.01.2008Ø-l- 277 ds leku izcyrk dkap dh cksry

279. eYVhfoVkfeu fyfDoM 20 fefy 6.50 202(v) 29.01.2008Ø-l- 277 ds leku izcyrk dkap dh cksry

280. eYVhfoVkfeu fyfDoM 30 fefy 7.33 202(v) 29.01.2008Ø-l- 277 ds leku izcyrk dkap dh cksry

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 260: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 241 -

281. eYVhfoVkfeu fyfDoM 50 fefy 8.85 202(v) 29.01.2008Ø-l- 277 ds leku izcyrk dkap dh cksry

282. eYVhfoVkfeu fyfDoM 100 fefy 13.10 202(v) 29.01.2008Ø-l- 277 ds leku izcyrk dkap dh cksry

283. eYVhfoVkfeu fyfDoM 200 fefy 21.66 202(v) 29.01.2008Ø-l- 277 ds leku izcyrk dkap dh cksry

284. eYVhfoVkfeu fyfDoM 250 fefy 25.56 202(v) 29.01.2008Ø-l- 277 ds leku izcyrk dkap dh cksry

285. eYVhfoVkfeu fyfDoM 500 fefy 45.89 202(v) 29.01.2008Ø-l- 277 ds leku izcyrk dkap dh cksry

286. eYVhfoVkfeu flji 150 fefy 19.98 204(v) 29.01.2008foVkfeu , -3000 vkbZ;w dh cksryfoVkfeu Mh3 -400 vkbZ;wfoVkfeu ch1 -1.5 fexzk-foVkfeu ch2 -12 vkbZ;wfudksfVukekbM-10 fexzk-foVkfeu ch6 -1 fexzk-foVkfeu ch12 -3 fexzk-Mh iSfUFkuksy-5 fexzk-foVkfeu lh -50 fexzk-iksVkf’k;e vk;ksMkbM ¼,fyesUVy vk;ksMkbM 75 fexzk- ds cjkcj½ - 98 ,elhthdSfY’k;e ysDVsV - 158 fexzk-dSfY’k;e gkbiks&QkslQkbV - 82 fexzk-dqy dSfY’k;e - 40 fexzk-esx- XywdksusV - 55 fexzk-esxusf’k;e XywdksusV - 4.5 fexzk-ftad XywdksusV - 3.9 fexzk-@5 fefy

287. eYVhfoVkfeu flji 10 fefy 5.39 204(v) 29.01.2008Ø-l- 286 ds leku izcyrk dh cksry

288. eYVhfoVkfeu flji 20 fefy 6.34 204(v) 29.01.2008Ø-l- 286 ds leku izcyrk dh cksry

289. eYVhfoVkfeu flji 30 fefy 7.34 204(v) 29.01.2008Ø-l- 286 ds leku izcyrk dh cksry

290. eYVhfoVkfeu flji 50 fefy 9.20 204(v) 29.01.2008Ø-l- 286 ds leku izcyrk dh cksry

291. eYVhfoVkfeu flji 100 fefy 14.30 204(v) 29.01.2008Ø-l- 286 ds leku izcyrk dh cksry

292. eYVhfoVkfeu flji 200 fefy 24.55 204(v) 29.01.2008Ø-l- 286 ds leku izcyrk dh cksry

293. eYVhfoVkfeu flji 250 fefy 29.29 204(v) 29.01.2008Ø-l- 286 ds leku izcyrk dh cksry

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 261: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 242 -

294. eYVhfoVkfeu flji 500 fefy 53.86 204(v) 29.01.2008Ø-l- 286 ds leku izcyrk dh cksry

295. eYVhfoVkfeu flji 150 fefy 18.12 205(v) 29.01.2008foVkfeu , -2500 vkbZ;w dh cksryFkk;feu ,plh,y-1.5 fexzk-fjcw¶ysfou-1.7 fexzk-ik;fjMksDlhu ,plh,y-1.5 fexzk-lk;ukdksckykekbu-1 ,elhth,ldksjfcd ,sflM-50 fexzk-dksydSfY’kQsjksy-200 vkbZ;wVksdksQsjksy ,sflVsV-10 vkbZ;wfudksfVukekbM-20 fexzk-Mh iSfUFkuksy-5 fexzk-ck;ksfVu-30 ,elhthftad-3 fexzk-vk;ksfMu -150 ,elhthesxful-2.5 fexzk-vk;ju -9 fexzk-Øksfe;e-25 ,elhtheksfycMsue-25 ,elhth

296. eYVhfoVkfeu flji 10 fefy 5.26 205(v) 29.01.2008Ø-l- 295 ds leku izcyrk dh cksry

297. eYVhfoVkfeu flji 20 fefy 6.09 205(v) 29.01.2008Ø-l- 295 ds leku izcyrk dh cksry

298. eYVhfoVkfeu flji 30 fefy 6.97 205(v) 29.01.2008Ø-l- 295 ds leku izcyrk dh cksry

299. eYVhfoVkfeu flji 50 fefy 8.58 205(v) 29.01.2008Ø-l- 295 ds leku izcyrk dh cksry

300. eYVhfoVkfeu flji 100 fefy 13.06 205(v) 29.01.2008Ø-l- 295 ds leku izcyrk dh cksry

301. eYVhfoVkfeu flji 200 fefy 22.07 205(v) 29.01.2008Ø-l- 295 ds leku izcyrk dh cksry

302. eYVhfoVkfeu flji 250 fefy 26.19 205(v) 29.01.2008Ø-l- 295 ds leku izcyrk dh cksry

303. eYVhfoVkfeu flji 500 fefy 47.66 205(v) 29.01.2008Ø-l- 295 ds leku izcyrk dh cksry

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 262: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 243 -

304. eYVhfoVkfeu VkWfud 200 fefy dh 58.98 206(v) 29.01.2008ysoksdkfuZfVu-50 fexzk- cksry ,e-diFkk;feu ,plh,y-1 fexzk-fjcw¶ysfou-1.5 fexzk-ik;fjMksDlhu ,plh,y - 0.75 fexzk-lk;uksdksckykekbu - 0.5 ,elhthfu;kflukekbM - 1.5 fexzk-lksjfcVksy 70% lksY;w’ku ¼ukWu fØlVkfyu½@ 5 fefy

305. eYVhfoVkfeu VkWfud 10 fefy dh 7.88 206(v) 29.01.2008Ø-l- 304 ds leku izcyrk cksry ,e-di

306. eYVhfoVkfeu VkWfud 20 fefy dh 10.43 206(v) 29.01.2008Ø-l- 304 ds leku izcyrk cksry ,e-di

307. eYVhfoVkfeu VkWfud 30 fefy dh 13.03 206(v) 29.01.2008Ø-l- 304 ds leku izcyrk cksry ,e-di

308. eYVhfoVkfeu VkWfud 50 fefy dh 18.38 206(v) 29.01.2008Ø-l- 304 ds leku izcyrk cksry ,e-di

309. eYVhfoVkfeu VkWfud 100 fefy dh 31.76 206(v) 29.01.2008Ø-l- 304 ds leku izcyrk cksry ,e-di

310. eYVhfoVkfeu VkWfud 150 fefy dh 46.42 206(v) 29.01.2008Ø-l- 304 ds leku izcyrk cksry ,e-di

311. eYVhfoVkfeu VkWfud 250 fefy dh 71.70 206(v) 29.01.2008Ø-l- 304 ds leku izcyrk cksry ,e-di

312. eYVhfoVkfeu VkWfud 500 fefy dh 137.16 206(v) 29.01.2008Ø-l- 304 ds leku izcyrk cksry ,e-di

313. eYVhfoVkfeu Mªksi 15 fefy dh 7.88 207(v) 29.01.2008foVkfeu , ¼ikfeVsV cksryds leku½-2500 vkbZ;wfoVkfeu bZ -25 vkbZ;wfoVkfeu Mh -200 vkbZ;wfoVkfeu ch1 ,plh,y-1 fexzk-foVkfeu ch2 QksLQsV-1 fexzk-foVkfeu ch6 ,plh,y-0.5 fexzk-fu;kflukekbM-10 fexzk-Mh&isUFkhuksy -1 fexzk-] foVkfeu lh-40 fexzk-ftad lYQsV - 13.0 fexzk-,y&yk;L;wc eksuksgkbMªksDyksjkbM - 10 fexzk-lksyfcVksy csl - D;w-,l-@1 fefy

314. eYVhfoVkfeu Mªksi 5 fefy dh 5.63 207(v) 29.01.2008Ø-l- 313 ds leku izcyrk cksry

315. eYVhfoVkfeu Mªksi 10 fefy dh 6.70 207(v) 29.01.2008Ø-l- 313 ds leku izcyrk cksry

316. eYVhfoVkfeu Mªksi 20 fefy dh 8.96 207(v) 29.01.2008Ø-l- 313 ds leku izcyrk cksry

317. eYVhfoVkfeu Mªksi 30 fefy dh 11.28 207(v) 29.01.2008Ø-l- 313 ds leku izcyrk cksry

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 263: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 244 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Ø- fofufeZfr@dEiksft+’ku iSd flfyax ewY; jkti=k jkti=k fofufeZrkvksala- dk uke vkdkj ¼fcuk mRikn vkns’k vkns’k dk uke

’kqYd ds½IykfLVd dk¡p dh dk-vk- dh frFkhcksry cksry la[;k¼#i;s½ ¼#i;s½¼d½ ¼[k½

1. MsDlVªkst+ bUtSaD’ku lksY;w’ku 5% 500 fefy 17.00 21.00 725¼v½ 27.08.1998 eS- csdLVj

2. MsDlVªkst+ bUtSaD’ku lksY;w’ku 5% 540 fefy 17.80 21.80 725¼v½ 27.08.1998 eS- Dysfjl ykbQ lkbal

3. MsDlVªkst+ bUtSaD’ku lksY;w’ku 5% 1000 fefy 27.00 31.00 725¼v½ 27.08.1998 eS- zQsflfu;l dfc

4. MsDlVªkst+ lkekU; lsykbu lfgr 500 fefy 17.00 21.00 725¼v½ 27.08.1998 eS- MsfuldsebUtSaD’ku@lksY;w’ku eS- ihMhih,y5% $ 0.9%

5. MsDlVªkst+ lkekU; lsykbu lfgr 540 fefy 17.80 21.80 725¼v½ 27.08.1998 eS- Jh d‘".kk ds’kobUtSaD’ku@lksY;w’ku eS- yosl MªXl5% $ 0.9%

6. MsDlVªkst+ lkekU; lsykbu lfgr 1000 fefy 27.00 31.00 725¼v½ 27.08.1998 eS- #lksekbUtSaD’ku@lksY;w’ku5% $ 0.9%

7. lkekU; lsykbu bUtSaD’ku@lksY;w’ku 500 fefy 17.00 21.00 725¼v½ 27.08.1998

5% $ 0.9%

8. lkekU; lsykbu bUtSaD’ku@lksY;w’ku 540 fefy 17.80 21.80 725¼v½ 27.08.1998

5% $ 0.9%

9. lkekU; lsykbu bUtSaD’ku@lksY;w’ku 1000 fefy 27.00 31.00 725¼v½ 27.08.1998

5% $ 0.9%

10. Åij nh xbZ lHkh fofufeZfr ¼d½ 100 fefy 9.00 13.00 725¼v½ 27.08.1998

Øekad la- 1 ls 9 rd rd¼Åij fn;s x;s iSd vkdkj ls vyx½

¼[k½ 100 fefy 9.00 13.00 725¼v½ 27.08.1998

ls Åij

vkSj 1000 fefy 100 fefy 100 fefyrd ls Åij ls Åij 725¼v½ 27.08.1998

izfr 10 fefy izfr 10 fefyesa 0.20 tksM+s esa 0.20 tksM+s

lkekU;r% mi;ksx esa yk;s tkus okys vkbZ oh f¶y;wM~l ds Mhihlhvks] 1995 ds iSjk 10 ¼c½ ds v/khu fu/kkZjfrvf/kdre [kqnjk ewY;

Page 264: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 245 -

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Mhihlhvks] 1995 ds iSjk 10 ¼c½ ds v/khu fu/kkZjfr vf/kdre [kqnjk ewY;¼mRikn ’kqYd* vkSj LFkkuh; djksa lfgr½

1. tkW;UVsl xksfy;ka 1x15 xksfy;ksa dk 84.84 951(v) 13.06.2007 eS- es;j gsYFkds;j izk- fy-izR;sd fQYe fyfir fVfd;k esa iRrk eS- es;j vkWjxsfuDl izk- fy-Xywdkslkekbu lYQsViksVkf’k;e ;w-,l-ih- 750 fexzk-]feFkk;y lYQksfuy feFksu¼,e,l,e½ 200 fexzk-]foVkfeu Mh 3 ¼LVsfcykbTM esa½ 200 vkbZ;weSxful lYQsV ;w-,l-ch- 9.3 fexzk-,sfyesUVy eSxful 3 fexzk- ds cjkcjlksfM;e cksjsV ch-ih- 4.4 fexzk-,sfyesUVy cksjksu 0.5 fexzk- ds cjkcjdksij lYQsV ;w-,l-ih- 2 fexzk-,sfyesUVy dksij 0.5 fexzk- ds cjkcj]ftad lYQsV eksuksgkbMªsV ;w-,l-ih- 8.24 fexzk-,sfyesUVy ftad 3 fexzk- ds cjkcj

2. uksjesDlhu xksfy;ka 10 dk iRrk 18.68 952(v) 13.06.2007 eS- fllVksfid yscksjsVªht+ fy-izR;sd fQYe fyfir fVfd;k esafdfyfMfu;e czksekbM ;w-,l-ih &2.5 fexzk-DyksjfM;ktsiksDlkbM vkbZih&5.0 fexzk-MkbZlkbDyksekbu ,plh,y vkbZih&10.0 fexzk-

3. jscysV&vkbZ-oh- bUtSaD’ku 20 fexzk- ¼ok;y$,Ei;wy½ 57.40 953(v) 13.06.2007 eS- yk;dk ysc fy-izR;sd ok;y esa eS-Y;wfiu fyfeVsMjscsizkt+ksy lksfM;e 20 fexzk-lksfM;e DyksjkbM bUtS-10 fefy ¼0.9% MCY;w@oh½ esabUtSa- ds fy, ikuh

4. jkslhflyhu 500 dSilwy 8 dk iRrk 66.77 954(v) 13.06.2007 eS- jsucsDlh ysc fyfeVsMizR;sd dSilwy esa,Eihlhfyu VªkbZgkbMªsV,Eihlhfyu&500 fexzk- ds cjkcj

5. fi;kst&th 2/15 10 dk iRrk 61.92 955(v) 13.06.2007 eS- ;w,loh fyfeVsMizR;sd fVfd;k esafi;ksfxfyVkt+ksu ,plh,yfi;ksfxfyVkt+ksu 15 fexzk- ds cjkcjfxfyesfijkbM 2 fexzk-

6. vylhfdV 6 dk fdV 43.34 956(v) 13.06.2007 eS- fxzlk ysc izk- fyeVsMizR;sd fVfd;k esa,eksDlhlhfyu VªkbZgkbMªsV vkbZih,eksDlhlhfyu&750 fexzk-xksfy;ksa ds cjkcjvksesizkt+ksy dSilwyvksesizkt+ksy 20 fexzk- ds cjkcjfVfuMkt+ksy vkbZ ih xksfy;kafVfuMkt+ksy vkbZih 500 fexzk- ds cjkcj

Page 265: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 246 -

7. vdZysj 250 fexzk- xksfy;ka 4 dk iRrk 99.84 957(v) 13.06.2007 eS- baM&LohQ~V fyfeVsMDysfjFkzksekbflu&250 fexzk- eS- uksokfVZl bafM;k fy-

8. Qsujxu flji 60 fefy 22.96 958(v) 13.06.2007 eS- fudksYl fijkeyizksesFkkft+u gkbMªksDyksjkbM vkbZih 5 fexzk- bafM;k fyfeVsM

9. jkslhflyhu 250 dSilwy 8 dk iRrk 36.23 1043(v) 27.06.2007 eS- jsucsDlh ysc fyfeVsMizR;sd dSilwy esa,Eihlhfyu VªkbZgkbMªsV,Eihlhfyu&250 fexzk- ds cjkcj

10. fjysUV 10 dk iRrk 35.78 1292(v) 30.07.2007 eS- MkW- jsM~Mh ysc fyfeVsMfLVªht+u ,plh,y chih&5 fexzk-vkSj ,EczksDlksy ,plh,yxksfy;ka chih&60 fexzk-

11. flykuse 500 fexzk- bUtsD’ku 1 ok;y iSd 1113.00 1293(v) 30.07.2007 eS- jsucsDlh ysc fyfeVsM,UgkbMªsl behisue 500 fexzk-ds cjckj behisue ih,p- bZ;wvkj-cQj 500 fexzk- ds #i esa tksM+s x,flyklVsfVu lksfM;e ck;dkcksZusV;w,lih ds cjkcj flyklVsfVu lksfM;e

12. dkosjVk 50 fexzk- xksfy;ka 4 dk iRrk 89.77 1294(v) 30.07.2007 eS- jsucsDlh ysc fyfeVsMflYMsusfQy 50 fexzk-ds cjkcj flYMsusfQy lkbVªsV

13. ,uokl 2.5 fexzk- xksfy;ka 15 dk iRrk 26.35 1295(v) 30.07.2007 eS- dsfMyk QkekZfL;wfVdYl fy-bekykfizy esfy,sV vkbZih 2.5 fexzk-

14. ,uokl 5 fexzk- xksfy;ka 15 dk iRrk 42.98 1296(v) 30.07.2007 eS- dsfMyk QkekZfL;wfVdYl fy-bekykfizy esfy,sV vkbZih 5 fexzk-

15. osysekbflu lLisUlu 30 fefy 30 fefy 25.46 1297(v) 30.07.2007 eS- osysl QkekZfL;wfVdYl fy-dksfyLVhu lYQsV ;w,lih eS- osysl ysc izk- fy-¼dksfyLVhu 12.5 fexzk- ds cjkcj½jax lulsV ihyk ,Qlh,Q

16. VsuksosV th,u Øhe 10 xzke dh V~;wc 20.98 1298(v) 30.07.2007 eS- XysDlks fLeFkdykbuizR;sd fVfd;k esa QkekZfL;wfVdYl fy-DykscsVklksy izksfi;ksusV chih 0.05% MCY;w@MCY;wfu;ksekbflu lYQsV vkbZih 0.5% MCY;w@MCY;wbehM;wfj;k ;w,lih,u,Q ¼izsljosfVo dsleku½ 0.3% ukWu&xzslh csl

17. ysljht+Wy 5 xzke 5 xzke x 1 53.66 1299(v) 30.07.2007 eS- luost bafM;k izk- fy-izR;sd ok;y esa eS- nhIrh ds;j gsYFk izk- fy-gkbMªksDlh izksfiy feFkk;y lsY;wyksl ;w,lih 2%lksfM;e DyksjkbM vkbZih 0.490%iksVkf’k;e DyksjkbM vkbZih 0.075%esxfufl;e DyksjkbM vkbZih 0.030%lksfM;e ,sflVsV vkbZih 0.390%lksfM;e lkbVªsV vkbZih 0.170%bUtSD’ku ds fy, ikuh &D;w-,l-

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 266: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 247 -

18. ih,uoh xksfy;ka 25 fexzk- 10 dk iRrk 19.97 1300(v) 30.07.2007 eS- ;’k QkekZ fy-esdfyft+u ,plh,y vkbZih 25fexzk-vkSj ik;fjMksDlhu ,plh,y 50 fexzk-

19. jsfeLVkj&, 10 dk iRrk 47.61 1301(v) 30.07.2007 eS- Y;wfiu ysc fy-izR;sd dSilwy esa eS- esizks QkekZfL;wfVdYl izk- fy-jsehfizy chih 2.5 fexzk-,fe;ksfMfiu&5.0 fexzk-ck;lk;ysV ,Dlhfi;sUV D;w-,l-

20. oksts+V 5 fexzk- 10 dk iRrk 44.73 1302(v) 30.07.2007 eS- XysDlks fLeFkdykbuizR;sd fVfd;k esa QkekZfL;wfVdYl fy-ysoksflVªht+u MkbZgkbMªksDyksjkbM&5 fexzk- eS- ;wlhch bafM;k izk- fy-

21. dsysfMªy yks’ku 100 fefy x 1 100 fefy 55.91 1584(v) 21.09.2007 eS- euh"k QkekZfL;wfVdYl izk- fy-dsykekbu vkbZih 8% w/v eS- Qkbt+j fyfeVsMMkbZQsfuMªkekbu gkbMªksDyksjkbM vkbZih 1%w/vdsEQj chih 0.1% w/vfo’ks"kdj fMusP;wjM fLizhV 2.37% v/v

22. csukfMªy dQ flji 100 fefy 100 fefy 38.61 1585(v) 21.09.2007 eS- euh"k QkekZfL;wfVdYl izk- fy-MkbZQsfuMªkekbu eS- Qkbt+j fyfeVsMgkbMªksDyksjkbM vkbZih 14.08 fexzk-,eksfu;e DyksjkbM vkbZih 0.138 xzk0lksfM;e lkbVªsV vkbZih 57.03 fexzk0esUFkksy vkbZih 1.14 fexzk0,sFksuksy ¼95 izfr’kr½ vkbZih 0.2625 fefy,sFksuksy lkexzh 5% v/v

23. oksoju ,E;wytWy 30 xzke dh 70.24 129(v) 23.01.2008 eS- dseosy izk- fy-fMDyksQsusd MkbZbFkk;ykekbu V~;wc eS- uksokfVZt bafM;k fy-chih 1.16% MCY;w@MCY;wfMDyksQsusd lksfM;ech ih 1% MCY;w@MCY;w tWy ds cjkcj

24. vksUMe bUtSD’ku 2 fefy dk 16.02 130(v) 23.01.2008 eS- dseosy izk- fy-vksUMsLVªksu gkbMªksDyksjkbM ok;y eS- uksokfVZt bafM;k fy-;w,lih vksUMsLVªksu 2 fexzk- ds cjkcj

Ø- Mkslst QkWeZ@dEiksft+’ku iSd vkdkj flfyax ewY; jkti=k jkti=k fofufeZfr& fofufeZfr dkla- dk uke ¼fcuk mRikn vkns’k vkns’k mRikndksa dk uke

’kqYd ds½ dh dk-vk- dh frfFk uke¼#i;s½ la[;k

Page 267: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 248 -

layXud-1

dk-vk- la[;k 1666¼v½ fnukad 03.10.2006 ds lanHkZ esa

¼d½ vU; lHkh bC;wizksQsu$ikjkflVkeksy fofufefrZ;ksa dh xksfy;ksa ds fy, ¼vU; ysfcy buxzsfM;UV lfgr vkSj jfgr½]ftudh dEiksft’ku@izcyRkk mDr lkj.kh ds LrEHk 3 esa ifjorZu gksrk gSa] rc mRiknd }kjk] mldh fofufefrZds fy, bl vkns’k ds LrEHk 2 ds fofufeZr ds fy, vf/kdre dhre ds fy, lkeUtL; fd;k tkrk gSA vf/kdre dher tks fd LrEHk la[;k 5 esa izdkf’kr gS] fuEu dkjd ¼ftuesa Lohdk;Z esi ’kkfey gS½ ds vk/kkj ijtksM+dj vkSj@;k ?kVkdj fudkys tk;sxsaA

izR;sd 10 xksfy;k¡@dSilwy iRrk@fCyLVj esa

(i) izR;sd 10 fexzk- ;k mlds [k.M ds fy;s bC;wizksQsu ds fy, 0.090 #- tksM+s ;k ?kVk;s tk ldsaxsA

(ii) izR;sd 10 fexzk- ;k mlds [k.M ds fy;s ikjkflVkeksy ds fy, 0.0328 #- tksM+s ;k ?kVk;s tk ldsaxsA

(iii) izR;sd 10 fexzk- ;k mlds [k.M ds fy;s dSfQu ¼,UgkbMªsl½ ds fy, 0.1052 #- tksM+s ;k ?kVk;s tk ldsaxsA

(iv) izR;sd 10 fexzk- ;k mlds [k.M ds fy;s eSxfu’k;e VªkbZflfydsV ds fy, 0.0089 #- tksM+s ;k ?kVk;s tk ldsaxsA

(v) izR;sd 5 fexzk- ;k mlds [k.M ds fy;s fl;wMks,sQsMjhu ,plh,y ds fy, 0.1949 #- tksM+s ;k ?kVk;s tk ldsaxsA

(vi) izR;sd 1 fexzk- ;k mlds [k.M ds fy;s DyksjksQSfujkekbu esfy,sV ds fy, 0.0161 #- tksM+s ;k ?kVk;s tk ldsaxsA

(vii) izR;sd 10 fexzk- ;k mlds [k.M ds fy;s DyksjktksDlkt+ksu ds fy, 0.0941 #- tksM+s ;k ?kVk;s tk ldsaxsA

(viii) izR;sd 10 fexzk- ;k mlds [k.M ds fy;s eSFkkdkckZeksy ds fy, 0.1882 #- tksM+s ;k ?kVk;s tk ldsaxsA

(ix) izR;sd 5 fexzk- ;k mlds [k.M ds fy;s MSDlVªksizksiksDlhQsu ,plh,y ds fy, 0.4258 #- tksM+s ;k ?kVk;s tkldsaxsA

(x) izR;sd 10 fexzk- ;k mlds [k.M ds fy;s fMDyksQsusd iksVkf’k;e@lksfM;e ds fy, 0.1007 #- tksM+s ;k ?kVk;stk ldsaxsA

(xi) izR;sd 1 fexzk- ;k mlds [k.M ds fy;s dksfMu QksLQsV ds fy, 0.7306 #- tksM+s ;k ?kVk;s tk ldsaxsA

(xii) izR;sd 5 fexzk- ;k mlds [k.M ds fy;s ckjkytsu fdVksu ds fy, 0.2721 #- tksM+s ;k ?kVk;s tk ldsaxsA

(xiii) izR;sd 5 fexzk- ;k mlds [k.M ds fy;s ckjkytsu ,sekbM ds fy, 0.0435 #- tksM+s ;k ?kVk;s tk ldsaxsA

(xiv) izR;sd 0.1 fexzk- ;k mlds [k.M ds fy;s lsjk,sfVvksisiVhMkst+ ds fy, 0.2989 #- tksM+s ;k ?kVk;s tk ldsaxsA

@uksV

¼d½ ;s dhersa fofufnZ"V iSd o leku izcyrk ds iSdksa ij mRikn ’kqYd vkSj LFkkuh; dj dks NksM+dj vf/kdredher ds #i esa fu;r dh tkrh gSa] vkSj dEiuh fdlh NwV dk nkok ugha dj ldrh] tc rd mls NwV ds fy;sljdkj@,u-ih-ih-,- ls vkns’k izkIr u gksaA

Page 268: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 249 -

¼[k½ leku la;kstu fofufeZfr ds lHkh iSdks ds fy,] tc ikjkflVkeksy ds la?kVu esa dksbZ cnyko gksrk gS rks mDrlkj.kh ds lHkh dkWye ¼5½ esa nh xbZ vf/klwfpr vf/kdre dher esa ikjkflVkeksy ds izR;sd 5 fexzk- ds fy,;k mlds Hkkx ds fy,] tSlk Hkh ekeyk gks] izfr 10- xksfy;ksa ds vuqlkj 0.017 #i;s tksM+s@?kVk, tk,axsA

¼x½ og iSd ftldh dEiksft’ku leku gS ysfdu vkdkj esa vUrj gS] og izks&jkVk izkbftax vkns’k dk- vk- 83¼v½fnukad 27.1.1998 ds rgr vk;sxhA

¼?k½ vxj dEiuh] fofHkUu izdkj dh iSfdax lkekxzh ;k mlesa fo’ks"k y{k.k dk nkok djrh gS rks mls jk"Vªh;vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ds ikl dher ds vuqeksnu@fu;r djkus ds fy;s vkuk gksxkA

Page 269: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 250 -

layXud-2

dk-vk- la[;k 1665¼v½ fnukad 27.09.2007 ds lanHkZ esa A

I. Mªx ,aM dksLesfVd ,DV dh vuqlwph V esa vkus okyh lHkh dEiksft’ku ds foVkfeu dh fofufeZfr esa] mRiknd }kjk],d mRikn ds fy, fuEu vkns’k esa LrEHk 2 dh fofufeZfr ds fy, vf/kdre dher ds fy, fuEu lkeUtL; fd;ktkrk gS tc izcyrk esa ifjorZu gksrk gS tks fuEu dkjd ¼ftuesa Lohdk;Z esi ’kkfey gS½ tksM+s ;k ?kVk;s tk ldsaxstks fd LrEHk la[;k 5 esa fn;s izdkf’kr vf/kdre dher ds vk/kkj ij fuEu rjhds ls gks ldrs gSa&

izR;sd 10 xksfy;k¡@dSilwy iRrk@fCyLVj esa

(i) izR;sd 500 ;wfuV ;k mlds [k.M ds fy;s foVkfeu , ¼,sflVsV MªkbZ ikmMj½ ds fy, 0.0344 #- tksM+s ;k ?kVk;stk ldsaxsA

(ii) izR;sd 100 ;wfuV ;k mlds [k.M ds fy;s foVkfeu Mh 3 ds fy, 0.0078 #- tksM+s ;k ?kVk;s tk ldsaxsA(iii) izR;sd 5 fexzk- ;k mlds [k.M ds fy;s fu;kflukekbM ds fy, 0.0408 #- tksM+s ;k ?kVk;s tk ldsaxsA(iv) izR;sd 5 fexzk- ;k mlds [k.M ds fy;s dSfY’k;e iSUVksfFkusV ds fy, 0.0556 #- tksM+s ;k ?kVk;s tk ldsaxsA(v) izR;sd 5 fexzk- ;k mlds [k.M ds fy;s Mh iSUFkksuksy ds fy, 0.1124 #- tksM+s ;k ?kVk;s tk ldsaxsA(vi) izR;sd 0.05 fexzk- ¼50 ,elhth½ ;k mlds [k.M ds fy;s Qksfyd ,sflM ds fy, 0.0011 #- tksM+s ;k ?kVk;s tk

ldsaxsA(vii) izR;sd 1 ,elhth ;k mlds [k.M ds fy;s foVkfeu ch12 ds fy, 0.00566 #- tksM+s ;k ?kVk;s tk ldsaxsA(viii) izR;sd 1 fexzk- ;k mlds [k.M ds fy;s foVkfeu ch1 ds fy, 0.0222 #- tksM+s ;k ?kVk;s tk ldsaxsA(ix) izR;sd 1 fexzk- ;k mlds [k.M ds fy;s foVkfeu ch2 ds fy, 0.0563 #- tksM+s ;k ?kVk;s tk ldsaxsA(x) izR;sd 0.5 fexzk- ;k mlds [k.M ds fy;s foVkfeu ch6 ds fy, 0.0267 #- tksM+s ;k ?kVk;s tk ldsaxsA(xi) izR;sd 10 fexzk- ;k mlds [k.M ds fy;s foVkfeu lh ds fy, 0.0858 #- tksM+s ;k ?kVk;s tk ldsaxsA(xii) izR;sd 5 fexzk- ;k mlds [k.M ds fy;s foVkfeu bZ ds fy, 0.1061 #- tksM+s ;k ?kVk;s tk ldsaxsA(xiii) izR;sd 10 fexzk- ;k mlds [k.M ds fy;s ftad feujy ,sfyesUV ds fy, 0.0422 #- tksM+s ;k ?kVk;s tk ldsaxsA(xiv) izR;sd 0.05 fexzk- ¼50 ,elhth½ ;k mlds [k.M ds fy;s foVkfeu ,p ¼Mh ck;ksfVu½ ds fy, 0.0268 #- tksM+s

;k ?kVk;s tk ldsaxsA(xv) izR;sd 50 ,elhth ;k mlds [k.M ds fy;s vk;ksfMu ds ,sfyesUV ds fy, 0.0027 #- tksM+s ;k ?kVk;s tk ldsaxsA(xvi) izR;sd 1 fexzk- ;k mlds [k.M ds fy;s vk;ju ds fy, 0.0049 #- tksM+s ;k ?kVk;s tk ldsaxsA(xvii) izR;sd 5 fexzk- ;k mlds [k.M ds fy;s eSxusf’k;e ds feujy ,sfyesUV ds fy, 0.0219 #- tksM+s ;k ?kVk;s tk

ldsaxsA(xviii) izR;sd 1 fexzk- ;k mlds [k.M ds fy;s eSxuht ds ,sfyesUV ds fy, 0.0052 #- tksM+s ;k ?kVk;s tk ldsaxsA(xix) izR;sd 1 fexzk- ;k mlds [k.M ds fy;s dkWij ds feujy ,sfyesUV ds fy, 0.0108 #- tksM+s ;k ?kVk;s tk ldsaxsA(xx) izR;sd 10 fexzk- ;k mlds [k.M ds fy;s dSfY’k;e ds feujy ,sfyesUV ds fy, 0.0228 #- tksM+s ;k ?kVk;s tk

ldsaxsA(xxi) izR;sd 10 fexzk- ;k mlds [k.M ds fy;s QkslQksjl ds feujy ,sfyesUV ds fy, 0.0152 #- tksM+s ;k ?kVk;s tk

ldsaxsA(xxii) izR;sd 10 fexzk- ;k mlds [k.M ds fy;s iksVkf’k;e ds feujy ,sfyesUV ds fy, 0.0128 #- tksM+s ;k ?kVk;s tk

ldsaxsA

Page 270: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 251 -

(xxiii) izR;sd 10 fexzk- ;k mlds [k.M ds fy;s DyksjkbM ds feujy ,sfyesUV ds fy, 0.0141 #- tksM+s ;k ?kVk;s tkldsaxsA

(xxiv) izR;sd 10 ,elhth ;k mlds [k.M ds fy;s Øksfe;e ds feujy ,sfyesUV ds fy, 0.0012 #- tksM+s ;k ?kVk;s tkldsaxsA

(xxv) izR;sd 10 ,elhth ;k mlds [k.M ds fy;s eksfycsuMe ds feujy ,sfyesUV ds fy, 0.0007 #- tksM+s ;k ?kVk;stk ldsaxsA

(xxvi) izR;sd 10 ,elhth ;k mlds [k.M ds fy;s lsysfu;e ds feujy ,sfyesUV ds fy, 0.0086 #- tksM+s ;k ?kVk;stk ldsaxsA

(xxvii) izR;sd 5 ,elhth ;k mlds [k.M ds fy;s fudy ds feujy ,sfyesUV ds fy, 0.0003 #- tksM+s ;k ?kVk;s tkldsaxsA

(xxviii) izR;sd 10 ,elhth ;k mlds [k.M ds fy;s fVu ds feujy ,sfyesUV ds fy, 0.0004 #- tksM+s ;k ?kVk;s tkldsaxsA

(xxix) izR;sd 1 fexzk- ;k mlds [k.M ds fy;s flfydkWu ds feujy ,sfyesUV ds fy, 0.0148 #- tksM+s ;k ?kVk;s tkldsaxsA

(xxx) izR;sd 10 ,elhth ;k mlds [k.M ds fy;s osusfM;e ds feujy ,sfyesUV ds fy, 0.0021 #- tksM+s ;k ?kVk;stk ldsaxsA

(xxxi) izR;sd 100 ,elhth ;k mlds [k.M ds fy;s cksjksu ds feujy ,sfyesUV ds fy, 0.0016 #- tksM+s ;k ?kVk;s tkldsaxsA

(xxxii) izR;sd 10 fefy;u LiksZl ;k mlds [k.M ds fy;s ysfDVd ,sflM csflyl ds fy, 0.017 #- tksM+s ;k ?kVk;s tkldsaxsA

II. mijksDr lHkh] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k }kjk tkjh 27.1.1998 ds dk- vk- 83¼v½ ds micU/k ds fo"k;gksaxsA

III ;s dhersa fofufnZ"V iSd o leku izcyrk ds iSdksa ij mRikn ’kqYd vkSj LFkkuh; dj dks lfEefyr dj LraHk¼6½ es vf/kdre [kqnjk dher ds #i esa fu;r dh tkrh gSa] vkSj dEiuh fdlh NwV dk nkok ugha dj ldrh]tc rd mls NwV ds fy;s ljdkj@jk-vkS-ew-fu-izk- ls vkns’k izkIr u gksaA

IV dEifu;k¡@fofuekZrk dsoy rHkh dj tksM+ ldrs gSa ;fn mUgksaus LraHk (5) esa mfYyf[kr ewY; ij ljdkj dks okLroesa Hkqxrku fd;k gSA ;fn vf/kdre [kqnjk ewY; ¼lHkh djksa lfgr½ esa dksbZ fofHkUurk gks rks og ,uihih, dksMhihlhvks] 1995 ds QkWeZ&V esa lwfpr fd;k tkuk pkfg,A

V og iSd ftldh dEiksft’ku leku gS ysfdu vkdkj esa vUrj gS] og izks&jkVk izkbftax vkns’k dk- vk- 83¼v½fnukad 27.1.1998 ds rgr xksfy;ka vkSj dSilwy ds iRrk@fCyLVj ds fy, vk;sxhA

IV vxj dEiuh] fofHkUu izdkj dh iSfdax lkekxzh ;k mlesa fo’ks"k y{k.k dk nkok djrh gS rks mls jk"Vªh; vkS"k/kewY; fu/kkZj.k izkf/kdj.k ds ikl dher ds vuqeksnu@fu;r djkus ds fy;s vkuk gksxkA

VII mDr dfFkr fofufeZfr dh [email protected] dEiuh ds fy, vfuok;Z gS fd og mDr dfFkr fofufeZfr ds la?kVuesa fdlh Hkh cnyko ds fy, ,uihih, dks fyf[kr iwoZ lwpuk ds lkFk l{ke izkf/kdkjh ls vko’;d iwoZ vuqeksnuizkIr djsaA

VIII bl vkns’k esa fofufeZr iSdksa dh vf/kdre dher fu;r gksus ds ifj.kke Lo#i] fuEufyf[kr vkns’k tks fd blvkns’k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsaA

Page 271: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 252 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ dk-vk-@frFkh

1. ,cksV ysc bafM;k fyfeVsM vkfjusd ,,p xksfy;ka 6 dk iRrk@fCyLVj 4.81 29.03.2006

,jFkksflu Mªksi 10 fefy dh cksry 12.17 07.02.2006

Mªksij lfgr

ljcsDl&Vh xksfy;ka 30 dh cksry 20.05 24.12.2002

ljcsDl&Vh xksfy;ka 110 dh cksry 62.52 24.12.2002

tsucsDl&Vh xksfy;ka 30 dh cksry 20.00 24.12.2002

,aVh&vksDlhMsaV dSilwy 10 dk ,,y_iRrk 14.85 08.03.2001

,aVh&vksDlhMsaV dSilwy 10 dk ,,y_ihohMhlh fCyLVj 14.66 08.03.2001

,aVh&vksDlhMsaV dSilwy 10 dk ,,y_ihohlh fCyLVj 14.26 08.03.2001

,aVh&vksDlhMsaV dSilwy 30 dh cksry 45.35 08.03.2001

ljcsDl&Vh dSilwy 30 dh cksry 25.35 16.08.2001

ljcsDl&Vh dSilwy 30 dh cksry 75.69 16.08.2001

2. ,dksLV jsesfMt+ izkbosV fyfeVsM ,dkstsfld dSilwy 10 dk iRrk@fCyLVj 8.40 29.03.2006

3. ,Øku QkekZ dksQfMªu VscysV 10 dk iRrk@fCyLVj 1.76 05.10.2006

VW;MSDl&lh,l 100 fefy dh cksry 16.06 05.10.2006

4. ,xyksesM fyfeVsM bUlVkfjy flji 100 fefy dh cksry 14.08 29.03.2006

bUlVkfjy&ih flji 100 fefy dh cksry 15.10 29.03.2006

5. vxzke jsesfMt+ ,xzksQkbfyu xksfy;ka 10 dk iRrk@fCyLVj 2.35 29.03.2006

6. ,xzksu jsesfMt+ dksQjku&chvkj VscysV 20 dk iRrk@fCyLVj 6.48 05.10.2006

100 fefy dh cksry 13.74 05.10.2006

7. vxzoky QkekZfl;wfVdy czkseksgsDlh;y flji 1000 fefy dh cksry 89.17 29.03.2006

8. vtUrk QkekZ ,uksDl&fdV 4 dk fdV 10.07 15.06.2005

9. ,ycVZ MsfoM fyfeVsM lk;ksØkse xksfy;ka 10 dk iRrk 4.38 24.12.2002

lk;ksØkse xksfy;ka 500 dh cksry 197.56 24.12.2002

lk;ksfu;ksjksu QksVZ bUtSaD’ku 2 fefy ,Ei;wy 197.56 24.12.2002

fCyLVj iSd lfgr

10. ,yD;wj QkekZfl;wfVdy yscksjsfVªt+ ¼bafM;k½ dsfMdkWQ&,,Dl flji 100 fefy dh cksry 14.57 29.03.2006

11. ,YMs esfM bEiSDl fyfeVsM fMdksEc lLisUlu 60 fefy dh cksry 12.59 29.03.2006

rqLi xksfy;ka 10 dk iRrk@fCyLVj 3.88 05.10.2006

MsQsu xksfy;ka 10 dk iRrk@fCyLVj 1.28 05.10.2006

MsQsu 100 fefy dh cksry 11.82 05.10.2006

MsQsu 50 fefy dh cksry 7.86 05.10.2006

12. ,yfEcd dsfedyl odZl fyfeVsM ftulksek dSilwy 10 dk iRrk@fCyLVj 12.99 29.03.2006

,YFkzksflu 100fexzk- pckus okyh xksfy;ka 10 dk iRrk@fCyLVj 16.28 30.03.2005

Page 272: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 253 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ dk-vk-@frFkh

,YFkzksflu 250 fexzk- xksfy;ka 10 dk iRrk@fCyLVj 36.66 30.03.2005

,YFkzksflu 500 fexzk- xksfy;ka 10 dk iRrk@fCyLVj 72.50 30.03.2005

,YFkzksflu fdM xksfy;ka 10 dk iRrk@fCyLVj 18.76 30.03.2005

,YFkzksflu Mªksi 10 fefy dk ok;y 19.90 30.03.2005

,YFkzksflu fyfDoM 60 fefy dh cksry 28.94 30.03.2005

fMesV dEikmaM xksfy;ka 10 dk iRrk 7.87 09.03.1998

,YFkzksflu QksVZ fyfDoM & ,LVksysV 60 fefy dh cksry 53.43 11.03.1998

,e- di lfgrfoØksy xksfy;ka 10 dk iRrk@fCyLVj 3.26 05.10.2006

13. ,ydse ysc- fyfeVsM , Vw tsM xksfy;ka 15 dk iRrk 10.52 19.05.2006

fyokst+ xksfy;ka 15 dk iRrk 19.66 19.05.2006

,fjFkzksdse xksfy;ka 10 dk iRrk@fCyLVj 22.46 07.02.2006

,fjFkzksdse lLisUlu 60 fefy dh cksry@,e-di 21.55 07.02.2006

14. ,fYid jsesfMt+ dksDlD;wj&3 xksfy;ka 10 dk iRrk@fCyLVj 61.72 15.06.2005

dksDlD;wj&4 xksfy;ka 10 dk iRrk@fCyLVj 30.00 15.06.2005

15. ,yikbu csVuksflu ,uth Øhe 15 xzke dh V~;wc 14.84 11.03.1998

MekZlksu ,u Øhe 15 xzke dh V~;wc 10.44 11.03.1998

fjQkfeM xksfy;ka 10 dk iRrk@fCyLVj 20.53 15.06.2005

16. ,Yil QkekZfl;wfVdy izkbosV fyfeVsM ikjfty&,QMh xksfy;k 10 dk iRrk@fCyLVj 4.57 29.03.2006

17. vyfV;l ¼;wfuekdZ QkekZ½ osUVhjsDl&chvkj flji 100 fefy dh cksry 14.03 29.03.2006

18. vejhdu jsesfMt+ bZ&dsjksfVu uje dSilwy 10 dk iRrk 14.14 24.12.2002

lsy fe;wdksfyV fyfDoM 50 fefy dh cksry 9.98 30.03.2005

lsy fe;wdksfyV fyfDoM 60 fefy dh cksry 11.59 30.03.2005

,fjiflu dSilwy 10 dk iRrk@fCyLVj 23.01 07.02.2006

,UVksDlhM dSilwy 30 dk iRrk 38.21 28.09.1998

,UVksDlhM dSilwy 150 dk iRrk 184.41 28.09.1998

19. ,aXyks zQsap Mªx ,aM baMLVªht fyfeVsM dksfMysDl , xksfy;ka 10 dk iRrk@fCyLVj 8.54 29.03.2001

dksfMysDl Mh,l xksfy;ka 10 dk iRrk@fCyLVj 8.36 29.03.2001

dksfMysDl xksfy;ka 10 dk iRrk@fCyLVj 4.65 29.03.2001

csiysDl bUtSaD’ku 2 fefy ,Ecj ,ei;wy 3.15 09.07.2003

fCyLVj lfgrcsiysDl bUtSaD’ku 2 fefy ,Ecj ,ei;wy 2.90 09.07.2003

csiysDl bUtSaD’ku 10 fefy ok;y 8.56 09.07.2003

csiysDl bUtSaD’ku 10 fefy ok;y fCyLVj 8.81 09.07.2003

csiysDl QksVZ ,fyDlj 200 fefy dh cksry 50.18 24.12.2002

csiysDl ,fyDlj 120 fefy dh ,Ecj dyj 19.66 1669(E)

isV cksry ,e-di vkSj dkVZu lfgr 27.09.2007

Page 273: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 254 -

csiysDl ,fyDlj 400 fefy dh cksry 33.94 05.10.2006

eSDlkfeu QksVZ VscysV 10 dk ,,y_fCyLVj 9.42 24.12.2002

eSDlkfeu QksVZ VscysV 10 dk ,,y_fCyLVj 8.47 24.12.2002

eYVhfoVkfeu bUtSD’ku 11 fefy dk ,Ecj ok;y 12.94 1349(E)01.08.2007

eYVhfoVkfeu ,fyDlj 120 fefy dkap dh cksry 26.10 1349(E)01.08.2007

eYVhfoVkfeu bUtSD’ku dksEch iSd 26.10 1349(E)

(11 fefy ok;y$ 01.08.2007

1 fefy ,Ei;wy)

csiysDl xksfy;ka 100 dh cksry@tkj 100.80 1669(E)

27.09.2007

csiysDl QksVZ ,fyDlj 200 fefy dkap dh 37.76 1669(E)

cksry ,e-di vkSj dkVZu lfgr 27.09.2007

csiysDl QksVZ ,Ei;wy 2 fefy ,Ecj ,Ei;wy 3.72 1669(E)

fCyLVj iSfdax esa 27.09.2007

20. ,aVht+u ,p- ds;j ,uksDl dSilwy 10 dk ,,y_fCyLVj 19.64 29.03.2006

21. ,idks QkekZ ,Yij flji 30 fefy dh cksry 6.86 05.10.2006

fVªDlh flji 100 fefy dh cksry 12.16 05.10.2006

22. visDl jsesfMt+ ,fjflu xksfy;ka 10 dk iRrk@fCyLVj 27.60 19.05.2006

23. vkjczks QkekZfl;wfVdy fyfeVsM LiksjhfoV dSilwy 10 dk iRrk@fCyLVj 10.20 10.08.1999

24. vkjs&,Dl yscksjsfVªt izkbosV fyfeVsM cQjhu Iyl xksfy;ka 10 dk iRrk@fCyLVj 6.11 29.03.2001

25. vkjxksu jesfMt+ ,djhM xksfy;ka 20x10 dk iRrk@fCyLVj 130.67 29.03.2006

26. ,fjLVks QkekZ izkbosV fyfeVsM fjovi dSilwy 10 dk iRrk 13.75 24.12.2002

,EczksfMy Iyl 50 fefy dh cksry 11.82 03.09.2003

,EczksfMy Iyl 100 fefy dh cksry 20.79 03.09.2003

,fjLVksfty ,Q xksfy;ka 10 dk iRrk 7.60 09.03.1998

,EczksfMy&,l flji 100 fefy dh cksry 13.81 30.03.2005

27. vjlk QkekZfl;wfVdy izk- fy- Mh,eih&3 flji 60 fefy dh cksry 9.70 05.10.2006

28. v’kksd QkekZfl;wfVdy ysDVks dSilwy 10 dk iRrk@fCyLVj 5.60 10.08.1999

29. ,LVªk&vkbZMh,y fyfeVsM isuXyksc xksfy;ka&400 fexzk- 6 dk ,,y_iRrk 49.62 17.01.2001

isuXyksc xksfy;ka&400 fexzk- 6 dk ,,y_fCyLVj 49.35 17.01.2001

isuXyksc xksfy;ka&200 fexzk- 6 dk ,,y_iRrk 25.26 17.01.2001

isuXyksc xksfy;ka&200 fexzk- 6 dk ,,y_fCyLVj 24.99 17.01.2001

30. ,ofUVl QkekZ fyfeVsM bUlweu fyfDoM 25/75 bUtSDVscy 10 fefy dk ok;y 217.68 17.02.2003

bUlweu fyfDoM 50/50 bUtSDVscy 10 fefy dk ok;y 217.68 17.02.2003

bUlweu jsfiM fyfDoM bUtSDVscy 10 fefy dk ok;y 217.68 17.02.2003

bUlweu cly fyfDoM bUtSDVscy 10 fefy dk ok;y 217.68 17.02.2003

bUlweu 25/75 vkWfIVlsV fyfDoM 5x3 fefy dk 1206.64 17.02.2003

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ dk-vk-@frFkh

Page 274: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 255 -

bUtSDVscy dkfVZt+ isu lfgrbUlweu 50/50 vkWfIVlsV fyfDoM 5x3 fefy dk 1206.64 17.02.2003

bUtSDVscy dkfVZt+ isu lfgrbUlweu jsfiM vkWfIVlsV fyfDoM 5x3 fefy dk 1206.64 17.02.2003

bUtSDVscy dkfVZt+ isu lfgrbUlweu 25/25 10 fefy dk ok;y 238.03 01.05.2006

bUlweu jsfiM 10 fefy dk ok;y 238.03 01.05.2006

bUlweu cly 10 fefy dk ok;y 238.03 01.05.2006

ysUV~l 100vkbZ;w@fefy vkWfIVlsV 3 fefy dk ok;y 821.39 1347(E)

flfjat vkSj 01.08.2007

fuMy lfgrysUV~l 100vkbZ;w@fefy vkWfIVlsV 10 fefy dk ok;y 2439.27 1347(E)

flfjat vkSj 01.08.2007

fuMy lfgrysUV~l 100vkbZ;w@fefy vkWfIVlsV 3 fefy dk ok;y 903.09 11.08.2006

¼vkWfIVlsV ok;y o fuMy½bUlweu 25/75 vkWfIVlsV 5x3 fefy 5x3 fefy dkfVZt 1133.87 11.08.2006

isu lfgr3 fefy dkfVZt 208.94 11.08.2006

eksuksdEiksusaV balqfyu 3 fefy dk dkfVZt 481.35 1667(E)

Xysjftu ysUV~l 100vkbZ;w@fefy 27.09.2007

eksuksdEiksusaV balqfyu 3 fefy dk dkfVZt 2797.56 14.02.2007

Xysjftu ysUV~l 100vkbZ;w@fefy vkWVks ius o fuMy lfgrbUlweu 25/75 40vkbZ;w@fefy 10 fefy dk ok;y 191.89 1667(E)

17.02.2003

bUlweu cly 40 vkbZ;w@fefy 10 fefy dk ok;y 191.89 1667(E)

27.09.2007

bUlweu cly 40 vkbZ;w@fefy 10 fefy dk ok;y 191.89 1667(E)

27.09.2007

uksoyftu bUtSD’ku 30 fefy dk ok;y 25.26 1673(E)

f¶yi@fV;j vkWQ&lhy 27.09.2007

uksoyftu xksfy;ka 10 dk iRrk@fCyLVj 6.26 2066(E)

f¶yi@fV;j vkWQ&lhy 30.11.2007

uksoyftu bUtSD’ku 2 fefy dk ,Ei;wy 4.03 2066(E)

30.11.2007

31. csuj QkekZdSi ¼bafM;k½ izkbosV fyfeVsM ,fDVfMu xksfy;ka 10 dk ,,y_ihohMhlh fCyLVj 17.91 11.07.2006

csaVhfMu lks¶VysV 10 dk fCyLVj 9.84 05.10.2006

ihohMhlh_ihohlhcsaVksfVªe lks¶VysV 10 dk fCyLVj 10.70 05.10.2006

ihohMhlh_ihohlh¶ySfou 20 lks¶VysV 14 dk fCyLVj 9.82 05.10.2006

ihohMhlh_ihohlh

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ dk-vk-@frFkh

Page 275: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 256 -

¶ySfou 40 lks¶VysV 14 dk fCyLVj 11.46 05.10.2006

ihohMhlh_ihohlhcqzlks¶V&400 fyfDodSIl 10 dk fCyLVj 15.08 07.02.2006

ihohMhlh_ihohlh

32. cSDlVj ¼bafM;k½ ih- fyfeVsM ¼chvkbZih,y½ vksUdksfMu xksfy;ka 10 dk iRrk@fCyLVj 10.50 29.03.2006

33. cSUxy bE;wfufV fyfeVsM ch-vkbZ-ch dkWEiysDl xksfy;ka 1000 dh cksry 108.68 11.03.1998

¼Fksfj;wisfVd½fM;k& dkWEiysDl ¼Vh,p½ fyfDoM 200 fefy dh cksry 26.92 26.05.1998

ch-vkbZ-ch dWQ flji 60 fefy dh cksry 10.73 09.03.1998

fjQSfEiflu 450 fexzk- dSilwy 100 dh cksry 395.14 15.06.2005

34. csuSV QkekZL;wfVdYl VksDl VscysV 15 dk iRrk@fCyLVj 4.26 05.10.2006

35. csLVksdse lsVkfMªu xksfy;ka 10 dk iRrk@fCyLVj 3.53 29.03.2006

36. Hkfo";k QkekZ izk- fy- ,sMªkbZu Iyl 10 dk iRrk@fCyLVj 5.54 05.10.2006

37. ck;ksdse QkekZ baMLVhªt ,EihyksDl xksfy;ka 4 dk ,,y_iRrk 2.59 29.03.2006

,EihyksDl fu;ksusV bUtSaD’ku 1 ok;y 5.37 29.03.2006

38. ck;ksflu tsusfVd ,aM QkekZ ,DVw;sV&3 xksfy;ka 10x10 dk iRrk@fCyLVj 61.72 15.06.2005

39. ck;ksdksu fyfeVsM bUlwt+u&vkj ¼jsX;wyj½ bUlwfyu 10 fefy dk ok;y 117.60 29.03.2006

bUlwt+u&,u¼,uih,p½ vkblksQsu bUlwfyu 10 fefy dk ok;y 120.70 29.03.2006

bUlwt+u 30/70 bUlwfyu bUtSaD’ku 10 fefy dk ok;y 122.20 29.03.2006

bUlwt+u 50:50 10 fefy dk ok;y 121.24 11.07.2006

40. ck;ksxkMZ vkSjxSfud lqMkjsLV Iyl 10 dk iRrk@fCyLVj 5.68 05.10.2006

lqMkjsLV Mh,e 100 fefy dh cksry 19.02 05.02.2006

41. ck;ksyksft+dy&bZ fyfeVsM cSFkkMksDlhu&ih 200 fefy dh cksry 33.88 29.03.2006

dksLdksfjy xksfy;ka 10 dk iRrk@fCyLVj 3.86 29.03.2006

xslikt&Mh,l xksfy;ka 10 dk ,,y_iRrk 0.04 ,e-,e 14.07 20.10.2004

cSFk&12 bUtSaD’ku 2 fefy dk ,Ecj@,Ei;wy 4.77 05.02.1999

cSFkkMksDlhu&12 flji 220 fefy dh cksry 41.30 05.02.1999

ckbusDl tsM MhVh xksfy;k 10 dk ,,y_iRrk 31.74 24.05.1999

ckbusDl fdM xksfy;k 10 dk iRrk@fCyLVj 16.10 15.06.2005

ckbusDl fdM xksfy;k 10 dk iRrk@fCyLVj 16.27 15.06.2005

ckbusDl tsM fdM xksfy;k 10 dk iRrk@fCyLVj 24.76 15.06.2005

ckbusDl tsM xksfy;k 2 dk iRrk@fCyLVj 7.96 15.06.2005

ckbusDl tsMbZ xksfy;k 3 dk dksEch iSd 8.96 15.06.2005

xSLVªksfty Iyl xksfy;k 10 dj iÙrk@ 19.14 23.03.2007

ihohlh@ihohMhlh@ fCyLVj

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

Page 276: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 257 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

42. ck;ks&LVkj QkekZ vkfjusd xksfy;ka 10 dk iRrk@fCyLVj 4.36 13.06.2000

vkfjusd QksVZ xksfy;ka 6 dk iRrk@fCyLVj 4.61 13.06.2000

vkfjusd flji 60 fefy dh cksry 10.32 13.06.2000

43. ck;ks&Lohl QkekZ fLodksQ 50 fefy dhs cksry 7.80 05.10.2006

fLodksQ 100 fefy dhs cksry 11.72 05.10.2006

,fjlhu flji@lLisUlu 60 fefy dhs cksry 19.56 1671(E)27.09.2007

44. ck;ksVsd esfMdy izkbosV fyfeVsM csDlksIysDl dSilwy 10 dk iRrk@fCyLVj 10.38 09.08.1999

45. chvkbZih,y ¼jsfMdks jsesfMt½ isMhdwy@ihMh&5 60 fefy dhs cksry 10.22 05.10.2006

46. CY;w ØkWl ,fjcsLV fdM xksfy;ka 10 dk iRrk@fCyLVj 12.30 07.02.2006

,fjcsLV xksfy;ka 10 dk iRrk@fCyLVj 21.69 07.02.2006

47. cksgfjatj bUxsyfge bafM;k izk- fyfeVsM ,XxzhuksDl dSilwy 60 dh cksry 2737.80 184(E)29.01.2008

48. cwVl QkekZfl;wfVDyl fyfeVsM ,dusekbflu Iyl lksY;w’ku 25fefy 25 fefy dhs cksry 26.92 08.03.2001

Msc ,IyhdsVj lfgr

49. czkWu yscksjsVhªt fyfeVsM lsyC;wVksy 100 fefy dhs cksry 14.09 29.03.2006

50. czksfl;k QkekZ ¼vkbZ½ izkbosV fyfeVsM czwQsu 400 fexzk- xksfy;ka 10 dk ,,y@ihohlh 5.50 07.02.2006

fCyLVj gksyksxzke lfgrczwQsu 600 fexzk- xksfy;ka 10 dk ,,y@ihohlh 7.87 07.02.2006

fCyLVj gksyksxzke lfgr

51. czkWu ,aM cdZ izkbosV fyfeVsM fyUdk flji 60 fefy dhs cksry 10.34 17.01.2001

fyUdk flji 100 fefy dhs cksry 13.93 17.01.2001

,ysjsDV&Mhlh 10 dk iRrk@fCyLVj 4.74 17.01.2001

MfeZuksy Øhe 15 xzke dh V~;wc 9.31 15.06.2005

flfVªesu Iyl 10 dk iRrk 3.28 03.09.2003

52. ch,l, QkekZ chdksQ&,,Dl flji 100 fefy dhs cksry 16.84 05.10.2006

53. dspsV ,ubZ&200 Iyl dSilwy 10 dk iRrk@fCyLVj 10.97 20.09.2005

vks&,ubZ dSilwy 10 dk iRrk@fCyLVj 29.88 20.09.2005

,ubZ&400 Iyl dSilwy 10 dk iRrk@fCyLVj 17.25 20.09.2005

,ubZ&200 Iyl dSilwy 10 dk iRrk@fCyLVj 9.44 08.11.2005

vks&,ubZ dSilwy 10 dk iRrk@fCyLVj 26.70 08.11.2005

,ubZ&400 Iyl dSilwy 10 dk iRrk@fCyLVj 14.80 08.11.2005

54. dsfMyk gsYFk ds;j ih- fyfeVsM áwekusDlV ,u 10 fefy dk ok;y 117.28 20.09.2005

áwekLVkMZ 30/70 10 fefy dk ok;y 121.80 20.09.2005

áwekjsi 10 fefy dk ok;y 117.20 20.09.2005

MsDlksuk isfM;fVªd vksjy Mªksi 10 fefy dh cksry 6.92 28.09.1999

Mªksij lfgr

Page 277: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 258 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

dsfMQkbysV ,fyDlj 100 fefy cksry@,e-di 15.86 28.12.1999

dsfMQkbysV ,fyDlj 450 fefy cksry@,e-di 53.40 28.12.1999

yksfjfMu&Mh bZvkj@ck;ys;jM xksfy;ka 10 dk ,,y&ihohMhlh 15.47 11.07.2006

fCyLVjlh,Dl&5fdV dksEch iSd 1 fdV@dksEch iSd 10.46 15.06.2005

55. dsfMyk QkekZ ¼izkbosV½ fyfeVsM bZlh 350 xksfy;ka 10 dk iRrk@fCyLVj 25.87 20.09.2005

bZlh 350 dSilwy 10 dk iRrk@fCyLVj 28.26 20.09.2005

ysfUVl;wfyu ,pihvkbZ bUtSaD’ku 10 fefy dk ok;y 134.68 03.09.2003

feDl;wfyu 30/70 ,pihvkbZ 10 fefy dk ok;y 343.86 03.09.2003

jsfil;wfyu ,pihvkbZ 10 fefy dk ok;y 134.68 03.09.2003

feDl;wfyu 30/70 ,pihvkbZ 10 fefy dk ok;y 345.43 27.05.2003

100 vkbZ;w@fefylsyQk;ysV xksfy;ka 10 dk iRrk@fCyLVj 3.88 30.03.2005

yksjkQkLV&Mh xksfy;ka 10 dk ,,y_iRrk 11.93 11.07.2006

yksjkQkLV&Mh xksfy;ka 10 dk ,,y_fCyLVj 11.57 11.07.2006

ekbdksMkWV fdV 10 xksfy;ksa dk fdV 20.11 13.04.1999

,,y@ihohMhlh fCyLVjekbdksMkWV 4 fdV 16 xksfy;ksa dk fdV 58.48 13.04.1999

,,y@ihohMhlh fCyLVjekbdksMkWV bZ fdV 13 xksfy;ksa dk fdV 32.03 13.04.1999

,,y@ihohMhlh fCyLVjekbdksMkWV tsM fdV 13 xksfy;ksa dk fdV 45.69 13.04.1999

,,y@ihohMhlh fCyLVjvkbfilh xksfy;ka 6 dk ,,y_iRrk 5.61 29.03.2001

vkbfilh xksfy;ka 6 dk ,,y_fCyLVj 5.27 29.03.2001

jsfil;wfyu lhihvkbZ 100vkbZ;w@10 fefy 10 fefy dk ok;y 87.49 19.12.2001

jsfil;wfyu ,pihvkbZ 100vkbZ;w@10 fefy 10 fefy dk ok;y 122.59 19.12.2001

ysfUVl;wfyu ,pihvkbZ 100vkbZ;w@10 fefy10 fefy dk ok;y 122.59 19.12.2001

feDl;wfyu ,pihvkbZ 30/70- 10 fefy dk ok;y 132.86 04.03.2004

40vkbZ;w@10 fefy ¼13 ,e-,e- ok;y½MfeZVksi Øhe 5 xzke dh V~;wc 5.59 29.03.2006

ysDVksdkse QksVZ dSilwy 10 dk ,,y_iRrk 11.19 10.08.1999

ysDVksdkse QksVZ dSilwy 10 dk ,,y_ihohMhlh fCyLVj 10.05 10.08.1999

bZlh 350 xksfy;ka 10 dk iRrk@fCyLVj 26.61 04.01.2005

bZlh 350 xksfy;ka 10 dk iRrk@fCyLVj 22.96 08.11.2006

bZlh 350 dSIlwyl 10 dk iRrk@fCyLVj 25.14 08.11.2006

56. dsiysV bafM;k izkbosV fyfeVsM osuVsDl xksfy;ka 10 dk iRrk@fCyLVj 2.84 29.03.2006

osuVsDl flji 100 fefy dh cksry 15.50 29.03.2006

57. lsUV;wj yscksjsVªht izkbosV fyfeVsM fyoksfly ch QksVZ 10 dk dSilwy 17.56 29.03.2006

QkWe tWy 10 xzke dh V~;wc 6.38 29.03.2006

dksQkjsLV fyfDoM 100 fefy dh cksry 15.05 29.03.2006

dksQkjsLV ihMh fyfDoM 60 fefy dh cksry 11.17 29.03.2006

Page 278: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 259 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

VªkUl fyiks&chth vkW;uVesaV 5 xzke vuysdMZ V~;wc 5.78 27.05.2003

VªkUl fyiks&chth vkW;uVesaV 10 xzke vuysdMZ V~;wc 7.93 27.05.2003

csLVksfid vkW;uVesaV 5 xzke vuysdMZ V~;wc 6.20 27.05.2003

csLVksfid vkW;uVesaV 10 xzke vuysdMZ V~;wc 8.81 27.05.2003

flukjsLV&,,Q xksfy;ka 10 dk iRrk@fCyLVj 3.68 05.10.2006

flukjsLV Mªki 15 fefy dh cksry 7.28 05.10.2006

58. lsVkMsy lsVkekbflu fdM xksfy;ka 10 dk iRrk@fCyLVj 12.30 07.02.2006

lsVkekbflu xksfy;ka 10 dk iRrk@fCyLVj 21.69 07.02.2006

59. lh,Q,y QkekZ ¼ih½ fyfeVsM dksfli flji 60 fefy dh cksry 13.51 09.03.1998

dksfli flji 60 fefy dh cksry@,e-di 12.11 08.12.2000

dksfli flji 100 fefy dh cksry@,e-di 16.87 08.12.2000

dkslks dksYM flji 60 fefy dh cksry@,e-di 9.87 08.12.2000

60. pSMjQ ls¶VhjksM Øhe 15 xzke dh V~;wc 8.10 11.03.1998

61. psfeMk ysc jsLihVl&, flji 100 fefy dh cksry 15.32 29.03.2006

62. psfeuksok jsesfMt+ izkbosV fyfeVsM lWy E;wdkykbV fyfDoM 50 fefy dh cksry 9.98 30.03.2005

lWy E;wdkykbV fyfDoM 60 fefy dh cksry 11.59 30.03.2005

63. fliyk fyfeVsM lkW¶VMeZ Øhe 25 xzke dh V~;wc 9.84 04.01.2005

lkW¶VMeZ Øhe 50 xzke dh V~;wc 15.35 04.01.2005

cqMsly 2.5 fefy 4.30 29.03.2006

csVkQkWe Øhe 50 xzke dh V~;wc 14.79 29.03.2006

,ysfjM dksYM xksfy;ka 10 dk iRrk@fCyLVj 4.74 29.03.2006

xkjfM;u dSilwy 10 dk iRrk@fCyLVj 21.42 29.03.2006

vkslhxkMZ lh xksfy;ka 10 dk iRrk@fCyLVj 11.36 05.10.2006

64. dkWecsV MªXl fyfeVsM ekbdksEcsdV QksVZ xksfy;ka 10 dk iRrk@fCyLVj 57.60 20.11.2001

65. dksesM dsfedyl izkbosV fyfeVsM MksyksesM xksfy;ka 10 dk iRrk@fCyLVj 8.71 29.03.2006

,jksesM xksfy;ka 10 dk iRrk@fCyLVj 27.60 19.05.2006

66. dUlsIV QkekZfl;wfVDy fyfeVsM fjQk 16 fdM QksVZ xksfy;ka 10 dk iRrk@fCyLVj 19.97 15.06.2005

fjQk 16 QksVZ xksfy;ka 10 dk iRrk@fCyLVj 54.21 15.06.2005

fjQklsIV fdM 3 xksfy;ka 10x10 dk iRrk@fCyLVj 146.17 15.06.2005

fjQklsIV 3 xksfy;ka 10x10 dk iRrk@fCyLVj 214.25 15.06.2005

lk;ukczksu ,DlisDVksjsUV 100 fefy dh cksry 14.23 29.03.2006

67. dksleksl dkslfjy&,ych flji 50 fefy dh cksry 12.79 29.03.2006

,Dl&Vl 20 dk iRrk@fCyLVj 5.90 05.10.2006

,Dl&Vl 60 fefy dh cksry 9.24 05.10.2006

,Dl&Vl 100 fefy dh cksry 12.16 05.10.2006

dQ&vkÅV 10 dk iRrk@fCyLVj 2.64 05.10.2006

Page 279: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 260 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

68. ØkWl ysUMl fMizksosV&vkjMh Øhe 15 xzke dh V~;wc 10.87 11.03.1998

,DlVªktslsd ,,Q lLisUlu 50 fefy dh cksry 10.07 29.03.2000

,DlVªktsylsd ,,Q lLisUlu 60 fefy dh cksry@,e-di 10.02 29.03.2001

QwflfcV Øhe 10 xzke dh V~;wc 28.95 29.03.2006

69. lk;ukfeM bafM;k fyfeVsM ysMjekbflu 150 fexzk- dSilwy 10 dk ,,y_iRrk 21.00 18.12.1997

ysMjekbflu 150 fexzk- dSilwy 10 dk ,,y_fCyLVj 20.49 18.12.1997

ysMjekbflu 150 fexzk- ,Qlh dSilwy 10 dk ,,y_fCyLVj 18.77 18.12.1997

ysMjekbflu 300 fexzk- ,Qlh dSilwy 10 dk ,,y_fCyLVj 36.49 18.12.1997

LVªsl dSilwy 30 dh cksry 24.27 24.12.2002

LVªsl dSilwy 120 dh cksry 82.59 24.12.2002

70. MsQksfgYl QkekZ izkbosV fyfeVsM ,DlisDV&,l flji 450 fefy dh cksry 45.01 29.03.2006

,uksDl dSilwy 10 dk ,,y_fCyLVj 19.64 29.03.2006

71. MsYVk ,jksesfVd izkbosV fyfeVsM fjdksfu;k xksfy;ka 10 dk iRrk@fCyLVj 11.87 08.12.2000

72. Ms~l esfMdy LVksjl ¼esU;wQsDpfjax½ fyfeVsM dksikekbM xksfy;ka 10 dk iRrk 2.89 10.08.1999

73. Mksdks jsesfMt+ DyksfdV twfu;j 4 dk iRrk 3.84 19.05.2006

74. MkW- jsM~Mh yscksjsVªht fyfeVsM lWy E;wdkykbV fyfDoM 50 fefy dh cksry 9.98 30.03.2005

lWy E;wdkykbV fyfDoM 60 fefy dh cksry 11.59 30.03.2005

uksfotu xksfy;ka 10 dk iRrk@fCyLVj 4.88 29.03.2001

csflysd dSilwy 10 dk iRrk@fCyLVj 10.20 10.08.1999

csflysd dSilwy ¼ih,p½ 10 dk ,,y_iRrk 5.82 27.05.2003

,fjiflu dSilwy 10 dk iRrk@fCyLVj 23.01 07.02.2006

75. MªkDV baVjus’kuy VsªfDlu ,DlisDVksjsaV 450 fefy dh cksry 45.16 05.10.2006

76. MªkDV QkekZfl;wfVDy ih- fyfeVsM bUQkfdM xksfy;ka 10 dk ,,y_fCyLVj 2.85 29.03.2001

77. M~d fcy MªXl czksQsUVksy flji 400 fefy dh cksry@,e-di 39.49 08.12.2000

czksQsUVksy flji 100 fefy dh cksry@,e-di 13.30 08.12.2000

78. MhMCY;wMh QkekZL;wfVdyl fy- ,Dl,y&80 VscysV 15 ,lVh_ch,y 5.04 05.10.2006

,Dl,y&80 100 ,e,y cksry 13.66 05.10.2006

79. Mk;ukfed usfyfMfDld ,sflM fyfDoM 50 fefy dh cksry 20.28 29.03.2006

80. bZ-edZ ¼vkbZ½ fyfeVsM fu;wjksfc;ksu ,e- bUtSaD’ku 3 fefy x 50 dk fCyLVj 296.68 20.09.2005

,fo;ksu isfM;fVªd Mªksi 15 fefy dh cksry Mªksij lfgr 9.04 20.09.2005

,fo;ksu Øhe bZ 50 xzke dh V~;wc 14.52 20.09.2005

,fo;ksu ,ylh xksfy;ka 10 dk ,,y@ihohlh@ihohMhlh 26.32 20.09.2005

,usfeMksDl dSilwy 10 dk ,,y_iRrk 10.02 05.02.1999

,usfeMksDl dSilwy 10 dk ,,y_fCyLVj 8.48 05.02.1999

Page 280: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 261 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

fu;wjksfc;ksu QksVZ ,Ei;wy 50x2 fefy dk ,Ecj ,Ei;wy 273.34 13.06.2000

,,y_ihohlh fCyLVj lfgrfu;wjksfc;ksu QksVZ ,Ei;wy 50x2 fefy dk ,Ecj ,Ei;wy 260.98 13.06.2000

,,y_ihohlh fCyLVj jfgrLdysjksfc;ksu dSilwy 10 dk ,,y_ihohlh@ 6.54 20.11.2001

ihohMhlh fCyLVjiksfyftad dSilwy 10 dk ,,y_ihohlh@ 9.18 09.03.1998

ihohMhlh fCyLVj@iRrkdsfc;ksu 10 dk iRrk 8.77 11.03.1998

fu;wjksfc;ksu QksVZ ,Ei;wy 50x2 fefy dk ,Ecj ,Ei;wy 259.61 28.12.1999

,,y_ihohlh fCyLVj lfgrfu;wjksfc;ksu QksVZ ,Ei;wy 50x2 fefy dk ,Ecj ,Ei;wy 247.25 28.12.1999

iksfyfc;ksu ,Ei;wy 50x2 fefy dk ,Ei;wy 155.83 09.07.2003

fCyLVj lfgriksfyfc;ksu ,Ei;wy 50x2 fefy dk ,Ei;wy 143.47 09.07.2003

,usfeMksDl dSilwy 10 dk ,,y_iRrk 9.82 24.12.2002

,usfeMksDl dSilwy 10 dk ,,y_fCyLVj 8.27 24.12.2002

,sfovksu&,ylh xksfy;ka 10 dk ,,y_ihohlh@ 20.48 08.11.2006

ihohMhlh fCyLVjvksLVks iksfyfcvksu flji 250 fefy isV cksry 25.10 08.11.2006

81. bZLV vQjhdu ¼vkbZ½ jsesfMt+ ¼ih½ fyfeVsM ih-ds- lLisUlu 60 fefy dh cksry 12.25 29.03.2006

jWydksy bZ flji 100 fefy dh cksry 13.28 29.03.2006

fjoksfjy flji 100 fefy dh cksry 14.65 29.03.2006

dksYMªkbZo flji 60 fefy dh cksry 18.60 05.10.2006

82. bZLV vejhdu vkWDlhM&,y, dSilwy 10 dk ,,y_fCyLVj 25.12 29.03.2006

83. bZLV bafM;k QkekZ odZl dsyjksu fyfDoM 450 fefy Qk;y 34.06 02.09.1998

dsyjksu fyfDoM 280 fefy Qk;y ,e-di lfgr 24.18 09.03.1998

dsyjksu lhtsM dSilwy 10 dk ,,y_ihohMhlh fCyLVj 7.82 09.07.2003

dsyjksu VkWfud 300 fefy dk¡p dh cksry 31.39 09.07.2003

,e- di lfgrdsyjksu VkWfud 400 fefy dk¡p dh cksry 38.41 09.07.2003

,e- di lfgrdsyjksu 300 fefy 300 fefy dk Qk;y 31.24 04.03.2004

,e- di vkSj dkVZu lfgrdsyjksu 400 fefy 400 fefy dk Qk;y 38.43 04.03.2004

,e- di vkSj dkVZu lfgrMeksZfD;wuksy 4% Øhe 15 xzke ,Y;w- V;wc ysdMZ~ 6.63 15.06.2005

MeksZfD;wuksy 8% Øhe 15 xzke ,Y;w- V;wc ysdMZ~ 7.54 15.06.2005

dkfVZfD;;wuksy vkW;uVesaV 15 xzke ,Y;w- V;wc ysdMZ~ 22.70 15.06.2005

Page 281: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 262 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

84. ,YMj gsYFkds;j izkbosV fyfeVsM ,e zQw xksfy;ksa 10 dk iRrk@fCyLVj 5.63 29.03.2006

vkbZ&foV dSilwy 10 dk iRrk 5.74 28.09.1998

vkbZ&foV dSilwy 30 dk iRrk 17.23 28.09.1998

,YMjfoV bUtSaD’ku 5 dk dksEch iSd 43.43 11.03.1998

¼2 fefy $ 2 fefy ,Ei;wy½,ydksQ flji 100 fefy dh cksry 13.86 30.03.2005

,yV~l flji 100 fefy dh cksry 15.08 30.03.2005

,yV~l flji 50 fefy dh cksry 8.94 05.10.2006

85. ,fytsUV dsfedy baVjizkbtsl csfufyu dWQ flji 60 fefy dh cksry 10.91 30.03.2005

izkbosV fyfeVsM csfufyu dWQ flji 100 fefy dh cksry 14.85 30.03.2005

csfufyu bZ ,DlisDVksjsUV 60 fefy dh cksry 9.75 30.03.2005

csfufyu bZ ,DlisDVksjsUV 100 fefy dh cksry 12.95 30.03.2005

86. ,sfy&fyYyh ,.M dEiuh izk- fy- eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 208.94 01.05.2006

áebUlwfyu 30/70 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 406.48 01.05.2006

áebUlwfyu 50/50 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 419.13 01.05.2006

áwekykWx 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 408.10 01.05.2006

áebUlwfyu jsX;wyj 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 408.10 01.05.2006

áebUlwfyu 30/70 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 408.10 01.05.2006

áebUlwfyu ,uih,p 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 208.94 01.05.2006

áebUlwfyu jsX;wyj 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 445.74 01.05.2006

áwekykWx feDl 50 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy fMLikslscy iSu 588.75 01.05.2006

áwekykWx feDl&50 iSu 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy fMLikslscy iSu 588.75 01.05.2006

áwekykWx iSu 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy fMLikslscy iSu 588.75 01.05.2006

áwekykWx feDl 25 iSu 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 414.46 23.06.2006

áebUlwfyu ,uih,p 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 414.46 23.06.2006

áebUlwfyu 30/70 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 414.16 23.06.2006

áebUlwfyu jsX;wyj 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 453.12 23.06.2006

áwekykWx feDl 50 100 vkbZ;w@fefy

Page 282: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 263 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 208.94 23.06.2006

áebUlwfyu 30/70 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 208.94 23.06.2006

áebUlwfyu ,uih,p 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 425.37 23.06.2006

áwekykWx 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 206.79 23.06.2006

áebUlwfyu 30/70 40 vkbZ;w@fefyfyokstsu Vksfud 120 fefy vEcj cksry 21.84 8.12.2000

,e di ,oa dkVZwu ds lkFkeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 452.28 14.07.2006

áwekykWx feDl 50-100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 452.28 14.07.2006

áwekykWx feDl 25-100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 208.94 14.07.2006

áwekykWx 30/70 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 208.94 24.07.2006

áebUlwfyu 30/70 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 189.82 24.07.2006

áebUlwfyu 30/70 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 208.94 24.07.2006

áebUlwfyu jsX;wyj 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 433.06 24.07.2006

áwekykWx 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 208.94 24.07.2006

áebUlwfyu ,uih,p 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 424.60 14.09.2006

áebUlwfyu 30/70 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy fMLikslscy iSu 610.03 14.09.2006

áwekykWx feDl 25 iSu ¼100 vkbZ;w@fefy½eksuksdEiksusV bUlwfyu 3 fefy fMLikslscy iSu 610.03 14.09.2006

áwekykWx iSu ¼100 vkbZ;w@fefy½eksuksdEiksusV bUlwfyu 3 fefy fMLikslscy iSu 610.03 14.09.2006

áwekykWx feDl 50 iSu ¼100 vkbZ;w@fefy½eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 190.59 14.09.2006

áebUlwfyu 30/70 40 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 462.78 14.09.2006

áwekykWx feDl 25 iSu ¼100 vkbZ;w@fefy½eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 455.35 09.10.2006

áwekykWx feDl 50 iSu 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 208.94 09.10.2006

áebUlwfyu ,uih,p 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 208.94 09.10.2006

áebUlwfyu 30/70 100 vkbZ;w@fefy

Page 283: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 264 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 208.94 09.10.2006

áebUlwfyu jsX;wyj 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 419.25 29.11.2006

áwekykWx feDl 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 409.91 29.11.2006

áebUlwfyu 30/70 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 409.91 29.11.2006

áebUlwfyu jsX;wyj 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 409.91 29.11.2006

áebUlwfyu ,uih,p 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 445.95 29.11.2006

áwekykWx feDl 25 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy fMLikslscy iSu 589.08 29.11.2006

áwekykWx feDl 25 iSu 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 408.18 12.12.2006

áebUlwfyu ,uih,p 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 208.94 12.12.2006

áebUlwfyu jsX;wyj 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy fMLikslscy iSu 583.44 12.12.2006

áwekykWx feDl 50 iSu 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 208.94 12.12.2006

áebUlwfyu 30/70 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 414.46 14.02.2007

áwekykWx 100 vkbZ;w@fefy ¼bUlwfyu fyLizks½eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 441.10 14.02.2007

áwekykWx feDl 50-100 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 221.85 14.02.2007

áwekykWx jsX;wyj 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy fMLikslscy iSu 581.74 14.02.2007

áwekykWx isu 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 181.90 14.02.2007

áebUlwfyu ,uih,p 40 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 181.90 14.02.2007

áebUlwfyu jsX;wyj 40 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 221.85 14.02.2007

áebUlwfyu ,uih,p 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 221.85 14.02.2007

áebUlwfyu ,uih,p 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 221.85 14.02.2007

áebUlwfyu 30/70 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 405.07 14.02.2007

áebUlwfyu 30/70 100 vkbZ;w@fefy ok;yeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 405.07 14.02.2007

áebUlwfyu 30/70 100 vkbZ;w@fefy ok;y

Page 284: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 265 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 441.10 14.02.2007

áwekykWx feDl 25-100 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 414.46 14.02.2007

áwekykWx 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 221.85 14.02.2007

áebUlwfyu jsX;wyj 100 vkbZ;w@fefy ok;yeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 415.33 14.02.2007

áwekykWx 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 221.85 23.03.2007

áebUlwfyu 30/70 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 221.85 23.03.2007

áebUlwfyu 30/70 100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 440.91 23.03.2007

áwekykWx feDl 50-100 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 181.72 23.03.2007

áebUlwfyu 30/70 40 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 181.72 23.03.2007

áebUlwfyu 30/70 40 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 181.72 23.03.2007

áebUlwfyu 30/70 40 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 10 fefy dk ok;y 181.72 23.03.2007

áebUlwfyu ,uih,p 40 vkbZ;w@fefyeksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 403.35 1346(E)

áwekykWx 100 vkbZ;w@fefy 01.08.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 403.35 1346(E)

áwekykWx feDl 25-100 vkbZ;w@fefy 01.08.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 221.85 1346(E)

áebUlwfyu 30/70-100 vkbZ;w@fefy 01.08.2007

eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 166.40 1346(E)

áebUlwfyu 30/70-40 vkbZ;w@fefy 01.08.2007

eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 333.68 1346(E)

áebUlwfyu ,uih,p -100 vkbZ;w@fefy 01.08.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 403.92 1346(E)

áwekykWx feDl 50-100 vkbZ;w@fefy 01.08.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 221.85 1346(E)

áebUlwfyu ,uih,p -100 vkbZ;w@fefy 01.08.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 403.35 1346(E)

áwekykWx feDl 25-100 vkbZ;w@fefy 01.08.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 403.35 1346(E)

áwekykWx 100 vkbZ;w@fefy 01.08.2007

eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 166.40 1346(E)

áebUlwfyu jsxwyj-40 vkbZ;w@fefy 01.08.2007

eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 166.40 1346(E)

áebUlwfyu 30/70-40 vkbZ;w@fefy 01.08.2007

Page 285: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 266 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 333.68 1346(E)

áebUlwfyu jsxwyj-100 vkbZ;w@fefy 01.08.2007

eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 329.26 1666(E)

áebUlwfyu ,uih,p-100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 329.26 1666(E)

áebUlwfyu jsxwyj-100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 329.26 1666(E)

áebUlwfyu 30/70 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 199.84 1666(E)

áebUlwfyu jsxwyj 100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 398.49 1666(E)

áebUlwfyu feDl 25-100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 199.84 1666(E)

áebUlwfyu ,uih,p 100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 199.84 1666(E)

áebUlwfyu 30/70-100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 199.84 1666(E)

áebUlwfyu 30/70-100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 329.43 1666(E)

áebUlwfyu 30/70-100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 398.01 1666(E)

áwekykWx feDl 50-100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 398.01 1666(E)

áwekykWx -100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 199.84 1666(E)

áebUlwfyu 30/70-100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 369.43 1666(E)

áebUlwfyu 30/70-100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 369.43 1666(E)

áebUlwfyu 30/70-100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 199.84 1666(E)

áebUlwfyu jsxwyj 100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 397.73 1666(E)

áwekykWx feDl 25-100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 199.84 1666(E)

áebUlwfyu 30/70-100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 164.36 1666(E)

áebUlwfyu 30/70-100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 164.36 1666(E)

áebUlwfyu 30/70-40 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 398.01 1666(E)

áwekykWx 100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 398.01 1666(E)

áwekykWx feDl 25-100 vkbZ;w@fefy 27.09.2007

Page 286: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 267 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 199.84 1666(E)

áebUlwfyu ,uih,p 100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 199.84 1666(E)

áebUlwfyu jsxwyj 100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 199.84 1666(E)

áebUlwfyu ,uih,p 100 vkbZ;w@fefy 27.09.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 392.89 2064(E)

áwekyksx feDl 50 - 100 vkbZ;w@fefy 30.11.2007

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 397.74 186(E)

áwekyksx 100 vkbZ;w@fefy 29.01.2008

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 397.38 186(E)

áwekyksx 100 vkbZ;w@fefy 29.01.2008

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 397.38 186(E)

áwekyksx feDl 25 - 100 vkbZ;w@fefy 29.01.2008

eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 397.38 186(E)áwekyksx feDl 50 - 100 vkbZ;w@fefy 29.01.2008eksuksdEiksusV bUlwfyu 3 fefy dk 523.23 186(E)áwekyksx isu -100 vkbZ;w@fefy fMLikstscy isu 29.01.2008eksuksdEiksusV bUlwfyu 3 fefy dk 523.23 186(E)áwekyksx feDl 25 isu-100 vkbZ;w@fefy fMLikstscy isu 29.01.2008eksuksdEiksusV bUlwfyu 3 fefy dk 523.23 186(E)áwekyksx feDl 50 isu-100 vkbZ;w@fefy fMLikstscy isu 29.01.2008eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 203.32 186(E)áebUlqfyu jsxwyj-100 vkbZ;w@fefy 29.01.2008eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 397.81 186(E)áwekyksx feDl 25-100 vkbZ;w@fefy 29.01.2008eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 203.66 186(E)áebUlqfyu 30/70-100 vkbZ;w@fefy 29.01.2008eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 397.21 186(E)áwekyksx feDl 50-100 vkbZ;w@fefy 29.01.2008eksuksdEiksusV bUlwfyu 3 fefy dk dkfVZt 397.26 186(E)áwekyksx -100 vkbZ;w@fefy 29.01.2008eksuksdEiksusV bUlwfyu 3 fefy isu 525.00 186(E)áwekyksx isu -100 vkbZ;w@fefy 29.01.2008eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 369.87 186(E)áebUlqfyu jsxwyj-100 vkbZ;w@fefy 29.01.2008eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 369.87 186(E)áebUlqfyu 30/70 -100 vkbZ;w@fefy 29.01.2008eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 369.12 186(E)áebUlqfyu 30/70 -100 vkbZ;w@fefy 29.01.2008eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 369.12 186(E)áebUlqfyu jsxwyj-100 vkbZ;w@fefy 29.01.2008eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 369.12 186(E)áebUlqfyu ,uih,p-100 vkbZ;w@fefy 29.01.2008

eksuksdEiksusV bUlwfyu 10 fefy dk ok;y 369.12 186(E)

áebUlqfyu 30/70 -100 vkbZ;w@fefy 29.01.2008

Page 287: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 268 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

87. ,eD;wj QkekZ fyfeVsM ,chlh MeZ Øhe 15 xzke dh V~;wc 8.38 29.03.2006

bC;wLisu ,lvkj xksfy;ka 800 fexzk- 10 dk iRrk@fCyLVj 9.35 29.03.2000

VsuksosV th Øhe 20 xzke dh V~;wc 16.27 20.10.2004

88. ,fey QkekZfl;wfVdy bafM;k fyfeVsM fjuksLVsV fyfDoM 60 fefy dh cksry@,e-di 10.40 04.01.2005

bcsjksy xksfy;ka 30 dh cksry 14.14 07.02.2006

fdMVksu Mªksi 15 fefy dh cksry 12.33 07.02.2006

Mªksij vkSj dkVZu lfgrljhfoV Mªksi 15 fefy dh cksry 11.86 07.02.2006

Mªksij vkSj dkVZu lfgr

89. ,UMksdkMZ bafM;k izkbosV fyfeVsM ,ulsV Mh xksfy;ka 6 dk iRrk@fCyLVj 2.17 29.03.2006

90. bjkst+ QkekZ fyfeVsM lyfcM ,DlisDVksjsUV 120 fefy dh cksry 15.54 29.03.2006

91. ,ldst+ QkekZ VjQsDl flji 100 fefy dh cksry 17.87 29.03.2006

VjQsDl xksfy;ka 10 dk iRrk@fCyLVj 3.19 29.03.2006

92. ,fFkdks QkekZ iSjkfDohu fdV 2+5 xksfy;ka dh fdV 6.56 02.04.2003

93. ,fFkysDl gsYFkds;j izkbosV fyfeVsM jsesV~l&ih flji 100 fefy dh cksry@,e-di 16.72 08.12.2000

jsesV~l&Mh flji 100 fefy dh cksry@,e-di 18.65 08.12.2000

94. b;wQksfjd QkekZ izkbosV fyfeVsM QwMksu lLisUlu 450 fefy dh cksry 36.26 09.03.1998

95. ,QMhlh fyfeVsM vksVsd&,lh dku dh Mªksi 5 fefy dh ok;y 11.79 09.03.1998

Mªksij vkSj dkVZu lfgrftQh&,ych,Dl 50 xksfy;ka 10 dk ,,y_iRrk gksyksxzke lfgr 47.42 15.06.2005

ftQh&,ych,Dl 100 xksfy;ka 10 dk ,,y_iRrk gksyksxzke lfgr 93.47 15.06.2005

ftQh&,ych,Dl 200 xksfy;ka 10 dk ,,y_iRrk gksyksxzke lfgr 164.10 15.06.2005

,Vks&lycsVksy flji 100 fefy dh cksry 13.90 29.03.2006

96. Qkbu ds;j QkekZ lst Mh xksfy;ka 10 dk iRrk@fCyLVj 4.54 29.03.2006

97. QkbuD;wj ,jksek 250 bZ xksfy;ka 10 dk iRrk@fCyLVj 21.69 07.02.2006

98. QksjV~l bafM;k lsyVksd ,lh xksfy;ka 10 dk ,,y_ihohMhlh fCyLVj 4.83 24.12.2002

99. zQsadks bafM;k QkekZ ih- fyfeVsM ,ehdfyu Iyl xksfy;ka 10 dk iRrk 9.29 09.03.1998

bZ dsjksfVu dSilwy 10 dk iRrk 14.22 28.09.1998

Vksfidklksu Øhe 5 xzke dh V~;wc 5.64 11.03.1998

Vksfidklksu Øhe 15 xzke dh V~;wc 9.85 11.03.1998

Vksfidklksu Øhe fu;ksekbflu lfgr 5 xzke dh V~;wc 5.84 11.03.1998

Vksfidklksu Øhe fu;ksekbflu lfgr 15 xzke dh V~;wc 10.44 11.03.1998

usfV~o 100 D;w dSilwy 10 dk iRrk@fCyLVj 14.17 29.03.2006

usfV~o 200 D;w dSilwy 10 dk iRrk@fCyLVj 16.58 29.03.2006

usfV~o 400 D;w dSilwy 10 dk iRrk@fCyLVj 21.08 29.03.2006

Page 288: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 269 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

Vdlhu xksfy;ka 10 dk iRrk@fCyLVj 11.44 29.03.2006

,LekL;wy xksfy;ka 10 dk iRrk@fCyLVj 2.53 29.03.2006

V~;wfDlu xksfy;ka 10 dk iRrk@fCyLVj 4.30 05.10.2006

100. zQsadfyu yscksjsVªht ¼bafM;k½ izkbosV fyfeVsM bC;wl lLisUlu 50 fefy dh cksry 10.39 29.03.2006

101. QwyQksMZ ¼vkbZ½ fyfeVsM yksVªhMeZ Øhe 10 xzke dh V~;wc 6.36 29.03.2006

fVukMeZ&,e Øhe 10 xzke dh V~;wc 9.07 29.03.2006

fVukMeZ Øhe 10 xzke dh V~;wc 5.32 15.06.2005

fVukMeZ lksY;w’ku@yks’ku 20 fefy dh cksry 11.46 15.06.2005

VksYukQVsV Øhe 10 xzke dh V~;wc 8.67 15.06.2005

iksykjkekbu ,DlisDVksjsUV 50 fefy dh cksry 11.64 09.03.1998

tS+MkbZu&eSDlh xksfy;ka 10 dk iRrk@fCyLVj 3.50 05.10.2006

iksykjkekbu ,DlisDVksjsUV 50 fefy dh cksry 9.18 05.10.2005

tS+MkbZu&eSDlh 50 fefy dh cksry 8.65 05.10.2006

102. th ukbu ekdsZfVax ,duWt Øhe 15 xzke dh V~;wc 8.65 19.05.2006

103. th-lh-,e- yscksjsVªht ,LFkkeksy&chth xksfy;ka 10 dk iRrk@fCyLVj 2.55 29.03.2006

104. tsusdk ,p- ds;j ,ldse&Iyl flji 100 fefy dh cksry 15.28 29.03.2006

105. ftuks QkekZfl;wfVdy fyfeVsM tsuksfty ,Q xksfy;ka 10 dk iRrk 4.19 09.03.1998

jslikbjk xksfy;k 10 dk iRrk@fCyLVj 3.15 29.03.2006

¶;wflt+u&ch Øhe 10 xzke dh V~;wc 28.95 29.03.2006

ÝwlsusDl xksfy;ka 10 dk iRrk@fCyLVj 4.74 29.03.2006

lkbu vkWQ xksfy;ka 100 dh IykfLVd cksry 46.47 11.07.2006

106. teZu jsesfMt+ fyfeVsM lyQwuks xksfy;ka 10 dk ,,y_iRrk 8.86 16.04.1998

lyQwuks xksfy;ka 10 dk ,,y_fCyLVj 8.43 16.04.1998

izsyksu flji 100 fefy dh cksry 50.90 16.08.2001

,e-di lfgrfu;ksjksVsV ,ei;wy 3 fefy dk ,Ecj ,Ei;wy 5.55 15.02.2000

lyQwuks xksfy;ka 10 dk ,,y_iRrk 9.14 15.02.2000

lyQwuks xksfy;ka 10 dk ,,y_fCyLVj 8.71 15.02.2000

izsyksu flji 100 fefy dh cksry 45.90 17.01.2001

,e-di vkSj dkVZu lfgrlqijhLVksy , xksfy;ka 10 dk ,,y_fCyLVj 8.47 03.09.2003

lqijhLVksy isfM;fVªd xksfy;ka 10 dk ,,y_iRrk 2.83 03.09.2003

lqijhLVksy isfM;fVªd xksfy;ka 10 dk ,,y_fCyLVj 2.49 03.09.2003

lqijhLVksy Mh,l xksfy;ka 10x6 dk ,,y_fCyLVj 96.70 03.09.2003

VªkbZfeFkksfize$ 60 fefy dh cksry 13.46 03.09.2003

lYQkeksDlksy lLisUlu ¼lqijhLVksy½ ,e- di lfgr

107. XySDlks bafM;k fyfeVsM b;weklksu th Øhe 10 xzke vuysd~MZ V~;wc 9.51 27.05.2003

tksosV th,u Øhe 15 xzke vuysd~MZ V~;wc 10.76 27.05.2003

Page 289: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 270 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

csVuslksy ,u vk¡[k@dku dh Mªksi 5 fefy dk ok;y Mªksij lfgr 8.87 16.05.2000

csVuksosV LdYi ,Iyhds’ku 20 fefy dh Ldhfot+h cksry 18.16 16.05.2000

ukst+y dSivksfVuk dku dh Mªksi 5 fefy dh cksry Mªksij lfgr 9.44 16.05.2000

108. XySDlks fLeFk ykbZu QkekZ fy- csVuksosV ,u Ldhu Øhe 30 xzke dh V~;wc 25.30 20.10.2004

foVfu;ksfju bUtsD’ku 2 fefy ,Ecj ,Ei;wy 4.76 20.10.2004

csVuksosV Ldhu Øhe 20 xzke ysd~MZ V~;wc 18.49 29.03.2006

csVuksosV lh Ldhu Øhe 20 xzke V~;wc 18.98 29.03.2006

csVuksosV ,u Ldhu Øhe 20 xzke ysd~MZ V~;wc 19.02 29.03.2006

csVuksosV ,e Ldhu Øhe 20 xzke V~;wc 20.51 29.03.2006

csVuksosV th,e Ldhu Øhe 20 xzke V~;wc 21.15 29.03.2006

csVuksosV ,l Ldhu Øhe 20 xzke ysd~MZ V~;wc 19.93 29.03.2006

,uksosV vkW;UVesUV 20 xzke V~;wc 13.99 29.03.2006

csVuksosV Ldhu Øhe 30 xzke V~;wc 25.76 29.03.2006

csVuksosV lh Ldhu Øhe 30 xzke V~;wc 26.89 29.03.2006

Xysl dSilwy 30 dk 33.61 29.03.2006

osUVªksfyu ,DlisDVksjsUV 120 fefy dh cksry 15.41 29.03.2006

csVuksosV Ldhu Øhe 20 xzke fLdfot cksry 15.50 23.03.2007

,oa uksty dicsVuksosV Ldhu Øhe 20 xzke ysd~MZ V~;wc 16.42 23.03.2007

csVuksosV ,u Ldhu Øhe 20 xzke ysd~MZ V~;wc 16.66 23.03.2007

csVuksosV ,e Ldhu Øhe 20 xzke V~;wc 17.04 23.03.2007

csVuksosV th,e Ldhu Øhe 20 xzke V~;wc 17.20 23.03.2007

csVuksosV ,l Ldhu Øhe 20 xzke ysd~MZ V~;wc 16.52 23.03.2007

,suksosV vksfuesaV 20 xzke V~;wc 11.78 23.03.2007

csVuksosV Ldhu Øhe 30 xzke V~;wc 22.68 23.03.2007

109. XysuekdZ QkekZ izkbosV fyfeVsM ,yksosjk Øhe 50 xzke dh V~;wc 15.10 20.09.2005

,Ldksfjy ,DlisDVksjsUV 100 fefy dh cksry 14.30 29.03.2006

,Ldksfjy ,DlisDVksjsUV 100 fefy dh cksry 14.30 29.03.2006

,Ldksfjy Mh flji 100 fefy dh cksry 18.65 13.06.2000

E;wdkfjy flji eSUFkksy lfgr 100 fefy dh cksry@,e-di 14.65 08.12.2000

E;wdkfjy flji 100 fefy dh cksry@,e-di 14.63 08.12.2000

uslksds;j flji 60 fefy dh cksry@,e-di 10.81 08.12.2000

dsUMhMekZ Øhe 5 xzke vuysd~MZ V~;wc 5.89 27.05.2003

110. feysfl;’k ¼XysuekdZ½ uslksds;j Iyl xksfy;ka 10 dk iRrk 5.87 03.09.2003

uslksds;j xksfy;ka 10 dk iRrk @ fcfyLVj 2.88 05.10.2006

ew;wdksfjy ,DlisDVksjsaV 100 fefy dh cksry 13.36 05.10.2006

uslksfjy 60 fefy dh cksry 09.80 05.10.2006

111. xqM yd QkekZfl;wfVdy izkbosV fyfeVsM ,LFkhyd xksfy;ka 10 dk iRrk@fCyLVj 2.66 29.03.2006

Page 290: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 271 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

112. xzsfUMDl QkekZfl;fVdy fyfeVsM lkbusDl QksVZ xksfy;ka 10 dk ,,y_iRrk 7.72 29.03.2006

lkbusDl QksVZ xksfy;ka 10 dk ,,y_fCyLVj 7.36 29.03.2006

lkbusDl xksfy;ka 10 dk ,,y_iRrk 4.76 29.03.2001

lkbusDl xksfy;ka 10 dk ,,y_ihohMhlh fCyLVj 4.34 29.03.2001

113. xzqi LdhuVkWi Øhe 5 xzke dh V~;wc 7.06 11.03.1998

lqfnu xksfy;ka 10 dk iRrk@fCyLVj 3.10 05.10.2006

lqfnu flji 100 fefy dh cksry 14.16 05.10.2006

114. xqtjkr VªWl ysc fyfeVsM ,dksysV xksfy;ka 10 dk iRrk@fCyLVj 2.53 29.03.2006

115. gennZ ¼okDQ½ yscksjsVªht flUdkjk fyfDoM flji 500 fefy dh cksry 44.20 11.07.2006

dkVZu lfgrxseu flji 200 fefy dh cksry 22.90 11.07.2006

dkVZu lfgruksfugky csch VkWfud&100 fefy 100 fefy dk¡p dh cksry 12.46 08.03.2001

dkVZu lfgrflUdkjk fyfDoM flji 500 fefy dh cksry 37.67 15.06.2005

dkVZu lfgrlnwjh 100 fefy dh cksry 14.98 06.05.1998

116. gsesDl QkekZ lqnksfgLV&Mh,evkj VscysV 10 dk iRrk@fCyLVj 5.86 05.10.2006

lqnksfgLV&Mh,evkj 60 fefy dh cksry 14.28 05.10.2006

117. gsYFk ds;j QksjE;wys’ku izkbosV fyfeVsM Liw;jsDl&,th 100 fefy dh cksry 15.28 29.03.2006

Liw;jsDl&,th 60 fefy dh cksry 11.32 29.03.2006

dksYMkj lLisa’ku 50 fefy dh cksry 9.26 05.10.2006

118. fg;jys LVªhV QkekZ lksyfou xksfy;ka 10 dk iRrk@fCyLVj 3.98 13.06.2000

lksyfou xksfy;ka 10 dk iRrk@fCyLVj 6.00 13.06.2000

lksyfou fyfDoM 60 fefy dh cksry 10.29 13.06.2000

lksyfou fyfDoM 100 fefy dh cksry 13.87 13.06.2000

119. gsyDl gsYFk ds;j lsV&Mh xksfy;ka 10 dk iRrk@fCyLVj 4.08 29.03.2006

lsV&Mh lLisUlu 60 fefy dh cksry 12.79 29.03.2006

120. gsfy;l QkekZfl;wfVdy Vh,Q&th,e tWy 10 xzke dh V~;wc 6.25 29.03.2006

121. fgUnqLrku ,aVhck;ksfVDl fyfeVsM yksLVªhy dSilwy&150 fexzk- 1000 dk fVu 1495.70 15.06.2005

yksLVªhy dSilwy&300 fexzk- 1000 dk fVu 2057.53 15.06.2005

yksLVªhy dSilwy&450 fexzk- 1000 dk fVu 3920.03 15.06.2005

yksLVªhy dSilwy&450 fexzk- 100 dk fVu 397.24 15.06.2005

csatkFkkbZu isuflfyu th batSD’ku 1 ok;y 8.54 05.02.2007

6 yk[k vkbZ;w@ok;ycsatkFkkbZu isuflfyu th batSD’ku 5 ok;y 42.68 05.02.2007

6 yk[k vkbZ;w@ok;y

Page 291: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 272 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

csatkFkkbZu isuflfyu th batSD’ku 1 ok;y 13.08 05.02.2007

12 yk[k vkbZ;w@ok;ycsatkFkkbZu isuflfyu th batSD’ku 5 ok;y 65.38 05.02.2007

12 yk[k vkbZ;w@ok;ycsatkFkkbZu isuflfyu th batSD’ku 1 ok;y 20.32 05.02.2007

24 yk[k vkbZ;w@ok;ycsatkFkkbZu isuflfyu th batSD’ku 1 ok;y 34.80 05.02.2007

24 yk[k vkbZ;w@ok;y

122. gkbZVsd dSilwy izkbosV fyfeVsM Xysl uje dSilwy 30 dh cksry 52.02 21.07.1998

123. gksLV esfj;u jly fyfeVsM ,foy 25 xksfy;ka 100x10 dk ,,y_iRrk 207.55 06.05.1998

,foy 25 xksfy;ka 100x10 dk ,,y_fCyLVj 165.10 06.05.1998

,foy 50 xksfy;ka 100x10 dk ,,y_iRrk 262.03 06.05.1998

,foy 50 xksfy;ka 100x10 dk ,,y_fCyLVj 219.59 06.05.1998

,foy bUtsD’ku 10x2 lh-lh- ,Ei;wy 27.59 06.05.1998

,foy bUtsD’ku 10 lh-lh- ok;y 7.11 06.05.1998

,foy bUtsD’ku ¼osV-½ 10 fefy dk ok;y 7.21 16.11.1999

lksQjkekbflu Ldhu Øhe 20 xzke 20 xzke dh V~;wc 17.84 01.08.2000

lksQjkekbflu Ldhu Øhe 100 xzke 100 xzke dh V~;wc 72.90 01.08.2000

dksMfjuy ikmMj 100 xzke osV- 100 xzke ,,y_lspsV 13.03 02.09.1998

124. gkbft;k QkekZfl;wfVdy czksesDl ,DlisDVksjsUV 100 fefy dh cksry 14.92 29.03.2006

fM;wosUV&ihMh ,DlisDVksjsUV 100 fefy dh cksry 15.21 29.03.2006

125. vkbZMhih,y DyksjkDohu QksLQsV xksfy;ka ¼lknh½ 1000 dh IykfLVd cksry 447.66 25.07.2003

lscsDlhu xksfy;ka 30 dh cksry 22.02 24.12.2002

126. baM&LohQ~V fyfeVsM ,y;wflu 33 fexzk- xksfy;ka 10 dk iRrk@fCyLVj 31.35 07.02.2006

,y;wflu lLisUlu 60 fefy dh cksry@,e-di 21.55 07.02.2006

127. baMdseh dksMlkW¶V dSilwy 10 dk iRrk@fCyLVj 13.21 20.09.2005

128. bafMdks jsesfMt+ fyfeVsM bC;w¶ysej ih- xksfy;ka 10 dk iRrk@fCyLVj 5.78 29.03.2001

129. baMh QkekZ ,DlisDVl Mh 100 fefy dh cksry 14.28 05.10.2006

130. baMksdks jsesfMt+ fyfeVsM baMsfjFk xksfy;ka 10 dk iRrk@fCyLVj 21.69 07.02.2006

baMsfjFk lLisUlu 60 fefy dh cksry@,e- di 21.55 07.02.2006

,Qfyu xksfy;ka 10 dk iRrk@fCyLVj 3.72 29.03.2006

,Qfyu ihMh flji 100 fefy dh cksry 13.72 29.03.2006

131. baMks zQsap ysc fyfeVsM czksufeDl flji 100 fefy dh cksry 19.13 29.03.2006

132. bUQkj ¼bafM;k½ fyfeVsM vksjkcksfyu xksfy;ka 10 dk iRrk 5.01 09.12.1997

vksjkcksfyu Mªksi 5 fefy dh cksry Mªksij lfgr 6.02 09.12.1997

vksjxkesfVªy xksfy;ka 10 dk iRrk 9.24 09.12.1997

Page 292: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 273 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

yk;ufM;ksy xksfy;ka 22 dk iRrk 5.08 09.12.1997

yk;ufM;ksy xksfy;ka 21 dk iRrk 4.82 09.12.1997

vksjxsfyVe xksfy;ka 10 dk iRrk 5.17 09.12.1997

133. bUVªk ysc fc;wfoe Iyl xksfy;ka 10 dk iRrk@fCyLVj 7.71 29.03.2006

134. bidk ysc fyfeVsM ,YVksflu Mh,l xksfy;ka 10 dk iRrk@fCyLVj 42.32 07.02.2006

,YVksflu chvkj xksfy;ka 10 dk iRrk@fCyLVj 22.08 07.02.2006

,YVksflu chvkj xksfy;ka 10 dk iRrk@fCyLVj 42.72 07.02.2006

,YVksflu xksfy;ka 10 dk iRrk@fCyLVj 21.69 07.02.2006

lksyfou fyfDoM 60 fefy dh cksry 10.29 13.06.2000

lksyfou fyfDoM 100 fefy dh cksry 13.87 13.06.2000

DyksjksDohu QksLQsV xksfy;ka 100 fexzk- 10 dk ,,y_iRrk 2.90 25.07.2003

DyksjksDohu QksLQsV xksfy;ka 100 fexzk- 10 dk ,,y_fCyLVj 2.54 25.07.2003

,YVksflu MªkbZ flji@lLisUlu 30 fefy dh cksry@,e-di 13.15 30.03.2005

135. vkbZvkj,e QkekZ ftVkWi fM;ksysV 10 dk iRrk@fCyLVj 10.84 11.07.2006

¼,DlVsUMsM fjfyt+½ dSilwy

136. ts-ds- MªXl ,aM QkekZ vkWDlh zQh xksfy;ka 10 dk iRrk 12.09 24.12.2002

¼,DlVsUMsM fjfyt+½ dSilwy

137. txluiky QkekZfl;wfVdy ikjoksMsDl dSilwy 10 dk iRrk@fCyLVj 9.51 20.09.2005

ikjoksMsDl dSilwy 100 dh dk¡p dh cksry 91.27 20.09.2005

ikjoksu&,u dSilwy 100 dh dk¡p dh cksry 65.00 20.09.2005

fDol QksVZ ¼1 iSd½ 5 xzke dh V~;wc 5.85 29.03.2006

138. tkjlu QkekZfl;wfVdy czksUdksfuy flji 100 fefy dh cksry 15.12 29.03.2006

139. tsu cjDV isjsVksfDly flji 100 fefy dh cksry 22.87 09.03.1998

VªkbZcu Iyl Øhe 10 xzke vuysd~MZ V~;wc 8.74 27.05.2003

gsDlhFkzksflu xksfy;ka 10 dk iRrk@fCyLVj 20.24 19.05.2006

140. tqxr QkekZ eqyfeu flji 100 fefy dh 17.27 19.05.2006

,Ecj ekbØks cksryeqyfeu Mªksi 15 fefy dh cksry 12.74 19.05.2006

Mªksij vkSj dkVZu lfgrb;wQksfeu flji 100 fefy ,Ecj jkmaM 14.28 19.05.2006

Mªksij lfgr

141. dukZVdk ,aVhck;ksfVd jsefldh xksfy;ka 10 dk iRrk@fCyLVj 4.57 13.06.2000

QkekZfl;wfVdy fyfeVsM jsefldh fyfDoM 60 fefy dh cksry 10.88 13.06.2000

142. dseosy izkbosV fyfeVsM osUVksjfyu ,DlisDVksjsUV 120 fefy dh cksry 15.41 29.03.2006

143. dsuVªsd ysc ijfly 100 fefy dh cksry 14.50 05.10.2006

Page 293: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 274 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

144. [kaMsyoky yscl fyfeVsM ,DlkWy ,DlisDVksjsUV 50 fefy dh cksry 10.38 29.03.2006

,DlhIyksu chvkj ,DlisDVksjsUV 50 fefy dh cksry 8.56 30.03.2005

,DlhIyksu chvkj ,DlisDVksjsUV 100 fefy dh cksry 13.15 30.03.2005

jsch¶yse 400 xksfy;ka 6 dk iRrk@fCyLVj 9.26 29.03.2000

145. fde ysc izk- fyfeVsM ,fEcfyu flji 100 fefy dh cksry 15.18 05.10.2006

146. dykj lsgu izkbosV fyfeVsM ,Eczkslksy ,DlisDVksjsUV 100 fefy dh cksry 15.92 29.03.2006

147. uksy QkekZfl;wfVdy fyfeVsM vkfjusd xksfy;ka 200 $ 30 fexzk- 10 dk iRrk@fCyLVj 4.26 29.03.2006

vkfjusd xksfy;ka 400 $ 60 fexzk- 6 dk iRrk@fCyLVj 4.54 29.03.2006

fjcwQsu tWy 30 xzke dh V~;wc 11.55 29.03.2001

vkfjusd flji 60 fefy dh cksry 10.27 29.03.2001

,e- di lfgrbUlwfyu bUtsD’ku vkbZih 40;wfuV 10 fefy dk ok;y 136.34 08.03.2001

bUlwfyu ftad lLisUlu vkbZih 40;wfuV 10 fefy dk ok;y 136.32 08.03.2001

bUlwfyu bUtsD’ku vkbZih 40;wfuV 10 fefy dk ok;y 88.38 08.03.2001

bUlwfyu ftad lLisUlu vkbZih 40;wfuV 10 fefy dk ok;y 88.42 08.03.2001

148. dksijsu fyfeVsM fVuk ,Q xksfy;ka 10 dk iRrk 4.98 09.03.1998

fVuk ,Q lLisUlu 60 fefy dh cksry 9.38 09.03.1998

fVuk ,Q lLisUlu 50 fefy dh cksry 8.10 09.03.1998

czsu ih,Dl xksfy;ka 10x10 dk ,,y_fCyLVj 61.52 20.09.2005

czsu ih,Dl xksfy;ka 10 dk ,,y_fCyLVj 7.94 20.09.2005

fgLVkdkWQ fyfDoM 100 fefy dh cksry 15.23 29.03.2006

czscQsM QksVZ xksfy;ka 6 dk iRrk@fCyLVj 4.14 29.03.2006

czsuQsM xksfy;ka 10 dk iRrk@fCyLVj 3.99 29.03.2006

fgLVkdkWQ flji 60 fefy dh cksry 10.62 30.03.2005

149. ØsLi osUVkdkWQ flji 100 fefy dh cksry 16.16 29.03.2006

150. fDod gsYFk ds;j ØSc Mh,Dl flji 60 fefy dh cksry 9.94 05.10.2006

ØSc Mh,Dl flji 100 fefy dh cksry 13.34 05.10.2006

151. ykW ck;ksfØLV QkekZfl;wfVdy fyfeVsM vksDlsyk MhVh 10 dk ,,y_fCyLVj 22.13 29.03.2006

152. ysUlj gsYFk ds;j izkbosV fyfeVsM yk;ukdksDl&fdM tsM,p 10 dk iRrk@fCyLVj 15.76 15.06.2005

ekbdksMkWV fdV 10 xksfy;ksa dk dysUMj iSd 14.39 15.06.2005

ekbdksMkWV&4 fdV 8 xksfy;ka dk dksEch iSd 11.28 15.06.2005

ekbdksMkWV&tsM fdV 1 fdV 21.86 15.06.2005

,YVªhQsM xksfy;ka 10 dk iRrk@fCyLVj 4.12 29.03.2006

153. ysUlj QkekZ izkbosV fyfeVsM VjcksysDl Mh 60 fefy dh cksry 11.58 05.10.2006

VjcksysDl Mh 100 fefy dh cksry 16.06 05.10.2006

ykW;ukdksYM 60 fefy dh cksry 10.90 05.10.2006

Page 294: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 275 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

154. ykdZ yscksjsVªht ¼vkbZ½ izkbosV fyfeVsM vkjbZ,l fyfDoM 100 fefy dh cksry 14.19 29.03.2006

iksyh ch flji 60 fefy dh cksry@,e-di 10.68 20.10.2004

iksyh ch flji 60 fefy dh cksry 10.20 20.10.2004

iksyh ch flji 100 fefy dh cksry@,e-di 14.50 20.10.2004

iksyh ch flji 100 fefy dh cksry 14.02 20.10.2004

iksyh ch flji 200 fefy dh cksry@,e-di 24.42 20.10.2004

iksyh ch flji 200 fefy dh cksry 23.94 20.10.2004

flizksyj flji 30 fefy dh cksry 15.26 25.11.2003

flizksyj flji 60 fefy dh cksry 27.15 25.11.2003

155. fyUdksu QkekZfl;wfVdy fyfeVsM DyksjksDohu QksLQsV Mªksi 15 fefy dh cksry 8.14 26.09.2000

Mªksij lfgrDyksjksDohu QksLQsV Mªksi 10 fefy dh cksry 6.40 02.04.2003

Mªksij lfgrDyksjksDohu QksLQsV Mªksi 15 fefy dh cksry 7.82 02.04.2003

Mªksij lfgr

156. fyVkdk QkekZfl;wfVdy fyfeVsM ,ihfDly ,y-Mh- flji 60 fefy dh cksry 11.00 29.03.2006

,ihfDly ,DlisDVksjsUV 100 fefy dh cksry 13.75 29.03.2006

,ihfDly ,yMh flji 60 fefy dh cksry 12.59 29.03.2006

157. yksxksl QkekZ VkWitsfld&,eMh xksfy;ka 10 dk iRrk@fCyLVj 5.94 29.03.2006

158. Y;wfiu yscksjsVªht fyfeVsM vkWfIVfu;ksjksu bUtsD’ku 3 fefy ,Ei;wy ,Ecj 5.59 28.12.1999

vkWfIVfu;ksjksu bUtsD’ku 3 fefy ,Ei;wy 5.35 09.07.2003

ywfIgLV 100 fefy cksry 13.74 05.10.2006

,jks&ch flji 60 fefy dh cksry 19.68 1672(E)27.09.2007

159. yk;dk ysc fyfeVsM ,sUxsesV xksfy;ka 20x100 dk IykfLVd tkj 580.34 20.10.2004

,sUxsesV xksfy;ka 10x100 dk IykfLVd tkj 546.36 20.10.2004

,sUxsQj xksfy;ka 20x100 dk IykfLVd tkj 200.47 20.10.2004

160. ,e- ts- QkekZ izkbosV fyfeVsM bysfVu&jsX;wyj bUtsD’ku 10 fefy dk ok;y 90.22 16.08.2001

bysfVu&,uih,p bUtsD’ku 10 fefy dk ok;y 90.54 16.08.2001

bysfVu&ysUVs bUtsD’ku 10 fefy dk ok;y 92.70 16.08.2001

bysfVu 30/70 bUtsD’ku 10 fefy dk ok;y 90.50 16.08.2001

áweu yksUxsDV 10 fefy dk ok;y 220.88 09.09.2002

áweu feDlsDV 50 : 50 10 fefy dk ok;y 219.24 09.09.2002

áweu feDlsDV 30 : 70 10 fefy dk ok;y 219.26 09.09.2002

áweu QkLVsDV 10 fefy dk ok;y 218.96 09.09.2002

cksfou yksUxsDV 10 fefy dk ok;y 72.78 09.09.2002

cksfou QkLVsDV 10 fefy dk ok;y 70.86 09.09.2002

cksfou feDlsDV 10 fefy dk ok;y 71.16 09.09.2002

iksjflu feDlsDV 10 fefy dk ok;y 145.14 09.09.2002

iksjflu yksUxsDV 10 fefy dk ok;y 146.78 09.09.2002

Page 295: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 276 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

iksjflu QkLVsDV 10 fefy dk ok;y 144.86 09.09.2002

áebUlwfyu 30/70 10 fefy dk ok;y 162.02 04.01.2005

áebUlwfyu 50/50 10 fefy dk ok;y 162.00 04.01.2005

áebUlwfyu & jsX;wyj 10 fefy dk ok;y 162.08 04.01.2005

áebUlwfyu & ,uih,p 10 fefy dk ok;y 162.76 04.01.2005

161. eku QkekZ flVªheu Iyl 10 dk iRrk@fCyLVj 4.74 17.01.2001

esu¶yse&,l xksfy;ka 10 dk iRrk@fCyLVj 6.67 17.01.2001

162. esd ysc izkbosV fyfeVsM fl;weksy xksfy;ka 10 dk iRrk@fCyLVj 2.35 29.03.2006

fl;weksy Iyl xksfy;ka 8 dk iRrk@fCyLVj 3.95 29.03.2006

lksyfou ,DlisDVksjsUV xksfy;ka 10 dk iRrk@fCyLVj 2.84 29.03.2006

lksyfou ,DlisDVksjsUV xksfy;ka 15 dk iRrk@fCyLVj 3.33 29.03.2006

lksyfou ,DlisDVksjsUV lLisUlu 60 fefy dh cksry 12.90 29.03.2006

lksyfou ,DlisDVksjsUV lLisUlu 100 fefy dh cksry 18.16 29.03.2006

ik;DyksjMsDlk Mªksi 5 fefy dk ok;y 10.25 20.11.2001

163. esdfy;ksMl fyfeVsM bczwoksu QksVZ dSilwy 10 dk ,,y_fCyLVj 14.44 29.03.2006

164. esxul ck;ksVsd jslfiVl&, flji 100 fefy dh cksry 15.32 29.03.2006

165. eykMh M�ªXl ,aM QkekZ fyfeVsM jkbuvkWQ flji 60 fefy dh cksry@,e-di 10.76 08.12.2000

fdysLV flji 60 fefy dh cksry@,e-di 10.34 08.12.2000

fdysLV ,DlisDVksjsUV 100 fefy dh cksry@,e-di 13.93 08.12.2000

jkbuvkWQ xksfy;ka 60 fefy dh cksry@,e-di 10.76 08.12.2000

166. eerk QkekZ FkzksV fdM xksfy;ka 10 dk iRrk@fCyLVj 12.30 07.02.2006

FkzksV xksfy;ka 10 dk iRrk@fCyLVj 21.69 07.02.2006

167. euh"k ,p- ds;j ,llhlh &4 ikmp 1 ikmp 10.29 15.06.2005

,llhlh &4 ,yMCY;w ikmp 1 ikmp 7.63 15.06.2005

,llhlh &3 ikmp 1 ikmp 7.01 15.06.2005

,llhlh &3 xksfy;ka 10 dk iRrk@fCyLVj 61.72 15.06.2005

,llhlh &3 ,yMCY;w xksfy;ka 10 dk iRrk@fCyLVj 41.75 15.06.2005

,llhlh fdV 1 fdV 9.27 15.06.2005

,llhlh &3 ,yMCY;w ikmp 1 ikmp 6.00 20.09.2005

eksDlheSDl ih xksfy;ka 10 dk ,,y_fCyLVj 17.51 29.03.2006

FkzekdksYM 60 fefy dh cksry 10.60 05.10.2006

168. esudkbaM QkekZfl;wfVdy izkbosV fyfeVsM flizkstkby lLisUlu 30 fefy dh cksry 15.60 25.11.2003

flizkstkby lLisUlu 60 fefy dh cksry 27.82 25.11.2003

169. ekijk yscksjsVªht izkbosV fyfeVsM lsyksfoV dSilwy 10 dk iRrk 6.11 28.09.1998

osUVhysV QksVZ xksfy;ka 10 dk iRrk@fCyLVj 2.04 29.03.2006

osUVhysV QksVZ xksfy;ka 10 dk iRrk@fCyLVj 2.24 29.03.2006

flysd dSilwy 15 dk iRrk 20.67 24.12.2002

Page 296: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 277 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

170. ejlbZ QkekZ izkbZosV fyfeVsM lkbZdksYM Mh,e 100 dh cksry 17.90 05.10.2006

171. eSDl bafM;k fyfeVsM DyksjksDohu QksLQsV xksfy;ka 100 dh cksry 593.34 09.03.1998

172. ,eMhlh dks¶lksy flji 100 fefy dh cksry 15.10 29.03.2006

dksEiyhLdsu dSilwy 10 dk ,,y_iRrk 15.67 29.03.2006

ewdksfMy 100 fefy dh cksry 13.70 05.10.2006

173. esfMdks ysc isfjcw xksfy;ka 10 dk iRrk@fCyLVj 6.85 29.03.2006

174. esfM;ksjYl ysc izkbosV fyfeVsM ,Dtsfyu ,DlisDVksjsUV 100 fefy dh cksry 14.72 30.03.2005

175. esfMiksy QkekZL;wfVdYl ewdksflu 60 fefy dh cksry 10.18 05.10.2006

ewdksflu 100 fefy dh cksry 13.72 05.10.2006

176. esfMLisu VªkbfUVfcu xksfy;ka@dSilwy 10 dk iRrk@fCyLVj 46.47 21.07.1998

177. esfMLisu fyfeVsM ysDVksfoV dSilwy 15 dk iRrk@fCyLVj 12.25 10.08.1999

ysDVksfoV fdM xksfy;ka 10 dk iRrk@fCyLVj 2.72 10.08.1999

178. esxnwr dsfedy fyfeVsM ,feekbM xksfy;ka 10 dk ,,y iRrk 5.36 28.09.1998

esxkVl ih flji 100 fefy dh cksry 16.72 13.06.2000

179. edZ ¼vkbZ½ fyfeVsM dsMfo;ksu dSilwy 10 dk iRrk@fCyLVj 14.17 29.03.2006

,eDohu xksfy;ka ¼fyfir½ 1000 dh IykfLVd cksry 478.00 02.04.2003

,ulsQkckWy 100 fexzk- xksfy;ka 10 dk ,,y_fCyLVj 40.23 20.10.2004

,ulsQkckWy 200 fexzk- xksfy;ka 10 dk ,,y_fCyLVj 79.22 20.10.2004

,ulsQkckWy lLisUlu 100 fefy 100 fefy dh cksry@,e-di 125.53 20.10.2004

Ldsyjksfc;ksu dSilwy 90 dh dk¡p dh cksry 53.96 09.09.2002

180. ejdjh yscksjsVªht fyfeVsM ,fjej xksfy;ka 10 dk iRrk@fCyLVj 21.69 07.02.2006

,fjej lLisUlu 45 fefy dh cksry@,e-di 16.89 07.02.2006

isUVkMeZ vkW;UVesUV 5 xzke dh V~;wc 6.81 04.01.2005

eSjh dksYM xksfy;ka 10 dk ,,y ihohlh fCyLVj 4.56 08.12.2000

isUVkMeZ vkW;UVesUV 5 xzke dh V~;wc 6.70 15.06.2005

181. esfjfM;u esfMds;j fyfeVsM dksQfjM Iyl 100 fefy dh cksry 14.80 05.10.2006

182. esfjUM fyfeVsM fjQSfEilhu 450 fexzk- xksfy;ka 50 dh cksry 234.10 20.11.2001

fjQSfEilhu 450 fexzk- dSilwy 50 dh cksry 192.32 15.06.2005

183. es;j vkWjxsfud izkbosV fyfeVsM dkWQsM flji 100 fefy dh cksry 13.75 29.03.2006

184. ekbØks ysc fyfeVsM Mksyks dksYM 10 dk iRrk@fCyLVj 4.88 13.06.2000

felsfyd vkW;UVesUV 20 xzke dh V~;wc 7.94 29.03.2006

VªkbZosV ,e,Q vkW;UVesUV 30 xzke dh V~;wc 11.79 29.03.2006

185. ekbZØksuksok QkekZL;wfVdYl fy- fyadk flji 60 fefx dh cksry 10.14 05.10.2006

Page 297: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 278 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

186. ,e-vkbZ-th gsYFkds;j lkiZ xksfy;ka 10 dk iRrk@fCyLVj 8.91 20.09.2005

187. eksnh eqaMh QkekZfl;wfVdy fyfeVsM fM;ks dksfUVu & ds xksfy;ka 10 dk iRrk@fCyLVj 2.39 29.03.2006

fM;ks dksfUVu & ds xksfy;ka 10 dk iRrk@fCyLVj 3.50 29.03.2006

188. eksfj’k QkekZfl;wfVdy izk- fyfeVsM dksQfj’k Mh,Dl 100 fefx dh cksry 15.42 05.10.2006

189. eksjisu ysc fyfeVsM ,DlhdkWQ&fdM 10 dk iRrk 3.15 03.09.2003

dysfjfMu & Mh xksfy;ka 10 dk ,,y_iRrk 11.93 11.07.2006

dysfjfMu & Mh xksfy;ka 10 dk ,,y_fCyLVj 11.57 11.07.2006

190. ekmUV esVVj osfUVy & ch QksVZ xksfy;ka 10 dk iRrk@fCyLVj 2.00 29.03.2006

191. eqdwj QkekZ dksft+ Iyl xksfy;ka 10 dk iRrk 5.87 03.09.2003

dksft+ Iyl fyfDoM 60 fefy dh cksry@,e-di 9.89 08.12.2000

192. ,u-vkj- tsV baVjizkbts+l isfM;k 3 fyfDoM 60 fefy dh cksry 9.84 13.06.2000

193. usllsUV esfMds;j izkbosV fyfeVsM T;wykbV &,l flji 60 fefy dh cksry 12.53 29.03.2006

194. usVdks QkekZ fyfeVsM usVdksYM Iyl xksfy;ka 10 dk iRrk@fCyLVj 6.12 29.03.2006

Vh-vkj- Qkbfyu 125fexzk- dSilwy 10 dk iRrk@fCyLVj 4.92 29.03.2006

Vh-vkj- Qkbfyu 250fexzk- dSilwy 10 dk iRrk@fCyLVj 7.78 29.03.2006

195. usfoy yscksjsVªht MsjhosUV flji 100 fefy dh cksry 14.77 29.03.2006

,yjÝh Vsc 10 dk iRrk@fCyLVj 6.26 05.10.2006

,yjÝh ,Mh 100 fefy 15.36 05.10.2006

196. fu;ks QkekZ izkbosV fyfeVsM flyksMeZ feDlh Øhe 10 xzke dh V~;wc 10.46 11.03.1998

flyksMeZ Øhe 15 xzke dh vuysd~MZ V~;wc 10.34 27.05.2003

197. usLVj flfeu ,DlisDVksjsaV 100 fefy dh cksry 15.40 05.10.2006

198. fudksYl fijkey ¼vkbZ½ fyfeVsM ekbØksik;fju xksfy;ka 10 dk ,,y_iRrk 2.66 05.02.1999

esMksij xksfy;ka 30 dh cksry 165.10 17.01.2001

esMksij 250 fexzk- xksfy;ka 10 dk ,,y_iRrk 92.50 22.07.2002

,LekisDl fMiksV xksfy;ka ¼,lvkj½ 10 dk ,,y_iRrk 6.14 10.04.2002

czksuksfdysV flji 100 fefy dh cksry 13.99 30.03.2005

czksuksfdysV flji 120 fefy dh cksry 16.78 30.03.2005

VsVªklkbdfyu dSilwy 500 fexzk- 200 dh cksry 248.96 25.08.1999

izsM QksVZ vksifVdy lksY;w’ku 5 fefy dh ok;y Mªksij 13.24 16.04.1998

czksuksfdysV xksfy;ka 10 dk iRrk@fCyLVj 3.03 29.03.2006

;wjsfdax xksfy;ka 10 dk iRrk@fCyLVj 2.87 29.03.2006

MsfyVl xksfy;ka 10 dk ,,y_iRrk 5.76 11.07.2006

MsfyVl xksfy;ka 10 dk ,,y_fCyLVj 5.52 11.07.2006

,e ,.M ch flji 100 fefy dh cksry 14.58 05.10.2006

esMksikj 250 fexzk- 10 dk ,,y_iRrk 98.60 2065(E)05.10.2006

Page 298: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 279 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

199. fu¶y ck;kslkbal ukbdkWQ flji 30 fefy dk¡p dh cksry 7.72 29.03.2006

200. ukscy esfMds;j izkbosV fyfeVsM ftulsV&Mh xksfy;ka 10 dk iRrk@fCyLVj 8.11 13.06.2000

201. uksbj DyksjfeDlhu Mh vkW;UVesUV 3 xzke dh V~;wc 5.80 11.03.1998

202. uksjfMd QksjE;wys’ku lqidks&Mh 100 fefy dh cksry 14.42 05.10.2006

203. uksjfMd QkekZ dksQsaM 100 fefy dh cksry 11.92 05.10.2006

204. uksfjl esfMflUl lqjdksQ 60 fefy dh cksry 11.16 05.10.2006

lqjdksQ 100 fefy dh cksry 15.36 05.10.2006

205. uksokjfVt+ foVkyDl Iyl xksfy;ka 30 dh cksry 315.10 11.07.2006

foVkyDl Iyl Vhvkj xksfy;ka 30 dh cksry 315.10 14.02.2007

foVkyDl Iyl Vhvkj xksfy;ka 30 dh cksry 313.11 23.03.2007

206. uksok uksjfMLd fyfeVsM ysosfej ¶ysDliSu 5x3 fefy dkfVZt 4667.75 29.03.2006

uksok jsfiM ¶ysDl iSu lksY;wcy 5x3 fefy 2625.20 03.09.2003

bUlwfyu ,LikVZ fMfyojh fMokbl lfgruksok feDl 30 ¶ysDl iSu 5x3 fefy 2625.20 03.09.2003

lksY;wcy bUlwfyu dk feJ.k fMfyojh fMokbl lfgr,DVªkfiM uksoksysV 5x3 fefy iSd izsflf’k;u 1367.97 1668(E)

fMfyojh fMokbl lfgr 27.09.2007

bUlwysVkMZ uksoksysV 5x3 fefy iSd izsflf’k;u 1367.97 1668(E)

fMfyojh fMokbl lfgr 27.09.2007

feDlVkMZ 30 uksoksysV 5x3 fefy iSd izsflf’k;u 1367.97 1668(E)

fMfyojh fMokbl lfgr 27.09.2007

feDlVkMZ 50 uksoksysV 5x3 fefy iSd izsflf’k;u 1367.97 1668(E)

fMfyojh fMokbl lfgr 27.09.2007

,DVªkfiM ,p,e ok;y&100vkbZ;w@fefy 10 fefy ok;y 547.89 10.04.2002

gkbfy I;wfjQkbM fu;wVªy bUlwfyueksuksVkMZ ,p,e 100vkbZ;w ok;y 10 fefy ok;y 544.66 10.04.2002

gkbfy I;wfjQkbM bUlwfyu ftad lLisUlufeDlVkMZ 30 ,p,e 100vkbZ;w ok;y 10 fefy ok;y 543.63 10.04.2002

gkbfy I;wfjQkbM fu;wVªy bUlwfyulksY;w’ku vkSj vkblksQsulLisUlu dk feJ.k,DVªkfiM ,p,e iSufQy 100vkbZ;w@fefy 5x3 fefy dkfVZt 999.22 1668(E)

gkbfy I;wfjQkbM fu;wVªy bUlwfyu 27.09.2007

bUlwysVkMZ ,p,e iSufQy 100vkbZ;w@fefy 5x3 fefy dkfVZt 999.22 1668(E)

gkbfy I;wfjQkbM vkblksQsu bUlwfyu 27.09.2007

lLisUlufeDlVkMZ 30,p,e iSufQy 100vkbZ;w@fefy5x3 fefy dkfVZt 999.22 1668(E)

gkbfy I;wfjQkbM fu;wVªy bUlwfyu 27.09.2007

lksY;w’ku vkSj vkblksQsu lLisUlu dk feJ.k

Page 299: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 280 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

feDlVkMZ 50,p,e iSufQy 100vkbZ;w@fefy5x3 fefy dkfVZt 999.22 1668(E)

gkbfy I;wfjQkbM fu;wVªy bUlwfyu 27.09.2007

lksY;w’ku vkSj vkblksQsulLisUlu dk feJ.kuksok jsfiM iSufQy lksY;wcy 5x3 fefy iSd 1964.24 11.08.2004

bUlwfyu ,LikVZuksok feDl 30 iSufQy 5x3 fefy iSd 1964.24 11.08.2004

lksY;wcy bUlwfyu ,LikVZ vkSj izksVkekbufØLVkykbTM bUlwfyu ,LikVZ dk feJ.k,DVªkfiM buksysV lksY;wcy bUlwfyu 5x3 fefy iSd 1688.84 11.08.2004

bUlwysVkMZ buksysV vkblksQsu bUlwfyu 5x3 fefy iSd 1688.84 11.08.2004

feDlVkMZ 30 buksysV ckbQsfld 5x3 fefy iSd 1688.84 11.08.2004

vkblksQsu bUlwfyu

baL;wykjVMZ ,p,e isufQy 100 vkbZ;w 5x3 fefy dkfVZt 1109.26 29.11.2006

feDlVMZ 30 ,p,e isufQy 100 vkbZ;w 5x3 fefy dkfVZt 1109.26 29.11.2006

feDlVMZ 50 ,p,e isufQy 100 vkbZ;w 5x3 fefy dkfVZt 1109.26 29.11.2006

,DVªkfiM ,p,e isufQy 100 vkbZ;w 5x3 fefy dkfVZt 1109.26 29.11.2006

feDlVMZ 30 uksokysV 5x3 fefy dkfVZt 1518.98 29.11.2006

,DVªkfiM uksoksysV 5x3 fefy dkfVZt 1518.98 29.11.2006

feDlVMZ 50 uksokysV 5x3 fefy dkfVZt 1518.98 29.11.2006

baL;wykjVMZ uksokysV 5x3 fefy dkfVZt 1518.98 29.11.2006

uksoksjsfiM 100 vkbZ;w@fefy 10 fefy dk ok;y 1424.22 2062(E)

30.11.2007

uksoksfeDl 30 isufQy 5x3 fefy dk dkfVZt 2126.59 187(E)

29.01.2008

uksoksjsfiM isufQy 5x3 fefy dk dkfVZt 2126.59 187(E)

29.01.2008

207. uwry QkekZ jsLVksfeu VscysV 10 dk iÙkk@fCyLVj 5.64 05.10.2006

208. vksscltZ ck;ksVsd fM;wflMky QksVZ dSilwy 10 dk ,,y_fCyLVj 27.96 29.03.2006

¶yksjkyksDl ,ych xksfy;ka 10 dk ,,y_fCyLVj 9.64 29.03.2006

209. vksdkok ysc fyfeVsM jsUFkzksflu MhVh xksfy;ka 10 dk iRrk 21.72 11.07.2006

,DlhC;wV &,l Øhe 15 xzke dh V~;wc 7.09 29.03.2006

,Dl&lsl Øhe 50 xzke dh V~;wc 15.10 20.10.2005

210. vksjfcV baVjus’kuy vkbZ&lkbZV QksVZ dSIlwy 10 dk ,,y_fCyLVj 12.50 05.10.2006

211. vksojfll gsYFkds;j fyfeVsM ckbdksDl fdM QksVZ xksfy;ka 10 dk iRrk@fCyLVj 19.97 15.06.2005

ckbdksDl&bZ fdV 30x2 dk fdV 197.14 15.06.2005

ckbdksDl&bZ xksfy;ka 5x6 dk iRrk@fCyLVj 173.97 15.06.2005

212. ih ,aM ch yscksjsVªht izkbosV fyfeVsM osUVkczkse flji 110 fefy dh cksry 17.02 29.03.2006

Page 300: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 281 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

213. isutkWu QkekZ fcdksDl QksVZ fdV 4 dk dksEch iSd 10.53 15.06.2005

214. isjsUVªy MªXl ¼vkbZ½ fyfeVsM ck;dksYM xksfy;ka 10 dk iRrk@fCyLVj 7.58 11.07.2006

215. isjSDl QkekZ dqQjSDl flji 60 fefy dh cksry 8.98 05.10.2006

dqQjSDl flji 100 fefy dh cksry 11.72 05.10.2006

216. ikdZ Msfol ¼bafM;k½ fyfeVsM csfufyu dWQ flji 60 fefy dh cksry 10.91 30.03.2005

csfufyu dWQ flji 100 fefy dh cksry 14.85 30.03.2005

csfufyu bZ ,DlisDVksjsUV 60 fefy dh cksry 9.75 30.03.2005

csfufyu bZ ,DlisDVksjsUV 100 fefy dh cksry 12.95 30.03.2005

VsMjkWy ,l, xksfy;ka 10 dk iRrk@fCyLVj 5.39 29.03.2006

217. ihlhvkbZ QkekZfl;wfVdy izkbosV fyfeVsM vkblks&fjQk xksfy;ka 30 dk iRrk 215.84 21.07.1998

vkblks&fjQkft+u xksfy;ka 10 dk iRrk 55.44 21.07.1998

DyksjksDohu QksLQsV xksfy;ka 10 fexzk- 6 dk ,,y_iRrk 1.54 02.04.2003

esykDohu bUtsD’ku 50 fefy dk ok;y 14.90 02.04.2003

DyksjksDohu QksLQsV xksfy;ka 10 fexzk- 6 dk ,,y_iRrk 1.52 25.07.2003

esykDohu xksfy;ka 6 dk ,,y_iRrk 1.64 26.02.2000

esykDohu flji 90 fefy dh cksry@,e-di 14.98 26.02.2000

esykDohu Mªksi 10 fefy dh cksry@Mªksij 6.60 26.02.2000

esykDohu Mªksi 15 fefy dh cksry@Mªksij 8.14 26.02.2000

vkblks&fjQkft+u xksfy;ka 10 dk iRrk@fCyLVj 41.83 15.06.2005

218. ipZ vYVªkfoV yks’ku 10 fefy dh cksry 17.54 11.03.1998

ekbdkscsu & ch Øhe 10 xzke dh V~;wc 17.88 11.03.1998

ekbdkscsu & ch yks’ku 10 fefy dh cksry 17.79 11.03.1998

219. QkbesDl baVjus’kuy fyfeVsM csflysd dSilwy 10 dk iRrk@fCyLVj 10.20 10.08.1999

220. fQLdj fyfeVsM ,flxks bUtsD’ku 5x10 fefy dk ,Ei;wy 25.64 20.09.2005

221. Qkbt+j fyfeVsM csfufyu dWQ flji 60 fefy dh cksry 10.91 30.03.2005

csfufyu dWQ flji 100 fefy dh cksry 14.85 30.03.2005

csfufyu bZ ,DlisDVksjsUV 60 fefy dh cksry 9.75 30.03.2005

csfufyu bZ ,DlisDVksjsUV 100 fefy dh cksry 12.95 30.03.2005

Vsjkekbflu ,l,Q dSilwy 4 dk ,,y_iRrk 3.21 20.10.2004

Vsjkekbflu ,l,Q dSilwy 4 dk ,,y_fCyLVj 2.92 20.10.2004

Vsjkekbflu vkWifVdy vkW;UVesUV 3 xzke dh V~;wc 3.42 9.12.1997

lksY;w esMjksy ,vksoh 40fexzk- bUtsD’ku 1 fefy dk ok;y 150.96 01.05.2006

lksY;w esMjksy ,vksoh 500fexzk- 4 fefy 696.80 01.05.2006

bUtsD’ku ,DVks&vks&ok;yfMiks esMjksy 40fexzk- bUtsD’ku 1 fefy dk ok;y 61.23 01.05.2006

fMiks esMjksy 40fexzk- bUtsD’ku 2 fefy dk ok;y 90.61 01.05.2006

lksY;w esMjksy 125fexzk- bUtsD’ku 2 fefy dk ok;y 287.04 19.05.2006

Page 301: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 282 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

222. Qkbt+j izksMDVl bafM;k izk- fy- lksyw esMjksy lsVsfj;y ikmMj 1 xzke 8 fefy ok;y 1134.00 31.07.2006

¼,DV&vks&ok;y½fMiks esMjksy 40fexzk- bUtsD’ku 1 fefy dk ok;y 48.69 2061(E)

01.05.2006fMiks esMjksy 40fexzk- bUtsD’ku 2 fefy dk ok;y 72.35 2061(E)

01.05.2006lksY;w esMjksy ,vksoh 40fexzk- bUtsD’ku 1 fefy dk ok;y 139.71 2061(E)

01.05.2006lksY;w esMjksy ,vksoh 500fexzk- bUtsD’ku 4 fefy dk ok;y 615.23 2061(E)

01.05.2006lksY;w esMjksy ,vksoh 8 fefy dk ok;y 917.25 2061(E)

1000fexzk- bUtsD’ku 01.05.2006

lksY;w esMjksy 125fexzk- bUtsD’ku 2 fefy dk ok;y 253.80 2061(E)01.05.2006

esMjksy 4fexzk- xksfy;ka 10x10 dk iRrk@fCyLVj 323.63 2061(E)01.05.2006

esMjksy 4fexzk- xksfy;ka 10x10 dk iRrk@fCyLVj 323.63 2061(E)01.05.2006

esMjksy 16fexzk- xksfy;ka 14 dk iRrk@fCyLVj 143.40 2061(E)01.05.2006

esMjksy 4fexzk- xksfy;ka 10x10 dk iRrk@fCyLVj 325.77 2061(E)01.05.2006

esMjksy 4fexzk- xksfy;ka 10x10 dk iRrk@fCyLVj 324.59 2061(E)01.05.2006

fMiksesMjksy 80fexzk- bUtsD’ku 2 fefy dk ok;y 72.01 188(E)29.01.2008

fMiksesMjksy 40fexzk- bUtsD’ku 1 fefy dk ok;y 48.99 188(E)29.01.2008

lksY;w esMjksy ,vksoh 40fexzk- bUtsD’ku 1 fefy dk ok;y 120.35 188(E)29.01.2008

lksY;w esMjksy ,vksoh 125fexzk- bUtsD’ku 2 fefy dk ok;y 228.14 188(E)29.01.2008

esMjksy 4fexzk- xksfy;ka 10x10 dk iRrk@fCyLVj 291.94 188(E)29.01.2008

esMjksy 4fexzk- xksfy;ka 10x10 dk iRrk@fCyLVj 291.55 188(E)29.01.2008

esMjksy 4fexzk- xksfy;ka 10x10 dk iRrk@fCyLVj 290.92 188(E)29.01.2008

esMjksy 4fexzk- xksfy;ka 10x10 dk iRrk@fCyLVj 291.94 188(E)29.01.2008

esMjksy 16fexzk- xksfy;ka 14 dk iRrk@fCyLVj 127.84 188(E)29.01.2008

esMjksy 16fexzk- xksfy;ka 14 dk iRrk@fCyLVj 127.84 188(E)29.01.2008

esMjksy 16fexzk- xksfy;ka 14 dk iRrk@fCyLVj 128.73 188(E)29.01.2008

esMjksy 16fexzk- xksfy;ka 14 dk iRrk@fCyLVj 128.01 188(E)29.01.2008

lksY;w esMjksy ,vksoh 500fexzk- bUtsD’ku 4 fefy dk ok;y 555.54 188(E)29.01.2008

Page 302: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 283 -

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

223. QkekZ MªXl ,aM dsfedy dks¶eksy flji 100 fefy dh cksry 12.90 29.03.2006

224. QkesZf’k;k ,jFkzksflu 250fexzk- xksfy;ka 10 dk iRrk@fCyLVj 21.69 07.02.2006

,jFkzksflu 500fexzk- xksfy;ka 10 dk iRrk@fCyLVj 42.32 07.02.2006

225. QkesZf’k;k ,aM vit+kWu bafM;k fyfeVsM fefufM;sc xksfy;ka 2.5 fexzk- 4x15 dk fCyLVj 17.58 16.11.1999

fefufM;sc xksfy;ka 5 fexzk- 4x15 dk fCyLVj 28.83 16.11.1999

lksY;w esMjksy 2 fefy dk ok;y 244.86 27.05.2003

¼Xy;wdksdksfVZdksbM½ bUtsD’kulksY;w esMjksy 16 fefy dk ok;y 877.10 27.05.2003

¼Xy;wdksdksfVZdksbM½ bUtsD’kufMiks esMjksy 1 fefy dk ok;y 51.98 27.05.2003

¼Xy;wdksdksfVZdksbM½ bUtsD’kufMiks esMjksy 2 fefy dk ok;y 78.45 27.05.2003

¼Xy;wdksdksfVZdksbM½ bUtsD’kuesMjksy xksfy;ka 4 fexzk- 10x10 dk iRrk 384.57 27.05.2003

lksY;w esMjksy 40 fexzk- bUtsD’ku 1 fefy dk ok;y 128.48 27.05.2003

esMjksy xksfy;ka 16 fexzk- 1x14 dk iRrk 168.90 27.05.2003

lksY;w esMjksy 4 fefy dk 632.64 27.05.2003

¼Xy;wdksdksfVZdksbM½ bUtsD’ku ,DVks&vks&ok;ylksY;w esMjksy 8 fefy dk 1045.35 27.05.2003

¼Xy;wdksdksfVZdksbM½ bUtsD’ku ,DVks&vks&ok;yfyUdksflu bUtsD’ku 2 fefy dk ok;y 20.31 02.09.1998

fyUdksflu dSilwy 2x10 dk iRrk 198.98 02.09.1998

226. QkesZf’k;k gsYFkds;j ,fjFkzksflu xksfy;ka 10 dk iRrk@fCyLVj 23.06 30.03.2005

,fjFkzksflu xksfy;ka 10 dk iRrk@fCyLVj 45.09 30.03.2005

,fjFkzksflu lLisUlu 60 fefy dh cksry@,e-di 21.17 30.03.2005

lksY;w esMjksy 40 fexzk- bUtsD’ku 1 fefy dk ok;y 146.44 11.08.2004

lksY;w esMjksy 125 fexzk- bUtsD’ku 2 fefy dk ok;y 278.19 11.08.2004

lksY;w esMjksy ¼Xy;wdksdksfVZdksbM½ 4 fefy ,DVks&vks&ok;y 657.66 11.08.2004

lksY;w esMjksy ¼Xy;wdksdksfVZdksbM½ 8 fefy ,DVks&vks&ok;y 1103.02 11.08.2004

fMiks esMjksy bUtsD’ku 1 fefy dk ok;y 59.19 11.08.2004

fMiks esMjksy bUtsD’ku 2 fefy dk ok;y 87.08 11.08.2004

227. QkekZflUFk QkWE;wZys’kUl fyfeVsM vksflQsu Iyl fdM xksfy;ka 10 dk iRrk@fCyLVj 2.79 29.03.2006

ysDVksfc;ksu dSilwy 6 dk iRrk@fCyLVj 3.66 10.08.1999

ysDVksfc;ksu dSilwy 10 dk iRrk@fCyLVj 5.96 10.08.1999

lsMksfjy Iyl 100 fefy dh cksry 11.95 05.10.2006

lsedksYM 60 fefy dh cksry 9.90 05.10.2006

228. QkekZVSd gsYFkds;j flusDV 60 fefy dh cksry 9.83 05.10.2006

flusDV Mh,e 60 fefy dh cksry 10.64 05.10.2006

229. ihvkbZ,y vksjFkksMsDl QksVZ xksfy;ka 10 dk iRrk@fCyLVj 12.46 20.09.2005

vksjFkksMsDl xksfy;ka 12 dk iRrk@fCyLVj 10.60 29.03.2006

Page 303: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 284 -

230. ik;ks’k QkekZfl;wfVdy fyfeVsM gsUxksojt+ ,QjoslsUV xksfy;ka 2 dk ,,y_iRrk 2.92 04.03.2004

231. fijkey gsYFk ds;j fyfeVsM esMksij 250 fexzk- xksfy;ka 30 dh cksry 149.93 19.03.1998

232. iysfFkdks QkekZ fyfeVsM okbZ&osDl fdV 1 fdV 11.28 19.05.2006

fjdksQkWLV xksfy;ka 10 dk iRrk@fCyLVj 6.27 13.06.2000

fjdksQkWLV Iyl xksfy;ka 10 dk iRrk 8.74 03.09.2003

fjdksQkWLV Iyl flji@lLisUlu 30 fefy dh cksry 8.25 03.09.2003

233. izse QkekZfl;wfVdy ch ysDV dSilwy 10 dk iRrk@fCyLVj 10.20 10.08.1999

234. fiz;ky QkekZ foLdkWQ&Mh flji 100 fefy dh cksry 18.65 08.12.2000

235. izksdse lsVjk Mhlh xksfy;ka 10 dk iRrk@fCyLVj 3.37 29.03.2006

236. izksfQd vkWjxsfud fyfeVsM ,lyksV&,DlVh xksfy;ka 10 dk ,,y_fCyLVj 10.52 29.03.2001

237. izksVsd ¼fliyk dk ,d fMfot+u½ xkfMZ;u dSilwy 10 dk iRrk@fCyLVj 21.42 19.05.2006

psLVu xksfy;ka 10 dk iRrk@fCyLVj 2.68 11.07.2006

psLVu flji 60 fefy dh cksry 10.34 13.06.2000

psLVu flji 100 fefy dh cksry 13.93 13.06.2000

VsjQsM Mh xksfy;ka 10 dk iRrk@fCyLVj 15.64 13.06.2000

238. I;ksj gsYFk ,yksb&bZ Øhe 30 xzke dh V~;wc 10.58 20.09.2005

239. jsfMDl ck;ksVsd czweksy&,l xksfy;ka 10x10 dk iRrk@fCyLVj 93.11 29.03.2006

240. jsfyl bafM;k fyfeVsM jsyusi xksfy;ka 250 fexzk- 10x10 dk ,,y_iRrk 298.16 09.12.1997

jsyusi xksfy;ka 250 fexzk- 10x10 dk ,,y_fCyLVj 294.77 09.12.1997

241. jsekst+ yscksjsVªht izkbosV fyfeVsM dksQsfy flji 100 fefy dh cksry 17.45 29.03.2006

242. jsucSDlh ysc- fyfeVsM jksysVªk Mh ,DlVsUMsM fjfyt+ xksfy;ka 6 dk ihohMhlh fCyLVj 17.17 20.07.2000

,fYVok Mh ,DlVsUMsM fjfyt+ xksfy;ka 10 dk ,,y_iRrk 39.52 20.07.2000

,fYVok Mh ,DlVsUMsM fjfyt+ xksfy;ka 10 dk ,,y_fCyLVj 38.49 20.07.2000

VªsDlhfMu xksfy;ka 10 dk iRrk 16.32 08.12.2000

isUVkMeZ vkW;UVesUV 5 xzke dh V~;wc 6.89 29.03.2006

bUlwds;j ,u bUtsD’ku 40 vkbZ;w@fefy 10 fefy dk ok;y 126.74 07.02.2006

bUlwds;j ,e 50 bUtsD’ku 40vkbZ;w@fefy 10 fefy dk ok;y 129.06 07.02.2006

bUlwds;j vkj bUtsD’ku 40vkbZ;w@fefy 10 fefy dk ok;y 126.64 07.02.2006

bUlwds;j ,e 30 bUtsD’ku 40vkbZ;w@fefy 10 fefy dk ok;y 129.70 07.02.2006

fjgksfyu fjgksdSi 200 2x14 dk ,pMhihbZ cksry 43.58 20.09.2005

jsfufVfMu xksfy;ka 150 fexzk- 2 dk ,,y_iRrk 3.35 20.09.2005

¼fgLVsd bZohVh xksfy;ka½

fgLVsd bZohVh xksfy;ka ¼feaV½ 2 dk ,,y_iRrk 2.96 14.02.2007

243. jsiVkdksl czsV ,aM dEiuh fyfeVsM gksfoV Mªksi 15 fefy dk¡p dh cksry 12.43 24.12.2003

Mªksij vkSj dkVZu lfgrjsU;w QksVZ dSilwy 10 dk ,,y_fCyLVj 7.44 09.03.1998

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

Page 304: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 285 -

fu;ksxkfMu ,fyDlj 300 fefy dh cksry 35.50 09.03.1998

,e-di vkSj dkVZu lfgrfu;ksxkfMu ,fyDlj 450 fefy dh cksry 48.29 09.03.1998

,e-di vkSj dkVZu lfgrfu;ksxkfMu ,l-th- ,fyDlj 300 fefy dh cksry 42.91 09.03.1998

,e-di vkSj dkVZu lfgrfu;ksxkfMu ,l-th- ,fyDlj 450 fefy dh cksry 59.26 09.03.1998

,e-di vkSj dkVZu lfgrjsU;w QksVZ dSilwy 10 dk ,,y_fCyLVj 11.13 28.09.1998

Xyk;dksQ flji 120 fefy cksry 10.99 05.10.2006

244. jSDl gSYFk ds;j izkbosV fyfeVsM dqQWDl Mh 10 dk ,,y_fCyLVj 3.70 05.10.2006

jSDl dksYM lh flji 50 fefy 12.28 05.10.2006

245. jSfou gSYFk ds;j fMVksj VscysV 10 dk iRrk@fCyLVj 2.06 05.10.2006

fMVksj ,DlisDVksjsaV 200 fefy cksry 26.18 05.10.2006

246. jseUM QkekZfl;wfVdy izkbosV fyfeVsM czksV~l flji 60 fefy dh cksry 10.35 29.03.2006

247. jsfdV~ csudkbt+j ¼bafM;k½ fyfeVsM fMlfizu xksfy;ka 10 dk ,,y_iRrk 2.70 04.03.2004

gksyksxzkfQd iRrk lfgrdksylfizu xksfy;ka 10 dk ,,y_iRrk 2.52 04.03.2004

gksyksxzkfQd iRrs lfgrMsVkWy ,afVlsfIVd fyfDoM 50 fefy x 12 cksry 112.43 04.03.2004

MsVkWy ,afVlsfIVd fyfDoM 50 fefy x 12 cksry 114.59 04.03.2004

gksyksxzkfQd iRrs lfgrMsVkWy ,afVlsfIVd fyfDoM 50 fefy x 12 cksry 115.40 04.03.2004

yscy ij gksyksxzkfQd iRrsvkSj vkjvksihih dSi lfgr

MsVkWy ,afVlsfIVd fyfDoM 100 fefy x 12 cksry 178.07 04.03.2004

MsVkWy ,afVlsfIVd fyfDoM 100 fefy x 12 cksry 180.77 04.03.2004

gksyksxzkfQd iRrs lfgrMsVkWy ,afVlsfIVd fyfDoM 100 fefy x 12 cksry 181.84 04.03.2004

yscy ij gksyksxzkfQd iRrsvkSj vkjvksihih dSi lfgr

MsVkWy ,afVlsfIVd fyfDoM 200 fefy x 12 cksry 304.46 04.03.2004

MsVkWy ,afVlsfIVd fyfDoM 200 fefy x 12 cksry 307.70 04.03.2004

gksyksxzkfQd iRrs lfgrMsVkWy ,afVlsfIVd fyfDoM 200 fefy x 12 cksry 309.05 04.03.2004

yscy ij gksyksxzkfQd iRrsvkSj vkjvksihih dSi lfgr

MsVkWy ,afVlsfIVd fyfDoM 500 fefy x 12 cksry 671.54 04.03.2004

MsVkWy ,afVlsfIVd fyfDoM 500 fefy x 12 cksry 675.85 04.03.2004

gksyksxzkfQd iRrs lfgr

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

Page 305: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 286 -

MsVkWy ,afVlsfIVd fyfDoM 500 fefy x 12 cksry 677.20 04.03.2004

yscy ij gksyksxzkfQd iRrsvkSj vkjvksihih dSi lfgr

fMlfizu LVªksax xksfy;ka 2 dk ,,y_iRrk 0.93 04.01.2005

fMlfizu LVªksax xksfy;ka 10 dk ,,y_iRrk 4.67 04.01.2005

dksylfizu xksfy;ka 14 dk ,,y_iRrk 4.67 04.01.2005

gksyksxzkfQ lfgrfMlfizu xksfy;ka 10 dk ,,y_iRrk 2.90 04.01.2005

MsVkWy ,afVlsfIVd fyfDoM 12x50 fefy 112.44 1670(E)

dkap dh cksry 27.09.2007

MsVkWy ,afVlsfIVd fyfDoM 12x100 fefy 174.88 1670(E)

dkap dh cksry 27.09.2007

MsVkWy ,afVlsfIVd fyfDoM 12x200 fefy 297.32 1670(E)

dkap dh cksry 27.09.2007

MsVkWy ,afVlsfIVd fyfDoM 12x500 fefy 646.00 1670(E)

dkap dh cksry 27.09.2007

MsVkWy ,afVlsfIVd fyfDoM 12x5 fyVj 5828.00 1670(E)

dkap dh cksry 27.09.2007

248. jsfMdks jsesfMt+ ¼chvkbZih,y½ ,sMh lhtsM xksfy;ka 10 dk iRrk@fCyLVj 4.54 29.03.2006

249. jsdfouk ysc fyfeVsM jsfDlu lksY;w’ku 30 fefy dh cksry@dkVZu 13.78 15.02.2000

esxkQsu xksfy;ka 10 dk ,,y_fCyLVj 6.72 29.03.2001

250. jsesM ,p- ds;j fjeksDl fdM@tsM,p xksfy;ka 10 dk iRrk@fCyLVj 15.87 15.06.2005

251. jsesfMDl QkekZ izkbosV fyfeVsM fFk;ksfczd&,lvkj xksfy;ka 10 dk iRrk@fCyLVj 4.92 29.03.2006

252. jsdLVj LVsVe &ch Øhe 10 xzke dh V~;wc 6.36 29.03.2006

LVsVe &ch yks’ku 15 fefy dh cksry 8.11 29.03.2006

LVsVe &Iyl Øhe 10 xzke dh V~;wc 7.38 29.03.2006

253. jksgEcl QkekZfl;wfVdy izkbosV fyfeVsM ysfjczks ,DlisDVksjsUV 50 fefy dh cksry 9.67 29.03.2006

254. jksgu iksysUd ¼vkbZ½ fyfeVsM ljeksfUVy xksfy;ka 10 fexzk- 10 dk iRrk 7.28 30.10.1998

ljeksfUVy xksfy;ka 20 fexzk- 10 dk iRrk 16.14 30.10.1998

255. fjdfouk QkekZ jsfDlu xksfy;ka 10 dk iRrk@fCyLVj 27.58 19.05.2006

256. jly bafM;k fyfeVsM zQsfefLVu lks zQkekbflu 15 xzke dh cksry 13.63 30.10.1998

zQsfefLVu vk¡[kksa dk Mªksi 5 fefy dk ok;y 8.30 30.10.1998

Mªksij vkSj dkVZu lfgrizksDVkslsfMy vkW;UVesUV 10 xzke dh ysd~MZ V~;wc 27.25 30.10.1998

izksDVkslsfMy vkW;UVesUV 10 xzke dh ysd~MZ V~;wc 25.57 16.04.1998

zQsehlsfVu ikmMj 15 xzke dh cksry 12.20 11.03.1998

lksÝkekbflu ,Q Øhe 15 xzke dh ysd~MZ V~;wc 20.09 02.12.1998

lksÝkMsDl Øhe 20 xzke dh V~;wc 23.86 02.12.1998

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

Page 306: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 287 -

lksÝkdkVZ bZ@bZ Mªksi 5 fefy ok;y Mªksij vkSj dkVZu 16.22 02.12.1998

lksÝkfV;wy ,afVck;ksfVd@Mªsflax 1 dk 10ls-eh- x 10 ls-eh- 12.85 05.02.1999

257. vkj-ih-th ykbQ lkbal fjuksLVsV fyfDoM 60 fefy dh cksry@,e-di 10.40 04.01.2005

fjuksLVsV xksfy;ka 8 dk ,,y_iRrk 4.74 03.09.2003

258. lQZ Qjfevksu fyfeVsM flizks¶yksDlkflu lLisa’ku@flji 50 fefy cksry 12.30 23.03.2007

259. ,l-th- QkekZfl;wfVdy bUlwukeZ 5fefy fyfDoM bUtsDVscy 5 fefy ok;y 64.50 10.05.2001

bUlwukeZ 10fefy fyfDoM bUtsDVscy 10 fefy ok;y 121.34 10.05.2001

bUlwfyad 70/30 fyfDoM bUtsDVscy 5 fefy ok;y 64.59 10.05.2001

bUlwfyad 70/30 fyfDoM bUtsDVscy 10 fefy ok;y 121.52 10.05.2001

bUlwyksax ,uih,p 5fefy fyfDoM bUtsDVscy 5 fefy ok;y 64.60 10.05.2001

bUlwyksax ,uih,p 10fefy fyfDoM bUtsDVscy10 fefy ok;y 121.54 10.05.2001

bUlwyksax tsM 5fefy fyfDoM bUtsDVscy 5 fefy ok;y 64.56 10.05.2001

bUlwyksax tsM 10fefy fyfDoM bUtsDVscy 10 fefy ok;y 121.46 10.05.2001

áweu bUlwukeZ 5fefy fyfDoM bUtsDVscy 5 fefy ok;y 108.87 10.05.2001

áweu bUlwukeZ 10fefy fyfDoM bUtsDVscy 10 fefy ok;y 210.08 10.05.2001

áweu bUlwfyad 70/30 fyfDoM bUtsDVscy 5 fefy ok;y 108.98 10.05.2001

áweu bUlwfyad 70/30 fyfDoM bUtsDVscy 10 fefy ok;y 210.30 10.05.2001

áweu bUlwyksax ,uih,p fyfDoM bUtsDVscy 5 fefy ok;y 108.99 10.05.2001

áweu bUlwyksax ,uih,p fyfDoM bUtsDVscy 10 fefy ok;y 210.32 10.05.2001

áweu bUlwyksax tsM fyfDoM bUtsDVscy 5 fefy ok;y 108.89 10.05.2001

áweu bUlwyksax tsM fyfDoM bUtsDVscy 10 fefy ok;y 210.12 10.05.2001

tksykufMu Øhe 20 xzke ysd~MZ V~;wc 9.35 09.03.1998

260. lehj jsesfMt+ fjEikfej tsM,p xksfy;ka 10 dk iRrk 28.70 21.07.1998

261. lselu ysc izkbosV fyfeVsM czwQkstsfld lLisUlu 450 fefy cksry 44.63 29.03.2001

262. lsucjh gsYFk ds;j eqVsDl 100 fefy cksry 12.68 05.10.2006

263. lsaMkst QkekZ fy- ,UVh Vhch ’kSM;wy&1 24x7 dEiksflV 271.60 14.02.2007

,y@ihohMhlh@ihohlh izR;sd fdV,UVh Vhch ’kSM;wy&2 18x13 xksfy;ka@dSIlwy 278.28 14.02.2007

dEiksflV,y@ihohMhlh@ihohlh izR;sd fdV

,UVh Vhch ’kSM;wy&3 247x5 xksfy;ka@dSIlwy 190.60 14.02.2007

dksEch iSdizR;sd fdV 7.94 14.02.2007

264. lsUVs~ fot+u vksdfoV dSilwy 10 dk iRrk@fCyLVj 9.31 20.09.2005

265. lkjkHkkbZ dsfedy #cjkIysDl fyfDoM 240 fefy dk¡p dh cksry 22.15 18.06.1999

áweu jsfifMdk 10 fefy ok;y 210.08 17.01.2001

izksfMdk 10 fefy ok;y 121.54 17.01.2001

áweu izksfMdk 10 fefy ok;y 210.32 17.01.2001

jsfifMdk bUtsD’ku ch-ih- 40;wfuV@fefy 10 fefy ok;y 121.34 17.01.2001

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

Page 307: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 288 -

áweu jsfifeDl 10 fefy ok;y 210.30 17.01.2001

jsfifeDl 10 fefy ok;y 121.52 17.01.2001

áweu ftU;wfyu 10 fefy ok;y 210.12 17.01.2001

áweu ftU;wfyu 10 fefy ok;y 121.46 17.01.2001

csfuV~l ,DlisDVksjsUV lLisUlu 60 fefy dh cksry 14.26 29.03.2006

QksLQksfeu VkWfud 250 fefy dh cksry dkVZu 18.27 28.09.1998

QksLQksfeu vkW;ju VkWfud 250 fefy dh cksry dkVZu 18.57 28.09.1998

266. lhxy ysc ¼bafM;k½ izkbosV fyfeVsM ftusMks xksfy;ka 10 dk iRrk@fCyLVj 5.50 15.06.2005

267. lsfeV QkekZ ,aM dsfedy izkbosV fyfeVsM vkbZ&foV dSilwy 10 dk iRrk 5.74 28.09.1998

vkbZ&foV dSilwy 30 dk iRrk 17.23 28.09.1998

268. lselu QkekZ izkbZosV fyfeVsM focwfjy & ,,l dWQ flji 60 fefy dh cksry 10.73 29.03.2006

focwfjy & ,,l dWQ flji 100 fefy dh cksry 14.30 29.03.2006

lsedksYM 10 dk iRrk@fCyLVj 4.60 05.10.2006

269. lkYd QkekZ izkbosV fyfeVsM jksbuQWj lLisUlu 60 fefy dh cksry 11.05 09.03.1998

jksbuQWj lLisUlu 450 fefy dh cksry 55.61 09.03.1998

czwQkeksy xksfy;ka 250 dh cksry 144.43 29.03.2000

czwQkeksy fdM xksfy;ka 10 dk iRrk@fCyLVj 2.72 29.03.2000

czwQkeksy fdM xksfy;ka 250 dh cksry 61.69 29.03.2000

,Dusysd Øhe@vkW;UVesUV 15 xzke dh V~;wc 12.45 15.02.2000

270. lUFkk ck;ksVsdfud izkbosV fyfeVsM lsufoo flji 100 fefy dh cksry 17.85 29.03.2006

lsufoo flji 200 fefy dh cksry 30.88 29.03.2006

lsufoo lhtsM dSilwy 10 dk iRrk@fCyLVj 13.32 29.03.2006

271. f’kUVks vkWjxsfud izkbosV fyfeVsM ,C;wQsu&lh xksfy;ka 10 dk iRrk@fCyLVj 7.34 29.03.2006

czslh flji 100 fefy dh cksry 14.59 29.03.2006

dkseksDl MhVh xksfy;ka 10 dk ,,y_fCyLVj 10.53 29.03.2006

dkseksDl ch dSilwy 10 dk ,,y_fCyLVj 21.75 29.03.2006

272. Js;k ykbQ lkbal izkbosV fyfeVsM fjdkslwfyu ,e&30 40vkbZ;w@fefy 10 fefy dk ok;y 130.17 29.03.2006

fjdkslwfyu vkj 40vkbZ;w@fefy 10 fefy dk ok;y 131.07 29.03.2006

fjdkslwfyu ,u 40vkbZ;w@fefy 10 fefy dk ok;y 129.11 29.03.2006

fjdkslwfyu vkj ¼lknh½ 40vkbZ;w@fefy 10 fefy dk ok;y 139.00 11.07.2006

fjdkslwfyu ,u ¼,uih,p½ 40vkbZ;w@fefy10 fefy dk ok;y 139.16 11.07.2006

fjdkslwfyu ,e&30 (30/70) 40vkbZ;w@fefy10 fefy dk ok;y 139.10 11.07.2006

fjdkslwfyu ,e&50 (50/50) 40vkbZ;w@fefy10 fefy dk ok;y 139.06 11.07.2006

bUQst+ 3 dksEchiSd 3 dk dksEch iSd 7.83 15.06.2005

fjdksQkLV Iyl 10 dk iRrk@fCyLVj 7.04 05.10.2006

fjdksQkLV 60 fefy cksry 10.50 05.10.2006

fjdksQkLV Iyl 15 fefy cksry 6.42 05.10.2006

fjdkslwfyu ,e 30 40 vkbZ;w@fefy 10 fefy dk ok;y 134.77 11.08.2006

fjdkslwfyu ,e 50 100 vkbZ;w@fefy 10 fefy dk ok;y 343.87 09.10.2006

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

Page 308: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 289 -

fjdkslwfyu ,e 30 100 vkbZ;w@fefy 10 fefy dk ok;y 343.87 09.10.2006

fjdkslwfyu ,e 30 100 vkbZ;w@fefy 3 fefy dk dkfVZt 185.31 1348(E)01.08.2007

fjdkslwfyu ,e 50 100 vkbZ;w@fefy 3 fefy dkfVZt 200.73 14.02.2007

fjdkslwfyu vkj 100 100 vkbZ;w@fefy 3 fefy dkfVZt 200.73 14.02.2007

fjdkslwfyu ,u 100 100 vkbZ;w@fefy 3 fefy dkfVZt 200.73 14.02.2007

fjdkslwfyu ,e 50 100 vkbZ;w@fefy 10 fefy dk ok;y 312.10 1348(E)01.08.2007

fjdkslwfyu ,uih,p 100 vkbZ;w@fefy 10 fefy dk ok;y 305.74 1348(E)01.08.2007

fjdkslwfyu vkj 100 vkbZ;w@fefy 3 fefy dk dkfVZt 218.90 185(E)29.01.2008

fjdkslwfyu ,u 100 vkbZ;w@fefy 3 fefy dk dkfVZt 218.90 185(E)29.01.2008

273. fljk QkekZfl;wfVdy fyfeVsM osUVh ,DlisDVksjsUV 60 fefy dh cksry 12.30 29.03.2006

osUVh ,DlisDVksjsUV 100 fefy dh cksry 16.91 29.03.2006

osUVh Mh 60 fefy dh cksry 10.60 05.10.2006

osUVh Mh 100 fefy dh cksry 14.44 05.10.2006

274. flLVk QkekZfl;wfVdy ,fjM xksfy;ka 10 dk iRrk@fCyLVj 4.54 29.03.2006

275. flxek ysc fyfeVsM isUtkby bUtsD’ku 10 fefy dk ok;y 34.70 30.03.2005

276. flfydkWu QkekZ flfydkWQ ,DlisDVksjsUV 60 fefy dh cksry 10.97 29.03.2006

fleczks flji 100 fefy dh cksry 14.71 29.03.2006

fleczks flji 60 fefy dh cksry 10.91 29.03.2006

277. fl;kseksUM QkekZfl;wfVdy czksfUle lLisUlu 60 fefy dh cksry 10.80 29.03.2006

czksfUle lLisUlu 100 fefy dh cksry 14.41 29.03.2006

278. flofyax VsDuksyksfTl floksDlksy xksfy;ka 10 dk iRrk@fCyLVj 8.71 29.03.2006

279. LdkbZesDl yscksjsVªht+ izkbosV fyfeVsM dks¶lh flji 100 fefy dh cksry 15.03 29.03.2006

280. fLeFk LVsuLVªhV QkekZ fyfeVsM lsyfcd ,y ¼ih,p½ dSilwy 10x10 dk ,,y_iRrk 55.00 16.04.1998

gseksfyfoV dSilwy 10x10 dk ,,y_iRrk 78.79 16.04.1998

QseksLVu xksfy;ka 20 fexzk- 5x14 ,,y_iRrk 24.47 09.12.1999

QseksLVu xksfy;ka 20 fexzk- 5x14 ,,y_fCyLVj 22.04 09.12.1999

QseksLVu xksfy;ka 40 fexzk- 5x14 ,,y_iRrk 39.77 09.12.1999

QseksLVu xksfy;ka 40 fexzk- 5x14 ,,y_fCyLVj 37.41 09.12.1999

gseksfyfoV dSilwy 10x10 dk iRrk 75.94 24.12.2002

281. lksy QkekZfl;wfVdy fyfeVsM Qsufyax ,lvkj xksfy;ka 200 fexzk- 10 dk iRrk@fCyLVj 3.48 29.03.2001

Qsufyax ,lvkj xksfy;ka 400 fexzk- 10 dk iRrk@fCyLVj 5.24 29.03.2001

282. lksyl lksfØV dSilwy 30 dk iRrk 42.45 24.12.2002

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

Page 309: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 290 -

283. lksesfVdks ysc lksekosUV ,Dl 100 fefy dh cksry 13.86 29.03.2006

dksEchfMu xksfy;ka 10 dk iRrk@fCyLVj 9.93 29.03.2006

lksy&,Dl xksfy;ka 10 dk iRrk@fCyLVj 2.38 05.10.2006

lksy&,u xksfy;ka 10 dk iRrk@fCyLVj 3.14 05.10.2006

osVdksQ xksfy;ka 10 dk iRrk@fCyLVj 3.30 05.10.2006

284. ,lihih,y ,fFkdy fMfot+u ,fyElh dSilwy 10 dk iRrk@fCyLVj 9.31 20.09.2005

285. LVsMesM izkbosV fyfeVsM LVkbIVksflM xksfy;ka 10 dk iRrk 3.55 24.12.2002

bC;wMksy 650 fexzk- xksfy;ka 10 dk iRrk@fCyLVj 7.44 29.03.2000

iqYeks jsLV flji 100 fefy dk¡p dh cksry 13.72 29.03.2006

286. LVªkbMl ,jdksysc fyfeVsM fyokMsDl bUtsD’ku 10 fefy dk¡p dk 12.11 19.11.2003

,Ecj ,Ei;wyfyokMsDl bUtsD’ku 30 fefy dk¡p dk 23.02 19.11.2003

,Ecj ,Ei;wy

287. lu QkekZ flVªhtsV Mh xksfy;ka 10 dk iRrk@fCyLVj 8.11 13.06.2000

áebUlwfyu&,uih,p ¼40vkbZ;w@fefy½ 10 fefy dk ok;y 160.48 19.05.2006

áebUlwfyu&jsX;wyj ¼40vkbZ;w@fefy½ 10 fefy dk ok;y 160.26 19.05.2006

áebUlwfyu&30/70 ¼40vkbZ;w@fefy½ 10 fefy dk ok;y 160.46 19.05.2006

áebUlwfyu&50/50 ¼40vkbZ;w@fefy½ 10 fefy dk ok;y 160.42 19.05.2006

flUdsiksu 50 xksfy;ka 10 dk iRrk@fCyLVj 53.54 07.02.2006

flUdsiksu 100 xksfy;ka 10 dk iRrk@fCyLVj 61.43 07.02.2006

flUdsiksu 150 xksfy;ka 10 dk iRrk@fCyLVj 69.84 07.02.2006

,jksVkbM fMLd 8 dk fMLd 1.95 30.03.2005

288. lquht+ QkekZ izkbosV fyfeVsM lsyC;wlu QksVZ xksfy;ka 10 dk iRrk@fCyLVj 2.46 29.03.2006

289. lujkbZt baVjus’kuy ySc fy- xkjysDl flji 100 fefy dh cksry 11.82 05.10.2006

290. ljekmUV ysc VksYukdksEc vkW;UVesUV 5 xzke dh V~;wc 6.67 15.06.2005

VksYukdksEc vkW;UVesUV 10 xzke dh V~;wc 10.24 15.06.2005

291. lk;uksdse QkekZ izkbosV fyfeVsM LVkWi Mh xksfy;ka 10 dk iRrk 6.34 09.03.1998

dkWQdksYM xksfy;ka 10 dk iRrk 4.61 08.12.2000

fefu dksYM flji 60 fefy dh cksry@,e-di 10.94 08.12.2000

292. lk;uksdse QkekZL;wfVdYl fyfeVsM Msfjy xksfy;ka 10 dk iRrk@fCyLVj 3.24 05.10.2006

fefu dksYM 50 fefy dh cksry 8.44 05.10.2006

293. flfUFkdks QkWE;wZys’kUl fyfeVsM jsfLVQsu QksVZ xksfy;ka 10 dk iRrk@fCyLVj 14.80 29.03.2001

fiVjsfLVQsu&,e vkj xksfy;ka 10 dk ,,y_fCyLVj 7.30 29.03.2001

jsfLVQsu QksVZ xksfy;ka 10 dk iRrk@fCyLVj 14.49 20.09.2005

czkslfeu flji 100 fefy dh cksry 11.13 29.03.2006

czkslfeu QksVZ flji 60 fefy dh cksry 11.44 29.03.2006

294. fllesM bZch&333 xksfy;ka 10 dk iRrk@fCyLVj 27.60 19.05.2006

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

Page 310: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 291 -

295. VsCysVl bafM;k fyfeVsM ,EczksykbV & 2,l flji 100 fefy dh cksry 16.69 29.03.2006

296. VkVk QkekZ fyfeVsM dsoh xksfy;ka 3 xksfy;ka dk fdV 17.21 28.09.1998

Dohujksl Mh,l xksfy;ka ¼fyfir½ 100 dk IykfLVd cksry 52.38 25.07.2003

fjQSEihflu 450fexzk- dSilwy 50 dh cksry 192.32 15.06.2005

297. Vksjl QkekZ Dohuksfou flji 50 fefy dh cksry@,e-di 9.88 26.09.2000

298. Vksjl ysc foLdksQ&Mhih flji 100 fefy dh cksry 14.46 05.10.2006

299. fn ,axyks zQsap MªXl ,aM baMLVªht+ fyfeVsM csiysDl bUtsD’ku 2 fefy ,Ei;wy fCylVj iSd esa 3.19 29.03.2000

csiysDl bUtsD’ku 2 fefy ,Ei;wy 2.95 29.03.2000

csiysDl bUtsD’ku 10 fefy ok;y fCylVj iSd esa 9.14 29.03.2000

csiysDl bUtsD’ku 10 fefy ok;y 8.90 29.03.2000

csiysDl bUtsD’ku 3 fefy ,Ei;wy fCylVj iSd esa 5.49 29.03.2000

csiysDl bUtsD’ku 3 fefy ,Ei;wy 5.24 29.03.2000

dksfMysDl , xksfy;ka 10 dk iRrk@fCyLVj 9.16 29.03.2000

dksfMysDl Mh,l xksfy;ka 10 dk iRrk@fCyLVj 8.56 29.03.2000

dksfMysDl xksfy;ka 10 dk iRrk@fCyLVj 4.76 29.03.2000

300. Fksfel dsfedy fyfeVsM bZ&ekbflu 100 fexzk- xksfy;ka 10 dk iRrk@fCyLVj 9.33 07.02.2006

bZ&ekbflu 250 fexzk- xksfy;ka 10 dk iRrk@fCyLVj 22.46 07.02.2006

VsjhQkbfyu xksfy;ka 10 dk iRrk@fCyLVj 2.75 29.03.2006

bZ&ekbflu xksfy;ka 10 dk iRrk@fCyLVj 9.76 30.03.2005

bZ&ekbflu xksfy;ka 10 dk iRrk@fCyLVj 23.06 30.03.2005

bZ&ekbflu MªkbZ flji 30 fefy dh cksry@,e-di 11.68 30.03.2005

bZ&ekbflu MªkbZ flji@lLisUlu 60 fefy dh cksry@,e-di 18.78 30.03.2005

301. VksjsUV QkekZ áweu feDlVkMZ (50:50) 10 fefy dk¡p dk ok;y 152.56 19.05.2006

áweu ,DVªkfiM 40 10 fefy dk¡p dk ok;y 152.48 19.05.2006

áweu feDlVkMZ (30:70) 10 fefy dk¡p dk ok;y 152.56 19.05.2006

áweu bUlwysVkMZ 40vkbZ;w@fefy 10 fefy dk¡p dk ok;y 152.58 19.05.2006

áweu eksuksVkMZ 40vkbZ;w@fefy 10 fefy dk¡p dk ok;y 152.50 19.05.2006

302. VkWLd baVjus’kuy isuMksDl Iyl QksVZ&,e xksfy;ka 10 dk ,,y_fCyLVj 7.12 29.03.2001

303. VªkbZMksl ysc fyfeVsM tsMsDl ih fyfDoM 60 fefy dh cksry 11.42 13.06.2000

isMsDl flji 60 fefy dh cksry 11.86 11.03.1998

oksdsDlh Iyl fdV 1 fdV 12.90 15.06.2005

oksdsDlh ,QMh fdV 1 fdV 5.54 15.06.2005

oksdsDlh&2 xksfy;ka 10 dk iRrk 55.86 21.07.1998

304. VhVhds gsYFkds;j fyfeVsM usiksDyksDl osV bUtsD’ku 1 ok;y 32.48 29.03.2006

usiksDyksDl osV bUtsD’ku V~fou iSd ¼ok;y$,Ei;wy 37.35 20.10.2004

bUtsD’ku ds fy, ikuh½¼20fefy x 20fefy½

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

Page 311: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 292 -

305. V~foykbV esjdsUVkbYl VksDlksykbV flji 100 fefy dh cksry 13.52 29.03.2006

306. ;wlhch ¼vkbZ½ fyfeVsM tk;jVsd&Mh dSilwy 10 dk iRrk@fCyLVj 10.11 11.07.2006

307. vYVªk&fpjksu QkekZ fjuksfLM VscysV 10 dk iRrk@fCyLVj 5.368 05.10.2006

308. ;wfudse ysc bafM;k fyfeVsM tk;ulsV&Mh dSilwy 10 dk iRrk@fCyLVj 8.11 13.06.2000

fjMst+ xksfy;ka 10 dk iRrk 12.64 28.09.1998

VªkbZujft+d dSilwy 10 dk iRrk@fCyLVj 14.08 29.03.2006

309. ;wfudse@flMesd ysc fyfeVsM fjMst+ xksfy;ka 10 dk iRrk 12.70 24.12.2002

310. ;wfuekdZ osUVhjsDl xksfy;ka 10 dk iRrk@fCyLVj 1.84 29.03.2006

osUVhjsDl Iyl flji 100 fefy dh cksry 13.68 29.03.2006

esjhMeZ Øhe 5 xzke dh V~;wc 5.63 15.06.2005

dksthfeu ,,Q xksfy;ka 10 dk iRrk@fCyLVj 3.38 05.10.2006

311. ;wfud QkekZ ysc fyfeVsM bdksMsDl th Øhe 10 xzke dh V~;wc 11.16 11.03.1998

jsM;wflu , xksfy;ka 10 dk iRrk 6.88 11.03.1998

esVªksfty ,Q xksfy;ka 100 dh IykfLVd cksry 70.85 30.10.1998

esVªksfty xksfy;ka 200fexzk- 100 dh IykfLVd cksry 33.37 02.09.1998

esVªksfty xksfy;ka 200fexzk- 500 dh IykfLVd cksry 148.53 02.09.1998

esVªksfty xksfy;ka 200fexzk- 1000 dh IykfLVd cksry 286.28 02.09.1998

esVªksfty xksfy;ka 400fexzk- 100 dh IykfLVd cksry 60.75 02.09.1998

esVªksfty xksfy;ka 400fexzk- 500 dh IykfLVd cksry 278.29 02.09.1998

esVªksfty xksfy;ka 400fexzk- 1000 dh IykfLVd cksry 544.55 02.09.1998

312. ;wfu&lsuD;ks fyfeVsM csdksIyl dSilwy 10 dk iRrk@fCyLVj 10.18 10.08.1999

lsuosVksu dSilwy 10 dk iRrk@fCyLVj 10.29 10.08.1999

313. ;wuhlpZ izks&fjMst xksfy;ka 10 dk iRrk@fCyLVj 6.83 29.03.2006

314. ;wfuolZy esfMds;j fyfeVsM csVk Ldysjfc;ksu dSilwy 10 dk iRrk 13.59 28.09.1998

csVk Ldysjfc;ksu dSilwy 30 dk iRrk 40.80 28.09.1998

bZ dksM dSilwy 10 dk iRrk@fCyLVj 13.21 20.09.2005

bZ dksM xksfy;ka 10 dk iRrk@fCyLVj 10.77 20.09.2005

lsys’k dSilwy 15 dk iRrk 20.62 28.09.1998

315. ;w,loh fyfeVsM MsDlkoksu dSilwy 10 dk iRrk@fCyLVj 10.96 20.09.2005

316. oslQkWj ¼bafM;k½ czksfli&, flji 120 fefy dh cksry 18.42 29.03.2006

317. osadkVs’kojk ck;kslsUVªh ¼vkbZ½ fyfeVsM fcVksy fyfDoM 100 fefy dh 17.00 11.07.2006

IykfLVd fizy cksryfcVksy fyfDoM 100 fefy dk¡p dh cksry 14.65 11.07.2006

fcVksy fyfDoM 500 fefy dh 55.96 11.07.2006

IykfLVd fizy cksryfcVksy fyfDoM 500 fefy dk¡p dh cksry 53.27 11.07.2006

fcVksy fyfDoM 5 yhVj IykfLVd 485.37 11.07.2006

t+sjh dsu {kerk 5 yhVj

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

Page 312: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 293 -

318. osysl QkekZfl;wfVdy fyfeVsM fjoksDl dSilwy 10 dk iRrk@fCyLVj 5.90 29.03.2006

319. osUMj dksfjfefud & ,Dl flji 100 fefy dk¡p dh cksry 16.43 29.03.2006

320. fou esfMds;j lwFksDl dWQ QkWewZyk fyfDoM 60 fefy dh cksry 12.97 29.03.2006

lwFksDl xksfy;ka 10 dk ,,y_fCyLVj 3.16 05.10.2006

lwFksDl dWQ QkWewZyk 60 fefy dh cksry 10.72 05.10.2006

MsokscsV vkW;UVesUV 15 xzke V~;wc 1000.05 29.11.2006

MsokscsV vkW;UVesUV 15 xzke dh V~;wc 797.89 2063(E)30.11.2007

MsokscsV vkW;UVesUV 15 xzke dh V~;wc 795.26 2063(E)30.11.2007

321. oksdkMZ fyfeVsM zQh dsM lkW¶V dSilwy 15 dk iRrk 20.59 24.12.2002

izksDlhVsc xksfy;ka 10 dk ,,y_fCyLVj ihohlh@ 8.58 30.03.2005

ihohMhlh gksyksxzke lfgrusIlhoksu dSilwy 6 dk ,,y_fCyLVj ihohlh@ 12.05 04.01.2005

ihohMhlh gksyksxzke lfgrlkbDyksusIlhoksu dSilwy 6 dk ,,y_fCyLVj ihohlh@ 12.23 04.01.2005

ihohMhlh gksyksxzke lfgrLisLeks izksDlhoksu dSilwy 8 dk ,,y_fCyLVj ihohlh@ 10.90 04.01.2005

ihohMhlh gksyksxzke lfgrizksDlhoksu dSilwy 8 dk ,,y_fCyLVj ihohlh@ 10.76 04.01.2005

ihohMhlh gksyksxzke lfgrbcwizksDlhoksu dSilwy 6 dk ,,y_fCyLVj ihohlh@ 8.97 04.01.2005

ihohMhlh gksyksxzke lfgresMhjksu Øhe 5 xzke dh V~;wc 5.84 11.03.1998

vkj&áweu&bUlwfyu ¼jsX;wyj½ 10 fefy dk ok;y 286.58 29.03.2006

100 vkbZ;w@fefyvkj&áweu&bUlwfyu ¼,uih,p½ 10 fefy dk ok;y 287.14 29.03.2006

100 vkbZ;w@fefyvkj&áweu&bUlwfyu ckbZ&Qsfld (30-70%) 10 fefy dk ok;y 287.00 29.03.2006

vkj&áweu&bUlwfyu ckbZ&Qsfld (50-50%) 10 fefy dk ok;y 286.90 29.03.2006

ysUVs] áweu&bUlwfyu 100 vkbZ;w 10 fefy dk ok;y 286.50 29.03.2006

vkj&áweu&bUlwfyu ¼jsX;wyj½ 10 fefy dk ok;y 117.05 29.03.2006

40vkbZ;w@fefyvkj&áweu&bUlwfyu ¼jsX;wyj½ 3 fefy dk dkfVZt 118.37 29.03.2006

100vkbZ;w@fefyysUVs] áweu&bUlwfyu ftad 10 fefy dk ok;y 117.03 29.03.2006

40 vkbZ;w@fefyysUVs] áweu&bUlwfyu ftad 3 fefy dk dkfVZt 118.37 29.03.2006

100 vkbZ;w@fefyvkj&áweu&bUlwfyu ¼,uih,p½ 10 fefy dk ok;y 117.28 29.03.2006

40 vkbZ;w@fefyvkj&áweu&bUlwfyu ¼,uih,p½ 3 fefy dk dkfVZt 118.55 29.03.2006

100 vkbZ;w@fefy

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

Page 313: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;

- 294 -

vkj&áweu&bUlwfyu ckbZ&Qsfld (50-50%) 10 fefy dk ok;y 117.17 29.03.2006

vkj&áweu&bUlwfyu ckbZ&Qsfld (50-50%) 3 fefy dk dkfVZt 118.46 29.03.2006

vkj&áweu&bUlwfyu ckbZ&Qsfld (30-70%) 10 fefy dk ok;y 117.22 29.03.2006

vkj&áweu&bUlwfyu ckbZ&Qsfld (30-70%) 3 fefy dk dkfVZt 120.81 29.03.2006

vkj&áweu&bUlwfyu ¼jsX;wyj½ 3 fefy dk dkfVZt 227.24 29.03.2006

100vkbZ;w@fefy iSu lfgrvkj&áweu&bUlwfyu ftad 3 fefy dk dkfVZt 227.24 29.03.2006

100vkbZ;w@fefy iSu lfgrvkj&áweu&bUlwfyu ,uih,p 3 fefy dk dkfVZt 227.24 29.03.2006

100vkbZ;w@fefy iSu lfgrvkj&áweu&bUlwfyu ckbZ&Qsfld (50-50%) 3 fefy dk dkfVZt 227.24 29.03.2006

iSu lfgrvkj&áweu&bUlwfyu ckbZ&Qsfld (30-70%) 3 fefy dk dkfVZt 227.24 29.03.2006

iSu lfgrtsMsDl ih fyfDoM 60 fefy dh cksry 11.42 29.03.2000

fMdMsu 1 fefy bUtsD’ku 1 fefy dk ,Ei;wy 4.45 26.09.2000

fjQSEihflu 450 fexzk- xksfy;ka 50 dh cksry 234.10 20.11.2001

esMhjksu Øhe 5 xzke dh vuysd~MZ V~;wc 5.82 27.05.2003

322. ok;Fk ysMjys fyfeVsM bD;wtsfld xksfy;ka 10x10 dk thih@iRrk 76.80 09.03.1998

ysMjIysDl Vh fyfDoM 115 fefy dk¡p dh cksry 15.78 18.06.1999

¼foVkfeu ch dkWEiysDl fyfDoM½ysMjekbflu@fMesDykslkbdfyu 10 dk ,,y_iRrk 22.74 18.06.1999

,plh,y 150 dSilwyysMjekbflu@fMesDykslkbdfyu 10 dk ,,y_fCyLVj 21.71 18.06.1999

,plh,y 150 dSilwyysMjekbflu@fMesDykslkbdfyu 10 dk ,,y_iRrk 19.93 18.06.1999

,plh,y 150 xksfy;ka ¼fyfir½ysMjekbflu@fMesDykslkbdfyu 10 dk ,,y_fCyLVj 38.67 18.06.1999

,plh,y 150 xksfy;ka ¼fyfir½ohvkbZ&esxuk flji 200 fefy dk¡p dh cksry 23.93 19.11.2003

ysMjIysDl Vh fyfDoM 200 fefy dk¡p dh cksry 23.55 19.11.2003

,UMªkbu Mªksi 10 fefy dh cksry 8.51 29.03.2006

323. ;’k QkekZ izkbosV fyfeVsM osUVhQkbfyu xksfy;ka 10 dk iRrk@fCyLVj 2.97 29.03.2006

osUVhQkbfyu flji 100 fefy dh cksry 14.85 29.03.2006

osUVhQkbfyu flji 60 fefy dh cksry 10.35 29.03.2006

yEczhy xksfy;ka 10 dk ,,y_iRrk 6.63 29.03.2001

324. tsesV QkekZ osaVfli&Mh 100 fefy dh cksry 16.04 05.10.2006

325. tsuu gsYFk ds;j fyfeVsM bukslsV&Mh xksfy;ka 10 dk iRrk@fCyLVj 4.54 29.03.2006

326. tk;Ml dsfMyk fyikcksy xksfy;ka 20 fexzk- 10 dk ,,y_iRrk 1.89 09.07.2003

fyikcksy xksfy;ka 20 fexzk- 10 dk ,,y_fCyLVj 1.55 09.07.2003

yksjhfMu Mh xksfy;ka 10 dk ,,y_iRrk 11.93 11.07.2006

yksjhfMu Mh xksfy;ka 10 dk ,,y_fCyLVj 11.57 11.07.2006

Ø-la- dEiuh dk uke mRikn dk uke iSd vkdkj ewY; ¼#0½ vuqeksfnr frFkh

Page 314: Lkkj&laxzg - National Pharmaceutical Pricing Authority · 2020. 4. 15. · iii,e&(M) 1 escgkbM“ksfyu xksfy;ka 112 2-4 feFkk;yMksik xksfy;ka 112 5-133 eSV“ksfuMkt+ksy vkSj vU;